Citrus Sinensis ID: 041433
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 470 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.980 | 0.689 | 0.580 | 1e-153 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.991 | 0.690 | 0.548 | 1e-149 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.976 | 0.732 | 0.560 | 1e-146 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.991 | 0.689 | 0.518 | 1e-143 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.980 | 0.681 | 0.523 | 1e-138 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.978 | 0.698 | 0.528 | 1e-138 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.982 | 0.685 | 0.51 | 1e-137 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.985 | 0.557 | 0.498 | 1e-135 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.963 | 0.687 | 0.526 | 1e-133 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.968 | 0.683 | 0.510 | 1e-133 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 540 bits (1392), Expect = e-153, Method: Compositional matrix adjust.
Identities = 288/496 (58%), Positives = 353/496 (71%), Gaps = 35/496 (7%)
Query: 1 RGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLW 60
R +S+GF NAT GQ P+RV GLF CRGD +T C+ CV++A + L CP K+ TL+
Sbjct: 70 RNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLY 129
Query: 61 YAECLLRYSDQSFFSTMAAAPTVSLLNTENVTDQ--GRFNELVGTQMSQAVTQAVNNTKR 118
Y EC+LRYS+Q+ ST+ V L+NT NVT ++LV ++QA T A+N++K+
Sbjct: 130 YDECVLRYSNQNILSTLITTGGVILVNTRNVTSNQLDLLSDLVLPTLNQAATVALNSSKK 189
Query: 119 FATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVW 178
F TRK NFTA Q+ Y L QCTPDL+ C+RCL+ I ++P + + G R++ PSC
Sbjct: 190 FGTRKNNFTALQSFYGLVQCTPDLTRQDCSRCLQLVINQIP---TDRIGARIINPSCTSR 246
Query: 179 YELYPFYNESATAPPAPAPVLLSP---PPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVL 235
YE+Y FY ESA PP P P + +P PP S GK G S +IAIV PI+V +L
Sbjct: 247 YEIYAFYTESAVPPPPPPPSISTPPVSAPPRS-----GKDGNSKVLVIAIVVPIIVAVLL 301
Query: 236 FIVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFG 295
FI G+CFL R+A+K Y P A +D+TT +SLQ D+ I+ AT+ F NK+G GGFG
Sbjct: 302 FIAGYCFLTRRARKSY-YTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFG 360
Query: 296 EVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------- 348
EVYKG L G E+AVKRLSKSSGQG EFKNEVV+VAKLQHRNLVRLLGFCL+
Sbjct: 361 EVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLV 420
Query: 349 --------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394
DP K+GQLDW+RRYKIIG +ARGILYLH+DSRL IIHRDLK SNIL
Sbjct: 421 YEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNIL 480
Query: 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454
LDA+MNPKI+DFGMA+IFG+DQT+ NTSRI GTYGYM+PEYAMHGQ+S+KSDVYSFGVLV
Sbjct: 481 LDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLV 540
Query: 455 LEIITGKKNSSFYQTD 470
LEII+GKKNSSFYQTD
Sbjct: 541 LEIISGKKNSSFYQTD 556
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 527 bits (1357), Expect = e-149, Method: Compositional matrix adjust.
Identities = 271/494 (54%), Positives = 334/494 (67%), Gaps = 28/494 (5%)
Query: 4 GFSSGFFNATAGQ--DPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWY 61
++S F NA AG+ D NRVYG+FLCRGD + C+DCV +A LQ CP K +WY
Sbjct: 63 AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122
Query: 62 AECLLRYSDQSFFSTMAAAPTVSLLNTENVTDQ--GRFNELVGTQMSQAVTQAVNNTKRF 119
EC++RYS+QS M P V L N +N+T+ RFNE + + +A ++++F
Sbjct: 123 DECMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKF 182
Query: 120 ATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWY 179
AT KANFT QT+YSL QCTPDL++ C CLR+ I LP CC GGRV+ PSC+ Y
Sbjct: 183 ATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRY 242
Query: 180 ELYPFYNESATAPPAPAPVLLS-PPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIV 238
ELYPFYNE+ A P P + PP ++ + +GK + + AI P+ V VL +
Sbjct: 243 ELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSV-CVLLLG 301
Query: 239 GFCFL-RRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEV 297
C+L R+ K +A E ++ +T+ E+LQF F AI+ ATNKFS NKLG GGFGEV
Sbjct: 302 AMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEV 361
Query: 298 YKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--------- 348
YKG L +G +A+KRLS+ S QGAEEFKNEV VVAKLQHRNL +LLG+CL+
Sbjct: 362 YKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYE 421
Query: 349 ------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD 396
D EK+ LDW RRYKII IARGILYLH DSRL IIHRDLK SNILLD
Sbjct: 422 FVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLD 481
Query: 397 AEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 456
A+M+PKISDFGMA+IFGVDQTQ NT RI GTYGYM+PEYA+HG++SVKSDVYSFGVLVLE
Sbjct: 482 ADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLE 541
Query: 457 IITGKKNSSFYQTD 470
+ITGKKNSSFY+ D
Sbjct: 542 LITGKKNSSFYEED 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 518 bits (1335), Expect = e-146, Method: Compositional matrix adjust.
Identities = 276/492 (56%), Positives = 340/492 (69%), Gaps = 33/492 (6%)
Query: 5 FSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAEC 64
+S+GF +A AGQ P+RV GLFLCRGD + + C++CV ++ + L CP +++ +Y EC
Sbjct: 61 YSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDEC 120
Query: 65 LLRYSDQSFFSTMAAAPTVSLLNTENVTDQG---RFNELVGTQMSQAVTQAVNNTKRFAT 121
+LRYSDQ+ ST+A +N DQ RF + V + M+QA +A ++ ++F T
Sbjct: 121 MLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYT 180
Query: 122 RKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYEL 181
KA +TA QTLY L QCTPDL+ C CL +I +P+ K GGR L SCN YEL
Sbjct: 181 VKATWTALQTLYGLVQCTPDLTRQDCFSCLESSIKLMPLY---KTGGRTLYSSCNSRYEL 237
Query: 182 YPFYNESATAPPAPAPVLLSPPPPGSVTTSR--GKSGISSSTIIAIVAPIVVTAVLFIVG 239
+ FYNE+ T AP L P VT+ GKS S+ ++AIV I+V A+L I G
Sbjct: 238 FAFYNET-TVRTQQAPPPLPPSSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAG 296
Query: 240 FCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYK 299
+CF +R NA P + D D+TT ESLQ D+ I+ ATNKFS +NK+G GGFGEVYK
Sbjct: 297 YCFAKRVKNSSDNA-PAFDGD-DITT-ESLQLDYRMIRAATNKFSENNKIGQGGFGEVYK 353
Query: 300 GVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC------------- 346
G +G E+AVKRLSKSSGQG EFKNEVVVVAKLQHRNLVRLLGF
Sbjct: 354 GTFSNGTEVAVKRLSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYM 413
Query: 347 --------LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE 398
L DP KQ QLDW+RRYK+IG IARGILYLH+DSRL IIHRDLK SNILLDA+
Sbjct: 414 PNKSLDYFLFDPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 473
Query: 399 MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458
MNPK++DFG+A+IFG+DQTQ NTSRI GT+GYMAPEYA+HGQFSVKSDVYSFGVLVLEII
Sbjct: 474 MNPKLADFGLARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEII 533
Query: 459 TGKKNSSFYQTD 470
+GKKN+SFY+TD
Sbjct: 534 SGKKNNSFYETD 545
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 257/496 (51%), Positives = 334/496 (67%), Gaps = 30/496 (6%)
Query: 1 RGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLW 60
R +S+GF N AGQ P+RV GLFLCRGD + C +CV ++ L CP ++ +
Sbjct: 70 RNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFY 129
Query: 61 YAECLLRYSDQSFFSTMAAAPTVSLLNTENVT----DQGRFNELVGTQMSQAVTQAVNNT 116
Y EC+LRYS ++F ST+ + + N N++ + +F +LV + M+QA +A N++
Sbjct: 130 YEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSS 189
Query: 117 KRFATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARL-PICCSGKQGGRVLTPSC 175
++F+T K T+ QTLY L QCTPDL+ C CL +I R+ P+ + G R PSC
Sbjct: 190 RKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLF---RIGARQFWPSC 246
Query: 176 NVWYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVL 235
N YELY FYNE+A P+P P+ PP + + GKSG +S+ ++ + + V +
Sbjct: 247 NSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSG-NSTVLVVAIVVLAVLLFI 305
Query: 236 FIVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFG 295
+VG+CFL ++ KK ++ +D+ T +SLQ D+ I+ ATN F+ NK+G GGFG
Sbjct: 306 ALVGYCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFG 365
Query: 296 EVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------- 348
EVYKG +G+E+AVKRLSK+S QG EFK EVVVVAKLQHRNLVRLLGF L+
Sbjct: 366 EVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILV 425
Query: 349 --------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394
DP KQ QLDW +RY IIG IARGILYLH+DSRL IIHRDLK SNIL
Sbjct: 426 YEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNIL 485
Query: 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454
LDA++NPKI+DFGMA+IFG+DQTQ NTSRI GTYGYMAPEYAMHGQFS+KSDVYSFGVLV
Sbjct: 486 LDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLV 545
Query: 455 LEIITGKKNSSFYQTD 470
LEII+G+KNSSF ++D
Sbjct: 546 LEIISGRKNSSFDESD 561
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1267), Expect = e-138, Method: Compositional matrix adjust.
Identities = 265/506 (52%), Positives = 335/506 (66%), Gaps = 45/506 (8%)
Query: 1 RGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLW 60
R +S+GF ATAGQ P+RV GLFLCRGD + C++CV ++ + L CP +K+ L+
Sbjct: 63 RNASYSTGFQTATAGQAPDRVTGLFLCRGDVSQEVCRNCVAFSVKETLYWCPYNKEVVLY 122
Query: 61 YAECLLRYSDQSFFSTMAAAPTVSLLNTENVTDQGR-----FNELVGTQMSQAVTQAVNN 115
Y EC+LRYS ++ ST+ + LLN N++ + F +LV + ++ A +A N+
Sbjct: 123 YDECMLRYSHRNILSTVTYDGSAILLNGANISSSNQNQVDEFRDLVSSTLNLAAVEAANS 182
Query: 116 TKRFATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSC 175
+K+F TRK Q LY L QCTPDL+ C RCL+++I + + + GGR PSC
Sbjct: 183 SKKFYTRKV--ITPQPLYLLVQCTPDLTRQDCLRCLQKSIKGMSLY---RIGGRFFYPSC 237
Query: 176 NVWYELYPFYNESATAPPAPA----------PVLLSPPPPGSVTTSRGKSGISSSTIIAI 225
N YE Y FYNE+AT +P + L+PPP + + RGK G +SS II +
Sbjct: 238 NSRYENYSFYNETATRSSSPPSLPPRSTPQQQLKLAPPP---LISERGK-GRNSSVIIVV 293
Query: 226 VAPIVVTAVLFIVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFST 285
V PI+ +LF+ F +K + Y P +D+TT SLQFDF+AI+ ATNKF
Sbjct: 294 VVPIIALLLLFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCE 353
Query: 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
NKLG GGFGEVYKG+ PSG ++AVKRLSK+SGQG EF NEV+VVAKLQHRNLVRLLGF
Sbjct: 354 TNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGF 413
Query: 346 CLEDPEK---------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384
CLE E+ Q LDW+RRYKIIG IARGILYLH+DSRL II
Sbjct: 414 CLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTII 473
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVK 444
HRDLK NILL +MN KI+DFGMA+IFG+DQT+ NT RI GTYGYM+PEYAM+GQFS+K
Sbjct: 474 HRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMK 533
Query: 445 SDVYSFGVLVLEIITGKKNSSFYQTD 470
SDVYSFGVLVLEII+GKKNS+ YQ D
Sbjct: 534 SDVYSFGVLVLEIISGKKNSNVYQMD 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1263), Expect = e-138, Method: Compositional matrix adjust.
Identities = 262/496 (52%), Positives = 330/496 (66%), Gaps = 36/496 (7%)
Query: 1 RGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLW 60
R +S+GF NAT GQ +RV GLFLCRGD + C++CVT+A N CP ++ +
Sbjct: 59 RNASYSTGFQNATVGQALDRVTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFY 118
Query: 61 YAECLLRYSDQSFFSTMAAAPTVSLLNTEN----VTDQ-GRFNELVGTQMSQAVTQAVNN 115
Y EC+LRYS ++ ST +L N + +Q +F LV + M+Q +A +N
Sbjct: 119 YEECILRYSHKNILSTAITNEGEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADN 178
Query: 116 TKRFATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSC 175
++F+T K TA QT Y L QCTPDLS C CL +I R+P + G R PSC
Sbjct: 179 PRKFSTIKTELTALQTFYGLVQCTPDLSRQNCMNCLTSSINRMPF---SRIGARQFWPSC 235
Query: 176 NVWYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVL 235
N YELY FYNE+A P P L+ + KSG S+ ++A+V PI+V ++
Sbjct: 236 NSRYELYDFYNETAIGTPPPPLPPLA------SPSLSDKSGNSNVVVVAVVVPIIVAVLI 289
Query: 236 FIVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFG 295
FI G+CF ++AKK Y P + D D TT+ESLQ D+ AI+ ATN FS +NK+G GGFG
Sbjct: 290 FIAGYCFFAKRAKKTYGTTPALDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFG 348
Query: 296 EVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------- 348
+VYKG +G E+AVKRLSK+S QG EFKNEVVVVA L+H+NLVR+LGF +E
Sbjct: 349 DVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILV 408
Query: 349 --------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394
DP K+GQL W++RY IIG IARGILYLH+DSRL IIHRDLK SNIL
Sbjct: 409 YEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNIL 468
Query: 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454
LDA+MNPKI+DFGMA+IFG+DQTQ NTSRI GTYGYM+PEYAM GQFS+KSDVYSFGVLV
Sbjct: 469 LDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLV 528
Query: 455 LEIITGKKNSSFYQTD 470
LEII+G+KN+SF +TD
Sbjct: 529 LEIISGRKNNSFIETD 544
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-137, Method: Compositional matrix adjust.
Identities = 255/500 (51%), Positives = 326/500 (65%), Gaps = 38/500 (7%)
Query: 5 FSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAEC 64
+S+GF NATAG+ P+RV GLFLCRGD + C++CV ++ L LCP ++ +Y +C
Sbjct: 64 YSTGFQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQC 123
Query: 65 LLRYSDQSFFSTMAAAPTVSLLNTENVTDQGR-----FNELVGTQMSQAVTQAVNNTKRF 119
+LRYS ++ ST +L+ N + F V + MS+A +A N++++
Sbjct: 124 ILRYSHKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKL 183
Query: 120 ATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWY 179
T TA Q LY L QCTPDL+ + C CL+ +I + + + G R+ PSC Y
Sbjct: 184 YTVNTELTAYQNLYGLLQCTPDLTRADCLSCLQSSINGMAL---SRIGARLYWPSCTARY 240
Query: 180 ELYPFYNESATAPPAPAPVL--------LSPPPPGSVTTSRGKSGISSSTIIAIVAPIVV 231
ELYPFYNESA P P L PP S ++ GKSG +S+ ++ V + V
Sbjct: 241 ELYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPGKSG-NSTVLVVAVVVLAV 299
Query: 232 TAVLFIVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGA 291
+ +VG+CFL +K KK ++ +D+ T +SLQ D+ I+ ATN F+ NK+G
Sbjct: 300 LLFIALVGYCFLAKKKKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGR 359
Query: 292 GGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--- 348
GGFGEVYKG +G+E+AVKRLSK+S QG EFK EVVVVAKLQHRNLVRLLGF L+
Sbjct: 360 GGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEE 419
Query: 349 ------------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKV 390
DP KQ QLDW +RY IIG IARGILYLH+DSRL IIHRDLK
Sbjct: 420 RILVYEYMPNKSLDCLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKA 479
Query: 391 SNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSF 450
SNILLDA++NPKI+DFGMA+IFG+DQTQ NTSRI GTYGYMAPEYAMHGQFS+KSDVYSF
Sbjct: 480 SNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSF 539
Query: 451 GVLVLEIITGKKNSSFYQTD 470
GVLVLEII+G+KNSSF ++D
Sbjct: 540 GVLVLEIISGRKNSSFGESD 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 480 bits (1236), Expect = e-135, Method: Compositional matrix adjust.
Identities = 271/544 (49%), Positives = 338/544 (62%), Gaps = 81/544 (14%)
Query: 5 FSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAEC 64
+S+GF NATAG+ P+RV GLF CRGD + C+ CV++A CP+ K+ TL+Y +C
Sbjct: 176 YSTGFQNATAGKHPDRVTGLFNCRGDVSPEVCRRCVSFAVNETSTRCPIEKEVTLYYDQC 235
Query: 65 LLRYSDQSFFSTMAAAPTVSLLNTENVT--DQGRFNELVGTQMSQAVTQAVNNTKRFATR 122
LRYS+++ ST + L N++N+T +Q RF +LV T M+QA A N++KRF R
Sbjct: 236 TLRYSNRNILSTSNTNGGIILANSQNMTSNEQARFKDLVLTTMNQATIAAANSSKRFDAR 295
Query: 123 KANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELY 182
ANFT +LY+L QCT DL+ C CL++ I +LP + K GG+ + PSC+ +EL
Sbjct: 296 SANFTTLHSLYTLVQCTHDLTRQDCLSCLQQIINQLP---TEKIGGQFIVPSCSSRFELC 352
Query: 183 PFYNESATAPPAPA-----------------------PVL--LSPP---------PPG-- 206
FYN+SA P P P++ LS PG
Sbjct: 353 LFYNQSAVTTPQPQQNSAPPPPPTSIPSPRPGLNSRFPLITCLSAVSFEKFKDLLKPGFI 412
Query: 207 -----SVTTSRGKSGISSSTIIAIVAPIVVTAVLFIVGFCFLRRKAKKKYNAVPEGNAD- 260
V+ + GK G SS IIA+V I +LF+ F ++ KK A+P N
Sbjct: 413 CILIKIVSENTGKGGNSSVIIIAVVVSITALLLLFVAVFSVRTKRRKKMIGAIPLLNVKR 472
Query: 261 -------------NDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGRE 307
+ +TT SLQFDF+AI ATN F NKLG GGFGEVYKG PSG +
Sbjct: 473 KDTEVTEPLAENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQ 532
Query: 308 IAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK--------------- 352
+AVKRLSK+SGQG EF+NEVVVVAKLQHRNLVRLLG+CLE EK
Sbjct: 533 VAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYF 592
Query: 353 ------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
+ QLDW+RRYKIIG IARGILYLH+DSRL IIHRDLK NILLDA+MNPK++DF
Sbjct: 593 LFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADF 652
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466
GMA+IFG+DQT+ NT R+ GTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNSS
Sbjct: 653 GMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSL 712
Query: 467 YQTD 470
YQ D
Sbjct: 713 YQMD 716
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-133, Method: Compositional matrix adjust.
Identities = 262/498 (52%), Positives = 339/498 (68%), Gaps = 45/498 (9%)
Query: 5 FSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAEC 64
FS G + T GQ+ + V+GL+LC+GD + C++CV +A ++ CP K+ + Y EC
Sbjct: 64 FSLGSHSLTKGQNSDMVFGLYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDEC 123
Query: 65 LLRYSDQSFFSTMAAAPTVSLLNTENVT-DQG-RFNELVGTQMSQAVTQAVNNT-KRFAT 121
+L YSD++ F T+ NT+ VT DQ RFN+ V + M ++ +A N+T K+FA
Sbjct: 124 MLGYSDRNIFMDTVTTTTIITWNTQKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAV 183
Query: 122 RKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYEL 181
+K++F++SQ+LY+ QC PDL+S C CL+++I L K GGR L PSCN YE+
Sbjct: 184 KKSDFSSSQSLYASVQCIPDLTSEDCVMCLQQSIKELYF---NKVGGRFLVPSCNSRYEV 240
Query: 182 YPFYNES------ATAPPAPAPVLLSPP--PPGSVTTSRGKSGISSSTIIAIVAPIVVTA 233
YPFY E+ AP L+S P PPG +GK+ S+ IIAIV P+ ++
Sbjct: 241 YPFYKETIEGTVLPPPVSAPPLPLVSTPSFPPG-----KGKN--STVIIIAIVVPVAISV 293
Query: 234 VLFIVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGG 293
++ + F F K KK PE ++D+TT SLQFDF+ I+ AT+KFS NKLG GG
Sbjct: 294 LICVAVFSFHASKRAKKTYDTPE---EDDITTAGSLQFDFKVIEAATDKFSMCNKLGQGG 350
Query: 294 FGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK- 352
FG+VYKG LP+G ++AVKRLSK+SGQG +EFKNEVVVVAKLQHRNLV+LLGFCLE EK
Sbjct: 351 FGQVYKGTLPNGVQVAVKRLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKI 410
Query: 353 --------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSN 392
Q QLDW+ RYKIIG IARGILYLH+DSRL IIHRDLK N
Sbjct: 411 LVYEFVSNKSLDYFLFDSRMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGN 470
Query: 393 ILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGV 452
ILLDA+MNPK++DFGMA+IF +DQT+ +T R+ GTYGYM+PEYAM+GQFS+KSDVYSFGV
Sbjct: 471 ILLDADMNPKVADFGMARIFEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGV 530
Query: 453 LVLEIITGKKNSSFYQTD 470
LVLEII+G+KNSS YQ D
Sbjct: 531 LVLEIISGRKNSSLYQMD 548
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 476 bits (1224), Expect = e-133, Method: Compositional matrix adjust.
Identities = 260/509 (51%), Positives = 322/509 (63%), Gaps = 54/509 (10%)
Query: 1 RGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLW 60
R +S+GF NATAGQ P+ V GLFLCRG+ + C+ C+ + L CP ++ +
Sbjct: 59 RNASYSTGFQNATAGQAPDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFY 118
Query: 61 YAECLLRYSDQSFFSTMAAAPTVSLLNTEN--VTDQGRFNELVGTQMSQAVTQAVNNTKR 118
Y +C+LRYS+++ ST+ V + N N Q RF +LV M+ A +A + KR
Sbjct: 119 YEQCMLRYSNRNILSTLNTDGGVFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKR 178
Query: 119 FATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVW 178
FA K + A Q+LY + QCTPDL+ C CL+++I ++ K GGR PSC
Sbjct: 179 FAVTKFDLNALQSLYGMVQCTPDLTEQDCLDCLQQSINQVTY---DKIGGRTFLPSCTSR 235
Query: 179 YELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIV 238
Y+ Y FYNE P + SP P GK G SS +IA+V PI V +LF+
Sbjct: 236 YDNYEFYNEFNVGTPQDS----SPRP--------GKGGNSSVIVIAVVVPITVLFLLFVA 283
Query: 239 GFCFLRRKAKKKYNAVP----------------EGNADNDLTTLESLQFDFEAIKVATNK 282
F R K KK A+P E +D+TT SLQFDF+AI AT+
Sbjct: 284 FFSVRRAKRKKTIGAIPLFKVKRKETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDI 343
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
F NKLG GGFGEVYKG PSG ++AVKRLSK+SGQG +EF+NEVVVVAKLQHRNLV+L
Sbjct: 344 FLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKL 403
Query: 343 LGFCLE---------------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
LG+CLE DP QGQLDWSRRYKIIG IARGILYLH+DSRL
Sbjct: 404 LGYCLEGEEKILVYEFVPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRL 463
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
IIHRDLK NILLDA+MNPK++DFGMA+IFG+DQT+ NT R+ GTYGYMAPEYAM+G+F
Sbjct: 464 TIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKF 523
Query: 442 SVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
S+KSDVYSFGVLVLEI++G KNSS Q D
Sbjct: 524 SMKSDVYSFGVLVLEIVSGMKNSSLDQMD 552
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 470 | ||||||
| 255555033 | 579 | ATP binding protein, putative [Ricinus c | 0.980 | 0.796 | 0.641 | 1e-175 | |
| 255555035 | 671 | ATP binding protein, putative [Ricinus c | 0.980 | 0.687 | 0.617 | 1e-171 | |
| 255555031 | 674 | ATP binding protein, putative [Ricinus c | 0.985 | 0.686 | 0.608 | 1e-168 | |
| 359474715 | 684 | PREDICTED: cysteine-rich receptor-like p | 0.989 | 0.679 | 0.597 | 1e-167 | |
| 351721533 | 667 | cysteine-rich protein precursor [Glycine | 0.993 | 0.700 | 0.606 | 1e-164 | |
| 224113935 | 674 | predicted protein [Populus trichocarpa] | 0.985 | 0.686 | 0.6 | 1e-163 | |
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.972 | 0.689 | 0.600 | 1e-163 | |
| 356575777 | 671 | PREDICTED: cysteine-rich receptor-like p | 0.978 | 0.685 | 0.584 | 1e-163 | |
| 356575779 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.968 | 0.683 | 0.584 | 1e-161 | |
| 356575785 | 675 | PREDICTED: cysteine-rich receptor-like p | 0.968 | 0.674 | 0.571 | 1e-159 |
| >gi|255555033|ref|XP_002518554.1| ATP binding protein, putative [Ricinus communis] gi|223542399|gb|EEF43941.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1605), Expect = e-175, Method: Compositional matrix adjust.
Identities = 317/494 (64%), Positives = 374/494 (75%), Gaps = 33/494 (6%)
Query: 8 GFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECLLR 67
GFFN +GQ P+ VYG FLCRGD +T CQDCVT+AT+++++ CP+ K +WY ECLLR
Sbjct: 66 GFFNIPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDECLLR 125
Query: 68 YSDQSFFSTMAAAPTVSLLNTENVT--DQGRFNELVGTQMSQAVTQA---VNNTKRFATR 122
Y +QSF STM P + + NT+N++ DQ RFN L+ + M+ T+A + K+FA +
Sbjct: 126 YENQSFISTMDQTPGLYMWNTQNISTSDQVRFNALLASTMNNLATEASTAASGEKKFAVK 185
Query: 123 KANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELY 182
+ +FT+ Q LYSL QCTPDLS+S C +CL+ AI+ LP CC GKQGGRVL PSCN+ YE+Y
Sbjct: 186 EDSFTSFQKLYSLVQCTPDLSTSDCGQCLQTAISNLPSCCGGKQGGRVLYPSCNIRYEVY 245
Query: 183 PFYNESATAPPAPAPVLLSPPPP-----GSVTTSRGKSGISSSTIIAIVAPIVVTAVLFI 237
F+N +A PP PAP + P PP G+ GK GIS+ TIIAIVAPI V VLF
Sbjct: 246 LFFNATALEPPPPAPSPVVPLPPPPTGLGAKPQIEGKRGISTVTIIAIVAPIAVATVLFS 305
Query: 238 VGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEV 297
+G C+LRR+ KKY AV E +A N++TT ESLQ D I+VATNKFS DNKLG GGFGEV
Sbjct: 306 LGCCYLRRR--KKYEAVQEDDARNEITTAESLQIDLNTIEVATNKFSADNKLGEGGFGEV 363
Query: 298 YKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--------- 348
YKG LP+G+EIAVK+LS+SSGQGAEEFKNEV ++AKLQHRNLVRLLGFCLE
Sbjct: 364 YKGTLPNGQEIAVKKLSRSSGQGAEEFKNEVALLAKLQHRNLVRLLGFCLEGAEKILVYE 423
Query: 349 ------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD 396
DPEKQ QLDWSRRYKIIG IARGI+YLHEDSRLRIIHRDLK SNILLD
Sbjct: 424 FVPNKSLDYFLFDPEKQAQLDWSRRYKIIGGIARGIVYLHEDSRLRIIHRDLKASNILLD 483
Query: 397 AEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 456
MN KISDFGMA+IFGVDQTQGNTSRI GTYGYM+PEYAMHGQFSVKSD+YSFG+LVLE
Sbjct: 484 RNMNSKISDFGMARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDMYSFGILVLE 543
Query: 457 IITGKKNSSFYQTD 470
II+GKKNSSFYQ D
Sbjct: 544 IISGKKNSSFYQID 557
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 303/491 (61%), Positives = 367/491 (74%), Gaps = 30/491 (6%)
Query: 8 GFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECLLR 67
GFFN +GQ P+ VYG FLCRGD +T CQDCVT+AT+++++ CP+ K +WY +CLLR
Sbjct: 65 GFFNIPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDQCLLR 124
Query: 68 YSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQA---VNNTKRFATRKA 124
Y +QSF STM P V L NT++++D RF+ L+ T M T A + K+FA
Sbjct: 125 YENQSFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGEKKFAATDD 184
Query: 125 NFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELYPF 184
NFTA Q LYSL QCTPDLS+ C +CLR AI+ LP CC GK+G VL PSCNV YE+YPF
Sbjct: 185 NFTAFQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCNVRYEVYPF 244
Query: 185 YNESATAPPAPAPVLLSPPP----PGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIVGF 240
+N +A PP P+P PPP G+ + G+SGIS+ I+AIVAP+ + VLF + +
Sbjct: 245 FNATAVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIAIVLFSLAY 304
Query: 241 CFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKG 300
C+LRR+ +KKY+AV E N++TT+ESLQ D ++ ATNKFS DNKLG GGFGEVYKG
Sbjct: 305 CYLRRRPRKKYDAVQEDG--NEITTVESLQIDLNTVEAATNKFSADNKLGEGGFGEVYKG 362
Query: 301 VLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------------ 348
+LP+G+EIAVK+LS+SSGQGA+EFKNEVV++AKLQHRNLVRLLGFCLE
Sbjct: 363 ILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVS 422
Query: 349 ---------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399
DPEKQ QLDWS RYKI+G IARGILYLHEDS+LRI+HRDLKVSNILLD M
Sbjct: 423 NKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVSNILLDRNM 482
Query: 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
NPKISDFG A+IFGVDQ+QGNT RI GTYGYM+PEYAMHGQFSVKSD+YSFGVL+LEII
Sbjct: 483 NPKISDFGTARIFGVDQSQGNTKRIVGTYGYMSPEYAMHGQFSVKSDMYSFGVLILEIIC 542
Query: 460 GKKNSSFYQTD 470
GKKNSSFY+ D
Sbjct: 543 GKKNSSFYEID 553
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555031|ref|XP_002518553.1| ATP binding protein, putative [Ricinus communis] gi|223542398|gb|EEF43940.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1540), Expect = e-168, Method: Compositional matrix adjust.
Identities = 298/490 (60%), Positives = 371/490 (75%), Gaps = 27/490 (5%)
Query: 6 SSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECL 65
S GF+N ++GQDP+ +YGLFLCRGD +T CQDCVT+A++++++ CP+ K +WY ECL
Sbjct: 65 SIGFYNRSSGQDPDDIYGLFLCRGDVSTDVCQDCVTFASQDIVKRCPIEKVAIVWYDECL 124
Query: 66 LRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVN---NTKRFATR 122
L Y+++S +S MA P V LLN +N+ DQ RFN L+ T M + T+A + K+FA +
Sbjct: 125 LHYANRSLYSIMAQEPGVFLLNVQNIADQDRFNNLLATTMGKLATEAASAASGEKKFAVK 184
Query: 123 KANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELY 182
NFTA + LYSL QCTPDLS+ C RCL+ AI+ LP CC GK+GGRVL PSCN+ YE+Y
Sbjct: 185 IDNFTAFEKLYSLVQCTPDLSNLDCGRCLQAAISNLPTCCDGKRGGRVLYPSCNIRYEVY 244
Query: 183 PFYNESA---TAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIVG 239
PF+N +A P V P G+ ++GKSG+S+ TI+AIVAP+ V V F +G
Sbjct: 245 PFFNVTALEPPPPSPSPVVPPPPTSSGTRPETKGKSGLSTVTIVAIVAPVAVAIVFFFLG 304
Query: 240 FCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYK 299
C+LRR+A+KKY+A E +A N++TT+ESLQ D I+ AT+KFS NKLG GGFG+VYK
Sbjct: 305 CCYLRRRARKKYDAGQEDDAGNEITTVESLQIDLNTIEAATDKFSAANKLGEGGFGKVYK 364
Query: 300 GVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE----------- 348
G LP+G+EIAVK+LS+SS QGA+EFKNEVV++AKLQHRNLVRLLGFCLE
Sbjct: 365 GTLPNGQEIAVKKLSRSSVQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFV 424
Query: 349 ----------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE 398
D +KQGQLDW RYKI+G IARGI+YLHEDS+L+IIHRDLKVSNILLD +
Sbjct: 425 PNKSLDYFLFDAKKQGQLDWQTRYKIVGGIARGIIYLHEDSQLKIIHRDLKVSNILLDKD 484
Query: 399 MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458
MNPKISDFGMA+IFGVDQTQGNT+RI GTYGYM+PEYAMHG FSVKSD+YSFGVLVLEII
Sbjct: 485 MNPKISDFGMARIFGVDQTQGNTNRIVGTYGYMSPEYAMHGHFSVKSDIYSFGVLVLEII 544
Query: 459 TGKKNSSFYQ 468
GKKNSSFY+
Sbjct: 545 CGKKNSSFYE 554
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474715|ref|XP_003631522.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-167, Method: Compositional matrix adjust.
Identities = 300/502 (59%), Positives = 363/502 (72%), Gaps = 37/502 (7%)
Query: 6 SSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECL 65
++GF+NATAGQ P+ YGLFLCRGD C+DCV A+ +LQ C K+ +WY +C+
Sbjct: 65 ANGFYNATAGQSPDVAYGLFLCRGDVAIDDCRDCVANASAEILQQCSGVKKAIIWYDQCM 124
Query: 66 LRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVNNT--KRFATRK 123
L YS++S FS + P + L N +NVTD G FN+LV M+ T A N+ K+FAT++
Sbjct: 125 LHYSNRSIFSRVEENPMLQLYNLQNVTDPGPFNQLVVDTMNATATLAANDESGKKFATKE 184
Query: 124 ANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELYP 183
NFT SQTLYSL QCTPDLS + C++CL AI L +CCSGKQG R LTPSCN YELYP
Sbjct: 185 ENFTGSQTLYSLVQCTPDLSIADCSKCLEGAIGALSLCCSGKQGARTLTPSCNARYELYP 244
Query: 184 FYNESA-------TAPPAPAPVLLSPPPPGSVT------TSRGKSGISSSTIIAIVAPIV 230
FY A P A VLL PPP S ++ GK GISS TI+ IV P
Sbjct: 245 FYQLEAGPLAPALAPAPTSATVLLPPPPAPSSKSSATEPSTEGKGGISSKTIVIIVVPTF 304
Query: 231 VTAVLF-IVGFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKL 289
V+ V+F I+ +CF+RR AKK+Y+ + N + ++TT +SLQFD I+ ATN FS NK+
Sbjct: 305 VSVVIFSILCYCFIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNFSDHNKI 364
Query: 290 GAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE- 348
G GGFG VYKG L SG+EIA+KRLSKSSGQGA EFKNEVV+VAKLQHRNLVRLLGFCLE
Sbjct: 365 GEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEG 424
Query: 349 --------------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388
DP+K+GQLDWSRRYKIIG IARGILYLHEDSRLR+IHRDL
Sbjct: 425 EEKILVYEYVPNKSLDYFLFDPDKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHRDL 484
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVY 448
K SN+LLD +MNPKISDFGMA+IFGVDQTQGNT+R+ GTYGYM+PEYAMHG+FSVKSDVY
Sbjct: 485 KASNVLLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVKSDVY 544
Query: 449 SFGVLVLEIITGKKNSSFYQTD 470
SFGVLVLEII+GK+++ F+++D
Sbjct: 545 SFGVLVLEIISGKRSNCFHESD 566
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 301/496 (60%), Positives = 354/496 (71%), Gaps = 29/496 (5%)
Query: 3 NGFSSGFFNATAG---QDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTL 59
N ++ F N T G +RVYGLF+CRGD ++ CQ CV AT + C ++KQ +
Sbjct: 60 NATTTEFSNNTVGLGTSPSDRVYGLFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVI 119
Query: 60 WYAECLLRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVN---NT 116
WY EC +RYS++SFFST+ P V LLNT N+++Q F L+ +++ +A N
Sbjct: 120 WYDECTVRYSNRSFFSTVDTRPRVGLLNTANISNQDSFMRLLFQTINRTADEAANFSVGL 179
Query: 117 KRFATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCN 176
K++A +AN + Q+LY LAQCTPDLS C CL I LP CC GKQGGRVL PSCN
Sbjct: 180 KKYAVNQANISGFQSLYCLAQCTPDLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCN 239
Query: 177 VWYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLF 236
V YELYPFY +A+ P + PP + S G SGIS+ TI+AIV PI V ++F
Sbjct: 240 VRYELYPFYRVTASPPSSSPSPPTLLPP-PTSPISPGSSGISAGTIVAIVVPITVAVLIF 298
Query: 237 IVGFCFLRRKAKKKYN-AVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFG 295
IVG CFL R+A+KK +V EG D+ T++SLQFDF I+ ATNKFS DNKLG GGFG
Sbjct: 299 IVGICFLSRRARKKQQGSVKEGKTAYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFG 358
Query: 296 EVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------- 348
EVYKG L SG+ +AVKRLSKSSGQG EEFKNEVVVVAKLQHRNLVRLLGFCL+
Sbjct: 359 EVYKGTLSSGQVVAVKRLSKSSGQGGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILV 418
Query: 349 --------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394
DPEKQ +LDW RRYKIIG IARGI YLHEDSRLRIIHRDLK SNIL
Sbjct: 419 YEYVPNKSLDYILFDPEKQRELDWGRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNIL 478
Query: 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454
LD +MNPKISDFGMA+IFGVDQTQGNTSRI GTYGYMAPEYAMHG+FSVKSDVYSFGVL+
Sbjct: 479 LDGDMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLL 538
Query: 455 LEIITGKKNSSFYQTD 470
+EI++GKKNSSFYQTD
Sbjct: 539 MEILSGKKNSSFYQTD 554
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113935|ref|XP_002316618.1| predicted protein [Populus trichocarpa] gi|222859683|gb|EEE97230.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1501), Expect = e-163, Method: Compositional matrix adjust.
Identities = 294/490 (60%), Positives = 365/490 (74%), Gaps = 27/490 (5%)
Query: 7 SGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECLL 66
+GF+N +AGQDP+ VYG+FLCRGD + S C++CV +A ++VL+ CP+ K +W+ EC L
Sbjct: 65 NGFYNVSAGQDPDAVYGMFLCRGDVSNSVCRNCVNFAAKDVLERCPIEKVAMIWFDECEL 124
Query: 67 RYSDQSFFSTMAAAPTVSLLNTENVTDQ-GRFNELVGTQMSQAVTQAVN---NTKRFATR 122
RYS+++ FST+ T+ +++ NVT Q RFN+LV T ++ +A + K+FA +
Sbjct: 125 RYSNRNIFSTVDQDFTLFMMSPNNVTVQPDRFNQLVETTINDIAARAASAPSGAKKFAVQ 184
Query: 123 KANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELY 182
+ N+T Q LY+L QCTPDLS+ C+RCL+ AI++L CC+ KQGGRVL SCN YELY
Sbjct: 185 QVNYTGIQKLYTLVQCTPDLSTPDCSRCLQGAISKLGNCCNRKQGGRVLFASCNFRYELY 244
Query: 183 PFYNESATAPPAPAPVLLSPPPPGSV--TTSRGKSGISSSTIIAIVAPIVVTAVLFIVGF 240
FYN +A A AP P ++ PP + T +GK G+S+ IIAI+ P+ V+ VLF +GF
Sbjct: 245 EFYNATAAAEAAPPPPPVALSPPPTSGPETRKGKGGVSTVLIIAILIPVTVSLVLFCLGF 304
Query: 241 CFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKG 300
CFL R+AK N+ E + N++T +ESLQFD +I+ ATN FS DNKLG GGFGEVYKG
Sbjct: 305 CFLSRRAKSNKNSAQENDVGNEITNVESLQFDLSSIQDATNHFSADNKLGEGGFGEVYKG 364
Query: 301 VLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------------ 348
LP+G+ IAVKRLSK SGQGA EFKNEV++VAKLQHRNLVRLLGFCLE
Sbjct: 365 TLPNGQAIAVKRLSKGSGQGAAEFKNEVILVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
Query: 349 ---------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399
DPEKQG LDWS+RYKIIG IARGILYLHEDSRLR+IHRDLK SNILLD +M
Sbjct: 425 NKSLDYFVFDPEKQGLLDWSKRYKIIGGIARGILYLHEDSRLRVIHRDLKASNILLDGDM 484
Query: 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
N K+SDFGMA+IFGVDQTQG T+RI GTYGYM+PEYAMHGQFSVKSD YSFGVL+LEII+
Sbjct: 485 NAKVSDFGMARIFGVDQTQGCTNRIVGTYGYMSPEYAMHGQFSVKSDAYSFGVLILEIIS 544
Query: 460 GKKNSSFYQT 469
GKKNSSFYQT
Sbjct: 545 GKKNSSFYQT 554
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1500), Expect = e-163, Method: Compositional matrix adjust.
Identities = 296/493 (60%), Positives = 358/493 (72%), Gaps = 36/493 (7%)
Query: 7 SGFFNATAGQDPNRV-YGLFLCRGDQTTSGCQDCV-TYATRNVLQLCPVSKQTTLWYAEC 64
+GF+N TAG+ P V YGLFLCRGD T+ CQDCV T V Q C KQ +WY EC
Sbjct: 60 TGFYNVTAGRTPPDVAYGLFLCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDEC 119
Query: 65 LLRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVNNT--KRFATR 122
+LRYS++SFFS ++ +P VS+ NT+N+T+ +FN+++G + TQAVN+ K+FAT+
Sbjct: 120 MLRYSNESFFSQVSESPRVSMWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATK 179
Query: 123 KANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELY 182
+ NFT Q +YSL QCTPDLS C+RCL IA LP CC GKQG RVL PSCNV YELY
Sbjct: 180 EENFTGFQRVYSLVQCTPDLSPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELY 239
Query: 183 PFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLF-IVGFC 241
PFY A P P S ++ GK GISS TI+ IV P V+ V+F I+ +C
Sbjct: 240 PFYQSVAAPPSPPPARP-------SEPSTEGKGGISSKTIVIIVVPTFVSVVIFSILCYC 292
Query: 242 FLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV 301
F+RR AKK+Y+ + N + ++TT +SLQFD I+ ATN FS NK+G GGFG VYKG
Sbjct: 293 FIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNFSDHNKIGEGGFGAVYKGT 352
Query: 302 LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------------- 348
L SG+EIA+KRLSKSSGQGA EFKNEVV+VAKLQHRNLVRLLGFCLE
Sbjct: 353 LSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPN 412
Query: 349 -----------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA 397
P K+GQLDWSRRYKIIG IARGILYLHEDSRLR+IHRDLK SN+LLD
Sbjct: 413 KSLDYFLFGLAQPTKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDG 472
Query: 398 EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 457
+MNPKISDFGMA+IFGVDQTQGNT+R+ GTYGYM+PEYAMHG+FSVKSDVYSFGVLVLEI
Sbjct: 473 DMNPKISDFGMARIFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVKSDVYSFGVLVLEI 532
Query: 458 ITGKKNSSFYQTD 470
I+GK+++ F+++D
Sbjct: 533 ISGKRSNCFHESD 545
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 285/488 (58%), Positives = 354/488 (72%), Gaps = 28/488 (5%)
Query: 9 FFNAT-AGQDP-NRVYGLFLCRGDQTTSGCQDCVTYATRNV---LQLCPVSKQTTLWYAE 63
F+N+T AG +P + VYGLF+CRGD C CV AT+ + LQ C +SKQ +WY E
Sbjct: 69 FYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQ-CSLSKQAVIWYDE 127
Query: 64 CLLRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVNNTKRFATRK 123
C++RYS++SFFST+ P + LLN+ N+++Q F L+ M++ +A K++AT++
Sbjct: 128 CMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEAAIGAKKYATKQ 187
Query: 124 ANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELYP 183
AN + QTLY L QCTPDLS+ C CL +AI LP CC GKQGGR+L PSCNV Y+LYP
Sbjct: 188 ANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILNPSCNVRYDLYP 247
Query: 184 FYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIVGFCFL 243
FY + +APPA P S G++ S G S IS TI+AIV PI V +LFIVG L
Sbjct: 248 FYRTNVSAPPASVPPTDSSNSGGNII-SYGGSEISPGTIVAIVVPITVAVLLFIVGIWLL 306
Query: 244 RRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP 303
++A KK N+ + + +++ +ESL+FDF I+ AT+KFS NKLG GGFGEVYKG+LP
Sbjct: 307 SKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLLP 366
Query: 304 SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--------------- 348
SG+E+AVKRLSK+SGQG EFKNEV VVAKLQH+NLVRLLGFCLE
Sbjct: 367 SGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKS 426
Query: 349 ------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
DPEKQ LDW+RRYKI+ IARGI YLHEDSRL+IIHRDLK SN+LLD +MNPK
Sbjct: 427 LDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPK 486
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
ISDFGMA+IFGVDQTQ NT+RI GTYGYM+PEYAMHG++S KSDVYSFGVL+LEII+GK+
Sbjct: 487 ISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEIISGKR 546
Query: 463 NSSFYQTD 470
NSSFY+TD
Sbjct: 547 NSSFYETD 554
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575779|ref|XP_003556014.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 285/488 (58%), Positives = 353/488 (72%), Gaps = 33/488 (6%)
Query: 9 FFNAT-AGQDP-NRVYGLFLCRGDQTTSGCQDCVTYATRNV---LQLCPVSKQTTLWYAE 63
F+N+T AG +P + VYGLF+CRGD C CV AT+ + LQ C +SKQ +WY E
Sbjct: 69 FYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQ-CSLSKQAVIWYDE 127
Query: 64 CLLRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVNNTKRFATRK 123
C++RYS++SFFST+ P + LLN+ N+++Q F L+ M++ +A K++AT++
Sbjct: 128 CMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEAAIGAKKYATKQ 187
Query: 124 ANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELYP 183
AN + QTLY L QCTPDLS+ C CL +AI LP CC GKQGGR+L PSCNV Y+LYP
Sbjct: 188 ANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILNPSCNVRYDLYP 247
Query: 184 FYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIVGFCFL 243
FY + +APPA S PP S + G S IS TI+AIV PI V +LFIVG L
Sbjct: 248 FYRTNVSAPPA------SVPPTDSSNSGGGGSEISPGTIVAIVVPITVAVLLFIVGIWLL 301
Query: 244 RRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP 303
++A KK N+ + + +++ +ESL+FDF I+ AT+KFS NKLG GGFGEVYKG+LP
Sbjct: 302 SKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLLP 361
Query: 304 SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--------------- 348
SG+E+AVKRLSK+SGQG EFKNEV VVAKLQH+NLVRLLGFCLE
Sbjct: 362 SGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKS 421
Query: 349 ------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
DPEKQ LDW+RRYKI+ IARGI YLHEDSRL+IIHRDLK SN+LLD +MNPK
Sbjct: 422 LDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPK 481
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
ISDFGMA+IFGVDQTQ NT+RI GTYGYM+PEYAMHG++S KSDVYSFGVL+LEII+GK+
Sbjct: 482 ISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEIISGKR 541
Query: 463 NSSFYQTD 470
NSSFY+TD
Sbjct: 542 NSSFYETD 549
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575785|ref|XP_003556017.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 5 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1463), Expect = e-159, Method: Compositional matrix adjust.
Identities = 284/497 (57%), Positives = 353/497 (71%), Gaps = 42/497 (8%)
Query: 9 FFNAT-AGQDP-NRVYGLFLCRGDQTTSGCQDCVTYATRNV---LQLCPVSKQTTLWYAE 63
F+N+T AG +P + VYGLF+CRGD C CV AT+ + LQ C +SKQ +WY E
Sbjct: 69 FYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQ-CSLSKQAVIWYDE 127
Query: 64 CLLRYSDQSFFSTMAAAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVNNTKRFATRK 123
C++RYS++SFFST+ P + LLN+ N+++Q F L+ M++ +A K++AT++
Sbjct: 128 CMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEAAIGAKKYATKQ 187
Query: 124 ANFTASQTLYSLAQCTPDLSSSACNRCLREAIARLPICCSGKQGGRVLTPSCNVWYELYP 183
AN + QTLY L QCTPDLS+ C CL +AI LP CC GKQGGR+L PSCNV Y+LYP
Sbjct: 188 ANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILNPSCNVRYDLYP 247
Query: 184 FYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIVVTAVLFIVGFCFL 243
FY + +APPA S PP S + G S IS TI+AIV PI V +LFIVG L
Sbjct: 248 FYRTNVSAPPA------SVPPTDSSNSGGGGSEISPGTIVAIVVPITVAVLLFIVGIWLL 301
Query: 244 RRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP 303
++A KK N+ + + +++ +ESL+FDF I+ AT+KFS NKLG GGFGEVYKG+LP
Sbjct: 302 SKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLLP 361
Query: 304 SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--------------- 348
SG+E+AVKRLSK+SGQG EFKNEV VVAKLQH+NLVRLLGFCLE
Sbjct: 362 SGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKS 421
Query: 349 ---------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393
+PEKQ LDW+RRYKI+ IARGI YLHEDSRL+IIHRDLK SN+
Sbjct: 422 LDYILFGRFIFSEFFNPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNV 481
Query: 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVL 453
LLD +MNPKISDFGMA+IFGVDQTQ NT+RI GTYGYM+PEYAMHG++S KSDVYSFGVL
Sbjct: 482 LLDGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVL 541
Query: 454 VLEIITGKKNSSFYQTD 470
+LEII+GK+NSSFY+TD
Sbjct: 542 ILEIISGKRNSSFYETD 558
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 470 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.272 | 0.191 | 0.820 | 8.1e-140 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.272 | 0.189 | 0.789 | 1.2e-134 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.272 | 0.189 | 0.734 | 5.7e-125 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.263 | 0.192 | 0.75 | 6.5e-120 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.272 | 0.191 | 0.796 | 6.5e-118 | |
| TAIR|locus:2123056 | 656 | CRK32 "cysteine-rich RLK (RECE | 0.263 | 0.189 | 0.733 | 3.9e-106 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.272 | 0.192 | 0.695 | 1.2e-104 | |
| TAIR|locus:2121711 | 660 | CRK22 "cysteine-rich RLK (RECE | 0.280 | 0.2 | 0.689 | 9.1e-103 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.248 | 0.172 | 0.756 | 1.6e-102 | |
| TAIR|locus:2123071 | 636 | CRK33 "cysteine-rich RLK (RECE | 0.263 | 0.194 | 0.725 | 5.5e-95 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 8.1e-140, Sum P(3) = 8.1e-140
Identities = 105/128 (82%), Positives = 119/128 (92%)
Query: 343 LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
L + L DP K+GQLDW+RRYKIIG +ARGILYLH+DSRL IIHRDLK SNILLDA+MNPK
Sbjct: 429 LDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPK 488
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
I+DFGMA+IFG+DQT+ NTSRI GTYGYM+PEYAMHGQ+S+KSDVYSFGVLVLEII+GKK
Sbjct: 489 IADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKK 548
Query: 463 NSSFYQTD 470
NSSFYQTD
Sbjct: 549 NSSFYQTD 556
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 1.2e-134, Sum P(3) = 1.2e-134
Identities = 101/128 (78%), Positives = 112/128 (87%)
Query: 343 LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
L + L D EK+ LDW RRYKII IARGILYLH DSRL IIHRDLK SNILLDA+M+PK
Sbjct: 428 LDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPK 487
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
ISDFGMA+IFGVDQTQ NT RI GTYGYM+PEYA+HG++SVKSDVYSFGVLVLE+ITGKK
Sbjct: 488 ISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKK 547
Query: 463 NSSFYQTD 470
NSSFY+ D
Sbjct: 548 NSSFYEED 555
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 5.7e-125, Sum P(3) = 5.7e-125
Identities = 94/128 (73%), Positives = 108/128 (84%)
Query: 343 LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
L + + D Q LDW+RRYKIIG IARGILYLH+DSRL IIHRDLK NILL +MN K
Sbjct: 432 LDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAK 491
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
I+DFGMA+IFG+DQT+ NT RI GTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+GKK
Sbjct: 492 IADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKK 551
Query: 463 NSSFYQTD 470
NS+ YQ D
Sbjct: 552 NSNVYQMD 559
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 6.5e-120, Sum P(3) = 6.5e-120
Identities = 93/124 (75%), Positives = 107/124 (86%)
Query: 347 LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
L D + +LDW+RRYKIIG IARGILYLH+DSRL IIHRDLK NILLD +MNPKI+DF
Sbjct: 411 LFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADF 470
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466
GMA+IFG+DQT+ T R+ GTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+G KNSS
Sbjct: 471 GMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSL 530
Query: 467 YQTD 470
YQ D
Sbjct: 531 YQMD 534
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 6.5e-118, Sum P(3) = 6.5e-118
Identities = 102/128 (79%), Positives = 114/128 (89%)
Query: 343 LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
L + L DP KQG+LDW+RRY IIG IARGILYLH+DSRL IIHRDLK SNILLDA+MNPK
Sbjct: 426 LDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPK 485
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
I+DFGMA+IFGVDQ+Q NT RIAGT+GYM+PEYAM G FS+KSDVYSFGVLVLEII+GKK
Sbjct: 486 IADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKK 545
Query: 463 NSSFYQTD 470
NSSFY D
Sbjct: 546 NSSFYNID 553
|
|
| TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 3.9e-106, Sum P(3) = 3.9e-106
Identities = 91/124 (73%), Positives = 104/124 (83%)
Query: 347 LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
L DP K+ QLDW RRY IIG I RG+LYLH+DSRL IIHRD+K SNILLDA+MNPKI+DF
Sbjct: 414 LLDPTKKSQLDWKRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADF 473
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466
GMA+ F VDQT+ NT R+ GT+GYM PEY HGQFS KSDVYSFGVL+LEI+ GKKNSSF
Sbjct: 474 GMARNFRVDQTEDNTRRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSF 533
Query: 467 YQTD 470
Y+ D
Sbjct: 534 YKID 537
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 1.2e-104, Sum P(3) = 1.2e-104
Identities = 89/128 (69%), Positives = 105/128 (82%)
Query: 343 LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
L + L DP+ + QLDW RRY IIG + RG+LYLH+DSRL IIHRD+K SNILLDA+MNPK
Sbjct: 420 LDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPK 479
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
I+DFGMA+ F VDQT+ T R+ GT+GYM PEY HGQFS KSDVYSFGVL+LEI+ GKK
Sbjct: 480 IADFGMARNFRVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKK 539
Query: 463 NSSFYQTD 470
NSSF+Q D
Sbjct: 540 NSSFFQMD 547
|
|
| TAIR|locus:2121711 CRK22 "cysteine-rich RLK (RECEPTOR-like protein kinase) 22" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 9.1e-103, Sum P(3) = 9.1e-103
Identities = 91/132 (68%), Positives = 116/132 (87%)
Query: 339 LVRLLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE 398
L + L + L DPEKQG+LDW+RRYKIIG IA+GIL+LH+D +L II+RD K SNILLDA+
Sbjct: 430 LNKSLDYFLFDPEKQGELDWTRRYKIIGGIAQGILHLHQDPQLTIIYRDFKASNILLDAD 489
Query: 399 MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458
MNPKISDFGMA +FG+++++GNT+ IA T+ YM+PEYA+HG+FS+KSDVYSFG+L+LEII
Sbjct: 490 MNPKISDFGMATVFGMEESRGNTNWIAETFVYMSPEYAVHGKFSMKSDVYSFGILILEII 549
Query: 459 TGKKNSSFYQTD 470
+GKKNSS YQ D
Sbjct: 550 SGKKNSSLYQND 561
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 1.6e-102, Sum P(3) = 1.6e-102
Identities = 90/119 (75%), Positives = 103/119 (86%)
Query: 349 DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408
D EK+ LDW RYK+IG IARG+LYLHEDSR RIIHRDLK SNILLD EMNPKI+DFG+
Sbjct: 444 DTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGL 503
Query: 409 AKIFGVDQTQGN--TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465
AK+F QT + TSRIAGTYGYMAPEYAMHGQFSVK+DV+SFGVLV+EIITGK+N++
Sbjct: 504 AKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNN 562
|
|
| TAIR|locus:2123071 CRK33 "cysteine-rich RLK (RECEPTOR-like protein kinase) 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 5.5e-95, Sum P(3) = 5.5e-95
Identities = 90/124 (72%), Positives = 110/124 (88%)
Query: 347 LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
L +P K+GQLDW++RYKII ARGILYLH DS L+IIHRDLK SNILLDAEM PK++DF
Sbjct: 406 LFEPTKKGQLDWAKRYKIIVGTARGILYLHHDSPLKIIHRDLKASNILLDAEMEPKVADF 465
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466
GMA+IF VDQ++ +T R+ GT+GY++PEY MHGQFSVKSDVYSFGVLVLEII+GK+NS+F
Sbjct: 466 GMARIFRVDQSRADTRRVVGTHGYISPEYLMHGQFSVKSDVYSFGVLVLEIISGKRNSNF 525
Query: 467 YQTD 470
++TD
Sbjct: 526 HETD 529
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GYA4 | CRK10_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5806 | 0.9808 | 0.6890 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 470 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-24 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-22 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 8e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-20 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 6e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 67/192 (34%), Positives = 100/192 (52%), Gaps = 28/192 (14%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346
LG GGFG VY +G+++A+K + K S EE E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 347 LEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRD 387
++ E +G+L +I+ I G+ YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 388 LKVSNILLDA-EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKS 445
LK NILLD+ K++DFG++K+ D++ T GT YMAPE + G +S KS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKS 175
Query: 446 DVYSFGVLVLEI 457
D++S GV++ E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 73/202 (36%), Positives = 97/202 (48%), Gaps = 35/202 (17%)
Query: 286 DNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNL 339
KLG G FGEVYKG L E+AVK L + + + EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 340 VRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
V+LLG C E+ + + +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT---YGYMAPEYAM 437
IHRDL N L+ + KISDFG+++ D + R G +MAPE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 438 HGQFSVKSDVYSFGVLVLEIIT 459
G+F+ KSDV+SFGVL+ EI T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 76/201 (37%), Positives = 100/201 (49%), Gaps = 32/201 (15%)
Query: 286 DNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNL 339
KLG G FGEVYKG L E+AVK L + S Q EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 340 VRLLGFCLEDPE--------KQGQLD---WSRRYKIIGL---------IARGILYLHEDS 379
V+LLG C E+ G L R K + L IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
IHRDL N L+ + KISDFG+++ ++ D + ++ +MAPE
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178
Query: 439 GQFSVKSDVYSFGVLVLEIIT 459
G+F+ KSDV+SFGVL+ EI T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 69/196 (35%), Positives = 95/196 (48%), Gaps = 27/196 (13%)
Query: 288 KLGAGGFGEVYKGVLPS-GREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLG 344
KLG+G FG VYK G+ +AVK L K S + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 345 FCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
+ + G L KI I RG+ YLH IIHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS---NGIIHR 122
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE-YAMHGQFSVKS 445
DLK NILLD KI+DFG+AK + + + GT YMAPE + K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 446 DVYSFGVLVLEIITGK 461
DV+S GV++ E++TGK
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 5e-44
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 26/199 (13%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLV 340
+ KLG G FG+VY +G+ +A+K + K + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 341 RLLGFCLEDPE--------KQGQL-DWSRRYKIIGL---------IARGILYLHEDSRLR 382
RL ++ + + G L D ++ + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS---KG 117
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
I+HRDLK NILLD + + K++DFG+A+ + GT YMAPE + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 443 VKSDVYSFGVLVLEIITGK 461
D++S GV++ E++TGK
Sbjct: 175 KAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 5e-42
Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 43/217 (19%)
Query: 288 KLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLVR 341
KLG G FGEVYKG L + ++AVK L + + + EEF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 342 LLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
LLG C + + +L ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KN 122
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVD---QTQGNTSRIAGTYGYMAPEYAMH 438
+HRDL N L+ + KISDFG+++ I+ D + G I +MAPE
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLKD 178
Query: 439 GQFSVKSDVYSFGVLVLEIIT-------GKKNSSFYQ 468
G+F+ KSDV+SFGVL+ EI T G N +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 215
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 69/207 (33%), Positives = 95/207 (45%), Gaps = 39/207 (18%)
Query: 287 NKLGAGGFGEVYKGVL----PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLVR 341
KLG G FGEVYKG L E+AVK L + + + ++F E V+ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 342 LLGFCLED---------------------------PEKQGQLDWSRRYKIIGLIARGILY 374
LLG C E+ ++ L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT--YGYMA 432
L + +HRDL N L+ ++ KISDFG+++ V + G +MA
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD--VYDDDYYRKKTGGKLPIRWMA 175
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIIT 459
PE G F+ KSDV+SFGVL+ EI T
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 28/199 (14%)
Query: 287 NKLGAGGFGEVYKGVLP-SGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
LG G FG VY + +G +AVK LS S + E + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 344 GFCLEDPEK----------QGQLDWSRRYKIIGL-----------IARGILYLHEDSRLR 382
G ++ + G L S K L I G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNG 121
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
I+HRD+K +NIL+D++ K++DFG AK G +T T + GT +MAPE ++
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 443 VKSDVYSFGVLVLEIITGK 461
+D++S G V+E+ TGK
Sbjct: 182 RAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 52/213 (24%)
Query: 282 KFSTDNKLGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
F K+G GGFGEVYK +G+E+A+K + S + E+ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 341 RLLG-------------FC----LED---------PEKQGQLDWSRRYKIIGLIARGIL- 373
+ G FC L+D E Q I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----------IAYVCKELLK 109
Query: 374 ---YLHEDSRLRIIHRDLKVSNILL--DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY 428
YLH IIHRD+K +NILL D E+ K+ DFG++ + + GT
Sbjct: 110 GLEYLHS---NGIIHRDIKAANILLTSDGEV--KLIDFGLSAQL---SDTKARNTMVGTP 161
Query: 429 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+MAPE + K+D++S G+ +E+ GK
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 27/198 (13%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
F+ + KLG+G FGEV++G+ + +A+K L ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 343 LGFC---------------------LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
C L PE Q L + + +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
IHRDL NIL+ ++ K++DFG+A++ D + +I Y + APE A HG F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTF 181
Query: 442 SVKSDVYSFGVLVLEIIT 459
S KSDV+SFG+L+ E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 40/205 (19%)
Query: 289 LGAGGFGEVYKGV-LPSGR----EIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLVRL 342
LG+G FG VYKGV +P G +A+K L + + A +E +E V+A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 343 LGFC----------------LEDPEKQGQ--------LDWSRRYKIIGLIARGILYLHED 378
LG C L D + + L+W + IA+G+ YL E
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
R++HRDL N+L+ + KI+DFG+AK+ VD+ + + +MA E +H
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 439 GQFSVKSDVYSFGVLVLEIIT-GKK 462
++ KSDV+S+GV V E++T G K
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 68/197 (34%), Positives = 99/197 (50%), Gaps = 28/197 (14%)
Query: 287 NKLGAGGFGEVYKGV--LPSGREI--AVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG V KGV + SG+E+ AVK L + G +EF E V+A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 342 LLGFCLEDP-------EKQGQL-DWSRRYKIIGL---------IARGILYLHEDSRLRII 384
L+G C +P G L + ++ + I + +A G+ YL +
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFV 117
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFS 442
HRDL N+LL KISDFGM++ G + AG + + APE +G+FS
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINYGKFS 176
Query: 443 VKSDVYSFGVLVLEIIT 459
KSDV+S+GV + E +
Sbjct: 177 SKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 71/202 (35%), Positives = 102/202 (50%), Gaps = 31/202 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ KLGAG FGEV+ G ++AVK L K E F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 341 RLLGFC-LEDP--------EKQGQLDW-----SRRYKIIGL------IARGILYLHEDSR 380
+L C E+P K LD+ ++ ++ L IA G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---S 121
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTSRIAGTYGYMAPEYAM 437
IHRDL NIL+ + KI+DFG+A++ D+ +G I T APE A
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAAN 177
Query: 438 HGQFSVKSDVYSFGVLVLEIIT 459
+G+F++KSDV+SFG+L+ EI+T
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 41/210 (19%)
Query: 289 LGAGGFGEVY----KGVLPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVR 341
LG G FG+V K +G+ A+K L K + E E +++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 342 LLGFCLEDPEK---------QGQL------------DWSRRYKIIGLIARGILYLHEDSR 380
L + + EK G+L + +R Y I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLH---S 111
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ 440
L II+RDLK NILLDA+ + K++DFG+AK + ++ NT GT Y+APE +
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKG 169
Query: 441 FSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
+ D +S GVL+ E++TGK FY D
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK--PPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 67/191 (35%), Positives = 96/191 (50%), Gaps = 34/191 (17%)
Query: 289 LGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348
+G G FG+V G G+++AVK L K A+ F E V+ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 349 DP---------EKQGQLDW--SRRYKIIGL---------IARGILYLHEDSRLRIIHRDL 388
K +D+ SR +I L + G+ YL E +HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVKSD 446
N+L+ ++ K+SDFG+AK + +QG S G + APE +FS KSD
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKKFSTKSD 181
Query: 447 VYSFGVLVLEI 457
V+SFG+L+ EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 68/194 (35%), Positives = 102/194 (52%), Gaps = 29/194 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC- 346
KLGAG FGEV++G+ + +AVK L K ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 347 LEDP-------EKQGQL------DWSRRYKIIGLI------ARGILYLHEDSRLRIIHRD 387
LE+P K G L R K+ LI A G+ YL + IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVKS 445
L N+L+ K++DFG+A++ D +R + + APE A++ +FS+KS
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIY---EAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 446 DVYSFGVLVLEIIT 459
DV+SFG+L+ EI+T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 44/215 (20%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRL-SKSSGQGAEEFKNEVV 329
D E +KV LG G G VYK P+G+ A+K++ + ++ E+
Sbjct: 2 DLERVKV----------LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK 51
Query: 330 VVAKLQHRNLVRLLG-FCLEDPEKQGQL-------DWS------RRYKII-----GLIAR 370
+ + +V+ G F K+G++ D ++ I IAR
Sbjct: 52 TLRSCESPYVVKCYGAFY-----KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR 106
Query: 371 GIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426
IL YLH ++ IIHRD+K SN+L++++ KI+DFG++K+ ++ T + G
Sbjct: 107 QILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVG 162
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
T YM+PE +S +D++S G+ +LE GK
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 32/204 (15%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRN 338
+ + +G G FG VYKG+ L +G +A+K++S + + E+ ++ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 339 LVRLLGF---------CLEDPEKQGQLDWSRRYKIIG-----LIAR-------GILYLHE 377
+V+ +G LE E G L + K G L+A G+ YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAEN-GSL--RQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+IHRD+K +NIL + K++DFG+A + + GT +MAPE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
S SD++S G V+E++TG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 287 NKLGAGGFGEVYKGVLP-----SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLV 340
+LG G FG+V +G ++AVK L+ S Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 341 RLLGFCLED---------------------PEKQGQLDWSRRYKIIGLIARGILYLHEDS 379
+ G C + + Q++ R I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-- 127
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT--QGNTSRIAGTYGYMAPEYAM 437
R IHRDL NIL+++E KISDFG+AK+ D+ + + Y APE
Sbjct: 128 -QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR 185
Query: 438 HGQFSVKSDVYSFGVLVLEIIT-GKKNSS 465
+FS SDV+SFGV + E+ T G + S
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 28/193 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
KLGAG FGEV+ G ++A+K L K E F E ++ +LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 348 EDP--------EKQGQLDWSRR--------YKIIGL---IARGILYLHEDSRLRIIHRDL 388
++P E +D+ + K+I + IA G+ ++ R IHRDL
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVKSD 446
+ +NIL+ + KI+DFG+A++ ++ T+R + + APE +G F++KSD
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 447 VYSFGVLVLEIIT 459
V+SFG+L+ EI+T
Sbjct: 186 VWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (274), Expect = 2e-26
Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 282 KFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSK---SSGQGAEEFKNEVVVVAKLQH-R 337
+ KLG G FGEVY + +A+K L+K S + E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 338 NLVRLLGFC---------------------LEDPEKQGQLDWSRRYKIIGLIARGILYLH 376
N+V+L F L+ ++G L S I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 377 EDSRLRIIHRDLKVSNILLDAEMN-PKISDFGMAKIFGVDQT----QGNTSRIAGTYGYM 431
IIHRD+K NILLD + K+ DFG+AK+ + S GT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 432 APEYAMH---GQFSVKSDVYSFGVLVLEIITGK 461
APE + S SD++S G+ + E++TG
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 42/207 (20%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHRNLVRL- 342
++G G FG+VY G+ +K LS S + E+ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 343 ------------LGFC--------LEDPEKQGQ-------LDWSRRYKIIGLIARGILYL 375
+ + ++ +K+G+ LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H +I+HRD+K NI L + K+ DFG++K+ T + GT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ ++ KSD++S G ++ E+ T K
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 31/198 (15%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLS-----KSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG+G FG VY+G+ L G AVK +S ++ + ++ + E+ +++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 343 LGFCLEDPE--------KQGQLD------WSRRYKIIGLIARGIL----YLHEDSRLRII 384
LG E+ G L S +I L R IL YLH+ +
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTV 124
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSV 443
HRD+K +NIL+D K++DFGMAK G+ +MAPE G + +
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 444 KSDVYSFGVLVLEIITGK 461
+D++S G VLE+ TGK
Sbjct: 182 AADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 37/213 (17%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
NK+G G FG+VY V L +G +AVK R+ + + +E +E+ V+ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 344 G-------------FC----LEDPEKQGQLD---WSRRYKIIGLIARGILYLHEDSRLRI 383
G +C LE+ + G++ R Y + + G+ YLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL--QLLEGLAYLHSH---GI 120
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT----QGNTSRIAGTYGYMAPEYAMHG 439
+HRD+K +NI LD K+ DFG A + T + + +AGT YMAPE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTPAYMAPEVITGG 178
Query: 440 QFSVK---SDVYSFGVLVLEIITGKKNSSFYQT 469
+ +D++S G +VLE+ TGK+ S
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 53/219 (24%)
Query: 289 LGAGGFGEVYKGVLPSGRE------IAVKRLSKSSGQGAEE-FKNEVVVVAKLQHRNLVR 341
LG G FG+V+ G +AVK L +++ A + F+ E ++ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 342 LLGFCLE--------------------------------DPEKQGQLDWSRRYKIIGLIA 369
G C E G+L S+ +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGT- 427
G++YL + +HRDL N L+ ++ KI DFGM++ ++ D R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY-----RVGGHT 184
Query: 428 ---YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 462
+M PE M+ +F+ +SDV+SFGV++ EI T GK+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 46/211 (21%)
Query: 289 LGAGGFGEVYKG--VLPSGRE----IAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVR 341
LG G FG+VYKG P+ R +A+K L ++ + +EF+ E +++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 342 LLGFCL----------------------------------EDPEKQGQLDWSRRYKIIGL 367
LLG C D + LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAG 426
IA G+ YL S +HRDL N L+ + KISDFG+++ I+ D + + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 457
+M PE ++G+F+ +SD++SFGV++ EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 65/201 (32%), Positives = 109/201 (54%), Gaps = 39/201 (19%)
Query: 289 LGAGGFGEVYKGV-LPSGREI----AVKRLSKSSGQGAE-EFKNEVVVVAKLQHRNLVRL 342
LG+G FG VYKG+ +P G + A+K L++++G A EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 343 LGFCL------------------------EDPEKQGQLDWSRRYKIIGLIARGILYLHED 378
LG CL ++ Q L+W + IA+G++YL E
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEER 128
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
R++HRDL N+L+ + + KI+DFG+A++ D+ + N +MA E +
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 439 GQFSVKSDVYSFGVLVLEIIT 459
+F+ +SDV+S+GV + E++T
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 30/199 (15%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKR-----LSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FG VY + +GRE+AVK+ S + + + E+ ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 343 LGFCLEDPEK-------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
G CL D E G L + K I G+ YLH + I
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MI 125
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
+HRD+K +NIL D+ N K+ DFG +K + + + + GT +M+PE +
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 443 VKSDVYSFGVLVLEIITGK 461
K+DV+S G V+E++T K
Sbjct: 186 RKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 28/204 (13%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH 336
++ KLG G FGEV+ G ++AVK L K E F E ++ KL+H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60
Query: 337 RNLVRLLGFCLEDP--------EKQGQLDW-----SRRYKIIGL------IARGILYLHE 377
LV+L E+P K LD+ R K+ L +A G+ Y+
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEY 435
R+ IHRDL+ +NIL+ + KI+DFG+A++ + T+R + + APE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEA 174
Query: 436 AMHGQFSVKSDVYSFGVLVLEIIT 459
A++G+F++KSDV+SFG+L+ E++T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 36/198 (18%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL--- 343
K+G G GEVYK +G+E+A+K++ + Q E NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 344 --------------GFCLEDPEKQGQLDWSRRYKIIGLIA-------RGILYLHEDSRLR 382
G L D + + IA +G+ YLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTD-----IITQNFVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
+IHRD+K NILL + + K++DFG A ++++ N+ + GT +MAPE +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 443 VKSDVYSFGVLVLEIITG 460
K D++S G++ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 27/202 (13%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREI----AVKRLSKSSGQGA-EEFKNEVVVVAKLQ 335
+F LG+G FG VYKG+ +P G ++ A+K L +++ A +E +E V+A +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 336 HRNLVRLLGFCLEDPEKQGQ--------LDWSRRYK-IIG---------LIARGILYLHE 377
+ ++ RLLG CL + LD+ R +K IG IA+G+ YL E
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
R++HRDL N+L+ + KI+DFG+AK+ G D+ + + +MA E +
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 438 HGQFSVKSDVYSFGVLVLEIIT 459
H ++ +SDV+S+GV V E++T
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 36/199 (18%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLS-KSSGQGAEEFKNEVVVVAKLQH---RNLVRLL 343
+G G +G VY+G +P+GR +A+K ++ + + + EV ++++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 344 GFCLEDPE-----------------KQGQLDWSRRYKIIGLIARGIL----YLHEDSRLR 382
G L+ P K G + +Y I +I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA--EKY--ISVIIREVLVALKYIHKVG--- 121
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ-F 441
+IHRD+K +NIL+ N K+ DFG+A + +Q S GT +MAPE G+ +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 442 SVKSDVYSFGVLVLEIITG 460
K+D++S G+ + E+ TG
Sbjct: 180 DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 63/245 (25%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEF-KNE 327
DF+ K+ +G G F V + +E A+K L K + ++ K E
Sbjct: 2 DFKFGKI----------IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE 51
Query: 328 VVVVAKL-QHRNLVRLLGFCLEDPE-------------------KQGQLD--WSRRYKII 365
V+ +L H +++L + +D E K G LD +R Y
Sbjct: 52 KEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY--A 108
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ--------- 416
I + YLH IIHRDLK NILLD +M+ KI+DFG AK+ +
Sbjct: 109 AEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 417 ----TQGNTSRIA-----GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK---KNS 464
+Q +R GT Y++PE SD+++ G ++ +++TGK + S
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
Query: 465 SFYQT 469
+ Y T
Sbjct: 226 NEYLT 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-23
Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 28/195 (14%)
Query: 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
+ KLGAG FGEV+ ++AVK + K E F E V+ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 346 CLEDP--------EKQGQLDWSRRY--------KIIGL---IARGILYLHEDSRLRIIHR 386
++P K LD+ + K+I IA G+ ++ + + IHR
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVK 444
DL+ +NIL+ A + KI+DFG+A++ + T+R + + APE G F++K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 445 SDVYSFGVLVLEIIT 459
SDV+SFG+L++EI+T
Sbjct: 184 SDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-23
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 28/193 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
KLG G FGEV+ G +A+K L K E F E V+ KL+H LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 348 EDP-------EKQGQL------DWSRRYKIIGL------IARGILYLHEDSRLRIIHRDL 388
E+P +G L + + ++ L IA G+ Y+ R+ +HRDL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVKSD 446
+ +NIL+ + K++DFG+A++ + T+R + + APE A++G+F++KSD
Sbjct: 129 RAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 447 VYSFGVLVLEIIT 459
V+SFG+L+ E+ T
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 31/198 (15%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---EVVVVAKLQHRNLVRL 342
+LGAG G V K + P+G+ +AVK + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 343 LGFCLEDPE--------KQGQLDWSRRY-------KIIGLIARGIL----YLHEDSRLRI 383
G + + G LD + +I+G IA +L YLHE +I
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K SNIL+++ K+ DFG++ V+ + T GT YMAPE +SV
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPERIQGNDYSV 178
Query: 444 KSDVYSFGVLVLEIITGK 461
KSD++S G+ ++E+ TG+
Sbjct: 179 KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 42/208 (20%)
Query: 287 NKLGAGGFGEVYKGVL------PSGREIAVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNL 339
LG G FGEVY+G+ ++AVK L S Q +F E ++++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 340 VRLLGFCLE-------------------------DPEKQGQLDWSRRYKIIGLIARGILY 374
VRL+G E PE+ L +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAK-IFGVDQTQGNTSRIAGTYG 429
L E+ IHRD+ N LL + P KI+DFGMA+ I+ + R
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG-GRAMLPIK 186
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEI 457
+M PE + G F+ K+DV+SFGVL+ EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-23
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 34/198 (17%)
Query: 287 NKLGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
+KLG G +GEVY+GV +AVK L K EEF E V+ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 346 CLEDPE--------KQGQ-LDWSRRYK------IIGL-----IARGILYLHEDSRLRIIH 385
C +P G LD+ R ++ L I+ + YL + + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGT---YGYMAPEYAMHGQF 441
RDL N L+ K++DFG++++ G+T + AG + APE + +F
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 442 SVKSDVYSFGVLVLEIIT 459
S+KSDV++FGVL+ EI T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 7e-23
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 30/196 (15%)
Query: 289 LGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL- 347
LG+G FG V+ G ++A+K + + + ++F E V+ KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 348 --------EDPEKQGQLDWSRRYKIIGL----------IARGILYLHEDSRLRIIHRDLK 389
E L++ R K + + YL + IHRDL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127
Query: 390 VSNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTSRIAGTYGYMAPEYAMHGQFSVKSD 446
N L+ + K+SDFG+A+ DQ +QG + + PE + +FS KSD
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK----WAPPEVFDYSRFSSKSD 183
Query: 447 VYSFGVLVLEIITGKK 462
V+SFGVL+ E+ + K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 64/195 (32%), Positives = 104/195 (53%), Gaps = 28/195 (14%)
Query: 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
D KLG G FGEV+ G ++A+K L K E F E ++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 346 CLEDP----------------EKQGQLDWSRRYKIIGL---IARGILYLHEDSRLRIIHR 386
E+P K+G + + +++ + IA G+ Y+ R+ IHR
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVK 444
DL+ +NIL+ + KI+DFG+A++ + T+R + + APE A++G+F++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 445 SDVYSFGVLVLEIIT 459
SDV+SFG+L+ E++T
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 39/208 (18%)
Query: 287 NKLGAGGFGEVYKGV--LPSGREIAVKRLSKSSGQGAE--EFKNEVVVVAKLQHRNLVRL 342
+G G FG V K V G+ + K + + E + +EV ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 343 LGFCLEDPEKQ--------------GQLDWSRRYK----------IIGLIARGILYLHE- 377
+ D Q QL ++ K I ++ + +L L+E
Sbjct: 65 YDRII-DRSNQTLYIVMEYCEGGDLAQL--IQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 378 ----DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
D ++HRDLK +NI LDA N K+ DFG+AKI G D + T GT YM+P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSP 179
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E H + KSD++S G L+ E+
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 39/209 (18%)
Query: 289 LGAGGFGEV----YKGVLPS-GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
LG G FG V Y + + G +AVK+L S+ + +F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 344 GFC-------------------LED--PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
G C L D + + +LD + I +G+ YL R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKR 128
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRIAGTYGYMAPEYAM 437
+HRDL NIL+++E KI DFG+ K+ D+ + S I + APE
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPESLT 184
Query: 438 HGQFSVKSDVYSFGVLVLEIIT-GKKNSS 465
+FSV SDV+SFGV++ E+ T K+ S
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 66/195 (33%), Positives = 107/195 (54%), Gaps = 27/195 (13%)
Query: 289 LGAGGFGEVYKGV-LPSGREI----AVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG+G FG VYKG+ +P G + A+K L + +S + +E +E V+A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 343 LGFCLEDPEKQGQ--------LDWSRRYK-IIG---------LIARGILYLHEDSRLRII 384
LG CL + LD+ R K IG IA+G+ YL E +R++
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLV 131
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVK 444
HRDL N+L+ + + KI+DFG+A++ +D+T+ + +MA E +H +F+ +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 445 SDVYSFGVLVLEIIT 459
SDV+S+GV V E++T
Sbjct: 192 SDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 46/221 (20%)
Query: 278 VATNKFSTDNKLGAGGFGEVYKGVLPS------GREIAVKRLSKSSGQGAE-EFKNEVVV 330
+ K + +LG G FG VY+G+ +A+K +++++ EF NE V
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62
Query: 331 VAKLQHRNLVRLLGFCL----------------------------EDPEKQGQLDWSRRY 362
+ + ++VRLLG E+ G +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
++ IA G+ YL + +HRDL N ++ ++ KI DFGM + D + +
Sbjct: 123 QMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYY 175
Query: 423 RIAGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R G +MAPE G F+ KSDV+SFGV++ E+ T
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 29/194 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
KLGAG FGEV+ G + ++AVK L K + F E ++ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 348 -EDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRD 387
E+P ++ G++ + IA G+ Y+ R IHRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVKS 445
L+ +N+L+ + KI+DFG+A++ ++ T+R + + APE G F++KS
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 446 DVYSFGVLVLEIIT 459
DV+SFG+L+ EI+T
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 34/205 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHR 337
F+ +G G FGEVYK + + + +A+K L ++ + E+ + E+ +++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 338 NLVRLLGFCLEDPE-----------------KQGQLDWSRRYKIIGLIARGIL----YLH 376
+ + G L+ + K G+LD I I R +L YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLD----ETYIAFILREVLLGLEYLH 115
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
E+ IHRD+K +NILL E + K++DFG++ ++ NT GT +MAPE
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVI 170
Query: 437 MHGQFSVKSDVYSFGVLVLEIITGK 461
+ K+D++S G+ +E+ G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 6e-22
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 30/197 (15%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
++G+G FG V+ G R++A+K + + E+F E V+ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 348 EDPE--------KQGQL-DWSRRYK-------IIGL---IARGILYLHEDSRLRIIHRDL 388
E + G L D+ R + ++G+ + G+ YL + +IHRDL
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT---YGYMAPEYAMHGQFSVKS 445
N L+ K+SDFGM + DQ +T GT + +PE ++S KS
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKS 182
Query: 446 DVYSFGVLVLEIITGKK 462
DV+SFGVL+ E+ + K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 6e-22
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 49/210 (23%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
F KLG G +G VYK + +G+ +A+K + + +E E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 342 LLG-------------FC----LED---------PEKQGQLDWSRRYKIIGLIARGIL-- 373
G +C + D E++ I I L
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE-----------IAAILYQTLKG 111
Query: 374 --YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
YLH + IHRD+K NILL+ E K++DFG++ T + + GT +M
Sbjct: 112 LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWM 166
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
APE ++ K+D++S G+ +E+ GK
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-22
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 43/210 (20%)
Query: 289 LGAGGFGEVYKG----VLPSGRE---IAVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLV 340
LG+G FGEVY+G +L G +AVK L K ++ Q +EF E +++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 341 RLLGFCLE-DP--------EKQGQLDWSRRYKIIGL----------------IARGILYL 375
+LLG CL +P E L + R ++ +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 376 HEDSRLRIIHRDLKVSNILL-----DAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYG 429
++ IHRDL N L+ DA+ KI DFG+A+ I+ D + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE + G+F+ +SDV+SFGVL+ EI+T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 8e-22
Identities = 60/197 (30%), Positives = 80/197 (40%), Gaps = 28/197 (14%)
Query: 288 KLGAGGFGEVYKG--VLPSGREI--AVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLVRL 342
KLG G FG V +G G+ I AVK L ++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 343 LGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
G L P + G S IA G+ YL R
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGV-DQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
IHRDL NILL ++ KI DFG+ + + + + + APE FS
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 443 VKSDVYSFGVLVLEIIT 459
SDV+ FGV + E+ T
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-22
Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 2/94 (2%)
Query: 92 TDQGRFNELVGTQMSQAVTQAV-NNTKRFATRKANFTASQTLYSLAQCTPDLSSSACNRC 150
T F + +S + A ++ K FA + A T+Y LAQC DLS+S C C
Sbjct: 14 TANSTFESNLNALLSSLSSNAASSSGKGFAAG-TSGAAPDTVYGLAQCRGDLSASDCRSC 72
Query: 151 LREAIARLPICCSGKQGGRVLTPSCNVWYELYPF 184
L A++ L CC K+GGR+ SC + YE YPF
Sbjct: 73 LATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 35/202 (17%)
Query: 286 DNKLGAGGFGEVYKGVL--PSGREI--AVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +G G FGEV +G L P +EI A+K L + SS + +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 341 RLLGF-----------------CLED--PEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
RL G L+ E G+ + ++ IA G+ YL S +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIF----GVDQTQGNTSRIAGTYGYMAPEYAM 437
+HRDL NIL+++ + K+SDFG+++ T+G I T APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIA 181
Query: 438 HGQFSVKSDVYSFGVLVLEIIT 459
+ +F+ SDV+SFG+++ E+++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 27/195 (13%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFC 346
K+G G FG+VYKGVL E+AVK + +F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 347 LE-DP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRD 387
++ P +K+ +L + ++ A G+ YL +S+ IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIHRD 118
Query: 388 LKVSNILLDAEMNPKISDFGMAK--IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKS 445
L N L+ KISDFGM++ G+ +I + APE +G+++ +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP--IKWTAPEALNYGRYTSES 176
Query: 446 DVYSFGVLVLEIITG 460
DV+S+G+L+ E +
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-21
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPS-GREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHRNL 339
F NK+G G FG V+K V + R A+K+ LSK + + EE +E V+AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 340 VR---------LLGFCLEDPEKQGQLDWSRRY-----------KIIGLIARGILYLHEDS 379
+R L +E E + + I G+ +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+I+HRD+K N+ LDA N KI D G+AK+ + NT I GT Y++PE
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDK 176
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
++ KSDV++ GV++ E TGK
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 30/197 (15%)
Query: 282 KFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
K + +G G FG V +G +G+++AVK + A+ F E V+ KL H+NLVR
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 342 LLGFCL--------EDPEKQGQLDW--SRRYKIIGLI---------ARGILYLHEDSRLR 382
LLG L E K +++ +R ++ +I A G+ YL +
Sbjct: 64 LLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---K 120
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
++HRDL NIL+ + K+SDFG+A+ V + S++ + APE H +FS
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKLP--VKWTAPEALKHKKFS 175
Query: 443 VKSDVYSFGVLVLEIIT 459
KSDV+S+GVL+ E+ +
Sbjct: 176 SKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 41/206 (19%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLS----KSSGQGA--EEFKNEVVVVAKLQHRNLVR 341
LG G F Y+ + +G +AVK+++ SS Q E + E+ ++A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 342 LLGFCLEDPEKQGQLDW--------------------SRRYKIIGLIARGILYLHEDSRL 381
+LG ED ++W Y + RG+ YLHE+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLLRGLSYLHEN--- 122
Query: 382 RIIHRDLKVSNILLDAE-MNPKISDFGMA-----KIFGVDQTQGNTSRIAGTYGYMAPEY 435
+IIHRD+K +N+L+D+ +I+DFG A K G + QG ++ GT +MAPE
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPEV 179
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
Q+ DV+S G +++E+ T K
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 40/206 (19%)
Query: 289 LGAGGFGEVY----KGVLPSGRE--IAVKRLSKSSGQGAE-EFKNEVVVVAKLQHRNLVR 341
LG G FGEV+ KG+ G E + VK L K+ + + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 342 LLGFCLE---------------------------DPEKQGQLDWSRRYKIIGLIARGILY 374
LLG C E + K L ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGYMAP 433
L S R +HRDL N L+ ++ K+S ++K ++ + + + I ++AP
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--LRWLAP 187
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIIT 459
E FS KSDV+SFGVL+ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 35/205 (17%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE---------FKNEVVVVAKLQHRN 338
+G+G FG VY G+ SG +AVK++ S + + E+ ++ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 339 LVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
+V+ LG L+ G + + + I +G+ YLH +R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--NR 125
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG--NTSR--IAGTYGYMAPEYA 436
IIHRD+K +NIL+D + KISDFG++K + N +R + G+ +MAPE
Sbjct: 126 -GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 437 MHGQFSVKSDVYSFGVLVLEIITGK 461
++ K+D++S G LV+E++TGK
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 34/202 (16%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEF----KNEVVVVAKLQHRNLVR 341
++G G +G+VYK +G +A+K++ E F E+ ++ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 342 LLGFCLEDPEK-------------QGQLDWSRRYK-----IIGL---IARGILYLHEDSR 380
L + G LD S K I + G+ YLH +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLD-SPEVKFTESQIKCYMKQLLEGLQYLHSN-- 119
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG- 439
I+HRD+K SNIL++ + K++DFG+A+ + + T+R+ T Y PE +
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
++ + D++S G ++ E+ GK
Sbjct: 178 RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKS---SGQGAEEFKNEVVVVAKLQHRN 338
F +G G FG+V +++ A+K ++K NE ++ +L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 339 LVRLLGFCLEDPEKQ---------GQLDW--SRRYK--------IIGLIARGILYLHEDS 379
LV L + +D E G L + S++ K I I + YLH
Sbjct: 62 LVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK- 119
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
IIHRD+K NILLD + + I+DF +A T+ +GT GYMAPE
Sbjct: 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 440 QFSVKSDVYSFGVLVLEIITGKK 462
+SV D +S GV E + GK+
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 41/208 (19%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFK----NEVVVVAKLQ 335
+ KLG G +G VYK +G +A+K RL E E+ ++ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELK 56
Query: 336 HRNLVRLL-------------GFCLEDPEK-----QGQLDWSRRYKIIGL-IARGILYLH 376
H N+V+LL +C D +K G L K I + RG+ Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAYCH 115
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
S RI+HRDLK NIL++ + K++DFG+A+ FG+ T + T Y APE
Sbjct: 116 --SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEIL 170
Query: 437 MHGQF---SVKSDVYSFGVLVLEIITGK 461
+ + +V D++S G + E+ITGK
Sbjct: 171 LGSKHYSTAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-20
Identities = 27/68 (39%), Positives = 35/68 (51%)
Query: 6 SSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECL 65
GF T+G P+ VYGL CRGD + S C+ C+ A + + CP K +WY C
Sbjct: 39 GKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCF 98
Query: 66 LRYSDQSF 73
LRY F
Sbjct: 99 LRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 64/195 (32%), Positives = 100/195 (51%), Gaps = 27/195 (13%)
Query: 289 LGAGGFGEVYKGV-LPSGREI----AVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRL 342
LG+G FG V+KG+ +P G I A+K + SG Q +E + ++ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 343 LGFC----------------LEDPEKQ--GQLDWSRRYKIIGLIARGILYLHEDSRLRII 384
LG C L D +Q LD R IA+G+ YL E R++
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMV 131
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVK 444
HR+L NILL ++ +I+DFG+A + D + S +MA E + G+++ +
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191
Query: 445 SDVYSFGVLVLEIIT 459
SDV+S+GV V E+++
Sbjct: 192 SDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 55/226 (24%)
Query: 288 KLGAGGFGEVY----KGVLPSGRE--IAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG+V+ +LP + +AVK L ++S ++F+ E ++ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 342 LLGFC-------------------------------LEDPEKQ--GQLDWSRRYKIIGLI 368
G C L E GQL + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 369 ARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAG- 426
A G++YL + L +HRDL N L+ + KI DFGM++ I+ D R+ G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-----RVGGR 183
Query: 427 ---TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468
+M PE ++ +F+ +SD++SFGV++ EI T GK+ +YQ
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ--PWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 30/197 (15%)
Query: 289 LGAGGFGEVYKGVL--PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLL 343
+GAG FGEV++G+L P +E+AV + G + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 344 G--------FCLEDPEKQGQLDWSRR--------YKIIGL---IARGILYLHEDSRLRII 384
G + + + G LD R Y+++G+ IA G+ YL S + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG--YMAPEYAMHGQFS 442
HRDL NIL+++ + K+SDFG++++ D +G + G + APE + +F+
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 443 VKSDVYSFGVLVLEIIT 459
SDV+SFG+++ E+++
Sbjct: 189 SASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
F+ ++G G FGEVYKG+ +E+ A+K + + E+ + E+ V+++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 341 RLLGFCLE-----------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
R G L+ D K G L+ + I+ I +G+ YLH + R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K +N+LL + + K++DFG+A Q + NT GT +MAPE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDF 180
Query: 444 KSDVYSFGVLVLEIITGKKNSS 465
K+D++S G+ +E+ G+ +S
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGAE-EFKNEVVVVAKLQHRN 338
K ++LG G G V K L + I A+K ++ + + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 339 LVRLLGFCLEDPEKQ----------GQLDWSRRYK------------IIGLIARGIL--- 373
+V+ G L++ G LD YK ++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD--SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 374 -YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432
YLH +IIHRD+K SNILL + K+ DFG++ T GT YMA
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMA 171
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE +S+ SDV+S G+ +LE+ +
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-19
Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 31/203 (15%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKR--LSKSSGQGAE----EFKNEVVVVAKLQHRNLV 340
LG G +G VY G+ G+ IAVK+ L S+ AE + + EV ++ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 341 RLLGFCLED----------P--------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
+ LG CL+D P + G L K I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAK---IFGVDQTQGNTSR-IAGTYGYMAPEYAMH 438
++HRD+K +N++L K+ DFG A+ G+ T N + + GT +MAPE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
+ KSD++S G V E+ TGK
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 286 DNKLGAGGFGEVYKGV--LPSGREI--AVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLV 340
+G G FG+VY+GV P +I AVK +S E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 341 RLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
+L+G E+P + LD + ++ + YL R
Sbjct: 71 KLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KR 127
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
+HRD+ N+L+ + K+ DFG+++ D++ S+ +MAPE +F+
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 443 VKSDVYSFGVLVLEIIT-GKK 462
SDV+ FGV + EI+ G K
Sbjct: 187 SASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 48/212 (22%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRL---SKSSGQGAEE-------FKNEVVVVAKLQHR 337
+G G +G VY + + +G +AVK++ + +G+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 338 NLVRLLGF---------------------CLEDPEKQGQLDWSRRYKIIGLIARGILYLH 376
N+V+ LGF CL G+ + + G+ YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH 125
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK----IFGVDQTQGNTSRIAGTYGYMA 432
I+HRDLK N+L+DA+ KISDFG++K I+ DQ N S + G+ +MA
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMS-MQGSVFWMA 178
Query: 433 PE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 462
PE ++ +S K D++S G +VLE+ G++
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
+LG+G FG V+ G + ++A+K +++ + E+F E V+ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 348 EDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388
+ ++QG+L + + G+ YL +S IHRDL
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDL 126
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVY 448
N L+ + K+SDFGM + + +D ++S + PE ++S KSDV+
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 449 SFGVLVLEIIT-GK---KNSSFYQ 468
SFGVL+ E+ T GK + S Y+
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 64/223 (28%), Positives = 93/223 (41%), Gaps = 58/223 (26%)
Query: 288 KLGAGGFGEVY------------KGVLPSGRE-----IAVKRLSKSSGQGA-EEFKNEVV 329
KLG G FGEV+ K + +AVK L + A E+F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 330 VVAKLQHRNLVRLLGFCLEDP-----------------------------EKQGQLDWSR 360
++++L N+ RLLG C DP L +S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 361 RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420
+ IA G+ YL L +HRDL N L+ KI+DFGM++ + +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184
Query: 421 TSRIAGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R+ G +MA E + G+F+ KSDV++FGV + EI+T
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 7e-19
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 34/199 (17%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
LG GGFGEV V +G+ A K+L K +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 345 FCLEDPEK---------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
+ E + + +R I G+ +LH + RI
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQFS 442
++RDLK N+LLD N +ISD G+A V+ G + AGT GYMAPE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 443 VKSDVYSFGVLVLEIITGK 461
D ++ G + E+I G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 32/199 (16%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
LG G +G VY L + IA+K + + + + E+ + + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 348 EDPEKQ--------GQLDWSRRYK---------IIGLIARGIL----YLHEDSRLRIIHR 386
E+ + G L R K I + IL YLH+ +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132
Query: 387 DLKVSNILLDAEMNP-KISDFGMAK-IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ--FS 442
D+K N+L++ KISDFG +K + G++ T GT YMAPE G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYG 189
Query: 443 VKSDVYSFGVLVLEIITGK 461
+D++S G ++E+ TGK
Sbjct: 190 APADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 30/196 (15%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKSS--GQGAEE-FKNEVVVVAKLQHRNLVR--- 341
LG GGFG V V R A+K + K G +E +E ++ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 342 ----------LLGFCLEDP-----EKQGQLD-WSRRYKIIGLIARGILYLHEDSRLRIIH 385
L+ +CL +G D ++ R+ I + YLH II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAFEYLH---NRGIIY 116
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKS 445
RDLK N+LLD+ K+ DFG AK Q T GT Y+APE ++ +
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 446 DVYSFGVLVLEIITGK 461
D +S G+L+ E++TG+
Sbjct: 174 DYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 36/201 (17%)
Query: 289 LGAGGFGE--VYK----GVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FGE +Y+ L +E+ + RLS+ + A NE+V+++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIAY 64
Query: 343 LGFCLEDP-------------------EKQGQLDWSRRYKIIGL--IARGILYLHEDSRL 381
++D ++GQL + + L I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
I+HRD+K NI L K+ DFG++KI G + + T + GT YM+PE ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 442 SVKSDVYSFGVLVLEIITGKK 462
+ KSD+++ G ++ E++T K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 52/228 (22%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLS-KSSGQGAEEFKNEV 328
I ++T +F + LG FG+VYKG L + +A+K L K+ G EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 329 VVVAKLQHRNLVRLLG-------------FC----------LEDPEKQ-GQLDWSRRYK- 363
++ ++LQH N+V LLG +C + P G D + K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 364 ---------IIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFG 413
I+ IA G+ +L S ++H+DL N+L+ ++N KISD G+ + ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 414 VD--QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
D + GN+ +M+PE M+G+FS+ SD++S+GV++ E+ +
Sbjct: 177 ADYYKLMGNSLL---PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 45/207 (21%)
Query: 289 LGAGGFGEVYKGVL-PSGREIAVKRL-SKSSGQGAEEFKNEVVVVAKLQH-RNLVRLLG- 344
+G G FG V K + PSG +AVKR+ S + + ++ VV + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 345 --------FCLEDPEKQGQLDWS--RRYKIIGLIARGIL-----------------YLHE 377
C+E +D S + YK + + + ++ YL E
Sbjct: 72 LFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ L+IIHRD+K SNILLD N K+ DFG I G +R AG YMAPE
Sbjct: 126 E--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERID 180
Query: 438 HGQ---FSVKSDVYSFGVLVLEIITGK 461
+ V+SDV+S G+ + E+ TGK
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 41/207 (19%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
+G G VY + LP+ ++A+KR L K +E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 344 GFCLEDPE---------------------KQGQLDWSRRYKIIGLIARGIL----YLHED 378
+ E +G LD II + + +L YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD----EAIIATVLKEVLKGLEYLHSN 121
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF--GVDQTQGNTSRIAGTYGYMAPEYA 436
+ IHRD+K NILL + + KI+DFG++ G D+T+ GT +MAPE
Sbjct: 122 GQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-V 177
Query: 437 MHGQ--FSVKSDVYSFGVLVLEIITGK 461
M + K+D++SFG+ +E+ TG
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 29/197 (14%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN--EVVVVAKLQHRNLVRLLG 344
K+G G +G VYK +G +A+K++ E+ ++ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 345 -------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
F D K Q L S + + +G+ + H I+HR
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE--YAMHGQFSVK 444
DLK N+L++ E K++DFG+A+ FG T + T Y APE +S
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVV-TRWYRAPELLLGD-KGYSTP 179
Query: 445 SDVYSFGVLVLEIITGK 461
D++S G + E+++ +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLG--- 344
LG G FG+VYK +G A K + S + E+F E+ ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 345 ----------FC-----------LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
FC LE + Q+ + R + L +LH ++
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALN-----FLHSH---KV 124
Query: 384 IHRDLKVSNILLDAEMNPKISDFGM-AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
IHRDLK NILL + + K++DFG+ AK Q + I GT +MAPE F
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFI-GTPYWMAPEVVACETFK 181
Query: 443 -----VKSDVYSFGVLVLEI 457
K+D++S G+ ++E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 51/223 (22%)
Query: 288 KLGAGGFGEVY----KGVLPSGRE--IAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG+V+ + P+ + +AVK L + ++F+ E ++ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 342 LLGFCLE-DP---------------------------------EKQGQLDWSRRYKIIGL 367
G C + DP + +G+L S+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG- 426
IA G++YL + +HRDL N L+ A + KI DFGM++ D + R+ G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 427 ---TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466
+M PE M+ +F+ +SDV+SFGV++ EI T K F
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 50/216 (23%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEV----YKGVLPSGREIAVKRLSKS----SGQGAEE 323
DFE IK LG G FG V +K SG+ A+K LSK+ Q E
Sbjct: 2 DFEFIKT----------LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEH 47
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEK---------QGQL-DWSRRYKIIGL------ 367
NE ++ ++H LV L G +D G+L R+
Sbjct: 48 VLNEKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY 106
Query: 368 ---IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
+ + YLH L I++RDLK N+LLD++ KI+DFG AK +G T +
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGRTYTL 158
Query: 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
GT Y+APE + + D ++ G+L+ E++ G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 9e-18
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 50/225 (22%)
Query: 289 LGAGGFGEVYKGVL----PSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FG V +G L S ++AVK +L + EEF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 343 LGFCLEDPEKQGQ------------------LDWSRR------------YKIIGLIARGI 372
+G C E Q L +SR K + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD-QTQGNTSRIAGTYGY 430
YL S IHRDL N +L +M ++DFG++ KI+ D QG +++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP--VKW 181
Query: 431 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFYQ 468
+A E ++ KSDV++FGV + EI T G +N Y
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-18
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 31/202 (15%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
K++ K+G G G VY + + +G+E+A+K+++ E NE++V+ + +H N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 341 RLL-----------------GFCLEDPEKQGQLDWSRRYKIIGLIARGIL----YLHEDS 379
L G L D + +D I + R L +LH +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN- 134
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
++IHRD+K NILL + + K++DFG +Q++ +T + GT +MAPE
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 190
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
+ K D++S G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 40/203 (19%)
Query: 289 LGAGGFGEVYKGVL--PSGREI--AVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
+G G FG VY G L G++I AVK L++ + + E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 344 GFCLEDPE----------KQGQL-----DWSRRYKIIGLI------ARGILYLHEDSRLR 382
G CL E K G L + + LI A+G+ YL +
Sbjct: 63 GICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAK------IFGVDQTQGNTSRIAGTYGYMAPEYA 436
+HRDL N +LD K++DFG+A+ + V G + +MA E
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALESL 174
Query: 437 MHGQFSVKSDVYSFGVLVLEIIT 459
+F+ KSDV+SFGVL+ E++T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QH 336
T F +G G +G+VYK +G+ +A+K + EE K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 337 RNLVRLLG-FCLEDPE-KQGQL--------------------DWSRRYK--IIGLIARGI 372
N+ G F ++P QL +R K I I R
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 373 L----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY 428
L YLHE+ ++IHRD+K NILL K+ DFG++ +D T G + GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTP 177
Query: 429 GYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 461
+MAPE + +SDV+S G+ +E+ GK
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 32/190 (16%)
Query: 289 LGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348
+G G FG+V G G ++AVK + + A+ F E V+ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 349 DP----------EKQGQLDW--SRRYKIIG---------LIARGILYLHEDSRLRIIHRD 387
+ K +D+ SR ++G + + YL ++ +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDV 447
L N+L+ + K+SDFG+ K TQ +T ++ + APE +FS KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 448 YSFGVLVLEI 457
+SFG+L+ EI
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 31/205 (15%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRL---SKSSGQGAEEFKNEVVVVAKLQHR 337
++ K+G G +G VYKG +G+ +A+K++ S+ G + + E+ ++ +LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 338 NLVRLLGFCLEDPE--------------------KQGQLDWSRRYKIIGLIARGILYLHE 377
N+V L +++ K +D + I +GIL+ H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
R++HRDLK N+L+D + K++DFG+A+ FG+ + T + T Y APE +
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLL 174
Query: 438 HGQ-FSVKSDVYSFGVLVLEIITGK 461
+S D++S G + E+ T K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 2e-17
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 24/198 (12%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
F+ K+G G FGEV+KG+ +++ A+K + + E+ + E+ V+++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 341 RLLGFCLEDPE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
+ G L+D + + G LD ++ I+ I +G+ YLH + +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K +N+LL K++DFG+A + TQ + GT +MAPE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 444 KSDVYSFGVLVLEIITGK 461
K+D++S G+ +E+ G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 49/223 (21%)
Query: 289 LGAGGFGEVYKGVL---PSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
LG G FG V +G L S ++AVK +++ + E+F +E V + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 344 GFCLEDPEKQGQ------------------LDWSRR------------YKIIGLIARGIL 373
G CL+ E +G L +SR K + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD-QTQGNTSRIAGTYGYM 431
YL S IHRDL N +L+ MN ++DFG++ KI+ D QG +++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP--VKWI 181
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFY 467
A E ++ KSDV+SFGV + EI T G +NS Y
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 34/196 (17%)
Query: 288 KLGAGGFGEVYKGVL---PSGREIAVKRLSKSSGQGA--EEFKNEVVVVAKLQHRNLVRL 342
+LG+G FG V KG+ S + +AVK L + A +E E V+ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 343 LGFC--------LEDPE---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385
+G C +E E K + +++ ++ G+ YL E + +H
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVH 118
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG-----YMAPEYAMHGQ 440
RDL N+LL + KISDFG++K G D+ A T+G + APE + +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECMNYYK 174
Query: 441 FSVKSDVYSFGVLVLE 456
FS KSDV+SFGVL+ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 56/220 (25%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK----NEVVVVAKLQHRNLVRL 342
KLG G FGEVYK + +GR +A+K++ + + + F E+ ++ KL+H N+V L
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPL 72
Query: 343 LGFCLEDPEKQGQLDWSRRYKII------------GL-------------------IARG 371
+ +E P+K R+ + GL + G
Sbjct: 73 IDMAVERPDKS-----KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEG 127
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG----- 426
I YLHE+ I+HRD+K +NIL+D + KI+DFG+A+ + G
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 427 ----TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 461
T Y PE + +++ D++ G + E+ T +
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 54/220 (24%)
Query: 289 LGAGGFGEVYK----GVLPSGRE---IAVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLV 340
+G G FG V++ G+LP +AVK L + +S +F+ E ++A+ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 341 RLLGFCLE-----------------------DPEKQGQLDWSR----------------- 360
+LLG C P Q L S
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 361 RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVDQTQG 419
+ I +A G+ YL E + +HRDL N L+ M KI+DFG++ I+ D +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ + A +M PE + +++ +SDV+++GV++ EI +
Sbjct: 189 SEND-AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 64/201 (31%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 289 LGAGGFGEV----YKGVLP----SGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHRNL 339
LG G FG+V Y P +G +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 340 VRLLGFCLEDPEKQGQL-----------DWSRRYKIIGL---------IARGILYLHEDS 379
V+ G C E K QL D+ ++K+ L I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHSQ- 126
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT-YGYMAPEYAMH 438
IHRDL N+LLD + KI DFG+AK + + A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 439 GQFSVKSDVYSFGVLVLEIIT 459
+FS SDV+SFGV + E++T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 42/203 (20%)
Query: 288 KLGAGGFGEVYK-GVLPSGREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL- 343
++G G G V+K +G +A+K+ L + G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 344 ------------GFCLED------------PEKQGQLDWSRRYKIIGLIARGILYLHEDS 379
+ D PE Q + Y ++ +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQ-----VKSYMR--MLLKGVAYMHA-- 117
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
I+HRDLK +N+L+ A+ KI+DFG+A++F ++ + + ++A T Y APE ++G
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPEL-LYG 174
Query: 440 Q--FSVKSDVYSFGVLVLEIITG 460
+ D+++ G + E++ G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 36/210 (17%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRL-----SKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FGEVY +GRE+AVK++ S+ + + + E+ ++ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 343 LGFCLEDPEKQ---------------------GQL--DWSRRYKIIGLIARGILYLHEDS 379
G CL DPE++ G L + +RRY I +G+ YLH +
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT--RQILQGVSYLHSN- 125
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
I+HRD+K +NIL D+ N K+ DFG +K I + + + GT +M+PE
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 439 GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
+ K+DV+S V+E++T K + Y+
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 10/101 (9%)
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQTQGN 420
KI + G+ YL+ RI+HRD+K SNIL+++ K+ DFG++ I + T
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--- 161
Query: 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
GT YM+PE G+++VKSDV+S G+ ++E+ GK
Sbjct: 162 ---FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 50/216 (23%)
Query: 288 KLGAGGFGEVYKG--VLPS---GREIAVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG FG++YKG LP + +A+K L ++ Q EF+ E ++A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 342 LLG-------FCL----------------------------EDPEKQGQLDWSRRYKIIG 366
LLG C+ ED + LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 367 LIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVD--QTQGNTSR 423
IA G+ YL S +H+DL NIL+ +++ KISD G+++ I+ D + Q +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+M PE M+G+FS SD++SFGV++ EI +
Sbjct: 189 ---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 29/196 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
+LG G FG V G ++A+K + + S +EF E V+ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 348 -EDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388
+ P E + S+ ++ + G+ YL + IHRDL
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSVKSD 446
N L+D + K+SDFG+++ D+ TS + + + PE ++ +FS KSD
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 447 VYSFGVLVLEIIT-GK 461
V++FGVL+ E+ + GK
Sbjct: 184 VWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 49/222 (22%)
Query: 288 KLGAGGFGEVY----KGVLPSGREI--AVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG+V+ + P +I AVK L +S ++F E ++ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 342 LLGFCLE-DP-------EKQGQLD-----------------------WSRRYKIIGLIAR 370
G C+E DP K G L+ S+ I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 371 GILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG---- 426
G++YL + +HRDL N L+ + KI DFGM++ D + R+ G
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 184
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
+M PE M+ +F+ +SDV+S GV++ EI T K +YQ
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ-PWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 30/198 (15%)
Query: 289 LGAGGFGEVYKGVL--PSGREI--AVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
+GAG FGEV +G L P REI A+K L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 344 G--------FCLEDPEKQGQLDWSRRYK--------IIGL---IARGILYLHEDSRLRII 384
G + + + G LD R ++G+ IA G+ YL E + +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN-TSRIAGTYG--YMAPEYAMHGQF 441
HRDL NIL+++ + K+SDFG+++ D + TS + G + APE + +F
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 442 SVKSDVYSFGVLVLEIIT 459
+ SDV+S+G+++ E+++
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLS---KSSGQGAEEFKNEVVVVAKLQ 335
F + K+G G F VYK + L GR +A+K++ + ++ E+ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 336 HRNLVRLLGFCLEDPEKQGQLDWSRR----------------------YKIIGLIARGIL 373
H N+++ L +E+ E L+ + +K + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
++H RI+HRD+K +N+ + A K+ D G+ + F +T S + GT YM+P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSP 175
Query: 434 EYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
E +H ++ KSD++S G L+ E+ + S FY
Sbjct: 176 E-RIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 36/201 (17%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN----EVVVVAKLQHRNLVR 341
N++G+G G VYK + P+GR A+K + G + + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 342 LLGFCLEDPEKQ--------GQLD----WSRRYKIIGLIAR----GILYLHEDSRLRIIH 385
+ E Q G L+ ++ + +AR GI YLH R I+H
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF--LADVARQILSGIAYLH---RRHIVH 191
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA----MHGQF 441
RD+K SN+L+++ N KI+DFG+++I + QT + GT YM+PE HG +
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 442 S-VKSDVYSFGVLVLEIITGK 461
D++S GV +LE G+
Sbjct: 250 DGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 30/197 (15%)
Query: 289 LGAGGFGEVYKGVL--PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLL 343
+GAG FGEV G L P REI V + +G + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 344 G--------FCLEDPEKQGQLDWSRR-----YKIIGL------IARGILYLHEDSRLRII 384
G + + + G LD R + +I L IA G+ YL S + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG--YMAPEYAMHGQFS 442
HRDL NIL+++ + K+SDFG++++ D T+R G + APE + +F+
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTAPEAIAYRKFT 187
Query: 443 VKSDVYSFGVLVLEIIT 459
SDV+S+G+++ E+++
Sbjct: 188 SASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 40/203 (19%)
Query: 289 LGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKN---EVVVVAKLQHR--NLVR- 341
+G+G G+VYK +G +AVK++ ++ EE K ++ VV K H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 342 ---------------LLGFCLEDPEKQGQLDWSRRYKIIGLIARGIL----YLHEDSRLR 382
L+ CL+ K+ Q I+G + I+ YL E
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPED--ILGKMTVAIVKALHYLKEKHG-- 135
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY----AMH 438
+IHRD+K SNILLDA N K+ DFG++ VD ++ T R AG YMAPE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG-RLVD-SKAKT-RSAGCAAYMAPERIDPPDPN 192
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
++ +++DV+S G+ ++E+ TG+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 39/203 (19%)
Query: 289 LGAGGFGEV----YKGVLP----SGREIAVKRLS-KSSGQGAEEFKNEVVVVAKLQHRNL 339
LG G FG+V Y P +G ++AVK L +S G + K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 340 VRLLGFCLED---------------------PEKQGQLDWSRRYKIIGLIARGILYLHED 378
V+ G C ED P + +++ ++ K I +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--G 126
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS--RIAGTYGYMAPEYA 436
SR + +HRDL N+L+++E KI DFG+ K D+ + + Y APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 437 MHGQFSVKSDVYSFGVLVLEIIT 459
+ +F + SDV+SFGV + E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 29/200 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGR---EIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLVRLL 343
+LG+G FG V KGV + ++A+K L + + +E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 344 GFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385
G C + K+ ++ S +++ ++ G+ YL + +H
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY--GYMAPEYAMHGQFSV 443
RDL N+LL + KISDFG++K G D + +R AG + + APE +FS
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRKFSS 177
Query: 444 KSDVYSFGVLVLEIIT-GKK 462
+SDV+S+G+ + E + G+K
Sbjct: 178 RSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 24/202 (11%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
F+ ++G G FGEV+KG+ +++ A+K + + E+ + E+ V+++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 341 RLLGFCLE-----------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
+ G L+ D + G D + ++ I +G+ YLH + +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K +N+LL + + K++DFG+A Q + NT GT +MAPE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDS 180
Query: 444 KSDVYSFGVLVLEIITGKKNSS 465
K+D++S G+ +E+ G+ +S
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 50/204 (24%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLG- 344
++G+G +G+VYK + +G +A+K + G E + E+ ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 345 ------------FC----LED---------PEKQGQLDWSRRYKIIGLIAR----GILYL 375
+C L+D E Q I + R G+ YL
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-----------IAYVCRETLKGLAYL 117
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
HE IHRD+K +NILL + + K++DFG++ + T GT +MAPE
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEV 172
Query: 436 A---MHGQFSVKSDVYSFGVLVLE 456
A G + K D+++ G+ +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 283 FSTDNKLGAGGFGEVYK-GVLPSGREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHRNL 339
F KLG G +G VYK L + A+K L S + E+ NE+ ++A + H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 340 VRL---------------------LGFCLEDPEKQG-----QLDWSRRYKIIGLIARGIL 373
+ L + +K+ Q W R I + RG+
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI--QLLRGLQ 117
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
LHE +I+HRDLK +NILL A KI D G++K+ + GT YMAP
Sbjct: 118 ALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAP 170
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E +S KSD++S G L+ E+ T
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 32/195 (16%)
Query: 289 LGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAE-EFKNEVVVVAKLQHRNLVRLLGFCL 347
LG G FGEV+KG L +AVK + Q + +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 348 E-DP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388
+ P +K+ +L + K A G+ YL + IHRDL
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDL 119
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG----TYGYMAPEYAMHGQFSVK 444
N L+ KISDFGM++ Q +G + APE +G++S +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 445 SDVYSFGVLVLEIIT 459
SDV+S+G+L+ E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 9e-16
Identities = 50/198 (25%), Positives = 102/198 (51%), Gaps = 23/198 (11%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
K++ K+G G G V+ + + +G+E+A+K+++ E NE++V+ +L++ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 341 RLL-----------------GFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L G L D + +D ++ + + + +LH + ++
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K N+LL + + K++DFG +Q++ +T + GT +MAPE +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 194
Query: 444 KSDVYSFGVLVLEIITGK 461
K D++S G++ +E++ G+
Sbjct: 195 KVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 48/223 (21%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGVL-------PSGREIAVKRLSKSSGQGAE-EFKNEV 328
+VA K + +LG G FG VY+G+ P R +A+K +++++ EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 60
Query: 329 VVVAKLQHRNLVRLLGFCLED-----------------------PEKQGQL-----DWSR 360
V+ + ++VRLLG + PE + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 361 RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420
++ G IA G+ YL+ + + +HRDL N ++ + KI DFGM + D + +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETD 173
Query: 421 TSRIAGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R G +M+PE G F+ SDV+SFGV++ EI T
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 30/198 (15%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRL---SKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
K+G G +G VYK +G +A+K++ ++ G + + E+ ++ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 344 -----GFCLE--------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384
L D LD + + +GI Y H S R++
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-RVL 121
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSV 443
HRDLK N+L+D E K++DFG+A+ FGV + T + T Y APE + Q+S
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQYST 179
Query: 444 KSDVYSFGVLVLEIITGK 461
D++S G + E++ +
Sbjct: 180 PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRL-----SKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FG VY + +GRE+A K++ S + + + E+ ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 343 LGFCLEDPEKQ---------------------GQLDWSRRYKIIGLIARGILYLHEDSRL 381
G CL D ++ G L S K I G+ YLH +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--- 125
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQ 440
I+HRD+K +NIL D+ N K+ DFG +K G R + GT +M+PE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 441 FSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
+ K+DV+S G V+E++T K + Y+
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 32/201 (15%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRL-----SKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FG VY +GRE+AVK++ S + + + E+ ++ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 343 LGFCLEDPEKQ---------------------GQLDWSRRYKIIGLIARGILYLHEDSRL 381
G CL DP ++ G L + K I G+ YLH +
Sbjct: 70 YG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--- 125
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQ 440
I+HRD+K +NIL D+ N K+ DFG +K G + + GT +M+PE
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 441 FSVKSDVYSFGVLVLEIITGK 461
+ K+D++S G V+E++T K
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 282 KFSTDNKLGAGGFGEVYKGV------LPSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKL 334
LG G FG+V K +AVK L +++ + +E ++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 335 QHRNLVRLLGFCLEDP------------EKQGQLDWSRRYKIIGL--------------- 367
H ++++L G C +D + L SR+ L
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 368 ---------------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412
I+RG+ YL E ++++HRDL N+L+ KISDFG+++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ + S+ +MA E ++ +SDV+SFGVL+ EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 38/201 (18%)
Query: 289 LGAGGFGEV------YKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG GGFGEV G + + +++ KRL K SG+ + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 343 ---------------------LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
L + + + ++G L+ R I GIL+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---M 114
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGTYGYMAPEYAMHGQ 440
I++RD+K N+LLD + N ++SD G+A V+ G T ++ AGT GYMAPE
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 441 FSVKSDVYSFGVLVLEIITGK 461
+S D ++ G + E++ G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 7/112 (6%)
Query: 351 EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410
++ G+ D R I G+ +LHE II+RDLK+ N+LLD+E + KI+DFGM K
Sbjct: 88 QRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
Query: 411 IFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
G+ G T+ GT Y+APE + + D ++ GVL+ E++ G+
Sbjct: 145 -EGI--LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 51/198 (25%), Positives = 100/198 (50%), Gaps = 23/198 (11%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
K++ K+G G G VY + + +G+E+A+K+++ E NE++V+ + ++ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 341 RLL-----------------GFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L G L D + +D + + + + +LH + ++
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K NILL + + K++DFG +Q++ +T + GT +MAPE +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 194
Query: 444 KSDVYSFGVLVLEIITGK 461
K D++S G++ +E++ G+
Sbjct: 195 KVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 33/198 (16%)
Query: 289 LGAGGFGEVY--KGVLP--SGREIAVKRLSKSSGQGAEEF--KNEVVVVAKLQHRNLVRL 342
LG G FG+V+ + + +G+ A+K L K++ + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 343 -LGFCLEDPEKQGQ----LDWSRRYKIIGLIARGILYLHEDSR---------------LR 382
F + +G+ LD+ R + +++ +++ ED + L
Sbjct: 64 HYAF-----QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
II+RDLK NILLD E + K++DFG++K +D + S GT YMAPE +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEYMAPEVVNRRGHT 176
Query: 443 VKSDVYSFGVLVLEIITG 460
+D +SFGVL+ E++TG
Sbjct: 177 QSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 289 LGAGGFGEVY------KGVLPSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVR 341
LG GGFGEV G L + +++ KRL K G +GA K ++AK+ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57
Query: 342 L-------LGFCLE----------------DPEKQGQLDWSRRYKIIGLIARGILYLHED 378
L CL D E G R I G+ +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQR 116
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
RII+RDLK N+LLD + N +ISD G+A + Q T AGT G+MAPE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
++ D ++ GV + E+I +
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 41/114 (35%), Positives = 62/114 (54%), Gaps = 29/114 (25%)
Query: 364 IIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG--------MAKI 411
I+G IA I+ YLH +L +IHRD+K SN+L++ K+ DFG +AK
Sbjct: 104 ILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161
Query: 412 FGVDQTQGNTSRIAGTYGYMAPEY---AMHGQ-FSVKSDVYSFGVLVLEIITGK 461
+D AG YMAPE ++ + + VKSDV+S G+ ++E+ TG+
Sbjct: 162 --ID---------AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 23/198 (11%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
K++ K+G G G VY + + +G+E+A+++++ E NE++V+ + ++ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 341 RLL-----------------GFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L G L D + +D + + + + +LH + ++
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRD+K NILL + + K++DFG +Q++ S + GT +MAPE +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 444 KSDVYSFGVLVLEIITGK 461
K D++S G++ +E+I G+
Sbjct: 196 KVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 53/224 (23%)
Query: 282 KFSTDNKLGAGGFGEVYKGV---LPSGRE---IAVKRLSKSSGQGAEEFKNEV--VVVAK 333
+ + LG G FG+V K L + E +AVK L + + ++ + V + + K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMK 70
Query: 334 L--QHRNLVRLLGFCLEDPE--------KQGQL-DWSRRYKIIGL--------------- 367
+ +H+N++ LLG C ++ G L D+ R + G
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 368 ----------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQ 416
+ARG+ +L S+ + IHRDL N+L+ + KI+DFG+A+ I +D
Sbjct: 131 QKDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 417 TQGNTS-RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ T+ R+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 188 YRKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 42/97 (43%), Positives = 60/97 (61%), Gaps = 11/97 (11%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQTQGNTSR-I 424
IA G+ +LH II+RDLK+ N++LDAE + KI+DFGM K IFG G T+R
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-----GKTTRTF 161
Query: 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
GT Y+APE + + D ++FGVL+ E++ G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 30/198 (15%)
Query: 288 KLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGAEEFK-NEVVVVAKLQHRNLVRL--- 342
KLG G + VYKG + EI A+K + + +G E+ ++ +L+H N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 343 ----------LGFCLEDPEK-------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385
+ +D +K +G LD + + +GI + HE+ R++H
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGTYGYMAPEYAMHGQ-FSV 443
RDLK N+L++ K++DFG+A+ FG+ NT S T Y AP+ + + +S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 444 KSDVYSFGVLVLEIITGK 461
D++S G ++ E+ITG+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 42/201 (20%)
Query: 288 KLGAGGFGEVYK------GVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG+VYK G L + + I K S + E++ E+ ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 342 LLG-------------FCLEDPEKQGQLDWSRRYK--IIGLIARGIL----YLHEDSRLR 382
LLG FC L+ R I +I R +L YLH ++
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MK 130
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGM-AKIFGVDQTQGNTSRIAGTYGYMAPEYAM---- 437
IIHRDLK N+LL + + K++DFG+ AK V Q S I GT +MAPE M
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFI-GTPYWMAPEVVMCETM 187
Query: 438 -HGQFSVKSDVYSFGVLVLEI 457
+ K+D++S G+ ++E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 281 NKFSTDNKLGAGGFGEVY----KGVLP---------SGRE--IAVKRLSKSSGQGAE-EF 324
+ KLG G FGEV+ +G+ G+ +AVK L + A +F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 325 KNEVVVVAKLQHRNLVRLLGFCL-EDP--------------------EKQGQLDWSRRYK 363
E+ ++++L++ N++RLLG C+ +DP E + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 364 IIGL---------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414
+ + IA G+ YL + L +HRDL N L+ KI+DFGM++
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR---- 177
Query: 415 DQTQGNTSRIAG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ G+ RI G +MA E + G+F+ SDV++FGV + E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 41/111 (36%), Positives = 58/111 (52%), Gaps = 13/111 (11%)
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
D +R Y I I + YLH IIHRDLK NIL+D+ + K++DFG++K G+ +
Sbjct: 93 DVARIY--IAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVR 146
Query: 417 TQGN-------TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
Q N RI GT Y+APE + S D +S G ++ E + G
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGRE-IAVK--RLSKSSGQGAEEFKNEVVVVAKLQHR 337
+++ K+G G +G VYK E IA+K RL + E+ ++ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 338 NLVRL-----------LGFCLEDPEKQGQLD----WSRRYKIIGL----IARGILYLHED 378
N+VRL L F D + + +D +++ ++I I RGI Y H
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH-- 119
Query: 379 SRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
S R++HRDLK N+L+D N K++DFG+A+ FG+ + T + T Y APE +
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILL 176
Query: 438 HG-QFSVKSDVYSFGVLVLEIITGK 461
+S D++S G + E++ K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 40/264 (15%)
Query: 225 IVAPIVVTAVLFIV---GFCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVAT- 280
+ + ++ + GF F+R + + V +N+ T E FD + K T
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRV-----ENEDGTWELQFFDSKVSKSITI 685
Query: 281 ----NKFSTDNKLGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ 335
+ +N + G G YKG + +G + VK ++ + + E + + KLQ
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQ 741
Query: 336 HRNLVRLLGFC---------LEDPEKQG------QLDWSRRYKIIGLIARGILYLHEDSR 380
H N+V+L+G C E E + L W RR KI IA+ + +LH
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ 440
++ +L I++D + P + + + D +S Y+APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKD 854
Query: 441 FSVKSDVYSFGVLVLEIITGKKNS 464
+ KSD+Y FG++++E++TGK +
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPA 878
|
Length = 968 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 22/175 (12%)
Query: 304 SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR-----------------LLGFC 346
SGR++AVK + Q E NEVV++ QH+N+V L G
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 347 LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
L D Q +L+ + + + + + YLH +IHRD+K +ILL + K+SDF
Sbjct: 105 LTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDF 161
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
G D + + + GT +MAPE + + D++S G++V+E++ G+
Sbjct: 162 GFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 32/203 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGAEEFK---NEVVVVAKLQH 336
F ++G GG+G+V+ EI A+KR+ KS E + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 337 RNLVRLLGFCLEDPEKQGQLDWSRRYKIIG-----LIARGIL-------YLHE-----DS 379
LV+LL + +D E L + Y G L G+L Y+ E D+
Sbjct: 61 EWLVKLL-YAFQDDEY---LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA 116
Query: 380 --RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
L IHRDLK N L+DA + K++DFG++K T N+ + G+ YMAPE
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLR 171
Query: 438 HGQFSVKSDVYSFGVLVLEIITG 460
+ D +S G ++ E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 36/207 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKN----EVVVVAKLQ 335
NK+ +G G +G V K +G +A+K+ +S + E+ K EV V+ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLR 58
Query: 336 HRNLVRLLGFC-----------------LEDPEKQ-GQLDWSRRYKIIGLIARGILYLHE 377
H N+V L LE E G L I + + I Y H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH- 117
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE--- 434
IIHRD+K NIL+ K+ DFG A+ T +A T Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLV 174
Query: 435 -YAMHGQFSVKSDVYSFGVLVLEIITG 460
+G V DV++ G ++ E++ G
Sbjct: 175 GDTNYG-KPV--DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 29/196 (14%)
Query: 287 NKLGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR---- 341
K+G G G V +GR++AVK++ Q E NEVV++ QH N+V
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 342 -------------LLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388
L G L D +++ + + + + + +LH +IHRD+
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDI 141
Query: 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR---IAGTYGYMAPEYAMHGQFSVKS 445
K +ILL ++ K+SDFG Q R + GT +MAPE + +
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCA-----QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 446 DVYSFGVLVLEIITGK 461
D++S G++V+E++ G+
Sbjct: 197 DIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 58/232 (25%)
Query: 288 KLGAGGFGEVY----KGVL----------PSGRE---IAVKRLSKSSGQGAE-EFKNEVV 329
KLG G FGEV+ +G+ SG + +AVK L + + + A +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 330 VVAKLQHRNLVRLLGFCLED-----------------------PEKQGQLDWSRRYKIIG 366
++++L+ N++RLL C+ P++ +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 367 L------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420
L IA G+ YL S L +HRDL N L+ KI+DFGM++ + G+
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGD 184
Query: 421 TSRIAG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
RI G +M+ E + G+F+ SDV++FGV + EI+T K + Q
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN-----EVVVVAKLQ 335
++ KLG G + VYK +GR +A+K++ + A++ N E+ ++ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 336 HRNLVRLLG-------------FCLEDPEKQGQL--DWSRRYK------IIGLIARGILY 374
H N++ LL F D EK + D S + + RG+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEK---VIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
LH I+HRDLK +N+L+ ++ K++DFG+A+ FG + T ++ T Y APE
Sbjct: 118 LH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYRAPE 172
Query: 435 YAMHG--QFSVKSDVYSFGVLVLEIITGK 461
G + V D++S G + E++
Sbjct: 173 LLF-GARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 42/204 (20%)
Query: 289 LGAGGFGEVY--------KGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+G G FG V+ K V+ ++I V++++K A+ NE V+ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 341 RLLGFCLEDPEKQGQLDWSRRYKIIGLIARGI-----LYLHEDSRLR------------- 382
LED L Y G +A I L ED+ L
Sbjct: 63 EYYENFLED----KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 383 ---IIHRDLKVSNILLDA-EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
I+HRDLK NILLD +M KI DFG++KI ++ + GT Y++PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEG 175
Query: 439 GQFSVKSDVYSFGVLVLEIITGKK 462
++ KSD+++ G ++ E+ + K+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 66/230 (28%)
Query: 288 KLGAGGFGEVY------KGVLPS---------GRE--IAVKRLSKSSGQGAE-EFKNEVV 329
KLG G FGEV+ LP+ GR +AVK L + + A +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 330 VVAKLQHRNLVRLLGFCL-EDP-----------------------EKQGQ---------- 355
++++L+ N++RLLG C+ EDP +K+
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 356 ---LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412
+ +S + IA G+ YL S L +HRDL N L+ + KI+DFGM++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR-- 186
Query: 413 GVDQTQGNTSRIAG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458
+ G+ RI G +MA E + G+F+ SDV++FGV + EI+
Sbjct: 187 --NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 37/207 (17%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKLQH 336
TN++ +G G FG V +G+ +A+K++ K S+ A+ E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 337 RNLVRLLGFC---LED----PEKQG----QLDWSRR----------YKIIGLIARGILYL 375
N++ L LED E G +L SR Y+I+ RG+ Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL----RGLKYV 124
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H ++HRDLK SNIL++ + KI DFG+A+I Q T ++ Y Y APE
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAPEI 176
Query: 436 AMHGQ-FSVKSDVYSFGVLVLEIITGK 461
+ Q + V+ D++S G + E++ GK
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 48/213 (22%)
Query: 282 KFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRL--SKSSGQGAEEFKNEVVVVAKLQ 335
K+ K+G G FG K +L G++ +K + SK S + EE + EV V++ ++
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 336 HRNLVRLLGFCLEDPEKQGQL-------DWSRRYKIIGLIARGILYLHEDSRL------- 381
H N+V+ E E+ G L + YK I RG+L+ ED L
Sbjct: 58 HPNIVQYQ----ESFEENGNLYIVMDYCEGGDLYKKINA-QRGVLF-PEDQILDWFVQIC 111
Query: 382 ---------RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA----GTY 428
+I+HRD+K NI L + K+ DFG+A++ +T +A GT
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIGTP 165
Query: 429 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y++PE + ++ KSD+++ G ++ E+ T K
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLS---KSSGQGAEEFKNEVVVVAKLQHRN 338
F + K+G G F EVY+ L + +A+K++ + ++ E+ ++ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 339 LVRLLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL----------------- 381
+++ L +ED E L+ + G +++ I Y + RL
Sbjct: 64 VIKYLDSFIEDNELNIVLELAD----AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 382 ------RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
R++HRD+K +N+ + A K+ D G+ + F T ++ + GT YM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
++ KSD++S G L+ E+ S FY
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM--AALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 282 KFSTDNKLGAGGFGEVYKGVL---PSGREIAVKRL--SKSSGQG-AEEFKNEVVVVAKLQ 335
K+ + +G G +G VYK G+E A+K+ K G ++ E+ ++ +L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 336 HRNLVRLLGFCLEDPEKQ-------------GQLDWSRRYK-----------IIGLIARG 371
H N+V L+ LE +K + + R+ K ++ I G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGVD-QTQGNTSRIAG 426
+ YLH + ++HRDLK +NIL+ E KI D G+A++F + + +
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 427 TYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIIT 459
T Y APE + + K+ D+++ G + E++T
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 46/219 (21%)
Query: 289 LGAGGFGEVYK-------GVLPSGREIAVKRLS-----KSSGQGAEEFKNEVVVVAK-LQ 335
LG+G FG VYK L + +EI V + + + + +EV ++ + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 336 HRNLVRLLGFCLED----------------------PEKQGQLDWSRRYKIIGLIARGIL 373
H N+VR LE+ EK+ + R + I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT--SRIAGTYGYM 431
YLH++ R I+HRDL +NI+L + I+DFG+AK Q Q + + + GT Y
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
PE + + K+DV++FG ++ ++ T FY T+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 66/199 (33%), Positives = 91/199 (45%), Gaps = 34/199 (17%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRL-- 342
LG GGFGEV V +G+ A K+L K +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 343 -------------------LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L F + + G D R I G+ LH R RI
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLH---RERI 123
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQFS 442
++RDLK NILLD + +ISD G+A V+ +G T R GT GYMAPE + +++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 443 VKSDVYSFGVLVLEIITGK 461
D + G L+ E+I GK
Sbjct: 180 FSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 38/195 (19%)
Query: 292 GGFGEVY--KGVLPSGREIAVKRLSKSSGQGAEEFKN------------EVVVVAKL--- 334
G FG VY K +G A+K L KS + N E VAKL
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 335 -QHRNLVRLL------GFCLEDPEKQGQL--DWSRRYKIIGLIARGILYLHEDSRLRIIH 385
Q ++ + L+ G C + G L DW+++Y I + G+ LH+ IIH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIH 120
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKS 445
RD+K N+L+D + K++DFG+++ ++ + GT Y+APE + S
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMS 174
Query: 446 DVYSFGVLVLEIITG 460
D +S G ++ E + G
Sbjct: 175 DWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 41/105 (39%), Positives = 62/105 (59%), Gaps = 11/105 (10%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQTQGNTSRIA 425
I G+ +LH+ II+RDLK+ N+LLD + + KI+DFGM K + G +G S
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT Y+APE +++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ--SPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 48/209 (22%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVVVVAKLQHRN 338
+G+G +G V V +GR++A+K++S F + E+ ++ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 339 LVRLLGFCL-EDPEKQG---------QLDWSR-------------RYKIIGLIARGILYL 375
++ LL PE + D + +Y + ++ RG+ YL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL-RGLKYL 119
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN--TSRIAGTYGYMAP 433
H + +IHRDLK SNIL+++ + KI DFG+A+ D+ + T + T Y AP
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAP 175
Query: 434 EYAMHGQ-FSVKSDVYSFGVLVLEIITGK 461
E + ++ D++S G + E++T K
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 43/122 (35%), Positives = 66/122 (54%), Gaps = 11/122 (9%)
Query: 351 EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410
+ +G+ D R I G+ +LH II+RDLK+ N++LD + + KI+DFGM K
Sbjct: 88 QDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
Query: 411 --IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
+FG S GT Y+APE +++ D +SFGVL+ E++ G+ S F+
Sbjct: 145 ENVFG----DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHG 198
Query: 469 TD 470
D
Sbjct: 199 DD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 50/231 (21%)
Query: 283 FSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQH 336
F+ LG G FG V + L S +++AVK L S EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 337 RNLVRLLGFCLEDPEKQ--------------GQLDWSRRYKIIGL--------------- 367
N+++L+G L K G L IG
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 368 -IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD-QTQGNTSRI 424
IA G+ YL S IHRDL N +L+ M ++DFG++ KI+ D QG S++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFYQ 468
++A E ++ SDV++FGV + EI+T G +NS Y
Sbjct: 178 P--VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 28/192 (14%)
Query: 288 KLGAGGFGEVYKGVLPSGRE-IAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
++G G FGEV+ G L + +AVK ++ +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 346 CLEDPE-------KQG------------QLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
C + QG +L +++ A G+ YL IHR
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 387 DLKVSNILLDAEMNPKISDFGMAK--IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVK 444
DL N L+ + KISDFGM++ GV + G +I + APE +G++S +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP--VKWTAPEALNYGRYSSE 176
Query: 445 SDVYSFGVLVLE 456
SDV+SFG+L+ E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
LG GGFGEV V +G+ A K+L K +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 345 FCLEDPEK---------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
+ E + + + R I G+ LH++ RI
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
++RDLK NILLD + +ISD G+A V + Q R+ GT GYMAPE + +++
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNERYTF 180
Query: 444 KSDVYSFGVLVLEIITGKKNSSFYQ 468
D ++ G L+ E+I G+ S F Q
Sbjct: 181 SPDWWALGCLLYEMIAGQ--SPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 43/218 (19%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSS----GQGAEE 323
+FE ++V LG G +G+V+ G +G+ A+K L K++ + AE
Sbjct: 1 NFELLRV----------LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH 50
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEK-------------------QGQLDWSRRYKI 364
+ E V+ ++ + L + + K + S
Sbjct: 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
I I + +LH+ L II+RD+K+ NILLD+E + ++DFG++K F ++ + S
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-F 166
Query: 425 AGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITG 460
GT YMAPE G D +S GVL E++TG
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 36/200 (18%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
LG GGFGEV V +G+ A K+L K +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 345 FCLEDPE---------KQGQLDWSRRYKIIGL------IARGILY-------LHEDSRLR 382
+ E + G L ++ I + R I Y L + R R
Sbjct: 67 YAYETKDALCLVLTIMNGGDL----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQF 441
I++RDLK NILLD + +ISD G+A V +G T R GT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 442 SVKSDVYSFGVLVLEIITGK 461
+ D + G L+ E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 50/205 (24%)
Query: 288 KLGAGGFGEVYK------GVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG+VYK GVL + + I K S + E++ E+ ++A H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66
Query: 342 LLG-------------FC-----------LEDPEKQGQLDWSRRYKIIGLIARGILYLHE 377
LL FC LE P + Q+ + + L YLHE
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN-----YLHE 121
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ +IIHRDLK NIL + + K++DFG++ +T GT +MAPE M
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 438 -----HGQFSVKSDVYSFGVLVLEI 457
+ K+DV+S G+ ++E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 37/204 (18%)
Query: 289 LGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLG-FC 346
+G G +G+VYKG ++A ++ +G EE K E+ ++ K HRN+ G F
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 347 LEDPEKQGQLDW---------------------SRRYKIIGLIARGIL----YLHEDSRL 381
++P W + + + I I R IL +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--- 130
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM---- 437
++IHRD+K N+LL K+ DFG++ +D+T G + GT +MAPE
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 438 -HGQFSVKSDVYSFGVLVLEIITG 460
+ KSD++S G+ +E+ G
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 42/118 (35%), Positives = 63/118 (53%), Gaps = 11/118 (9%)
Query: 355 QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IF 412
+ D R I G+ +LH I++RDLK+ NILLD + + KI+DFGM K +
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148
Query: 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
G T GT Y+APE + +++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 149 G----DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 23/192 (11%)
Query: 288 KLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR----- 341
K+G G G V +G+++AVK++ Q E NEVV++ H N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 342 ------------LLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLK 389
L G L D +++ + + + R + YLH +IHRD+K
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIK 145
Query: 390 VSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYS 449
+ILL ++ K+SDFG V + + GT +MAPE + + D++S
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 450 FGVLVLEIITGK 461
G++V+E+I G+
Sbjct: 204 LGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 47/207 (22%)
Query: 289 LGAGGFGEVYK----GVLPSGR--EIAVKRLSKSSGQGAEE--FKNEVVVVAKL-QHRNL 339
LGAG FG+V + G+ S ++AVK L K + +E +E+ +++ L H N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 340 VRLLGFCLEDPEKQGQ-------------LDWSRRYKIIGL-----------IARGILYL 375
V LLG C G L++ RR + L +A+G+ +L
Sbjct: 102 VNLLGAC----TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTSRIAGTYGYMA 432
+ IHRDL N+LL KI DFG+A+ D +GN R+ +MA
Sbjct: 158 ASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA-RLP--VKWMA 211
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIIT 459
PE + ++ +SDV+S+G+L+ EI +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 56/201 (27%), Positives = 81/201 (40%), Gaps = 39/201 (19%)
Query: 289 LGAGGFGEV----YKGVLPSGREIAVKRLSKS---SGQGAEEFKNE---VVVVAKLQHRN 338
LG G FG+V YK +G A+K L K + E E +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 339 LVRLLGFCLEDPEK------------------QGQLDWSRRYKIIGLIARGILYLHEDSR 380
LV L C + + R + G+ YLHE+
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN-- 120
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI-FGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+I++RDLK+ N+LLD E KI+DFG+ K G TS GT ++APE
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPEVLTET 176
Query: 440 QFSVKSDVYSFGVLVLEIITG 460
++ D + GVL+ E++ G
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 46/206 (22%)
Query: 292 GGFGEVYKGVL---PSGREIAVKRLSKSSGQGAEE-----FKNEVVVVAKLQHRNLVRLL 343
G FG ++ G+L G+E V K+ A E E ++ L H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEV--FVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 344 GFCLEDPE---------------------KQGQLDWSRRYKIIGL------IARGILYLH 376
C+ED E + G+ + + L IA G+ YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVD-QTQG-NTSRIAGTYGYMAP 433
+ +IH+D+ N ++D E+ KI+D +++ +F +D G N +R +MA
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR---PVKWMAL 188
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIIT 459
E ++ ++S SDV+SFGVL+ E++T
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 26/111 (23%)
Query: 363 KIIGLIA----RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG--------MAK 410
I+G I+ RG+ YL E + +I+HRD+K SNIL+++ K+ DFG MA
Sbjct: 99 NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156
Query: 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
F GT YM+PE ++V+SD++S G+ ++E+ G+
Sbjct: 157 SF------------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 38/95 (40%), Positives = 59/95 (62%), Gaps = 7/95 (7%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAG 426
I+ G+ +LH II+RDLK+ N++LD+E + KI+DFGM K VD G T+R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCG 163
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
T Y+APE + + D +++GVL+ E++ G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 33/194 (17%)
Query: 289 LGAGGFGEVYKG-VLPSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLG-- 344
LG G G VYK L + R +AVK + + + ++ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 345 -------FCLEDPEKQGQLD--WSRRYKIIGLIA----RGILYLHEDSRLRIIHRDLKVS 391
C E + G LD ++G IA +G+ YL L+I+HRD+K S
Sbjct: 69 FVENRISICTEFMDG-GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPS 124
Query: 392 NILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY----GYMAPEYAMHGQFSVKSDV 447
N+L++ K+ DFG++ TQ S IA TY YMAPE Q+ + SDV
Sbjct: 125 NMLVNTRGQVKLCDFGVS-------TQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 448 YSFGVLVLEIITGK 461
+S G+ +E+ G+
Sbjct: 177 WSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 61/242 (25%), Positives = 95/242 (39%), Gaps = 70/242 (28%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKS----SGQGAEEFKN 326
DFE IKV +G G FGEV+ ++ A+K L KS Q A +
Sbjct: 2 DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRA 50
Query: 327 EVVVVAKLQHRNLVRLLGFCLEDPE-------------------KQGQLD--WSRRYKII 365
E ++A +V+L + +D E ++ +R Y
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--- 106
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--------------- 410
IA +L L +L IHRD+K NIL+DA+ + K++DFG+ K
Sbjct: 107 --IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 411 ----------IFGVDQTQGNTSR--IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458
+ D Q GT Y+APE + ++ D +S GV++ E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 459 TG 460
G
Sbjct: 225 YG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 48/223 (21%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGVL-------PSGREIAVKRLSKSSGQGAE-EFKNEV 328
+V+ K + +LG G FG VY+G R +AVK +++S+ EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEA 60
Query: 329 VVVAKLQHRNLVRLLGF------------------------CL----EDPEKQGQLDWSR 360
V+ ++VRLLG L E+ +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 361 RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420
++ IA G+ YL+ + +HRDL N ++ + KI DFGM + D + +
Sbjct: 121 MIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETD 173
Query: 421 TSRIAGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R G +MAPE G F+ SD++SFGV++ EI +
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 23/192 (11%)
Query: 288 KLGAGGFGEV-YKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR----- 341
K+G G G V V SG+ +AVK++ Q E NEVV++ QH N+V
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 342 ------------LLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLK 389
L G L D +++ + + + + + LH +IHRD+K
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIK 143
Query: 390 VSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYS 449
+ILL + K+SDFG V + + GT +MAPE + + D++S
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 450 FGVLVLEIITGK 461
G++V+E++ G+
Sbjct: 202 LGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 40/219 (18%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK----NEVVVV 331
K +KF ++G G +G+VYK +G +A+K++ + + E F E+ ++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 332 AKLQHRNLVRLLGFCLEDPEKQGQLDWSRR------------YKIIGLIARGILYLHED- 378
+L HRN+V L + KQ LD+ + + ++GL+ G+++ ED
Sbjct: 61 RQLNHRNIVNLKEIVTD---KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 117
Query: 379 --SRLR-------------IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423
S ++ +HRD+K SNILL+ + K++DFG+A+++ ++++ T++
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 424 IAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
+ T Y PE + ++ DV+S G ++ E+ T K
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 24/148 (16%)
Query: 288 KLGAGGFGEVYKGVLPSGREI-AVKRLS-KSSGQGAEEFK-NEVVVVAKLQHRNLVRL-- 342
K+G G +G V+K EI A+KR+ +G E+ ++ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 343 -----------LGFCLEDPEK-----QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
+C +D +K G +D + + +G+ + H ++HR
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHR 123
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGV 414
DLK N+L++ K++DFG+A+ FG+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 46/206 (22%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGAEEFKN---EVVVVAKLQHRN 338
F+ ++G G FG VY E+ A+K++S S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 339 LVRLLG-------------FCL-------EDPEKQGQLDWSRRYKIIGLIARGIL----Y 374
+ G +CL E +K Q I I G L Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVE------IAAICHGALQGLAY 130
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
LH R IHRD+K NILL K++DFG A + + GT +MAPE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPE 181
Query: 435 --YAM-HGQFSVKSDVYSFGVLVLEI 457
AM GQ+ K DV+S G+ +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 55/215 (25%)
Query: 289 LGAGGFGEVYKGVLPSG---REIAVKRLSKSSGQG-AEEFKNEVVVVAKL-QHRNLVRLL 343
+G G FG+V K + + A+KR+ + + + +F E+ V+ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 344 GFC---------LEDPEKQGQLDWSRRYKIIGL-------------------------IA 369
G C +E LD+ R+ +++ +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
RG+ YL S+ + IHRDL NIL+ KI+DFG+++ G + T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183
Query: 430 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MA E + ++ SDV+S+GVL+ EI++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 34/205 (16%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRL---SKSSGQGAEEFKNEVVVVAKLQHRN 338
F K+G G +G VYK +G +A+K++ +++ G + + E+ ++ +L H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 339 LVRLLG-------------FCLEDPEKQGQLDWSRRYKI-IGLIA-------RGILYLHE 377
+V+LL F +D +K +D S I + LI +G+ + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKF--MDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
R++HRDLK N+L++ E K++DFG+A+ FGV + T + T Y APE +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 173
Query: 438 HGQF-SVKSDVYSFGVLVLEIITGK 461
++ S D++S G + E++T +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 51/217 (23%)
Query: 289 LGAGGFGEVYK----GVLPSGRE----IAVKRLS-KSSGQGAEEFKNEVVVVAKL-QHRN 338
LG G FG+V + G+ S + +AVK L ++ + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 339 LVRLLGFCLED--------------------------PE--------KQGQLDWSRRYKI 364
++ LLG C ++ P+ + QL +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ--GNTS 422
+ARG+ YL +SR R IHRDL N+L+ + KI+DFG+A+ GV TS
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE ++ +SDV+SFG+L+ EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLS---KSSGQGAEEFKNEVVVVAKLQHRN 338
F + K+G G F EVY+ L G +A+K++ + + E+ ++ +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 339 LVRLLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL----------------- 381
+++ +ED E L+ + G ++R I + + RL
Sbjct: 64 VIKYYASFIEDNELNIVLELAD----AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 382 ------RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
R++HRD+K +N+ + A K+ D G+ + F T ++ + GT YM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
++ KSD++S G L+ E+ S FY
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM--AALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 36/201 (17%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG-QGAEEFK-NEVVVVAKLQ---HRNLV 340
++G G +G VYK L +GR +A+K++ +G E+ ++ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 341 RLLGFCL-EDPEKQGQL-------DW---------------SRRYK-IIGLIARGILYLH 376
RLL C +++ +L D K ++ + RG+ +LH
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
RI+HRDLK NIL+ ++ KI+DFG+A+I+ + TS + T Y APE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLWYRAPEVL 178
Query: 437 MHGQFSVKSDVYSFGVLVLEI 457
+ ++ D++S G + E+
Sbjct: 179 LQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 34/198 (17%)
Query: 289 LGAGGFGEVYKGVL--PSGRE--IAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLL 343
LG G FGE+ +G L PS RE +A+ L S + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 344 GFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384
G + +GQL + ++ +A G+ YL E + +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYV 129
Query: 385 HRDLKVSNILLDAEMNPKISDFGMA---KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
H+ L +L+++++ KIS F K + T S + + APE + F
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQYHHF 185
Query: 442 SVKSDVYSFGVLVLEIIT 459
S SDV+SFG+++ E+++
Sbjct: 186 SSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 40/202 (19%)
Query: 289 LGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKN---EVVVVAKLQHRNLVRLLG 344
+G+G +G+V +GR++A+K+LS+ Q A K E+ ++ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 345 -FC----LEDPE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
F LED + K +L ++ I RG+ Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AG 138
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA---MHG 439
IIHRDLK SNI ++ + KI DFG+A+ T + T Y APE MH
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
+V D++S G ++ E++TGK
Sbjct: 194 NQTV--DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 41/205 (20%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLL 343
N++G G +G VY+ SG +A+K R+ E+ ++ L+H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 344 ---------------GFCLED----------PEKQGQLDWSRRYKIIGL-IARGILYLHE 377
+C +D P + Q+ K + L + RG+ YLHE
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQV------KCLMLQLLRGLQYLHE 126
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ IIHRDLKVSN+LL + KI+DFG+A+ +G+ T ++ T Y APE +
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVV-TLWYRAPELLL 181
Query: 438 HGQFSVKS-DVYSFGVLVLEIITGK 461
+ D+++ G ++ E++ K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 37/207 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK-------NEVVVVA 332
K+ +G G +G V K +G+ +A+K+ +S E+ K E+ ++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLK 55
Query: 333 KLQHRNLVRLLGFC-----------------LEDPEK-QGQLDWSRRYKIIGLIARGILY 374
+L+H NLV L+ L+D EK LD SR K + I RGI +
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
H + IIHRD+K NIL+ K+ DFG A+ + T +A T Y APE
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA-TRWYRAPE 170
Query: 435 YAM-HGQFSVKSDVYSFGVLVLEIITG 460
+ ++ D+++ G LV E++TG
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 34/200 (17%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---EVVVVAKLQHRN 338
FS ++G G FG VY + + +A+K++S S Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 339 LVRLLG-------------FCLEDPEKQGQLDWSRRYKI-IGLIARGIL----YLHEDSR 380
++ G +CL ++ ++ I + G L YLH +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM--- 437
+IHRD+K NILL K+ DFG A I + GT +MAPE +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMD 187
Query: 438 HGQFSVKSDVYSFGVLVLEI 457
GQ+ K DV+S G+ +E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 55/218 (25%)
Query: 286 DNKLGAGGFGEVYKGVLPS-GREI--AVKRLSK-SSGQGAEEFKNEVVVVAKL-QHRNLV 340
++ +G G FG+V + ++ G ++ A+K L + +S +F E+ V+ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 341 RLLGFC---------LEDPEKQGQLDWSRRYKIIGL------------------------ 367
LLG C +E LD+ R+ +++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 368 -IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426
+A G+ YL E + IHRDL N+L+ + KI+DFG+++ G +
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKK 175
Query: 427 TYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
T G +MA E + ++ KSDV+SFGVL+ EI++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 37/94 (39%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
IA G+ +LH II+RDLK+ N++LD+E + KI+DFGM K D T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y+APE + + D ++FGVL+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 49/213 (23%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL----- 342
LG G G V+ V + +AVK++ + Q + E+ ++ +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 343 -----LGFCLEDPEK--------------------QGQL--DWSR--RYKIIGLIARGIL 373
L + + QG L + +R Y+++ RG+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL----RGLK 128
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQT---QGNTSRIAGTYG 429
Y+H + ++HRDLK +N+ ++ E + KI DFG+A+I VD +G S T
Sbjct: 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKW 183
Query: 430 YMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 461
Y +P + K+ D+++ G + E++TGK
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 34/196 (17%)
Query: 287 NKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGAEEFKN---EVVVVAKLQHRNLVRL 342
+++G G FG VY E+ AVK++S S Q E++++ EV + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 343 LG-------------FCLEDPEKQGQLDWSRRYKI-IGLIARGIL----YLHEDSRLRII 384
G +CL ++ ++ I I G L YLH + +I
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM---HGQF 441
HRD+K NILL K++DFG A + N+ GT +MAPE + GQ+
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVILAMDEGQY 197
Query: 442 SVKSDVYSFGVLVLEI 457
K DV+S G+ +E+
Sbjct: 198 DGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 37/208 (17%)
Query: 282 KFSTDNKLGAGGFGEVYKGVLPSGREIAVKR---LSKSSGQGAEEFKNEVVVVAKLQHRN 338
++ K+G G FG++Y S E V + L+K + E K EV+++AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 339 LVRLLGFCLEDPEKQGQL----------DWSRRY-----------KIIGL---IARGILY 374
+V E+ G+L D +R +I+ I+ G+ +
Sbjct: 61 IVTFFASFQEN----GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 375 LHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+H+ +I+HRD+K NI L M K+ DFG+A+ T GT Y++P
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSP 171
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E + ++ K+D++S G ++ E+ T K
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 47/206 (22%)
Query: 289 LGAGGFGEV----YKGVLPSGREIAVKRLS--KSSGQGAEEFKNEVVVVAKLQHRNLVR- 341
+G G +GEV ++ G++ +K+L+ +S + + + E ++++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 342 -------------LLGFC------LEDPEKQGQL-------DWSRRYKIIGLIARGILYL 375
++GFC + E++G+L +W + IA + YL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYL 118
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
HE I+HRDLK N+ L K+ D G+A++ ++ S + GT YM+PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPEL 173
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
+ ++ KSDV++ G V E+ T K
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 34/200 (17%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGRE-IAVKRLSKSSGQGAEEFKN---EVVVVAKLQHRN 338
F+ ++G G FG VY E +A+K++S S Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 339 LVRLLG-------------FCLEDPEKQGQLDWSRRYKI-IGLIARGIL----YLHEDSR 380
+ G +CL ++ ++ I I G L YLH +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 145
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM--- 437
+IHRD+K NILL K++DFG A I + GT +MAPE +
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMD 197
Query: 438 HGQFSVKSDVYSFGVLVLEI 457
GQ+ K DV+S G+ +E+
Sbjct: 198 EGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK----NEVVVVAKLQ 335
+K+ K+G G FGEV+K + + +A+K++ E F E+ ++ L+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLK 69
Query: 336 HRNLVRL---------------------LGFCLED-----PEKQGQLDWSRRYKIIGLIA 369
H N+V L FC D K + S K++ ++
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV---DQTQGNTSRIAG 426
G+ Y+H R +I+HRD+K +NIL+ + K++DFG+A+ F + + T+R+
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185
Query: 427 TYGYMAPE 434
T Y PE
Sbjct: 186 TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 49/212 (23%)
Query: 289 LGAGGFGEVYKGVLPSG---REIAVKRLSK-SSGQGAEEFKNEVVVVAKL-QHRNLVRLL 343
+G G FG+V K + + A+KR+ + +S +F E+ V+ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 344 GFC---------LEDPEKQGQLDWSRRYKII--------------GLIARGILYLHED-- 378
G C +E LD+ R+ +++ L ++ +L+ D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 379 ------SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG--- 429
S+ + IHRDL NIL+ KI+DFG+++ G + T G
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLP 174
Query: 430 --YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MA E + ++ SDV+S+GVL+ EI++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 34/198 (17%)
Query: 289 LGAGGFGEVYKGVLP-SGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
LG G FG+V L SGR AVK L K E E +++ ++ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 345 FCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385
C + P+ K + D +R I +++LH+ II+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIY 119
Query: 386 RDLKVSNILLDAEMNPKISDFGMAK--IF-GVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
RDLK+ N+LLD E + K++DFGM K IF G TS GT Y+APE +
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-----TTSTFCGTPDYIAPEILQEMLYG 174
Query: 443 VKSDVYSFGVLVLEIITG 460
D ++ GVL+ E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 34/199 (17%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRL-- 342
LG GGFGEV V +G+ A KRL K +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 343 -------------------LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L F + + G + R I G+ LH ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHREN---T 123
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMA-KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
++RDLK NILLD + +ISD G+A KI + +G GT GYMAPE + +++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYT 179
Query: 443 VKSDVYSFGVLVLEIITGK 461
+ D + G L+ E+I G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 49/234 (20%)
Query: 260 DNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG 318
D DL+ L FE ++V +G G +G+VYKG + +G+ A+K + +
Sbjct: 5 DIDLSALRDPAGIFELVEV----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED 54
Query: 319 QGAEEFKNEVVVVAKL-QHRNLVRLLG-FCLEDPEKQGQLDW------------------ 358
+ EE K E+ ++ K HRN+ G F + P W
Sbjct: 55 E-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 359 ---SRRYKIIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411
+ + I I R IL +LH ++IHRD+K N+LL K+ DFG++
Sbjct: 114 KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA- 169
Query: 412 FGVDQTQGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG 460
+D+T G + GT +MAPE + +SD++S G+ +E+ G
Sbjct: 170 -QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 43/218 (19%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY--KGVL--PSGREIAVKRLSKSS----GQGAEE 323
+FE +KV LG G +G+V+ + V SG+ A+K L K++ + E
Sbjct: 1 NFELLKV----------LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEH 50
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEK---------QGQL--DWSRRYKI-------- 364
+ E V+ ++ + L + + K G+L S+R +
Sbjct: 51 TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
G I + +LH +L II+RD+K+ NILLD+ + ++DFG++K F D+ + S
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-F 166
Query: 425 AGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITG 460
GT YMAP+ G D +S GVL+ E++TG
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 47/215 (21%)
Query: 270 QFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEV 328
Q DFE I+ ++G+G +G+VYK + +G A+K + G+ + E+
Sbjct: 8 QEDFELIQ----------RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI 57
Query: 329 VVVAKLQHRNLVRLLG-------------FC----LED------PEKQGQLDWSRRYKII 365
+++ +H N+V G FC L+D P + Q+ + R +
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL- 116
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
+G+ YLH + +HRD+K +NILL + K++DFG++ + T
Sbjct: 117 ----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFI 167
Query: 426 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 457
GT +MAPE A G ++ D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 39/202 (19%)
Query: 288 KLGAGGFGEVYKG--VLPSGREIAVKRLSKSSGQGAEEFKN--EVVVVAKLQ---HRNLV 340
++G G +G+V+K + GR +A+KR+ +G+ EV V+ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 341 RLLGFC-------------------------LEDPEKQGQLDWSRRYKIIGLIARGILYL 375
RL C L+ + G + + + L+ RG+ +L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL-RGLDFL 126
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H R++HRDLK NIL+ + K++DFG+A+I+ Q + + T Y APE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEV 180
Query: 436 AMHGQFSVKSDVYSFGVLVLEI 457
+ ++ D++S G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 47/215 (21%)
Query: 270 QFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEV 328
Q D+E I+ ++G+G +G+VYK L +G AVK + G + E+
Sbjct: 8 QHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI 57
Query: 329 VVVAKLQHRNLVRLLG---------FCLE--------------DPEKQGQLDWSRRYKII 365
+V + +H N+V G C+E P + Q+ + R +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
+G+ YLH ++ HRD+K +NILL + K++DFG+A + T
Sbjct: 117 ----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFI 167
Query: 426 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 457
GT +MAPE A +G ++ D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 70/229 (30%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK 325
S E++ T+ + +G G +G+VYK G AVK L S EE +
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 326 NEVVVVAKL-QHRNLVRLLG-FCLEDPEKQGQLDW---------SRRYKIIGLIARG--- 371
E ++ L H N+V+ G F D GQL W S + GL+ G
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRL 125
Query: 372 -------ILY--------LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
ILY LH + RIIHRD+K +NILL E K+ DFG++ +
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 417 TQGNTSRIAGTYGYMAPEYAMHGQ-----FSVKSDVYSFGVLVLEIITG 460
+ NTS GT +MAPE Q + + DV+S G+ +E+ G
Sbjct: 183 LRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 288 KLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKN--EVVVVAKLQ---HRNLVR 341
++G G +G VYK P SG +A+K + + + EV ++ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 342 LLGFCLE---DPEKQGQLDWS------RRY------------KIIGLIA---RGILYLHE 377
L+ C D E + L + R Y I L+ RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ I+HRDLK NIL+ + K++DFG+A+I+ Q + + T Y APE +
Sbjct: 127 N---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVLL 180
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
++ D++S G + E+ K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 32/202 (15%)
Query: 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHR-NLVR 341
F ++LGAG G V K I ++L + A +N+++ ++ H N
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPY 64
Query: 342 LLGF------------CLEDPEKQGQLDW----SRRY--KIIGLIA----RGILYLHEDS 379
++GF C+E + G LD ++R +I+G ++ RG+ YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDG-GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+ +I+HRD+K SNIL+++ K+ DFG++ +D + GT YM+PE
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPERLQGT 177
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
+SV+SD++S G+ ++E+ G+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN-TSRIAGTYGY 430
+++LH +I+RDLK+ NILLDAE + K++DFGM K G T+ GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162
Query: 431 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+APE ++ D ++ GVL+ E++ G+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 37/200 (18%)
Query: 287 NKLGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKN--EVVVVAKLQ-HRNLVRL 342
K+G G F EV K +G+ A+K + K + E+ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 343 LGFCLEDPEKQGQL-------DWS-------RRY--------KIIGLIARGILYLHEDSR 380
+ + K G+L D + R+ + + + + ++H R
Sbjct: 64 IEVLFD--RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-HG 439
I HRD+K NIL+ + K++DFG + G+ T I+ T Y APE + G
Sbjct: 119 NGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYIS-TRWYRAPECLLTDG 174
Query: 440 QFSVKSDVYSFGVLVLEIIT 459
+ K D+++ G + EI++
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 260 DNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEV---YKGVLPSGREIAVKRLSK- 315
DN+ ++E F +K ++ +G+G G V Y +L R +A+K+LS+
Sbjct: 7 DNNFYSVEIGDSTFTVLK----RYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRP 60
Query: 316 -SSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK---------------------- 352
+ A+ E+V++ + H+N++ LL + P+K
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLCQV 118
Query: 353 -QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+A+
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
G T + Y Y APE + + D++S G ++ E+I G
Sbjct: 176 AGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 36/93 (38%), Positives = 56/93 (60%), Gaps = 8/93 (8%)
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
IL L +L I++RD+K+ NILLD+E + ++DFG++K F + + + T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173
Query: 432 APEY----AMHGQFSVKSDVYSFGVLVLEIITG 460
APE HG+ D +S G+L+ E++TG
Sbjct: 174 APEIIRGKGGHGK---AVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 47/212 (22%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKLQHRN 338
++++ ++G+G +G V + +G ++A+K+LS+ S A+ E+ ++ +QH N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 339 LVRLL-------------GFCLEDPEKQGQLDWSRRYKIIGL-------------IARGI 372
++ LL F L P Q L KI+G + G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQ-----KIMGHPLSEDKVQYLVYQMLCGL 130
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432
Y+H IIHRDLK N+ ++ + KI DFG+A+ + T +R Y A
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRA 182
Query: 433 PEYA---MHGQFSVKSDVYSFGVLVLEIITGK 461
PE MH +V D++S G ++ E++TGK
Sbjct: 183 PEVILNWMHYNQTV--DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 58/226 (25%)
Query: 271 FDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVV 329
FD + ++ +G+G +G V + SG+++A+K++ + +V
Sbjct: 1 FDVGS------RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVP 45
Query: 330 VVAKLQHRNLVRLLGF------CLED----PEKQGQ-------LDWSRRYKII------- 365
+AK R L L F + D P + L S + II
Sbjct: 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 366 --------GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI---FGV 414
+ RG+ Y+H + +IHRDLK SN+L++ + +I DFGMA+
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
Query: 415 DQTQGNTSRIAGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEII 458
+ T +A T Y APE ++ +++ D++S G + E++
Sbjct: 163 EHKYFMTEYVA-TRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 8e-11
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 59/221 (26%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVVVV 331
K+ KLG G +G V+K + + +A+K++ A F+N E++ +
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF-----DA--FRNATDAQRTFREIMFL 60
Query: 332 AKL-QHRNLVRL-------------LGFCLEDPE-----KQGQL-DWSRRYKIIGLIARG 371
+L H N+V+L L F + + + L D +RY I+ + +
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY-IMYQLLKA 119
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG-VDQTQGN---TSRIAGT 427
+ Y+H S +IHRDLK SNILL+++ K++DFG+A+ +++ N T +A T
Sbjct: 120 LKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-T 175
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGV-------LVLEIITGK 461
Y APE + S Y+ GV ++ E++ GK
Sbjct: 176 RWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 35/88 (39%), Positives = 53/88 (60%), Gaps = 5/88 (5%)
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+LHE II+RDLK+ N+LLDAE + K++D+GM K G+ + TS GT Y+AP
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGI-RPGDTTSTFCGTPNYIAP 165
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E + D ++ GVL+ E++ G+
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 33/201 (16%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK----NEVVVVAKLQHRNLVR 341
N++ G +G VY+ +G +A+K+L + E F E+ ++ KLQH N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVT 68
Query: 342 L----LGFCLED----------------PEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+ +G L+ + S ++ + G+ +LH++
Sbjct: 69 VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW-- 126
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-HGQ 440
I+HRDLK SN+LL+ KI DFG+A+ +G +++ T Y APE + +
Sbjct: 127 -ILHRDLKTSNLLLNNRGILKICDFGLAREYGS--PLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 441 FSVKSDVYSFGVLVLEIITGK 461
+S D++S G + E++T K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 50/212 (23%)
Query: 286 DNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
D +G G FG V+ P G+ +A+K++ F+N +V K R L ++L
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQN--LVSCKRVFREL-KMLC 54
Query: 345 FCLED----------PEKQG---------QLDWSRRYKII---------------GLIAR 370
F D P +L S +KII I R
Sbjct: 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 371 GILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY 430
G+ YLH I+HRD+K N+L+++ KI DFG+A++ D+++ T + Y Y
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 431 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 461
APE M + ++ D++S G + E++ +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
I+ + YLHE II+RDLK+ N+LLD+E + K++D+GM K G+ + TS GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGL-RPGDTTSTFCGT 159
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y+APE + D ++ GVL+ E++ G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 38/201 (18%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKLQHRNLVRLL-- 343
+G+G +G V +G +AVK+LS+ S A+ E+ ++ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 344 --------------------GFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
G L + K +L +I I RG+ Y+H I
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---I 141
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA---MHGQ 440
IHRDLK SN+ ++ + KI DFG+A+ T + T Y APE MH
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 441 FSVKSDVYSFGVLVLEIITGK 461
++ D++S G ++ E++TG+
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 35/97 (36%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF--GVDQTQGNTSRIA 425
I RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+A+I D T T +A
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 426 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 461
T Y APE ++ + K+ D++S G ++ E+++ +
Sbjct: 172 -TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 52/221 (23%)
Query: 288 KLGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQHRNLVRLL 343
+G GG GEVY P R +A+K++ + + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 344 GFCLED-------PEKQG----QLDWSRRYK------------------IIGLIARGILY 374
C + P +G L S K I I I Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI----------FGVDQTQGNTS-- 422
+H S+ ++HRDLK NILL I D+G A VD+ S
Sbjct: 129 VH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 423 ----RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+I GT YMAPE + S +D+Y+ GV++ +++T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 34/205 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHR-N 338
+ F ++LGAG G V+K PSG +A K + + +N+++ ++ H N
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL---EIKPAIRNQIIRELQVLHECN 61
Query: 339 LVRLLGF------------CLEDPEKQGQLDWSRRY------KIIGLIA----RGILYLH 376
++GF C+E + G LD + +I+G ++ +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDG-GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
E + +I+HRD+K SNIL+++ K+ DFG++ +D + GT YM+PE
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPERL 174
Query: 437 MHGQFSVKSDVYSFGVLVLEIITGK 461
+SV+SD++S G+ ++E+ G+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 51/229 (22%)
Query: 277 KVATNKFSTDNKLGAGGFGEVY--------KGVLPSGREIAVKRL-SKSSGQGAEEFKNE 327
+V ++ LG G FG+V K ++AVK L S ++ + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 328 VVVVAKL-QHRNLVRLLGFCLEDP--------EKQGQL-DWSRRYKIIGL---------- 367
+ ++ + +H+N++ LLG C +D +G L ++ R + G+
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 368 ---------------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-I 411
+ARG+ YL + + IHRDL N+L+ + KI+DFG+A+ I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 412 FGVDQTQGNTS-RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+D + T+ R+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 191 HHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IF-GVDQTQGNTSRIA 425
+ARG+ +L SR + IHRDL NILL KI DFG+A+ I+ D + +R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE ++ +SDV+SFGVL+ EI +
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 43/204 (21%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN--------EVVVVAKLQ-HR 337
+LG G FG VY +G +A+K++ K +F + EV + KL H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHP 58
Query: 338 NLVRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHED 378
N+V+L E+ E K S II I +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-- 116
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
+ HRDLK N+L+ KI+DFG+A+ + T + T Y APE +
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV-STRWYRAPEILLR 172
Query: 439 GQF-SVKSDVYSFGVLVLEIITGK 461
S D+++ G ++ E+ T +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 44/223 (19%)
Query: 273 FEAIKVATNKFSTDNK------LGAGGFGEV---YKGVLPSGREIAVKRLSK--SSGQGA 321
F +++V + F+ + +G+G G V Y VL R +A+K+LS+ + A
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 322 EEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK-----------------------QGQLDW 358
+ E+V++ + H+N++ LL + P+K Q +LD
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH 118
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418
R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+A+ G
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
T + Y Y APE + + D++S G ++ E++ K
Sbjct: 176 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 36/208 (17%)
Query: 289 LGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGAEEFKNEV----VVVAKLQHRNLVRLL 343
+G G FG+V + G+ AVK L K + +E K+ + V++ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 344 GFCLEDPEK---------QGQLDW------------SRRYKIIGLIARGILYLHEDSRLR 382
+ + +K G+L + +R Y IA + YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYA--AEIASALGYLHS---LN 116
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
II+RDLK NILLD++ + ++DFG+ K G+ + TS GT Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-EGI-EHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 443 VKSDVYSFGVLVLEIITGKKNSSFYQTD 470
D + G ++ E++ G FY D
Sbjct: 175 RTVDWWCLGAVLYEMLYGL--PPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 52/223 (23%)
Query: 286 DNKLGAGGFGEVYKGV-LPSGREIAVKR--LSKSSGQGAEEFKN------------EVVV 330
LG G +G+V K +G+ +A+K+ + + S ++ + E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 331 VAKLQHRNLVRLLG-FCLED----------------PEKQGQLDWSRRYKIIGLIARGIL 373
+ +++H N++ L+ + D +++ +L S+ I+ I G+
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG------- 426
LH+ +HRDL +NI ++++ KI+DFG+A+ +G S+
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 427 -----TYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 461
T Y APE M + F+V D++S G + E++TGK
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKSSGQGAEEF-----KNEVVVVAKLQHRNLVRL 342
+G G FG+VY+ + R A+K LSK +E + ++V L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 343 LGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L F + +K+G+ R I + + +LH+ I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---I 117
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ-FS 442
++RDLK NILLDA + + DFG++K D NT GT Y+APE + + ++
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEKGYT 175
Query: 443 VKSDVYSFGVLVLEIITGKKNSSFYQTD 470
D +S GVLV E+ G S FY D
Sbjct: 176 KHVDFWSLGVLVFEMCCGW--SPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 352 KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411
+ L + I I G+ YLH RIIHRD+K NI ++ I D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ- 205
Query: 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458
F V +AGT APE +++ K+D++S G+++ E++
Sbjct: 206 FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 351 EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410
+++G+ D SR + + LH+ +I+RDLK NILLD + + + DFG+ K
Sbjct: 85 QREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK 141
Query: 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
+ D + NT GT Y+APE + ++ D ++ GVL+ E++TG
Sbjct: 142 LNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 59/201 (29%), Positives = 88/201 (43%), Gaps = 40/201 (19%)
Query: 288 KLGAGGFGEVY-----KGV----LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
+LG G FG VY K V L +EI V L+ + A + E +++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63
Query: 339 LVRLLG-------FCLEDPEKQGQ-LDWS-RRYKIIGLIAR-------------GILYLH 376
+V+ FC+ +G+ LD K G G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
+ RI+HRDLK NI L + KI DFG++++ T GT YM+PE
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177
Query: 437 MHGQFSVKSDVYSFGVLVLEI 457
H + KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 23/161 (14%)
Query: 327 EVVVVAKLQHRNLVRLLGF-------CLEDPEKQGQL----DWSRRYKIIGLIA------ 369
E ++ + H ++++L G CL P + L R I ++A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
R I YLHE+ RIIHRD+K NI ++ + + DFG A F VD AGT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
APE + D++S G+++ E+ T S ++ D
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH--DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 4/93 (4%)
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG--VDQTQGNTSRIAGTYG 429
+L +H +IHRD+K +NILL + K+ DFG +K++ V G T GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPY 210
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
Y+APE +S K+D++S GVL+ E++T K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 52/208 (25%)
Query: 289 LGAGGFGEV---YKGVLPSGREIAVKRLSKSSGQGAEEFKN---------EVVVVAKLQH 336
+G+G G V Y V G+ +A+K+LS+ F+N E+V++ + H
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNH 74
Query: 337 RNLVRLLGFCLEDPEK-----------------------QGQLDWSRRYKIIGLIARGIL 373
+N++ LL + P+K Q LD R ++ + GI
Sbjct: 75 KNIIGLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+LH IIHRDLK SNI++ ++ KI DFG+A+ G T + Y Y AP
Sbjct: 133 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAP 186
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E + + D++S G ++ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 33/87 (37%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
YLH II+RDLK N+LLD + + K++DFG AK + T + GT Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITG 460
E D ++ GVL+ E I G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 34/88 (38%), Positives = 53/88 (60%), Gaps = 5/88 (5%)
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+LHE II+RDLK+ N+LLDA+ + K++D+GM K G+ TS GT Y+AP
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK-EGL-GPGDTTSTFCGTPNYIAP 165
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E ++ D ++ GVL+ E++ G+
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 51/225 (22%)
Query: 281 NKFSTDNKLGAGGFGEVY--------KGVLPSGREIAVKRLS-KSSGQGAEEFKNEVVVV 331
+K + LG G FG+V K +AVK L ++ + + +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 332 AKL-QHRNLVRLLGFCLEDP--------EKQGQL-DWSRRYKIIGL-------------- 367
+ +H+N++ LLG C +D +G L ++ R + G+
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 368 -----------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVD 415
+ARG+ YL + + IHRDL N+L+ KI+DFG+A+ + +D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 416 QTQGNTS-RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ T+ R+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 192 YYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 49/207 (23%)
Query: 289 LGAGGFGEVYKGVLPSGRE----IAVKRLSKS----SGQGAEEFKNEVVVVAKLQHRNLV 340
LG GG+G+V++ +G + A+K L K+ + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 341 RLL-GFCLEDPEKQGQLDWSRRYKIIGLIARGILYLH--------EDS------------ 379
L+ F + G+L Y I+ ++ G L++H ED+
Sbjct: 64 DLIYAF-----QTGGKL-----YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 380 ----RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN--TSRIAGTYGYMAP 433
+ II+RDLK NILLDA+ + K++DFG+ K + T GT YMAP
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAP 169
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITG 460
E M D +S G L+ +++TG
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 38/201 (18%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKLQHRNLVRLLG- 344
+G+G +G V + +G ++A+K+L + S A+ E+ ++ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 345 ------------FCLEDP---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
F L P K +L R ++ + +G+ Y+H I
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---I 139
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA---MHGQ 440
IHRDLK N+ ++ + KI DFG+A+ QT + T Y APE MH
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMH-- 192
Query: 441 FSVKSDVYSFGVLVLEIITGK 461
++ D++S G ++ E++TGK
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 273 FEAIKVATNKFSTDNK------LGAGGFGEV---YKGVLPSGREIAVKRLSK--SSGQGA 321
F +++VA + F+ + +G+G G V + VL G +AVK+LS+ + A
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64
Query: 322 EEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK-----------------------QGQLDW 358
+ E+V++ + H+N++ LL + P+K +LD
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH 122
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418
R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+A+ +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179
Query: 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
T + Y Y APE + + D++S G ++ E++ G
Sbjct: 180 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 43/193 (22%)
Query: 304 SGREIAVKRLSKSSGQGAEE---FKNEVVVVAKLQHRNLVRLLGFCLEDPEKQGQLDWSR 360
+G E+A+K L + + + F+ E + A+L H N+V LL G+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL--------DSGEAPPGL 53
Query: 361 RYKIIGLI----------ARGILYLHEDSRLR--------------IIHRDLKVSNILL- 395
+ + + A G L E RL I+HRDLK NI++
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 396 --DAEMNPKISDFGMAKIF-GVD----QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVY 448
+ K+ DFG+ + GV T T+ + GT Y APE + SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 449 SFGVLVLEIITGK 461
++G++ LE +TG+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
I + YLH I++RDLK NILLD E + K++DFG AK + + T + GT
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y+APE + D ++ G+L+ E++ G
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 289 LGAGGFGEVYK-GVLPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRN--LVRL 342
+G GGFGEVY +G+ A+K L K QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 343 LGFCLEDPEK---------QGQLDW-----------SRRYKIIGLIARGILYLHEDSRLR 382
+ + P+K G L + R+ +I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-GLEHMH--NRF- 117
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ-F 441
+++RDLK +NILLD + +ISD G+A F + + GT+GYMAPE G +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGTAY 173
Query: 442 SVKSDVYSFGVLVLEIITGKKNSSFYQ 468
+D +S G ++ +++ G +S F Q
Sbjct: 174 DSSADWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 57/232 (24%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVV------V 330
+++ + + LG G FG+V V+ I + +K + K++ +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 331 VAKLQ-------HRNLVRLLGFCLEDP--------EKQGQL-DWSRRYKIIGL------- 367
V++++ H+N++ LLG C +D +G L ++ R + G+
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 368 ------------------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409
+ARG+ YL + + IHRDL N+L+ + KI+DFG+A
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 410 K-IFGVDQTQGNTS-RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ + +D + T+ R+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 182 RDVHNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 289 LGAGGFGEVY---KGVLPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRN--LV 340
+G GGFGEVY K +G+ A+K L K QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 341 RLLGFCLEDPEK---------QGQLDWS-------RRYKIIGLIARGILYL-HEDSRLRI 383
+ + P+K G L + ++ A IL L H +R +
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF-V 118
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFS 442
++RDLK +NILLD + +ISD G+A F + + GT+GYMAPE G +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYD 174
Query: 443 VKSDVYSFGVLVLEIITGKKNSSFYQ 468
+D +S G ++ +++ G +S F Q
Sbjct: 175 SSADWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 44/204 (21%)
Query: 289 LGAGGFGEVYKGVLPSGRE-IAVKRLSK--SSGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
+G+G +G V R+ +AVK+LS+ S A E+ ++ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD- 81
Query: 346 CLEDPEKQGQLDWSRRYKIIGLIA-------------------------RGILYLHEDSR 380
+ P + +++ Y + L+ RG+ Y+H
Sbjct: 82 -VFTPATSIE-NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG- 138
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA---M 437
IIHRDLK SN+ ++ + +I DFG+A+ Q + T Y APE M
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWM 191
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
H +V D++S G ++ E++ GK
Sbjct: 192 HYNQTV--DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 32/206 (15%)
Query: 289 LGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGAEEFKNEV----VVVAKLQHRNLVRLL 343
+G G FG+V S G AVK L K + +E + + V++ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 344 GFCLEDPEK--------QG-----QLDWSRRYK------IIGLIARGILYLHEDSRLRII 384
+ + EK G L R + +A I YLH L II
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNII 118
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVK 444
+RDLK NILLD++ + ++DFG+ K GV+ + TS GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGVEP-EETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 445 SDVYSFGVLVLEIITGKKNSSFYQTD 470
D + G ++ E++ G FY D
Sbjct: 177 VDWWCLGAVLYEMLYGL--PPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 38/94 (40%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IF-GVDQTQGNTSRIA 425
+ARG+ +L SR + IHRDL NILL KI DFG+A+ I+ D + ++R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE ++ +SDV+SFGVL+ EI +
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 37/204 (18%)
Query: 288 KLGAGGFGEVYKGVLPSG---REIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLL 343
++G G FG+V G + SG ++ VK L S+ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 344 GFCLE-DP-----------EKQGQLDWSRRYKIIGL-----------IARGILYLHEDSR 380
G C E P + +G L R+ +++ IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA--MH 438
IH DL + N LL A++ KI D+G++ + ++ ++APE +H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 439 GQFSV-----KSDVYSFGVLVLEI 457
G V +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGVL--PSGREIAVKRLSKSSGQGAEEFKNEVVV 330
F++ ++ + +G G +G+V+K VL +G + AVK L EE + E +
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAEYNI 67
Query: 331 VAKLQ-HRNLVRLLGFCLEDPEKQGQLDW---------SRRYKIIGLIARG--------- 371
+ L H N+V+ G + K G W S + G + RG
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 372 ---------ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
+ +LH + + IHRD+K +NILL E K+ DFG++ + + NTS
Sbjct: 128 YILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 423 RIAGTYGYMAPEY-----AMHGQFSVKSDVYSFGVLVLEIITG 460
GT +MAPE + + + DV+S G+ +E+ G
Sbjct: 185 --VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN---TSRI 424
I G+ Y+H + ++HRDLK N+L++A+ KI DFG+A+ F + + T +
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 425 AGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 461
A T Y APE + Q K+ DV+S G ++ E++ K
Sbjct: 171 A-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAG 426
I + YLH +++RDLK+ N++LD + + KI+DFG+ K + G T G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T Y+APE + D + GV++ E++ G+ FY D
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 39/206 (18%)
Query: 287 NKLGAGGFGEVYKGVL--PSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
++LG G +G VYK VL P+G +A+K RL + + E+ ++ K +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDF 64
Query: 343 LG---------FCLE------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
G C+E + +I + +G+ +L E+
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY------ 435
IIHRD+K +N+L++ K+ DFG++ + N G YMAPE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGP 178
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
+ ++V+SDV+S G+ +LE+ G+
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 43/203 (21%)
Query: 289 LGAGGFGEVYKGVL----PSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
+G G FG + +L S ++ A+K RL KSS E+ + E V++AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 343 LGFCLEDPEKQGQL----------DWSRRYKI--------------IGLIARGILYLHED 378
E E G L D ++ K+ + G+ ++HE
Sbjct: 64 K----ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
R++HRD+K NI L K+ DFG A++ T GT Y+ PE +
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWEN 174
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
++ KSD++S G ++ E+ T K
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 31/88 (35%), Positives = 50/88 (56%)
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+L L E +++HRDLK +NI L K+ DFG +K + + S GT Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIIT 459
APE ++S K+D++S GV++ E++T
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IF-GVDQTQGNTSRIA 425
+A+G+ +L SR + IHRDL NILL KI DFG+A+ I+ D + +R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE ++++SDV+SFGVL+ EI +
Sbjct: 245 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 51/213 (23%), Positives = 83/213 (38%), Gaps = 49/213 (23%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIA---VKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRL 342
+++G G FG+V G G A VK L S+ F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 343 LGFCLE-----------------------------DPEKQGQLDWSRRYKIIGLIARGIL 373
LG C+E +K ++ +A G+L
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLL 114
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+LH + IH DL + N L A+++ KI D+G+A + A ++AP
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 434 EYAMHGQFSV-------KSDVYSFGVLVLEIIT 459
E + KS+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 40/210 (19%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFC 346
K+G G +G VYK G++ L + G G + E+ ++ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 347 LEDPEKQ----------------------------GQLDWSRRYKIIGLIARGILYLHED 378
L +++ QL S ++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 379 SRLRIIHRDLKVSNILLDAEMNP-----KISDFGMAKIFGVD-QTQGNTSRIAGTYGYMA 432
++HRDLK +NIL+ E P KI+D G A++F + + + T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 433 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK 461
PE + + K+ D+++ G + E++T +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 287 NKLGAGGFGEVYKGVLP-SGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL- 342
+KLG G + V+KG + +A+K RL G + EV ++ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 343 ----------LGF-CLEDPEKQ-----GQLDWSRRYKIIGL-IARGILYLHEDSRLRIIH 385
L F L+ KQ G L KI + RG+ Y H + +I+H
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVK 444
RDLK N+L++ + K++DFG+A+ V T+ ++ + T Y P+ + ++S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 445 SDVYSFGVLVLEIITGK 461
D++ G ++ E+ TG+
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFC 346
K+G G +G VYK G++ L + G G + E+ ++ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 347 LEDPEKQGQL--DWSRR--YKIIGL------------------------IARGILYLHED 378
L +++ L D++ + II I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 379 SRLRIIHRDLKVSNILLDAEMNP-----KISDFGMAKIFGVD-QTQGNTSRIAGTYGYMA 432
++HRDLK +NIL+ E P KI+D G A++F + + + T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 433 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK 461
PE + + K+ D+++ G + E++T +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 60/255 (23%), Positives = 97/255 (38%), Gaps = 87/255 (34%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEV----YKGVLPSGREIAVKRLSKSS----GQGAEE 323
DFE+IKV +G G FGEV K +G A+K+L KS Q
Sbjct: 2 DFESIKV----------IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQ-VAH 47
Query: 324 FKNEVVVVAKLQHRNLVRLLGFC-LEDPE-------------------KQGQL--DWSRR 361
+ E ++A+ + +V+L + +D K+ + +R
Sbjct: 48 VRAERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRF 105
Query: 362 YKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG-------- 413
Y IA IL + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 106 Y-----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160
Query: 414 --VDQTQGNTSRIA--------------------------GTYGYMAPEYAMHGQFSVKS 445
+ + GT Y+APE + ++ +
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220
Query: 446 DVYSFGVLVLEIITG 460
D +S GV++ E++ G
Sbjct: 221 DWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGR--EIAVKRLSKSS---GQGAEEFKNEVVVV 331
K+ F+ LG G FG V + +A+KR KS + + +E ++
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 332 AKLQHRNLVRLLGFCLEDPEKQGQLDWS---------RRYKI----IGLI--ARGILYLH 376
+ H V L G ++ L++ RR K +G A+ +L
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
L I++RDLK N+LLD + K++DFG AK+ T + GT Y+APE
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEIL 200
Query: 437 MHGQFSVKSDVYSFGVLVLEIITG 460
++ +D ++ G+ + EI+ G
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
I + YLH +I++RDLK+ N++LD + + KI+DFG+ K D T GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGT 158
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
Y+APE + D + GV++ E++ G+ FY D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ RG+ Y+H + ++HRDLK SN+LL+A + KI DFG+A+ + + T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 428 YGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGK 461
Y APE ++ +++ DV+S G + E++ K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 288 KLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFK--NEVVVVAKLQHRNLVRL-- 342
KLG G + VYKG+ +G+ +A+K +S + +G F E ++ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 343 -------LGFCLED---------PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
L F E + G L + + RG+ Y+H I+HR
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHR 127
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKS 445
DLK N+L+ K++DFG+A+ + +Q +S + T Y P+ + +S
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185
Query: 446 DVYSFGVLVLEIITGK 461
D++ G + +E++ G+
Sbjct: 186 DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 37/200 (18%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN-------EVVVVAKLQHRNL 339
K+G G +G V+K +G+ +A+K+ +S E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 340 VRLL-------------GFC----LEDPEKQGQ-LDWSRRYKIIGLIARGILYLHEDSRL 381
V L+ +C L + EK + + KII + + + H +
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-HGQ 440
IHRD+K NIL+ + K+ DFG A+I + + + T Y APE + Q
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 441 FSVKSDVYSFGVLVLEIITG 460
+ DV++ G + E++TG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 72/277 (25%), Positives = 111/277 (40%), Gaps = 71/277 (25%)
Query: 231 VTAVLFIVGFCFLRRKAK-----KKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFST 285
VTA+++ LR+ +Y E +T L DF+ IKV
Sbjct: 3 VTALVYDCDIPALRKNKNIDNFLSRYEKAAE-----KITKLRMKAEDFDVIKV------- 50
Query: 286 DNKLGAGGFGEVYKGVLPSGREI-AVKRLSK-------SSGQGAEE-----FKNEVVVVA 332
+G G FGEV S +++ A+K LSK S EE N +V
Sbjct: 51 ---IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 333 KLQHR-----------------NLVRLLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYL 375
L + +LV L+ + PEK W+R Y A +L L
Sbjct: 108 -LHYAFQDDKYLYMVMEYMPGGDLVNLMS-NYDIPEK-----WARFY-----TAEVVLAL 155
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD-QTQGNTSRIAGTYGYMAPE 434
+ IHRD+K N+LLD + K++DFG + + +T+ GT Y++PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPE 213
Query: 435 YAM----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
G + + D +S GV + E++ G ++ FY
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 46/206 (22%)
Query: 289 LGAGGFGEVYKGVL---------PSGREIAVKR-LSKSSGQGAEEFKNEVVVVAKLQHRN 338
LG G F +YKGVL G+E++V + S + + F ++++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 339 LVRLLGFCLEDPE-------KQGQLD-WSRR--------YKIIGL--IARGILYLHEDSR 380
LV+L G C+ D K G LD + R +K+ +A + YL +
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK-- 120
Query: 381 LRIIHRDLKVSNILL----DAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+++H ++ NIL+ E K+SD G+ V + RI ++AP
Sbjct: 121 -KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERIP----WIAP 173
Query: 434 EYAMHGQFSVKS--DVYSFGVLVLEI 457
E +GQ S+ D +SFG +LEI
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 13/116 (11%)
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
D +R Y IA +L +H +L +HRD+K N+LLD + +++DFG D
Sbjct: 102 DMARFY-----IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156
Query: 417 TQGNTSRIAGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
T +S GT Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 42/208 (20%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKR-LSKSSGQGAEEFK-NEVVVVAKLQHRN-LVRLL 343
K+G G +G+VYK +G+ +A+K+ + +G E+ ++ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 344 GFCLED-PEKQGQ-----------------LDWSRRYKIIGL-----------IARGILY 374
+E EK G+ +D + R L + +G+ +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
H + ++HRDLK N+L+D + KI+D G+ + F + + T I T Y AP
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAP 180
Query: 434 EYAMHG-QFSVKSDVYSFGVLVLEIITG 460
E + +S D++S G + E+
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI-FGVDQTQGNTSRIAGTY 428
R + Y+H + + HRDLK NIL +A+ KI DFG+A++ F T + T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 429 GYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGK 461
Y APE + +++ D++S G + E++TGK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 44/134 (32%), Positives = 67/134 (50%), Gaps = 17/134 (12%)
Query: 346 CLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405
ED E LD + +A+G+ +L + IHRD+ N+LL KI D
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICD 255
Query: 406 FGMAKIFGVDQT---QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GK 461
FG+A+ D +GN +R+ +MAPE ++V+SDV+S+G+L+ EI + GK
Sbjct: 256 FGLARDIMNDSNYVVKGN-ARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312
Query: 462 K-------NSSFYQ 468
NS FY+
Sbjct: 313 SPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
IA + YLH L I++RDLK NILLD++ + ++DFG+ K + G TS GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
Y+APE + D + G ++ E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 38/202 (18%)
Query: 287 NKLGAGGFGEVYKGV------LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+KLG G + VYKG L + +EI RL G + EV ++ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 341 RL-----------LGFCLEDPEKQGQLDWSRRYKIIGL---------IARGILYLHEDSR 380
L L F D + + LD I + + RG+ Y H R
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---R 122
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG- 439
+++HRDLK N+L++ K++DFG+A+ + T+ ++ + T Y P+ +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGST 180
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
+S + D++ G + E+ TG+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 65/242 (26%), Positives = 102/242 (42%), Gaps = 57/242 (23%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKN---EVVVVAKLQHR 337
N++ K+G G FGEV+ +E + G E EV V+ +L+H+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 338 NLVRLLGFCLEDPEKQGQL--------DWSRR----YKIIGLI--------ARGIL---- 373
N+VR + L ++ + D SR YK+ G I R +L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 374 YLHE----DSRLRIIHRDLKVSNILLD----------AEMN-------PKISDFGMAKIF 412
Y H + R++HRDLK NI L A+ N KI DFG++K
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 413 GVDQTQGNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGK----KNSSF 466
G++ GT Y +PE +H + KSD+++ G ++ E+ +GK K ++F
Sbjct: 193 GIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 467 YQ 468
Q
Sbjct: 250 SQ 251
|
Length = 1021 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAG 426
I + YLH +++RD+K+ N++LD + + KI+DFG+ K G+ + G T + G
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGI--SDGATMKTFCG 157
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T Y+APE + D + GV++ E++ G+ FY D
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 44/222 (19%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN-EVV 329
D + + + N +G G FG VY+ + + + ++A+K++ + ++KN E++
Sbjct: 57 DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELL 111
Query: 330 VVAKLQHRNLVRLLGF----CLEDPEKQGQLD----------------WSRRYKIIGL-- 367
++ L H N++ L + C + EK L+ ++R + L
Sbjct: 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL 171
Query: 368 -------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQG 419
+ R + Y+H S+ I HRDLK N+L+D + K+ DFG AK + Q
Sbjct: 172 VKLYSYQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQR 226
Query: 420 NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITG 460
+ S I + Y APE + ++ D++S G ++ E+I G
Sbjct: 227 SVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT---QGNTSRI 424
+A+G+ +L + IHRDL NILL KI DFG+A+ D +GN +R+
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN-ARL 278
Query: 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE + ++ +SDV+S+G+L+ EI +
Sbjct: 279 P--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 34/200 (17%)
Query: 287 NKLGAGGFGEVYKGV------LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
KLG G + V+KG L + +EI RL G + EV ++ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 341 RL---------LGFCLEDPEKQ--------GQLDWSRRYKI-IGLIARGILYLHEDSRLR 382
L L E +K G + KI + I RG+ Y H R +
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-HGQF 441
++HRDLK N+L++ K++DFG+A+ V T+ ++ + T Y P+ + ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 442 SVKSDVYSFGVLVLEIITGK 461
S + D++ G + E+ +G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
I + YLH S +++RDLK+ N++LD + + KI+DFG+ K D T GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 159
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
Y+APE + D + GV++ E++ G+ FY D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNT 421
KII + + LH + IIH D+K+ N+L D + + D+G+ KI G
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-- 167
Query: 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
GT Y +PE + V D ++ GVL E++TGK
Sbjct: 168 ----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 31/205 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSKSSGQGAEEFKN----EVVVVAKLQ 335
NKF +G G +G V K +EI A+K+ S + EE K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 336 HRNLVRL---------LGFCLEDPEKQ----------GQLDWSRRYKIIGLIARGILYLH 376
N+V L L E EK G R I LI + I + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI-KAIHWCH 117
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
++ I+HRD+K N+L+ K+ DFG A+ + + N + T Y +PE
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELL 173
Query: 437 MHGQFSVKSDVYSFGVLVLEIITGK 461
+ + D++S G ++ E+ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
IA + YLH + I++RDLK NILLD++ + ++DFG+ K G+ Q+ T+ GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSD-TTTTFCGT 159
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
Y+APE + D + G ++ E++ G FY D
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL--PPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+A +L +H ++ +HRD+K N+L+D + K++DFG A ++ + + GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GT 166
Query: 428 YGYMAPEY--AMHG----QFSVKSDVYSFGVLVLEIITGK 461
Y+APE M+G + V+ D +S GV+ E+I G+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+A G+ +L + +HRDL N+L+ KI DFG+A+ D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE + ++ SDV+SFG+L+ EI T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ARG+ +L + +HRDL N+LL KI DFG+A+ D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE ++ SDV+S+G+L+ EI +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 293 GFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN-------------- 338
G +G R IA KR+ K+ + A + +NE++ + +L H N
Sbjct: 181 GVNSTNQGKPKCERLIA-KRV-KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANT 238
Query: 339 --LVRLLGFCLEDPEKQGQLDWSRR------YKIIGLIARGILYLHEDSRLRIIHRDLKV 390
+ + F L DW R I+ + + Y+H+ ++IHRD+K+
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295
Query: 391 SNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM------APEYAMHGQFSVK 444
NI L+ + + DFG A F R A YG++ +PE +
Sbjct: 296 ENIFLNCDGKIVLGDFGTAMPF-------EKEREAFDYGWVGTVATNSPEILAGDGYCEI 348
Query: 445 SDVYSFGVLVLEIIT 459
+D++S G+++L++++
Sbjct: 349 TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 9e-07
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 288 KLGAGGFGEVYKGVLP-SGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL-- 342
KLG G + VYKG +G+ +A+K RL + G + E ++ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 343 ----------------LGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
C + G L + + RG+ Y+H+ I+HR
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHR 127
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKS 445
DLK N+L+ K++DFG+A+ V + + T Y P+ + ++S
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYSTCL 185
Query: 446 DVYSFGVLVLEIITG 460
D++ G + +E+I G
Sbjct: 186 DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 49/244 (20%)
Query: 258 NADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREI-AVKRLSK- 315
N DN L E + +++ + +G G FGEV S +++ A+K LSK
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 316 ------SSGQGAEE------------------FKNE---VVVVAKLQHRNLVRLLGFCLE 348
S EE F+++ +V+ + +LV L+ +
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-NYD 138
Query: 349 DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408
PEK W++ Y A +L L + +IHRD+K N+LLD + K++DFG
Sbjct: 139 VPEK-----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 188
Query: 409 AKIFGVDQT-QGNTSRIAGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKKN 463
+D+T GT Y++PE G + + D +S GV + E++ G +
Sbjct: 189 C--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--D 244
Query: 464 SSFY 467
+ FY
Sbjct: 245 TPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 10/106 (9%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT-QGNTSRIAG 426
+A +L + +L +HRD+K N+LLD + +++DFG D T Q N + G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 427 TYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
T Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 16/100 (16%)
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI-------------FGVDQTQGN 420
YLH I+HRDLK N+L+ + + K++DFG++KI D +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
++ GT Y+APE + + D ++ G+++ E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 368 IARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423
I R +L YLH IIHRD+K NI LD N + DFG A
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
+GT +PE + K+D++S G+++ E+ KN + +
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTLF 288
|
Length = 392 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 288 KLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFK--NEVVVVAKLQHRNLV---- 340
KLG G + VYKG +G+ +A+K + +GA F E ++ L+H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHD 70
Query: 341 -----RLLGFCLE--DPEKQGQLDWSRR-----------YKIIGLIARGILYLHEDSRLR 382
+ L E D + + +D ++++ RG+ Y H + R
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH---QRR 123
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QF 441
++HRDLK N+L+ K++DFG+A+ V ++ ++ + T Y P+ + ++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 442 SVKSDVYSFGVLVLEIITG 460
S D++ G + E+ TG
Sbjct: 182 STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 43/208 (20%), Positives = 80/208 (38%), Gaps = 53/208 (25%)
Query: 292 GGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFK---NEVVVVAKLQHRNLVRLLGFCLE 348
+ K P+ +AVK+++ S E+ K E++ +LQH N++ + +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70
Query: 349 DPEKQGQL-------------DWSRRY-------KIIGLIARGIL----YLHEDSRLRII 384
D +L D + + I I + +L Y+H I
Sbjct: 71 D----SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFI 123
Query: 385 HRDLKVSNILLDAEMNPKISDF---------GMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
HR +K S+ILL + +S G + D + + + +++PE
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP----WLSPEV 179
Query: 436 ---AMHGQFSVKSDVYSFGVLVLEIITG 460
+ G ++ KSD+YS G+ E+ G
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 13/116 (11%)
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
D +R Y +A ++ + +L +HRD+K NIL+D + +++DFG D
Sbjct: 102 DMARFY-----LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156
Query: 417 TQGNTSRIAGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
T +S GT Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 157 TV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 35/127 (27%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM------------------- 408
IA +L + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 409 ---------------AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVL 453
A+ + ++ Q S + GT Y+APE M ++ D +S GV+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 454 VLEIITG 460
+ E++ G
Sbjct: 226 MYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 37/128 (28%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-------- 419
IA +L + +L IHRD+K N+LLD++ + K+SDFG+ G+ +
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLN 164
Query: 420 ------------NTSRIA---------------GTYGYMAPEYAMHGQFSVKSDVYSFGV 452
N+ R A GT Y+APE M ++ D +S GV
Sbjct: 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 453 LVLEIITG 460
++ E++ G
Sbjct: 225 IMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 37/123 (30%), Positives = 59/123 (47%), Gaps = 19/123 (15%)
Query: 350 PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409
PEK W+R Y A +L L + IHRD+K N+LLD + K++DFG
Sbjct: 140 PEK-----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 410 KIFGVD-QTQGNTSRIAGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKKNS 464
+ + +T+ GT Y++PE G + + D +S GV + E++ G ++
Sbjct: 190 MKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DT 245
Query: 465 SFY 467
FY
Sbjct: 246 PFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 34/138 (24%), Positives = 54/138 (39%), Gaps = 45/138 (32%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF--------------- 412
+A +L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 413 -------------GVDQ---TQGNTSRIA--------------GTYGYMAPEYAMHGQFS 442
VD T + +IA GT Y+APE + +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 443 VKSDVYSFGVLVLEIITG 460
+ D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 35/147 (23%), Positives = 64/147 (43%), Gaps = 29/147 (19%)
Query: 288 KLGAGGFGEVYKGVL---PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLL 343
++G G FG+V + + VK L ++ + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 344 GFCLE--------DPEKQGQL-------DWSRR-------YKIIGLIARGILYLHEDSRL 381
G C+E + + G L W RR ++ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGM 408
+H DL + N L +++ K+ D+G+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 21/49 (42%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411
K I +A + YLH IIHRDLK N+L+ E + K++DFG++K+
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK 333
E I V+T +F + LG G FG+V + +E ++ ++ + + K E+ + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 334 LQHRN------LVRLLGF--------CLEDPEKQGQ--LDW-------SRRY--KIIGLI 368
++ + L+++ + C+ P K G LDW S R+ +II
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSHRHLAQIIFQT 240
Query: 369 ARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNP-------------KISDFGMAKIF 412
+ Y H + L ++H DLK NIL+ D ++P +I D G
Sbjct: 241 GVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--- 295
Query: 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
D+ T+ I T Y +PE + + +D++S G ++ E+ TGK
Sbjct: 296 -CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 36/153 (23%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVK--RLSKSSGQGAEEFKNEV--------VVVAKL-- 334
K+G G +VY + P GR++AVK RL ++S + + ++ + + V++L
Sbjct: 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAA 156
Query: 335 --QHRNLVRLLGFCLEDPEKQGQLDWSRRYKIIGLI--------------ARGILY---- 374
+ L RL ++ P+ + W+R ++ I IL
Sbjct: 157 EREFEALQRLYPEGVKVPKP---IAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILE 213
Query: 375 -LHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
+ + R I+H DL NIL+ + + + D+
Sbjct: 214 EVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 49/210 (23%)
Query: 289 LGAGGFGEVYKGVLPS--------GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
LG G F +++KG+ E+ +K L KS +E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 341 RLLGFCLEDPE--------KQGQLD-------------WSRRYKIIGLIARGILYLHEDS 379
G C+ E K G LD W + ++ +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 380 RLRIIHRDLKVSNILL-----DAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ H ++ N+LL NP K+SD G++ V + RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP----WV 171
Query: 432 APEYAMHGQ-FSVKSDVYSFGVLVLEIITG 460
PE + Q S+ +D +SFG + EI +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 365 IGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420
+ +AR +L Y+H + IIHRD+K N+L++ + + DFG A +G+
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF-----ARGS 313
Query: 421 TSR-----IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 456
S IAGT APE ++ D++S G+++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 46/146 (31%)
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM-------- 408
D +R Y I + I +H ++ IHRD+K NIL+D + + K++DFG+
Sbjct: 101 DLARFY--IAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155
Query: 409 -AKIFGV--------------------------------DQTQGNTSRIAGTYGYMAPEY 435
+K + + + GT Y+APE
Sbjct: 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
+ ++ D +S GV++ E++ G+
Sbjct: 216 LLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 17/64 (26%), Positives = 26/64 (40%), Gaps = 10/64 (15%)
Query: 358 WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI------ 411
R ++ + R + LH+ I+H DL SNI+L DFG+ +
Sbjct: 91 EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVED 146
Query: 412 FGVD 415
VD
Sbjct: 147 KAVD 150
|
Length = 204 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 30/108 (27%), Positives = 54/108 (50%), Gaps = 28/108 (25%)
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRI 424
RG+ YLH++ IHR++K S+IL IS G+ + G+ G +++
Sbjct: 112 RGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 425 AGTYG--------YMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 461
+ +++PE ++G ++VKSD+YS G+ E+ TG+
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 62/248 (25%), Positives = 94/248 (37%), Gaps = 80/248 (32%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSSGQGAEEFKN- 326
F+ IK+ LG G G V+ KG +G+ A+K L K + K
Sbjct: 2 HFKKIKL----------LGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRV 48
Query: 327 --EVVVVAKLQHRNLVRL---------LGFCLE-------------DPEKQGQLDWSRRY 362
E ++A L H L L L ++ P K + +R Y
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY 108
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ---- 418
L+A + YLH L I++RDLK NILL + +SDF ++K V+
Sbjct: 109 AAEVLLA--LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 419 -------GNTSRIA----------------GTYGYMAPEY---AMHGQFSVKSDVYSFGV 452
+ + I GT Y+APE HG +V D ++ G+
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGI 220
Query: 453 LVLEIITG 460
L+ E++ G
Sbjct: 221 LLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 35/193 (18%), Positives = 84/193 (43%), Gaps = 37/193 (19%)
Query: 297 VYKGVLPSGREIAVKRL---SKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--DP- 350
+YKG+ + +E+ ++ K + +NE+ + ++ N++++ GF ++ D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKV 390
+K+ L + + + +G+ L++ ++ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTS 151
Query: 391 SNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA--MHGQFSVKSDVY 448
+ L+ KI G+ KI + N + + Y + + + ++++K D+Y
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKMLNDIFSEYTIKDDIY 206
Query: 449 SFGVLVLEIITGK 461
S GV++ EI TGK
Sbjct: 207 SLGVVLWEIFTGK 219
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 470 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.52 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.51 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.85 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.68 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.33 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.21 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.93 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.35 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.01 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.9 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.34 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.12 | |
| PLN02236 | 344 | choline kinase | 96.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.44 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.42 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.38 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 93.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.49 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.93 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.5 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.27 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.78 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.65 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.28 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 90.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.67 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=328.40 Aligned_cols=199 Identities=53% Similarity=0.885 Sum_probs=173.2
Q ss_pred ccchhhHHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEe
Q 041433 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346 (470)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 346 (470)
....|.++++..+|++|...+.||+|+||.||+|.++++..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999988899999988765443145699999999999999999999999
Q ss_pred eeCCC-C-------------------CC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 347 LEDPE-K-------------------QG-QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 347 ~~~~~-~-------------------~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
.+... . .. .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 87652 1 22 789999999999999999999999888999999999999999999999999
Q ss_pred cCCceeccCCCCccccccc-ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 406 FGMAKIFGVDQTQGNTSRI-AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 406 fG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||+++..... ....... .||.+|++||++..+..+.|+|||||||+|+||+||++|.+..
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999754331 1111112 7999999999999999999999999999999999999987753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.48 Aligned_cols=181 Identities=34% Similarity=0.571 Sum_probs=160.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
..+|...++||+|+|++||+|++ +++..||||.+.+. ..+..+.+..|+++|+.++|||||.+++++..+.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36788899999999999999994 56899999999766 5566677899999999999999999999887654
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC------CceEEeecCCceec
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE------MNPKISDFGMAKIF 412 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------~~~kl~DfG~a~~~ 412 (470)
...+.+++.....++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+++.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 24568999999999999999999999998 9999999999999764 45899999999987
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... ......+|++.|||||++...+|+.|+|+||+|+|||+|++|+.||.-
T Consensus 166 ~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 166 QPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred Cch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 633 234567899999999999999999999999999999999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.20 Aligned_cols=184 Identities=30% Similarity=0.445 Sum_probs=161.5
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|++.+.||+|+||+||+++ .++++.+|+|.+++.. ....+...+|..+|.+++||.||+++-.+++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999 5579999999998763 344567889999999999999999987776643
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
++.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-- 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-- 178 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence 35678999999999999999999999998 999999999999999999999999999854322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
...+...+||+.|||||++.+..|+..+|+||||+++|||++|.+||...+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 234455799999999999999999999999999999999999999997654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=320.16 Aligned_cols=182 Identities=30% Similarity=0.514 Sum_probs=165.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.+|...+.||+|+|..+|+++. .+|+.||+|++.+. .....+.+.+||++.++|+|||||++++++++..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999995 89999999999764 4556788999999999999999999999998865
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+|||||..|+||++++++||+|||+|..+..+..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE- 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence 24678999999999999999999999998 99999999999999999999999999998765433
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++|||.|+|||++....++..+||||+|||||-||.|++||+..
T Consensus 174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 345589999999999999999999999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=291.81 Aligned_cols=185 Identities=26% Similarity=0.441 Sum_probs=158.7
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.+|+++++||+|.||+||++. +.+|..||.|.+.-. +....+.+..|+.+|++|+|||||+++++...+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468889999999999999999 678999999998643 3444567889999999999999999998433322
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDS-RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.....+++..+++++.|++.||.++|+.- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 23567899999999999999999999842 123999999999999999999999999999988
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .....+|||.||+||.+.+.+|+.+|||||+||++|||..-++||...
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 65433 344578999999999999999999999999999999999999999753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=301.04 Aligned_cols=184 Identities=25% Similarity=0.404 Sum_probs=158.9
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... .....-..+||.+|++|+||||++|.+...+..
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778999999999999999 6789999999987654 444556789999999999999999988765542
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....|++.++..+++||+.||.|+|+++ |+|||||.+|||||++|.+||+|||+++++.....
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 23457899999999999999999999998 99999999999999999999999999998876554
Q ss_pred cccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
...+ ..+-|++|.|||.+.+. .|+.++|+||.||||.||++|++.|....
T Consensus 274 ~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 274 APYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred cccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 4433 34569999999999874 79999999999999999999999987543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=301.61 Aligned_cols=182 Identities=37% Similarity=0.633 Sum_probs=154.7
Q ss_pred CCccccccccCceeEEEEEcCCCcEEEEEEccCcCccC--HHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQG--AEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
+.+.+.||+|+||+||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+++|.+.+..
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999544449999997653322 568999999999999999999999998764
Q ss_pred ----------C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCCCCc
Q 041433 351 ----------E-KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ----------~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 418 (470)
. ....+++..+++++.+|+.||.|||++++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 1 25789999999999999999999999863 99999999999999997 99999999998754332
Q ss_pred ccccccccccCcccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 2233367999999999999 6699999999999999999999999998643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=277.56 Aligned_cols=180 Identities=33% Similarity=0.425 Sum_probs=159.9
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||.|+||.|.+++. .+|..+|+|++++.. ....+...+|..+|+.+.||+++++.+.+.+..
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5688899999999999999994 468899999997763 344566788999999999999999998776643
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.+.+.+++..+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+++...
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 24568999999999999999999999998 9999999999999999999999999999754
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
..+..++|||.|+|||+++.+.++.++|+|||||++|||+.|.+||-..+
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 23567899999999999999999999999999999999999999997554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=292.54 Aligned_cols=184 Identities=29% Similarity=0.448 Sum_probs=154.9
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCcc-------CHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ-------GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... ......+|+++|++|+|||||++++++....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999999 568999999999765221 2234579999999999999999999987755
Q ss_pred C------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEeecCCc
Q 041433 351 E------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE---MNPKISDFGMA 409 (470)
Q Consensus 351 ~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~DfG~a 409 (470)
. ....+.+.....+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||++
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence 3 2455677777889999999999999998 9999999999999765 78999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF---SVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+..+ ....+...+||+.|.|||++.++.+ ..++|+||+|||||-+|+|.+||+-.-
T Consensus 327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9865 2334567899999999999976543 358899999999999999999998543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=279.14 Aligned_cols=183 Identities=25% Similarity=0.377 Sum_probs=155.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+.|+...++|+|+||.||+++. ++|+.||||++..... .-.+-..+|+++|++|+|+|+|.++++|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577889999999999999995 5799999999865432 22344679999999999999999876653322
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....++.+...+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.. ...
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 23566888999999999999999999998 99999999999999999999999999998763 223
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
..+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|...+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 3455678999999999987 689999999999999999999999887654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.27 Aligned_cols=180 Identities=30% Similarity=0.503 Sum_probs=160.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+.. .+..+.+.+|++++++++|||||.+++++....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688889999999999999994 478999999997653 344567899999999999999999998886644
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
+..+.++++++..++.++..||.|||+.. |+|||+||.|||++..+.+|++|||+++.+..+. ..
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~v 156 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SV 156 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc--ee
Confidence 34678999999999999999999999987 9999999999999999999999999999875432 33
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.+.+.|||.|||||.+.+.+|+..+|+||+|||+|||++|++||-
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 456789999999999999999999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=296.34 Aligned_cols=188 Identities=29% Similarity=0.440 Sum_probs=161.7
Q ss_pred HhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc---CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC--
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-- 350 (470)
....+|.+.+.||+|+|++|++|+ ..+++++|||++.+. .....+.+..|-..|.+| .||.|++|+--++++.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345689999999999999999999 568999999999765 233345577888999999 8999999998777654
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.+.+.|++.....++.+|+.||+|||++| ||||||||+|||||+||++||+|||.++.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 24678899999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCc---------ccc--cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 415 DQTQ---------GNT--SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 415 ~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.... ... ..++||..|.+||+|..+..+..+|+|+||||||+|+.|++||.-.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 3322 111 44789999999999999999999999999999999999999997644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=283.63 Aligned_cols=180 Identities=31% Similarity=0.453 Sum_probs=156.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.+.+..+.||+|..|+||++++ .+++.+|+|.+... .....+++.+|++++++.+||+||+++|.+..+..
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3455678999999999999995 57899999998544 44556789999999999999999999999887663
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
..+.+++...-+|+.++++||.|||+ ++ ||||||||+||||+..|++||+|||.++.+...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 13458888889999999999999996 54 999999999999999999999999999876443
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||..|||||.+.+..|+.++||||||+.++||.+|+.||...
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 334578999999999999999999999999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=265.83 Aligned_cols=183 Identities=25% Similarity=0.424 Sum_probs=155.2
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCcc--CHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.+|...++||+|.||.||+|+ .++|+.||||+++..... -.....+||+.|+.++|+||+.+++.+....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 568999999999765332 2235689999999999999999998765432
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.+...+...+...++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+++.+.......
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 34567888999999999999999999998 9999999999999999999999999999987554433
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.. .+-|.+|.|||.+.+ +.|+..+|+||.|||+.||+-|.+-|...+
T Consensus 159 ~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 159 TH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred cc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 22 256889999999987 479999999999999999999987766543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.06 Aligned_cols=192 Identities=34% Similarity=0.590 Sum_probs=161.4
Q ss_pred HHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 273 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
.+++.+..+++.+.+.||+|.||+||+|++. -.||||+++... ....+.|++|+..+++-+|.||+-++|++....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3566777778888999999999999999984 369999997653 345678999999999999999999999987754
Q ss_pred C------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 E------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 ~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
. ....|+..+.+.|++||++|+.|||.++ |||||||..||+|.+++.+||+|||++..-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 2 2356788888999999999999999998 999999999999999999999999998754
Q ss_pred cCCCCcccccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
.............|...|||||++.. .+|++.+||||||+|+|||+||..||...+.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 43322223334567889999999864 4789999999999999999999999995543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.80 Aligned_cols=188 Identities=28% Similarity=0.376 Sum_probs=163.1
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC-
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~- 350 (470)
....++|.+.++||+|.||+|+++.. .+++.+|||.+++.. ....+..+.|.+++.... ||.++.++..++...
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34457899999999999999999995 468899999998873 455667788888887775 999999998776643
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|++||+|||+++..-.
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 23578999999999999999999999998 99999999999999999999999999986321
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
....+..++||+.|||||++.+..|+..+|+|||||+|||||.|+.||...+.
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 22356678999999999999999999999999999999999999999996554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.30 Aligned_cols=183 Identities=27% Similarity=0.402 Sum_probs=157.9
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHH--HHHHHHHhcCC-CCCccceeeEeeeCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEF--KNEVVVVAKLQ-HRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-h~niv~l~~~~~~~~---- 350 (470)
.-++|.+.++||.|.||.||+|+ ..+++.||||++++.... +++. .+|++.|++|+ |||||+|.+++.+..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34789999999999999999999 567999999999766443 4443 57999999999 999999988776644
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.+...|++..+..|+.||++||.|+|.+| +.|||+||+|||+..+..+||+|||+|+.+...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence 34788999999999999999999999998 999999999999998889999999999976533
Q ss_pred CCcccccccccccCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
. ..+..+.|.+|.|||++. .+-|+.+.|+||+|||++|+.+-++-|...+
T Consensus 164 p---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 164 P---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred C---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 2 345567899999999875 5689999999999999999999999887543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.10 Aligned_cols=179 Identities=36% Similarity=0.596 Sum_probs=153.2
Q ss_pred CCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
+...+.||+|.||.||+|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4457899999999999999977779999999654 445678999999999999999999999997743
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 351 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
.....+...+.+.++.||++|++||++++ +|||||..+||||+++..+||+|||+++....+.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 23567888999999999999999999998 9999999999999999999999999999654443322211
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
..-...|.|||.+..+.++.|||||||||+||||+| |+.||+-
T Consensus 364 -~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 364 -GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred -CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 122468999999999999999999999999999998 8888764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.38 Aligned_cols=190 Identities=32% Similarity=0.511 Sum_probs=158.8
Q ss_pred HHHhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeee
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 348 (470)
......+.+..+.||+|.||+||+|+. ++...||||.++..... ...+|++|++++..|+|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 344456667789999999999999983 23567999999877555 67899999999999999999999999976
Q ss_pred CC----------------------------CC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 041433 349 DP----------------------------EK----QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD 396 (470)
Q Consensus 349 ~~----------------------------~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~ 396 (470)
++ .. ..+|+..+.+.|+.||+.||.||-++. +|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 43 01 344899999999999999999999987 99999999999999
Q ss_pred CCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 397 AEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 397 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
++..+||+|||+++..-..+.........-.++||+||.+..++|+.+||||||||+|||+++ |+.||.-..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 999999999999986543333322222233579999999999999999999999999999998 999986544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=280.81 Aligned_cols=189 Identities=25% Similarity=0.341 Sum_probs=160.7
Q ss_pred HHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
+...++|++++.||+|+||.||+++ ..+|+.+|+|++++.. ....+.+..|-.+|....+|+||+|+-.+++..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 4566889999999999999999999 5679999999998763 345567788999999999999999998777644
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.+...|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+|||++.-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 24678999999999999999999999998 99999999999999999999999999864321
Q ss_pred CC---------------------Ccc------c------------------ccccccccCcccccccccCCCCchhhHHH
Q 041433 415 DQ---------------------TQG------N------------------TSRIAGTYGYMAPEYAMHGQFSVKSDVYS 449 (470)
Q Consensus 415 ~~---------------------~~~------~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 449 (470)
.. ... . ....+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 000 0 01246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 041433 450 FGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 450 lG~vl~elltG~~P~~~~~ 468 (470)
|||||||||.|-+||....
T Consensus 374 LG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.10 Aligned_cols=182 Identities=26% Similarity=0.380 Sum_probs=153.9
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccC--HHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQG--AEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|+.+++|++|+||.||+|+. .+++.||+|+++...... .-.-.+||.+|.+++|||||.+-.+.....
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5688889999999999999995 578999999997553221 123478999999999999999876554322
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+...+..-++.|+++|++|||.+. |+|||||++|+|+.+.|.+||+|||+|+.++...
T Consensus 156 Me~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred HHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 23468889999999999999999999998 9999999999999999999999999999887543
Q ss_pred cccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|..-
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 334556779999999998874 6899999999999999999999988643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=284.11 Aligned_cols=182 Identities=30% Similarity=0.500 Sum_probs=161.3
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
...|...++||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.++...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3568888999999999999999 5678999999998877777788899999999999999999987554432
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++.++..|.+++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+..... ..
T Consensus 352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR 426 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR 426 (550)
T ss_pred cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence 23456889999999999999999999998 99999999999999999999999999988765543 34
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...+||+.|||||++....|++|.||||||++++||+-|++||=+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 557899999999999999999999999999999999999999854
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=279.61 Aligned_cols=178 Identities=31% Similarity=0.517 Sum_probs=145.4
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHh--cCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVA--KLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~~~~~~~~-------- 350 (470)
...+..+.||+|+||.||+|++ +++.||||++.... .+.|++|-+|.+ .++|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455668899999999999998 56999999996543 345666666655 468999999987543321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHED------SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.+...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|++..|+|||++..
T Consensus 286 Vt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred EeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 2356789999999999999999999975 457899999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCcccccccccCC-C-----CchhhHHHHHHHHHHHHhCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQ-F-----SVKSDVYSFGVLVLEIITGKK 462 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dv~SlG~vl~elltG~~ 462 (470)
+............+||.+|||||++.+.- + -.+.||||+|.|||||++.-.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 88776666666678999999999986532 1 246899999999999998653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.83 Aligned_cols=187 Identities=28% Similarity=0.432 Sum_probs=153.0
Q ss_pred HHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc--------------cCHHHHHHHHHHHhcCCCCCccc
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--------------QGAEEFKNEVVVVAKLQHRNLVR 341 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~h~niv~ 341 (470)
....++|++.+.||+|.||.|-+|+ ..+++.||||++.+... ...++..+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3445889999999999999999999 45799999999865421 22457899999999999999999
Q ss_pred eeeEeeeCC-------------------CCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 342 LLGFCLEDP-------------------EKQGQ-LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 342 l~~~~~~~~-------------------~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
|+.+..+-. ..... +.+.++++++.++..||+|||.++ ||||||||+|+||+++|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 987654321 11223 889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceeccCCCC---cccccccccccCcccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQT---QGNTSRIAGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||+|||.+........ ........|||.|+|||...++. .+.+.||||+||+||-|+.|+.||--
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 9999999987632211 11223367999999999887632 35789999999999999999999853
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=275.56 Aligned_cols=183 Identities=32% Similarity=0.528 Sum_probs=151.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
.++...+.||+|+||.||++.. ++|+..|||.+...+....+.+.+|+.+|.+++|||||+.+|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4567789999999999999995 458999999987654333677899999999999999999999521111
Q ss_pred -----------CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCceeccC-CC
Q 041433 351 -----------EK-QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAKIFGV-DQ 416 (470)
Q Consensus 351 -----------~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~~~~-~~ 416 (470)
.+ ...|++..+..+..||++||.|||+++ |+||||||+|||++. ++.+||+|||+++.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 01 227999999999999999999999998 999999999999999 79999999999987653 11
Q ss_pred CcccccccccccCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.........||+.|||||++..+. ...++|||||||++.||+||++||..
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 112234578999999999998543 33599999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=281.56 Aligned_cols=185 Identities=30% Similarity=0.488 Sum_probs=157.9
Q ss_pred HhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc----Cc-cCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS----SG-QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 350 (470)
...++|.+.+.||+|+||+|++|. ..+++.||+|++.+. .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999998 457899999987654 22 23456778999999999 999999998875532
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCcee
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKI 411 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~ 411 (470)
...+.+.+.++..+++||+.|++|||+++ |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 12578899999999999999999999998 9999999999999999 9999999999987
Q ss_pred ccCCCCcccccccccccCcccccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQ-FS-VKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 63 1223345578999999999999877 76 8899999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=254.83 Aligned_cols=182 Identities=30% Similarity=0.451 Sum_probs=159.3
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|++.+.||+|-||.||+|+ .+++..||+|++.+.. .....++.+|+++.+.|+||||+++++++.++.
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3678999999999999999999 4568899999987652 344567899999999999999999999987744
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.....++.|++.||.|+|..+ |+||||||+|+|++..+.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 24566888899999999999999999987 9999999999999999999999999987532
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||+...
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 223455789999999999999999999999999999999999999998643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=264.73 Aligned_cols=186 Identities=27% Similarity=0.444 Sum_probs=157.8
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccC--cCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
...|...+.||+|+||.|..+. ..+|+.||||++.. ......++..+|+++|+.++|+||+.+++......
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3556667899999999999999 45799999999973 35556678899999999999999999998775521
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
..+..|+......++.||+.||+|+|+.+ |+||||||+|+|++.+..+||+|||+++....
T Consensus 101 vYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence 12344889999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcccccccccccCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.......+..+.|.+|.|||++. ...|+...||||+||||.||++|++-|...+
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 43333445667899999999875 4689999999999999999999999887654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=263.26 Aligned_cols=183 Identities=26% Similarity=0.405 Sum_probs=153.6
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCcc--CHHHHHHHHHHHhcCCCCC-ccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKLQHRN-LVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~----- 351 (470)
..|...++||+|+||+||+|+ ..+|+.||+|++...... ......+|+.++++|+|+| |+++++++..+..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667889999999999999 457899999998765432 3345689999999999999 9999998876441
Q ss_pred -------------------CC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 352 -------------------KQ---GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 352 -------------------~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
.. ..++...+..++.||+.||.|||+++ |+||||||.||||+++|.+||+|||++
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 01 35677788999999999999999998 999999999999999999999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+.+..+.. .....++|..|.|||++.+. .|+...||||+|||+.||+++++-|.-..
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 96653332 24445789999999999876 79999999999999999999998887543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=264.40 Aligned_cols=176 Identities=28% Similarity=0.448 Sum_probs=145.4
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK-------- 352 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-------- 352 (470)
.|...+++|.|+||.||+|+. .+++.||||+.-..... -.+|+++|++++|||||+++-++....+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466678999999999999994 46799999998544332 24699999999999999999888764433
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCceecc
Q 041433 353 ------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFG 413 (470)
Q Consensus 353 ------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~~~ 413 (470)
+..++...+.-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 344555556678999999999999987 9999999999999876 899999999999875
Q ss_pred CCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|..-
T Consensus 178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 44332 23456889999999887 57999999999999999999999988753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.58 Aligned_cols=183 Identities=25% Similarity=0.331 Sum_probs=153.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||+||++.. .+++.||||++.+.. ......+.+|+.++.+++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788999999999999999984 468999999986542 233456788999999999999999998765532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 12456889999999999999999999988 999999999999999999999999998754321100
Q ss_pred ---------------------------------ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 419 ---------------------------------GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 419 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123468999999999999999999999999999999999999996
Q ss_pred C
Q 041433 466 F 466 (470)
Q Consensus 466 ~ 466 (470)
.
T Consensus 238 ~ 238 (363)
T cd05628 238 S 238 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=264.03 Aligned_cols=185 Identities=26% Similarity=0.446 Sum_probs=157.0
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.+.|++.+.||.|..++||+|+ .+.++.||||++..+.- ...+.+.+|+..|+.++||||++++..+..+.+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999999 67889999999976533 336889999999999999999999987766442
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 2345889999999999999999999998 99999999999999999999999998766543322
Q ss_pred cc-cc-cccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QG-NT-SRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .. ....||+.|||||++.. ..|+.|+||||||+...||.+|..||.-+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 11 11 45689999999999643 47999999999999999999999999754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.84 Aligned_cols=170 Identities=34% Similarity=0.503 Sum_probs=147.9
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
.++-||.|+.|.||+|++ .++.||||+++... +.+|+-|++|+||||+.+.|+|....
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 457799999999999998 67899999984332 35789999999999999999986643
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccc
Q 041433 351 ----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 351 ----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
.....+.......|.++|+.|+.|||.+. |||||||.-||||..+..+||+|||-++.+... .....+.|
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 23556777888899999999999999987 999999999999999999999999999876433 33456789
Q ss_pred ccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 427 t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
|..|||||++.+.+.+.|+|||||||||||||||+.||...+
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 999999999999999999999999999999999999997543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.16 Aligned_cols=187 Identities=29% Similarity=0.430 Sum_probs=151.3
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
+..++|++.++||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4557899999999999999999973 2356899999865432 3345788999999999 899999999876432
Q ss_pred CCC-----------------------------------------------------------------------------
Q 041433 350 PEK----------------------------------------------------------------------------- 352 (470)
Q Consensus 350 ~~~----------------------------------------------------------------------------- 352 (470)
...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 100
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccccc
Q 041433 353 ----QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY 428 (470)
Q Consensus 353 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~ 428 (470)
...+++.+...++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124777888899999999999999987 9999999999999999999999999998653322211222234567
Q ss_pred CcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 429 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 429 ~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999998999999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=265.59 Aligned_cols=180 Identities=30% Similarity=0.412 Sum_probs=151.3
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.|+..+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|++++++++|+||+++++.+.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367889999999999999994 579999999986542 223346788999999999999999987765422
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 12235889999999999999999999988 9999999999999999999999999998653222
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 122346899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.58 Aligned_cols=183 Identities=25% Similarity=0.347 Sum_probs=151.6
Q ss_pred CCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.|++.+.||+|+||+||+|+ ..+++.||||++.+.. ......+.+|++++++++||||+++++.+.+...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999998 4578999999986542 2334568899999999999999999988765331
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc-
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ- 418 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 418 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 2345788888999999999999999988 999999999999999999999999997643211000
Q ss_pred --------------------------------------------ccccccccccCcccccccccCCCCchhhHHHHHHHH
Q 041433 419 --------------------------------------------GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454 (470)
Q Consensus 419 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl 454 (470)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCC
Q 041433 455 LEIITGKKNSSFY 467 (470)
Q Consensus 455 ~elltG~~P~~~~ 467 (470)
|||++|+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (381)
T cd05626 239 FEMLVGQPPFLAP 251 (381)
T ss_pred HHHHhCCCCCcCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=268.21 Aligned_cols=179 Identities=27% Similarity=0.345 Sum_probs=151.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999995 468999999986432 233456889999999999999999987654322
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 12346788899999999999999999988 999999999999999999999999999765321
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22346899999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=265.63 Aligned_cols=182 Identities=26% Similarity=0.393 Sum_probs=151.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.++|++.++||+|+||.||+|+. .+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36899999999999999999995 4789999999865432 23346788999999999999999998775533
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 12355888899999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1223467899999998865 4588999999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=273.19 Aligned_cols=178 Identities=29% Similarity=0.387 Sum_probs=153.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++++++||||+++++.+.+..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5788999999999999999995 468999999986542 234467889999999999999999998776533
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 12346788888999999999999999988 999999999999999999999999999865322
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 1235689999999999998999999999999999999999999964
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=263.49 Aligned_cols=182 Identities=25% Similarity=0.473 Sum_probs=159.7
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.+|++.+.||+|.||.|-++. ...|+.||||.+++.... +.-.+.+||++|..|+||||+.++.++....
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 468888999999999999999 468999999999876444 4445789999999999999999998876543
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
...+.|++.++..++.||..|+.|+|.+. ++|||||.+|||||.++++||+|||++.++....
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence 23567999999999999999999999987 9999999999999999999999999998775433
Q ss_pred ccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
....++|++.|.+||++.+.+|. +.+|-|||||+||.|+.|..||...+
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 34567899999999999999885 88999999999999999999998764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.34 Aligned_cols=175 Identities=22% Similarity=0.312 Sum_probs=148.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..+|++.++||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999994 578999999753 235678999999999999999998765432
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~ 240 (391)
T PHA03212 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKY 240 (391)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccc
Confidence 12346788999999999999999999987 9999999999999999999999999997532211 1122
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 3457899999999999889999999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=276.86 Aligned_cols=184 Identities=26% Similarity=0.349 Sum_probs=153.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+++++.++||||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999995 468999999986532 233456788999999999999999998776532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 12456889999999999999999999988 999999999999999999999999998754321110
Q ss_pred c------------------------------------cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 041433 419 G------------------------------------NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462 (470)
Q Consensus 419 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~ 462 (470)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0112358999999999998899999999999999999999999
Q ss_pred CCCCC
Q 041433 463 NSSFY 467 (470)
Q Consensus 463 P~~~~ 467 (470)
||...
T Consensus 238 Pf~~~ 242 (364)
T cd05599 238 PFCSD 242 (364)
T ss_pred CCCCC
Confidence 99653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=278.52 Aligned_cols=184 Identities=27% Similarity=0.311 Sum_probs=151.6
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.++||+|+||.||++. ..+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468899999999999999998 4578999999986532 233456888999999999999999998776533
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 12356788888999999999999999998 999999999999999999999999998643210000
Q ss_pred ------------c---------------------------------cccccccccCcccccccccCCCCchhhHHHHHHH
Q 041433 419 ------------G---------------------------------NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVL 453 (470)
Q Consensus 419 ------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~v 453 (470)
. ......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012468999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 041433 454 VLEIITGKKNSSFY 467 (470)
Q Consensus 454 l~elltG~~P~~~~ 467 (470)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (377)
T cd05629 238 MFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhcCCCCCCCC
Confidence 99999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=263.48 Aligned_cols=182 Identities=24% Similarity=0.375 Sum_probs=151.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.++||+|+||.||++.. .+++.||+|+++... ......+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5689999999999999999984 478999999986543 233456789999999999999999998765432
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~ 159 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T 159 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence 12335788889999999999999999988 99999999999999999999999999976432221 1
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 223467899999998865 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=264.03 Aligned_cols=182 Identities=27% Similarity=0.464 Sum_probs=158.0
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..|...+.||+|.||.||+|. ..+++.||+|++... .....+++++|+.+|.+++++||.++++.++...
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777999999999999999 457899999999765 4455688999999999999999999998776643
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.+..-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-- 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-- 167 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence 23344578888889999999999999998 999999999999999999999999999877654433
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...++||+.|||||++....|+.|+||||||++.+||.+|.+||.-.
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 35678999999999999889999999999999999999999999754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=270.43 Aligned_cols=182 Identities=25% Similarity=0.410 Sum_probs=150.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.++||+|+||.||+|+. .+++.||||++... .......+.+|++++++++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999994 57899999998643 2233456889999999999999999987654321
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 12345889999999999999999999998 9999999999999999999999999997543221
Q ss_pred Cc-ccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQ-GNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 11 11233568999999998865 6789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=278.03 Aligned_cols=183 Identities=26% Similarity=0.349 Sum_probs=151.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+|++.++||+|+||.||+++. .+++.||+|++.+.. ......+.+|++++++++||||+++++.+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999994 578899999986542 233456889999999999999999998876533
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC--
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT-- 417 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 417 (470)
.....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 12345788888999999999999999988 99999999999999999999999999753311000
Q ss_pred -------------------------------------------cccccccccccCcccccccccCCCCchhhHHHHHHHH
Q 041433 418 -------------------------------------------QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454 (470)
Q Consensus 418 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl 454 (470)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001224689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 041433 455 LEIITGKKNSSFY 467 (470)
Q Consensus 455 ~elltG~~P~~~~ 467 (470)
|||++|++||...
T Consensus 239 ~elltG~~Pf~~~ 251 (382)
T cd05625 239 YEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=272.22 Aligned_cols=179 Identities=28% Similarity=0.394 Sum_probs=153.6
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.++||+|+||.||+|+.. +++.||||++++.. ......+.+|++++..++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999954 68999999986542 233456889999999999999999998765532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 12356788999999999999999999988 99999999999999999999999999975432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 223456899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=273.85 Aligned_cols=180 Identities=30% Similarity=0.422 Sum_probs=156.8
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
+-|++++.||.|+-|.|-+|+ ..+|+.+|||++.+.. ......+++||-+|+.+.|||++++++++.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 447888999999999999999 5689999999997663 233456889999999999999999999886643
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
...+.+.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 24678999999999999999999999988 999999999999999999999999999864322
Q ss_pred ccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....-+|++.|.+||++.+.+|. .++||||.|||||-||||+.||+-
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 233445899999999999999886 789999999999999999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=269.70 Aligned_cols=175 Identities=26% Similarity=0.330 Sum_probs=147.0
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++++++||||+++++.+....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999987542 233456788999999999999999988765532
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccce
Confidence 12456788999999999999999999998 999999999999999999999999998753211 1122345
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=276.54 Aligned_cols=184 Identities=26% Similarity=0.350 Sum_probs=151.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.+|++.+.||+|+||.||+++. .+++.||||++.+.. ......+.+|++++++++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999994 568999999986532 233466889999999999999999998765533
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC-
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT- 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 417 (470)
.....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 12345788888899999999999999988 99999999999999999999999999753311000
Q ss_pred ----------------------------------------cccccccccccCcccccccccCCCCchhhHHHHHHHHHHH
Q 041433 418 ----------------------------------------QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 457 (470)
Q Consensus 418 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~el 457 (470)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134689999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 041433 458 ITGKKNSSFY 467 (470)
Q Consensus 458 ltG~~P~~~~ 467 (470)
++|+.||...
T Consensus 238 l~G~~Pf~~~ 247 (376)
T cd05598 238 LVGQPPFLAD 247 (376)
T ss_pred hhCCCCCCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=271.04 Aligned_cols=180 Identities=26% Similarity=0.370 Sum_probs=153.0
Q ss_pred hcCCCccccccccCceeEEEEEcC-C-CcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-S-GREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.+.||+|+||.||+|... + +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357899999999999999999843 2 368999998643 2334567889999999999999999998876543
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 12456888899999999999999999988 999999999999999999999999999865321
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 22356899999999999888999999999999999999999999754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=268.42 Aligned_cols=181 Identities=29% Similarity=0.443 Sum_probs=147.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.+|+..++||+|+||.||+++. .+++.||||++..... ...+.+.+|++++++++|+||+++++++.....
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3456778999999999999994 4789999999865432 334678899999999999999999987754321
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 352 -------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 352 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..... .....
T Consensus 154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~ 228 (353)
T PLN00034 154 MDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSS 228 (353)
T ss_pred CCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--ccccc
Confidence 1234567778899999999999999988 99999999999999999999999999986543221 12334
Q ss_pred ccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 425 AGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 68999999998743 2345689999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=261.98 Aligned_cols=183 Identities=23% Similarity=0.338 Sum_probs=153.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4689999999999999999995 468899999986542 233567889999999999999999987765432
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-A 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-c
Confidence 12346888999999999999999999987 99999999999999999999999999986543221 1
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|++.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 222346889999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=274.32 Aligned_cols=190 Identities=23% Similarity=0.278 Sum_probs=155.6
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
..+....++|++.+.||+|+||.||+++. .+++.||+|++.+. .......+.+|+.+++.++||||+++++.+...
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34455567899999999999999999995 46889999998643 223345678899999999999999999877553
Q ss_pred CC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 350 PE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 350 ~~-----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.. ....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++..+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 31 1235788888999999999999999988 999999999999999999999999999875
Q ss_pred cCCCCcccccccccccCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 43221 122345689999999998654 3788999999999999999999999643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=266.47 Aligned_cols=176 Identities=26% Similarity=0.334 Sum_probs=147.2
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++.+....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999994 578999999986542 233456778999999999999999988765432
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence 12446889999999999999999999988 9999999999999999999999999987532211 112235
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 6899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=260.13 Aligned_cols=181 Identities=27% Similarity=0.439 Sum_probs=148.3
Q ss_pred cCCCccccccccCceeEEEEEc-C-CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcC---CCCCccceeeEeeeCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-P-SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKL---QHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~--- 350 (470)
++|++.+.||+|+||.||+++. . +++.||+|+++... ......+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999999984 3 46889999886542 22234566777777665 6999999998764211
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 351 ---------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 351 ---------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 11234788999999999999999999988 999999999999999999999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..... .......|++.|+|||.+.+..++.++||||||+++|||++|++||...
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 865432 2233456899999999998889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=266.79 Aligned_cols=176 Identities=27% Similarity=0.339 Sum_probs=147.6
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+++++.++||||+++++.+....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 578999999987542 234457788999999999999999987765432
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence 12356889999999999999999999988 9999999999999999999999999987532211 122335
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 6899999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=271.93 Aligned_cols=191 Identities=22% Similarity=0.274 Sum_probs=156.2
Q ss_pred HHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeee
Q 041433 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348 (470)
Q Consensus 273 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 348 (470)
+.++....++|++.+.||+|+||.||+++. .+++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445566678999999999999999999995 46889999998643 22234557889999999999999999987655
Q ss_pred CCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 349 DPE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 349 ~~~-----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 321 1235778888899999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcccccccccccCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 543221 122345689999999998653 3789999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=264.29 Aligned_cols=173 Identities=29% Similarity=0.380 Sum_probs=146.3
Q ss_pred ccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||+|+||.||+++. .+++.||+|++.+. .......+.+|+.++++++||||+++++.+....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999995 46889999998653 2334466788999999999999999988775532
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccc
Q 041433 351 ----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 351 ----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence 12456889999999999999999999988 9999999999999999999999999987532221 12234568
Q ss_pred ccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 427 t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 9999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=263.07 Aligned_cols=184 Identities=34% Similarity=0.587 Sum_probs=151.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
..+|++.+.||+|+||.||+|++ .+++ .||+|+++... ....+++.+|+.+++.++||||+++++++....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~ 85 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 85 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCcee
Confidence 35689999999999999999984 3343 48999986543 334567889999999999999999999876532
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++...+.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 12345788888999999999999999988 999999999999999999999999999876533
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
...........+..|++||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 32221222234668999999999999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=279.10 Aligned_cols=188 Identities=24% Similarity=0.328 Sum_probs=155.8
Q ss_pred HHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeC---
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED--- 349 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--- 349 (470)
.+...++|.+.+.||+|+||+||+++ ..+++.||||++.... ......+.+|+.++..++|+||++++..+...
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34456799999999999999999998 4579999999986542 33445678999999999999999876533211
Q ss_pred --------------C-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 350 --------------P-------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 350 --------------~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 0 11245788888999999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999876543333333446789999999999999999999999999999999999999974
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=267.69 Aligned_cols=183 Identities=27% Similarity=0.371 Sum_probs=153.4
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999984 46899999998654 23345677899999999999999999987643221
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 0234678888899999999999999988 99999999999999999999999999975432
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 NF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred Cc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 21 123346789999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=263.82 Aligned_cols=180 Identities=29% Similarity=0.390 Sum_probs=148.3
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHH---hcCCCCCccceeeEeeeCC-----
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVV---AKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~----- 350 (470)
|++.+.||+|+||.||++.. .+++.||||++++.. ....+.+.+|++++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999984 478999999986542 23345566676654 5678999999998775532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--G 155 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC--C
Confidence 12456899999999999999999999988 999999999999999999999999998743221 1
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 1223456899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=271.50 Aligned_cols=184 Identities=26% Similarity=0.332 Sum_probs=153.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++.+++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999995 46899999998653 2334567888999999999999999998765532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 13456888999999999999999999988 999999999999999999999999998754221100
Q ss_pred ---------------------------------ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 419 ---------------------------------GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 419 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113468999999999999999999999999999999999999996
Q ss_pred CC
Q 041433 466 FY 467 (470)
Q Consensus 466 ~~ 467 (470)
..
T Consensus 238 ~~ 239 (360)
T cd05627 238 SE 239 (360)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=270.51 Aligned_cols=184 Identities=25% Similarity=0.351 Sum_probs=154.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|.+.+.||+|+||.||+++. .+++.||||++++.. ......+.+|++++..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4789999999999999999995 478999999986542 234567889999999999999999987665432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC--
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-- 416 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 416 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 12356889999999999999999999987 9999999999999999999999999998654332
Q ss_pred -------------------------CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 -------------------------TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 001122346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=270.48 Aligned_cols=180 Identities=23% Similarity=0.362 Sum_probs=152.3
Q ss_pred hhcCCCccccccccCceeEEEEEc---CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL---PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
...+|.+.+.||+|+||.||++.. ..++.|++|.+... ....+|++++++++||||+++++.+....
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 346899999999999999999974 24678999988543 23568999999999999999987664422
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 165 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred ehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 23467899999999999999999999988 999999999999999999999999999866543333
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 233345789999999999988999999999999999999999999854
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=259.95 Aligned_cols=178 Identities=28% Similarity=0.450 Sum_probs=144.1
Q ss_pred cccccccCceeEEEEEcC---CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----------
Q 041433 286 DNKLGAGGFGEVYKGVLP---SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----------- 351 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----------- 351 (470)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++.+.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999843 56889999986442 23457889999999999999999887643210
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEeecCCce
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKISDFGMAK 410 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~DfG~a~ 410 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 1235788889999999999999999988 9999999999999 456789999999998
Q ss_pred eccCCCCc-ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 411 IFGVDQTQ-GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 411 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76433211 12234568999999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=263.42 Aligned_cols=176 Identities=30% Similarity=0.413 Sum_probs=146.3
Q ss_pred ccccccCceeEEEEEc----CCCcEEEEEEccCc----CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 287 NKLGAGGFGEVYKGVL----PSGREIAVKRLSKS----SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++||+|+||.||+++. .+++.||+|+++.. .......+.+|+.+++.++||||+++++.+..+..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 35789999998653 22334567889999999999999999987765431
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TV 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cc
Confidence 2345677888889999999999999988 9999999999999999999999999987532221 12
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 23356899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.84 Aligned_cols=183 Identities=21% Similarity=0.256 Sum_probs=154.2
Q ss_pred CCCccccccccCceeEEEEEc-CC-CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PS-GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.|.+.+.||+|++|.||++.. .+ ++.||+|.+..........+.+|+.+++.++||||+++++++.....
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999984 33 67899998765555555677889999999999999999998765321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 1235788888999999999999999987 99999999999999999999999999987644332
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22234456899999999999899999999999999999999999999643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=271.11 Aligned_cols=187 Identities=24% Similarity=0.282 Sum_probs=153.1
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
....++|++.++||+|+||.||+++. .+++.||+|++.+. .......+.+|+.+++.++||||+++++++.+...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34457899999999999999999995 46899999998643 22334557889999999999999999987655331
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 1235778888899999999999999988 999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 21 112335689999999988643 4789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=261.00 Aligned_cols=181 Identities=29% Similarity=0.392 Sum_probs=153.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||.||+++. .++..+|+|++.... ....+.+.+|++++++++||||+++++++..+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 47899999999999999999995 468899999986542 2334678999999999999999999988765431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence 2345788888999999999999999853 4999999999999999999999999998765322
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12334689999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=240.56 Aligned_cols=188 Identities=26% Similarity=0.327 Sum_probs=157.6
Q ss_pred HhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
+..++|.+.++||+|||+.||+++ ..+++.+|+|++.-.+.++.+..++|++..++++|||+++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445789999999999999999999 6789999999998777788889999999999999999999886554321
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 351 ---------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 351 ---------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
.++..+++.+.+.|+.+|.+||++||+.. +++.||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 23557899999999999999999999986 57999999999999999999999999998
Q ss_pred eeccCCCCcc-------cccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 410 KIFGVDQTQG-------NTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 410 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.......... .......|..|.|||.+. +...+.++|||||||+||+|+.|..||+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 7643221111 011123578899999774 44678999999999999999999999974
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.05 Aligned_cols=182 Identities=24% Similarity=0.394 Sum_probs=151.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999994 57899999998653 2234467889999999999999999988765432
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 12356889999999999999999999988 9999999999999999999999999998654322
Q ss_pred CcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 158 SK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred cc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 21 12234578899999988764 5789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-34 Score=247.65 Aligned_cols=182 Identities=28% Similarity=0.422 Sum_probs=153.1
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|.|+.|++.. .++|+.+|+|++... +..+.+++.+|+++.+.|+||||++|.+.+.++.-
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45778889999999999999988 568999999988543 44577889999999999999999999865544321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEeecCCceeccC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD---AEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~DfG~a~~~~~ 414 (470)
....+++..+-..++||+++|.|+|.++ |||||+||+|+|+- ..--+||+|||++..++
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 1233566667788999999999999998 99999999999993 33468999999999876
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.........|||.|||||++...+|+..+|||+.|||||-||.|.+||.-
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 22334456899999999999999999999999999999999999999975
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=263.98 Aligned_cols=182 Identities=26% Similarity=0.392 Sum_probs=152.5
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
....++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34457899999999999999999984 578899999986542 223456778999999999999999987653211
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 12346889999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 168 ADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred cCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 5322 223468899999999876 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=263.10 Aligned_cols=182 Identities=30% Similarity=0.369 Sum_probs=149.1
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~------ 350 (470)
+|++.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 478899999999999999985 467899999987542 22334566788888777 5888888887765432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--
Confidence 12356788999999999999999999988 9999999999999999999999999987543211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=261.32 Aligned_cols=181 Identities=30% Similarity=0.371 Sum_probs=148.5
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCC-CccceeeEeeeCC------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHR-NLVRLLGFCLEDP------ 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~------ 350 (470)
+|++.+.||+|+||.||+|+. .+++.||||++.+. .....+.+..|++++..++|+ +|+++++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478899999999999999995 46789999998754 233456678899999999765 5777776654422
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--
Confidence 12345788999999999999999999987 9999999999999999999999999987432111
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=270.52 Aligned_cols=179 Identities=25% Similarity=0.415 Sum_probs=146.9
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
...++|++.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++....
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3457899999999999999999995 578999999885432 23457999999999999999877653210
Q ss_pred -----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeec
Q 041433 351 -----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDF 406 (470)
Q Consensus 351 -----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Df 406 (470)
.....+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 12356788888999999999999999988 99999999999998665 6999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9998654322 12234678999999988664 689999999999999999999999964
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=270.46 Aligned_cols=176 Identities=22% Similarity=0.294 Sum_probs=148.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
...|.+.+.||+|+||.||++.. ..++.||||... ...+.+|+++|++++|+||+++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 44799999999999999999995 458899999642 234578999999999999999998765432
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+........
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 12346899999999999999999999988 99999999999999999999999999986543322222
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
.....||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 23456899999999999999999999999999999999988654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=263.83 Aligned_cols=181 Identities=29% Similarity=0.398 Sum_probs=149.0
Q ss_pred CCCccccccccCceeEEEEEc----CCCcEEEEEEccCc----CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC--
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKS----SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-- 350 (470)
+|++.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+++++.+ +|+||+++++++..+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 36889999998643 223345678899999999 4999999987665432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.+...++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 12456889999999999999999999988 99999999999999999999999999976532
Q ss_pred CCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... .......||+.|+|||++.+. .++.++||||||+++|||+||+.||..
T Consensus 158 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 158 EEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 222 122345689999999998765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=262.47 Aligned_cols=182 Identities=25% Similarity=0.339 Sum_probs=150.5
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.++..++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999994 46899999998642 2233456888999999999999999988765432
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 11346788889999999999999999988 99999999999999999999999999876543222
Q ss_pred cccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 1 1222468999999998863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=264.12 Aligned_cols=182 Identities=28% Similarity=0.374 Sum_probs=152.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999984 468899999986542 2334567889999999999999999987653221
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 0224678888899999999999999988 99999999999999999999999999986432
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 172 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 172 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 12234688999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=258.82 Aligned_cols=184 Identities=29% Similarity=0.457 Sum_probs=148.1
Q ss_pred hcCCCccccccccCceeEEEEEcC-----------------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccc
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-----------------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVR 341 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 341 (470)
.++|.+.++||+|+||.||++.++ ++..||+|++.... .....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 467899999999999999999743 23469999987543 333467899999999999999999
Q ss_pred eeeEeeeCCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 041433 342 LLGFCLEDPE-------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384 (470)
Q Consensus 342 l~~~~~~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 384 (470)
+++++.+... ....+++.+..+++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9987754321 0124677888999999999999999988 99
Q ss_pred eecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh--CCC
Q 041433 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKK 462 (470)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt--G~~ 462 (470)
||||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543322222223345778999999988899999999999999999997 556
Q ss_pred CCCC
Q 041433 463 NSSF 466 (470)
Q Consensus 463 P~~~ 466 (470)
||..
T Consensus 241 p~~~ 244 (304)
T cd05096 241 PYGE 244 (304)
T ss_pred CCCc
Confidence 6653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=260.15 Aligned_cols=176 Identities=33% Similarity=0.443 Sum_probs=143.8
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhc-CCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAK-LQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|+++... ....+.+..|..++.. .+||||+++++.+....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999986542 2334455667777665 48999999998765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.+...++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 12346888889999999999999999987 9999999999999999999999999997643222 22334
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 56899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=266.27 Aligned_cols=188 Identities=30% Similarity=0.470 Sum_probs=151.0
Q ss_pred HHhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeee
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE 348 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 348 (470)
....++|++.+.||+|+||.||+++. .+++.||+|+++... ....+.+.+|+++++.+ +|+||+++++.+..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34456899999999999999999873 234579999996543 23345688999999999 89999999987654
Q ss_pred CCC-----------------------------------------------------------------------------
Q 041433 349 DPE----------------------------------------------------------------------------- 351 (470)
Q Consensus 349 ~~~----------------------------------------------------------------------------- 351 (470)
...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++.+..+++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 0124778889999999999999999987 99999999999999999999999999986543322111
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.....++..|||||++.+..++.++||||||+++|||++ |+.||...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 122234567999999988899999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=267.10 Aligned_cols=179 Identities=27% Similarity=0.359 Sum_probs=150.6
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-C-----CCccceeeEeeeCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-H-----RNLVRLLGFCLEDP--- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~~--- 350 (470)
.+|.+.+.||+|.||.|.++. .++++.||||++++... -..+-..|+.+|..|+ | -|+|++++++....
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 389999999999999999999 56799999999965533 3445577999999997 3 47999999875532
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC--ceEEeecCCceec
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM--NPKISDFGMAKIF 412 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~DfG~a~~~ 412 (470)
++...++......++.||+.+|.+||+.+ |||+||||+||||.+.. .+||+|||.++..
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 34567899999999999999999999988 99999999999996443 7999999999865
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
..... ....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|...+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 43221 3456788999999999999999999999999999999988776543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=263.94 Aligned_cols=176 Identities=27% Similarity=0.332 Sum_probs=146.6
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|+++++.++||||+++++.+....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999987542 233456778999999999999999987765432
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccc
Confidence 124568899999999999999999997 56 9999999999999999999999999987532211 11223
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 56899999999999899999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=254.69 Aligned_cols=181 Identities=28% Similarity=0.431 Sum_probs=143.6
Q ss_pred HHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhc--CCCCCccceeeEeeeCC--
Q 041433 275 AIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK--LQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 275 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~-- 350 (470)
-.+...++..+.+.||+|.||.||+|.+ .|+.||||++...++ ..+.+|.++.+. |+|+||+.+++.-..+.
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3455667889999999999999999999 789999999965543 445566666554 69999999886432221
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHE-----DSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
.....++.+..++++..++.||.|||. +++|.|.|||||++|||+.+++.+.|+|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 234567888899999999999999995 57899999999999999999999999999
Q ss_pred CCceeccCCC--CcccccccccccCcccccccccC----CC--CchhhHHHHHHHHHHHHh
Q 041433 407 GMAKIFGVDQ--TQGNTSRIAGTYGYMAPEYAMHG----QF--SVKSDVYSFGVLVLEIIT 459 (470)
Q Consensus 407 G~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~Dv~SlG~vl~ellt 459 (470)
|++....... ........+||.+|||||++... .+ -..+||||||.|+||+.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9998765432 12234556899999999988543 12 256899999999999974
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=263.66 Aligned_cols=182 Identities=29% Similarity=0.382 Sum_probs=152.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999994 46889999998654 23344677899999999999999999886543210
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 0224678888899999999999999988 999999999999999999999999999865322
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......+|..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 180 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 180 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred C---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 1 122346889999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=260.88 Aligned_cols=175 Identities=29% Similarity=0.396 Sum_probs=146.8
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|..++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999995 468999999997542 23345678899999998 6999999998775532
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcccc
Confidence 12456899999999999999999999988 999999999999999999999999998742111 112234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 5789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=265.45 Aligned_cols=183 Identities=26% Similarity=0.348 Sum_probs=152.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||.||+++. .+++.||+|+++... ....+.+.+|+.+++.++|+||+++++.+.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999994 478999999987542 2344568899999999999999999877654321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 1256888999999999999999999988 99999999999999999999999999987643322
Q ss_pred cccccccccccCcccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 1 122346899999999886 456789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=261.09 Aligned_cols=175 Identities=29% Similarity=0.400 Sum_probs=145.7
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 468899999987542 23345677888888776 7999999998775532
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence 12356888999999999999999999988 9999999999999999999999999987532211 12234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 5689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=263.12 Aligned_cols=183 Identities=28% Similarity=0.395 Sum_probs=159.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
++|..+++||+|+||.+++.+. .+++.+++|++... .........+|+.++++++|||||.+.+.+.++..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999999984 36789999998654 33344567899999999999999999887766442
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
+...+++++...++.||+.|+.|||++. |+|||||+.||+++.+..+||+|||+++.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 3467899999999999999999999877 9999999999999999999999999999886554
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.......||+.||+||++.+.+|+.|+|||||||++|||++-+++|.-.+
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 23455789999999999999999999999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=263.85 Aligned_cols=187 Identities=32% Similarity=0.446 Sum_probs=150.7
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
...++|++.++||+|+||.||+++. .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456789999999999999999962 346689999986443 33446788999999999 899999999876542
Q ss_pred CC------------------------------------------------------------------------------
Q 041433 350 PE------------------------------------------------------------------------------ 351 (470)
Q Consensus 350 ~~------------------------------------------------------------------------------ 351 (470)
..
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 21
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 0124788889999999999999999987 9999999999999999999999999998654332
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 2111112234567999999999999999999999999999998 88998643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=260.56 Aligned_cols=176 Identities=29% Similarity=0.400 Sum_probs=146.1
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
++||+|+||.||+|+. .+++.||+|++.+.. ....+.+..|.+++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 468899999986542 23345677888888866 7999999998775532
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence 12346788899999999999999999988 9999999999999999999999999987532221 12233
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 56899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=255.59 Aligned_cols=182 Identities=24% Similarity=0.380 Sum_probs=150.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|.+.++||+|+||.||+++. .+++.||+|.++... ......+.+|++++++++||||+++++++..+..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5689999999999999999995 468899999986543 2333467889999999999999999998765331
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 160 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--T 160 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc--c
Confidence 2345788889999999999999999988 99999999999999999999999999976433221 1
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||++||...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222457889999998865 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.95 Aligned_cols=183 Identities=25% Similarity=0.354 Sum_probs=146.7
Q ss_pred HHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCC------CccceeeEeee
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHR------NLVRLLGFCLE 348 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~~~~~~ 348 (470)
+....++|++.++||+|+||+||++.. .+++.||||+++... .....+..|++++++++|. +++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 344568899999999999999999984 468899999986432 2234556677777777554 47777776654
Q ss_pred CC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCC----------
Q 041433 349 DP------------------EKQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEM---------- 399 (470)
Q Consensus 349 ~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~---------- 399 (470)
.. .+...+++.++..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence 32 1235688899999999999999999974 6 99999999999998765
Q ss_pred ------ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 400 ------NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 400 ------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764221 123457899999999999999999999999999999999999999754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=262.20 Aligned_cols=182 Identities=25% Similarity=0.328 Sum_probs=150.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.++||+|+||.||+++. .+++.||+|++.+. .......+.+|+.++..++|+||+++++++.+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999995 46889999998653 22234457889999999999999999887654321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 1356788889999999999999999988 99999999999999999999999999986543322
Q ss_pred cccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
. ......||+.|+|||++.+ +.++.++||||||+++|||++|+.||..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 1 1223468999999998865 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.09 Aligned_cols=176 Identities=27% Similarity=0.343 Sum_probs=143.8
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHH-HHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVV-VVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|.. +++.++||||+++++.+....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999994 578999999986542 223344555554 577899999999988765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCccc
Confidence 12456889999999999999999999988 999999999999999999999999998753211 112234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 56899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=256.89 Aligned_cols=184 Identities=24% Similarity=0.392 Sum_probs=156.5
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.+-|.+.+.||+|.|..|-+++ .-+|+.||||++.+... .....+.+|++.|+.++|||||+|+.+.....
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3558888999999999999998 45899999999977643 34457889999999999999999998753321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-CCCCceEEeecCCceeccCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL-DAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+.+....+++.||+.|+.|+|..+ +|||||||+||.+ .+-|-+||.|||++..+....
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 23456888999999999999999999988 9999999999977 667889999999998775443
Q ss_pred CcccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
. ....+|++.|.|||++.+..|+ +++||||||||||.|+.|++||+-.++
T Consensus 174 k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 174 K---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred h---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 2 3456899999999999999987 789999999999999999999986554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=247.81 Aligned_cols=186 Identities=24% Similarity=0.301 Sum_probs=155.4
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||.|.-|+||++++. ++..+|+|++.+.... ...+.+.|-+||+.++||.++.|++.+..+.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45677899999999999999964 4689999999876433 3445667999999999999999998776543
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC-
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD- 415 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~- 415 (470)
+....+++..+.-++.+++-||+|||-.| ||.|||||+||||.++|++.|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 45677999999999999999999999998 999999999999999999999999987543110
Q ss_pred -------------------------------C-C---------------------cccccccccccCcccccccccCCCC
Q 041433 416 -------------------------------Q-T---------------------QGNTSRIAGTYGYMAPEYAMHGQFS 442 (470)
Q Consensus 416 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 442 (470)
. . .......+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0112235799999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 443 VKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 443 ~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
.++|+|+|||+|||||.|+.||...+.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 999999999999999999999987653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=257.91 Aligned_cols=176 Identities=32% Similarity=0.427 Sum_probs=146.0
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||||++.+. .....+.+..|+.++..+ +||||+++++++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 46889999998653 223445677888888876 6999999998765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccc
Confidence 12456888999999999999999999988 9999999999999999999999999987532211 12234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 56899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=260.37 Aligned_cols=186 Identities=30% Similarity=0.444 Sum_probs=151.2
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
...++|++.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4456899999999999999999963 2357899999864432 2345678899999999 899999999876432
Q ss_pred CC------------------------------------------------------------------------------
Q 041433 350 PE------------------------------------------------------------------------------ 351 (470)
Q Consensus 350 ~~------------------------------------------------------------------------------ 351 (470)
..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 10
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccC
Q 041433 352 --KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429 (470)
Q Consensus 352 --~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~ 429 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++..+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 0126789999999999999999999987 99999999999999999999999999986543222222223345678
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 430 y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=258.34 Aligned_cols=182 Identities=29% Similarity=0.400 Sum_probs=153.0
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.++||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999954 68899999886542 2334678999999999999999999998776431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.....++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 2345778888899999999999999752 3999999999999999999999999998754321
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346889999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=250.53 Aligned_cols=183 Identities=33% Similarity=0.553 Sum_probs=149.5
Q ss_pred cCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
++|++.+.||+|+||.||+|.+ .+++ .+++|.+..... ....++..|+..+++++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 5678889999999999999995 3454 478888754322 23456788888999999999999998864321
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.....++.||+.||.|||+++ ++|+||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 12346789999999999999999999987 9999999999999999999999999998654332
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.........++..|++||.+.++.++.++||||||+++|||++ |+.||..
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 2222333456778999999988899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=233.91 Aligned_cols=182 Identities=30% Similarity=0.487 Sum_probs=151.9
Q ss_pred CccccccccCceeEEEEEc-CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC---------
Q 041433 284 STDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~--------- 351 (470)
+.+..||.|..|.|++.+. .+|...|||.+... +.+..+++...+.++.+-+ .|.||+.+|++..+..
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4467899999999999994 56899999999765 3445567777777776654 8999999999988652
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 352 ---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
...++++...-++...+.+||.||.+++ +|+|||+||+|||+|+.|++||+|||++..+-.... .+
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---ht 249 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HT 249 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---cc
Confidence 3567888888899999999999999876 699999999999999999999999999987644332 33
Q ss_pred ccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~d 470 (470)
...|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.....|
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 457889999999885 347899999999999999999999999986654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=252.51 Aligned_cols=179 Identities=27% Similarity=0.457 Sum_probs=146.6
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcC---CCCCccceeeEeeeCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKL---QHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~----- 350 (470)
+|++.+.||+|+||.||++.. .+++.||+|.++.... .....+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999999994 4789999999865422 2233456777777665 6999999998764311
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 11234789999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..... ......++..|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 158 YSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred ccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 54322 12234678899999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=258.65 Aligned_cols=181 Identities=30% Similarity=0.381 Sum_probs=148.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~------ 350 (470)
+|+..+.||+|+||.||++.. .+++.||+|++.+.. ....+.+..|..++..+. |++|+++++++....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467889999999999999994 578999999987542 233456778889988886 567777877654422
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 12356889999999999999999999988 9999999999999999999999999987532221
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 1223356899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=258.82 Aligned_cols=176 Identities=28% Similarity=0.343 Sum_probs=143.1
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHH-HHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVV-VVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||+||+++. .+++.||+|++.+.. ......+.+|.. +++.++||||+++++.+....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 478999999986542 222334455544 567899999999988765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcccc
Confidence 12456788889999999999999999988 999999999999999999999999998753211 112334
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 56899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=258.84 Aligned_cols=176 Identities=28% Similarity=0.335 Sum_probs=142.6
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHH-HHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVV-VVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
++||+|+||.||+++. .+++.||+|++.+.. ......+.+|.. +++.++||||+++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468999999986542 222334555554 678899999999988765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.+...++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence 12345778888899999999999999987 9999999999999999999999999987532211 12234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 56899999999998889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=281.69 Aligned_cols=185 Identities=34% Similarity=0.530 Sum_probs=153.6
Q ss_pred hcCCCccccccccCceeEEEEEcC--CCc----EEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP--SGR----EIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
..+....+.||+|.||.||.|... .+. .||||.+++. +.+...+|.+|..+|++++|||||+++|++++..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456677889999999999999943 233 4899998765 4566778999999999999999999999998733
Q ss_pred -----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 351 -----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 351 -----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
.....+.....+.++.+|++|+.||++++ +|||||..+|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 12456888999999999999999999998 9999999999999999999999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+++.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~ 908 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR 908 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence 9995433322222211122468999999999999999999999999999998 88898754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=251.14 Aligned_cols=174 Identities=33% Similarity=0.444 Sum_probs=145.4
Q ss_pred ccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||+|+||+||++.. .+++.||+|++..... ...+.+..|++++++++|+||+++.+++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999984 4789999999865422 23356778999999999999999987654321
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 351 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 12345889999999999999999999988 99999999999999999999999999976543222 123
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 346889999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=258.80 Aligned_cols=175 Identities=27% Similarity=0.374 Sum_probs=146.3
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 568899999997542 23345678899999888 6999999998765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence 12356899999999999999999999988 9999999999999999999999999987532111 12234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 5689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=252.15 Aligned_cols=180 Identities=32% Similarity=0.419 Sum_probs=150.8
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.|++.++||+|+||.||++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999994 4789999999865322 22345778999999999999999987764422
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 12345889999999999999999999988 99999999999999999999999999986532221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....|++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 12346889999999998889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=266.48 Aligned_cols=180 Identities=32% Similarity=0.508 Sum_probs=153.7
Q ss_pred CCccccccccCceeEEEEE-cCCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeee------------
Q 041433 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------------ 348 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------------ 348 (470)
+...+.||+|+||.||+++ ..+|+.||||.+++. .....+...+|+++|++|+|+|||++++.-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 568999999999765 44566788899999999999999998865332
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCC--ceEEeecCCc
Q 041433 349 ---------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL--DAEM--NPKISDFGMA 409 (470)
Q Consensus 349 ---------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~--~~kl~DfG~a 409 (470)
.++....|++.+.+.++..+..||.|||+++ |+||||||.||++ ..+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 2345667999999999999999999999988 9999999999998 3334 4699999999
Q ss_pred eeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+.+..+. ....+.||..|.+||.... +.|+..+|.|||||++||..||..||..+.
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9875443 4556789999999999884 889999999999999999999999998654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=254.67 Aligned_cols=178 Identities=28% Similarity=0.449 Sum_probs=143.7
Q ss_pred cccccccCceeEEEEEcC---CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----------
Q 041433 286 DNKLGAGGFGEVYKGVLP---SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----------- 351 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----------- 351 (470)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999853 45789999986543 23467889999999999999999887643210
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEeecCCce
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKISDFGMAK 410 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~DfG~a~ 410 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 1235788889999999999999999988 9999999999999 566789999999998
Q ss_pred eccCCCCc-ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 411 IFGVDQTQ-GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 411 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
........ .......+|+.|+|||++.+ ..++.++||||||+++|||+||++||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433221 12233567899999998876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=260.46 Aligned_cols=182 Identities=25% Similarity=0.324 Sum_probs=149.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.++||+|+||.||+++. .+++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999995 45788999998643 2223345788999999999999999987765432
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 11346788889999999999999999988 99999999999999999999999999876432221
Q ss_pred cccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 1122346899999999885 34678999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=251.79 Aligned_cols=172 Identities=20% Similarity=0.372 Sum_probs=146.3
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCccC---HHHHHHHHHHHhcCCCCCccceeeEeee--CC-----------
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQG---AEEFKNEVVVVAKLQHRNLVRLLGFCLE--DP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~----------- 350 (470)
..|++|+++.||+|.+ +|+.||||.++...... .+.+.+|+.+|++++||||+++++++.+ +.
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 78999999997654333 4678899999999999999999998766 11
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 1234678899999999999999999985 5 8899999999999999999999999988653221
Q ss_pred ccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 12357889999999876 68999999999999999999999999754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=256.64 Aligned_cols=176 Identities=32% Similarity=0.433 Sum_probs=144.7
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|++++.. ....+.+..|..++..+ +||||+++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 468999999986542 23345567788887754 8999999998765533
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence 12346788899999999999999999988 9999999999999999999999999987432111 12234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 56899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.37 Aligned_cols=183 Identities=27% Similarity=0.400 Sum_probs=150.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.++||+|+||.||+|.. .+++.||+|++..... ...+++.+|++++++++||||+++++++.+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999995 4689999999865422 234578899999999999999999987755321
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 352 ------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 352 ------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
....+++...+.++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 0123455677889999999999999987 9999999999999999999999999
Q ss_pred CceeccCCCC----------------cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 408 MAKIFGVDQT----------------QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986521110 0011234689999999999999999999999999999999999999964
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=257.87 Aligned_cols=176 Identities=28% Similarity=0.344 Sum_probs=141.6
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHH-HHHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEV-VVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+++. .+++.||+|++.+.. ......+..|. .+++.++||||+++++.+....
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 467889999986532 12223444444 4578899999999988765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+.+.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence 12345778888889999999999999988 9999999999999999999999999987532211 12334
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 56899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=236.44 Aligned_cols=184 Identities=30% Similarity=0.474 Sum_probs=152.8
Q ss_pred HHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC----ccCH----HHHHHHHHHHhcCC-CCCccceeeEe
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS----GQGA----EEFKNEVVVVAKLQ-HRNLVRLLGFC 346 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~----~~~~~Ei~~l~~l~-h~niv~l~~~~ 346 (470)
+..-..|...+.||.|..+.|-++. .++|+++|+|++.... .... +.-.+|+.+|+++. ||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3445678888999999999999887 4578999999985431 1112 33457999999984 99999999998
Q ss_pred eeCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 347 LEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 347 ~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
..+. ...-.+++++..+|++|+++|+.|||.++ |+||||||+|||++++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 7753 22345788999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCcccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
++.+.... .....+|||+|+|||.+. ...|+..+|+|++|||||.||.|.+||..
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 99875443 345679999999999874 34688999999999999999999999864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=249.68 Aligned_cols=184 Identities=33% Similarity=0.572 Sum_probs=150.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
..+|++.++||+|+||.||+|++ .+++ .||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 46788899999999999999984 3444 48999986543 334567889999999999999999998775422
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.+.+.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 12346889999999999999999999988 999999999999999999999999999876433
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
..........++..|++||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 22211222234668999999988899999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=257.18 Aligned_cols=184 Identities=29% Similarity=0.419 Sum_probs=158.5
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCC-CCCccceeeEeeeCCCC-
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPEK- 352 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~- 352 (470)
....|++.+.||+|.||.||+++.+ +|+.+|+|++.+.... ..+.+.+|+.+|+++. |||||.+.+.+......
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888999999999999999954 5999999999776443 4468999999999999 99999999988764410
Q ss_pred ---------------CC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC----CCceEEeecCCceec
Q 041433 353 ---------------QG-QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA----EMNPKISDFGMAKIF 412 (470)
Q Consensus 353 ---------------~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~DfG~a~~~ 412 (470)
.. .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 01 3899999999999999999999988 999999999999943 357999999999987
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...+
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 54 334556799999999999999999999999999999999999999998654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=254.54 Aligned_cols=176 Identities=31% Similarity=0.440 Sum_probs=144.7
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhc-CCCCCccceeeEeeeCCC----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAK-LQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~---------- 351 (470)
+.||+|+||.||+|+. .+++.||||+++... ......+..|..++.. ++||||+++++++.+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 468899999987542 2334556677888876 489999999987755321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 352 --------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 352 --------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
....+++.+...++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence 2346888999999999999999999988 9999999999999999999999999987532211 12234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 56899999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=249.04 Aligned_cols=179 Identities=25% Similarity=0.368 Sum_probs=152.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|++++++++||||+++++.+.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999984 578999999986542 3334678899999999999999999998765431
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 352 -------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 352 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
....+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+... .....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~ 153 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTY 153 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCC
Confidence 1234678888999999999999999988 999999999999999999999999999765322 12234
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 688999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=251.02 Aligned_cols=187 Identities=19% Similarity=0.227 Sum_probs=142.4
Q ss_pred HhhcCCCccccccccCceeEEEEEcCC----CcEEEEEEccCcCccCH-----------HHHHHHHHHHhcCCCCCccce
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPS----GREIAVKRLSKSSGQGA-----------EEFKNEVVVVAKLQHRNLVRL 342 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~l 342 (470)
+..++|++.++||+|+||.||+|...+ +..+++|+......... .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345789999999999999999999543 45667776433222111 112233445667789999999
Q ss_pred eeEeeeCC---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 343 LGFCLEDP---------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 343 ~~~~~~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
++...... ......++.....++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 87543221 01223567778899999999999999987 9999999999999999999
Q ss_pred EEeecCCceeccCCCCc-----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQ-----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+|+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999876432111 1112346899999999999999999999999999999999999999765
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=254.87 Aligned_cols=176 Identities=34% Similarity=0.424 Sum_probs=146.3
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||++.. .+++.||||++++.. ....+.+.+|++++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999987542 33445677888999888 6999999998765432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence 12346899999999999999999999988 9999999999999999999999999987532211 12233
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 46899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=271.10 Aligned_cols=189 Identities=26% Similarity=0.356 Sum_probs=155.5
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCC-cEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceee-EeeeCC----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSG-REIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLG-FCLEDP---- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~-~~~~~~---- 350 (470)
+...++++.+.|.+|||+.||+|....+ .+||+|++-..+....+.+.+||++|++|+ |+|||.+++ ......
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3345678889999999999999996555 999999997778888899999999999998 999999998 322210
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 351 ----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 351 ----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
.....|++.++++|+.++++|+.+||... ++|||||||-+||||..+++.||+|||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 12345899999999999999999999985 7899999999999999999999999999
Q ss_pred ceeccCCCCccc-------ccccccccCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGN-------TSRIAGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+.-......... .-....|+.|.|||++ .+..++.|+|||+|||+||-|+....||+-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 864322211100 1112368999999987 5678999999999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=264.22 Aligned_cols=177 Identities=31% Similarity=0.490 Sum_probs=147.6
Q ss_pred CccccccccCceeEEEEEc-CCCcEEEEEEcc----CcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 284 STDNKLGAGGFGEVYKGVL-PSGREIAVKRLS----KSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
+...+||+|+|-+||+|.. .+|-+||--.++ ..+....++|..|+.+|+.|+||||++++..+.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4457899999999999995 357777633222 1244556889999999999999999999998877543
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecCCceeccCCCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~ 417 (470)
+...++......|++||++||.|||++. |||||||||-+||+|+ ..|.+||+|+|+|..+....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 2456777888999999999999999986 7899999999999996 45799999999999765432
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....|||.|||||+.. ..|+..+||||||+.|+||+|+..||+-
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 33478999999999776 7899999999999999999999999963
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=259.14 Aligned_cols=176 Identities=31% Similarity=0.356 Sum_probs=147.4
Q ss_pred ccccccCceeEEEEEc----CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 287 NKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|++++++++||||+++++.+....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999873 368899999987542 223456778999999999999999988775432
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 351 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
.+...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence 12346889999999999999999999988 9999999999999999999999999987643221 1223
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 456899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=252.03 Aligned_cols=184 Identities=32% Similarity=0.402 Sum_probs=154.9
Q ss_pred HhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
+..+.|+.-++||+|+||.||-++ ..+|+.+|.|++.+. .........+|-.+|.+++.+.||.+--.+....
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 345678889999999999999998 457999999988654 2334455678999999999999998754333211
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++..+..++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|++..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 22457999999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||.-.
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 44332 2347999999999999999999999999999999999999999643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=244.26 Aligned_cols=183 Identities=32% Similarity=0.528 Sum_probs=152.6
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..++|++.+.||+|++|.||++...+++.||+|.++... ...+++.+|++++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456789999999999999999997777899999986543 345678999999999999999999987654321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.+...++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 1235889999999999999999999987 999999999999999999999999999876522111
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 1111223457999999988899999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=256.12 Aligned_cols=189 Identities=30% Similarity=0.471 Sum_probs=157.0
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.+.....+.++||+|-||.|.++....+.+||||+++..... ...+|.+|+++|.+|+||||++++|+|..++-
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 345567788999999999999999877899999999876544 45899999999999999999999999987541
Q ss_pred --------------C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 --------------K-QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 --------------~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
. ...+.-+...+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+-...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 1 111345566789999999999999987 9999999999999999999999999999654443
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII--TGKKNSSFYQT 469 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell--tG~~P~~~~~~ 469 (470)
......+..-.++|||+|.+..++++.++|+|+||+.|||++ ..++||+-..+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 333333344567999999999999999999999999999986 47788875443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=247.60 Aligned_cols=184 Identities=26% Similarity=0.401 Sum_probs=149.9
Q ss_pred hcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
.++|++.+.||+|+||.||+|.+. .+..||+|+++.... .....+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457889999999999999999742 467899999876532 334578899999999999999999998765321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.+++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 1346889999999999999999999988 999999999999999999999999987653221
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 11 11112234578999999999999999999999999999875 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=248.88 Aligned_cols=184 Identities=32% Similarity=0.517 Sum_probs=151.5
Q ss_pred hcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.++|.+.+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|++++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999853 3578999998765443 45789999999999999999999988755321
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 041433 352 -------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN 400 (470)
Q Consensus 352 -------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 400 (470)
....+++.+...++.||+.+|.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 1234778889999999999999999988 999999999999999999
Q ss_pred eEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 401 PKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 401 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999976433222111222345678999999999999999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=259.35 Aligned_cols=173 Identities=32% Similarity=0.493 Sum_probs=151.7
Q ss_pred CCccccccccCceeEEEEE-cCCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
|.-++.||.|+||.||-++ ..+.+.||||+++-. +...+.++..|+.+|.+++|||++.+-|+++.+..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5567889999999999999 457889999999744 34456788999999999999999999999887542
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
...++.+.++..|..+.+.||.|||+.+ .||||||..|||+++.|.+||+|||.+.....
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------ 178 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ 178 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence 3567888999999999999999999998 99999999999999999999999999876432
Q ss_pred ccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
...++|||.|||||++. .+.|+-++||||||++..||.-.++|.
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 34578999999999874 578999999999999999999999985
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=248.10 Aligned_cols=185 Identities=30% Similarity=0.495 Sum_probs=152.7
Q ss_pred hcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
..+|.+.+.||+|+||.||++.. .++..+++|.+........+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999973 2345689999876665566789999999999999999999988764221
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 352 -----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 352 -----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
....+++.+++.++.|++.+|.|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 1124899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |++||...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999986533222112222345678999999988899999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=273.88 Aligned_cols=181 Identities=28% Similarity=0.529 Sum_probs=152.9
Q ss_pred cCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
....|.+.||.|.||.|++|+++ ....||||.++... .....+|..|..||.+++||||++|.|+.....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34568899999999999999964 24579999998663 455678999999999999999999999864422
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
++.+.+.+.+..-+++.|+.|++||-+.+ +|||||..+|||++.+..+|++|||+++.+..+.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 24567899999999999999999999988 9999999999999999999999999999886554
Q ss_pred Cccccccccc--ccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 041433 417 TQGNTSRIAG--TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 465 (470)
Q Consensus 417 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~ 465 (470)
.. ..+...| ..+|.|||.+...+++.++|||||||||||.++ |++||.
T Consensus 786 ~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 786 EA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred Cc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 22 2222223 358999999999999999999999999999886 999964
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=247.78 Aligned_cols=179 Identities=30% Similarity=0.408 Sum_probs=149.5
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++|+||+++.+.+..+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999995 578999999986542 222345788999999999999999987654322
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 12346899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 112346899999999998889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=245.72 Aligned_cols=183 Identities=32% Similarity=0.536 Sum_probs=152.5
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..++|++.++||+|++|.||+|...++..|++|.+.... ...+.+.+|+.++++++|+||+++++.+.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346789999999999999999998788899999986433 345788999999999999999999887644321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 2345778888999999999999999987 999999999999999999999999999875432211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
......++..|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 1122335668999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=256.14 Aligned_cols=175 Identities=24% Similarity=0.352 Sum_probs=146.3
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
....+|++.+.||+|+||.||+|+. .+++.||+|+.... ....|+.++++++||||+++++++....
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3456799999999999999999995 45788999985432 2356899999999999999998776533
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 12456889999999999999999999988 999999999999999999999999998743221
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999999999999999999999999865554
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=245.35 Aligned_cols=173 Identities=31% Similarity=0.428 Sum_probs=143.5
Q ss_pred ccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||+|+||.||+++. .+++.||+|.+.... ......+..|++++++++||||+++++.+....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999984 468999999986432 122344567999999999999999987765432
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 12235788888999999999999999988 99999999999999999999999999886543221 2234
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 6889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=249.33 Aligned_cols=184 Identities=31% Similarity=0.492 Sum_probs=148.4
Q ss_pred cCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
.+|++.++||+|+||.||+|... .++.||+|+++..... ..+.+.+|+.++.+++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677899999999999999842 3578999998754322 24568899999999999999999987643210
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 041433 352 --------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399 (470)
Q Consensus 352 --------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 399 (470)
....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 1234788888999999999999999988 99999999999999999
Q ss_pred ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 400 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999886543322222223345678999999988889999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.18 Aligned_cols=186 Identities=33% Similarity=0.484 Sum_probs=150.8
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcC--CC---cEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEee
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLP--SG---REIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 347 (470)
++...++..+.++||+|+||.||+|++. ++ ..||||..+.. ......+|.+|.++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3444455666799999999999999953 22 23899998742 3556678999999999999999999999876
Q ss_pred eCC------------------C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 348 EDP------------------E-KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 348 ~~~------------------~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
... . ....++..++..++.+.+.||+|||+++ ++||||-.+|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 543 1 2235999999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
++.-.. .........-...|+|||.+..+.|+.++|||||||++||+++ |..||.-
T Consensus 309 s~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 309 SRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred ccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 875321 1111101123468999999999999999999999999999999 8888864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=244.80 Aligned_cols=181 Identities=31% Similarity=0.474 Sum_probs=146.0
Q ss_pred CCccccccccCceeEEEEEcCC-Cc--EEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPS-GR--EIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
|.+.++||+|+||.||+|++.+ ++ .||+|.++.. .....+.+.+|+++++.++|+||+++++++....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999643 33 6899988654 2334567889999999999999999998753211
Q ss_pred -----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 351 -----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 351 -----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
.....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 01234788889999999999999999987 9999999999999999999999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+++.+.............+++.|++||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9986543222111122235678999999998899999999999999999999 8899864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=244.04 Aligned_cols=184 Identities=33% Similarity=0.542 Sum_probs=154.0
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+..++|++.++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||++++++...+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence 4457899999999999999999998888999999986543 34568899999999999999999998754321
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.+...++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 12346788999999999999999999987 999999999999999999999999999765422211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1112335678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=243.09 Aligned_cols=182 Identities=32% Similarity=0.495 Sum_probs=151.1
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
++|++.+.||+|+||.||++.+.++..+|+|.+... ....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999877889999988543 334567899999999999999999998875432
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||.++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence 12345789999999999999999999988 999999999999999999999999998764322211 11
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 12234568999999988889999999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=244.56 Aligned_cols=182 Identities=30% Similarity=0.439 Sum_probs=147.7
Q ss_pred CCccccccccCceeEEEEEcC----CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
|++.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|++.++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999853 24789999987542 2334678999999999999999999987644221
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 352 -------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 352 -------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 1235788889999999999999999987 999999999999999999999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|+++................+..|++||.+.+..++.++||||||+++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99986543322211222234568999999988889999999999999999999 88988643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=247.06 Aligned_cols=183 Identities=33% Similarity=0.534 Sum_probs=149.6
Q ss_pred cCCCccccccccCceeEEEEEcCC------CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPS------GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
++|++.+.||+|+||.||+|.... ...|++|.+.... ......+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998432 2579999986443 2334578999999999999999999987654210
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 041433 352 --------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399 (470)
Q Consensus 352 --------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 399 (470)
....+++.+.+.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 0145788889999999999999999988 99999999999999999
Q ss_pred ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 400 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999986533322222233456788999999988899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=247.43 Aligned_cols=186 Identities=27% Similarity=0.434 Sum_probs=153.5
Q ss_pred HhhcCCCccccccccCceeEEEEEcCC-----CcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPS-----GREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
+..++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999999644 688999988644 23345678899999999999999999998765210
Q ss_pred ---------------------C------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEe
Q 041433 352 ---------------------K------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKIS 404 (470)
Q Consensus 352 ---------------------~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 404 (470)
. ...+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 0 145889999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 405 DFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 405 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 9999986543322222222345678999999988889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=246.90 Aligned_cols=183 Identities=32% Similarity=0.481 Sum_probs=149.4
Q ss_pred cCCCccccccccCceeEEEEEc-----CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
++|++.++||+|+||.||+|.. .+++.|++|.+.... ......+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999983 356789999986543 2334678899999999999999999987654321
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 041433 352 --------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399 (470)
Q Consensus 352 --------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 399 (470)
....+++.+...++.|++.||.|||+++ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 0124678888999999999999999988 99999999999999999
Q ss_pred ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 400 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999986543322222223345678999999988889999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=262.76 Aligned_cols=174 Identities=33% Similarity=0.539 Sum_probs=148.7
Q ss_pred cccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------------
Q 041433 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------------- 350 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------------- 350 (470)
.||+|.||+||.|+ .++...+|||-+........+.+.+||.+-++|+|+|||+++|.+-++.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999 4567789999998887777888999999999999999999998765533
Q ss_pred ---CCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecCCceeccCCCCccccccc
Q 041433 351 ---EKQGQL--DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 351 ---~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
.+-+++ .+...-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+. .....+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence 123455 56777788999999999999998 99999999999995 57899999999998764 233345667
Q ss_pred ccccCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.||..|||||++..+ .|..++|||||||.+.||.||++||--
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 899999999999765 588999999999999999999999853
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=247.99 Aligned_cols=182 Identities=24% Similarity=0.380 Sum_probs=150.3
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|.+.++||+|+||.||+++. .+++.||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5789999999999999999985 468899999986543 333456788999999999999999999875432
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.....++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++........ .
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 160 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 160 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence 12345788889999999999999999988 99999999999999999999999999875432221 1
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122356889999998765 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=243.01 Aligned_cols=184 Identities=32% Similarity=0.537 Sum_probs=151.8
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..++|.+.++||+|+||.||+|+..+...||+|+++... ...+.+.+|++++++++||||+++++.+.+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence 346799999999999999999997666789999986533 34567899999999999999999988653321
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 11235788999999999999999999987 999999999999999999999999999865433221
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......++..|++||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1122345678999999988899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=240.63 Aligned_cols=185 Identities=26% Similarity=0.317 Sum_probs=153.9
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHH---HHHHHHHHHhcCCCCCccceeeEeee-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAE---EFKNEVVVVAKLQHRNLVRLLGFCLE------- 348 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~---~~~~Ei~~l~~l~h~niv~l~~~~~~------- 348 (470)
-++|..++.||+|.||+|.+++ ..+++.+|+|++++.-....+ .-..|-++|+..+||.+..|--.++.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3578888999999999999999 457999999999877443333 34568899999999998776422222
Q ss_pred -----------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 349 -----------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 349 -----------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
...+...+++.....+-.+|..||.|||+++ ||.||||.+|+|+|++|++||+|||+++.-- ..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KY 321 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--cc
Confidence 1234567888888889999999999999988 9999999999999999999999999998522 22
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
...+...+|||.|+|||++....|..++|+|.+||+||||+.|+.||-..+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 3345678999999999999999999999999999999999999999976543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=242.30 Aligned_cols=183 Identities=32% Similarity=0.485 Sum_probs=151.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-----cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-----QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
++|++.+.||+|++|.||++.. .+++.|++|.+..... ...+.+.+|++++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999984 5689999998864421 223568889999999999999999988765331
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 2345778888999999999999999988 9999999999999999999999999997653321
Q ss_pred Cccc-ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQGN-TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 1111 1234577899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=242.14 Aligned_cols=182 Identities=31% Similarity=0.492 Sum_probs=151.3
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999997677789999986443 34567899999999999999999998865422
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++.+++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||.++........ ..
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ec
Confidence 11236899999999999999999999988 999999999999999999999999998765332211 11
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 12234567999999988889999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=243.07 Aligned_cols=181 Identities=27% Similarity=0.434 Sum_probs=151.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++.+.....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999994 5788999999876655556678899999999999999999987754321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+..... .
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 2346788899999999999999999987 99999999999999999999999999986542221 1
Q ss_pred ccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 22345788999999874 3457889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=244.13 Aligned_cols=185 Identities=34% Similarity=0.563 Sum_probs=156.3
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
....+|++.++||+|+||.||+|...+++.+++|.+..........+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3456788999999999999999998779999999997776656778999999999999999999998764432
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 12346889999999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. .....++..|++||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 1 112335668999999988899999999999999999998 89999653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=245.77 Aligned_cols=179 Identities=32% Similarity=0.436 Sum_probs=148.8
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.|++.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++.+.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999994 4789999999865422 22345778999999999999999987654422
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 11235788899999999999999999987 99999999999999999999999999876432221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 1234689999999999988999999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=242.82 Aligned_cols=183 Identities=32% Similarity=0.540 Sum_probs=152.2
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..++|++.++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~ 82 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM 82 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEec
Confidence 3467899999999999999999987888899999865433 4567899999999999999999998764321
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++..+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 11345789999999999999999999988 9999999999999999999999999998654322111
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 112234567999999988889999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=247.11 Aligned_cols=184 Identities=34% Similarity=0.603 Sum_probs=149.1
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
.++|+..+.||+|+||.||++.. .+++ .||+|.+..... ....++.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~ 85 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL 85 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence 35678889999999999999984 3444 578998865432 22346889999999999999999999875422
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..+..++.|++.||.|||+++ |+|+||||+|||+++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 11235788899999999999999999987 999999999999999999999999999865433
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
..........++..|++||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22212222345678999999988899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=244.77 Aligned_cols=180 Identities=41% Similarity=0.643 Sum_probs=147.8
Q ss_pred ccccccccCceeEEEEEcC-----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 285 TDNKLGAGGFGEVYKGVLP-----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+.+.||.|.||.||+|.+. .+..|+||+++... ....+.+.+|++.+++++||||++++|++....
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999964 36789999996543 334688999999999999999999999998432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..|+.||++||.|||+++ ++|+||+++|||+++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 12467899999999999999999999987 999999999999999999999999999876322222
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
...........|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22223345678999999988889999999999999999999 78888654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=245.17 Aligned_cols=183 Identities=29% Similarity=0.422 Sum_probs=153.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.+.|++.++||+|+||.||+++. .+++.|++|.+........+.+.+|+.++++++||||+++++.+..+.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 46789999999999999999995 468999999997766666778899999999999999999998765532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 12346889999999999999999999987 9999999999999999999999999987542221 1
Q ss_pred cccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 122345788999999884 345788999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=245.57 Aligned_cols=187 Identities=30% Similarity=0.488 Sum_probs=149.8
Q ss_pred HhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
+..++|++.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999998742 35679999986432 233456889999999999999999998765422
Q ss_pred C--------C--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 351 E--------K--------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 351 ~--------~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
. . ...+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 1 0 123567788899999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999876533222211122345678999999988899999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=256.09 Aligned_cols=187 Identities=28% Similarity=0.416 Sum_probs=151.1
Q ss_pred HHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCC-CCCccceeeEeee
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLE 348 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 348 (470)
....++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344678999999999999999999841 235799999965432 33467899999999996 9999999988754
Q ss_pred CCC-----------------------------------------------------------------------------
Q 041433 349 DPE----------------------------------------------------------------------------- 351 (470)
Q Consensus 349 ~~~----------------------------------------------------------------------------- 351 (470)
...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 210
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 041433 352 -------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394 (470)
Q Consensus 352 -------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 394 (470)
....+++.++..++.||+.||.|||+.+ |+|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 0124677888899999999999999987 999999999999
Q ss_pred eCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 395 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999999999999986543322222223346778999999988899999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=242.27 Aligned_cols=184 Identities=28% Similarity=0.486 Sum_probs=150.6
Q ss_pred hcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.+.||+|+||.||+|.+. +...|++|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999853 24579999986543 333457889999999999999999998765432
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.|++.||.|||+++ |+|+||||+|||+++++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 11346889999999999999999999987 999999999999999999999999999876422
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 22111222234568999999988899999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=273.33 Aligned_cols=187 Identities=28% Similarity=0.449 Sum_probs=150.8
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
....++|.+.++||+|+||.||+++. .+++.||+|++... .......+..|+.++++|+|||||++++++.....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34457899999999999999999994 46788999988644 22335678899999999999999999987654211
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeecCCCCCeeeCC--------
Q 041433 352 ----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR----LRIIHRDLKVSNILLDA-------- 397 (470)
Q Consensus 352 ----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~dlkp~Nill~~-------- 397 (470)
....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 12468899999999999999999998531 34999999999999954
Q ss_pred ---------CCceEEeecCCceeccCCCCcccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 398 ---------EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 398 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654322 1233468999999998854 4588999999999999999999999964
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=243.97 Aligned_cols=184 Identities=31% Similarity=0.464 Sum_probs=149.2
Q ss_pred cCC-CccccccccCceeEEEEEc-----CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 281 NKF-STDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 281 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
++| ++.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988652 3678899999865432 345678899999999999999999987654321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.|++.||.|||+++ |+|+||||+|||+++++.+||+|||+++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 1235889999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCccc-ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGN-TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...... .....++..|++||.+.+..++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 221111 11123456799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=243.18 Aligned_cols=180 Identities=29% Similarity=0.454 Sum_probs=149.4
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|++|.||+|+. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999995 468999999986542 233467889999999999999999998876532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 11256889999999999999999999987 99999999999999999999999999976543221
Q ss_pred ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 11223567889999987654 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=237.97 Aligned_cols=183 Identities=28% Similarity=0.418 Sum_probs=149.6
Q ss_pred cCCCccccccccCceeEEEEEcC---C--CcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP---S--GREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
..|+....||+|.||.||+|... + .+.+|||+++.... .-.....+|+.+++.++|||++.|..++++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888999999999999999622 2 33789999865422 22245678999999999999999877665521
Q ss_pred --------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----CceEEeec
Q 041433 351 --------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE----MNPKISDF 406 (470)
Q Consensus 351 --------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Df 406 (470)
.+...++......|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+||
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 12357888888999999999999999998 9999999999999776 89999999
Q ss_pred CCceeccCCCCcc-cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 407 GMAKIFGVDQTQG-NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 407 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|+++.+...-... ....++-|.+|.|||.+.+. .|+.+.|||++|||+.||+|-++-|.-
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999886543332 33456679999999999874 689999999999999999999887754
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=240.54 Aligned_cols=182 Identities=31% Similarity=0.499 Sum_probs=149.3
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
.+|++.+.||+|+||.||++...++..+|+|++.... ...+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999998777789999986433 34467889999999999999999988764422
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence 11335788999999999999999999988 999999999999999999999999998765322111 11
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 11223457999999988899999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=243.36 Aligned_cols=180 Identities=36% Similarity=0.541 Sum_probs=151.6
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHH--HHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAE--EFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
|++.+.||+|+||+||+++. .+++.+|+|++......... ...+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 57789999999999999995 46779999999776543332 34569999999999999999988766331
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.++..++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENF 155 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccccc
Confidence 2467889999999999999999999998 99999999999999999999999999986411 12223
Q ss_pred cccccccCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++..|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3456788999999988 788999999999999999999999999854
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=245.63 Aligned_cols=183 Identities=31% Similarity=0.504 Sum_probs=151.9
Q ss_pred cCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
++|.+.+.||+|+||.||+++. .++..+++|.+........+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 5688889999999999999973 2356789999876665556789999999999999999999988654321
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 041433 352 -------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN 400 (470)
Q Consensus 352 -------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 400 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 1134788999999999999999999988 999999999999999999
Q ss_pred eEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 401 PKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 401 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976543322222223446778999999998899999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=241.12 Aligned_cols=181 Identities=24% Similarity=0.453 Sum_probs=151.5
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++||||+++++++.....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999994 478999999875432 2334568899999999999999999987654321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.....++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 2344788889999999999999999987 99999999999999999999999999886543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 221 12234578899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=243.65 Aligned_cols=184 Identities=32% Similarity=0.498 Sum_probs=151.5
Q ss_pred hcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
.++|+..++||+|+||.||++.. .++..+++|.+........+.+.+|+++++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35678889999999999999963 2456899999877666667789999999999999999999987654221
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 041433 352 -------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN 400 (470)
Q Consensus 352 -------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 400 (470)
....+++.+++.++.||+.||.|||+.+ ++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 0134788999999999999999999988 999999999999999999
Q ss_pred eEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 401 PKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 401 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |++||.-
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999976533222111222334678999999998899999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=239.99 Aligned_cols=183 Identities=26% Similarity=0.438 Sum_probs=155.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.+.||+|+||.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++.+....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46789999999999999999995 467899999997766666788999999999999999999998765432
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.+...++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 11257889999999999999999999987 99999999999999999999999999876543211
Q ss_pred cccccccccCcccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|++||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234578889999998766 8899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=243.30 Aligned_cols=181 Identities=26% Similarity=0.447 Sum_probs=152.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.++||+|+||.||+++. .+++.||+|.++.........+.+|+.+++.++||||+++++.+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788889999999999999984 568999999987665555567889999999999999999998765532
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.... ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 12456889999999999999999999988 9999999999999999999999999987654221 12
Q ss_pred ccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.....|+..|+|||.+. ...++.++|+||||+++|||++|+.||.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 23346889999999874 4568899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=243.45 Aligned_cols=180 Identities=29% Similarity=0.435 Sum_probs=150.6
Q ss_pred CCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567889999999999999954 57888999987665556678899999999999999999998765532
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 351 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
.....+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 12356889999999999999999999988 9999999999999999999999999987543221 1223
Q ss_pred ccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...+++.|+|||++. +..++.++||||||+++|||++|++||...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 346788999999873 345788999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.22 Aligned_cols=182 Identities=21% Similarity=0.410 Sum_probs=140.4
Q ss_pred hhcCCCccccccccCceeEEEEEcC--CCcEEEEEE--------------cc---CcCccCHHHHHHHHHHHhcCCCCCc
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP--SGREIAVKR--------------LS---KSSGQGAEEFKNEVVVVAKLQHRNL 339 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------~~---~~~~~~~~~~~~Ei~~l~~l~h~ni 339 (470)
..++|++.++||+|+||+||++... .+...++|. +. .........+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998742 222222221 11 1112234567899999999999999
Q ss_pred cceeeEeeeCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 041433 340 VRLLGFCLEDPEK----------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA 397 (470)
Q Consensus 340 v~l~~~~~~~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 397 (470)
+++++++...... .......+...++.||+.||.|||+++ |+||||||+|||++.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999877553311 112234566789999999999999988 999999999999999
Q ss_pred CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 398 EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 398 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999876433221 222356899999999999999999999999999999999998543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=238.91 Aligned_cols=177 Identities=30% Similarity=0.467 Sum_probs=143.4
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
+.||+|+||.||+++. .+++.||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999995 478999999876443 334567899999999999999999998865432
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccc
Q 041433 351 -----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425 (470)
Q Consensus 351 -----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 425 (470)
.....+++.+++.++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 12345789999999999999999999988 9999999999999999999999999987543221111111112
Q ss_pred cccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 426 gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.+..|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 2456999999988899999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=241.73 Aligned_cols=184 Identities=30% Similarity=0.451 Sum_probs=150.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-----ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-----GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
.+|++.+.||+|+||.||++.. .+++.|+||.+.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999995 468999999875321 1224578889999999999999999987654211
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 1245678888999999999999999988 99999999999999999999999999876532
Q ss_pred CCC-cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQT-QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 111 11122345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=251.09 Aligned_cols=186 Identities=29% Similarity=0.433 Sum_probs=149.0
Q ss_pred hhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 350 (470)
..++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999972 3578999999965432 2345688999999999 6899999988664321
Q ss_pred C-------------------------------------------------------------------------------
Q 041433 351 E------------------------------------------------------------------------------- 351 (470)
Q Consensus 351 ~------------------------------------------------------------------------------- 351 (470)
.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 0
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 352 -------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 352 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
....+++.+...++.||++||.|||+++ |+||||||+|||+++++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 0123677888899999999999999988 999999999999999999999999998765322221112223
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 35667999999988899999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=245.42 Aligned_cols=183 Identities=27% Similarity=0.491 Sum_probs=156.3
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..+|++.+.||.|++|.||++. ..+++.|++|.+........+.+.+|+.+++.++||||+++++.+.....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3569999999999999999998 45789999999876655566788999999999999999999988755321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.++..++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~ 172 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KR 172 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cC
Confidence 1345889999999999999999999988 99999999999999999999999999876543221 12
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2345788999999998888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=245.68 Aligned_cols=183 Identities=27% Similarity=0.465 Sum_probs=155.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..+|++.+.||+|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+.....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46789999999999999999984 5789999999877666666788999999999999999999987765321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.+...++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~ 173 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--cc
Confidence 1235788899999999999999999988 99999999999999999999999999875432221 12
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 2346788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=240.80 Aligned_cols=184 Identities=31% Similarity=0.460 Sum_probs=151.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-----cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-----QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.+|+..+.||+|+||.||++.. .+++.|++|++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999985 4689999998864321 22356888999999999999999998765421
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 11245788888999999999999999987 99999999999999999999999999876532
Q ss_pred CCC-cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQT-QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 111 11122345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=243.68 Aligned_cols=182 Identities=25% Similarity=0.393 Sum_probs=149.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+++|.+.+.||+|+||.||+|.. .+++.|++|++..... .....+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46899999999999999999984 4689999999865432 23346788999999999999999998765532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+.+.+...++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 11245678888899999999999999987 99999999999999999999999999875432211
Q ss_pred cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12223468899999988754 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=244.03 Aligned_cols=179 Identities=31% Similarity=0.420 Sum_probs=153.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999995 468999999986532 234567889999999999999999998765532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++..+..++.||+.||.|||+.+ ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 12456889999999999999999999987 999999999999999999999999999865432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+++.|++||.+.+...+.++||||||+++|+|++|+.||...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22346788999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=241.56 Aligned_cols=179 Identities=27% Similarity=0.465 Sum_probs=157.4
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
-|.++.+||+|+||.||++.. .+|+.+|||.+... .+.+++..|+.+|++.+.|++|+++|.+....
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 367789999999999999994 57999999998654 45688999999999999999999999776543
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.++..|.+.++..+++..++||+|||... -+|||||..|||++.+|.+||+|||.+..+.. .....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 24678999999999999999999999876 89999999999999999999999999986543 23334
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..+.||+.|||||++..-.|+.++||||||+...||..|++||.-.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 5678999999999999999999999999999999999999999753
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=244.91 Aligned_cols=183 Identities=27% Similarity=0.465 Sum_probs=156.1
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..+|++.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++.....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999994 5799999999976655566778899999999999999999988765331
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.++..++.|++.+|.|||+.+ ++|+||||+|||++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 172 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence 1345788899999999999999999987 99999999999999999999999999876543221 12
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=241.33 Aligned_cols=182 Identities=33% Similarity=0.533 Sum_probs=150.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..+|.+.++||+|++|.||++.. ++++.|++|++... ....+++.+|++++++++|+||+++++++..+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 34678889999999999999995 45889999998644 334567899999999999999999998765432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++..++.++.|++++|.|||+++ ++||||||+|||+++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 12345788999999999999999999987 999999999999999999999999999865432211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 1111233567999999988899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=238.42 Aligned_cols=181 Identities=33% Similarity=0.479 Sum_probs=153.1
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|.+.+.||+|++|.||++.. .+++.|++|.+... .....+.+.+|++++++++||||+++++.+.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999995 46899999998643 3344567889999999999999999998765532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 12356888999999999999999999987 99999999999999999999999999886643322
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 122346788999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=242.40 Aligned_cols=183 Identities=30% Similarity=0.469 Sum_probs=151.6
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----- 350 (470)
.+.+.|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567789999999999999999994 468899999986543 3456788999999998 6999999998765421
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 351 ---------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 351 ---------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
.....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 12345789999999999999999999987 999999999999999999999999999
Q ss_pred eeccCCCCcccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....... .......|+..|+|||++. +..++.++||||||+++|||++|+.||.-
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8653221 1223456888999999885 34578899999999999999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=238.06 Aligned_cols=181 Identities=28% Similarity=0.460 Sum_probs=154.8
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.+.||+|+||.||++... +++.+++|.++.... .+++.+|++++++++|+||+++++.+....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 367899999999999999999964 488999999865433 678999999999999999999998876542
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 12456889999999999999999999987 99999999999999999999999999886543221
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|++||++.+..++.++||||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122345788999999998889999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=241.28 Aligned_cols=182 Identities=26% Similarity=0.377 Sum_probs=151.6
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999954 68999999886442 223456789999999999999999998876532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.+|.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 12346899999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1222356788999998865 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=241.01 Aligned_cols=182 Identities=29% Similarity=0.483 Sum_probs=154.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|++.+.||.|++|.||+++. .+++.|++|++.... ......+.+|++++++++|+||+++++.+.++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4688899999999999999995 468999999986553 3445678899999999999999999987765421
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.....++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR 155 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence 1237899999999999999999999987 99999999999999999999999999987653321 22
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....+++.|++||.+.+..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 3346788999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=283.42 Aligned_cols=175 Identities=27% Similarity=0.512 Sum_probs=143.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK------ 352 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~------ 352 (470)
...+...+.||+|+||.||+|+. .+++.||||++...... ..+|++.+++++|||||++++++.+....
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35678889999999999999995 57899999998644322 23568899999999999999998764421
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 353 ---------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 353 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
-..++|.++.+++.||++||.|||....++|+||||||+||+++.++..++. ||....... ...
T Consensus 765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~ 837 (968)
T PLN00113 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTK 837 (968)
T ss_pred CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCC
Confidence 1247899999999999999999996655569999999999999999888875 665543211 112
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
..+++.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 357889999999999999999999999999999999999985
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=249.18 Aligned_cols=184 Identities=24% Similarity=0.438 Sum_probs=151.2
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.++|++.++||+|+||.||+|. ..+++.||+|.++... ......+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4789999999999999999998 4578999999986432 234456788999999999999999987654321
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 12346888999999999999999999988 9999999999999999999999999998654322
Q ss_pred Ccc-cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQG-NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 111 1223467889999998654 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=239.61 Aligned_cols=185 Identities=35% Similarity=0.570 Sum_probs=153.7
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+..++|.+.++||+|+||.||++..++++.|+||.+.... ...+++.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3457899999999999999999998778899999986443 34578999999999999999999998765422
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.+++.||.|||+++ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 11246889999999999999999999988 99999999999999999999999999986643211
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1112224567999999988889999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=238.00 Aligned_cols=177 Identities=33% Similarity=0.532 Sum_probs=144.5
Q ss_pred cccccCceeEEEEEc---CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 288 KLGAGGFGEVYKGVL---PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
+||+|+||.||+|.+ .+++.+|+|+++.... ...+++.+|+.+++.++||||+++++++..+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 689999999999963 3678999999865432 33567899999999999999999998764322
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc-ccccc
Q 041433 351 -----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-NTSRI 424 (470)
Q Consensus 351 -----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~ 424 (470)
.....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++..+....... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 12346788999999999999999999988 9999999999999999999999999998654332211 11112
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33578999999988889999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=239.15 Aligned_cols=183 Identities=33% Similarity=0.563 Sum_probs=150.7
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccC---------HHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQG---------AEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+....... .+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467889999999999999984 468899999886543221 2467889999999999999999988765321
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 2345788888999999999999999987 9999999999999999999999999998664
Q ss_pred CCCCcc----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQG----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 221111 112345788999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=253.76 Aligned_cols=174 Identities=30% Similarity=0.386 Sum_probs=139.2
Q ss_pred ccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcC---CCCCccceeeEeeeCC-----------
Q 041433 289 LGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKL---QHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~----------- 350 (470)
||+|+||+||+++. .+++.||||++.+... .....+..|..++..+ +||||+++++.+.+..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999994 4689999999864321 2223445566666655 6999999987665432
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence 12456888999999999999999999988 9999999999999999999999999987532221 12234
Q ss_pred cccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 5689999999988754 4789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=244.24 Aligned_cols=180 Identities=29% Similarity=0.417 Sum_probs=150.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.++||+|+||.||++.. .+++.+++|.+.... .....++.+|++++++++||||+++++.+..+.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688999999999999999994 468889999886542 233456889999999999999999998876533
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.....++.|+++||.|||+.. +++|+||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 12355788889999999999999999842 3999999999999999999999999998754322 1
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2234678899999999888899999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=242.30 Aligned_cols=185 Identities=34% Similarity=0.512 Sum_probs=148.3
Q ss_pred hhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
..++|.+.+.||+|++|.||+|... .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567899999999999999999853 35688999886443 2334568999999999999999999987654320
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEE
Q 041433 352 -------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKI 403 (470)
Q Consensus 352 -------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl 403 (470)
....+++.+++.++.||+.||.|||+.+ ++|+||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 1135888999999999999999999987 99999999999998654 5999
Q ss_pred eecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999986532221111112223467999999998899999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=241.74 Aligned_cols=182 Identities=32% Similarity=0.521 Sum_probs=149.3
Q ss_pred cCCCccccccccCceeEEEEEc-----CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.+|++.+.||+|+||.||++.. .+++.|++|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999973 357899999987666666678999999999999999999988654311
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++..+..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 11245789999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCccc-ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 415 DQTQGN-TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 415 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
...... .....++..|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 221111 111123446999999988899999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=240.25 Aligned_cols=181 Identities=24% Similarity=0.444 Sum_probs=152.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|++|.||++.. .+++.++||.+.... ....+++.+|+.+++.++|+||+++++++.+..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999994 578999999876432 233457889999999999999999998775532
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.+.+.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 12345789999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 2211 2234578899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=242.59 Aligned_cols=182 Identities=29% Similarity=0.436 Sum_probs=146.9
Q ss_pred CCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+..+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999842 235789998865432 334678899999999999999999887543210
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 041433 352 ---------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSN 392 (470)
Q Consensus 352 ---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 392 (470)
....+++...+.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 1134788899999999999999999987 9999999999
Q ss_pred eeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 393 ILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 393 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.-
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999976533222111222345678999999988889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-31 Score=263.46 Aligned_cols=182 Identities=35% Similarity=0.568 Sum_probs=154.9
Q ss_pred CCccccccccCceeEEEEEc-CCCc----EEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.+..++||+|+||+||+|.+ ++++ +||||++... ..+..+++.+|+.+|.+++|||+++|+++|+...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 34568999999999999994 5554 6899987654 4455688999999999999999999999998754
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
+.+..+.....+.|..||++||.|||++. ++||||..+|||+.+-.++||.|||+++.+..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 24566777888999999999999999887 999999999999999999999999999988766555
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.......-.+.|||-|.+....|+.++|||||||.+||+|| |.+|+...
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi 904 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI 904 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence 44444444678999999999999999999999999999998 88998643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=250.01 Aligned_cols=176 Identities=31% Similarity=0.497 Sum_probs=151.3
Q ss_pred cccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------
Q 041433 286 DNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------ 350 (470)
.+.||.|.||+||-|+ .++|+.||||++.+. ..+..+.+.+|+.||++++||.||.+.-.+...+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999999 568999999999765 3455678999999999999999999876554422
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEeecCCceeccCCCCccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~~~ 420 (470)
...+.|++.....++.||+.||.|||.++ |+|+||||+|||+.... ++||+|||+++.++....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--- 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--- 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence 13567888888889999999999999998 99999999999995443 699999999999875443
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...+.||+.|+|||++..+.|+..-|+||+|||+|--|+|..||.-.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 34578999999999999999999999999999999999999998643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=220.96 Aligned_cols=187 Identities=28% Similarity=0.405 Sum_probs=151.3
Q ss_pred HHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC--
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-- 350 (470)
+++..+.......||+|++|.|-+-+ ..+|...|+|.+... ..+..++..+|+.+..+- ..|.+|.++|......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 55566667777899999999998887 468999999998755 334455677888876554 6899999998654432
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.+...+++...-+|+..+.+||.|||++- .++|||+||+||||+.+|++|++|||.+..
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 35677888888999999999999999964 699999999999999999999999999987
Q ss_pred ccCCCCcccccccccccCcccccccc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAM----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+...... +-..|-..|||||.+. ...|+-++||||||+.+.||.+++.||+.-
T Consensus 199 L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 199 LVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 6433221 2235778899999874 347899999999999999999999998753
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=242.77 Aligned_cols=178 Identities=25% Similarity=0.437 Sum_probs=146.7
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|+||.||+++. .+|+.|++|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999995 478999999986542 222356788999999999999999887654322
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||+++.+..... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C 155 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence 12456899999999999999999999988 99999999999999999999999999986543221 1
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.|+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 1223567899999988764 4789999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=251.09 Aligned_cols=188 Identities=27% Similarity=0.383 Sum_probs=154.3
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccC--cCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC-
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~- 351 (470)
+.+....|++.++||+||.+.||++...+.+.+|+|++.. .+....+-|.+|+.+|.+|+ |.+||+|++|-..+..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3445567999999999999999999987788889887653 35556778999999999996 9999999998665431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
+...++.-.+..+.+||+.++.++|.++ |||.||||.|+|+- .|.+||+|||++..+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 1222221266778899999999999998 99999999999994 57899999999998877
Q ss_pred CCCcccccccccccCcccccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHG-----------QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+...-.....+||+.||+||.+... +.+.++||||||||||+|+.|+.||..+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 6665556667899999999988432 2568899999999999999999999754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=240.04 Aligned_cols=185 Identities=34% Similarity=0.565 Sum_probs=150.4
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCc----EEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGR----EIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
..+|++.+.||+|+||.||+|... +++ .+++|.+..... ....++.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQL 85 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEE
Confidence 357888999999999999999853 333 589998865543 34467889999999999999999998875421
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.....++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 12345889999999999999999999987 999999999999999999999999999876433
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..........++..|++||.+....++.++|+||||+++|||++ |+.||...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 22111111223567999999988889999999999999999999 99998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=243.60 Aligned_cols=184 Identities=33% Similarity=0.486 Sum_probs=150.1
Q ss_pred hcCCCccccccccCceeEEEEEcCC-----------------CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccc
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPS-----------------GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVR 341 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 341 (470)
..+|++.++||+|+||.||++.... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999988432 2468999987553 334567889999999999999999
Q ss_pred eeeEeeeCCC------------------C-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 041433 342 LLGFCLEDPE------------------K-----------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSN 392 (470)
Q Consensus 342 l~~~~~~~~~------------------~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 392 (470)
+++++..+.. . ...+++...+.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9987765321 0 126889999999999999999999987 9999999999
Q ss_pred eeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 041433 393 ILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSSF 466 (470)
Q Consensus 393 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt--G~~P~~~ 466 (470)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986543322222223445678999999988889999999999999999998 6777754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=248.50 Aligned_cols=183 Identities=28% Similarity=0.396 Sum_probs=152.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|+||.||++.. .+++.||+|++.+. .....+.+.+|+.++++++||||+++++++.....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999994 57899999998643 23334567889999999999999999987643221
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.+...++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 0123788888999999999999999987 99999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 171 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 221 22345788999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=238.37 Aligned_cols=183 Identities=30% Similarity=0.447 Sum_probs=150.9
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-----CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-----SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
.+|++.+.||+|+||.||++.. .+++.|++|.+... .......+.+|++++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999994 56899999987532 12334578899999999999999999987654221
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 1245788888999999999999999988 99999999999999999999999999986532
Q ss_pred CCC-cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQT-QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... ........++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 111 1111234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=242.12 Aligned_cols=183 Identities=26% Similarity=0.405 Sum_probs=153.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|++.+.||.|++|.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++.+.....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46789999999999999999995 4689999999876666666788999999999999999999998765331
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.++..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 1346889999999999999999999998 99999999999999999999999999875432211
Q ss_pred cccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|++||.+. ...++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 122346788999999874 345778999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=242.94 Aligned_cols=184 Identities=29% Similarity=0.443 Sum_probs=147.1
Q ss_pred hcCCCccccccccCceeEEEEEcCC---------------CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCcccee
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPS---------------GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLL 343 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~ 343 (470)
.++|++.++||+|+||.||++.... ...||+|+++... ....+.+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987532 2358999986542 33345789999999999999999999
Q ss_pred eEeeeCCCC------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 344 GFCLEDPEK------------------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 344 ~~~~~~~~~------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
+++...... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 887543210 123678888999999999999999988 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSSF 466 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt--G~~P~~~ 466 (470)
|+++++.+||+|||++..+.............++..|+|||.+.++.++.++||||||+++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999976533222111222334678999999988899999999999999999998 5667754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=238.16 Aligned_cols=182 Identities=32% Similarity=0.519 Sum_probs=151.1
Q ss_pred CCCccccccccCceeEEEEEcCCCcEEEEEEccCcCc------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+|++.+.||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999987899999998864321 12346888999999999999999998875532
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.....++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 12346788889999999999999999987 99999999999999999999999999875432111
Q ss_pred ----cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 ----QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 1112234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=243.87 Aligned_cols=186 Identities=30% Similarity=0.458 Sum_probs=151.0
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
...++|.+.+.||+|+||.||++.. ..+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4456799999999999999999973 235589999987543 23346788999999999 799999999877543
Q ss_pred C--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 350 P--------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 350 ~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
. .....+++.+...++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 2 11223789999999999999999999987 999999999999999999999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 86543222111122345678999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=251.47 Aligned_cols=182 Identities=27% Similarity=0.459 Sum_probs=157.7
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
...|.+.+.||+|.|+.|.+++ ..++.+||||++.+... .....+.+|+++|+.++|||||+++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4678999999999999999999 45799999999987643 33456889999999999999999998876533
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.+.+.+.+..+..++.|+.++++|||++. |+|||||.+||||+.+.++||+|||++..+....
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-- 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-- 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc--
Confidence 24566777888999999999999999998 9999999999999999999999999999876332
Q ss_pred ccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+|++.|.|||++.+.+|. +++|+||+|++||-|+.|..||+..
T Consensus 210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 23456899999999999988764 8999999999999999999999853
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=214.43 Aligned_cols=182 Identities=26% Similarity=0.427 Sum_probs=151.5
Q ss_pred CCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|...++||+|.||+||+++ .++++.||+|+++.. +........+|+-+++.++|+|||+++++...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 567899999998654 3333456789999999999999999988765443
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.-++.++.+....++.|+++||.++|+++ +.||||||.|+||+.+|++||+|||+++.++.+.. .
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 13567889999999999999999999998 99999999999999999999999999998765432 2
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
.+...-|.+|.+|.++.+. -|+...|+||-|||+.|+.. |++-|...+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 3334568999999999875 57899999999999999986 666666543
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=236.76 Aligned_cols=176 Identities=31% Similarity=0.524 Sum_probs=142.7
Q ss_pred cccccCceeEEEEEcC---CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------------
Q 041433 288 KLGAGGFGEVYKGVLP---SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------- 350 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------- 350 (470)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++....
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999742 456799999865532 33467899999999999999999998864321
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc-cccc
Q 041433 351 -----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN-TSRI 424 (470)
Q Consensus 351 -----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~ 424 (470)
.....+++.++..++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++..+........ ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 12456889999999999999999999987 99999999999999999999999999976543222111 1112
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.++..|+|||.+....++.++||||||+++|||++ |+.||.-
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 23568999999988889999999999999999996 9999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=237.11 Aligned_cols=182 Identities=33% Similarity=0.543 Sum_probs=150.1
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
.++|.+.++||+|++|.||++....+..+++|++.... ...+.+.+|++++++++|+|++++++++....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence 35688899999999999999997777789999886443 34567889999999999999999988754321
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 11234788889999999999999999987 999999999999999999999999999865432211 1
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.....++..|++||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112235678999999988899999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=243.25 Aligned_cols=184 Identities=27% Similarity=0.436 Sum_probs=151.6
Q ss_pred CCCccccccccCceeEEEEEcC---CCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP---SGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
+|++.++||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999953 57899999987633 3444677889999999999999999998876511
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC----CCceEEeecC
Q 041433 352 --------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA----EMNPKISDFG 407 (470)
Q Consensus 352 --------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~DfG 407 (470)
....+++.....++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 1135788889999999999999999988 999999999999999 8999999999
Q ss_pred CceeccCCCC-cccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 408 MAKIFGVDQT-QGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 408 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
++..+..... ........++..|+|||.+.+ ..++.++||||||+++|||++|++||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9986543322 112233467889999998766 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=233.25 Aligned_cols=180 Identities=27% Similarity=0.421 Sum_probs=150.9
Q ss_pred ccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC-------------
Q 041433 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE------------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~------------- 351 (470)
+.||+|+|+.|--++ +.++.++|||++.+.......++.+|++++.+.+ |+||++|++++.++..
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999988 7799999999999998888899999999999986 9999999999877652
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEeecCCceeccCCCC-----c
Q 041433 352 -----KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKISDFGMAKIFGVDQT-----Q 418 (470)
Q Consensus 352 -----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~-----~ 418 (470)
+...+++.++..++++|+.||.+||.++ |.||||||+|||..+.. -+||+||.+..-+..... .
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 3456889999999999999999999998 99999999999996554 479999988754322111 1
Q ss_pred ccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
......+|+..|||||+.. ...|+.+.|.||||||||-||+|-+||...+.
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1123457888999999763 24688999999999999999999999987654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=236.00 Aligned_cols=181 Identities=25% Similarity=0.460 Sum_probs=152.6
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|++|.||+|... +++.|++|.++.. .....+.+.+|++++++++|+||+++++.+....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999964 7899999988643 2233567899999999999999999998765432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 12345788999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 2211 2234578889999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=234.72 Aligned_cols=181 Identities=27% Similarity=0.387 Sum_probs=151.3
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|++|.||++.. .+++.|++|++.... ....+.+.+|++++++++|+|++++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999994 467899999986542 234457889999999999999999887654211
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.+++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 12345789999999999999999999988 99999999999999999999999999986643221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 223346788999999999889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=236.63 Aligned_cols=181 Identities=25% Similarity=0.374 Sum_probs=152.0
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
+|++.++||+|+||.||++.. .+++.+++|.++.. .....+.+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478889999999999999994 46899999988643 3344567889999999999999999998765432
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.....++.||+.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 12345788889999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 122346788999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=240.63 Aligned_cols=186 Identities=29% Similarity=0.457 Sum_probs=150.9
Q ss_pred hhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
..++|.+.+.||+|+||.||++... ++..|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3467889999999999999999853 24689999986443 2334578899999999999999999987654220
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 041433 352 ----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKI 403 (470)
Q Consensus 352 ----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 403 (470)
....+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 1224678889999999999999999987 999999999999999999999
Q ss_pred eecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999876543322112223345778999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=246.17 Aligned_cols=186 Identities=27% Similarity=0.414 Sum_probs=154.5
Q ss_pred HHHHHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 273 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
..++....++|.+.+.||+|+||.||++. ..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34566678999999999999999999998 4578999999986532 22345678899999999999999998876432
Q ss_pred C----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 350 P----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 350 ~----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
. .....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccc
Confidence 1 01245888999999999999999999988 9999999999999999999999999
Q ss_pred CceeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 166 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98754321 223457889999998766 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=243.69 Aligned_cols=179 Identities=30% Similarity=0.460 Sum_probs=150.7
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---------- 351 (470)
|....+||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+.....
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999985 4789999999876555556778899999999999999999987654321
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 352 -------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 352 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..... .....
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 2346789999999999999999999988 99999999999999999999999999875433221 12235
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 678899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=237.54 Aligned_cols=181 Identities=29% Similarity=0.439 Sum_probs=146.2
Q ss_pred CCccccccccCceeEEEEEcC----CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
|.+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999842 46899999986542 334567889999999999999999998653311
Q ss_pred ------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 351 ------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 351 ------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
.....+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 01124677888999999999999999987 999999999999999999999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|+++...............+++.|++||.+....++.++||||||+++|||++ |++||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 99986543322212222334568999999988889999999999999999999 8898864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=243.73 Aligned_cols=189 Identities=28% Similarity=0.446 Sum_probs=151.9
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
+....++|++.+.||+|+||.||++... ....+|+|++.... ......+.+|+++++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445577899999999999999999842 23689999987542 23345688999999999 7999999998764
Q ss_pred eCC----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 348 EDP----------------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 348 ~~~----------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.+. .....+++..++.++.||+.||.|||+.+ |+|+||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 432 11345788999999999999999999987 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999999986543322211222234567999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=248.91 Aligned_cols=186 Identities=29% Similarity=0.400 Sum_probs=159.6
Q ss_pred HHhhcCCCccccccccCceeEEEEEcCCCc-EEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGR-EIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
.+...+++++..||-|+||.|=++..+..+ .+|+|++++. .....+.+..|-.+|...+.|.||+++.-+.++.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 344566778889999999999999964433 4899988765 4455667888999999999999999986554432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
...+.++......++.-+++|++|||+++ ||.|||||+|+|++.+|.+||.|||+++.+..
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 35678888888899999999999999998 99999999999999999999999999998764
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
. ..+..++||+.|.|||++.++..+.++|.||||+++||||+|++||+..+
T Consensus 573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 3 34667899999999999999999999999999999999999999998754
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=241.44 Aligned_cols=184 Identities=29% Similarity=0.449 Sum_probs=147.3
Q ss_pred hcCCCccccccccCceeEEEEEcC-----------------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccc
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-----------------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVR 341 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 341 (470)
.++|++.++||+|+||.||++... ++..||+|++.... ....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998532 24468999987543 334567899999999999999999
Q ss_pred eeeEeeeCCC-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 041433 342 LLGFCLEDPE-----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSN 392 (470)
Q Consensus 342 l~~~~~~~~~-----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 392 (470)
+++++..... ....+++.+...++.||+.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9987654221 0124667889999999999999999988 9999999999
Q ss_pred eeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 041433 393 ILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSSF 466 (470)
Q Consensus 393 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt--G~~P~~~ 466 (470)
||++.++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999976533222111222234578999999888889999999999999999998 6778754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=240.17 Aligned_cols=182 Identities=25% Similarity=0.403 Sum_probs=149.0
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999954 689999999865432 22345678999999999999999998876532
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.....++.|+++||.|||+.+ |+|+||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 159 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T 159 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence 11346788999999999999999999987 99999999999999999999999999875432211 1
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112245788999998865 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=244.31 Aligned_cols=187 Identities=30% Similarity=0.446 Sum_probs=149.3
Q ss_pred HhhcCCCccccccccCceeEEEEEcC--------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP--------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
+..++|.+.+.||+|+||.||+++.. +...+|+|.+.... .....++.+|+++++++ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33467999999999999999999731 23579999987542 33445788899999999 7999999998765
Q ss_pred eCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 348 EDPE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 348 ~~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.... ....+++.+++.++.|++.||.|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 4320 1134788999999999999999999987 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999876532211111112234568999999988889999999999999999998 88898653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=238.62 Aligned_cols=181 Identities=26% Similarity=0.430 Sum_probs=148.9
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||.|++|.||+++. .+++.|+||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999985 468999999986543 223457889999999999999999988764422
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.+...++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 155 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 155 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence 12356789999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 112234678899999886644 688999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=250.30 Aligned_cols=188 Identities=28% Similarity=0.427 Sum_probs=150.7
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCC-CCCccceeeEee
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCL 347 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 347 (470)
+....++|.+.++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|+++|.++. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445567888999999999999999842 346899999975432 22456889999999997 999999998765
Q ss_pred eCCC----------------------------------------------------------------------------
Q 041433 348 EDPE---------------------------------------------------------------------------- 351 (470)
Q Consensus 348 ~~~~---------------------------------------------------------------------------- 351 (470)
....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4210
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 041433 352 ----------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVS 391 (470)
Q Consensus 352 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 391 (470)
....+++.....++.||+.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 0123667788899999999999999887 999999999
Q ss_pred CeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 392 NILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 392 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999986533222111222346788999999988889999999999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=242.06 Aligned_cols=184 Identities=26% Similarity=0.303 Sum_probs=152.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|++|.||++.. .+++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4688899999999999999995 45899999998765332 4467889999999999999999988764422
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.....++.||+.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 12356888999999999999999999988 9999999999999999999999999987543211
Q ss_pred Cc---------------------------ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQ---------------------------GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 10 0111245788999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-31 Score=256.41 Aligned_cols=181 Identities=28% Similarity=0.419 Sum_probs=153.6
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
+.|.|+..||.|+||.||++..+ ++-..|.|.+...+....+++.-||+||...+||+||+|++.|..+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44667788999999999999964 34556788888888888899999999999999999999987554332
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
+-...|.+.++..+.+|++.||.|||++. |||||||..|||++-+|.++|+|||.+-... .....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence 23678999999999999999999999998 9999999999999999999999999986432 22233
Q ss_pred ccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...+.|||+|||||++. ..+|+.++||||||+.|.||..+.+|-.-
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 45578999999999873 56899999999999999999999999653
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=232.48 Aligned_cols=176 Identities=31% Similarity=0.454 Sum_probs=145.3
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------------
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------------- 351 (470)
++||+|+||.||++...+++.+|+|++..... .....+.+|++++++++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999987889999999865533 234568899999999999999999988765321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccc
Q 041433 352 -----KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 352 -----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
....+++.++..++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 2345789999999999999999999987 999999999999999999999999998754322111 1111234
Q ss_pred ccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 427 t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+..|+|||++....++.++||||||+++|||++ |..||..
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 567999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=240.26 Aligned_cols=186 Identities=29% Similarity=0.438 Sum_probs=147.6
Q ss_pred HhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
+..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999742 24589999886443 223346788999999999999999998764422
Q ss_pred C----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 351 E----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 351 ~----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
. ....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 1 0123456677889999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999876533222111222234678999999988899999999999999999998 7888854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=234.48 Aligned_cols=175 Identities=32% Similarity=0.491 Sum_probs=146.9
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--------- 351 (470)
++|++.+.||+|+||.||++.. .+..|++|.++... ..+.+.+|+.++++++|+|++++++++.....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788899999999999999987 57889999985432 34678999999999999999999987543221
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.....++.|++.+|.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 1224788899999999999999999987 9999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234567999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=237.43 Aligned_cols=183 Identities=28% Similarity=0.507 Sum_probs=147.6
Q ss_pred cCCCccccccccCceeEEEEEcC-CC---cEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SG---REIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
..|++.+.||+|+||.||+|... ++ ..|+||.+... ......+|..|+.++++++||||+++++++.++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788999999999999999953 33 36999998654 3334568999999999999999999998765432
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 12345788999999999999999999987 9999999999999999999999999987654322
Q ss_pred Cccccc-ccc--cccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 417 TQGNTS-RIA--GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 417 ~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
...... ... .+..|++||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 211111 111 1347999999998899999999999999999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=242.99 Aligned_cols=184 Identities=29% Similarity=0.458 Sum_probs=149.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.++||+|++|.||++.. .+++.+++|++..... .....+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999995 4689999998864432 223467889999999999999999876533211
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 352 ---------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 352 ---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
....+++.++..++.||+++|.|||+++ |+|+||||+|||+++++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 2346899999999999999999999988 9999999999999999999999999997
Q ss_pred eccCCCCcc---------cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQG---------NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 654322111 11223567889999987654 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=239.23 Aligned_cols=182 Identities=27% Similarity=0.387 Sum_probs=153.6
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|++|.||++... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999954 6889999998654 2334567899999999999999999998876533
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~- 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS- 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence 12345889999999999999999999987 999999999999999999999999998876443321
Q ss_pred cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......++..|+|||++.+. .++.++||||||+++|+|++|++||..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22234578889999999887 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=241.96 Aligned_cols=186 Identities=30% Similarity=0.453 Sum_probs=150.1
Q ss_pred HhhcCCCccccccccCceeEEEEEc--------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
...++|.+.+.||+|+||.||+++. .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4456788999999999999999973 134579999986542 34456789999999999 8999999998765
Q ss_pred eCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 348 EDPE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 348 ~~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.... ....+++.++..++.||+.||.|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 4220 1134778888999999999999999988 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999987643322222222345678999999988889999999999999999998 7888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=236.10 Aligned_cols=185 Identities=30% Similarity=0.447 Sum_probs=150.1
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
..++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3455666668899999999999994 4678999999877666666789999999999999999999987655321
Q ss_pred --------------CCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCceeccC
Q 041433 352 --------------KQGQL--DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 --------------~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~~~~ 414 (470)
....+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 12334 77778889999999999999987 999999999999976 67899999999876532
Q ss_pred CCCcccccccccccCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ......+++.|+|||.+... .++.++||||||+++|+|++|+.||...
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 221 12233578899999988654 3789999999999999999999998643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=239.98 Aligned_cols=181 Identities=29% Similarity=0.417 Sum_probs=149.7
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||.||++..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999964 689999999865432 23456889999999999999999988765432
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence 12335889999999999999999999987 99999999999999999999999999886543221
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......++..|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 1223457889999998865 4578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=235.73 Aligned_cols=185 Identities=32% Similarity=0.545 Sum_probs=152.2
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+..++|++.++||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++.+.+.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence 3457899999999999999999997777889999886442 34567889999999999999999988754411
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 12345678888999999999999999987 999999999999999999999999999765432211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......++..|++||++....++.++|+||||+++|+|+| |+.||...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 1112234567999999988889999999999999999999 99998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=233.17 Aligned_cols=178 Identities=31% Similarity=0.480 Sum_probs=145.7
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------------
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------------- 351 (470)
++||+|++|.||++...+++.|++|++...... ....+.+|++++++++|+||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766999999998765433 45678999999999999999999987655321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccc
Q 041433 352 -----KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 352 -----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
....+++.....++.+++.+|.|||+++ ++||||||+|||++.++.+||+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 1345788888999999999999999988 99999999999999999999999999976532211111111223
Q ss_pred ccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 427 t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+..|+|||.+.++.++.++|+||||+++|||+| |+.||...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 567999999988899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=235.22 Aligned_cols=171 Identities=26% Similarity=0.408 Sum_probs=139.5
Q ss_pred ccccccCceeEEEEEcCC-------------CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 287 NKLGAGGFGEVYKGVLPS-------------GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
+.||+|+||.||+|++.. ...|++|.+..........+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998422 23589998876555555678899999999999999999998765321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-------eEEeecC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN-------PKISDFG 407 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~kl~DfG 407 (470)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 2356899999999999999999999987 999999999999987664 8999999
Q ss_pred CceeccCCCCcccccccccccCcccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEII-TGKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell-tG~~P~~~ 466 (470)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 98654221 1235678899999886 467899999999999999998 58888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=242.55 Aligned_cols=179 Identities=28% Similarity=0.450 Sum_probs=149.6
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---------- 351 (470)
|.....||+|+||.||++.. .+++.||||.+........+.+.+|+.++++++|+||+++++.+.....
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33446799999999999984 4688999999876555556778999999999999999999876544221
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 352 -------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 352 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
....+++.+...++.||+.||.|||+++ |+||||||+||++++++.++|+|||++........ .....
T Consensus 104 ~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 178 (292)
T cd06658 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSL 178 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCcee
Confidence 1345788999999999999999999987 99999999999999999999999999875432221 12234
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 678899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=237.71 Aligned_cols=180 Identities=29% Similarity=0.417 Sum_probs=145.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHH-HhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVV-VAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.+.||+|+||.||+++. .+++.||+|+++.... .....+..|+.+ ++.++||||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688999999999999999995 4699999999865432 233455556664 66678999999998775432
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..+..++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 1234688999999999999999999986 5 999999999999999999999999998865322
Q ss_pred CCcccccccccccCccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1122457889999998754 4568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=235.12 Aligned_cols=177 Identities=33% Similarity=0.521 Sum_probs=146.2
Q ss_pred ccccccCceeEEEEEcCC--C--cEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLPS--G--REIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
++||+|++|.||++.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+....
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999998532 3 3699999977655 55678999999999999999999998765410
Q ss_pred -------CCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc-cc
Q 041433 351 -------EKQ-GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-NT 421 (470)
Q Consensus 351 -------~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~ 421 (470)
... ..+++.....++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 011 46889999999999999999999987 9999999999999999999999999998764322111 11
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
....++..|++||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12346778999999988899999999999999999999 9999853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=234.09 Aligned_cols=178 Identities=39% Similarity=0.588 Sum_probs=149.7
Q ss_pred ccccccCceeEEEEEcCC----CcEEEEEEccCcCccC-HHHHHHHHHHHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLPS----GREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||++.... +..|++|+++...... .+.+.+|++++..++|+||+++++++....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999543 7899999987654333 678899999999999999999998876522
Q ss_pred -------CC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 -------EK---------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 -------~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.. ...+++.++..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 11 367899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
...........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 332222333456789999999988889999999999999999999 69998754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=237.20 Aligned_cols=184 Identities=27% Similarity=0.441 Sum_probs=149.9
Q ss_pred hcCCCccccccccCceeEEEEEcCC----CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPS----GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|.+.+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv 84 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV 84 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEE
Confidence 4568889999999999999998532 3468999886554 344567899999999999999999998765422
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 11335889999999999999999999987 9999999999999999999999999998654332
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
... .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 162 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 111 112234567999999988889999999999999999996 99998643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=236.10 Aligned_cols=178 Identities=28% Similarity=0.379 Sum_probs=137.2
Q ss_pred ccccccCceeEEEEEcC---CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLP---SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----------- 351 (470)
++||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999999743 345788888764432 234567899999999999999999987654321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 0122456777899999999999999987 9999999999999999999999999986532221111
Q ss_pred cccccccccCccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......++..|+|||++.. ..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1222345678999998642 356789999999999999999 78888653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=239.41 Aligned_cols=178 Identities=30% Similarity=0.445 Sum_probs=149.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
...|++.+.||+|+||.||++.. .+++.|++|.+..... ...+.+.+|+++++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688999999999999999995 4689999998864432 233568899999999999999999998765321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 2346889999999999999999999987 999999999999999999999999998754322
Q ss_pred cccccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....++..|+|||.+. ...++.++||||||+++|||+||+.||..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2235778899999874 45688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=240.98 Aligned_cols=182 Identities=29% Similarity=0.435 Sum_probs=149.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.++++++|+||+++++++.....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999995 4689999999864432 223356789999999999999999987754321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 1355889999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1122345778999998865 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=236.87 Aligned_cols=181 Identities=25% Similarity=0.447 Sum_probs=150.9
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|++|.||+|.. .+++.|++|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 578899999999999999995 478999999987654 334567899999999999999999998765432
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 12356889999999999999999999987 99999999999999999999999999986643321 11
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 2234678899999988654 468999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=232.81 Aligned_cols=181 Identities=27% Similarity=0.423 Sum_probs=153.3
Q ss_pred CCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
+|+..+.||+|+||.||.++ ..+++.+++|.+... ......++.+|++++++++|+||+++++++.+...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999998 457899999987644 34445678899999999999999999988765321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 1345788999999999999999999987 99999999999999999999999999986643321
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 223346789999999998888899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=246.53 Aligned_cols=182 Identities=29% Similarity=0.516 Sum_probs=153.2
Q ss_pred CCCccccccccCceeEEEEEcC---CCc--EEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP---SGR--EIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.....++||+|-||.||+|.+. .|+ .||||..+.. .....+.|..|..+|++++||||++++|+|.+..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 3445678999999999999942 233 5889988764 5566789999999999999999999999998754
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....|+......++.||..+|.|||+.. +|||||..+|||+....-+||+|||+++.+.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 23556778888889999999999999987 99999999999999999999999999998865544
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... ...-...|||||.+.-.+++.++|||.|||.|||++. |.+||...
T Consensus 547 YkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 547 YKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 3322 2334568999999999999999999999999999975 99999753
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=239.43 Aligned_cols=180 Identities=31% Similarity=0.488 Sum_probs=144.2
Q ss_pred cCCCccccccccCceeEEEEEcC-CC--cEEEEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SG--REIAVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~---- 351 (470)
++|++.+.||+|+||.||+|... ++ ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999853 33 35788887643 233456788999999999 79999999987644220
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 352 ------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 352 ------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 0124788899999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
||+|||++....... .......+..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999986422110 1111122457999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=238.46 Aligned_cols=181 Identities=30% Similarity=0.528 Sum_probs=148.8
Q ss_pred cCCCccccccccCceeEEEEEc-----CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
..|++.+.||+|+||.||+++. .+++.||+|.++... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999973 357899999986553 334567899999999999999999998775531
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++.++..++.||+.+|.|||+++ ++||||||+||+++.++.+||+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 01235789999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 414 VDQTQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 414 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
..... .......++..|+|||.+.+..++.++||||||+++|||+|++.|+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 32221 1112344667899999998888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=233.91 Aligned_cols=180 Identities=33% Similarity=0.505 Sum_probs=150.9
Q ss_pred CCCccccccccCceeEEEEEcC-CCcEEEEEEccCcC-----ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS-----GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999964 78999999886543 2244678899999999999999999987654321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.....++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 2345788999999999999999999988 9999999999999999999999999988654322
Q ss_pred cccccccccccCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||...
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 123345788999999987766 899999999999999999999998653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=242.24 Aligned_cols=179 Identities=19% Similarity=0.256 Sum_probs=143.0
Q ss_pred cccccccc--CceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 285 TDNKLGAG--GFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 285 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
+.++||+| +|++||++.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++..+..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999984 579999999986542 2234567789999999999999999988765431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc-
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ- 418 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 418 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 1245889999999999999999999988 999999999999999999999999865433211100
Q ss_pred ----ccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 ----GNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01112345678999999875 4688999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=239.67 Aligned_cols=180 Identities=32% Similarity=0.456 Sum_probs=147.7
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~------- 351 (470)
+|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.++. |+||+++++++.....
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455678899999999999994 468999999986543 234457889999999996 9999999987654321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 135688889999999999999999975 5 999999999999999999999999998765322
Q ss_pred CCcccccccccccCcccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 21 1223578899999998765 6889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=241.74 Aligned_cols=187 Identities=29% Similarity=0.450 Sum_probs=149.0
Q ss_pred HhhcCCCccccccccCceeEEEEEc--------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
...++|.+.++||+|+||.||+++. .....+|+|+++... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3446788999999999999999973 124578999986542 23456788999999999 6999999998765
Q ss_pred eCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 348 EDPE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 348 ~~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.... ....+++.+...++.||+.||.|||+++ ++|+||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 4220 1134788899999999999999999987 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999986543221111111223467999999988899999999999999999999 88998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=243.58 Aligned_cols=181 Identities=25% Similarity=0.423 Sum_probs=150.6
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
...++|.+.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 3357899999999999999999994 578999999986532 2234567899999999999999999887653211
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 1236788899999999999999999987 9999999999999999999999999987542
Q ss_pred CCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 169 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 169 AE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 123456788999998876 4688999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=232.58 Aligned_cols=178 Identities=33% Similarity=0.531 Sum_probs=151.0
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
.++|++.+.||.|+||.||++.. .++.|++|.+..... ..+++.+|+.++++++|+||+++++++....
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46788999999999999999997 488999999976544 5678899999999999999999998876422
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 11226899999999999999999999988 99999999999999999999999999986532211
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1234567999999988889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=239.05 Aligned_cols=185 Identities=25% Similarity=0.438 Sum_probs=149.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
-++|++.++||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999999995 468999999886432 2223456789999999999999999987643211
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 352 ---------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 352 ---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
....+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 1235789999999999999999999987 9999999999999999999999999998
Q ss_pred eccCCCCc--ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQ--GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+...... .......++..|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 65432211 111233567889999987664 4688999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=235.90 Aligned_cols=185 Identities=29% Similarity=0.526 Sum_probs=149.6
Q ss_pred hcCCCccccccccCceeEEEEEcC-CC---cEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SG---REIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|+..+.||+|+||.||+|+.. ++ ..+++|.+.... ....+.+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999953 33 379999986542 334567889999999999999999998875432
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 12356889999999999999999999987 999999999999999999999999999865432
Q ss_pred CCcccc-cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNT-SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
...... .....+..|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 221111 11122457999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=235.22 Aligned_cols=184 Identities=27% Similarity=0.472 Sum_probs=148.8
Q ss_pred cCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999852 23479999986543 233467899999999999999999998875432
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.+...++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 11345788999999999999999999988 9999999999999999999999999998664322
Q ss_pred Cccc-ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQGN-TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... .....++..|++||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 1111 111223467999999998899999999999999999987 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=265.67 Aligned_cols=179 Identities=34% Similarity=0.565 Sum_probs=141.6
Q ss_pred HhhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.-..+|+..+.||+||||.||+++.+ +|+.+|||++... +......+.+|+++|++|+|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888899999999999999943 8999999998755 3344467889999999999999999875432200
Q ss_pred --------------------------------------------------------------------------------
Q 041433 351 -------------------------------------------------------------------------------- 350 (470)
Q Consensus 351 -------------------------------------------------------------------------------- 350 (470)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C---------------------------CCCCC--CHHHHHHHHHHHHHHHHHHHh
Q 041433 351 ------------------------E---------------------------KQGQL--DWSRRYKIIGLIARGILYLHE 377 (470)
Q Consensus 351 ------------------------~---------------------------~~~~l--~~~~~~~i~~~i~~~l~~LH~ 377 (470)
+ ....+ .....++++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 00011 134557899999999999999
Q ss_pred CCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc----------------CCCCcccccccccccCcccccccccC--
Q 041433 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG----------------VDQTQGNTSRIAGTYGYMAPEYAMHG-- 439 (470)
Q Consensus 378 ~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~-- 439 (470)
++ ||||||||.||+++++..+||+|||++.... ........+..+||..|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 98 9999999999999999999999999998621 00111133456899999999998654
Q ss_pred -CCCchhhHHHHHHHHHHHHh
Q 041433 440 -QFSVKSDVYSFGVLVLEIIT 459 (470)
Q Consensus 440 -~~~~~~Dv~SlG~vl~ellt 459 (470)
.|+.|+|+|||||||+||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=235.18 Aligned_cols=182 Identities=30% Similarity=0.496 Sum_probs=148.1
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---c-------CHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---Q-------GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
+|.+.+.||+|++|.||+|.. .+++.||+|.++.... . ..+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999984 4689999998753211 1 1245788999999999999999998765432
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.....+++..+..++.||+.+|.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 12356888999999999999999999987 999999999999999999999999999764
Q ss_pred cCCCCcccccccccccCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.............++..|+|||.+.... ++.++|+||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 3222222223345788999999887654 78999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=232.25 Aligned_cols=182 Identities=31% Similarity=0.516 Sum_probs=150.5
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
.+|++.+.||+|+||.||++.+.+++.+++|++.... .....+.+|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999997678899999986443 33567899999999999999999998765422
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence 12345788999999999999999999987 999999999999999999999999998765332211 11
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 12234568999999988899999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=270.37 Aligned_cols=189 Identities=32% Similarity=0.457 Sum_probs=154.1
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.+-+++...+||.|.||.||-+. .++|+..|+|-+... .....+.+.+|+.++..|+|||+|+++|+-...++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34467778899999999999999 678999999977544 23445678899999999999999999988655431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC-
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ- 416 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 416 (470)
.....++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||.+..+..+.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 2334555556678899999999999998 9999999999999999999999999999875442
Q ss_pred -CcccccccccccCcccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 041433 417 -TQGNTSRIAGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470 (470)
Q Consensus 417 -~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~elltG~~P~~~~~~d 470 (470)
.........||+.|||||++.+. ....+.||||||||++||+||++||.-++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 11223356799999999999753 4567899999999999999999999877653
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=234.04 Aligned_cols=178 Identities=29% Similarity=0.414 Sum_probs=139.5
Q ss_pred ccccccCceeEEEEEcC---CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLP---SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----------- 351 (470)
+.||+|+||.||+|... ++..+++|.++.... .....+.+|+.++++++||||+++++.+.+...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999853 346799998865432 333578889999999999999999987654321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 1123456677789999999999999988 9999999999999999999999999987543222212
Q ss_pred cccccccccCcccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 22234567889999987542 35789999999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=238.08 Aligned_cols=183 Identities=28% Similarity=0.475 Sum_probs=154.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|.+.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++||||+++++.+.....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36789999999999999999984 4688999999876555556778999999999999999999987755321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 1345788889999999999999999988 99999999999999999999999999876543222 12
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=243.96 Aligned_cols=185 Identities=26% Similarity=0.444 Sum_probs=151.6
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc--CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS--SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~--- 351 (470)
..++|++.+.||+|+||.||+|... +++.+++|++... .......+.+|+.+++++ +||||+++++++.....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578899999999999999999954 6889999988543 233345677899999999 99999999998754321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 1236788899999999999999999987 9999999999999999999999999998654332
Q ss_pred Cc---ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQ---GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 21 12233467889999998754 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=233.51 Aligned_cols=184 Identities=28% Similarity=0.495 Sum_probs=153.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|++.+.||.|++|+||++.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788999999999999999994 468899999986543 2356788999999999999999999987654321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 1245888999999999999999999988 99999999999999999999999999876643322
Q ss_pred cc--cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QG--NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. ......++..|++||++... .++.++|+||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 21 12334578899999998776 7899999999999999999999998643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=232.36 Aligned_cols=178 Identities=37% Similarity=0.571 Sum_probs=144.4
Q ss_pred ccccccCceeEEEEEcC----CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLP----SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
++||+|+||.||+|++. .+..+|+|.+..... ...+++.+|+++++++.|+||+++++++..+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 47999999999999842 236899999875543 24567889999999999999999998764321
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc-ccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN-TSR 423 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~~ 423 (470)
.....+++..+..++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||+++.+........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 12235889999999999999999999987 99999999999999999999999999986643322111 111
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 223467999999988899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=235.25 Aligned_cols=183 Identities=31% Similarity=0.524 Sum_probs=151.0
Q ss_pred CCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
+|+..+.||+|++|.||++. ..+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999998 46789999999864431 124678899999999999999999988765431
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~ 415 (470)
....+++.....++.||+.||.|||+++ ++|+||+|+||+++.++ .+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 2346788899999999999999999988 99999999999998776 5999999998766433
Q ss_pred CCc--ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQ--GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 111 1122345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=237.60 Aligned_cols=181 Identities=27% Similarity=0.395 Sum_probs=149.9
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999964 688999999865432 22345678999999999999999998876541
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.+...++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 11335889999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||..
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 162 --PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred --ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234567889999988654 468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=237.82 Aligned_cols=191 Identities=29% Similarity=0.396 Sum_probs=155.1
Q ss_pred hhHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeee
Q 041433 271 FDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE 348 (470)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 348 (470)
+...++..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34455566788999999999999999999995 578899999986432 2345678899999999 79999999987653
Q ss_pred CC---------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 349 DP---------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 349 ~~---------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 21 12346788999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999998765422211 1234578899999987543 3688999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=238.30 Aligned_cols=184 Identities=28% Similarity=0.489 Sum_probs=148.7
Q ss_pred hhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
..++|++.+.||+|+||.||++... ++..||+|++.... ....+++.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999842 46789999986543 2334678899999999999999999987654321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 041433 352 ----------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVS 391 (470)
Q Consensus 352 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 391 (470)
....+++.+++.++.||+.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 0124678888999999999999999987 999999999
Q ss_pred CeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 041433 392 NILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 465 (470)
Q Consensus 392 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~ 465 (470)
|||++.++.++|+|||++..+..............+..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999876432221111112234567999999988899999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=237.64 Aligned_cols=180 Identities=30% Similarity=0.525 Sum_probs=150.3
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++.+.....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778899999999999984 467899999986443 3345678899999999999999999987654321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 352 ---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
....+++..+..++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||++..+..... ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 2345788999999999999999999987 99999999999999999999999999876543221 122
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...++..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 24578899999999988899999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=249.18 Aligned_cols=181 Identities=34% Similarity=0.511 Sum_probs=151.8
Q ss_pred CCccccccccCceeEEEEEcC--CCc--EEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP--SGR--EIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
....++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+.++..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 445689999999999999974 344 6899999876554 6789999999999999999999999988632
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....|.......++.||+.||.||.+++ +|||||..+|+||-....+||+|||+.+.++.....
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 23455667777889999999999999987 999999999999999999999999999988755443
Q ss_pred cccc-ccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 419 GNTS-RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 419 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.... ...-...|+|||.+....++.++|||+|||.||||+| |+.||..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 3221 1223457999999999999999999999999999998 7889864
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=243.67 Aligned_cols=186 Identities=30% Similarity=0.446 Sum_probs=148.5
Q ss_pred hhcCCCccccccccCceeEEEEEcC--------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeee
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP--------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE 348 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 348 (470)
...+|++.+.||+|+||.||++... ....||+|.+.... ....+++.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3457899999999999999999731 12368999886542 33456789999999999 79999999987654
Q ss_pred CCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 041433 349 DPE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394 (470)
Q Consensus 349 ~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 394 (470)
... ....+++.++..++.||+.||.|||+++ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 320 1124778888999999999999999988 999999999999
Q ss_pred eCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 395 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999986543222111222234567999999998899999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=237.23 Aligned_cols=180 Identities=26% Similarity=0.426 Sum_probs=147.1
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|++++++++|+||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999954 7899999988654 2333467889999999999999999987654422
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.||+.+|.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 01237899999999999999999999741 39999999999999999999999999987653221
Q ss_pred cccccccccccCcccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+.+. .++.++|+||||+++|||++|+.||..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 1223577889999988544 357899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=235.35 Aligned_cols=181 Identities=30% Similarity=0.391 Sum_probs=152.6
Q ss_pred CCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+|++.+.||.|+||.||++... +++.|++|++.+... ...+.+.+|++++++++||||+++++.+.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999954 689999999875432 34578899999999999999999876554322
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.+...++.||+++|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 12347889999999999999999999987 9999999999999999999999999987654322
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1223457889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=232.58 Aligned_cols=183 Identities=34% Similarity=0.516 Sum_probs=152.4
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc--CHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|+||.||++.. .+++.|++|.++..... ..+.+.+|++++++++|+||+++++......
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999984 47899999998765443 5678899999999999999999998764432
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 12345788899999999999999999988 99999999999999999999999999887643322111
Q ss_pred --ccccccccCcccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 --TSRIAGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 --~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|++||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 11245778999999987766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=232.58 Aligned_cols=176 Identities=31% Similarity=0.462 Sum_probs=139.2
Q ss_pred ccccccCceeEEEEEcC----CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----------
Q 041433 287 NKLGAGGFGEVYKGVLP----SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---------- 351 (470)
+.||+|+||.||+|... +...||+|++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999842 2457999998543 23345678899999999999999999997654221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc--c
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ--G 419 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~ 419 (470)
....+++.....++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 1234567778889999999999999987 999999999999999999999999998754322111 1
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSS 465 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG-~~P~~ 465 (470)
......++..|+|||.+.+..++.++||||||+++|||++| .+||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 11123456789999999888999999999999999999995 55664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=238.32 Aligned_cols=183 Identities=22% Similarity=0.324 Sum_probs=149.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||.||++.. .+++.|++|.+.... ....+.+.+|+++++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688899999999999999995 467899999986543 233457889999999999999999998765432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC-
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT- 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 417 (470)
.....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 12345788888999999999999999987 99999999999999999999999999864211100
Q ss_pred ------------cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 ------------QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
........++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0011123567889999999888899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=236.60 Aligned_cols=180 Identities=27% Similarity=0.414 Sum_probs=148.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc-----CHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ-----GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+|++.+.||+|++|.||+|.. .+++.|+||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999995 46899999998755332 2345678999999999999999998776532
Q ss_pred ------------CCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 ------------EKQ-GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 ------------~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
... ..+++..+..++.||++||.|||+++ ++|+||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 112 26899999999999999999999988 99999999999999999999999999987643321
Q ss_pred cccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|+|||.+.+ ..++.++||||||+++|||++|.+||..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 1222345778999998854 4678999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=235.33 Aligned_cols=181 Identities=23% Similarity=0.342 Sum_probs=147.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999995 4789999998765432 23457888999999995 6999999986644221
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCC
Q 041433 352 ----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGM 408 (470)
Q Consensus 352 ----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~ 408 (470)
....+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 1235789999999999999999999987 999999999999998 88999999999
Q ss_pred ceeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
+..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 886533211 1122346788999998865 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=239.74 Aligned_cols=181 Identities=31% Similarity=0.477 Sum_probs=144.8
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCc--EEEEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGR--EIAVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~--- 351 (470)
.++|++.+.||+|+||.||+|... ++. .+++|.++.. .......+.+|++++.++ +|+||+++++++..+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 467889999999999999999953 454 4577776543 233446788999999999 89999999987654320
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 041433 352 -------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN 400 (470)
Q Consensus 352 -------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 400 (470)
....+++.+++.++.||+.||.|||+++ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 1125788999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 401 PKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 401 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 9999999986321110 1111123567999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=237.19 Aligned_cols=189 Identities=26% Similarity=0.412 Sum_probs=153.2
Q ss_pred HHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC
Q 041433 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP 350 (470)
Q Consensus 273 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 350 (470)
++.+..+.++|++.+.||+|+||.||++.. .+++.+++|++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 345566788999999999999999999984 468899999875432 2345688899999999 6999999998763211
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 041433 351 ---------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKI 403 (470)
Q Consensus 351 ---------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 403 (470)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 11245778888899999999999999987 999999999999999999999
Q ss_pred eecCCceeccCCCCcccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+|||++..+..... ......|++.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999986543221 1223468899999998753 45788999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=234.11 Aligned_cols=181 Identities=29% Similarity=0.484 Sum_probs=150.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
+|++.++||.|++|.||+|+. .+++.||||.++.... ...+.+.+|++++++++|+||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 578899999999999999995 4689999999876533 234567889999999999999999988765321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 1245899999999999999999999987 99999999999999999999999999976533221
Q ss_pred cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|++||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223567889999987654 5688999999999999999999998743
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=241.49 Aligned_cols=183 Identities=26% Similarity=0.435 Sum_probs=152.3
Q ss_pred HHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
+....++|++.+.||+|+||.||++. ..+++.||||++.... ....+.+.+|++++++++||||+++++++..+..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34457889999999999999999998 4578999999985432 2234568899999999999999999887654321
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 352 ---------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 352 ---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 1246889999999999999999999988 9999999999999999999999999997
Q ss_pred eccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..... .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 64322 122356889999998875 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=236.77 Aligned_cols=182 Identities=30% Similarity=0.448 Sum_probs=152.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||+||++.. ++++.||+|++.... ....+.+.+|+++++.++||||+++++.+.....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35688889999999999999994 468899999876543 3345678999999999999999999988765331
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.....++.+++.+|.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 2346788899999999999999999742 39999999999999999999999999986542211
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 22346889999999998889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=231.52 Aligned_cols=176 Identities=34% Similarity=0.552 Sum_probs=147.1
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
++|++.+.||+|+||.||++.. +++.||+|+++... ..+.+.+|+.++++++||||+++++++..+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 5688999999999999999985 77889999986432 3467899999999999999999998764422
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 11235788899999999999999999987 9999999999999999999999999987543211
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 11233567999999988899999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=242.27 Aligned_cols=184 Identities=23% Similarity=0.405 Sum_probs=151.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.+.||+|++|.||++.. .+++.|++|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 37899999999999999999994 569999999987542 234567788999999999999999887553211
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 12456899999999999999999999987 999999999999999999999999999765432
Q ss_pred CCc--ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 416 QTQ--GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 416 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... .......++..|++||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 211 11123467889999998765 4688999999999999999999999953
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=234.07 Aligned_cols=181 Identities=28% Similarity=0.501 Sum_probs=152.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..|+..++||.|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++.+.++.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4577889999999999999995 468899999986543 344567889999999999999999999876543
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++.+...++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..... ..
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cc
Confidence 12345788888999999999999999987 99999999999999999999999999976543221 12
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 234578889999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=230.95 Aligned_cols=181 Identities=28% Similarity=0.468 Sum_probs=151.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||.|+||.||++.. .+++.|++|.+.... ....+.+.+|++++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999984 578899999986442 333457888999999999999999988664321
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLH-----EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
.....+++.+.+.++.||+.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 11356888999999999999999999 555 999999999999999999999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
........ ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 87643322 122346788999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=233.60 Aligned_cols=180 Identities=29% Similarity=0.446 Sum_probs=148.1
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
|++.++||.|++|.||++.. .+|+.|++|++.... ....+.+.+|++++++++|||++++++++.+...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56789999999999999985 479999999986543 2234568899999999999999999987654321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++..+..++.|++++|.|||+++ ++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 155 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--T 155 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--c
Confidence 1136889999999999999999999987 99999999999999999999999999976533221 1
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223457889999987654 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=235.66 Aligned_cols=189 Identities=29% Similarity=0.461 Sum_probs=153.4
Q ss_pred hHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
+..++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455556778999999999999999999995 568899999985543 3345688899999998 699999998876421
Q ss_pred C--------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 041433 350 P--------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKI 403 (470)
Q Consensus 350 ~--------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 403 (470)
. .....+++..+..++.||+.+|.|||+.+ |+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 0 12345778888999999999999999988 999999999999999999999
Q ss_pred eecCCceeccCCCCcccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
+|||++........ ......++..|+|||.+. +..++.++||||||+++|||++|+.||..
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 99999875432211 123346888999999875 34678899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=231.51 Aligned_cols=182 Identities=28% Similarity=0.414 Sum_probs=155.4
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+..+.+++|+||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999954 599999999876544 44678999999999999999999998765532
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.....++.|++++|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 123668899999999999999999999 87 999999999999999999999999999876433222
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 12345788999999998888999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=234.72 Aligned_cols=181 Identities=27% Similarity=0.417 Sum_probs=147.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
++|++.+.||+|++|.||+|.. .+++.|++|++..... ...+.+.+|++++++++||||+++++++.....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5788999999999999999995 4789999999865432 234568899999999999999999988765321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCceeccCCCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.....++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 1223567788899999999999999987 999999999999985 55799999999976543211
Q ss_pred cccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|++||.+.+ ..++.++||||||+++|+|+||++||..
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1122356789999998865 4578999999999999999999999964
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=233.19 Aligned_cols=181 Identities=25% Similarity=0.411 Sum_probs=150.8
Q ss_pred CCccccccccCceeEEEEEcC-CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeC--C-------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED--P------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~------- 350 (470)
|++.++||+|++|.||+++.. +++.+++|++.... ......+.+|++++++++|+|++++++++... .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999954 58999999997653 33446788999999999999999999988765 1
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.+++.++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence 11247889999999999999999999987 999999999999999999999999999876443221
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1222346778999997765 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=230.69 Aligned_cols=180 Identities=26% Similarity=0.406 Sum_probs=150.9
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.++||+|+||.||++.. .+++.|++|.+... .....+++.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999994 57899999998643 2334467899999999999999999998765432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.+...++.|++.+|.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 11235788889999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......+++.|+|||++.+..++.++|+||||+++++|++|+.||..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 12234578889999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=241.44 Aligned_cols=182 Identities=24% Similarity=0.396 Sum_probs=150.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|.+.+.||+|+||.||+++. .+++.||||.+... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999994 57899999998653 2333456788999999999999999987553221
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.....++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 12356889999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 21 11223457889999998764 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=240.47 Aligned_cols=191 Identities=34% Similarity=0.441 Sum_probs=155.3
Q ss_pred HhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC-c------cCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS-G------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
...++|-++++||+|+|+.||++. +...+.||+|+-.... . ...+...+|.+|-+.|.||.||++++++.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 344678888999999999999999 5678899999864321 1 1223456899999999999999999887443
Q ss_pred C-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEeecC
Q 041433 350 P-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD---AEMNPKISDFG 407 (470)
Q Consensus 350 ~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~DfG 407 (470)
. .....++++++..|+.||..||.||.+.. ++|||-||||.||||- ..|.+||.|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 2 23566889999999999999999999884 7899999999999994 45789999999
Q ss_pred CceeccCCCCc-----ccccccccccCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 408 MAKIFGVDQTQ-----GNTSRIAGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 408 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
+++.+..+... ..+....||.+|++||.+.-+ ..+.|+||||+|||+|..+.|++||+..++
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 99988655433 234556799999999987533 578899999999999999999999997653
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=233.58 Aligned_cols=180 Identities=31% Similarity=0.435 Sum_probs=151.4
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|+..+.||+|++|.||++... +++.|++|++.... ....+++.+|++++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999964 68999999987653 334567889999999999999999988765432
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.....++.|++.+|.|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 112678888999999999999999999 76 99999999999999999999999999875532211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++..|++||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1156788999999998889999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=241.81 Aligned_cols=184 Identities=24% Similarity=0.410 Sum_probs=149.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
..+|.+.+.||.|+||.||+|.. .+++.|++|++........+.+.+|++++++++||||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 37899999999999999999994 578999999987766666778899999999999999999875432211
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecC
Q 041433 351 ----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFG 407 (470)
Q Consensus 351 ----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG 407 (470)
.....+++.....++.||++||.|||+.+ |+||||||+||+++ +++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence 01245888999999999999999999988 99999999999997 45578999999
Q ss_pred CceeccCCCCcc-cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 408 MAKIFGVDQTQG-NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
++..+....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 997653221111 1122356888999997654 5678899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=228.51 Aligned_cols=180 Identities=41% Similarity=0.608 Sum_probs=148.5
Q ss_pred CCccccccccCceeEEEEEcCC-----CcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPS-----GREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
+++.+.||.|+||.||+++... +..||+|++...... ..+.+.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999543 388999999655433 56788999999999999999999988765321
Q ss_pred -------------C-CCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 -------------K-QGQ-LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 -------------~-~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
. ... +++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 1 112 889999999999999999999987 9999999999999999999999999998765432
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
..... ...+++.|++||.+.+..++.++||||||++++||++ |+.||..
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 21111 1236788999999988889999999999999999998 8888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=238.43 Aligned_cols=183 Identities=25% Similarity=0.391 Sum_probs=148.0
Q ss_pred CCCccccccccCceeEEEEEcC-C--CcEEEEEEccCcC--ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP-S--GREIAVKRLSKSS--GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----- 350 (470)
+|++.+.||+|+||.||+++.. + +..||+|++.... ....+.+.+|+.+++++ +||||+++++......
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999953 4 7899999986532 22345678899999999 5999999987532210
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 13456889999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCc--ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQ--GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 2211 11223468899999998765 46889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=234.06 Aligned_cols=183 Identities=32% Similarity=0.479 Sum_probs=149.9
Q ss_pred cCCCccccccccCceeEEEEEcC-----CCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-----SGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
+.|++.+.||+|+||.||++.+. +++.||||.++..... ..+.+.+|+++++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999843 3689999998765443 46789999999999999999999987654210
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 1224888999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 414 VDQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 414 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...... ......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 222111 11112345579999999888899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=234.70 Aligned_cols=185 Identities=25% Similarity=0.416 Sum_probs=151.4
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
...++|++.+.||+|+||.||+|.. .+++.|++|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999995 468999999986543 233456788999999999999999987765422
Q ss_pred ------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 351 ------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 351 ------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
.....+++.++..++.||+.||.|||+.+ |+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence 01236889999999999999999999987 999999999999999999999999
Q ss_pred CCceeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|++..+...... ......++..|++||.+.+ ..++.++||||||+++|||++|++||..
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 161 GLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred cccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999865433221 1122345778999998765 3578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=232.27 Aligned_cols=181 Identities=30% Similarity=0.539 Sum_probs=151.0
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCC---CCCccceeeEeeeCC------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQ---HRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~------ 350 (470)
.|++.+.||+|+||.||+|.. .+++.|++|.+... .....+++.+|+.++++++ |||++++++++....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999994 57899999998654 3344567889999999997 999999998775532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.....++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 11346889999999999999999999988 99999999999999999999999999987644331
Q ss_pred cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 12234688899999988654 5689999999999999999999999643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=237.25 Aligned_cols=183 Identities=28% Similarity=0.437 Sum_probs=152.3
Q ss_pred HHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
...+++|++.+.||+|+||.||++. ..+++.||+|++.+. .....+.+.+|++++++++||||+++++++.....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3467889999999999999999998 447999999987543 22345678899999999999999999998755321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.....++.||++||.|||+.+ |+|+||+|+|||+++++.+||+|||++......
T Consensus 86 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 86 YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 2345778888899999999999999988 999999999999999999999999998754321
Q ss_pred CcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|++||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122356788999998765 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=228.78 Aligned_cols=171 Identities=26% Similarity=0.465 Sum_probs=139.3
Q ss_pred ccccccCceeEEEEEcCC-C----------cEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 287 NKLGAGGFGEVYKGVLPS-G----------REIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 469999999999999643 3 25788877554433 678899999999999999999999875311
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-------ceEEeecCCce
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-------NPKISDFGMAK 410 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~DfG~a~ 410 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 11226889999999999999999999987 99999999999999887 79999999998
Q ss_pred eccCCCCcccccccccccCcccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 6432 1123456789999998776 78999999999999999999 57777544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=235.49 Aligned_cols=186 Identities=30% Similarity=0.358 Sum_probs=150.8
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~--- 350 (470)
-..+|..+..||+|+||.|.++.. .+.+.+|||++++.- ..+.+--+.|-++|+.. +.|.+++++.+++.-.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 345788899999999999999985 457889999998763 23333345677777665 4667777665443311
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
+..+.+.+..+..++.+|+-||-+||+++ ||.||||.+||||+.+|++||+|||+++.--.
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc-
Confidence 24567788888899999999999999998 99999999999999999999999999985321
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
....+...+||+.|+|||++...+|+..+|+|||||+|||||.|++||+.-+.
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 22345568999999999999999999999999999999999999999987554
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=232.30 Aligned_cols=177 Identities=36% Similarity=0.552 Sum_probs=142.8
Q ss_pred ccccccCceeEEEEEcCC-------CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 287 NKLGAGGFGEVYKGVLPS-------GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
+.||+|+||.||+++..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998532 2579999886543 2345678999999999999999999987754321
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-----ceEEeecCC
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-----NPKISDFGM 408 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~DfG~ 408 (470)
....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 1234678889999999999999999987 99999999999998877 899999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+................++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 876533222111222345678999999998999999999999999999998 9999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=232.03 Aligned_cols=182 Identities=30% Similarity=0.477 Sum_probs=151.3
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~----- 351 (470)
.+++|++.+.||+|++|.||+|.. .+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 468899999999999999999995 4678999999865443 346789999999999 69999999988754221
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 352 -----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 352 -----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 1356888899999999999999999988 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
+........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 876533221 2223457889999998753 3467899999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=232.84 Aligned_cols=180 Identities=27% Similarity=0.441 Sum_probs=150.4
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--------- 351 (470)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++.....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355568999999999999984 5788999999865555556678899999999999999999987654321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 352 --------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 352 --------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
....+++.++..++.|++.+|.|||+++ ++||||+|+||+++.++.++|+|||++........ ....
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 1245788899999999999999999988 99999999999999999999999998875432221 1223
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 4578899999999888899999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=231.91 Aligned_cols=182 Identities=31% Similarity=0.432 Sum_probs=148.8
Q ss_pred cCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
++|++.+.||+|+||.||+++.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999843 3467999988654433 4567899999999999999999998875422
Q ss_pred ---------------CCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 351 ---------------EKQ---------GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 351 ---------------~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
... ..+++..+..++.||+.+|.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 011 15899999999999999999999988 999999999999999999999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|++........ .......++..|++||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99864322211 11222345678999999988888999999999999999999 7888853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=225.91 Aligned_cols=180 Identities=33% Similarity=0.548 Sum_probs=154.6
Q ss_pred CCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--------- 351 (470)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999964 688999999977655566789999999999999999999987654321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++..+..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 1247899999999999999999999987 99999999999999999999999999986543321 2
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++..|++||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3356788999999998888999999999999999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=261.04 Aligned_cols=191 Identities=25% Similarity=0.319 Sum_probs=159.4
Q ss_pred hhhHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeE
Q 041433 270 QFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345 (470)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 345 (470)
.....+++...++|.+++.||+|+||.|..++. .+++.||+|++++. .......|..|-.+|..-+.+-|+.++-.
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 344566777789999999999999999999995 56889999999773 34455678889999988888888887654
Q ss_pred eeeCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 346 CLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 346 ~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
++++. .+...+++..+..++..|..||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 44432 13347899999999999999999999998 9999999999999999999999999
Q ss_pred CceeccCCCCcccccccccccCcccccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAM----H-GQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
.+-.+..+.. ......+|||.|++||++. + +.|+...|+||+||++|||+.|..||
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 9987764433 2344568999999999984 3 57999999999999999999999998
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=227.18 Aligned_cols=180 Identities=28% Similarity=0.402 Sum_probs=149.8
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|++++++++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578899999999999999984 578899999986542 334567889999999999999999988664432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCceeccCCCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.+++.+|.|||+++ ++|+||||+||+++++ ..+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 11345788999999999999999999987 9999999999999755 4689999999987643321
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 22345788999999998888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=235.07 Aligned_cols=176 Identities=30% Similarity=0.459 Sum_probs=147.5
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.|+..+.||+|+||.||+++. .+++.||+|++..... .....+.+|++++++++|||++++++++.++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999994 4689999999865422 233568889999999999999999998765321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.++..++.+|+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 2455889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+. .+.++.++||||||+++|||++|+.||..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 12345788999999873 45688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=225.61 Aligned_cols=186 Identities=27% Similarity=0.374 Sum_probs=158.1
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~- 350 (470)
....++|.+.+.||+|+|.+|.++++ ++.+.+|+|++++. ..++.+..+.|-.+..+. +||.+|-+..+++.+.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 34557899999999999999999995 56889999999765 334455566777777666 6999998877665432
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
+++..|+++.+..+..+|..||.|||+++ ||.||||.+|||||..|++||.|+|+++.-
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence 45778999999999999999999999998 999999999999999999999999999852
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
-.....++..+||+.|.|||++.+..|...+|+|+|||+|+||+.|+.||..-
T Consensus 402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 22334566789999999999999999999999999999999999999999864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=231.70 Aligned_cols=171 Identities=24% Similarity=0.354 Sum_probs=137.5
Q ss_pred cccccCceeEEEEEcC-------------------------CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccce
Q 041433 288 KLGAGGFGEVYKGVLP-------------------------SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 342 (470)
.||+|+||.||+|.+. ....|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999731 113589999866554445678889999999999999999
Q ss_pred eeEeeeCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----
Q 041433 343 LGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---- 399 (470)
Q Consensus 343 ~~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---- 399 (470)
++++.+... ....+++..+..++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 998766431 2456889999999999999999999987 99999999999997643
Q ss_pred ---ceEEeecCCceeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCC
Q 041433 400 ---NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEII-TGKKNSSFY 467 (470)
Q Consensus 400 ---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell-tG~~P~~~~ 467 (470)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3799999987643211 12246778999998865 56899999999999999994 799998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=231.83 Aligned_cols=180 Identities=29% Similarity=0.413 Sum_probs=150.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4678889999999999999995 4688999999875432 345678999999999999999999987654221
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.....++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 1234677888899999999999999988 99999999999999999999999999875432
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ....++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1235678899999998889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-30 Score=228.92 Aligned_cols=179 Identities=30% Similarity=0.430 Sum_probs=142.8
Q ss_pred CCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~-------- 351 (470)
.+.+..||.|.||+|++-. .+.|+..|||+++.... .+.+++..|.+...+- +.||||+++|.+..+..
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3345779999999999988 45799999999976543 5556788888765554 68999999987765432
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
+...+++...-.|..-...||.||.+.. .|||||+||+||||+..|.+||+|||++..+....
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 3455666666667777889999998754 69999999999999999999999999997654322
Q ss_pred cccccccccccCcccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..+...|-..|||||.+. +..|+.++||||||++|||+.||+.||.-
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 233456788999999885 34589999999999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=234.14 Aligned_cols=182 Identities=31% Similarity=0.494 Sum_probs=147.5
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|++|.||++..+ +++.||||+++.... .....+.+|+.++.+.. ||||+++++++.+...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3467888999999999999999965 489999999865432 23445667777776665 9999999998765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++..+..++.||+.||.|||+. + |+||||+|+||++++++.+||+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 134688899999999999999999974 5 9999999999999999999999999987653322
Q ss_pred CcccccccccccCcccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 1 12234678899999986543 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=230.23 Aligned_cols=180 Identities=30% Similarity=0.527 Sum_probs=150.8
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
-|++.++||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..+..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999984 468899999876443 2334678899999999999999999987765331
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 352 ---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
....+++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..... ...
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhc
Confidence 2346789999999999999999999987 99999999999999999999999999876543211 122
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...++..|++||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 34578899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=229.86 Aligned_cols=177 Identities=24% Similarity=0.350 Sum_probs=144.9
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCC-CCCccceeeEeeeC--C-------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLED--P------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~------- 350 (470)
|++.++||+|+||.||++.. .+++.||+|+++.... .......+|+.++.++. |+||+++++++.+. .
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999994 4789999999865422 22234457888999885 99999999988765 2
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.||.|||+.+ ++|+||||+||+++. +.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 11346899999999999999999999988 999999999999999 9999999999986543221
Q ss_pred cccccccccCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+. ++.++.++||||||+++|||++|+.||..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 12235788999999764 45678999999999999999999999964
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=233.05 Aligned_cols=176 Identities=28% Similarity=0.431 Sum_probs=148.6
Q ss_pred cccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------------
Q 041433 286 DNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------------- 351 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------------- 351 (470)
..+||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++|+||+++++.+.....
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999985 5789999999865555556678999999999999999999987655321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccc
Q 041433 352 ----KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427 (470)
Q Consensus 352 ----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt 427 (470)
....+++.....++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~ 179 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGT 179 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccC
Confidence 1345788999999999999999999987 99999999999999999999999999876543221 12234578
Q ss_pred cCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 428 ~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..|++||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 899999998888889999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=237.35 Aligned_cols=183 Identities=29% Similarity=0.451 Sum_probs=153.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|++|.||+++. .+++.|+||++.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588899999999999999995 458999999987643 344567899999999999999999988655432
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 12346889999999999999999999988 9999999999999999999999999998764432
Q ss_pred Cc-ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQ-GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 10 112334578899999999877 7899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=227.63 Aligned_cols=174 Identities=30% Similarity=0.439 Sum_probs=146.7
Q ss_pred ccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||.|++|.||+++. .+++.|++|++.+.. ....+.+.+|+++++.++||||+++++.+.+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999995 358999999986543 234467899999999999999999998765432
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccc
Q 041433 351 ----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 351 ----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
.+...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 12345788999999999999999999987 9999999999999999999999999998664332 1223457
Q ss_pred ccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 427 t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 889999999888889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=228.56 Aligned_cols=180 Identities=28% Similarity=0.474 Sum_probs=147.6
Q ss_pred CCCccccccccCceeEEEEEcCC--CcEEEEEEccCcC----------ccCHHHHHHHHHHHhc-CCCCCccceeeEeee
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLPS--GREIAVKRLSKSS----------GQGAEEFKNEVVVVAK-LQHRNLVRLLGFCLE 348 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~ 348 (470)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999643 7889999875321 2233457788888865 799999999987655
Q ss_pred CC----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 349 DP----------------------EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 349 ~~----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
+. .....+++.+++.++.|++.+|.|||+ .+ ++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 32 123457888999999999999999996 44 99999999999999999999999
Q ss_pred cCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 406 FGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 406 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||++....... ......++..|++||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 99998654332 223356788999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=226.15 Aligned_cols=184 Identities=34% Similarity=0.515 Sum_probs=155.7
Q ss_pred CCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeC--C------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLED--P------ 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~------ 350 (470)
+|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++..... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999964 789999999865543 4567889999999999999999999887665 2
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 11237889999999999999999999987 999999999999999999999999999876544321
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.......++..|++||.+.....+.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11233467889999999988889999999999999999999999997653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=231.08 Aligned_cols=184 Identities=27% Similarity=0.478 Sum_probs=154.8
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
..+.|+..+.||+|++|.||++..+ +++.|++|.+..... ..+.+.+|++++++++|+|++++++.+.....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999965 688999999876544 56778899999999999999999987755321
Q ss_pred ------------CC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 ------------KQ-GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 ------------~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.. ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 11 27899999999999999999999987 99999999999999999999999999865432211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1223356788999999988889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=228.33 Aligned_cols=177 Identities=22% Similarity=0.366 Sum_probs=134.6
Q ss_pred ccccccCceeEEEEEcCCC---cEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLPSG---REIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----------- 351 (470)
++||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999974332 356677765443 3345678999999999999999999987654321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 1123455667789999999999999987 99999999999999999999999999764221111112
Q ss_pred ccccccccCccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 223457889999998743 245789999999999999997 5678754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=227.98 Aligned_cols=174 Identities=31% Similarity=0.492 Sum_probs=138.9
Q ss_pred ccccccCceeEEEEEcC-CCc--EEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC----------
Q 041433 287 NKLGAGGFGEVYKGVLP-SGR--EIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~---------- 351 (470)
+.||+|+||.||+|+.. ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999964 343 56888886432 34456788999999999 79999999987654321
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 352 ------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 352 ------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
....+++.++..++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 1124788999999999999999999987 9999999999999999999999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
++....... .......+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 986321110 1111123567999999988889999999999999999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=230.44 Aligned_cols=181 Identities=30% Similarity=0.427 Sum_probs=147.1
Q ss_pred CCCccccccccCceeEEEEEc----CCCcEEEEEEccCcC----ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC--
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-- 350 (470)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++.+..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999984 478999999986532 22346678899999999 5999999987654432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.....++.||+.||.|||+.+ ++||||+|+|||+++++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 12345788888899999999999999987 99999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... ......++..|++||.+... .++.++||||||+++|+|++|+.||..
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 2211 12234578899999988653 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=228.95 Aligned_cols=179 Identities=27% Similarity=0.470 Sum_probs=146.9
Q ss_pred CCccccccccCceeEEEEEcC-CCcEEEEEEccCcCcc--CHHHHHHHHHHHhcC---CCCCccceeeEeeeCCC-----
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKL---QHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~----- 351 (470)
|++.+.||+|+||.||+++.. +++.||+|++...... ....+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999965 5899999998644222 234566787777665 69999999988765331
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 352 -------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 352 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 1235889999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .....++..|+|||.+.+..++.++|+||||+++|||++|++||...
T Consensus 158 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 158 SFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred cCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 43322 12234678899999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=229.01 Aligned_cols=173 Identities=31% Similarity=0.416 Sum_probs=143.2
Q ss_pred ccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||+|+||+||++.. .+++.|++|.+.... ......+.+|++++++++||||+++++.+....
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468999999986532 223445678999999999999999987764422
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 424 (470)
.....+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 11236889999999999999999999988 9999999999999999999999999987653211 12223
Q ss_pred ccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 425 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.++..|++||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 5678899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=229.56 Aligned_cols=180 Identities=26% Similarity=0.410 Sum_probs=149.7
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc--CHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
|++.+.||+|++|.||++.. .+++.+++|.+...... ....+.+|++++++++|+||+++++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999995 47899999998654332 4567889999999999999999987654422
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++.++..++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 11347889999999999999999999988 9999999999999999999999999998765433 112
Q ss_pred cccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....++..|++||.+.+. .++.++|+||||+++|+|+||+.||...
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 223567889999998776 7899999999999999999999998643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=234.99 Aligned_cols=184 Identities=26% Similarity=0.376 Sum_probs=146.9
Q ss_pred cCCC-ccccccccCceeEEEEEc-CCCcEEEEEEccCcCccC--------------HHHHHHHHHHHhcCCCCCccceee
Q 041433 281 NKFS-TDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQG--------------AEEFKNEVVVVAKLQHRNLVRLLG 344 (470)
Q Consensus 281 ~~~~-~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~~ 344 (470)
++|. +.+.||+|+||.||++.. .+++.||||++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457799999999999994 478999999986542221 124778999999999999999998
Q ss_pred EeeeCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 345 FCLEDPE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 345 ~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
++..... ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 8654321 2345788899999999999999999988 9999999999999999999999999
Q ss_pred CceeccCCCC------------cccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 408 MAKIFGVDQT------------QGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 408 ~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++........ ........++..|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9986541110 1111123457789999988764 4689999999999999999999999643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=224.10 Aligned_cols=180 Identities=30% Similarity=0.474 Sum_probs=152.8
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||+|++|.||+++. .+++.|++|.+..... ...+.+.+|++++++++|+|++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999985 4688999999876643 45567899999999999999999998765432
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 12356899999999999999999999987 999999999999999999999999999876433221
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|++||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2234578899999998887889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=230.16 Aligned_cols=175 Identities=31% Similarity=0.455 Sum_probs=146.5
Q ss_pred CCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
|...++||+|+||.||+|+. .+++.|++|++..... .....+.+|+++++.++|||++++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999994 4688999999865432 23356788999999999999999998876543
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.... .
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 12456889999999999999999999988 9999999999999999999999999986422 1
Q ss_pred ccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+. ...++.++||||||+++|||++|++||..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22346788999999874 45688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=225.10 Aligned_cols=181 Identities=25% Similarity=0.417 Sum_probs=149.7
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|.+.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478889999999999999995 468899999986542 234567889999999999999999998765432
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCCCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 12235789999999999999999999987 99999999999998875 469999999876543221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 112245788999999998888999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=228.43 Aligned_cols=171 Identities=26% Similarity=0.425 Sum_probs=138.5
Q ss_pred ccccccCceeEEEEEcC-C-------CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 287 NKLGAGGFGEVYKGVLP-S-------GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
+.||+|+||.||+|... . ...|++|.+........+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999842 2 23588888866555556788999999999999999999988765321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--------eEEeecCCcee
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN--------PKISDFGMAKI 411 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~DfG~a~~ 411 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 2335789999999999999999999988 999999999999987765 69999998865
Q ss_pred ccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGK-KNSSF 466 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~-~P~~~ 466 (470)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|. .||..
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 432 122457788999999876 45789999999999999999995 56543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=227.20 Aligned_cols=172 Identities=29% Similarity=0.392 Sum_probs=136.1
Q ss_pred cccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHH---HhcCCCCCccceeeEeeeCC----------
Q 041433 288 KLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVV---VAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~---l~~l~h~niv~l~~~~~~~~---------- 350 (470)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..+ +...+||||+.+++.+....
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 5689999998865422 112233444433 33447999999887665422
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 351 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
.....+++.+...++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence 12456899999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 2458899999998864 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=226.60 Aligned_cols=176 Identities=29% Similarity=0.412 Sum_probs=144.9
Q ss_pred ccccCceeEEEEEcC-CCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVLP-SGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999964 589999999865533 34567889999999999999999886554322
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC------ccc
Q 041433 351 ----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT------QGN 420 (470)
Q Consensus 351 ----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~------~~~ 420 (470)
.....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 01246889999999999999999999987 99999999999999999999999999875432211 012
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|++||.+.....+.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 22345778899999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=221.72 Aligned_cols=184 Identities=24% Similarity=0.441 Sum_probs=149.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
+.|....+||+|.||.||+++. ++++.||+|++-.. ...-.....+|+++|..|+|+|++.+++.|....
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566678999999999999994 46888999876432 2222345578999999999999999887654321
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
+....++..++.+++++++.||.|+|... |+|||+|+.|+||+.++.+||+|||+++.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 23456888999999999999999999887 99999999999999999999999999987
Q ss_pred ccCCCCcc--cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQG--NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+....... ..+..+-|.+|.+||.+.+ .+|+++.|||.-||||.||+|+.+-+...
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 75443222 2333456999999998876 57899999999999999999999877653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=223.04 Aligned_cols=178 Identities=27% Similarity=0.366 Sum_probs=142.4
Q ss_pred HHHhhcCCCccccc--cccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-
Q 041433 276 IKVATNKFSTDNKL--GAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP- 350 (470)
Q Consensus 276 ~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~- 350 (470)
.....++|++.+.+ |+|+||.||++.. .+++.+++|.+........ |+.....+ +||||+++++.+....
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677777777 9999999999994 5788999999865432211 22222222 6999999998875432
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceec
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIF 412 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~ 412 (470)
.....+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 12347899999999999999999999988 99999999999999988 9999999998765
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 422 1235788999999999889999999999999999999999999743
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=226.12 Aligned_cols=173 Identities=29% Similarity=0.394 Sum_probs=137.0
Q ss_pred cccccCceeEEEEEc-CCCcEEEEEEccCcCcc---CHHHHHHHH---HHHhcCCCCCccceeeEeeeCC----------
Q 041433 288 KLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---GAEEFKNEV---VVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~Ei---~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
.||+|+||.||++.. .+++.||+|.+.+.... ....+..|. ++++...||||+++++.+.+..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 46899999998654221 112233343 3455568999999887654422
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 351 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence 12456899999999999999999999987 9999999999999999999999999987553221 12
Q ss_pred ccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 34688999999998754 6889999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=221.87 Aligned_cols=181 Identities=27% Similarity=0.416 Sum_probs=153.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.+.||.|++|.||++.. .+++.|++|++..... ...+.+.+|++++++++|+|++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 578889999999999999995 4689999999875533 45567889999999999999999987654421
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.+...++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 01367889999999999999999999987 9999999999999999999999999998754432
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1222346788999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=238.19 Aligned_cols=189 Identities=32% Similarity=0.521 Sum_probs=154.7
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEcCC-CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
++++....+....++||-|.||.||.|.|+. .-.||||.++ .+....++|..|..+|+.++|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444444566778999999999999999854 5689999984 45566789999999999999999999999986543
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.....++....+.++.||..|++||..++ +|||||..+|+|+.++..+|++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 12334555666889999999999999887 999999999999999999999999999988
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..+....... ..-.+.|.|||.+....++.|+|||+|||+|||+.| |..||...
T Consensus 416 tgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 416 TGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred cCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 6543322211 112468999999999999999999999999999998 88888643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=223.60 Aligned_cols=179 Identities=33% Similarity=0.459 Sum_probs=150.4
Q ss_pred CCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
+|++.++||+|++|.||+++ ..+++.+++|.+.... .....++.+|++++++++|+||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47888999999999999998 4478899999986542 233457788999999999999999987654422
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 11356788889999999999999999988 999999999999999999999999999876433
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|++||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112235788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=220.45 Aligned_cols=179 Identities=26% Similarity=0.418 Sum_probs=147.4
Q ss_pred CccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 284 STDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
+..+.||.|+||.||.+.. .+|+.|++|++..- +-.+.+.+.+|+++|.-++|.|++..++..+-..
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4457899999999999995 47999999998654 2334577899999999999999998876543211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
-....++.....-++.||++||+|||+.+ |.||||||.|+|++.|..+||+|||+++..+.+...
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 13456777888889999999999999988 999999999999999999999999999976544333
Q ss_pred ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..+...-|..|.|||++++. .|+.+.||||.|||+.||+..+.-|.-
T Consensus 213 -hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 213 -NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred -hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 33344568899999999874 689999999999999999988876653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=228.06 Aligned_cols=184 Identities=30% Similarity=0.444 Sum_probs=152.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~----- 350 (470)
++|.+.+.||+|++|.||++.. .+++.|++|++.+.. ....+.+.+|++++++++ ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999995 478999999986532 233456888999999998 999999987654322
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 12346899999999999999999999988 99999999999999999999999999886543321
Q ss_pred c------------------ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 Q------------------GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .......++..|++||.+....++.++|+||||+++++|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 1222345788999999988888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=230.60 Aligned_cols=177 Identities=32% Similarity=0.465 Sum_probs=146.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
+.|+..+.||+|++|.||+|+. .+++.+++|.+... ......++.+|+++++.++|+|++++++++.....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477778999999999999994 46889999988643 22334567889999999999999999987655321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 2345788999999999999999999987 999999999999999999999999998765321
Q ss_pred ccccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....++..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2245788999999874 35678899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=236.26 Aligned_cols=180 Identities=29% Similarity=0.472 Sum_probs=149.3
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|++|.||+++. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999995 46889999998643 22334567789999999999999998765433221
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 1246889999999999999999999987 9999999999999999999999999998653
Q ss_pred CCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22 223356788999998765 3678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=225.83 Aligned_cols=179 Identities=31% Similarity=0.489 Sum_probs=148.4
Q ss_pred CCccccccccCceeEEEEEcC-CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
|+..+.||+|++|.||+++.. +++.|++|++.... ....+.+.+|+.++++++|+||+++++++.+...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999954 58999999987653 3344677889999999999999999877654320
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++..+..++.|++.+|.|||+++ |+|+||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY 155 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence 1146889999999999999999999988 99999999999999999999999999986543221 11
Q ss_pred cccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....++..|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 223456789999988766 789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=222.23 Aligned_cols=172 Identities=26% Similarity=0.348 Sum_probs=139.4
Q ss_pred ccccccCceeEEEEEc-CCCcEEEEEEccCcCcc---CHHHHHHHHHH-HhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---GAEEFKNEVVV-VAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~----------- 350 (470)
+.||+|+||.||+|.. .+++.||+|.+.+.... ....+..|..+ ....+|+|++++++.+....
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 46899999998654321 12234445444 44568999999998875532
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccc
Q 041433 351 -------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423 (470)
Q Consensus 351 -------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 12356889999999999999999999987 99999999999999999999999999875432 123
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 45788899999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=234.83 Aligned_cols=183 Identities=26% Similarity=0.363 Sum_probs=153.1
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.-|..++.||-|+||+|.++. .++...+|+|.+++.+ .......+.|-.||.....+-||+|+-.+++...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457888999999999999998 5677889999997764 3444567889999999999999999977766542
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
+.+.|++..+..++.++..|+++.|..| +|||||||+|||||.+|++||+|||++.-+......
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 3466788888899999999999999988 999999999999999999999999998654211000
Q ss_pred c----------------------------------------cccccccccCcccccccccCCCCchhhHHHHHHHHHHHH
Q 041433 419 G----------------------------------------NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458 (470)
Q Consensus 419 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell 458 (470)
. .....+||+.|+|||++....++...|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 011246999999999999999999999999999999999
Q ss_pred hCCCCCCC
Q 041433 459 TGKKNSSF 466 (470)
Q Consensus 459 tG~~P~~~ 466 (470)
.|+.||--
T Consensus 866 ~g~~pf~~ 873 (1034)
T KOG0608|consen 866 VGQPPFLA 873 (1034)
T ss_pred hCCCCccC
Confidence 99999964
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=227.58 Aligned_cols=179 Identities=20% Similarity=0.232 Sum_probs=141.2
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----------
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---------- 351 (470)
.+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+...
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666655 7899999998754 34455789999999999999999999987665321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC----
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT---- 417 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 417 (470)
....+++.....++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 1245788888999999999999999988 99999999999999999999999998875432111
Q ss_pred -cccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 -QGNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
........++..|+|||++.. ..++.++|+||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 011122346778999998865 3578999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=228.85 Aligned_cols=178 Identities=22% Similarity=0.309 Sum_probs=139.1
Q ss_pred cccccc--CceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----------
Q 041433 287 NKLGAG--GFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 287 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---------- 351 (470)
..||+| +||+||+++. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 8999999995 579999999986542 2334678899999999999999999988754321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc--
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-- 419 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-- 419 (470)
....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+++.||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 1234788888899999999999999987 9999999999999999999999998654321111100
Q ss_pred ---cccccccccCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 ---NTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......++..|++||++.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 01112245679999998763 4789999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-28 Score=219.05 Aligned_cols=176 Identities=27% Similarity=0.338 Sum_probs=144.2
Q ss_pred hhcCCCcc-ccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----
Q 041433 279 ATNKFSTD-NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 279 ~~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----- 350 (470)
.+++|++. ++||-|-.|.|..+. ..+++++|+|++... ....+|+++--.. .|||||.+++++...-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566654 579999999999998 457999999998433 3457788765554 5999999998875421
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCC
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGM 408 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~ 408 (470)
.....+++.++..|++||..|+.|||+.+ |.||||||+|+|... |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 23456899999999999999999999998 999999999999954 45789999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
++.-.. .......+-|+.|.|||++-..+|+...|+||+||++|-||.|-+||=
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 986432 223344677999999999988899999999999999999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=207.10 Aligned_cols=180 Identities=21% Similarity=0.380 Sum_probs=148.9
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPEK----- 352 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~----- 352 (470)
.++|++.+++|+|.++.||.|. ..++++++||+++.-. .+.+.+|+++|..|. ||||+++++...+...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999999 5678999999996543 467899999999998 99999999987664432
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCceeccCCCCcc
Q 041433 353 ------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 353 ------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~ 419 (470)
...|+...+...+.++++||.|+|+.| |+|||+||.|++||.. ..++|+|||++..+.....
T Consensus 114 FE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-- 188 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 188 (338)
T ss_pred hhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce--
Confidence 233555666778999999999999998 9999999999999865 4799999999988754433
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||-...
T Consensus 189 -YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 189 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred -eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 223345678899998865 568889999999999999999999986544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=224.21 Aligned_cols=181 Identities=31% Similarity=0.418 Sum_probs=146.2
Q ss_pred CCCccccccccCceeEEEEEc----CCCcEEEEEEccCcC----ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC--
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-- 350 (470)
+|++.+.||+|++|.||+++. .+++.||||.+++.. ....+.+.+|++++.++ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999873 357889999986432 22345688999999999 5999999986543321
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.....++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 12356788889999999999999999987 99999999999999999999999999876543
Q ss_pred CCCcccccccccccCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... ......++..|++||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 2211 122345788999999887654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.40 Aligned_cols=179 Identities=28% Similarity=0.371 Sum_probs=146.0
Q ss_pred CCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC--------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~-------- 351 (470)
|++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+++++ |+||+++++++.....
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567899999999999999964 588999999865432 22334567999999999 9999999877644321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 1246799999999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....++..|+|||.+. ...++.++|+||||+++|||++|++||...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 12245788999999875 446789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=233.87 Aligned_cols=177 Identities=27% Similarity=0.446 Sum_probs=149.2
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCcc--------CHHHHHHHHHHHhcCC---CCCccceeeEeee
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQ--------GAEEFKNEVVVVAKLQ---HRNLVRLLGFCLE 348 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 348 (470)
.+|...+.+|+|+||.|+++.++ +..+|+||.+.+...- ..-.+-.||+||..++ |+||+++++++.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999954 5778999998765321 1112446999999997 9999999999877
Q ss_pred CC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 349 DP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 349 ~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
+. +....+++.++..|++|++.|+++||+++ |||||||-+||.++.+|-+||+|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 54 23567889999999999999999999998 999999999999999999999999998
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~ 464 (470)
..... ......+||..|.|||++.+.+|- ..-|||++|++||.++..+-||
T Consensus 718 a~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 718 AYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 76432 234457899999999999888774 5589999999999999988887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=233.85 Aligned_cols=179 Identities=27% Similarity=0.371 Sum_probs=145.2
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPEK---- 352 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~---- 352 (470)
.+..|.+...+|.|+|+.|-.+. ..+++..++|++.+... +-.+|+.++... +||||+++.+.+.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35678888899999999999988 56789999999976622 234566555554 699999999888765421
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-CCCCceEEeecCCceeccCCCCc
Q 041433 353 -------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL-DAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 353 -------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.......++..|+.+|+.++.|||+++ |+||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 112222566779999999999999988 9999999999999 68999999999999876433
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
....+-|..|.|||++....|+.++||||||++||+||+|+.||.....
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 2233567899999999999999999999999999999999999986543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=215.37 Aligned_cols=174 Identities=33% Similarity=0.441 Sum_probs=145.2
Q ss_pred ccccCceeEEEEEcC-CCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------------
Q 041433 289 LGAGGFGEVYKGVLP-SGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------- 350 (470)
Q Consensus 289 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------------- 350 (470)
||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++|+||+++++.+....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 589999999876533 24557889999999999999999886654322
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccccccc
Q 041433 351 ----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 351 ----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
.....+++.....++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence 12336889999999999999999999987 9999999999999999999999999998654321 11233467
Q ss_pred ccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 427 t~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..|++||...+...+.++|+||||+++|||++|+.||...
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 88999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=215.96 Aligned_cols=179 Identities=27% Similarity=0.395 Sum_probs=142.2
Q ss_pred CCCccccccccCceeEEEEEcC-CCcEEEEEEccCc-----CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS-----SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+|.+.++||+|+||.||+++.. .+..+++|+++.. ......++.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999853 3455666655432 1223345678999999999999999887654321
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++.++..++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 12356889999999999999999999987 999999999999975 569999999987653
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 12234578899999998888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=240.77 Aligned_cols=127 Identities=30% Similarity=0.390 Sum_probs=108.4
Q ss_pred cCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|.+.++||+|+||.||+|... +++.||||+++.... .....+.+|+.+++.++||||+++++.+....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999954 689999999865432 22467889999999999999999987664422
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
.....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 12345788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=218.74 Aligned_cols=193 Identities=23% Similarity=0.355 Sum_probs=158.6
Q ss_pred hHHHHHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceee
Q 041433 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~ 344 (470)
...++.+...+++....+-+|.||.||+|.+. +.+.|-+|.++.. +......+..|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 44567777888999999999999999999643 3456778877543 4555677889999999999999999999
Q ss_pred EeeeCCC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 041433 345 FCLEDPE---------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA 397 (470)
Q Consensus 345 ~~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 397 (470)
++.++.. ....+...+...++.|++.|++|||+++ |||.||..+|.+|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 9877542 1234566777889999999999999998 999999999999999
Q ss_pred CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 398 EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 398 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..++||+|=.+++.+-..+.............||+||.+.+..|+.++|+|||||+||||+| |+.|+.-.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999987655544443333334568999999999999999999999999999998 88898643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=227.34 Aligned_cols=183 Identities=24% Similarity=0.339 Sum_probs=132.2
Q ss_pred hhcCCCccccccccCceeEEEEEc-----------------CCCcEEEEEEccCcCccCHHH--------------HHHH
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-----------------PSGREIAVKRLSKSSGQGAEE--------------FKNE 327 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 327 (470)
..++|++.++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 235689999986543322222 3447
Q ss_pred HHHHhcCCCCCc-----cceeeEeeeCC--------------------------------------------------CC
Q 041433 328 VVVVAKLQHRNL-----VRLLGFCLEDP--------------------------------------------------EK 352 (470)
Q Consensus 328 i~~l~~l~h~ni-----v~l~~~~~~~~--------------------------------------------------~~ 352 (470)
+.++.+++|.++ +++++++.... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777877654 45555443210 00
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccc
Q 041433 353 QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432 (470)
Q Consensus 353 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 432 (470)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++..+...... ......+++.|++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123467778899999999999999987 999999999999999999999999999765332211 1111234789999
Q ss_pred ccccccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCC
Q 041433 433 PEYAMHGQF----------------------SVKSDVYSFGVLVLEIITGKK-NSS 465 (470)
Q Consensus 433 PE~~~~~~~----------------------~~~~Dv~SlG~vl~elltG~~-P~~ 465 (470)
||.+..... ..+.||||+||+++||++|.. ||.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 124699999999999999985 664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=229.22 Aligned_cols=190 Identities=27% Similarity=0.475 Sum_probs=160.1
Q ss_pred hhhHHHHHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 270 QFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
..+++.+...++-|.+.+.||.|.+|.||+++ .++++.+|+|++..... ..++++.|.++|+.+ .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34556666778889999999999999999999 56899999999865543 346678889999888 5999999999875
Q ss_pred eCC-------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 348 EDP-------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 348 ~~~-------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
... .....++|+.+..|+..++.||.+||.+. ++|||||-.|||++.++.+|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 422 23677899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
|.|||.+..+... ........||+.|||||++.- ..|+..+|+||||++..||--|.+|+-
T Consensus 164 LvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 164 LVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred Eeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 9999999876533 334455689999999998843 357788999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=202.60 Aligned_cols=180 Identities=34% Similarity=0.505 Sum_probs=150.3
Q ss_pred CCccccccccCceeEEEEEcC-CCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--------- 351 (470)
|.+.+.||+|++|.||++... +++.+++|.+...... ..+.+.+|++.+++++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 566789999999999999965 4899999999766544 56788999999999999999999987654321
Q ss_pred ---------CCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ---------KQGQ-LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ---------~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.... +++.....++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 1223 788899999999999999999987 99999999999999999999999999987654321 112
Q ss_pred cccccccCccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234567789999988 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=208.11 Aligned_cols=162 Identities=23% Similarity=0.241 Sum_probs=131.8
Q ss_pred cCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------------------CC
Q 041433 292 GGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------------EK 352 (470)
Q Consensus 292 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------------------~~ 352 (470)
|.+|.||+++. .+++.||+|++.... .+.+|...+....||||+++++++.+.. ..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999994 578999999986543 2344555666677999999987655432 12
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccc
Q 041433 353 QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432 (470)
Q Consensus 353 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 432 (470)
...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+..+... .....++..|+|
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 235888999999999999999999987 999999999999999999999999987654322 112345677999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 433 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 433 PE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||.+.+..++.++|+||+|+++|||++|+.|+..
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999888899999999999999999999988654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=234.88 Aligned_cols=189 Identities=32% Similarity=0.456 Sum_probs=151.3
Q ss_pred HHHHhhcCCCccccccccCceeEEEEEcC----C----CcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceee
Q 041433 275 AIKVATNKFSTDNKLGAGGFGEVYKGVLP----S----GREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLG 344 (470)
Q Consensus 275 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~ 344 (470)
.++...++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45566666777789999999999999832 1 4579999987553 34567899999999998 5999999999
Q ss_pred EeeeCC-------------------CCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 041433 345 FCLEDP-------------------EKQ---------------GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKV 390 (470)
Q Consensus 345 ~~~~~~-------------------~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 390 (470)
.+.... ... ..+.....+.++.||+.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 876622 011 23888999999999999999999987 99999999
Q ss_pred CCeeeCCCCceEEeecCCceeccCCCCcccc-cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 391 SNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 391 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
+|||+.++..+||+|||+++........... ....-...|||||.+....|+.++|||||||+||||+| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999964433222111 11002346999999999999999999999999999998 8888874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=214.13 Aligned_cols=182 Identities=25% Similarity=0.314 Sum_probs=145.4
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCC--CC----ccceeeEeee--
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH--RN----LVRLLGFCLE-- 348 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~n----iv~l~~~~~~-- 348 (470)
..+++|.+...+|+|.||.|-.+.. ..+..||||+++.-. .-.+.-.-|+++|.++.+ |+ +|.+.+|+.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3478999999999999999999984 457899999996443 233455679999999932 22 3444333211
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------------
Q 041433 349 -----------------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-------------- 397 (470)
Q Consensus 349 -----------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------------- 397 (470)
..+...+++..++..|..|+++++.+||+.. ++|.||||+|||+-+
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 1235667889999999999999999999988 999999999999921
Q ss_pred ------CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 398 ------EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 398 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+..+||+|||.+...... ...++.|..|.|||++.+-.++..+||||+||||.||.||..-|....
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 335899999999864322 245678999999999999999999999999999999999999887654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=227.08 Aligned_cols=179 Identities=25% Similarity=0.294 Sum_probs=118.5
Q ss_pred hhcCCCccccccccCceeEEEEEc-CC----CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCc--------------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PS----GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL-------------- 339 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-------------- 339 (470)
..++|++.++||+|+||.||+|+. .+ +..||+|++...... +.+.+|. +....+.++
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNER--VRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHH--HHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999995 34 789999987543221 1111110 111111111
Q ss_pred -----cceeeEeeeCC------C-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 041433 340 -----VRLLGFCLEDP------E-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLK 389 (470)
Q Consensus 340 -----v~l~~~~~~~~------~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 389 (470)
.-++.+..... . ......+..+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 11111110000 0 0011123345679999999999999987 9999999
Q ss_pred CCCeeeCC-CCceEEeecCCceeccCCCCcccccccccccCcccccccccC----------------------CCCchhh
Q 041433 390 VSNILLDA-EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG----------------------QFSVKSD 446 (470)
Q Consensus 390 p~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 446 (470)
|+|||++. ++.+||+|||+++.+..... .......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57999999999986543222 122345688999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q 041433 447 VYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 447 v~SlG~vl~elltG~~P~~ 465 (470)
||||||+||||+++..|+.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999876654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=198.40 Aligned_cols=168 Identities=34% Similarity=0.526 Sum_probs=142.4
Q ss_pred CceeEEEEEcC-CCcEEEEEEccCcCccC-HHHHHHHHHHHhcCCCCCccceeeEeeeCCC------------------C
Q 041433 293 GFGEVYKGVLP-SGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------------------K 352 (470)
Q Consensus 293 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------------------~ 352 (470)
+||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+||+++++.+..... .
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999964 58999999997665544 6889999999999999999999887654320 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccc
Q 041433 353 QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432 (470)
Q Consensus 353 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 432 (470)
...+++.....++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 122788999999999999999999987 9999999999999999999999999998764332 2223457788999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 433 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 433 PE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999888899999999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=226.17 Aligned_cols=178 Identities=31% Similarity=0.458 Sum_probs=138.6
Q ss_pred CCccccccccCce-eEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC----------
Q 041433 283 FSTDNKLGAGGFG-EVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 283 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~---------- 350 (470)
|.-.+.+|.|+.| .||+|.. +++.||||++-... .+-..+|+..|+.- +|||||++++.-.++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4556778999987 5799998 78999999984332 34457899999887 5999999986533321
Q ss_pred -------CCC-CCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEEeecCCceeccC
Q 041433 351 -------EKQ-GQL---DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-----EMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 -------~~~-~~l---~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~DfG~a~~~~~ 414 (470)
+.. ..+ .-...+.+..|+++||++||+.+ ||||||||.||||+. ...++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 010 001 11334678999999999999987 999999999999965 24789999999998865
Q ss_pred CCCc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 041433 415 DQTQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSSFY 467 (470)
Q Consensus 415 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG-~~P~~~~ 467 (470)
.... .......||-+|+|||++....-+..+||||||||+|+.++| +.||+-.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 4432 234556799999999999988888899999999999999997 8999753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=194.65 Aligned_cols=178 Identities=28% Similarity=0.372 Sum_probs=145.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.+|.-.+.+|.|.- .|-.+.. -.++.||+|++... .....++..+|..++..++|+||++++.++.-...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777788999988 5655552 36899999987543 34456677899999999999999999988754321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....++-+....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+++.-...
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc-
Confidence 1234566777889999999999999998 999999999999999999999999999864332
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
...+....|..|.|||++.+-.+...+||||+||++.||++|+--|.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 23445677889999999998889999999999999999999987665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=193.01 Aligned_cols=177 Identities=22% Similarity=0.419 Sum_probs=136.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeee---------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE--------- 348 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~--------- 348 (470)
.+.|.+.+.||+|.||.+-++.. ++...+++|.+.... ....+|.+|...--.| .|.||+.-+++..+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 46789999999999999999995 567899999986543 3457788888765555 48999876543211
Q ss_pred ---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-C-CCCceEEeecCCceeccCCCC
Q 041433 349 ---------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL-D-AEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 349 ---------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-~-~~~~~kl~DfG~a~~~~~~~~ 417 (470)
..-....+.+....+++.|+++||.|||+++ +||||||.+|||| + +..++||+|||+.+..+....
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 1112345778888999999999999999998 9999999999999 3 344899999999986442211
Q ss_pred cccccccccccCccccccccc---C--CCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH---G--QFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
...-+..|.+||.... + ...+.+|+|.||++++.+|||+.||.
T Consensus 179 -----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 179 -----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred -----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 1223567999997642 2 35688999999999999999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=193.50 Aligned_cols=112 Identities=27% Similarity=0.401 Sum_probs=93.1
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-----C---CCccceeeEeeeCC-
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-----H---RNLVRLLGFCLEDP- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~~~~- 350 (470)
.+|.+.++||.|.|++||++. ..+.+.||+|+.+.. ..-.+....||++|++++ | .+||+|++.+....
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 789999999999999999999 457889999998543 333456678999999984 2 36999998775432
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 041433 351 ----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 351 ----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 395 (470)
.....++...+.+|++||+.||.|||... +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 23566888899999999999999999976 79999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=201.83 Aligned_cols=183 Identities=20% Similarity=0.254 Sum_probs=141.9
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC------CCCccceeeEeeeC
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ------HRNLVRLLGFCLED 349 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~~~~~~~ 349 (470)
+....+|.+....|+|-|++|.+|.. ..|..||||++.+..... +.=+.|+++|++|+ .-|.++|+..+...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 45568899999999999999999995 457899999997653321 23356888888884 23455554332221
Q ss_pred C--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCC
Q 041433 350 P--------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGM 408 (470)
Q Consensus 350 ~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~ 408 (470)
. .....|....+..++.|+..||..|-..+ |+|.||||.|||+++.. .+||+|||.
T Consensus 507 nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 1 23445667778889999999999999887 99999999999998654 689999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
|.......... ..-+..|.|||++.+.+|+...|+||+||.||||.||+.-|...
T Consensus 584 A~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 584 ASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 98765433221 22355799999999999999999999999999999999888653
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=161.95 Aligned_cols=101 Identities=41% Similarity=0.735 Sum_probs=77.3
Q ss_pred eEEec---ccCc-CchhhHHHHHHHHHHHHHHHHhcc-CCceEeeeeccCCCccEEEEeeccCCCChhhHHHHHHHHHhh
Q 041433 83 VSLLN---TENV-TDQGRFNELVGTQMSQAVTQAVNN-TKRFATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIAR 157 (470)
Q Consensus 83 ~~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~~a~~~~~~~~~~~vy~l~QC~~dls~~~C~~Cl~~~~~~ 157 (470)
|..|+ .+++ ++...|..++++||..|...|+.+ +.+|++++. ..+.++||||+||++||++++|..||+.|+..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 45676 3344 455669999999999999998865 479999986 55778999999999999999999999999999
Q ss_pred cccccCCCCCCeEeccccccccccccc
Q 041433 158 LPICCSGKQGGRVLTPSCNVWYELYPF 184 (470)
Q Consensus 158 ~~~~~~~~~~~~~~~~~C~lr~~~~~F 184 (470)
++.+|+.+.||++++++|++||+.++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=190.55 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=150.1
Q ss_pred hHHHHHHhhcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEe
Q 041433 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFC 346 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 346 (470)
..+.+....+.|..+++||+|.|++||++.+. ..+.||+|.+...+. ...+.+|+++|..+. +.||+++.++.
T Consensus 27 l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 27 LRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred HHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhh
Confidence 34445566778999999999999999999842 478999999865543 356889999999996 88999988765
Q ss_pred eeCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCce
Q 041433 347 LEDPE---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAK 410 (470)
Q Consensus 347 ~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~ 410 (470)
..... -...++..++..++..++.||.++|.+| ||||||||+|+|.+. .+.-.|.|||++.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 44331 1345678888899999999999999998 999999999999964 4578999999997
Q ss_pred eccCCC-------------Cc-----------------------------ccccccccccCccccccccc-CCCCchhhH
Q 041433 411 IFGVDQ-------------TQ-----------------------------GNTSRIAGTYGYMAPEYAMH-GQFSVKSDV 447 (470)
Q Consensus 411 ~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 447 (470)
...... .. ...-...||++|.|||++.. ...+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 211000 00 00012359999999999876 456889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCC
Q 041433 448 YSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 448 ~SlG~vl~elltG~~P~~~~~~ 469 (470)
||.|||++-+++++.||--..+
T Consensus 262 ws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred eeccceeehhhccccccccCcc
Confidence 9999999999999999865544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-23 Score=205.29 Aligned_cols=180 Identities=27% Similarity=0.440 Sum_probs=153.8
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
..++|.....+|.|.||.||+++ ..+++..|+|+++........-+++|+-+++..+||||+.++|-+....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45678899999999999999999 4579999999998887777888899999999999999999987554322
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.-.+.+++.++..+.+..++||.|||+++ -+|||||-.|||+++.+.+||+|||.+-.+.... .
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati--~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A 167 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--h
Confidence 23567899999999999999999999998 8999999999999999999999999987654322 2
Q ss_pred cccccccccCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCC
Q 041433 420 NTSRIAGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKN 463 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~vl~elltG~~P 463 (470)
....+.||+.|||||+. ..+.|.+++|||++|+...|+---++|
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 34457899999999976 456899999999999999998766655
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=172.85 Aligned_cols=164 Identities=40% Similarity=0.672 Sum_probs=135.6
Q ss_pred ccccCceeEEEEEcC-CCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------C------
Q 041433 289 LGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------E------ 351 (470)
Q Consensus 289 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------~------ 351 (470)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|+++++++++..... .
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999964 4899999998755432 3567899999999999999999998765521 0
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCceeccCCCCccccccccc
Q 041433 352 ----KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAKIFGVDQTQGNTSRIAG 426 (470)
Q Consensus 352 ----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 426 (470)
....+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 1136888999999999999999999987 999999999999999 89999999999986543321 1222456
Q ss_pred ccCcccccccccC-CCCchhhHHHHHHHHHHH
Q 041433 427 TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEI 457 (470)
Q Consensus 427 t~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~el 457 (470)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 7789999988776 788999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=176.38 Aligned_cols=182 Identities=23% Similarity=0.327 Sum_probs=149.0
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-------- 350 (470)
-+|++.++||+|.||.++.|+ +-+++.||||.-...+ ...++..|.+..+.|. .+.|...+-+-.+..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468999999999999999999 5689999999865443 3356777888887775 577777665544422
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----CceEEeecCCceeccCC
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-----MNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~DfG~a~~~~~~ 415 (470)
.-...++.+....++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+++.+...
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 12566888999999999999999999998 9999999999999543 35899999999987655
Q ss_pred CCccc-----ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGN-----TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+... .....||.+||+-....+.+.+.+.|+-|||-++++.|-|..||...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 44322 23467999999999999999999999999999999999999999754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=189.35 Aligned_cols=161 Identities=19% Similarity=0.205 Sum_probs=117.5
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcC--CCcEEEEEEccCc-----CccCHHHHHHHHHHHhcCCCCCccc-eeeEe-
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLP--SGREIAVKRLSKS-----SGQGAEEFKNEVVVVAKLQHRNLVR-LLGFC- 346 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~- 346 (470)
.....++|.+.+.||+|+||+||+|... +++.||||++... .....+.+.+|+++|++++|+|+++ ++++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~ 92 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGK 92 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCC
Confidence 3455688999999999999999999853 5777899986533 1123456899999999999999985 43221
Q ss_pred ---eeCCCCCCCCCH---HHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 347 ---LEDPEKQGQLDW---SRRYKIIGLIARGILYLHEDSRLRIIHRDL-KVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 347 ---~~~~~~~~~l~~---~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
..+......|.. .....++.+++++|.|||+++ |+|||| ||+|||++.++.+||+|||+++.+.......
T Consensus 93 ~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 93 DGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred cEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 000011111211 112568899999999999988 999999 9999999999999999999999765433221
Q ss_pred c------ccccccccCcccccccccC
Q 041433 420 N------TSRIAGTYGYMAPEYAMHG 439 (470)
Q Consensus 420 ~------~~~~~gt~~y~aPE~~~~~ 439 (470)
. .....+++.|++||.+...
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccCChh
Confidence 1 1345678889999988543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=187.76 Aligned_cols=184 Identities=24% Similarity=0.333 Sum_probs=146.7
Q ss_pred CCCccccccccCceeEEEEEcCC--CcEEEEEEccCcCccCHHHHHHHHHHHhcCCC----CCccceeeEee-eCC----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLPS--GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH----RNLVRLLGFCL-EDP---- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~~-~~~---- 350 (470)
+|.+.++||+|+||.||++.... ...+|+|............+..|+.++..+.+ +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999544 35789998766544333367889999888873 57777776653 211
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----CceEEeecCCce
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-----MNPKISDFGMAK 410 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~DfG~a~ 410 (470)
.....++....+.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 12478999999999999999999999998 9999999999999754 469999999998
Q ss_pred --eccCCCCc----c-c-ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 411 --IFGVDQTQ----G-N-TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 411 --~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.+...... . . .....||..|++++...+.+.+.+.|+||++.++.||+.|..||....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 33222211 1 1 223559999999999999999999999999999999999999997543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=171.99 Aligned_cols=184 Identities=23% Similarity=0.323 Sum_probs=145.9
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCC-CCccceeeEeeeCCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH-RNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~----- 351 (470)
..++|.++++||.|+||.+|.|. ..+|++||||.-+.... ..++..|.++...|+| ..|..+..+..+..-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999999 67899999998654432 3456778888888875 344444444333221
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCceeccCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a~~~~~~ 415 (470)
-...++.++.+-++.|++.-++|+|.++ ++||||||+|+|..- ...+.|+|||+++.+...
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 2345777888899999999999999998 999999999999953 346899999999987543
Q ss_pred CCcc-----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQG-----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+.. ......||..|.+-....+.+.+.+.|+-|+|.+|..+.-|..||.-.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 3222 233467999999999888888899999999999999999999999753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=202.51 Aligned_cols=110 Identities=16% Similarity=0.212 Sum_probs=86.6
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-------------------CceEEeecCCceecc
Q 041433 353 QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-------------------MNPKISDFGMAKIFG 413 (470)
Q Consensus 353 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------------~~~kl~DfG~a~~~~ 413 (470)
...+++.+++.++.||++||.|||+++ |+||||||+||||+.. +.+||+|||+++...
T Consensus 74 ~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~ 150 (793)
T PLN00181 74 DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE 150 (793)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence 356899999999999999999999988 9999999999999654 445666666665321
Q ss_pred CCCCc--------------ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 414 VDQTQ--------------GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 414 ~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
..... .......||+.|||||++.+..++.++|||||||+||||++|.+|+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 10000 00011357888999999999999999999999999999999998875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=160.85 Aligned_cols=96 Identities=23% Similarity=0.228 Sum_probs=85.5
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccc
Q 041433 353 QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432 (470)
Q Consensus 353 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 432 (470)
...+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++...... ..||+.|||
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~a 72 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMA 72 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccC
Confidence 346899999999999999999999875 999999999999999 99998654321 257899999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 433 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 433 PE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||++.+..++.++||||||+++|||+||+.||..
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=169.44 Aligned_cols=181 Identities=36% Similarity=0.529 Sum_probs=150.1
Q ss_pred CCccccccccCceeEEEEEcCCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCC-CccceeeEeeeCCC-------
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHR-NLVRLLGFCLEDPE------- 351 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~------- 351 (470)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999975 88999998765433 367899999999999988 79999887744320
Q ss_pred -----------CC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCCC
Q 041433 352 -----------KQ---GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 -----------~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 416 (470)
.. ..+.......++.|++.++.|+|+.+ ++||||||+||+++... .+++.|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 11 26888889999999999999999998 99999999999999988 79999999998654433
Q ss_pred Ccc----cccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 417 TQG----NTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 417 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
... ......++..|++||.+.+ .......|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 2345678999999999887 578899999999999999999999977654
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=145.25 Aligned_cols=68 Identities=43% Similarity=0.940 Sum_probs=56.8
Q ss_pred CCCceeeccCCCCCcEEEEEEccCCCCccchHHHHHHHHHHHhhhCCCCcceeEEccceEEEEccccc
Q 041433 6 SSGFFNATAGQDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECLLRYSDQSF 73 (470)
Q Consensus 6 ~~~f~~~~~g~~~~~v~~~~~C~~d~~~~~c~~c~~~a~~~~~~~c~~~~~~~~~~~~c~~ry~~~~f 73 (470)
+.+|+++.+|.++++||||+||++|+++.+|..||+.|+..+.+.|++.++|+||++.|+|||++++|
T Consensus 39 ~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 39 SKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp -TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred ccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 36899999999999999999999999999999999999999999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.4e-19 Score=159.62 Aligned_cols=162 Identities=13% Similarity=0.135 Sum_probs=119.4
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHH---------HHHHHHHHhcCCCCCccceeeEeee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEE---------FKNEVVVVAKLQHRNLVRLLGFCLE 348 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~h~niv~l~~~~~~ 348 (470)
...++|++.+.||.|+||.||+... ++..+|||.+.......... +++|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 57789999997654333322 6889999999999999998877553
Q ss_pred CCC----------------CCCCCCHHH--HHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 349 DPE----------------KQGQLDWSR--RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 349 ~~~----------------~~~~l~~~~--~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
... .+..+.... ......+++.+|..||+.+ ++||||||+||+++.++ ++|+|||...
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcc
Confidence 221 011111100 0235669999999999998 99999999999999988 9999999886
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHH
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 458 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell 458 (470)
........ ..++....+..++|+|+||+.+..+.
T Consensus 183 ~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 183 CTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 54211110 11344556778999999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=153.29 Aligned_cols=123 Identities=19% Similarity=0.169 Sum_probs=93.3
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCcc--C-------H-----------------HHHHHHHHHHhcCCCCCc
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ--G-------A-----------------EEFKNEVVVVAKLQHRNL 339 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~h~ni 339 (470)
...||+|++|.||+|...+|+.||||+++..... . . ....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998654211 1 1 122359999999977665
Q ss_pred ccee-----------eEeeeCC-----CCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 340 VRLL-----------GFCLEDP-----EKQGQLDWSRRYKIIGLIARGILYL-HEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 340 v~l~-----------~~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
.... +++.... .....+++.+...++.|++.+|.+| |+.+ |+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEE
Confidence 3311 1221110 1235678889999999999999999 6877 99999999999998 47899
Q ss_pred EeecCCceec
Q 041433 403 ISDFGMAKIF 412 (470)
Q Consensus 403 l~DfG~a~~~ 412 (470)
|+|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=149.93 Aligned_cols=124 Identities=21% Similarity=0.222 Sum_probs=96.2
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCcc---------------------C-----HHHHHHHHHHHhcCCCCCc
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ---------------------G-----AEEFKNEVVVVAKLQHRNL 339 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~h~ni 339 (470)
.+.||+|++|.||+|...+|+.||||+++..... . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999778999999998754211 0 1123578999999998887
Q ss_pred cce-----------eeEeeeCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceE
Q 041433 340 VRL-----------LGFCLEDP-----EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 340 v~l-----------~~~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
... ++++.... .....++..+...++.|++.++.+||+ .+ |+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEE
Confidence 432 12221110 123456778889999999999999999 77 99999999999998 78999
Q ss_pred EeecCCceecc
Q 041433 403 ISDFGMAKIFG 413 (470)
Q Consensus 403 l~DfG~a~~~~ 413 (470)
|+|||++..+.
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=146.19 Aligned_cols=179 Identities=17% Similarity=0.127 Sum_probs=125.1
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCcc----CHHHHHHHHHHHhcCC-CCCccceeeEe---ee-CCCCCC
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ----GAEEFKNEVVVVAKLQ-HRNLVRLLGFC---LE-DPEKQG 354 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~~~~---~~-~~~~~~ 354 (470)
.+...|++|+||+|+.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++. .. +.....
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 3567899999999998776 6788888877544321 1225789999999995 57788887642 11 111111
Q ss_pred CCCH---HHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCeeeCCCCceEEeecCCceeccCCCCc----cc------
Q 041433 355 QLDW---SRRYKIIGLIARGILYLHEDSRLRIIHRDL-KVSNILLDAEMNPKISDFGMAKIFGVDQTQ----GN------ 420 (470)
Q Consensus 355 ~l~~---~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~DfG~a~~~~~~~~~----~~------ 420 (470)
.|.. .....++.|++.+|.++|+++ |+|||| ||+|||++.++.++|+|||++......... ..
T Consensus 84 ~L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l 160 (218)
T PRK12274 84 AMYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL 160 (218)
T ss_pred cHHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence 1110 122467889999999999998 999999 799999999999999999999864432210 00
Q ss_pred -ccccccccCccccccccc-CCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 -TSRIAGTYGYMAPEYAMH-GQFS-VKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 -~~~~~gt~~y~aPE~~~~-~~~~-~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......++.|++|+...- ...+ ...++++-|.-+|.++|+..|+-.
T Consensus 161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 011225677888874322 1333 567889999999999999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-18 Score=176.58 Aligned_cols=182 Identities=25% Similarity=0.383 Sum_probs=137.8
Q ss_pred CccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCH----HHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 284 STDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGA----EEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~----~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
...+.+|.|.+|.|+... ....+..+.|..... ..... ..+..|+.+-..++|+|++..+...++..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999887776 223344444433210 11111 12556777888899999877543322211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc-
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ- 418 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 418 (470)
.....+...++..+++|++.|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+......
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 11236778888899999999999999998 999999999999999999999999999877654443
Q ss_pred -ccccccccccCcccccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 -GNTSRIAGTYGYMAPEYAMHGQFSV-KSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.....+.|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 4456678999999999999999874 5899999999999999999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-18 Score=170.38 Aligned_cols=168 Identities=30% Similarity=0.352 Sum_probs=133.0
Q ss_pred cccccCceeEEEEE----cCCCcEEEEEEccCcCccC--HHHHHHHHHHHhcCC-CCCccceeeEeeeCCC---------
Q 041433 288 KLGAGGFGEVYKGV----LPSGREIAVKRLSKSSGQG--AEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~--------- 351 (470)
.+|+|.||.|++++ .+.+..+|+|.+++..... ......|..++...+ ||.+|++.-.++.+..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 2457788999886653211 114456788888887 9999998876655431
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 352 ---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
+...+++.........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 2334556666677888999999999988 99999999999999999999999999986532221
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.+||..|||||++. ......|.||||++++||+||-.||..
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17899999999887 567789999999999999999999964
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-17 Score=153.25 Aligned_cols=178 Identities=21% Similarity=0.331 Sum_probs=118.0
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCC-C----------CccceeeEe
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQH-R----------NLVRLLGFC 346 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h-~----------niv~l~~~~ 346 (470)
.+...+.||.|+++.||.++. .+++++|||+.... .....+++++|.-....+.+ . -++.+ +..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEE
Confidence 345668899999999999995 46999999987533 23345677777655555433 1 11111 110
Q ss_pred e-e--------C--------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 041433 347 L-E--------D--------------------------------PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385 (470)
Q Consensus 347 ~-~--------~--------------------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 385 (470)
. . . ......+....++.+..|+++.+++||+.+ ++|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 0 0 0 001122334555677899999999999998 999
Q ss_pred ecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccccccccc--------CCCCchhhHHHHHHHHHHH
Q 041433 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEI 457 (470)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~vl~el 457 (470)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988764322111 223467999996633 2578899999999999999
Q ss_pred HhCCCCCCCCC
Q 041433 458 ITGKKNSSFYQ 468 (470)
Q Consensus 458 ltG~~P~~~~~ 468 (470)
.+|+.||....
T Consensus 244 WC~~lPf~~~~ 254 (288)
T PF14531_consen 244 WCGRLPFGLSS 254 (288)
T ss_dssp HHSS-STCCCG
T ss_pred HHccCCCCCCC
Confidence 99999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.1e-17 Score=173.56 Aligned_cols=181 Identities=21% Similarity=0.250 Sum_probs=136.0
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC---CCCcccee---------
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---HRNLVRLL--------- 343 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~--------- 343 (470)
.++....|.|.+.||+|+||+||+|...+|+.||||+-+....- +|.--.+++.+|+ -+.|+.+.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 44556678899999999999999999777999999997654321 1111122333333 01111111
Q ss_pred ---------eEeeeCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-------CCCceEEeecC
Q 041433 344 ---------GFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-------AEMNPKISDFG 407 (470)
Q Consensus 344 ---------~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-------~~~~~kl~DfG 407 (470)
|-.++-.+....++|.....++.|++..+++||..+ |||+||||+|+||. ++..++|+|||
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 111122246778999999999999999999999998 99999999999993 23468999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~ 462 (470)
.+..+..-.........++|-.+-.+|+..+.+++...|.|.|+.+++-||.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9976654444444556678999999999999999999999999999999999974
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-17 Score=171.85 Aligned_cols=183 Identities=19% Similarity=0.211 Sum_probs=133.1
Q ss_pred CCCccccccccCceeEEEEEcCCCcEEEEEEccCcC-ccCHHHHHHHHHH--HhcCCCCCccceeeEeeeCC--------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS-GQGAEEFKNEVVV--VAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++...+.||.+.|=+|.+++.++|. |+||++-+.. ......|.++++- ...++|||.+++.-+...+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777899999999999999988887 9999886554 4444555443332 55568999998764432211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC-CCccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD-QTQGN 420 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~ 420 (470)
....-+...+..-|+-||+.||..+|..+ |+|+|||.+||||+....+.|+||..-+..-.+ .....
T Consensus 103 vkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 103 VKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 22334566777889999999999999998 999999999999999999999999876532111 11111
Q ss_pred ccccc----cccCcccccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 421 TSRIA----GTYGYMAPEYAMHG----------Q-FSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 421 ~~~~~----gt~~y~aPE~~~~~----------~-~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
..... .-..|+|||.+... . .+++.||||+||++.||++ |++||.+.+
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ 243 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ 243 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence 11111 22369999976431 2 5788999999999999987 688898653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-16 Score=140.66 Aligned_cols=121 Identities=22% Similarity=0.340 Sum_probs=90.0
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-----CCCCccceeeEeeeCCC-------
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-----QHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~~------- 351 (470)
.-.+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ .||||++++|++.++..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 3234444 69988765555567899999999999 57999999988776531
Q ss_pred ---C-------------CCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeecCCCCCeeeCC----CCceEEee-cCCc
Q 041433 352 ---K-------------QGQLDWSRRYKIIGLIARGI-LYLHEDSRLRIIHRDLKVSNILLDA----EMNPKISD-FGMA 409 (470)
Q Consensus 352 ---~-------------~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~D-fG~a 409 (470)
. ...+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+| ||..
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 0 0122333 34577888777 8999998 999999999999964 34799999 5544
Q ss_pred ee
Q 041433 410 KI 411 (470)
Q Consensus 410 ~~ 411 (470)
..
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 43
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-17 Score=161.07 Aligned_cols=96 Identities=34% Similarity=0.553 Sum_probs=80.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC----CcccccccccccCcccc
Q 041433 358 WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ----TQGNTSRIAGTYGYMAP 433 (470)
Q Consensus 358 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aP 433 (470)
+.....++.|++.+++| ++ .+|+|+||.||+...+..+||.|||+........ .....+...||..||+|
T Consensus 358 ~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsP 431 (516)
T KOG1033|consen 358 LSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSP 431 (516)
T ss_pred hhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCH
Confidence 34446788899999999 55 9999999999999999999999999987654333 11233445799999999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHh
Q 041433 434 EYAMHGQFSVKSDVYSFGVLVLEIIT 459 (470)
Q Consensus 434 E~~~~~~~~~~~Dv~SlG~vl~ellt 459 (470)
|.+.+..|+.++||||||+||+||++
T Consensus 432 EQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 432 EQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred HHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-17 Score=169.01 Aligned_cols=166 Identities=24% Similarity=0.358 Sum_probs=121.2
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCCCCCCCCH
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEKQGQLDW 358 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~~~l~~ 358 (470)
..+|..++.|..|+||.||..+++ +.+.+|+|+- +... +.+- ++.....|.+| |-|..-....+.++.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilRn--ilt~a~npfvv---gDc~tllk~~g~lPv 150 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILRN--ILTFAGNPFVV---GDCATLLKNIGPLPV 150 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhhc--cccccCCccee---chhhhhcccCCCCcc
Confidence 367888999999999999999864 4678888542 2211 1111 34444555554 333332222233332
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC-------------cccccccc
Q 041433 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT-------------QGNTSRIA 425 (470)
Q Consensus 359 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~~~~ 425 (470)
. ++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+++....... +......+
T Consensus 151 d--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvc 219 (1205)
T KOG0606|consen 151 D--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVC 219 (1205)
T ss_pred h--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcccc
Confidence 2 278999999988 99999999999999999999999999875321110 01123457
Q ss_pred cccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 426 gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||+.|.|||++....|...+|+|++|+|+||.+.|+.||.-.
T Consensus 220 gTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred CCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 999999999999999999999999999999999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-17 Score=145.87 Aligned_cols=173 Identities=24% Similarity=0.346 Sum_probs=132.4
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----------
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------- 351 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---------- 351 (470)
.+.-+|.+...|..|+|++ .|..+++|++... ......+|..|.-.|+-+.||||+.++|.|.....
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3456788899999999999 5667788887543 33344678999999999999999999998866432
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEe--ecCCceeccCCCCcc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKIS--DFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~--DfG~a~~~~~~~~~~ 419 (470)
..-..+..++.+++.+|++|+.|||+..+ -|.---|.+..++||++.+++|+ |--++-.
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq-------- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------- 342 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee--------
Confidence 23346778899999999999999999862 24445789999999999988774 3222211
Q ss_pred cccccccccCcccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFS---VKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....-.+.||+||.++.++-+ .+.|+|||.+++|||.|.+.||.-.
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 1112346789999999876543 5789999999999999999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.8e-15 Score=134.04 Aligned_cols=137 Identities=19% Similarity=0.208 Sum_probs=98.2
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCcc----------------------CHHHHHHHHHHH
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ----------------------GAEEFKNEVVVV 331 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l 331 (470)
.++......|.+.+.||+|+||.||++..++|+.||||++...... ....+.+|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444458889999999999999999878999999987543210 112356788889
Q ss_pred hcCCCCC--ccceeeEe-----eeCCC--CCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 332 AKLQHRN--LVRLLGFC-----LEDPE--KQGQLDW-SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 332 ~~l~h~n--iv~l~~~~-----~~~~~--~~~~l~~-~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
.++.|++ +++.++.. .+... .-..+.. .....++.+++.++.++|+.+ |+|+||||+||++++++.+
T Consensus 88 ~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 88 KALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred HHHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcE
Confidence 8887774 33333211 11000 0011111 445678999999999999987 9999999999999999999
Q ss_pred EEeecCCceecc
Q 041433 402 KISDFGMAKIFG 413 (470)
Q Consensus 402 kl~DfG~a~~~~ 413 (470)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.3e-15 Score=135.61 Aligned_cols=131 Identities=18% Similarity=0.160 Sum_probs=96.6
Q ss_pred hcCCCccccccccCceeEEEEE--cCCCcEEEEEEccCcCcc------------------------CHHHHHHHHHHHhc
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV--LPSGREIAVKRLSKSSGQ------------------------GAEEFKNEVVVVAK 333 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~ 333 (470)
..-|++.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|+.++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3358899999999999999998 568999999998654210 01235689999999
Q ss_pred CCCCC--ccceeeE---------eeeCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 041433 334 LQHRN--LVRLLGF---------CLEDP-----EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA 397 (470)
Q Consensus 334 l~h~n--iv~l~~~---------~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 397 (470)
+.+.. +.+++++ +.... .....+...+...++.||+.+|.+||+.+ .++|+||||+||+++
T Consensus 107 L~~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~- 183 (237)
T smart00090 107 LYEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH- 183 (237)
T ss_pred HHhcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-
Confidence 97533 3333321 11100 12233455566789999999999999875 499999999999999
Q ss_pred CCceEEeecCCceecc
Q 041433 398 EMNPKISDFGMAKIFG 413 (470)
Q Consensus 398 ~~~~kl~DfG~a~~~~ 413 (470)
++.++|+|||.+....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-14 Score=136.49 Aligned_cols=107 Identities=26% Similarity=0.351 Sum_probs=79.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCC--ceEEeecCCceeccCCCC----cccccccccc
Q 041433 356 LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL--DAEM--NPKISDFGMAKIFGVDQT----QGNTSRIAGT 427 (470)
Q Consensus 356 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~~~gt 427 (470)
.+.....-|+.|+++|+.|||.++ |.|||+|++|||| |+|. .+.|+|||.+---..... ........|.
T Consensus 338 ~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN 414 (598)
T KOG4158|consen 338 RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN 414 (598)
T ss_pred CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence 445556678999999999999998 9999999999999 4444 468999998754222111 1112234567
Q ss_pred cCcccccccccC--C----CCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 428 YGYMAPEYAMHG--Q----FSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 428 ~~y~aPE~~~~~--~----~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
-.-||||+.... + --.|+|.|+.|.+.||+++..-||=
T Consensus 415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 788999987532 1 1268999999999999999998873
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=125.40 Aligned_cols=120 Identities=21% Similarity=0.284 Sum_probs=88.2
Q ss_pred cccccCceeEEEEEcCCCcEEEEEEccCcCcc--------CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ--------GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.||+|++|.||++.+ ++..|++|........ ..+.+.+|++++..++|+++.....+......
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 6788999986433211 12457789999999998875443333322221
Q ss_pred CCCCCCHHHHH---HHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 352 KQGQLDWSRRY---KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 352 ~~~~l~~~~~~---~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
....+...... .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 12222221111 78999999999999988 99999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.4e-14 Score=146.28 Aligned_cols=128 Identities=18% Similarity=0.266 Sum_probs=94.4
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEc-cCcCc-------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRL-SKSSG-------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
...|...++||+|+||.||++.+... .+++|+. .+... ...+.+.+|++++++++|++++....+......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556789999999999999997443 4444432 22111 123467899999999999998876655544221
Q ss_pred --------CCCCCCHH--HHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 352 --------KQGQLDWS--RRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 352 --------~~~~l~~~--~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
....+... ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 12223222 35678999999999999988 9999999999999 6788999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-13 Score=125.70 Aligned_cols=120 Identities=21% Similarity=0.277 Sum_probs=91.4
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCcc--------CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ--------GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|+++.....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999997 7788999986543221 12357789999999999988765554333221
Q ss_pred -CCCCCCH------HHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 352 -KQGQLDW------SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 352 -~~~~l~~------~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
....+.. .++..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 1111110 145689999999999999988 99999999999999 78899999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.2e-14 Score=124.39 Aligned_cols=123 Identities=20% Similarity=0.218 Sum_probs=84.6
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCcc--CHHH----------------------HHHHHHHHhcCCCCC--c
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ--GAEE----------------------FKNEVVVVAKLQHRN--L 339 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~h~n--i 339 (470)
.+.||+|+||.||++...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999988653221 1111 134555665554332 2
Q ss_pred cceee---------EeeeCCCCCCCC---CH-HHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 340 VRLLG---------FCLEDPEKQGQL---DW-SRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 340 v~l~~---------~~~~~~~~~~~l---~~-~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
.+.++ +..........+ .. .+...++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEE
Confidence 32222 111100000111 11 5677899999999999998 76 99999999999999 88999999
Q ss_pred cCCceec
Q 041433 406 FGMAKIF 412 (470)
Q Consensus 406 fG~a~~~ 412 (470)
||.+...
T Consensus 158 fg~a~~~ 164 (187)
T cd05119 158 VPQAVEI 164 (187)
T ss_pred Ccccccc
Confidence 9999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-12 Score=112.27 Aligned_cols=124 Identities=20% Similarity=0.165 Sum_probs=98.0
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCC--CCccceeeEeeeCC--------CCCC
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH--RNLVRLLGFCLEDP--------EKQG 354 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--------~~~~ 354 (470)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++.+..... ....
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999744 7899999865443 5678899999999976 47888776554321 1111
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 355 ---QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 355 ---~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.++......++.+++++|.+||.....+++|+||+|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 124577788999999999999986545699999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-14 Score=149.24 Aligned_cols=187 Identities=25% Similarity=0.357 Sum_probs=144.7
Q ss_pred hcCCCccccccccCceeEEEEEc--CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL--PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~---- 350 (470)
...|.+.+.||+|.|+.|-.... .....+|+|.+.... ....+....|..+-+.+. |+|++.+++......
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35677788899999999988874 334567777765443 333344556888888887 999999987543321
Q ss_pred ---------------CCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceec
Q 041433 351 ---------------EKQG-QLDWSRRYKIIGLIARGILYLH-EDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIF 412 (470)
Q Consensus 351 ---------------~~~~-~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~ 412 (470)
.... .++....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||++..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 1111 4555666788999999999999 777 99999999999999999 9999999999887
Q ss_pred cC-CCCccccccccc-ccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 041433 413 GV-DQTQGNTSRIAG-TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQT 469 (470)
Q Consensus 413 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~~~ 469 (470)
.. ...........| ++.|+|||...+. ...+..|+||.|+++.-|++|..||.....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 65 344444445667 9999999988874 446789999999999999999999987653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=134.14 Aligned_cols=135 Identities=28% Similarity=0.463 Sum_probs=105.9
Q ss_pred HhcCCCCCccceeeEeeeCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 041433 331 VAKLQHRNLVRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVS 391 (470)
Q Consensus 331 l~~l~h~niv~l~~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 391 (470)
|+.+.|.|+.+++|.+.+... ....++|.-...++++|+.||.|||... -..|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 457889999999998877542 3556788888999999999999999865 2399999999
Q ss_pred CeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccC-------CCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 392 NILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 392 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
|.+++....+||+|||+.....................|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765321111111112234579999988653 1467899999999999999999999
Q ss_pred CCC
Q 041433 465 SFY 467 (470)
Q Consensus 465 ~~~ 467 (470)
...
T Consensus 159 ~~~ 161 (484)
T KOG1023|consen 159 DLR 161 (484)
T ss_pred ccc
Confidence 864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.2e-12 Score=117.18 Aligned_cols=122 Identities=21% Similarity=0.224 Sum_probs=86.9
Q ss_pred cccc-ccCceeEEEEEcCCCcEEEEEEccCcC-------------ccCHHHHHHHHHHHhcCCCCCc--cceeeEeeeCC
Q 041433 287 NKLG-AGGFGEVYKGVLPSGREIAVKRLSKSS-------------GQGAEEFKNEVVVVAKLQHRNL--VRLLGFCLEDP 350 (470)
Q Consensus 287 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~~ 350 (470)
..|| .|+.|+||++.. .+..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5677 888899999887 47789999874321 1223567889999999998875 55554422211
Q ss_pred -------------CCCCCCCHH-----HHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 -------------EKQGQLDWS-----RRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 -------------~~~~~l~~~-----~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.....+... .....+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+|||.+...
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 000111000 01234678999999999998 999999999999999889999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-10 Score=113.29 Aligned_cols=125 Identities=21% Similarity=0.220 Sum_probs=80.5
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCH----------------------------------------HHHH
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGA----------------------------------------EEFK 325 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 325 (470)
.+.||.|++|.||+|++.+|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999998999999999865421100 0133
Q ss_pred HHHHHHhcC----CCCCccceeeEeeeC---------CCCCCCCCHH--------HHHHHHHHHHH-HHHHHHhCCCCCe
Q 041433 326 NEVVVVAKL----QHRNLVRLLGFCLED---------PEKQGQLDWS--------RRYKIIGLIAR-GILYLHEDSRLRI 383 (470)
Q Consensus 326 ~Ei~~l~~l----~h~niv~l~~~~~~~---------~~~~~~l~~~--------~~~~i~~~i~~-~l~~LH~~~~~~i 383 (470)
+|.+.+.++ +|.+-+.+-..+.+. ...+..+... ....++..++. .+..+|..+ +
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g---~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG---F 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---c
Confidence 455444444 222222221111110 0011111111 23456666665 467889887 9
Q ss_pred EeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 384 vH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
+|+|+||.||++++++.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7e-10 Score=111.93 Aligned_cols=153 Identities=17% Similarity=0.229 Sum_probs=111.2
Q ss_pred cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------CCCCCCC-------HHHHHHHHHHH
Q 041433 302 LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------EKQGQLD-------WSRRYKIIGLI 368 (470)
Q Consensus 302 ~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~~~l~-------~~~~~~i~~~i 368 (470)
..++.+|.|...+.......+...+-++.|+.++||||++++....++. ++-.++. .......+.||
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHH
Confidence 4578889998887666544566788899999999999999998776655 2223333 23344568899
Q ss_pred HHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHH
Q 041433 369 ARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVY 448 (470)
Q Consensus 369 ~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 448 (470)
+.||.|||+.+ .++|++|.-..|+++..|..||++|.++........ ......--..|..|+.+.... ...|.|
T Consensus 114 l~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~ 187 (690)
T KOG1243|consen 114 LAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSW 187 (690)
T ss_pred HHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhh
Confidence 99999999765 599999999999999999999999988764322111 011111122466666443322 346999
Q ss_pred HHHHHHHHHHhC
Q 041433 449 SFGVLVLEIITG 460 (470)
Q Consensus 449 SlG~vl~elltG 460 (470)
-||++++|++.|
T Consensus 188 ~Lg~li~el~ng 199 (690)
T KOG1243|consen 188 GLGCLIEELFNG 199 (690)
T ss_pred hHHHHHHHHhCc
Confidence 999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.5e-10 Score=96.88 Aligned_cols=123 Identities=20% Similarity=0.121 Sum_probs=85.7
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCcc-ceeeEeeeC------CCCCCCCCH
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV-RLLGFCLED------PEKQGQLDW 358 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~------~~~~~~l~~ 358 (470)
.+.|+.|..+.||++.. .++.|++|+...... ....+.+|+++++.+.+.+++ +++.+.... .-....+..
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 36789999999999997 478899999755432 223467899999988655544 444332211 011112221
Q ss_pred --HHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 359 --SRRYKIIGLIARGILYLHEDS--RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 359 --~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.....+..+++++|..||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 EDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 122356789999999999876 23369999999999998 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3e-10 Score=113.38 Aligned_cols=181 Identities=25% Similarity=0.326 Sum_probs=134.4
Q ss_pred cCCCccccccc--cCceeEEEEEc---CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC--
Q 041433 281 NKFSTDNKLGA--GGFGEVYKGVL---PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 281 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-- 350 (470)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+...++++ |+|.++....+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677888999 99999999985 36788999984332 2233333356777777774 999998655444322
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCc
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIAR----GILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMA 409 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a 409 (470)
.....++....+....+... ||.++|+.. ++|-|+||.||++..+ ...+++|||+.
T Consensus 194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCccee
Confidence 12233666777777888888 999999988 9999999999999998 88999999999
Q ss_pred eeccCCCCccc---ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 410 KIFGVDQTQGN---TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 410 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
..++....... .....|...|++||.+ .+-++..+|+|++|.++.+..++..+..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence 88765442211 1222567789999955 5677899999999999999988876544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-08 Score=88.66 Aligned_cols=123 Identities=15% Similarity=0.096 Sum_probs=84.8
Q ss_pred cccccccCceeEEEEEcCC-------CcEEEEEEccCcC----------------------ccCHHHHH----HHHHHHh
Q 041433 286 DNKLGAGGFGEVYKGVLPS-------GREIAVKRLSKSS----------------------GQGAEEFK----NEVVVVA 332 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~ 332 (470)
...||.|--+.||.|...+ +..+|||+.+... ....+.+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998542 4799999864320 00122233 7999998
Q ss_pred cCCC--CCccceeeEe-----ee---CC------CCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCCCCCeee
Q 041433 333 KLQH--RNLVRLLGFC-----LE---DP------EKQGQLDWSRRYKIIGLIARGILYL-HEDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 333 ~l~h--~niv~l~~~~-----~~---~~------~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlkp~Nill 395 (470)
++.. -++.+.+++. .+ +. .+...++..+...+..+++.+|..| |..+ ++|+||++.|||+
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~ 158 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLW 158 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 8853 3444444321 11 10 1122344456677889999999998 7877 9999999999999
Q ss_pred CCCCceEEeecCCceec
Q 041433 396 DAEMNPKISDFGMAKIF 412 (470)
Q Consensus 396 ~~~~~~kl~DfG~a~~~ 412 (470)
+ ++.+.|+|||.+...
T Consensus 159 ~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 159 H-DGKVWFIDVSQSVEP 174 (197)
T ss_pred E-CCcEEEEECCCceeC
Confidence 6 467999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.2e-09 Score=105.63 Aligned_cols=131 Identities=15% Similarity=0.181 Sum_probs=77.5
Q ss_pred hcCCCccccccccCceeEEEEEcCC-CcEEEEEEccCcCcc--------------------------C--------HH--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQ--------------------------G--------AE-- 322 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~-- 322 (470)
..+|+. +.||.|++|.||+|++++ |+.||||++++.... . .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999876 999999998654210 0 01
Q ss_pred ----HHHHHHHHHhcC----CCCCccceeeEeee---------CCCCCCCCCHHH--------HHHHHHHHHHH-HHHHH
Q 041433 323 ----EFKNEVVVVAKL----QHRNLVRLLGFCLE---------DPEKQGQLDWSR--------RYKIIGLIARG-ILYLH 376 (470)
Q Consensus 323 ----~~~~Ei~~l~~l----~h~niv~l~~~~~~---------~~~~~~~l~~~~--------~~~i~~~i~~~-l~~LH 376 (470)
++.+|...+.++ .+.+.+.+-.++.+ +...+..++... +..++...+.. +..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 133444444444 23333332222211 111112221100 01233222222 23345
Q ss_pred hCCCCCeEeecCCCCCeeeCCCC----ceEEeecCCceeccC
Q 041433 377 EDSRLRIIHRDLKVSNILLDAEM----NPKISDFGMAKIFGV 414 (470)
Q Consensus 377 ~~~~~~ivH~dlkp~Nill~~~~----~~kl~DfG~a~~~~~ 414 (470)
..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 555 99999999999999888 999999999987643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3e-07 Score=88.33 Aligned_cols=172 Identities=16% Similarity=0.212 Sum_probs=115.7
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCC----------------ccceeeEee
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRN----------------LVRLLGFCL 347 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~n----------------iv~l~~~~~ 347 (470)
..+.||+|+-+.+|-.-. -...+.|++.........+...| |.+. .||- =-+.+|+.+
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 457899999999986442 12235577765443322222222 2221 2332 222244432
Q ss_pred eCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 348 EDP----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 348 ~~~----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
-.. ......+|.-.++.++.++.+..-||+.| .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 211 22345789999999999999999999998 88999999999999999999998654332
Q ss_pred ccCCCCcccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG-KKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG-~~P~~~~ 467 (470)
. .........+|...|.+||... +-.-+...|.|.||++++++|.| +.||+..
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2 1112222346888999999654 23456789999999999999887 9999754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-08 Score=93.76 Aligned_cols=134 Identities=23% Similarity=0.253 Sum_probs=94.4
Q ss_pred HHHHhcCCCCCccceeeEeeeCCC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 041433 328 VVVVAKLQHRNLVRLLGFCLEDPE---------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR 380 (470)
Q Consensus 328 i~~l~~l~h~niv~l~~~~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 380 (470)
..-|-++.|.|||+++.|+.+... .+..+......+|..||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 344555679999998877654321 1234555666789999999999999986
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCceeccCC---CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHH
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD---QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 457 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~el 457 (470)
++|+|+++..+-|++..++-+||.---... .... ..........+.++|.+||.-.....+..+|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 789999999999999999988874321110 0000 000111223456789999977666778899999999999999
Q ss_pred HhCCCC
Q 041433 458 ITGKKN 463 (470)
Q Consensus 458 ltG~~P 463 (470)
..+.--
T Consensus 276 ailEiq 281 (458)
T KOG1266|consen 276 AILEIQ 281 (458)
T ss_pred HHheec
Confidence 877643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.3e-07 Score=84.00 Aligned_cols=124 Identities=19% Similarity=0.315 Sum_probs=92.4
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCC--CccceeeEeeeCC-------------
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHR--NLVRLLGFCLEDP------------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~------------- 350 (470)
+.|+.|..+.||++...+|+.+++|+...... .....+.+|.++++.+++. ++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999976678999999765432 2455788999999999763 3455655543311
Q ss_pred ----CCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 041433 351 ----EKQ---GQLDWSRRYKIIGLIARGILYLHEDS-------------------------------------------- 379 (470)
Q Consensus 351 ----~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 379 (470)
... ..++..+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 000 23667778888999999999998531
Q ss_pred ---------CCCeEeecCCCCCeeeCC--CCceEEeecCCce
Q 041433 380 ---------RLRIIHRDLKVSNILLDA--EMNPKISDFGMAK 410 (470)
Q Consensus 380 ---------~~~ivH~dlkp~Nill~~--~~~~kl~DfG~a~ 410 (470)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235799999999999988 5678999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-08 Score=101.69 Aligned_cols=177 Identities=24% Similarity=0.255 Sum_probs=125.0
Q ss_pred HhhcCCCccccccccCceeEEEEEc--CCCcEEEEEEccCcCccCHHHH--HHHHHHHhcC-CCCCccceeeEeeeCCC-
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL--PSGREIAVKRLSKSSGQGAEEF--KNEVVVVAKL-QHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~h~niv~l~~~~~~~~~- 351 (470)
....+|..+..||.|.|+.|+.... .++..+++|.+.+......+++ ..|+.+...+ .|.+++.....+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4456889999999999999999873 4678899998766543333222 3455555555 37777775433322111
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCceecc
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFG 413 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~~~ 413 (470)
....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||....+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc
Confidence 1234566777889999999999999887 9999999999999886 788999999986432
Q ss_pred CCCCcccccccccccCcc--cccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 041433 414 VDQTQGNTSRIAGTYGYM--APEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~ 462 (470)
-... ......+++ +++.+....+..+.|++|||.-+.|.+++..
T Consensus 419 ~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 FSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred eecc-----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence 1111 112223344 5555556678899999999999999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.4e-07 Score=88.76 Aligned_cols=148 Identities=23% Similarity=0.323 Sum_probs=113.1
Q ss_pred ceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeC-----------------------
Q 041433 294 FGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED----------------------- 349 (470)
Q Consensus 294 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----------------------- 349 (470)
..+.|++. ..+|..|++|+++............-++.++++.|+|+|++.+++...
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45788888 458999999999544444443445678899999999999987655421
Q ss_pred ---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 350 ---------------PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 350 ---------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.......++...|.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 123456778999999999999999999998 88899999999999999999999888776543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 463 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P 463 (470)
+.. |-+.. -++-|.=.||.+++-|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 2456899999999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.5e-06 Score=79.45 Aligned_cols=126 Identities=21% Similarity=0.225 Sum_probs=88.9
Q ss_pred CCccccccccCceeEEEEEcCCCcEEEEEEccCcC-----------------cc-----CHHHHHHHHHHHhcCCCC--C
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS-----------------GQ-----GAEEFKNEVVVVAKLQHR--N 338 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~Ei~~l~~l~h~--n 338 (470)
..+..+||-|--+.||.|..++|.++|||.-+... .. .....++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45778999999999999999999999999643210 00 122357899999999654 5
Q ss_pred ccceeeEeee---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 339 LVRLLGFCLE---------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 339 iv~l~~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
+.+-+++-.. .+.....++.+..-.++..|+.-+.-+-..| |||+|+++=||+++++|.+.++||--+
T Consensus 173 VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 173 VPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccc
Confidence 5555443211 1112222345555566667777666666666 999999999999999999999999766
Q ss_pred ee
Q 041433 410 KI 411 (470)
Q Consensus 410 ~~ 411 (470)
..
T Consensus 250 v~ 251 (304)
T COG0478 250 VP 251 (304)
T ss_pred cc
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.3e-07 Score=78.36 Aligned_cols=113 Identities=28% Similarity=0.327 Sum_probs=71.6
Q ss_pred eEEEEEcCCCcEEEEEEccCcCc---------------------cC-----HHHHHHHHHHHhcCCCC--CccceeeEe-
Q 041433 296 EVYKGVLPSGREIAVKRLSKSSG---------------------QG-----AEEFKNEVVVVAKLQHR--NLVRLLGFC- 346 (470)
Q Consensus 296 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~~-----~~~~~~Ei~~l~~l~h~--niv~l~~~~- 346 (470)
.||.|...+|..+|||+.+.... .. .....+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 48999988999999998643210 00 12356799999999765 455555432
Q ss_pred --------eeCCCCC-----CCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 347 --------LEDPEKQ-----GQLDWSRRYKIIGLIARGILY-LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 347 --------~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.++.... ..++.+....+..+++..+.. +|..+ |+|+||.+.|||++++ .+.|+|||.+...
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 1111101 111123456778888886555 57777 9999999999999887 8999999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.5e-08 Score=102.77 Aligned_cols=188 Identities=20% Similarity=0.253 Sum_probs=120.9
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeE-------
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGF------- 345 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~------- 345 (470)
+...+.+.+.+-+-+|.++.++.+.- ..|...++|...... ....+....+-.++-..+||-++...--
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34556777888889999999988772 234444444332221 1112222222222222334444432211
Q ss_pred -----eee------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 346 -----CLE------DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 346 -----~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
+.. ........+.+-....+..+...+++||... +.|+|++|.|+|+..+++.++.|||.....+.
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 110 0011122444445566777889999999876 89999999999999999999999984332211
Q ss_pred C-------------------------CCc----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 415 D-------------------------QTQ----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 415 ~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
- ... .......+|+.|.+||.+.+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 000 01223568999999999999999999999999999999999999997
Q ss_pred CC
Q 041433 466 FY 467 (470)
Q Consensus 466 ~~ 467 (470)
-.
T Consensus 1037 a~ 1038 (1205)
T KOG0606|consen 1037 AE 1038 (1205)
T ss_pred Cc
Confidence 53
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3e-06 Score=72.96 Aligned_cols=123 Identities=27% Similarity=0.359 Sum_probs=81.4
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEE-ccCcCc-------cCHHHHHHHHHHHhcCCCCCc--cceeeE-------ee
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKR-LSKSSG-------QGAEEFKNEVVVVAKLQHRNL--VRLLGF-------CL 347 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~Ei~~l~~l~h~ni--v~l~~~-------~~ 347 (470)
....|-+|+-+.|+++.+ .|+...||. +.+.-. -...+..+|.++|.+++--.| .+++.. ++
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457788999999999998 678877774 333211 123456789999988753222 222211 11
Q ss_pred e---CC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEeecCCcee
Q 041433 348 E---DP---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKISDFGMAKI 411 (470)
Q Consensus 348 ~---~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~DfG~a~~ 411 (470)
+ .. ........+....+++.|-+.+.-||..+ |+|+||..+||+|..++ .+.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 1 00 00111222223678888999999999998 99999999999996554 358999999865
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.5e-06 Score=72.83 Aligned_cols=120 Identities=22% Similarity=0.277 Sum_probs=78.4
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEE-ccCcCcc-------CHHHHHHHHHHHhcCCCC--CccceeeEeeeCC------
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKR-LSKSSGQ-------GAEEFKNEVVVVAKLQHR--NLVRLLGFCLEDP------ 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~------ 350 (470)
..+++|+-+.++.+.+ -|.++++|. +++.-.. ..+.-.+|.+++.+++-- +...++++.....
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4578999999999976 344566664 3332111 123456789999888633 3333443322211
Q ss_pred CCCCCCC---HHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 EKQGQLD---WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 ~~~~~l~---~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
-....+. +.....++..+-.-+.-||..+ |+|+||.++||++.... +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 0111111 1113467888888889999998 99999999999997665 99999999974
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-07 Score=96.60 Aligned_cols=99 Identities=24% Similarity=0.435 Sum_probs=75.1
Q ss_pred HHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc-------ccccccccccCcccccccc
Q 041433 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ-------GNTSRIAGTYGYMAPEYAM 437 (470)
Q Consensus 365 ~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~ 437 (470)
+.+.+.||.|+|... .+||++|.|++|.++.++.+||..|+++......... ....-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344559999999864 6999999999999999999999999987643321110 0011122356799999999
Q ss_pred cCCCCchhhHHHHHHHHHHHH-hCCCCCC
Q 041433 438 HGQFSVKSDVYSFGVLVLEII-TGKKNSS 465 (470)
Q Consensus 438 ~~~~~~~~Dv~SlG~vl~ell-tG~~P~~ 465 (470)
+...+.++|+||+|+++|.+. .|+.-+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh
Confidence 888889999999999999998 5554443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=74.95 Aligned_cols=114 Identities=17% Similarity=0.157 Sum_probs=76.5
Q ss_pred ceeEEEEEcCCCcEEEEEEccCcCc-----------cCHHHHHHHHHHHhcCCCCCc--cceeeEeee------------
Q 041433 294 FGEVYKGVLPSGREIAVKRLSKSSG-----------QGAEEFKNEVVVVAKLQHRNL--VRLLGFCLE------------ 348 (470)
Q Consensus 294 ~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~------------ 348 (470)
...|.+..+ +|+.+.||....... .....+.+|...+.++...+| ++.+++...
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667666 678999997643321 111247788888888743332 233333211
Q ss_pred -C-CCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-------CCceEEeecC
Q 041433 349 -D-PEK------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-------EMNPKISDFG 407 (470)
Q Consensus 349 -~-~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~kl~DfG 407 (470)
+ ... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 1 000 122344566789999999999999998 999999999999975 4679999999
Q ss_pred Ccee
Q 041433 408 MAKI 411 (470)
Q Consensus 408 ~a~~ 411 (470)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.4e-05 Score=69.91 Aligned_cols=135 Identities=15% Similarity=0.166 Sum_probs=93.1
Q ss_pred HHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCc------CccCHHHHHHHHHHHhcCCCCC--ccceee
Q 041433 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS------SGQGAEEFKNEVVVVAKLQHRN--LVRLLG 344 (470)
Q Consensus 273 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~ 344 (470)
++.+.....++...---|+||-+.|++..+ +|+.+-+|+-... .+.....|.+|+..|.+|...+ +.+...
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf 88 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF 88 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce
Confidence 344444444444333456799999999887 4557999986522 1345678999999999986433 333331
Q ss_pred E------------eeeC-CC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 041433 345 F------------CLED-PE------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399 (470)
Q Consensus 345 ~------------~~~~-~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 399 (470)
. .... .. .....+..++..++.+++..+.-||+.+ +.|+|+.+.|||++.++
T Consensus 89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g 165 (216)
T PRK09902 89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEG 165 (216)
T ss_pred eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCC
Confidence 1 1111 11 1123456667899999999999999998 99999999999998666
Q ss_pred c--eEEeecCCcee
Q 041433 400 N--PKISDFGMAKI 411 (470)
Q Consensus 400 ~--~kl~DfG~a~~ 411 (470)
. ++++||.-++.
T Consensus 166 ~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 KAEAGFLDLEKSRR 179 (216)
T ss_pred CeeEEEEEhhccch
Confidence 6 99999977653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.6e-05 Score=68.55 Aligned_cols=54 Identities=35% Similarity=0.437 Sum_probs=47.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEeecCCceec
Q 041433 356 LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKISDFGMAKIF 412 (470)
Q Consensus 356 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~DfG~a~~~ 412 (470)
++......++.+++..+.-||+.+ |+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 115 ~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 115 LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 445667789999999999999998 99999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00027 Score=64.31 Aligned_cols=139 Identities=19% Similarity=0.215 Sum_probs=89.2
Q ss_pred hHHHHHHhhcCCCccccc---cccCceeEEEEEcCCCcEEEEEEccCcCcc-------------------CHH-----HH
Q 041433 272 DFEAIKVATNKFSTDNKL---GAGGFGEVYKGVLPSGREIAVKRLSKSSGQ-------------------GAE-----EF 324 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~l---g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~~ 324 (470)
..+.+.....+..+.... ..|.-..||+|...++..+|+|++...... ... ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 345555556666665554 456677899999878999999998543111 111 12
Q ss_pred HHHHHHHhcCCCC--Ccc---------ceeeEeeeCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 041433 325 KNEVVVVAKLQHR--NLV---------RLLGFCLEDPE-----KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388 (470)
Q Consensus 325 ~~Ei~~l~~l~h~--niv---------~l~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 388 (470)
.+|..-|+++... .+. -+.++.-++.. +...++.++...+..++++.+.-|-... ++||+||
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDL 193 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDL 193 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--Ccccccc
Confidence 4577777776321 111 12233222221 2223334467777888888888877632 3999999
Q ss_pred CCCCeeeCCCCceEEeecCCceecc
Q 041433 389 KVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 389 kp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
+.=|||+. ++.+.|+|||-+....
T Consensus 194 SEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 194 SEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hhhheEEE-CCeEEEEECccccccC
Confidence 99999999 8889999999987554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=5.5e-05 Score=77.29 Aligned_cols=32 Identities=25% Similarity=0.387 Sum_probs=29.6
Q ss_pred eEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 383 ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
++|.|..|.||+++.++++.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00026 Score=63.62 Aligned_cols=128 Identities=14% Similarity=0.126 Sum_probs=78.7
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHH---------HHHHHHHhcCCCCCc---cceeeE
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEF---------KNEVVVVAKLQHRNL---VRLLGF 345 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~h~ni---v~l~~~ 345 (470)
....+|.+.+.+-......|.+-.. +|+.+++|..+.........| .+++..+.+++...+ ..++-.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888888888888777 678999998765543322222 233443333322211 111100
Q ss_pred --------------eeeCCCCCCCCCH-HH-HHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 346 --------------CLEDPEKQGQLDW-SR-RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 346 --------------~~~~~~~~~~l~~-~~-~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
..+.- .+..+.. .. .-.+...|.+.+.-||+.| +.|+|..|.|+++++++ ++++||+..
T Consensus 107 ~ekk~~~~~~~~~ll~EYI-eG~~l~d~~~i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYI-EGVELNDIEDIDEDLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred eeeeeccceeEEEEEEEEe-cCeecccchhcCHHHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECccc
Confidence 01100 1111111 00 0135566778899999998 99999999999998655 999999876
Q ss_pred ee
Q 041433 410 KI 411 (470)
Q Consensus 410 ~~ 411 (470)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00021 Score=63.63 Aligned_cols=88 Identities=20% Similarity=0.159 Sum_probs=71.0
Q ss_pred HHHHHHHhcCCC-CCccceeeEeee-----CCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 041433 325 KNEVVVVAKLQH-RNLVRLLGFCLE-----DPE------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386 (470)
Q Consensus 325 ~~Ei~~l~~l~h-~niv~l~~~~~~-----~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 386 (470)
.+|.-+++.+++ +++++++|.|-. ... ....-+|..+.+|+.++++.+.+|+......+...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc 86 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC 86 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 458888888986 699999998622 111 11345899999999999999999998654458889
Q ss_pred cCCCCCeeeCCCCceEEeecCCceec
Q 041433 387 DLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 387 dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
|++++|+-+++++++|++|...+...
T Consensus 87 Dv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 87 DVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred ecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=1e-05 Score=81.91 Aligned_cols=171 Identities=19% Similarity=0.137 Sum_probs=115.3
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC-ccceeeEeeeCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN-LVRLLGFCLEDPE------ 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~------ 351 (470)
.+.-+...+-++++++++++|.+--..+....+.+... ....-++++|.+++||| .+..++-+..+.-
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 33444555668899999999988322333345555332 34456889999999999 5544433322110
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+...+...+...-.++|.+||+.. -+|+| ||+..+ ...|+.||+....+....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 0111233344456666778899999864 48888 777755 678999999987664332
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
......+++.|++||+.....+..+.|.|++++--.+|--|-+|-.
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2344678999999999999999999999999986666766666643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00082 Score=61.80 Aligned_cols=118 Identities=19% Similarity=0.186 Sum_probs=72.4
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCc--cceeeEeeeCC---------CCC--
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL--VRLLGFCLEDP---------EKQ-- 353 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~~---------~~~-- 353 (470)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++..... ...
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24567889876433 34557889999988754333 34444332211 000
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------CCCCeEeecCC
Q 041433 354 ----GQLDWSRRYKIIGLIARGILYLHED----------------------------------------SRLRIIHRDLK 389 (470)
Q Consensus 354 ----~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------~~~~ivH~dlk 389 (470)
...+......++.++++.+.-||+. ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 0111222223444444444444421 12347899999
Q ss_pred CCCeeeCCCCceEEeecCCce
Q 041433 390 VSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 390 p~Nill~~~~~~kl~DfG~a~ 410 (470)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0013 Score=56.78 Aligned_cols=122 Identities=19% Similarity=0.176 Sum_probs=78.7
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccc-eeeEeeeCC----CCCCCC-C
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR-LLGFCLEDP----EKQGQL-D 357 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~----~~~~~l-~ 357 (470)
+..+.|++|.+|.||++.+ .|..+|+|+-...+ ....++.|.++|..++..++.+ ++.+-.+.. ....+| +
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~ 101 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhh
Confidence 3457899999999999998 56689999865443 3467889999999998777654 443332211 111122 2
Q ss_pred HHHH--HHHHHHHHHHHHHHHhCCCCCeEeecCC-CCCeeeCCCCceEEeecCCcee
Q 041433 358 WSRR--YKIIGLIARGILYLHEDSRLRIIHRDLK-VSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 358 ~~~~--~~i~~~i~~~l~~LH~~~~~~ivH~dlk-p~Nill~~~~~~kl~DfG~a~~ 411 (470)
+... .+-+..+++.-.-|...+ |-|+.|. |...+|-++..+.|+||..+..
T Consensus 102 ~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 2221 333444555544455555 9999886 4444444555899999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00031 Score=62.41 Aligned_cols=120 Identities=26% Similarity=0.340 Sum_probs=84.3
Q ss_pred cCCCccccccccCc-eeEEEEEcCCCcEEEEEEccC---cCc------------------cCHHHHHHHHHHHhcCC---
Q 041433 281 NKFSTDNKLGAGGF-GEVYKGVLPSGREIAVKRLSK---SSG------------------QGAEEFKNEVVVVAKLQ--- 335 (470)
Q Consensus 281 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 335 (470)
.+++..+.||.|.- |.||++++ +|+.+|+|++.. ... ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56777899999999 99999998 788999999321 100 11235778888877775
Q ss_pred CCCc--cceeeEeeeCCCC-----------CCC------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 041433 336 HRNL--VRLLGFCLEDPEK-----------QGQ------------LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKV 390 (470)
Q Consensus 336 h~ni--v~l~~~~~~~~~~-----------~~~------------l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 390 (470)
+.++ |+.+||..-..++ ... ........-+.+|.+-|..+|..+ |+-+|+++
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~g---I~~~Dv~~ 192 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLG---IVPRDVKP 192 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCC---eeeccCcc
Confidence 4566 8999987544210 000 011123445677888889999888 99999999
Q ss_pred CCeeeCCCCceEEeecCCc
Q 041433 391 SNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 391 ~Nill~~~~~~kl~DfG~a 409 (470)
.|.. .-||+|||.+
T Consensus 193 ~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 193 RNYR-----GGKLVDFSSS 206 (207)
T ss_pred cccc-----CCEEEecccC
Confidence 9975 3589999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00061 Score=62.66 Aligned_cols=56 Identities=21% Similarity=0.290 Sum_probs=40.3
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC--ccceee
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN--LVRLLG 344 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~ 344 (470)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~ 59 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLA 59 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEe
Confidence 3678999999999999866 69999997544 44567788888888885333 445554
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0052 Score=55.02 Aligned_cols=116 Identities=17% Similarity=0.281 Sum_probs=74.6
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEccCcC----------------ccCHHHHHHHHHHHhcCC------CCCccce
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS----------------GQGAEEFKNEVVVVAKLQ------HRNLVRL 342 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~l 342 (470)
....||+|+.-.||.- ++.....||++.... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999864 455667888886554 223456677777666665 7889999
Q ss_pred eeEeeeCCCC----------CCC--CCHHHHH-------HHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--C--
Q 041433 343 LGFCLEDPEK----------QGQ--LDWSRRY-------KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE--M-- 399 (470)
Q Consensus 343 ~~~~~~~~~~----------~~~--l~~~~~~-------~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~-- 399 (470)
+|+..++... .+. .+..+.. .+...+-+-..||-+.+ |+.+||+|.||++... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCce
Confidence 9987764311 111 1111111 23333444456777766 9999999999999432 2
Q ss_pred ceEEee
Q 041433 400 NPKISD 405 (470)
Q Consensus 400 ~~kl~D 405 (470)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0074 Score=55.76 Aligned_cols=49 Identities=10% Similarity=0.084 Sum_probs=33.7
Q ss_pred ccccccCceeEEEEEcCC--CcEEEEEEccCcCccCHHHHHHHHHHHhcCCC
Q 041433 287 NKLGAGGFGEVYKGVLPS--GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH 336 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h 336 (470)
+.|..|-...+|+....+ ++.|++|+....... .....+|+.+++.+..
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~ 54 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSK 54 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHh
Confidence 567778888999998654 678999987543222 1233578888888743
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0076 Score=56.10 Aligned_cols=31 Identities=26% Similarity=0.382 Sum_probs=27.0
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
+.++|+|+.|.|||++++....|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 3489999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0067 Score=56.14 Aligned_cols=31 Identities=26% Similarity=0.365 Sum_probs=26.0
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999998766567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.013 Score=64.68 Aligned_cols=61 Identities=16% Similarity=0.316 Sum_probs=43.3
Q ss_pred cccccccCceeEEEEEcCCC---cEEEEEEccCcC-ccCHHHHHHHHHHHhcCC-CCCc--cceeeEe
Q 041433 286 DNKLGAGGFGEVYKGVLPSG---REIAVKRLSKSS-GQGAEEFKNEVVVVAKLQ-HRNL--VRLLGFC 346 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~ 346 (470)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |.++ .+++.++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~ 110 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLC 110 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEe
Confidence 56789999999999886443 467888765432 233457889999999995 6664 6666554
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0048 Score=57.91 Aligned_cols=29 Identities=21% Similarity=0.298 Sum_probs=25.6
Q ss_pred CeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 382 ~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.++|+|+.|.||++++++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999998877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0051 Score=59.08 Aligned_cols=47 Identities=17% Similarity=0.099 Sum_probs=33.3
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCC
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH 336 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h 336 (470)
.+.|..|....+|+.... +..+++|+... ...+.+..|++++..+.+
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~ 65 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAE 65 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHH
Confidence 456777877899998764 45788898754 234566778888777743
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0058 Score=62.58 Aligned_cols=30 Identities=23% Similarity=0.397 Sum_probs=26.9
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCc
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKS 316 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~ 316 (470)
+.|+.-+.|.||+|++++|+.||||+-++.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~ 196 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPG 196 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcC
Confidence 679999999999999999999999987554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.012 Score=64.35 Aligned_cols=138 Identities=22% Similarity=0.204 Sum_probs=98.4
Q ss_pred HHHHHHHHHhcCCCCCccceeeEeeeCCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 041433 323 EFKNEVVVVAKLQHRNLVRLLGFCLEDPE----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR 380 (470)
Q Consensus 323 ~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 380 (470)
..+.|+..+.++.|+|++.++.|..+... ....++....+.+..++.+||.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 34567888999999999999998877542 2345667777888999999999999985
Q ss_pred CCeEeecCCCC---CeeeCCCCceEEe--ecCCceeccCCCCcccccccccccCcccccccccCCCCc--hhhHHHHHHH
Q 041433 381 LRIIHRDLKVS---NILLDAEMNPKIS--DFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV--KSDVYSFGVL 453 (470)
Q Consensus 381 ~~ivH~dlkp~---Nill~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~SlG~v 453 (470)
..|.-|..+ +--.+.++...++ ||+.++.+...... ........+.+||......+.. ..|+|.+|.+
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 556555554 4455666667766 99888765433221 1122345677888776655544 4799999999
Q ss_pred HHHHHhCCCCCCC
Q 041433 454 VLEIITGKKNSSF 466 (470)
Q Consensus 454 l~elltG~~P~~~ 466 (470)
+..+..|..+-..
T Consensus 382 ~~~~~~~~~i~~~ 394 (1351)
T KOG1035|consen 382 LLQLSQGEDISEK 394 (1351)
T ss_pred HhhhhhcCccccc
Confidence 9999998876543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.029 Score=54.48 Aligned_cols=31 Identities=29% Similarity=0.344 Sum_probs=26.4
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.+++|+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4699999999999998766568999998853
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.041 Score=52.97 Aligned_cols=32 Identities=31% Similarity=0.352 Sum_probs=28.0
Q ss_pred CCCeEeecCCCCCeeeCCC----CceEEeecCCcee
Q 041433 380 RLRIIHRDLKVSNILLDAE----MNPKISDFGMAKI 411 (470)
Q Consensus 380 ~~~ivH~dlkp~Nill~~~----~~~kl~DfG~a~~ 411 (470)
+..++|+|+.+.|||++++ +.++|+||..+..
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 4568999999999999875 7899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.12 Score=49.73 Aligned_cols=61 Identities=8% Similarity=0.017 Sum_probs=41.4
Q ss_pred CCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCC---CCccceeeEe
Q 041433 283 FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH---RNLVRLLGFC 346 (470)
Q Consensus 283 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~ 346 (470)
....+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.|.. -.+.++++.+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~ 79 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVM 79 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEe
Confidence 34456799999999999986555 467777432 1133578889998888753 2456666543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.098 Score=52.15 Aligned_cols=60 Identities=13% Similarity=0.195 Sum_probs=41.8
Q ss_pred cccccccCceeEEEEEcCCC-cEEEEEEccCc------C-ccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 041433 286 DNKLGAGGFGEVYKGVLPSG-REIAVKRLSKS------S-GQGAEEFKNEVVVVAKLQ---HRNLVRLLGF 345 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~Ei~~l~~l~---h~niv~l~~~ 345 (470)
.+.||.|.+..||++...+| +.|+||.-... . +...+++..|.+.|..+. ..++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 35789999999999998766 58999985321 1 234566777888887763 3456666654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.015 Score=55.22 Aligned_cols=138 Identities=17% Similarity=0.176 Sum_probs=85.4
Q ss_pred hhhHHHHHHhhc---CCCccccccccCceeEEEEEcCCCcEEEEEEccCc-----------------CccCH-----HHH
Q 041433 270 QFDFEAIKVATN---KFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS-----------------SGQGA-----EEF 324 (470)
Q Consensus 270 ~~~~~~~~~~~~---~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~~~~-----~~~ 324 (470)
.+++-.++.... -+.+.++||-|--+.||.+...+|++.++|+-+.. ...++ -..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 345555554433 36788999999999999999989999999963211 01111 123
Q ss_pred HHHHHHHhcCCC-C-CccceeeEeee----CCCCCCCCC----HHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 041433 325 KNEVVVVAKLQH-R-NLVRLLGFCLE----DPEKQGQLD----WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394 (470)
Q Consensus 325 ~~Ei~~l~~l~h-~-niv~l~~~~~~----~~~~~~~l~----~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 394 (470)
.+|...|+.|.. . -+.+.+++... +.....+|- ....-.+...++.-+.-|..+| +||+|..-=||+
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 568888887742 1 12233322211 000111110 1112234445555566677777 999999999999
Q ss_pred eCCCCceEEeecCCce
Q 041433 395 LDAEMNPKISDFGMAK 410 (470)
Q Consensus 395 l~~~~~~kl~DfG~a~ 410 (470)
++++..++++||--..
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999996544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.052 Score=53.33 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=26.7
Q ss_pred CCeEeecCCCCCeeeCC-CCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDA-EMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~ 411 (470)
..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 45899999999999976 46899999988864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.085 Score=50.08 Aligned_cols=31 Identities=29% Similarity=0.521 Sum_probs=25.8
Q ss_pred CCeEeecCCCCCeeeCCCCc-eEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMN-PKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~-~kl~DfG~a~~ 411 (470)
+.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.12 Score=49.94 Aligned_cols=31 Identities=32% Similarity=0.412 Sum_probs=27.2
Q ss_pred CCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 380 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
...++|+|+++.||++++++...|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3469999999999999988777899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.072 Score=47.90 Aligned_cols=110 Identities=20% Similarity=0.190 Sum_probs=66.2
Q ss_pred cCceeEEEEEcCCCcEEEEEEccCcCcc-CHHHHHHHHHHHhcCCCCCcccee-------eEeeeCCCCCCCCCHHHHHH
Q 041433 292 GGFGEVYKGVLPSGREIAVKRLSKSSGQ-GAEEFKNEVVVVAKLQHRNLVRLL-------GFCLEDPEKQGQLDWSRRYK 363 (470)
Q Consensus 292 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~-------~~~~~~~~~~~~l~~~~~~~ 363 (470)
++..+.-.++.+-| ...+|++....-. ...-|.++.+++++++. |+++. |+.++.-.+...+. ..
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~NDn~~~yGvIlE~Cy~~~i~~----~N 145 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKNDNNYKYGVILERCYKIKINF----SN 145 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeecCCCceeEEEEeeccCcccch----hH
Confidence 34445545543333 3455555433322 34567788888888753 55553 44444332222221 12
Q ss_pred HHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCc
Q 041433 364 IIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409 (470)
Q Consensus 364 i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a 409 (470)
++..=++.|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+..
T Consensus 146 ~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 146 FITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 2222246777889653 46999999999999999999999997653
|
The function of this family is unknown. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.017 Score=36.38 Aligned_cols=31 Identities=16% Similarity=0.292 Sum_probs=18.6
Q ss_pred cccceEEEEeehhhhHhhhheeeeEEEEeec
Q 041433 217 ISSSTIIAIVAPIVVTAVLFIVGFCFLRRKA 247 (470)
Q Consensus 217 ~~~~~ii~iv~~~vv~~~ll~~~~~~~~~~~ 247 (470)
....+.+++++|++++++++++++++++||+
T Consensus 9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred ceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 3444566677777776666655555555543
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.14 Score=49.73 Aligned_cols=125 Identities=20% Similarity=0.245 Sum_probs=85.6
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEccCcC----------------------ccCHH----HHHHHHHHHhcCCCCC
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS----------------------GQGAE----EFKNEVVVVAKLQHRN 338 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~----~~~~Ei~~l~~l~h~n 338 (470)
+...|..|--..||.+...+|..+|||+++..- ....+ ..+.|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445678899999999998899999999875320 00111 1356888888885333
Q ss_pred c-------cc----eeeEeeeC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 339 L-------VR----LLGFCLED-----PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 339 i-------v~----l~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
| ++ +..++-.+ ..+...++...+..+-.+++.-+.-|.... ++||.||.-=|+|+ .+|.+.
T Consensus 228 IP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~ly 304 (520)
T KOG2270|consen 228 IPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGKLY 304 (520)
T ss_pred CCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCEEE
Confidence 2 22 11111111 134556777777788888888888887665 59999999999998 457899
Q ss_pred EeecCCceec
Q 041433 403 ISDFGMAKIF 412 (470)
Q Consensus 403 l~DfG~a~~~ 412 (470)
|+|-+-+...
T Consensus 305 iIDVSQSVE~ 314 (520)
T KOG2270|consen 305 IIDVSQSVEH 314 (520)
T ss_pred EEEccccccC
Confidence 9998877643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.28 Score=47.92 Aligned_cols=30 Identities=27% Similarity=0.361 Sum_probs=25.7
Q ss_pred CeEeecCCCCCeeeCC-CCceEEeecCCcee
Q 041433 382 RIIHRDLKVSNILLDA-EMNPKISDFGMAKI 411 (470)
Q Consensus 382 ~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~ 411 (470)
-+.|.|+.+.|||+++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999974 57899999988764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.78 Score=45.54 Aligned_cols=60 Identities=13% Similarity=0.143 Sum_probs=39.3
Q ss_pred cccccccCceeEEEEEcCC-CcEEEEEEccC------cCccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 041433 286 DNKLGAGGFGEVYKGVLPS-GREIAVKRLSK------SSGQGAEEFKNEVVVVAKLQ---HRNLVRLLGF 345 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~ 345 (470)
.+.||.|.-..||++...+ ++.|+||.-.. .-+-..++..-|.+.|+.+. -..+.+++.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~ 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE
Confidence 4678999999999999743 57899996421 11334556666777776653 2345556654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.85 Score=44.71 Aligned_cols=59 Identities=19% Similarity=0.191 Sum_probs=37.6
Q ss_pred cccccCceeEEEEEcCCC-cEEEEEEccC-------cCccCHHHHHHHHHHHhcCC--CC-CccceeeEe
Q 041433 288 KLGAGGFGEVYKGVLPSG-REIAVKRLSK-------SSGQGAEEFKNEVVVVAKLQ--HR-NLVRLLGFC 346 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~ 346 (470)
.||.|....||++..+++ +.|+||.-.. .-+...++..-|.+.|+... -| .+.+++.+-
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D 71 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD 71 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc
Confidence 579999999999997654 6899996421 11334455556767666553 23 455566543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.03 Score=63.18 Aligned_cols=82 Identities=15% Similarity=0.058 Sum_probs=65.9
Q ss_pred CeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 041433 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461 (470)
Q Consensus 382 ~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~ 461 (470)
-.+|++||+-|.+|..+..+|+.++|+.+..... ........+++.|+.|++...-.++.++|+|..++.+|++-.|.
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 3689999999999999999999999999832211 11122345677899999888888898899999999999998888
Q ss_pred CCCC
Q 041433 462 KNSS 465 (470)
Q Consensus 462 ~P~~ 465 (470)
.+|-
T Consensus 1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred HHHH
Confidence 7764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.3 Score=46.55 Aligned_cols=58 Identities=19% Similarity=0.292 Sum_probs=36.2
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---HRNLVRLLGF 345 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~ 345 (470)
+..+.|+.|.-..+|+.. .+++.+.||+-. ......|..|.+-|+.|. .-.+.+.+++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~ 80 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAW 80 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEE
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 345678889999999988 478899999875 223356778888777773 3345555554
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.93 E-value=0.18 Score=48.88 Aligned_cols=55 Identities=22% Similarity=0.286 Sum_probs=47.2
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 354 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
..-.+++...++.+.+..+.-+..+ .+.-|||+.-.||||+ +|++-|+||-+++.
T Consensus 316 k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 316 KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence 3456889999999988877777664 3699999999999999 99999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.50 E-value=1.5 Score=42.79 Aligned_cols=42 Identities=17% Similarity=0.097 Sum_probs=29.9
Q ss_pred CceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC
Q 041433 293 GFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ 335 (470)
Q Consensus 293 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~ 335 (470)
.-..||+...+++..+++|+.+... ....++..|++.+..|.
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~ 78 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELA 78 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHH
Confidence 3457999988778889999875332 34566777887777663
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.27 E-value=0.056 Score=44.11 Aligned_cols=45 Identities=20% Similarity=0.366 Sum_probs=34.1
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhc
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK 333 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~ 333 (470)
.+.|+.|+.|.||+|++++|+.||||+.+..- .+.+..++.+|+.
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i---~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGI---EEQIEADLRILRR 60 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHH---HHHHHHHHHHHHH
Confidence 36799999999999999899999999986543 2344555555543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.17 E-value=1.4 Score=41.09 Aligned_cols=59 Identities=19% Similarity=0.092 Sum_probs=39.7
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEe
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 346 (470)
...+..|..+.|+.++..+|.++++|+......... + ......|+..+-...|++++.-
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E-~~g~~~L~~w~G~GaVrll~~d 65 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-E-ARGEAALRWWNGRGAVRLLAAD 65 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-h-hhHHhHhheeCCCCceeeeccc
Confidence 345677899999999988999999999854432211 1 1112446667777777777654
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.78 E-value=0.43 Score=46.38 Aligned_cols=29 Identities=38% Similarity=0.581 Sum_probs=26.0
Q ss_pred eEeecCCCCCeeeCCCCc-eEEeecCCcee
Q 041433 383 IIHRDLKVSNILLDAEMN-PKISDFGMAKI 411 (470)
Q Consensus 383 ivH~dlkp~Nill~~~~~-~kl~DfG~a~~ 411 (470)
+||+|+.|.||+++.+.. ..++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998875 88999998763
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.65 E-value=0.14 Score=45.18 Aligned_cols=29 Identities=21% Similarity=0.275 Sum_probs=25.5
Q ss_pred CeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 382 ~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
..+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998877 99999998863
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.63 E-value=1.5 Score=43.70 Aligned_cols=30 Identities=30% Similarity=0.314 Sum_probs=24.4
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
....|.|+-+.|||.+++ .+.++||..+..
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEeccccC
Confidence 347999999999997654 599999987753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.28 E-value=2.2 Score=42.64 Aligned_cols=61 Identities=16% Similarity=0.123 Sum_probs=38.8
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCc----C---ccCHHHHHHHHHHHhcCC---CCCccceeeEee
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKS----S---GQGAEEFKNEVVVVAKLQ---HRNLVRLLGFCL 347 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~---~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~ 347 (470)
.+.||.|....||+... .+..++||.-... . +...++-..|.+.|+.+. ..++.+++.++.
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de 107 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR 107 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC
Confidence 56789999999999886 4567999975421 1 113334445566665543 346677776654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.81 E-value=0.51 Score=53.27 Aligned_cols=32 Identities=38% Similarity=0.473 Sum_probs=26.3
Q ss_pred CCCeEeecCCCCCeeeCCCC--ceE-EeecCCcee
Q 041433 380 RLRIIHRDLKVSNILLDAEM--NPK-ISDFGMAKI 411 (470)
Q Consensus 380 ~~~ivH~dlkp~Nill~~~~--~~k-l~DfG~a~~ 411 (470)
+..+||+|+.+.|||++.+. ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 34599999999999998775 554 999998763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.67 E-value=0.5 Score=45.52 Aligned_cols=29 Identities=28% Similarity=0.363 Sum_probs=25.3
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 470 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-30 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-19 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = e-108
Identities = 90/242 (37%), Positives = 122/242 (50%), Gaps = 36/242 (14%)
Query: 258 NADNDLTTLESLQFDFEAIKVATNKFS------TDNKLGAGGFGEVYKGVLPSGREIAVK 311
N +++ F F +K TN F NK+G GGFG VYKG + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 312 RLSK----SSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED------------------ 349
+L+ ++ + ++F E+ V+AK QH NLV LLGF +
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 350 ---PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
+ L W R KI A GI +LHE+ IHRD+K +NILLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466
G+A+ TSRI GT YMAPE + G+ + KSD+YSFGV++LEIITG
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 467 YQ 468
++
Sbjct: 237 HR 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = e-107
Identities = 89/216 (41%), Positives = 126/216 (58%), Gaps = 24/216 (11%)
Query: 271 FDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAE-EFKNEVV 329
F ++VA++ FS N LG GGFG+VYKG L G +AVKRL + QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 330 VVAKLQHRNLVRLLGFCLEDPEK----------------------QGQLDWSRRYKIIGL 367
+++ HRNL+RL GFC+ E+ Q LDW +R +I
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
ARG+ YLH+ +IIHRD+K +NILLD E + DFG+AK+ T T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 463
G++APEY G+ S K+DV+ +GV++LE+ITG++
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 2e-99
Identities = 91/243 (37%), Positives = 133/243 (54%), Gaps = 29/243 (11%)
Query: 245 RKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPS 304
K K N++ + + + L ES + ++ ATN F +G G FG+VYKGVL
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 305 GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------------- 351
G ++A+KR + S QG EEF+ E+ ++ +H +LV L+GFC E E
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 352 ---------KQGQLDWSRRYKI-IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401
+ W +R +I IG ARG+ YLH + IIHRD+K NILLD P
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIG-AARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 402 KISDFGMAKIF-GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
KI+DFG++K +DQT +T + GT GY+ PEY + G+ + KSDVYSFGV++ E++
Sbjct: 179 KITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 461 KKN 463
+
Sbjct: 238 RSA 240
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 7e-79
Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 37/242 (15%)
Query: 257 GNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS 316
G+ + ++ + E + + G FG V+K L +AVK
Sbjct: 2 GHHHHHHSS--GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ 58
Query: 317 SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEKQGQ--------------------- 355
Q + + EV + ++H N+++ +G
Sbjct: 59 DKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 356 LDWSRRYKIIGLIARGILYLHED-------SRLRIIHRDLKVSNILLDAEMNPKISDFGM 408
+ W+ I +ARG+ YLHED + I HRD+K N+LL + I+DFG+
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKN 463
A F ++ G+T GT YMAPE ++ D+Y+ G+++ E+ +
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 464 SS 465
+
Sbjct: 238 AD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 7e-61
Identities = 52/244 (21%), Positives = 86/244 (35%), Gaps = 47/244 (19%)
Query: 269 LQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEV 328
++ + + +G G +G VYKG L R +AVK S ++ Q F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56
Query: 329 VV--VAKLQHRNLVRLLGFCLEDPE----------------------KQGQLDWSRRYKI 364
+ V ++H N+ R + DW ++
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL 116
Query: 365 IGLIARGILYLHED------SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF------ 412
+ RG+ YLH + + I HRDL N+L+ + ISDFG++
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 413 GVDQTQGNTSRIAGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGKKNSS 465
+ GT YMAPE + D+Y+ G++ EI +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 466 FYQT 469
++
Sbjct: 237 PGES 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 65/239 (27%), Positives = 111/239 (46%), Gaps = 27/239 (11%)
Query: 246 KAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSG 305
K ++ + + + D + + + + K+GAG FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 306 REIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------- 350
++AVK L + + EF EV ++ +L+H N+V +G + P
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 351 --------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402
+ QLD RR + +A+G+ YLH I+HR+LK N+L+D + K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ DFG++++ T ++ AGT +MAPE + KSDVYSFGV++ E+ T +
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-56
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 28/202 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ + +G G FG V K +++A+K++ S + + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 341 RLLGFC-------------------LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+L G C L E + ++G+ YLH
Sbjct: 65 KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 382 RIIHRDLKVSNILLDAEMN-PKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ 440
+IHRDLK N+LL A KI DFG A Q + + G+ +MAPE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 441 FSVKSDVYSFGVLVLEIITGKK 462
+S K DV+S+G+++ E+IT +K
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-56
Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 45/236 (19%)
Query: 259 ADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPS-GREIAVKRLSKSS 317
++ I+ + ++G GGFG V+KG L +A+K L
Sbjct: 4 GGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 318 GQGA-------EEFKNEVVVVAKLQHRNLVRLLGFCLEDP-----------------EKQ 353
+G +EF+ EV +++ L H N+V+L G P +K
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKA 116
Query: 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-----AEMNPKISDFGM 408
+ WS + +++ IA GI Y+ + I+HRDL+ NI L A + K++DFG+
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 409 AKIFGVDQTQGNTSRIAGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 462
++ + + S + G + +MAPE A ++ K+D YSF +++ I+TG+
Sbjct: 176 SQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-56
Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 41/219 (18%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS----SGQGAEEFKNE 327
DF + + + +G GGFG+VY+ G E+AVK Q E + E
Sbjct: 5 DFAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 328 VVVVAKLQHRNLVRLLGFCLEDPE--------KQG---------QLDWSRRYKIIGLIAR 370
+ A L+H N++ L G CL++P + G ++ IAR
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR 116
Query: 371 GILYLHEDSRLRIIHRDLKVSNILLDAEMNP--------KISDFGMAKIFGVDQTQGNTS 422
G+ YLH+++ + IIHRDLK SNIL+ ++ KI+DFG+A+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKM 172
Query: 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
AG Y +MAPE FS SDV+S+GVL+ E++TG+
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 35/208 (16%)
Query: 287 NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
LG G FG+ K +G + +K L + + F EV V+ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 346 CLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
+D Q WS+R IA G+ YLH + IIHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR------------IAGTYGYMAPE 434
DL N L+ N ++DFG+A++ ++TQ R + G +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ K DV+SFG+++ EII
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 28/198 (14%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
++G+G FG VYKG ++AVK L+ + + Q + FKNEV V+ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 345 FCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
+ + + + + I ARG+ YLH IIHR
Sbjct: 88 YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE---YAMHGQFSV 443
DLK +NI L + KI DFG+A +++G+ +MAPE +S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 444 KSDVYSFGVLVLEIITGK 461
+SDVY+FG+++ E++TG+
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 36/208 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRN 338
+ + KL GE++KG G +I VK L S + + +F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 339 LVRLLGFCLEDPE----------------------KQGQLDWSRRYKIIGLIARGILYLH 376
++ +LG C P +D S+ K +ARG+ +LH
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
L I L ++++D +M +IS + F Q+ G ++APE
Sbjct: 129 TLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAPAWVAPEAL 180
Query: 437 MHGQ---FSVKSDVYSFGVLVLEIITGK 461
+D++SF VL+ E++T +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 46/237 (19%)
Query: 258 NADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS- 316
A L+ FE +++ +G G FG+VY G G E+A++ +
Sbjct: 17 KASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRW-HG-EVAIRLIDIER 67
Query: 317 -SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------------------EKQGQL 356
+ + FK EV+ + +H N+V +G C+ P + + L
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
D ++ +I I +G+ YLH I+H+DLK N+ D I+DFG+ I GV Q
Sbjct: 128 DVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183
Query: 417 TQGNTSRI---AGTYGYMAPE---------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
++ G ++APE FS SDV++ G + E+ +
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 40/210 (19%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVV--VAKLQHRNLVRLLG 344
+G G +GEV++G G +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 345 FCLEDPEKQGQ---------------------LDWSRRYKIIGLIARGILYLHEDSRLR- 382
+ Q LD +I+ IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 383 ----IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI--AGTYGYMAPE-- 434
I HRDLK NIL+ I+D G+A + Q + GT YMAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 435 ----YAMHGQFSVKSDVYSFGVLVLEIITG 460
+ D+++FG+++ E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 51/212 (24%), Positives = 80/212 (37%), Gaps = 42/212 (19%)
Query: 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVV--VAKLQHRNLVRLL 343
++G G +GEV+ G G ++AVK + E + ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 344 GFCLEDPE---------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
++ K LD K+ G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 383 -----IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI--AGTYGYMAPE- 434
I HRDLK NIL+ I+D G+A F D + + GT YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 435 -----YAMHGQFSVKSDVYSFGVLVL-EIITG 460
H Q + +D+YSFG L+L E+
Sbjct: 218 LDESLNRNHFQSYIMADMYSFG-LILWEVARR 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-43
Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 40/211 (18%)
Query: 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNE--VVVVAKLQHRNLVRLL 343
+G G FGEV++G G E+AVK S + + E + L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 344 GFCLEDPEKQGQ---------------------LDWSRRYKIIGLIARGILYLHED---- 378
+D Q + K+ A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 379 -SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI--AGTYGYMAPE- 434
+ I HRDLK NIL+ I+D G+A + + GT YMAPE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 435 -----YAMHGQFSVKSDVYSFGVLVLEIITG 460
H + ++D+Y+ G++ EI
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-41
Identities = 62/204 (30%), Positives = 85/204 (41%), Gaps = 30/204 (14%)
Query: 286 DNKLGAGGFGEVYKGVL--PSGREI--AVKRL---SKSSGQGAEEFKNEVVVVAKLQHRN 338
KLG G FG V +G PSG+ + AVK L S + ++F EV + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 339 LVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
L+RL G L P + QG + +A G+ YL
Sbjct: 83 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT-YGYMAPEYAMHG 439
R IHRDL N+LL KI DFG+ + + + + APE
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 440 QFSVKSDVYSFGVLVLEIIT-GKK 462
FS SD + FGV + E+ T G++
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 34/201 (16%)
Query: 286 DNKLGAGGFGEVYKGVLPSGRE---IAVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLVR 341
D +LG G FG V +GV ++ +A+K L + + EE E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 342 LLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
L+G C + K+ ++ S +++ ++ G+ YL
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-----IAGTYGYMAPEYAMH 438
+HRDL N+LL KISDFG++K G D + + + APE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINF 187
Query: 439 GQFSVKSDVYSFGVLVLEIIT 459
+FS +SDV+S+GV + E ++
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 36/206 (17%)
Query: 286 DNKLGAGGFGEVYKGVLPSGRE-----IAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNL 339
LG+G FG VYKG+ E +A+K L +++ A +E +E V+A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 340 VRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
RLLG CL E + + IA+G+ YL
Sbjct: 80 CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR----IAGTYGYMAPEYAM 437
R++HRDL N+L+ + KI+DFG+AK+ G ++ + + I +MA E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 438 HGQFSVKSDVYSFGVLVLEIIT-GKK 462
H ++ +SDV+S+GV V E++T G K
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 35/205 (17%)
Query: 286 DNKLGAGGFGEVYKGVLPSGR---EIAVKRLSK--SSGQGAEEFKNEVVVVAKLQHRNLV 340
D +LG+G FG V KG + +AVK L + +E E V+ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 341 RLLGFCLEDP-----E--KQGQLD----WSRRYKIIGL------IARGILYLHEDSRLRI 383
R++G C + E + G L+ +R K + ++ G+ YL
Sbjct: 82 RMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL---EESNF 138
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-----IAGTYGYMAPEYAMH 438
+HRDL N+LL + KISDFG++K D+ + + APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECINY 194
Query: 439 GQFSVKSDVYSFGVLVLEIIT-GKK 462
+FS KSDV+SFGVL+ E + G+K
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 38/204 (18%)
Query: 287 NKLGAGGFGEVYKGVLP-----SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
+LG G FG V +G +AVK+L S+ + +F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 342 LLGFCLEDPEK---------------------QGQLDWSRRYKIIGLIARGILYLHEDSR 380
G C + + ++D + + I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 132
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRIAGTYGYMAPEY 435
R IHRDL NIL++ E KI DFG+ K+ D+ + S I + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAPES 188
Query: 436 AMHGQFSVKSDVYSFGVLVLEIIT 459
+FSV SDV+SFGV++ E+ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 26/199 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+LGAG FGEV+ G ++AVK L K + F E ++ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 341 RLLGFCLEDP-----E--KQGQLD---WSRRYKIIGL---------IARGILYLHEDSRL 381
RL ++P E + G L + + + IA G+ ++
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTSRIAGTYGYMAPEYAMHGQ 440
IHRDL+ +NIL+ ++ KI+DFG+A++ ++ T ++ + APE +G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGT 186
Query: 441 FSVKSDVYSFGVLVLEIIT 459
F++KSDV+SFG+L+ EI+T
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 45/239 (18%)
Query: 252 NAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP-----SGR 306
N +G + + QF+ +K +LG G FG V +G
Sbjct: 19 NLYFQGAMGSAFEDRDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGE 71
Query: 307 EIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK-------------- 352
+AVK+L S+ + +F+ E+ ++ LQH N+V+ G C +
Sbjct: 72 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 353 -------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405
+ ++D + + I +G+ YL R IHRDL NIL++ E KI D
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGD 188
Query: 406 FGMAKIFGVDQ-----TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
FG+ K+ D+ + S I + APE +FSV SDV+SFGV++ E+ T
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 35/202 (17%)
Query: 286 DNKLGAGGFGEVYKGVLPSGRE-----IAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNL 339
LG+G FG V+KGV E + +K + SG+ + + + ++ + L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 340 VRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
VRLLG C + +G L IA+G+ YL
Sbjct: 78 VRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR----IAGTYGYMAPEYAM 437
++HR+L N+LL + +++DFG+A + D Q S I +MA E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALESIH 190
Query: 438 HGQFSVKSDVYSFGVLVLEIIT 459
G+++ +SDV+S+GV V E++T
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 38/231 (16%)
Query: 264 TTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGA 321
L + F+++ V +S ++G+GG +V++ + + A+K ++ Q
Sbjct: 11 VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70
Query: 322 EEFKNEVVVVAKLQHRNL--VRLLGFCLEDPE------------------KQGQLDWSRR 361
+ ++NE+ + KLQ + +RL + + K+ +D R
Sbjct: 71 DSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKSIDPWER 129
Query: 362 YKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
+ + +H+ I+H DLK +N L+ + K+ DFG+A D T
Sbjct: 130 KSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 185
Query: 422 SRIAGTYGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
GT YM PE + S KSDV+S G ++ + GK
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 288 KLGAGGFGEVYKGVL--PSGREI--AVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNLVRL 342
LG G FGEVY+GV G +I AVK K + E+F +E V++ L H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 343 LGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384
+G E+P + L I + + YL + +
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCV 135
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG-----YMAPEYAMHG 439
HRD+ V NIL+ + K+ DFG+++ + + +M+PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESINFR 189
Query: 440 QFSVKSDVYSFGVLVLEIIT 459
+F+ SDV+ F V + EI++
Sbjct: 190 RFTTASDVWMFAVCMWEILS 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-39
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRL-SKSSGQGAEEFKNEVVVVAKLQHRN 338
++G G FGEV+ G L +AVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 339 LVRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDS 379
+VRL+G C + + +L +++G A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY----MAPEY 435
IHRDL N L+ + KISDFGM++ ++ G + G APE
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEA 286
Query: 436 AMHGQFSVKSDVYSFGVLVLEIIT 459
+G++S +SDV+SFG+L+ E +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-39
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVV 331
E I V +S ++G+GG +V++ + + A+K ++ Q + ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 332 AKLQHRNL--VRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARG 371
KLQ + +RL + + K+ +D R +
Sbjct: 62 NKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ +H+ I+H DLK +N L+ + K+ DFG+A D T GT YM
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 432 APE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE + S KSDV+S G ++ + GK
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 28/194 (14%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346
KLGAG FGEV+ ++AVK + K E F E V+ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 347 LEDP-----E--KQGQLD---WSRRYKIIGL---------IARGILYLHEDSRLRIIHRD 387
++P E +G L S L IA G+ ++ + IHRD
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY--MAPEYAMHGQFSVKS 445
L+ +NIL+ A + KI+DFG+A++ ++ T+R + APE G F++KS
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 446 DVYSFGVLVLEIIT 459
DV+SFG+L++EI+T
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL--PSGREI--AVKRLSK-SSGQGAEEFKNEVVVVAKLQ 335
+ +G G FG+V++G+ P + A+K +S E+F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 336 HRNLVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHE 377
H ++V+L+G E+P ++ LD + ++ + YL
Sbjct: 75 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-- 132
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG-----YMA 432
R +HRD+ N+L+ + K+ DFG+++ + G +MA
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMA 185
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIIT 459
PE +F+ SDV+ FGV + EI+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 28/199 (14%)
Query: 285 TDNKLGAGGFGEVYKGVL-PSGREI--AVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNLV 340
D +LG G FG V +GV ++I A+K L + EE E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 341 RLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
RL+G C + K+ ++ S +++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY--MAPEYAMHGQ 440
+HR+L N+LL KISDFG++K G D + T+R AG + APE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRK 515
Query: 441 FSVKSDVYSFGVLVLEIIT 459
FS +SDV+S+GV + E ++
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 38/204 (18%)
Query: 287 NKLGAGGFGEVYKGVLP-----SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
++LG G FG V +G +AVK+L S +F+ E+ ++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 342 LLGFCLEDPEK---------------------QGQLDWSRRYKIIGLIARGILYLHEDSR 380
G + + +LD SR I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRIAGTYGYMAPEY 435
R +HRDL NIL+++E + KI+DFG+AK+ +D+ + S I + APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPES 201
Query: 436 AMHGQFSVKSDVYSFGVLVLEIIT 459
FS +SDV+SFGV++ E+ T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 38/210 (18%)
Query: 287 NKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
LG G FG+V +G +AVK L +G +K E+ ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 341 RLLGFCLEDPE----------KQGQL-DWSRRYKI-----IGL---IARGILYLHEDSRL 381
+ G C + G L D+ R+ I + I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA---Q 153
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRIAGTYGYMAPEYA 436
IHRDL N+LLD + KI DFG+AK + S + + APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAPECL 209
Query: 437 MHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 465
+F SDV+SFGV + E++T + S
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 287 NKLGAGGFGEVYKGVLP-----SGREIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
LG G FG+V +G ++AVK L SG + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 341 RLLGFCLEDPEK---------------------QGQLDWSRRYKIIGLIARGILYLHEDS 379
+ G C ED + +++ ++ K I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRIAGTYGYMAPE 434
+ +HRDL N+L+++E KI DFG+ K D+ S + + APE
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----WYAPE 199
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 465
M +F + SDV+SFGV + E++T +SS
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 35/207 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGRE-----IAVKRLSKSSGQGA-EEFKNEVVVVAKL 334
+F LG+G FG VYKG+ E +A+K L +++ A +E +E V+A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 335 QHRNLVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLH 376
+ ++ RLLG CL E + + IA+G+ YL
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL- 133
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR----IAGTYGYMA 432
R++HRDL N+L+ + KI+DFG+AK+ G ++ + + I +MA
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMA 187
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIIT 459
E +H ++ +SDV+S+GV V E++T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 26/193 (13%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346
++G+G FG V+ G + ++A+K + + E+F E V+ KL H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 347 LEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRD 387
LE ++G + + G+ YL +IHRD
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTSRIAGTYGYMAPEYAMHGQFSVKSD 446
L N L+ K+SDFGM + DQ T ++ + +PE ++S KSD
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYSSKSD 187
Query: 447 VYSFGVLVLEIIT 459
V+SFGVL+ E+ +
Sbjct: 188 VWSFGVLMWEVFS 200
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 286 DNKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL 342
D ++G G F VYKG+ + E+A + K + + FK E ++ LQH N+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 343 LGFCLEDPEKQGQL-------------DWSRRYKIIGL---------IARGILYLHEDSR 380
+ + + + +R+K++ + I +G+ +LH +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 381 LRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
IIHRDLK NI + + KI D G+A + + + GT +MAPE
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YEE 204
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
++ DVY+FG+ +LE+ T +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSE 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 28/200 (14%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +LG G FG V G ++A+K + K +EF E V+ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 341 RLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+L G C + E + + + ++ + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESK 139
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY--MAPEYAMHG 439
+ +HRDL N L++ + K+SDFG+++ D+ TS + + PE M+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 196
Query: 440 QFSVKSDVYSFGVLVLEIIT 459
+FS KSD+++FGVL+ EI +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 26/193 (13%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346
KLG G FGEV+ G +A+K L K E F E V+ KL+H LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 347 LEDP-----E--KQGQLD---WSRRYKIIGL---------IARGILYLHEDSRLRIIHRD 387
E+P E +G L K + L IA G+ Y+ R+ +HRD
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTSRIAGTYGYMAPEYAMHGQFSVKSD 446
L+ +NIL+ + K++DFG+A++ ++ T ++ + APE A++G+F++KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSD 363
Query: 447 VYSFGVLVLEIIT 459
V+SFG+L+ E+ T
Sbjct: 364 VWSFGILLTELTT 376
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 50/210 (23%)
Query: 286 DNKLGAGGFGEVYKGVL--PSGREI--AVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +G+G GEV G L P R++ A+K L + + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 341 RLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
RL G GQ + ++ + G+ YL S L
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY----------- 430
+HRDL N+L+D+ + K+SDFG++++ D
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGKIPIR 219
Query: 431 -MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
APE FS SDV+SFGV++ E++
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 28/200 (14%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ + +LG+G FG V G ++AVK + K +EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 341 RLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+ G C ++ L+ S+ ++ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESH 123
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY--MAPEYAMHG 439
+ IHRDL N L+D ++ K+SDFGM + DQ S + + APE +
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYF 180
Query: 440 QFSVKSDVYSFGVLVLEIIT 459
++S KSDV++FG+L+ E+ +
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 40/214 (18%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL--PSGRE---IAVKRLSK-SSGQGAEEFKNEVVVVAKL 334
+ + +GAG FGEVYKG+L SG++ +A+K L + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 335 QHRNLVRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYL 375
H N++RL G + EK G+ + ++ IA G+ YL
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG------ 429
+ + +HRDL NIL+++ + K+SDFG++++ D T+ G
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIR 215
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 462
+ APE + +F+ SDV+SFG+++ E++T G++
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 8e-37
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 26/193 (13%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346
KLG G FGEV+ G +A+K L K E F E V+ KL+H LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 347 LEDP-----E--KQGQLD---WSRRYKIIGL---------IARGILYLHEDSRLRIIHRD 387
E+P E +G L K + L IA G+ Y+ R+ +HRD
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388
Query: 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTSRIAGTYGYMAPEYAMHGQFSVKSD 446
L+ +NIL+ + K++DFG+A++ ++ T ++ + APE A++G+F++KSD
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSD 446
Query: 447 VYSFGVLVLEIIT 459
V+SFG+L+ E+ T
Sbjct: 447 VWSFGILLTELTT 459
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL 339
+ +KLG G +GEVY+GV +AVK L K EEF E V+ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 340 VRLLGFCLEDP------E--KQGQLDW---SRRYKIIGL---------IARGILYLHEDS 379
V+LLG C +P E G L + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---E 128
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTSRIAGTYGYMAPEYAMH 438
+ IHRDL N L+ K++DFG++++ D T ++ + APE +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAY 186
Query: 439 GQFSVKSDVYSFGVLVLEIIT 459
+FS+KSDV++FGVL+ EI T
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-36
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVV 331
E I V +S ++G+GG +V++ + + A+K ++ Q + ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 332 AKLQHRNL--VRLLGFCLEDPEK--------QGQL-DWSRRYKIIGL---------IARG 371
KLQ + +RL + + L W ++ K I +
Sbjct: 109 NKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ +H+ I+H DLK +N L+ + K+ DFG+A D T G YM
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 432 APE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE + S KSDV+S G ++ + GK
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL--PSGREI--AVKRLSK-SSGQGAEEFKNEVVVVAKLQ 335
S D +GAG FGEV G L PS +EI A+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 336 HRNLVRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLH 376
H N++RL G + + Q + ++ IA G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTSRIAGTYGYM 431
S + +HRDL NIL+++ + K+SDFG+ ++ D T+G I +
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR----WT 217
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+PE + +F+ SDV+S+G+++ E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 32/200 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +G G FG+V G G ++AVK + + A+ F E V+ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 249
Query: 341 RLLGFCLEDPE---------KQGQLD---WSRRYKIIGL---------IARGILYLHEDS 379
+LLG +E+ +G L SR ++G + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+HRDL N+L+ + K+SDFG+ K + +T ++ + APE
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP--VKWTAPEALREK 361
Query: 440 QFSVKSDVYSFGVLVLEIIT 459
+FS KSDV+SFG+L+ EI +
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-36
Identities = 49/236 (20%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 248 KKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL--PSG 305
Y + + + + + E I++ +G G FG+V++G+ P
Sbjct: 364 TDDYAEIIDEEDTYTMPSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSPEN 416
Query: 306 REI--AVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350
+ A+K + +S E+F E + + + H ++V+L+G E+P
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGE 476
Query: 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKIS 404
++ LD + ++ + YL R +HRD+ N+L+ + K+
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLG 533
Query: 405 DFGMAK-IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
DFG+++ + + + ++ +MAPE +F+ SDV+ FGV + EI+
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 44/206 (21%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +G G FG+V G G ++AVK + + A+ F E V+ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 77
Query: 341 RLLGFCLEDPE---------KQGQLDW---SRRYKIIGL---------IARGILYLHEDS 379
+LLG +E+ +G L SR ++G + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG------YMAP 433
+HRDL N+L+ + K+SDFG+ K + + + AP
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAP 183
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIIT 459
E +FS KSDV+SFG+L+ EI +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 34/225 (15%)
Query: 264 TTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEE 323
+ + + V F + LG G G + + R++AVKR+ A+
Sbjct: 7 LEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD- 65
Query: 324 FKNEVVVVAKL-QHRNLVRLLGF-------------C---LED--PEKQGQLDWSRRYKI 364
EV ++ + +H N++R C L++ +K +
Sbjct: 66 --REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL 123
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILL-----DAEMNPKISDFGMAKIFGVDQ-TQ 418
+ G+ +LH L I+HRDLK NIL+ ++ ISDFG+ K V + +
Sbjct: 124 LQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 419 GNTSRIAGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 460
S + GT G++APE + D++S G + +I+
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL 339
+ +KLG G +GEVY+GV +AVK L K EEF E V+ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 340 VRLLGFCLEDP------E--KQGQLD---WSRRYKIIGL---------IARGILYLHEDS 379
V+LLG C +P E G L + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---E 335
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTSRIAGTYGYMAPEYAMH 438
+ IHR+L N L+ K++DFG++++ D T ++ + APE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAY 393
Query: 439 GQFSVKSDVYSFGVLVLEIIT 459
+FS+KSDV++FGVL+ EI T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 31/241 (12%)
Query: 244 RRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-L 302
+ K PE + + E L+ + + + ++G G FGEV++
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 303 PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------------ 350
+G + AVK++ + E+V A L +V L G E P
Sbjct: 81 QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135
Query: 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KI 403
++ G L R +G G+ YLH RI+H D+K N+LL ++ + +
Sbjct: 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAAL 192
Query: 404 SDFGMAKIFGVDQTQGNTSR---IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
DFG A D + I GT +MAPE M K D++S ++L ++ G
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 461 K 461
Sbjct: 253 C 253
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 45/215 (20%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRLSKSSGQGAEEFKNEVVVVA 332
+ LG G F +++KGV E+ +K L K+ +E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 333 KLQHRNLVRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGIL 373
KL H++LV G C+ + + ++ + ++ +A +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNP--------KISDFGMAKIFGVDQTQGNTSRIA 425
+L +IH ++ NILL E + K+SD G++ V RI
Sbjct: 128 FL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIP 182
Query: 426 GTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIIT 459
++ PE + ++ +D +SFG + EI +
Sbjct: 183 ----WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 53/228 (23%), Positives = 88/228 (38%), Gaps = 57/228 (25%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVV 330
DF+ I+ +G+GGFG+V+K G+ +KR+ ++ E+ + EV
Sbjct: 12 DFKEIE----------LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKA 57
Query: 331 VAKLQHRNLVRLLGFCLEDPEKQGQLDWSRRYKIIGL----------------------- 367
+AKL H N+V G +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 368 -------------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414
I +G+ Y+H ++I+RDLK SNI L KI DFG+
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-- 172
Query: 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ G +R GT YM+PE + + D+Y+ G+++ E++
Sbjct: 173 -KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 55/219 (25%)
Query: 287 NKLGAGGFGEVYKGVL----PSGREI--AVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+LG G FG+V+ P+ ++ AVK L + ++F+ E ++ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 341 RLLGFCLED----------------------------------PEKQGQLDWSRRYKIIG 366
+ G C + + +G+L S+ I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 367 LIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTS--- 422
IA G++YL + +HRDL N L+ A + KI DFGM++ ++ D +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 423 --RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R +M PE M+ +F+ +SDV+SFGV++ EI T
Sbjct: 198 PIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 38/205 (18%)
Query: 286 DNKLGAGGFGEVYKGVLPSGRE----IAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
D +G G FG VY G + A+K LS+ + E F E +++ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 341 RLLGFCL-EDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
L+G L + Q +ARG+ YL +
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYG-----YMAPE 434
+ +HRDL N +LD K++DFG+A+ I + S + + A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY----SVQQHRHARLPVKWTALE 198
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIIT 459
+F+ KSDV+SFGVL+ E++T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 44/224 (19%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
+ F LG G FG+V K R A+K++ + + +EV+++A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 339 LVRLLGFCLEDPEKQGQLDWSRRYKII---------G----LIARGILYLHEDSRLR--- 382
+VR LE + ++ + G LI L D R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 383 -------------IIHRDLKVSNILLDAEMNPKISDFGMAKIF------------GVDQT 417
IIHRDLK NI +D N KI DFG+AK + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 418 QGNTSRIAGTYGYMAPE-YAMHGQFSVKSDVYSFGVLVLEIITG 460
N + GT Y+A E G ++ K D+YS G++ E+I
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 29/203 (14%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK--NEVVVVAKL-QHR 337
F ++LG G +GEV+K GR AVKR + + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 338 NLVRLLG-------------FC----LEDPEKQGQ-LDWSRRYKIIGLIARGILYLHEDS 379
VRL C + E G L ++ + + + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-- 175
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
++H D+K +NI L K+ DFG+ G T G G YMAPE + G
Sbjct: 176 -QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE-LLQG 230
Query: 440 QFSVKSDVYSFGVLVLEIITGKK 462
+ +DV+S G+ +LE+ +
Sbjct: 231 SYGTAADVFSLGLTILEVACNME 253
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 286 DNKLGAGGFGEVYKGVL--PSGREI--AVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
+ +G G FG VY G L G++I AVK L++ + G +F E +++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 341 RLLGFCL--EDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
LLG CL E + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS--- 146
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG------YMAPE 434
+ +HRDL N +LD + K++DFG+A+ D + G +MA E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIIT 459
+F+ KSDV+SFGVL+ E++T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 34/200 (17%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
LG G +G VY G L + IA+K + + + ++ E+ + L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 348 ED-------------------PEKQGQLDWSRRYKIIGLIARGIL----YLHEDSRLRII 384
E+ K G L + + IG + IL YLH++ +I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIGFYTKQILEGLKYLHDN---QIV 144
Query: 385 HRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ--F 441
HRD+K N+L++ KISDFG +K T GT YMAPE G +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY 202
Query: 442 SVKSDVYSFGVLVLEIITGK 461
+D++S G ++E+ TGK
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 54/218 (24%)
Query: 287 NKLGAGGFGEVYKGVL----PSGREI--AVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+LG G FG+V+ P ++ AVK L ++S ++F+ E ++ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 341 RLLGFCLED---------------------------------PEKQGQLDWSRRYKIIGL 367
R G C E G L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTS---- 422
+A G++YL + L +HRDL N L+ + KI DFGM++ I+ D +
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 423 -RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R +M PE ++ +F+ +SDV+SFGV++ EI T
Sbjct: 224 IR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 50/220 (22%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL--PSGREI--AVKRLSK--SSGQGAEEFKNEVVVVAKL 334
N LG G FG V +G L G + AVK + SS + EEF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 335 QHRNLVRLLGFCLEDPEKQGQLDW----------------SRRYKIIGL----------- 367
H N++RLLG C+E + R +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 368 --IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRI 424
IA G+ YL S +HRDL N +L +M ++DFG++K I+ D +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR------ 204
Query: 425 AGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
G ++A E ++ KSDV++FGV + EI T
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 51/221 (23%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSK--SSGQGAEEFKNEVVVVAKL 334
+F+ LG G FG V + L S ++AVK L + EEF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 335 QHRNLVRLLGFCLED------------------------------PEKQGQLDWSRRYKI 364
H ++ +L+G L E L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVDQTQGNTSR 423
+ IA G+ YL S IHRDL N +L +M ++DFG++ KI+ D +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----- 194
Query: 424 IAGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
G ++A E ++V SDV++FGV + EI+T
Sbjct: 195 -QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 43/222 (19%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKL 334
+ + + + LG G V++G +G A+K + S + E V+ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 335 QHRNLVRLLG---------------FC--------LEDPEKQGQLDWSRRYKIIGLIARG 371
H+N+V+L FC LE+P L S ++ + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 372 ILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ +L E I+HR++K NI+ D + K++DFG A+ D Q + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
Query: 428 YGYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y+ P+ ++ D++S GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 56/220 (25%)
Query: 287 NKLGAGGFGEVYKGVL----PSGREI--AVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNL 339
+LG FG+VYKG L P + A+K L + G EEF++E ++ A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 340 VRLLGFCLED----------------------------------PEKQGQLDWSRRYKII 365
V LLG +D + L+ ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD--QTQGNTS 422
IA G+ YL S ++H+DL N+L+ ++N KISD G+ +++ D + GN+
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 423 ---RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
R +MAPE M+G+FS+ SD++S+GV++ E+ +
Sbjct: 192 LPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 50/214 (23%)
Query: 287 NKLGAGGFGEVYKGVLPSGRE------IAVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNL 339
+LG G FG VY+GV + +A+K +++ +S + EF NE V+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 340 VRLLGFCL----------------------------EDPEKQGQLDWSRRYKIIGLIARG 371
VRLLG + S+ ++ G IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVDQTQGNTS-----RIA 425
+ YL+ + +HRDL N ++ + KI DFGM I+ D + R
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+M+PE G F+ SDV+SFGV++ EI T
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 64/214 (29%), Positives = 89/214 (41%), Gaps = 50/214 (23%)
Query: 287 NKLGAGGFGEVYKGVL------PSGREIAVKRLSK-SSGQGAEEFKNEVVVVAKLQHRNL 339
LG G FGEVY+G + PS ++AVK L + S Q +F E ++++K H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 340 VRLLGFCLE-------------------------DPEKQGQLDWSRRYKIIGLIARGILY 374
VR +G L+ P + L + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 375 LHEDSRLRIIHRDLKVSNILLDAE---MNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGY 430
L IHRD+ N LL KI DFGMA+ I+ + G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR------KGGCAM 206
Query: 431 -----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
M PE M G F+ K+D +SFGVL+ EI +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 58/233 (24%), Positives = 88/233 (37%), Gaps = 58/233 (24%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA-EEFKNEVV 329
DFE I+ LG GGFG V++ A+KR+ + + A E+ EV
Sbjct: 6 DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55
Query: 330 VVAKLQHRNLVRLLGFCLEDPEKQGQL---------------------DWSRRYKIIGL- 367
+AKL+H +VR LE + DW I
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 368 -----------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
IA + +LH ++HRDLK SNI + K+ DFG+ D+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 417 TQGNTSRIA----------GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ GT YM+PE +S K D++S G+++ E++
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 38/205 (18%)
Query: 286 DNKLGAGGFGEVYKGVL--PSGREI--AVKRLSKSSGQGA-EEFKNEVVVVAKLQHRNLV 340
+ +G G FG VY G L G++I AVK L++ + G +F E +++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 341 RLLGFCL--EDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
LLG CL E + +A+G+ +L +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG------YMAPE 434
+ +HRDL N +LD + K++DFG+A+ D + G +MA E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIIT 459
+F+ KSDV+SFGVL+ E++T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 53/223 (23%), Positives = 82/223 (36%), Gaps = 40/223 (17%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL 334
+ + + KLG GGF V L G A+KR+ Q EE + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 335 QHRNLVRLLGFCLEDPEKQGQL-------------DWSRRYKIIGL-------------I 368
H N++RL+ +CL + + + + R K G I
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 369 ARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA--- 425
RG+ +H HRDLK +NILL E P + D G + +
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 426 ----GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 461
T Y APE H ++DV+S G ++ ++ G+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 43/222 (19%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKL 334
+ + + + LG G V++G +G A+K + S + E V+ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 335 QHRNLVRLLG---------------FC--------LEDPEKQGQLDWSRRYKIIGLIARG 371
H+N+V+L FC LE+P L S ++ + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 372 ILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ +L E I+HR++K NI+ D + K++DFG A+ D Q + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
Query: 428 YGYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y+ P+ ++ D++S GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 50/235 (21%), Positives = 97/235 (41%), Gaps = 42/235 (17%)
Query: 250 KYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREI 308
+ V G + ++E + ++ K+G G FG+ GR+
Sbjct: 7 HSSGVDLGTENLYFQSME----KYVRLQ----------KIGEGSFGKAILVKSTEDGRQY 52
Query: 309 AVK--RLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED----------------- 349
+K +S+ S + EE + EV V+A ++H N+V+ E+
Sbjct: 53 VIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFK 112
Query: 350 ---PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
+K + I + ++H+ +I+HRD+K NI L + ++ DF
Sbjct: 113 RINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
G+A++ GT Y++PE + ++ KSD+++ G ++ E+ T K
Sbjct: 170 GIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 63/214 (29%), Positives = 89/214 (41%), Gaps = 50/214 (23%)
Query: 287 NKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGAE-EFKNEVVVVAKLQHRNL 339
LG G FGEVY+G + PS ++AVK L + + E +F E ++++K H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 340 VRLLGFCLE-------------------------DPEKQGQLDWSRRYKIIGLIARGILY 374
VR +G L+ P + L + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 375 LHEDSRLRIIHRDLKVSNILLDAE---MNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGY 430
L IHRD+ N LL KI DFGMA+ I+ + G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR------KGGCAM 247
Query: 431 -----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
M PE M G F+ K+D +SFGVL+ EI +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE---FKNEVVVVAKLQH 336
F + K+G G F EVY+ L G +A+K++ A+ E+ ++ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 337 RNLVRLLGFCLEDPE--------KQGQL-DWSRRYKIIGL-------------IARGILY 374
N+++ +ED E G L + +K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
+H R++HRD+K +N+ + A K+ D G+ + F T ++ + GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIITGK 461
++ KSD++S G L+ E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 35/210 (16%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVA 332
+ A F LG G FG VY S +A+K L K+ + + EV + +
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 333 KLQHRNLVRLLGFCLEDPEK---------QGQL------------DWSRRYKIIGLIARG 371
L+H N++RL G+ D + G + + Y I +A
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANA 121
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ Y H R+IHRD+K N+LL + KI+DFG + ++ + GT Y+
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYL 174
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE K D++S GVL E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 64/234 (27%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAK 333
LG G FG+V K +AVK L +++ + +E V+ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 334 LQHRNLVRLLGFCLED-----------------------PEKQGQLDWSRRYKIIGL--- 367
+ H ++++L G C +D G L L
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 368 ----------------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-K 410
I++G+ YL + ++++HRDL NIL+ KISDFG++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 411 IFGVDQTQGNTS-----RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
++ D + + +MA E ++ +SDV+SFGVL+ EI+T
Sbjct: 200 VYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQH 336
+ + KLG+G +GEV + E A+K + K+ S + EV V+ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 337 RNLVRLLGFCLEDPEKQ---------GQLDWSR-----RY------KIIGLIARGILYLH 376
N+++L F ED G+L + ++ II + G+ YLH
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGEL-FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 377 EDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+ I+HRDLK N+LL + + KI DFG++ +F + GT Y+AP
Sbjct: 154 K---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAP 207
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
E + ++ K DV+S GV++ ++ G
Sbjct: 208 E-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
K++ K+G G G VY + + +G+E+A+++++ E NE++V+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 339 LVRLLG-------------FC----LEDPEKQGQLDWSRRYKIIGLIARGIL----YLHE 377
+V L + L D + +D I + R L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ ++IHRD+K NILL + + K++DFG +Q++ +T + GT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
+ K D++S G++ +E+I G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 35/207 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQH 336
+++ LG G FGEV K + +E AVK ++K+ + EV ++ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 337 RNLVRLLGFCLEDPEKQ---------GQLDWSR-----RY------KIIGLIARGILYLH 376
N+++L ED G+L + R+ +II + GI Y+H
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL-FDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 377 EDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+ I+HRDLK NILL + + + KI DFG++ F + GT Y+AP
Sbjct: 139 K---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAP 192
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITG 460
E + G + K DV+S GV++ +++G
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 58/242 (23%)
Query: 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRL-SKSSGQ 319
E L +D + ++ LG G FG+V + + R +AVK L ++
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 320 GAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---------KQGQLD---WSRRYKIIG 366
+E+ ++ + H N+V LLG C + K G L S+R + +
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 367 L-----------------------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKI 403
+A+G+ +L + + IHRDL NILL + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 404 SDFGMA-KIFGVDQTQGNTSRIAGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEI 457
DFG+A I+ + +MAPE ++++SDV+SFGVL+ EI
Sbjct: 190 CDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 458 IT 459
+
Sbjct: 244 FS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 59/229 (25%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLP--------SGREIAVKRL-SKSSGQGAEEFKNEVVVV 331
+K + LG G FG+V +AVK L ++ + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 332 AKL-QHRNLVRLLGFCLED----------------------------------PEKQGQL 356
+ +H+N++ LLG C +D + Q+
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD 415
+ +ARG+ YL + + IHRDL N+L+ KI+DFG+A I +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 416 QTQGNTSRIAGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
T G +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 212 ------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 64/228 (28%)
Query: 287 NKLGAGGFGEVYKGVLPSGRE------IAVKRL-SKSSGQGAEEFKNEVVVVAKLQHRNL 339
+G G FG V++ P +AVK L ++S +F+ E ++A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 340 VRLLGFCLED-----------------------PEKQGQLDWSRRYKIIGL--------- 367
V+LLG C P L S +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 368 ----------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD- 415
+A G+ YL S + +HRDL N L+ M KI+DFG++ I+ D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 416 -QTQGNTS---RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+ GN + R +M PE + +++ +SDV+++GV++ EI +
Sbjct: 230 YKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQHRNLVRLLG 344
LG GGF + ++ + A K + KS E+ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 345 FCLEDPEK---------QGQL------------DWSRRYKIIGLIARGILYLHEDSRLRI 383
ED + + L +R Y + ++ G YLH R R+
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQIVL-GCQYLH---RNRV 136
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRDLK+ N+ L+ ++ KI DFG+A D + + GT Y+APE S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 444 KSDVYSFGVLVLEIITGK 461
+ DV+S G ++ ++ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 56/235 (23%), Positives = 85/235 (36%), Gaps = 71/235 (30%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAK 333
N+ S LGAG FG+V + + +AVK L S+ E +E+ V++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 334 L-QHRNLVRLLGFCLED-----------------------PEKQGQLDWSRRYKIIGL-- 367
L H N+V LLG C + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 368 -----------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
+A+G+ +L + IHRDL NILL KI DFG+A+
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD----- 194
Query: 417 TQGNTSRIAGTYGY------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
I Y MAPE + ++ +SDV+S+G+ + E+ +
Sbjct: 195 -------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 45/220 (20%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK---NEV-VV 330
++V + +LG G +G V K +PSG+ +AVKR+ + +E K ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDIS 59
Query: 331 VAKLQHRNLVRLLG---------FCLE------------DPEKQGQLDWSRRYKIIGLIA 369
+ + V G C+E +K + I+G IA
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP----EDILGKIA 115
Query: 370 RGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
I+ +LH S+L +IHRD+K SN+L++A K+ DFG++ VD + A
Sbjct: 116 VSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--A 170
Query: 426 GTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGK 461
G YMAPE +SVKSD++S G+ ++E+ +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 31/210 (14%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHR 337
+ +G G +G K G+ + K L + + +EV ++ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 338 NLVRLLGFCLEDPEKQ----------GQL-DWSRRYKIIGL-------------IARGIL 373
N+VR ++ G L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 374 YLHE--DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
H D ++HRDLK +N+ LD + N K+ DFG+A+I D + T GT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+PE ++ KSD++S G L+ E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 54/227 (23%), Positives = 85/227 (37%), Gaps = 53/227 (23%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNL 339
N ++ LG G G V GR +AVKR+ + E+ ++ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 340 VRLLGF-------------C---LED--------PEKQGQLDWSRRYKIIGLIARGILYL 375
+R C L+D E ++ IA G+ +L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNP-------------KISDFGMAKIFGVDQT--QGN 420
H L+IIHRDLK NIL+ ISDFG+ K Q+ + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 421 TSRIAGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 460
+ +GT G+ APE + + D++S G + I++
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 36/208 (17%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE---FKNEVVVVAKLQ 335
++++ LG G FGEV +G+E AVK +SK + + EV ++ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 336 HRNLVRLLGFCLEDPEKQ---------GQLDWSR-----RY------KIIGLIARGILYL 375
H N+++L F ED G+L + R+ +II + GI Y+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 376 HEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432
H+ +I+HRDLK N+LL + N +I DFG++ F + GT Y+A
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIA 196
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIITG 460
PE +HG + K DV+S GV++ +++G
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 68/260 (26%), Positives = 101/260 (38%), Gaps = 74/260 (28%)
Query: 249 KKYNAVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGRE 307
KK++ G + D T D+ IK + +G G FG+V K + G
Sbjct: 2 KKHHHHHHGKNNPDPTIYP--VLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR 52
Query: 308 I--AVKRL-SKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP------E--KQGQ 355
+ A+KR+ +S +F E+ V+ KL H N++ LLG C E G
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 356 LD---WSRRYKIIGL-----------------------IARGILYLHEDSRLRIIHRDLK 389
L R +ARG+ YL S+ + IHRDL
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLA 169
Query: 390 VSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG----------YMAPEYAMHG 439
NIL+ KI+DFG+ SR Y +MA E +
Sbjct: 170 ARNILVGENYVAKIADFGL-------------SRGQEVYVKKTMGRLPVRWMAIESLNYS 216
Query: 440 QFSVKSDVYSFGVLVLEIIT 459
++ SDV+S+GVL+ EI++
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFK 325
L + ++ + F ++LGAG G V+K PSG +A K +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRN 76
Query: 326 ---NEVVVVAKLQHRNLVRLLG---------FCLE--DPEKQGQLDWSRRY------KII 365
E+ V+ + +V G C+E D G LD + +I+
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD---GGSLDQVLKKAGRIPEQIL 133
Query: 366 GLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
G ++ ++ YL E +I+HRD+K SNIL+++ K+ DFG++ + N+
Sbjct: 134 GKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS 189
Query: 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
GT YM+PE +SV+SD++S G+ ++E+ G+
Sbjct: 190 --FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 34/199 (17%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEE-FKNEVVVVAKLQHRNLVRLLG 344
LG G F VY+ + +G E+A+K + K + G + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 345 FCLEDPEK---------QGQL-------------DWSRRYKIIGLIARGILYLHEDSRLR 382
ED G++ + +R + + I G+LYLH
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH---SHG 132
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
I+HRDL +SN+LL MN KI+DFG+A + + T + GT Y++PE A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHG 190
Query: 443 VKSDVYSFGVLVLEIITGK 461
++SDV+S G + ++ G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 30/198 (15%)
Query: 288 KLGAGGFGEVYKG---VLPSGREIAVKRLSKSSGQGAE---EFKNEVVVVAKLQHRNLVR 341
KLG GG VY +L ++A+K + + E F+ EV ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 342 LLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
++ ED E G L I GI + H +RI
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
+HRD+K NIL+D+ KI DFG+AK + + T+ + GT Y +PE A
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 444 KSDVYSFGVLVLEIITGK 461
+D+YS G+++ E++ G+
Sbjct: 192 CTDIYSIGIVLYEMLVGE 209
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-30
Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 38/212 (17%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHRNL 339
+ +LG GGFG V + + +G ++A+K+ + E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 340 VRLLG-------------------FC--------LEDPEKQGQLDWSRRYKIIGLIARGI 372
V +C L E L ++ I+ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLHE RIIHRDLK NI+L KI D G AK GT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGTLQ 188
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y+APE +++V D +SFG L E ITG
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 64/272 (23%), Positives = 102/272 (37%), Gaps = 71/272 (26%)
Query: 244 RRKAKKKYN---AVPEGNADNDLTTLESLQFDF-EAIKVATNKFSTDNKLGAGGFGEVYK 299
+ K K KY + E N T ++ Q + E + N LGAG FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 300 GVL------PSGREIAVKRL-SKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED-- 349
+ ++AVK L S + E +E+ +++ L QH N+V LLG C
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 350 ---------------------PEKQGQLDWSRRYKIIGL---------IARGILYLHEDS 379
+ ++ +A+G+ +L +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---A 181
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY--------- 430
IHRD+ N+LL KI DFG+A+ I Y
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDSNYIVKGNARLP 229
Query: 431 ---MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
MAPE ++V+SDV+S+G+L+ EI +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 31/204 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
+ K+G G G V SGR++AVK + Q E NEVV++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 339 LVRLLG-------------FC----LEDPEKQGQLDWSRRYKIIGLIARGIL----YLHE 377
+V + F L D Q +L+ + I + +L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHA 159
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+IHRD+K +ILL + K+SDFG D + + + GT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
++ + D++S G++V+E++ G+
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQHRNLVRLLG 344
LG GGF + ++ + A K + KS E+ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 345 FCLEDPEK---------QGQL------------DWSRRYKIIGLIARGILYLHEDSRLRI 383
ED + + L +R Y + ++ G YLH R R+
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQIVL-GCQYLH---RNRV 162
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSV 443
IHRDLK+ N+ L+ ++ KI DFG+A D + + GT Y+APE S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 444 KSDVYSFGVLVLEIITGK 461
+ DV+S G ++ ++ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 59/229 (25%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRL-SKSSGQGAEEFKNEVVVV 331
+K + LG G FG+V +AVK L ++ + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 332 AKL-QHRNLVRLLGFCLED----------------------------------PEKQGQL 356
+ +H+N++ LLG C +D + Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVD 415
+ +ARG+ YL + + IHRDL N+L+ KI+DFG+A I +D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 416 QTQGNTSRIAGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
T G +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 258 ------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 267 ESLQFDFEAI-KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEF 324
L+ E ++G G +G V K V PSG+ +AVKR+ + + +E
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQ 64
Query: 325 K---NEVVVVAKL-QHRNLVRLLG-------------FC---LEDPEKQGQLDWSRRY-- 362
K ++ VV + +V+ G + K
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124
Query: 363 KIIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418
+I+G I + +L E+ L+IIHRD+K SNILLD N K+ DFG++ +
Sbjct: 125 EILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 419 GNTSRIAGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGK 461
AG YMAPE A + V+SDV+S G+ + E+ TG+
Sbjct: 183 TRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 57/196 (29%), Positives = 83/196 (42%), Gaps = 31/196 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
F LG+G F EV+ +G+ A+K + KS +NE+ V+ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 339 LVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGILYLHEDS 379
+V L E G+L D R +I + + YLHE
Sbjct: 68 IVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-- 124
Query: 380 RLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
I+HRDLK N+L + I+DFG++K+ G S GT GY+APE
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVL 179
Query: 437 MHGQFSVKSDVYSFGV 452
+S D +S GV
Sbjct: 180 AQKPYSKAVDCWSIGV 195
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 59/224 (26%)
Query: 286 DNKLGAGGFGEVYKGVLP--------SGREIAVKRL-SKSSGQGAEEFKNEVVVVAKL-Q 335
LG G FG+V ++AVK L S ++ + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 336 HRNLVRLLGFCLED-----------------------PEKQGQLDWSRRYKIIGL----- 367
H+N++ LLG C +D P L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 368 ------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA-KIFGVDQTQGN 420
+ARG+ YL + + IHRDL N+L+ + KI+DFG+A I +D
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----- 245
Query: 421 TSRIAGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
T G +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 246 -YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 32/202 (15%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLS-KSSGQGAEEFKNEVVVVAKLQHRNLV 340
F+ K+G G FGEV+KG+ + + +A+K + + + E+ + E+ V+++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 341 RLLG-------------FC----LEDPEKQGQLDWSRRYKIIGLIARGIL----YLHEDS 379
+ G + D + G LD I I R IL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD----ETQIATILREILKGLDYLHSE- 138
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+ IHRD+K +N+LL K++DFG+A Q + NT GT +MAPE
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
+ K+D++S G+ +E+ G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-30
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 33/198 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE--FKNEVVVVAKLQH 336
+++ LG G FGEV K + +E AVK ++K+S + + EV ++ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 337 RNLVRLLGFCLEDPE---------KQGQL-DW---SRRY------KIIGLIARGILYLHE 377
N+++L ED G+L D +R+ +II + GI Y+H+
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 378 DSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
I+HRDLK NILL + + + KI DFG++ F + GT Y+APE
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 435 YAMHGQFSVKSDVYSFGV 452
+ G + K DV+S GV
Sbjct: 194 -VLRGTYDEKCDVWSAGV 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHR 337
+ F KLG+G FG+V+ SG E +K ++K Q E + E+ V+ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 338 NLVRLLGFCLEDPE---------KQGQL--------DWSRRY------KIIGLIARGILY 374
N++++ ED + G+L + +++ + + Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 375 LHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
H ++H+DLK NIL KI DFG+A++F D+ + AGT YM
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYM 193
Query: 432 APEYAMHGQFSVKSDVYSFGV 452
APE + K D++S GV
Sbjct: 194 APE-VFKRDVTFKCDIWSAGV 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA-------------EEFK 325
+ KLG+G +GEV E A+K + KS EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 326 NEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQLDWSR-----RY------KII 365
NE+ ++ L H N+++L ED + G+L + + ++ I+
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL-FEQIINRHKFDECDAANIM 152
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTS 422
I GI YLH+ I+HRD+K NILL ++ +N KI DFG++ F D
Sbjct: 153 KQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---R 206
Query: 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 460
GT Y+APE + +++ K DV+S GV++ ++ G
Sbjct: 207 DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 77/282 (27%)
Query: 240 FCFLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAI-KVATNKFSTDNKLGAGGFGEVY 298
+ R + G++DN+ ++ +++++ + LG+G FG+V
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM 62
Query: 299 KGVL------PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKL-QHRNLVRLLGFCLED- 349
++AVK L + + E +E+ ++ +L H N+V LLG C
Sbjct: 63 NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122
Query: 350 -------------------------------PEKQGQLDWSRRYKIIGL---------IA 369
E Q +L+ ++ +A
Sbjct: 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
+G+ +L +HRDL N+L+ KI DFG+A+ I
Sbjct: 183 KGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD------------IMSDSN 227
Query: 430 Y------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
Y MAPE G +++KSDV+S+G+L+ EI +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 35/210 (16%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVA 332
K + F LG G FG VY + +A+K L KS + + E+ + +
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 333 KLQHRNLVRLLGFCLEDPEK---------QGQL------------DWSRRYKIIGLIARG 371
L+H N++R+ + D ++ +G+L S + + +A
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADA 126
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ Y H ++IHRD+K N+L+ + KI+DFG + + T GT Y+
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM--CGTLDYL 179
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE K D++ GVL E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 31/196 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
++ +N +G G +GEV V + A K++ K + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 339 LVRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDS 379
++RL ED + S +I+ + + Y H+
Sbjct: 68 IIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-- 124
Query: 380 RLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
L + HRDLK N L + K+ DFG+A F + GT Y++P+
Sbjct: 125 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-V 179
Query: 437 MHGQFSVKSDVYSFGV 452
+ G + + D +S GV
Sbjct: 180 LEGLYGPECDEWSAGV 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 43/237 (18%)
Query: 257 GNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSK 315
G++ + L + + N ++G+G G+V+K +G IAVK++ +
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 316 SSGQGAEEFKN---EVVVVAKL-QHRNLVRLLG---------FCLE---------DPEKQ 353
S + EE K ++ VV K +V+ G +E Q
Sbjct: 61 SGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 354 GQLDWSRRYKIIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409
G + +I+G + I+ YL E +IHRD+K SNILLD K+ DFG++
Sbjct: 119 GPIP----ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 410 KIFGVDQTQGNTSRIAGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 461
VD + S AG YMAPE + +++DV+S G+ ++E+ TG+
Sbjct: 173 GRL-VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 26/196 (13%)
Query: 288 KLGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQHRNLVRLL 343
+G GG G+VY+ R +A+K +S++ + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 344 GFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385
F D +QG L R I+ I + H H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATH 157
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKS 445
RD+K NIL+ A+ + DFG+A D+ GT YMAPE + ++
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYRA 216
Query: 446 DVYSFGVLVLEIITGK 461
D+Y+ ++ E +TG
Sbjct: 217 DIYALTCVLYECLTGS 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 44/230 (19%), Positives = 81/230 (35%), Gaps = 60/230 (26%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS-----------------SGQGAEE 323
N + L G F ++ + A+K+ KS ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEK-------------------QGQLDWSRRYKI 364
FKNE+ ++ +++ + G + + ++ LD + I
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 365 IGLIAR--------GILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
+ + Y+H + I HRD+K SNIL+D K+SDFG ++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---- 202
Query: 417 TQGNTSRIAGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 461
GTY +M PE + +G K D++S G+ + +
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 42/199 (21%), Positives = 78/199 (39%), Gaps = 37/199 (18%)
Query: 288 KLGAGGFGEVYKGV--LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHRNLVRLLG 344
+ GG G +Y + +GR + +K L S A+ E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 345 FCLEDPEK----------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
F +E ++ +L + + I + YLH +
Sbjct: 147 F-VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIG 202
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
+++ DLK NI+L E K+ D G + + GT G+ APE G +
Sbjct: 203 LVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRTGP-T 254
Query: 443 VKSDVYSFGVLVLEIITGK 461
V +D+Y+ G + +
Sbjct: 255 VATDIYTVGRTLAALTLDL 273
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 45/197 (22%), Positives = 78/197 (39%), Gaps = 30/197 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
+ + +LG+G FG V++ V +GR K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 339 LVRLLGFCLEDPEKQ---------GQL-----DWSRRY------KIIGLIARGILYLHED 378
L+ L ED + G+L + + G+ ++HE
Sbjct: 110 LINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE- 167
Query: 379 SRLRIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
I+H D+K NI+ + + KI DFG+A D+ T + APE
Sbjct: 168 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 222
Query: 437 MHGQFSVKSDVYSFGVL 453
+D+++ GVL
Sbjct: 223 DREPVGFYTDMWAIGVL 239
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 20/229 (8%), Positives = 45/229 (19%), Gaps = 64/229 (27%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRL-- 342
L G V+ + + A+K + S E A+L +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 343 ------------------------------------------------LGFCLEDPEKQG 354
+G
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 355 QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414
+ + + R L ++H N+ + + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 415 DQTQGNTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 461
+ Y E+ F+ + + G+ + +
Sbjct: 247 -----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
+ +LG G FG+VYK +G A K + S + E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 339 LVRLLG-------------FC----LED--PEKQGQLDWSRRYKIIGLIARGIL----YL 375
+V+LLG FC ++ E L I ++ R +L +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFL 133
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H RIIHRDLK N+L+ E + +++DFG++ + ++ GT +MAPE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEV 188
Query: 436 AMHGQFS-----VKSDVYSFGVLVLEIITGK 461
M K+D++S G+ ++E+ +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQH 336
++ + +LG G F V + V +G E A K ++ S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 337 RNLVRLLGFCLEDPE---------KQGQL-DW--SRRY-------KIIGLIARGILYLHE 377
N+VRL ++ G+L + +R + I I I Y H
Sbjct: 65 PNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 378 DSRLRIIHRDLKVSNILLDAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
I+HR+LK N+LL ++ K++DFG+A + AGT GY++PE
Sbjct: 124 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPE 177
Query: 435 YAMHGQFSVKSDVYSFGV 452
+S D+++ GV
Sbjct: 178 VLKKDPYSKPVDIWACGV 195
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 36/204 (17%)
Query: 288 KLGAGGFGEVYKG---VLPSGREIAVKRLSKSSGQGAEE----FKNEVVVVAKLQHRNLV 340
LG GG EV+ R++AVK L ++ F+ E A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 341 RLL---------------------GFCLEDP-EKQGQLDWSRRYKIIGLIARGILYLHED 378
+ G L D +G + R ++I + + + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAK-IFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ IIHRD+K +NI++ A K+ DFG+A+ I + T+ + GT Y++PE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
+SDVYS G ++ E++TG+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 44/246 (17%)
Query: 244 RRKAKKKYNAVPEGNADNDLT--TLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV 301
+AKK +A P+G + E D+ A K K+ + +G G V + V
Sbjct: 55 LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV 114
Query: 302 -LPSGREIAVKRLSKSSGQGAEE--------FKNEVVVVAKL-QHRNLVRLLGFCLEDPE 351
+G E AVK + ++ + + E + E ++ ++ H +++ L+ E
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSS 173
Query: 352 ---------KQGQL-DW---SRRY------KIIGLIARGILYLHEDSRLRIIHRDLKVSN 392
++G+L D+ I+ + + +LH I+HRDLK N
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPEN 230
Query: 393 ILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE------YAMHGQFSVKSD 446
ILLD M ++SDFG + + + GT GY+APE H + + D
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 447 VYSFGV 452
+++ GV
Sbjct: 288 LWACGV 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLS-KSSGQGAEEFKNEVVVVAKLQHRN 338
+ + +G+G V P ++A+KR++ + +E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 339 LVRLLG-------------FC----LEDPEKQGQLDWSRRYK-----IIGLIARGIL--- 373
+V + D K + I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 374 -YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM-AKIFGVDQTQGNTSR--IAGTYG 429
YLH++ IHRD+K NILL + + +I+DFG+ A + N R GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 430 YMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 461
+MAPE + + K+D++SFG+ +E+ TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 54/229 (23%), Positives = 88/229 (38%), Gaps = 44/229 (19%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL 334
+++ + L GGF VY+ + SGRE A+KRL + + EV + KL
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL 82
Query: 335 Q-HRNLVRLLG---------------------FC-------LEDPEKQGQLDWSRRYKII 365
H N+V+ C L+ E +G L KI
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
R + ++H + IIHRDLKV N+LL + K+ DFG A +++
Sbjct: 143 YQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 426 ----------GTYGYMAPE-YAMHGQFSV--KSDVYSFGVLVLEIITGK 461
T Y PE ++ F + K D+++ G ++ + +
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---------EEFKNEVV 329
+ LG G V + + P+ +E AVK + + G E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 330 VVAKL-QHRNLVRLLGFCLEDPE---------KQGQL-DW---SRRY------KIIGLIA 369
++ K+ H N+++L E K+G+L D+ KI+ +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
I LH+ L I+HRDLK NILLD +MN K++DFG + + + GT
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 188
Query: 430 YMAPE------YAMHGQFSVKSDVYSFGV 452
Y+APE H + + D++S GV
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
S LG G FG+V+K +G ++A K + + EE KNE+ V+ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 341 RLLGFCLEDPEKQ---------GQL-DW--SRRYK--------IIGLIARGILYLHEDSR 380
+L E G+L D Y + I GI ++H+
Sbjct: 150 QLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ--- 205
Query: 381 LRIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
+ I+H DLK NIL KI DFG+A+ + + GT ++APE +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNY 262
Query: 439 GQFSVKSDVYSFGVL 453
S +D++S GV+
Sbjct: 263 DFVSFPTDMWSVGVI 277
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 35/206 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
F KLG G +G VYK + +G+ +A+K++ +E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 339 LVRLLG-------------FC----LED--PEKQGQLDWSRRYKIIGLIARGIL----YL 375
+V+ G +C + D + L I I + L YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT----EDEIATILQSTLKGLEYL 141
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H R IHRD+K NILL+ E + K++DFG+A + NT + GT +MAPE
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEV 196
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
++ +D++S G+ +E+ GK
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 48/206 (23%), Positives = 76/206 (36%), Gaps = 38/206 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVK-----RLSKSSGQGAEEFKNEVVVVAK 333
+ + +G G F V + + +G++ AVK + + S G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 334 LQHRNLVRLLGFCLEDPE---------KQGQL--------DWSRRY------KIIGLIAR 370
L+H ++V LL L D Y + I
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 371 GILYLHEDSRLRIIHRDLKVSNILLDAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGT 427
+ Y H+ IIHRD+K +LL ++ N K+ FG+A G GT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVL 453
+MAPE + DV+ GV+
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQH 336
++ + +LG G F V + V +G E A K ++ S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 337 RNLVRLLGFCLEDPE---------KQGQL-DW--SRRY-------KIIGLIARGILYLHE 377
N+VRL ++ G+L + +R + I I I Y H
Sbjct: 88 PNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 378 DSRLRIIHRDLKVSNILLDAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
I+HR+LK N+LL ++ K++DFG+A + AGT GY++PE
Sbjct: 147 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPE 200
Query: 435 YAMHGQFSVKSDVYSFGV 452
+S D+++ GV
Sbjct: 201 VLKKDPYSKPVDIWACGV 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
++ F +++LG G VY+ + + A+K L K+ + + + E+ V+ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 339 LVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGILYLHEDS 379
+++L E P + G+L D + Y + I + YLHE
Sbjct: 110 IIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-- 166
Query: 380 RLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
I+HRDLK N+L + KI+DFG++KI + GT GY APE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEIL 222
Query: 437 MHGQFSVKSDVYSFGV 452
+ + D++S G+
Sbjct: 223 RGCAYGPEVDMWSVGI 238
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 49/229 (21%), Positives = 82/229 (35%), Gaps = 57/229 (24%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK--NEVVVVAKL-Q 335
T +F K+G+G FG V+K V G A+KR K +E EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 336 HRNLVRLLG-------------FC---------LEDPEKQGQLDWSRRYKIIGLIARGIL 373
H ++VR +C E+ + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNP-------------------KISDFGMAKIFGV 414
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFS--VKSDVYSFGVLVLEIITGK 461
Q + SR ++A E + ++ K+D+++ + V+ +
Sbjct: 187 PQVEEGDSR------FLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 67/232 (28%), Positives = 92/232 (39%), Gaps = 60/232 (25%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKS---SGQGAEEF 324
F +V LG GGFGEV + +G+ A K+L K +G
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMA 231
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL--------------DWSRR 361
NE ++ K+ R +V L + E + G L +
Sbjct: 232 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 362 YKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
Y I G+ LH RI++RDLK NILLD + +ISD G+A QT
Sbjct: 291 Y--AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 342
Query: 422 SRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT GYMAPE + FS D ++ G L+ E+I G+ S F Q
Sbjct: 343 KGRVGTVGYMAPEVVKNERYT-FSP--DWWALGCLLYEMIAGQ--SPFQQRK 389
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 41/197 (20%), Positives = 69/197 (35%), Gaps = 31/197 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
K+ LG G FG V++ V S + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62
Query: 339 LVRLLGFCLEDPEKQ---------GQL-----DWSRRY------KIIGLIARGILYLHED 378
++ L E E+ + + + + + +LH
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 379 SRLRIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
I H D++ NI+ + KI +FG A+ + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVH 175
Query: 437 MHGQFSVKSDVYSFGVL 453
H S +D++S G L
Sbjct: 176 QHDVVSTATDMWSLGTL 192
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 29/227 (12%), Positives = 63/227 (27%), Gaps = 45/227 (19%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGV------LPSGREIAVKRLSKSSGQGAEEFKNEVV 329
++ + + LG G F +VY+ + ++ +K ++ +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 330 VVAKLQHRNLVRLLGFCLEDPEK---------QGQL-DWSRRYK--------------II 365
+ ++ G L + YK
Sbjct: 120 RLKPSMQHMFMKFYS-AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILL-----------DAEMNPKISDFGMAKIFGV 414
+ I +H+ IIH D+K N +L D + D G + +
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ T G+ E + ++ + D + V ++ G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 47/228 (20%)
Query: 271 FDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVV 329
D A++ F +G G +G+VYKG + +G+ A+K + +G EE K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 330 VVAKL-QHRNLVRLLG-------------------FC-------LEDPEKQGQLDWSRRY 362
++ K HRN+ G FC L K L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK----E 128
Query: 363 KIIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418
+ I I R IL +LH+ ++IHRD+K N+LL K+ DFG++ +
Sbjct: 129 EWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 419 GNTSRIAGTYGYMAPEYAMHGQFS-----VKSDVYSFGVLVLEIITGK 461
NT GT +MAPE + KSD++S G+ +E+ G
Sbjct: 186 RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 30/198 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338
+ + +LG G FG V++ +G A K + E + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 339 LVRLLGFCLEDPE--------------------KQGQLDWSRRYKIIGLIARGILYLHED 378
LV L ED + ++ + + + +G+ ++HE
Sbjct: 216 LVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE- 273
Query: 379 SRLRIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
+H DLK NI+ + + K+ DFG+ Q + GT + APE A
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 328
Query: 437 MHGQFSVKSDVYSFGVLV 454
+D++S GVL
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 37/204 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS------GQGAEEFKNEVVVVA 332
+ + +LG+G F V K +G E A K + K G EE + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 333 KLQHRNLVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGIL 373
++ H N++ L E+ G+L D+ + I I G+
Sbjct: 71 QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLH +I H DLK NI+L + P K+ DFG+A I GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPE 183
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVL 453
++APE + +++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 31/198 (15%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE--FKNEVVVVAKLQH 336
T ++ +LG G F V + V + +G+E A ++ + + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 337 RNLVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGILYLHE 377
N+VRL + G+L + +R Y I I +L+ H+
Sbjct: 70 PNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 378 DSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
+ ++HR+LK N+LL K++DFG+A +Q AGT GY++PE
Sbjct: 129 ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPE 183
Query: 435 YAMHGQFSVKSDVYSFGV 452
+ D+++ GV
Sbjct: 184 VLRKDPYGKPVDLWACGV 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 40/206 (19%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE--------FKNEVVV 330
+++ LG+G GEV + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 331 VAKLQHRNLVRLLGFCLEDPE--------KQGQL-DW---SRRY------KIIGLIARGI 372
+ KL H ++++ F + + + G+L D ++R + +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 373 LYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLHE IIHRDLK N+LL + + KI+DFG +KI G + GT
Sbjct: 128 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPT 181
Query: 430 YMAPE---YAMHGQFSVKSDVYSFGV 452
Y+APE ++ D +S GV
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 55/228 (24%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKG-VLPSGREIAVKRLSKS---SGQGAEEFKNE 327
DF ++ +G GGFGEVY +G+ A+K L K QG NE
Sbjct: 190 DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 328 ---VVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DWSRRYK 363
+ +V+ +V + + P+K G L R Y
Sbjct: 240 RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY- 297
Query: 364 IIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423
I G+ ++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 298 -AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---- 349
Query: 424 IAGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
GT+GYMAPE G S D +S G ++ +++ G S F Q
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH--SPFRQ 393
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 37/204 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS------SGQGAEEFKNEVVVVA 332
+ + +LG+G F V K +G+E A K + K G EE + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 333 KLQHRNLVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGIL 373
+++H N++ L E+ G+L D+ + + + I G+
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLH RI H DLK NI+L + P K+ DFG+A I GT
Sbjct: 123 YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPE 176
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVL 453
++APE + +++D++S GV+
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVI 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE--------FKNEVVV 330
+++ LG+G GEV + +++A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 331 VAKLQHRNLVRLLGFCLEDPE--------KQGQL-DW---SRRY------KIIGLIARGI 372
+ KL H ++++ F + + + G+L D ++R + +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLHE IIHRDLK N+LL ++ KI+DFG +KI G + GT
Sbjct: 253 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPT 306
Query: 430 YMAPE---YAMHGQFSVKSDVYSFGVLV 454
Y+APE ++ D +S GV++
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 61/234 (26%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKS---SGQGAEEF 324
F +V LG GGFGEV+ K +G+ A K+L+K +G +
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGA 232
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL----------------DWS 359
E ++AK+ R +V L + E G + +
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 360 RRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419
Y I G+ +LH+ II+RDLK N+LLD + N +ISD G+A QT+
Sbjct: 292 IFY--TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 420 NTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
AGT G+MAPE + FSV D ++ GV + E+I + F
Sbjct: 347 KGY--AGTPGFMAPELLLGEEYD-FSV--DYFALGVTLYEMIAAR--GPFRARG 393
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 37/204 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS------SGQGAEEFKNEVVVVA 332
+ + T +LG+G F V K +G + A K + K G E+ + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 333 KLQHRNLVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGIL 373
++QH N++ L E+ G+L D+ + + + I G+
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLH L+I H DLK NI+L P KI DFG+A I GT
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPE 182
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVL 453
++APE + +++D++S GV+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 28/239 (11%), Positives = 60/239 (25%), Gaps = 75/239 (31%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQ--------- 335
LG + +G V + + ++ K EV+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 336 ----------------HRNLVR--------------------------LLGFCLEDPEKQ 353
+ ++R L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413
L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 414 VDQTQGNTSRIAGTYGYMAPEY-----------AMHGQFSVKSDVYSFGVLVLEIITGK 461
+ + G+ PE + D ++ G+++ I
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 37/204 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS------SGQGAEEFKNEVVVVA 332
+ + +LG+G F V K +G E A K + K G EE + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 333 KLQHRNLVRLLGFCLEDPEKQ---------GQL-DW--SRRY-------KIIGLIARGIL 373
++ H N++ L E+ G+L D+ + I I G+
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
YLH +I H DLK NI+L + P K+ DFG+A I GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPE 183
Query: 430 YMAPEYAMHGQFSVKSDVYSFGVL 453
++APE + +++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 39/207 (18%), Positives = 66/207 (31%), Gaps = 43/207 (20%)
Query: 290 GAGGFGEVYKGV-LPSGREIAVKR--LSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLG-- 344
G V P+G + V+R L S + + E+ V H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 345 -----------FC-------LEDPEKQGQLDWSRRYKIIGLIARGIL----YLHEDSRLR 382
F L ++ I I +G+L Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMN----ELAIAYILQGVLKALDYIHHM---G 148
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-----SRIAGTYGYMAPE--- 434
+HR +K S+IL+ + +S + +++PE
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ G + KSD+YS G+ E+ G
Sbjct: 209 QNLQG-YDAKSDIYSVGITACELANGH 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLS---KSSGQGAEEFKNEVVVVAKLQ 335
FS ++G G FG VY + + +A+K++S K S + ++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 336 HRNLVRLLG-------------FC---LEDPEKQGQLDWSRRYKIIGLIARGIL----YL 375
H N ++ G +C D + + I + G L YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE--IAAVTHGALQGLAYL 170
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H +IHRD+K NILL K+ DFG A I N+ GT +MAPE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVGTPYWMAPEV 221
Query: 436 AMH---GQFSVKSDVYSFGVLVLEIITGK 461
+ GQ+ K DV+S G+ +E+ K
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 29/238 (12%), Positives = 57/238 (23%), Gaps = 74/238 (31%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQHR------- 337
LG + +G V + + ++ K EV+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 338 --------------------------------------------NLVRLLGFCLEDPEKQ 353
NL L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413
L R ++ + R + LH ++H L+ +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 260
Query: 414 VDQTQGNTSRIAGTYGYMAPEY----------AMHGQFSVKSDVYSFGVLVLEIITGK 461
G ++ G+ PE + D ++ G+ + I
Sbjct: 261 ----DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 47/218 (21%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSS---GQGAEEF 324
DF+ K+ LG G F V + RE A+K L K
Sbjct: 31 DFKFGKI----------LGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYV 77
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEK---------QGQL------------DWSRRYK 363
E V+++L H V+L F +D EK G+L +R Y
Sbjct: 78 TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY- 135
Query: 364 IIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423
I + YLH IIHRDLK NILL+ +M+ +I+DFG AK+ + Q +
Sbjct: 136 -TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
GT Y++PE SD+++ G ++ +++ G
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 35/197 (17%)
Query: 285 TDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHR-NLV 340
T +LG G F V + + +G+E A K L K E +E+ V+ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 341 RLLGFCLEDPEKQ---------GQL------DWSRRY------KIIGLIARGILYLHEDS 379
L E+ + G++ + + ++I I G+ YLH+
Sbjct: 93 NLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 380 RLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
I+H DLK NILL + KI DFGM++ G I GT Y+APE
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEIL 205
Query: 437 MHGQFSVKSDVYSFGVL 453
+ + +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGII 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 44/195 (22%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHRNLVRLLGFC 346
LG G +GEV V + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 347 LEDPEKQ---------GQL------------DWSRRY--KIIGLIARGILYLHEDSRLRI 383
+ Q G+L ++R+ +++ G++YLH + I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLH---GIGI 126
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE------YAM 437
HRD+K N+LLD N KISDFG+A +F + + +++ GT Y+APE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-- 184
Query: 438 HGQFSVKSDVYSFGV 452
H + DV+S G+
Sbjct: 185 HAE---PVDVWSCGI 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 49/199 (24%), Positives = 78/199 (39%), Gaps = 38/199 (19%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFC 346
LG G V + L + +E AVK + K G EV ++ + Q HRN++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 347 LEDPE---------KQGQL-D--WSRRY-------KIIGLIARGILYLHEDSRLRIIHRD 387
E+ + + G + RR+ ++ +A + +LH I HRD
Sbjct: 81 -EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRD 136
Query: 388 LKVSNILL---DAEMNPKISDFGMAKIF-----GVDQTQGNTSRIAGTYGYMAPE----- 434
LK NIL + KI DF + + G+ YMAPE
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 435 YAMHGQFSVKSDVYSFGVL 453
+ + D++S GV+
Sbjct: 197 SEEASIYDKRCDLWSLGVI 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHR 337
T+ + +G G + + + + E AVK + KS + E+ ++ + QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTEEIEILLRYGQHP 76
Query: 338 NLVRLLGFCLEDPE---------KQGQL-DW--SRRY-------KIIGLIARGILYLHED 378
N++ L +D + K G+L D +++ ++ I + + YLH
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA- 134
Query: 379 SRLRIIHRDLKVSNILL-DAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
++HRDLK SNIL D NP +I DFG AK + T T ++APE
Sbjct: 135 --QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPE 190
Query: 435 YAMHGQFSVKSDVYSFGVL 453
+ D++S GVL
Sbjct: 191 VLERQGYDAACDIWSLGVL 209
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 58/218 (26%), Positives = 87/218 (39%), Gaps = 64/218 (29%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS--------------------------SGQGA 321
+G G +G V A+K LSK
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 322 EEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK-----------QGQL-----------DWS 359
E+ E+ ++ KL H N+V+L+ L+DP + QG + D +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 360 RRY--KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417
R Y +I GI YLH +IIHRD+K SN+L+ + + KI+DFG++ F
Sbjct: 140 RFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 418 QGNTSRIAGTYGYMAPE--YAMHGQFS-VKSDVYSFGV 452
+ + GT +MAPE FS DV++ GV
Sbjct: 193 LLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 44/195 (22%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHRNLVRLLGFC 346
LG G +GEV V + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 347 LEDPEKQ---------GQL------------DWSRRY--KIIGLIARGILYLHEDSRLRI 383
+ Q G+L ++R+ +++ G++YLH + I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLH---GIGI 126
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE------YAM 437
HRD+K N+LLD N KISDFG+A +F + + +++ GT Y+APE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-- 184
Query: 438 HGQFSVKSDVYSFGV 452
H + DV+S G+
Sbjct: 185 HAE---PVDVWSCGI 196
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 34/126 (26%), Positives = 53/126 (42%), Gaps = 19/126 (15%)
Query: 347 LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406
LED E L + IA + +LH ++HRDLK SNI + K+ DF
Sbjct: 158 LEDREHGVCLHIFIQ------IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 407 GMAKIFGVDQTQGNTSRIA----------GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 456
G+ D+ + GT YM+PE +S K D++S G+++ E
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
Query: 457 IITGKK 462
++
Sbjct: 269 LLYSFS 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 28/123 (22%), Positives = 47/123 (38%), Gaps = 12/123 (9%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVV 329
DFE I+ +G GGFG V++ A+KR+ + + A E EV
Sbjct: 7 DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 330 VVAKLQHRNLVRLLGFCLEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLK 389
+AKL+H +VR LE P ++ Q + + + + R +
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 390 VSN 392
+
Sbjct: 117 PFS 119
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 43/213 (20%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKN-EVVVVAKLQHRN 338
++ +G G FG V++ L E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 339 LVRLLGFCLEDPEKQGQLD--------------WSRRYKIIGL-------------IARG 371
+V L F + +K+ ++ SR Y + + R
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNTSRIAGTYGY 430
+ Y+H + I HRD+K N+LLD K+ DFG AKI + N S I Y Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-Y 207
Query: 431 MAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 461
APE + G ++ D++S G ++ E++ G+
Sbjct: 208 RAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 49/215 (22%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--------SGQGAEEFKNEVVVVA 332
K+ST + LG+G FG V+ V +E+ VK + K + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 333 KLQHRNLVRLLGFCLEDPEK--------------------QGQLDWSRRYKIIGLIARGI 372
+++H N++++L E+ +LD I + +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGTYGYM 431
YL IIHRD+K NI++ + K+ DFG A +G GT Y
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFCGTIEYC 196
Query: 432 APE------YAMHGQFSVKSDVYSFGVLVLEIITG 460
APE Y G + +++S GV + ++
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTLYTLVFE 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 47/194 (24%), Positives = 78/194 (40%), Gaps = 33/194 (17%)
Query: 284 STDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVR 341
D LG G F K V S + AVK +SK + E+ + + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 342 LLGFCLEDPEKQ---------GQL-D--WSRRY-------KIIGLIARGILYLHEDSRLR 382
L D G+L + +++ I+ + + ++H+ +
Sbjct: 71 LHEVF-HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VG 126
Query: 383 IIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
++HRDLK N+L + + KI DFG A++ D T T Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQN 184
Query: 440 QFSVKSDVYSFGVL 453
+ D++S GV+
Sbjct: 185 GYDESCDLWSLGVI 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 47/209 (22%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKLQHRNLVRL- 342
LG G +G+V + + + AVK L K G K E+ ++ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 343 ----------LGFCLE----------DPEKQGQL--DWSRRY--KIIGLIARGILYLHED 378
+ +E D + + + Y ++I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----GLEYLH-- 126
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA-GTYGYMAPEYAM 437
I+H+D+K N+LL KIS G+A+ +T R + G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH-PFAADDTCRTSQGSPAFQPPEIAN 184
Query: 438 -----HGQFSVKSDVYSFGVLVLEIITGK 461
G K D++S GV + I TG
Sbjct: 185 GLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 45/207 (21%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN------EVVVVAKLQHR--NL 339
LG+GGFG VY G+ + +A+K + K E N EVV++ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 340 VRLLGFC---------LEDPEKQGQL------------DWSRRY--KIIGLIARGILYLH 376
+RLL + LE PE L + +R + +++ + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHCH 166
Query: 377 EDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
++HRD+K NIL+D K+ DFG + + GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEW 219
Query: 436 AMHGQFS-VKSDVYSFGVLVLEIITGK 461
+ ++ + V+S G+L+ +++ G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 48/222 (21%)
Query: 267 ESLQFDFEAIKVATNKFS-----TDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQG 320
L+ F+ + + + LG G G+V + +G++ A+K L S
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---- 65
Query: 321 AEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE-----------------------KQGQL 356
+ + EV + ++V +L E+ ++G
Sbjct: 66 -PKARQEVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQ 123
Query: 357 DWSRRY--KIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKI 411
++ R +I+ I I +LH I HRD+K N+L + + K++DFG AK
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVL 453
TQ T Y+APE ++ D++S GV+
Sbjct: 181 T----TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 63/243 (25%)
Query: 253 AVPEGNADNDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREI 308
++P +N+ + FE ++ +G G FG+V + +
Sbjct: 1 SMPPVFDENEDVNFD----HFEILRA----------IGKGSFGKVCIVQKND---TKKMY 43
Query: 309 AVKRLSKSSGQGAEEFKN---EVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL 356
A+K ++K E +N E+ ++ L+H LV L + +D E G L
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL 102
Query: 357 ------------DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKIS 404
+ + + I + + YL RIIHRD+K NILLD + I+
Sbjct: 103 RYHLQQNVHFKEETVKLF--ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHIT 157
Query: 405 DFGMAKIFGVDQTQGNTSRIAGTYGYMAPE------YAMHGQFSVKSDVYSFGVLVLEII 458
DF +A + + + +AGT YMAPE A + F+V D +S GV E++
Sbjct: 158 DFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAYELL 211
Query: 459 TGK 461
G+
Sbjct: 212 RGR 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGF 345
+G G F +V + +GRE+A+K + K+ + ++ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 346 CLEDPEK---------QGQL------------DWSRRYKIIGLIARGILYLHEDSRLRII 384
+E + G++ +R I + Y H + RI+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--FRQIVSAVQYCH---QKRIV 136
Query: 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE------YAMH 438
HRDLK N+LLDA+MN KI+DFG + F V + G Y APE Y
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAF--CGAPPYAAPELFQGKKYD-- 191
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
+ DV+S GV++ +++G
Sbjct: 192 ---GPEVDVWSLGVILYTLVSGS 211
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 47/208 (22%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN------EVVVVAKL----QHR 337
LG GGFG V+ G L ++A+K + ++ G + EV ++ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 338 NLVRLLGFC---------LEDPEKQGQL------------DWSRRY--KIIGLIARGILY 374
++RLL + LE P L SR + +++ I +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQH 154
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
H ++HRD+K NIL+D K+ DFG + + GT Y P
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPP 207
Query: 434 EYAMHGQFS-VKSDVYSFGVLVLEIITG 460
E+ Q+ + + V+S G+L+ +++ G
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 44/214 (20%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKN-EVVVVAKLQHR 337
++ +G G FG VY+ L SG +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 338 NLVRLLGFCLEDPEKQGQLD--------------WSRRYKIIGL-------------IAR 370
N+VRL F EK+ ++ +R Y + R
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 371 GILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
+ Y+H I HRD+K N+LLD + K+ DFG AK + + N S I Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY- 221
Query: 430 YMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 461
Y APE + G ++ DV+S G ++ E++ G+
Sbjct: 222 YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 53/229 (23%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSS--GQGAEEFK 325
FE +KV LG G FG+V+ + + A+K L K++ + K
Sbjct: 25 QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74
Query: 326 NEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DWSRRYKI 364
E ++ ++ H +V+L + + K G L + + Y
Sbjct: 75 MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-- 131
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
+ +A + +LH L II+RDLK NILLD E + K++DFG++K +D +
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK-AYSF 186
Query: 425 AGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT YMAPE H Q S D +SFGVL+ E++TG F D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQ-SA--DWWSFGVLMFEMLTGT--LPFQGKD 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKS---SGQGAEEF 324
DFE +KV +G G FGEV K + + A+K L+K F
Sbjct: 75 DFEILKV----------IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACF 121
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL-------------DWSRRY 362
+ E V+ + + L + +D G L + +R Y
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
+ + I +H+ L +HRD+K NIL+D + +++DFG D T +S
Sbjct: 181 --LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSS 234
Query: 423 RIAGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT Y++PE G++ + D +S GV + E++ G+ + FY
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAES 285
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 58/232 (25%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKS---SGQGAEEF 324
DFE +KV +G G F EV K +G+ A+K ++K F
Sbjct: 62 DFEILKV----------IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL-------------DWSRRY 362
+ E V+ R + +L F +D G L + +R Y
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
+ I I +H L +HRD+K NILLD + +++DFG D T +
Sbjct: 168 --LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SL 221
Query: 423 RIAGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
GT Y++PE G + + D ++ GV E+ G+ + FY
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFY 271
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 55/231 (23%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY---KGVLPSGREI-AVKRLSKSS----GQGAEE 323
FE ++V LG GG+G+V+ K + +I A+K L K+ +
Sbjct: 18 CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DWSRRY 362
K E ++ +++H +V L+ + + K G+L D + Y
Sbjct: 68 TKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
+ I+ + +LH+ II+RDLK NI+L+ + + K++DFG+ K D T +T
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180
Query: 423 RIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT YMAPE + H + +V D +S G L+ +++TG F +
Sbjct: 181 -FCGTIEYMAPEILMRSGHNR-AV--DWWSLGALMYDMLTGA--PPFTGEN 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 44/199 (22%), Positives = 76/199 (38%), Gaps = 42/199 (21%)
Query: 285 TDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRL 342
T LG G G+V + + + A+K L + + EV + + ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 343 LGFCLEDPE-----------------------KQGQLDWSRRY--KIIGLIARGILYLHE 377
+ E+ +G ++ R +I+ I I YLH
Sbjct: 121 VDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 378 DSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
+ I HRD+K N+L K++DFG AK + + T Y+APE
Sbjct: 180 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPE 233
Query: 435 YAMHGQFSVKSDVYSFGVL 453
++ D++S GV+
Sbjct: 234 VLGPEKYDKSCDMWSLGVI 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 53/208 (25%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRL-- 342
LG G FG+V G +G ++AVK L++ S + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 343 -------LGFCLEDPE---------KQGQL--DWSRRY--KIIGLIARGILYLHEDSRLR 382
+E K G++ +RR +I+ + Y H R
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----AVDYCH---RHM 131
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN---TSRIAGTYGYMAPE----- 434
++HRDLK N+LLDA MN KI+DFG++ + + G TS G+ Y APE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPEVISGR 185
Query: 435 -YAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y G + D++S GV++ ++ G
Sbjct: 186 LY--AGP---EVDIWSCGVILYALLCGT 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 59/230 (25%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKS---SGQGAEEF 324
D+E +KV +G G FGEV K + + A+K LSK + F
Sbjct: 70 DYEVVKV----------IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL-----------DWSRRYKI 364
E ++A +V+L + +D G L W+R Y
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-- 173
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
+ + +H + IHRD+K N+LLD + K++DFG +
Sbjct: 174 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTA 229
Query: 425 AGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467
GT Y++PE +G+ D +S GV + E++ G + FY
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGR-EC--DWWSVGVFLYEMLVGD--TPFY 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 54/208 (25%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
LG G FG+V + +++A+K +S+ + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 345 FCLEDPEK------------------QGQL--DWSRRY--KIIGLIARGILYLHEDSRLR 382
+ P + ++ D RR+ +II I Y H R +
Sbjct: 77 V-ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC----AIEYCH---RHK 128
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN---TSRIAGTYGYMAPE----- 434
I+HRDLK N+LLD +N KI+DFG++ I T GN TS G+ Y APE
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTS--CGSPNYAAPEVINGK 182
Query: 435 -YAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y G + DV+S G+++ ++ G+
Sbjct: 183 LY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 52/228 (22%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSSGQGAEEF--- 324
+FE +K+ LG G FG+V K +GR A+K L K +E
Sbjct: 149 EFEYLKL----------LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHT 195
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEK--------QG-----QLDWSRRYKI------I 365
E V+ +H L L + + ++ G L R +
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 254
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
I + YLH S +++RDLK+ N++LD + + KI+DFG+ K D T
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FC 310
Query: 426 GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT Y+APE +G+ +V D + GV++ E++ G+ FY D
Sbjct: 311 GTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 353
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 55/233 (23%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY---KGVLPSGREI-AVKRLSKSS----GQGAEE 323
+FE +KV LG G +G+V+ K ++ A+K L K++ + E
Sbjct: 55 NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 324 FKNEVVVVAKLQHRN-LVRLLGFCLEDPEKQ---------GQL------------DWSRR 361
+ E V+ ++ LV L + + K G+L +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 163
Query: 362 YKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
Y +G I + +LH+ L II+RD+K+ NILLD+ + ++DFG++K F D+T+
Sbjct: 164 Y--VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-A 217
Query: 422 SRIAGTYGYMAPE---YAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT YMAP+ G +V D +S GVL+ E++TG S F
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDG 266
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 61/231 (26%), Positives = 90/231 (38%), Gaps = 62/231 (26%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSS----GQGAEE 323
F+ IK LG G FG V K SG A+K L K Q E
Sbjct: 42 QFDRIKT----------LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQ-IEH 87
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DWSRRY 362
NE ++ + LV+L F +D G++ +R Y
Sbjct: 88 TLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
I YLH L +I+RDLK N+L+D + +++DFG AK G T
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTW 196
Query: 423 RIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
+ GT +APE + + + +V D ++ GVL+ E+ G F+
Sbjct: 197 TLCGTPEALAPEIILSKGYNK-AV--DWWALGVLIYEMAAGY--PPFFADQ 242
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 52/227 (22%), Positives = 89/227 (39%), Gaps = 50/227 (22%)
Query: 273 FEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKR-LSKSSGQGAEEFKN---- 326
E + ++F + G G FG V G +G +A+K+ + F+N
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQ 68
Query: 327 EVVVVAKLQHRNLVRLLGFCLEDPEKQGQLD----------------WSRRYKIIGL--- 367
+ +A L H N+V+L ++ + D R Y +
Sbjct: 69 IMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP 127
Query: 368 ----------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQ 416
+ R I LH S + + HRD+K N+L++ K+ DFG AK +
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 417 TQGNTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 461
N + I Y Y APE + G ++ D++S G + E++ G+
Sbjct: 187 P--NVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 57/230 (24%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEV----YKGVLPSGREIAVKRLSKSSGQGAEEF--- 324
DF+ +K+ LG G FG+V K +GR A+K L K +E
Sbjct: 6 DFDYLKL----------LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHT 52
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPEK--------QG-----QLDWSRRYKI------I 365
E V+ +H L L + + ++ G L R +
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG 111
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQTQGNTSR 423
I + YLH +++RD+K+ N++LD + + KI+DFG+ K I T
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-- 164
Query: 424 IAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT Y+APE +G+ +V D + GV++ E++ G+ FY D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 55/209 (26%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
LG G FG+V G +G ++AVK L++ S + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 345 FCLEDPEK---------QGQL------------DWSRRY--KIIGLIARGILYLHEDSRL 381
+ P G+L SRR +I+ G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----GVDYCH---RH 135
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN---TSRIAGTYGYMAPE---- 434
++HRDLK N+LLDA MN KI+DFG++ + + G TS G+ Y APE
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPEVISG 189
Query: 435 --YAMHGQFSVKSDVYSFGVLVLEIITGK 461
YA + D++S GV++ ++ G
Sbjct: 190 RLYA-----GPEVDIWSSGVILYALLCGT 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 4e-19
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKN--------EVVVVA 332
K+ K+G G +G VYK GR +A+KR+ + E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 333 KLQHRNLVRLL-------------GFCLEDPEK-----QGQLDWSRRYKIIGLIARGILY 374
+L H N+V L+ F +D +K + L S+ + + RG+ +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
H+ RI+HRDLK N+L++++ K++DFG+A+ FG+ + T + T Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPD 189
Query: 435 YAMHG-QFSVKSDVYSFGVLVLEIITGK 461
M ++S D++S G + E+ITGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN--------EVVVV 331
++ + LG G F VYK + + +A+K++ E K+ E+ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 332 AKLQHRNLVRLLG-------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGIL 373
+L H N++ LL F D E L S + + +G+
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
YLH+ I+HRDLK +N+LLD K++DFG+AK FG + T ++ T Y AP
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYRAP 181
Query: 434 EYAMHG-QFSVKSDVYSFGVLVLEIITGK 461
E + V D+++ G ++ E++
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 47/195 (24%)
Query: 289 LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRL----- 342
+G+G FG + +AVK + + + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 343 ----LGFCLEDPE---------KQGQL--DWSRRY--KIIGLIARGILYLHEDSRLRIIH 385
L +E G+ D +R + +++ G+ Y H ++I H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS----GVSYCH---SMQICH 139
Query: 386 RDLKVSNILLDA--EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE------YAM 437
RDLK+ N LLD KI DFG +K V +Q ++ GT Y+APE Y
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST--VGTPAYIAPEVLLRQEYD- 195
Query: 438 HGQFSVKSDVYSFGV 452
G+ +DV+S GV
Sbjct: 196 -GK---IADVWSCGV 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 8e-19
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 58/229 (25%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSS----GQGAEE 323
DF+ ++ LG G FG V+ + +GR A+K L K Q E
Sbjct: 7 DFQILRT----------LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQ-VEH 52
Query: 324 FKNEVVVVAKLQHRNLVRLLGFCLEDPEK--------QG-----QLDWSRRYKI------ 364
+E ++++ + H ++R+ +D ++ +G L S+R+
Sbjct: 53 TNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY 111
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
+ + YLH II+RDLK NILLD + KI+DFG AK T +
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTL 163
Query: 425 AGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
GT Y+APE + + S+ D +SFG+L+ E++ G + FY ++
Sbjct: 164 CGTPDYIAPEVVSTKPYNK-SI--DWWSFGILIYEMLAGY--TPFYDSN 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKN--------EVVVVA 332
K+ K+G G +G VYK G A+K++ E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 333 KLQHRNLVRLLG-------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGILY 374
+L+H N+V+L +D +K +G L+ + + GI Y
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
H+ R++HRDLK N+L++ E KI+DFG+A+ FG+ + T I T Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPD 170
Query: 435 YAMHG-QFSVKSDVYSFGVLVLEIITGK 461
M ++S D++S G + E++ G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 57/213 (26%), Positives = 83/213 (38%), Gaps = 47/213 (22%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFKN----EVVVVAK 333
K+ +G G +G V K +GR +A+K S + K E+ ++ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 334 LQHRNLVRLLG-------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGILYL 375
L+H NLV LL F LD+ K + I GI +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE- 434
H IIHRD+K NIL+ K+ DFG A+ + +A T Y APE
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPEL 195
Query: 435 ------YAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y +V DV++ G LV E+ G+
Sbjct: 196 LVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 288 KLGAGGFGEVYKGV---LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLG 344
K+G G +G VYK ++ A+K++ + +G + E+ ++ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 345 FCLEDPEKQ-------------GQLDWSRRYKIIGL---------------IARGILYLH 376
L +++ + + R K I GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGV-DQTQGNTSRIAGTYGYM 431
+ ++HRDLK +NIL+ E KI+D G A++F + + + T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 432 APEYAMHG--QFSVKSDVYSFGVLVLEIITGK 461
APE + G ++ D+++ G + E++T +
Sbjct: 203 APELLL-GARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 67/237 (28%), Positives = 98/237 (41%), Gaps = 70/237 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEV----YKGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
DF + V LG G FG+V KG + AVK L K ++
Sbjct: 21 DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQ----DDD 63
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DW 358
V V+ + L +L C + ++ G L
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 122
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+ Y IA G+ +L II+RDLK+ N++LD+E + KI+DFGM K I+
Sbjct: 123 AVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T T GT Y+APE Y +G SV D ++FGVL+ E++ G+ + F D
Sbjct: 178 T--KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 70/237 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
DF +KV +G G FG+V K AVK L K + K E
Sbjct: 39 DFHFLKV----------IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILK----KKE 81
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DW 358
V++ ++H LV L F + +K G+L
Sbjct: 82 EKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+R Y IA + YLH L I++RDLK NILLD++ + ++DFG+ K I
Sbjct: 141 ARFY--AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T +T GT Y+APE + +V D + G ++ E++ G FY +
Sbjct: 196 T--ST--FCGTPEYLAPEVLHKQPYD-RTV--DWWCLGAVLYEMLYGL--PPFYSRN 243
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 31/205 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN----EVVVVAKLQ 335
K+ K+G G +G V+K +G+ +A+K+ +S K E+ ++ +L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLK 60
Query: 336 HRNLVRLLG-------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGILYLHE 377
H NLV LL +C Q + I + + + H
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH- 119
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+ IHRD+K NIL+ K+ DFG A++ + +A T Y +PE +
Sbjct: 120 --KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELLV 175
Query: 438 HG-QFSVKSDVYSFGVLVLEIITGK 461
Q+ DV++ G + E+++G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 5e-18
Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 39/210 (18%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN--------EVVVV 331
K+ K+G G +G V+K + +A+KR+ ++ E+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 332 AKLQHRNLVRLLG-------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGIL 373
+L+H+N+VRL FC +D +K G LD + + +G+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+ H ++HRDLK N+L++ K+++FG+A+ FG+ + ++ + T Y P
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPP 170
Query: 434 EYAMHG-QFSVKSDVYSFGVLVLEIITGKK 462
+ +S D++S G + E+ +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN-----EVVVVA 332
AT+++ ++G G +G VYK SG +A+K + +G G EV ++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 333 KLQ---HRNLVRLLGFCLEDPEKQGQ--------LDWS-----RRYKIIGL--------- 367
+L+ H N+VRL+ C + +D + GL
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 368 --IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
RG+ +LH + I+HRDLK NIL+ + K++DFG+A+I+ T +
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVV 181
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
T Y APE + ++ D++S G + E+ K
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 70/237 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEV----YKGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
DF K+ LG G FG+V +K + + A+K L K ++
Sbjct: 18 DFILHKM----------LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLM----DDD 60
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DW 358
V V+ +H L + + E G L
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 119
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+ Y I G+ +LH I++RDLK+ NILLD + + KI+DFGM K + G +
Sbjct: 120 ATFY--AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T NT GT Y+APE + SV D +SFGVL+ E++ G+ S F+ D
Sbjct: 175 T--NT--FCGTPDYIAPEILLGQKYN-HSV--DWWSFGVLLYEMLIGQ--SPFHGQD 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 53/222 (23%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFKN----EVVVVAK 333
+K+ K+G G FGEV+K +G+++A+K + E F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72
Query: 334 LQHRNLVRLLGFCLEDPEKQGQLDWSRRYKI-----------IGLIA------------- 369
L+H N+V L+ C + I GL++
Sbjct: 73 LKHENVVNLIEICRTKASPYN----RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 370 ------RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN--- 420
G+ Y+H + +I+HRD+K +N+L+ + K++DFG+A+ F + +
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 461
T+R+ T Y PE + + D++ G ++ E+ T
Sbjct: 186 TNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 46/206 (22%), Positives = 89/206 (43%), Gaps = 34/206 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKG-VLPSGREIAVKRLSKSSGQGAEEFKN-----EVVVVAKL 334
+ +KLG G + VYKG + +A+K + EE EV ++ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDL 57
Query: 335 QHRNLVRLLG-------------FCLEDPEK-----QGQLDWSRRYKIIGLIARGILYLH 376
+H N+V L + +D ++ ++ + + RG+ Y H
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA 436
+++HRDLK N+L++ K++DFG+A+ + T+ + + T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDIL 172
Query: 437 MHG-QFSVKSDVYSFGVLVLEIITGK 461
+ +S + D++ G + E+ TG+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 70/237 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
+FE I+V LG G FG+V K +G AVK L K ++
Sbjct: 24 NFEFIRV----------LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQ----DDD 66
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DW 358
V ++ H L +L C + P++ G L
Sbjct: 67 VECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR 125
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+R Y I +++LH+ II+RDLK+ N+LLD E + K++DFGM K I
Sbjct: 126 ARFY--AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T T GT Y+APE ++G +V D ++ GVL+ E++ G + F +
Sbjct: 181 T--AT--FCGTPDYIAPEILQEMLYG-PAV--DWWAMGVLLYEMLCGH--APFEAEN 228
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN-----EVVVVA 332
++++F KLG G + VYKG+ +G +A+K + +EE E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLMK 58
Query: 333 KLQHRNLVRLL-------------GFCLED----------PEKQGQLDWSRRYKIIGLIA 369
+L+H N+VRL F D L+ + +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
+G+ + HE+ +I+HRDLK N+L++ K+ DFG+A+ FG+ +S + T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLW 173
Query: 430 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 461
Y AP+ M +S D++S G ++ E+ITGK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 67/237 (28%), Positives = 98/237 (41%), Gaps = 70/237 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEV----YKGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
DF + V LG G FG+V KG + AVK L K ++
Sbjct: 342 DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILKK----DVVIQDDD 384
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEKQ---------GQL------------DW 358
V V+ + L +L C + ++ G L
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 443
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+ Y IA G+ +L II+RDLK+ N++LD+E + KI+DFGM K I+
Sbjct: 444 AVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
T T GT Y+APE Y +G SV D ++FGVL+ E++ G+ + F D
Sbjct: 499 T--KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 546
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+A+G+ +L + + IHRDL NILL + KI DFG+A+ D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
+MAPE ++++SDV+SFGVL+ EI +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 20/150 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAK 333
++ LG G FG+V + + R +AVK L + + +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 334 L-QHRNLVRLLGFCLEDPE---------KQGQLD---WSRRYKIIGLIARGILYLHEDSR 380
+ H N+V LLG C + K G L S+R + + +G +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAK 410
+ I DLK + + + S F K
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 68/228 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
DF+ ++V +G G + +V K + R A+K + K +
Sbjct: 10 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVND----DED 52
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEK-------------------QGQL--DW 358
+ V H LV L C + + Q +L +
Sbjct: 53 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+R Y I+ + YLHE II+RDLK+ N+LLD+E + K++D+GM K + D
Sbjct: 112 ARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 461
T +T GT Y+APE +G FSV D ++ GVL+ E++ G+
Sbjct: 167 T--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 68/228 (29%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVY----KGVLPSGREIAVKRLSKSSGQGAEEFKNE 327
DF+ ++V +G G + +V K + R A++ + K +
Sbjct: 53 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVND----DED 95
Query: 328 V--------VVVAKLQHRNLVRLLGFCLEDPEK-------------------QGQL--DW 358
+ V H LV L C + + Q +L +
Sbjct: 96 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 359 SRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK--IFGVDQ 416
+R Y I+ + YLHE II+RDLK+ N+LLD+E + K++D+GM K + D
Sbjct: 155 ARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209
Query: 417 TQGNTSRIAGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 461
T +T GT Y+APE +G FSV D ++ GVL+ E++ G+
Sbjct: 210 T--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 250
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 43/213 (20%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN--------EVVVV 331
+++ KLG G +GEVYK + + +A+KR+ E + EV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 332 AKLQHRNLVRLLGFCLEDP-----------------EKQGQLDWSRRYKIIGLIARGILY 374
+LQHRN++ L + +K + + + G+ +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNP-----KISDFGMAKIFGVDQTQGNTSRIAGTYG 429
H R +HRDLK N+LL KI DFG+A+ FG+ + T I T
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-TLW 202
Query: 430 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 461
Y PE + +S D++S + E++
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 49/218 (22%)
Query: 281 NKFSTDNKLGAGGFGEVYKG--VLPSGREIAVKRLSKSSGQGAEEFKN--------EVVV 330
++ ++G G +G+V+K + GR +A+KR+ + + EV V
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 331 VAKLQ---HRNLVRLL------------------GFC------LEDPEKQGQLDWSRRYK 363
+ L+ H N+VRL D + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 364 IIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR 423
++ + RG+ +LH R++HRDLK NIL+ + K++DFG+A+I+ TS
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 179
Query: 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ T Y APE + ++ D++S G + E+ K
Sbjct: 180 VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFK 325
ES ++ + + KLG G + EV++ + + + ++ VK L ++ K
Sbjct: 26 ESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIK 78
Query: 326 NEVVVVAKLQ-HRNLVRLLGFCLEDPEKQG---------QLDWSRRYKIIGL-------- 367
E+ ++ L+ N++ L ++DP + D+ + Y+ +
Sbjct: 79 REIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY 137
Query: 368 -IARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIA 425
I + + Y H S I+HRD+K N+++D E ++ D+G+A+ + Q R+A
Sbjct: 138 EILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVA 192
Query: 426 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGKK 462
Y + PE + Q S D++S G ++ +I K+
Sbjct: 193 SRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 39/153 (25%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGF 345
LG G G+V + + + A+K L + + EV + + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 346 CLEDPE-----------------------KQGQLDWSRRY--KIIGLIARGILYLHEDSR 380
E+ +G ++ R +I+ I I YLH
Sbjct: 80 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--- 135
Query: 381 LRIIHRDLKVSNILL---DAEMNPKISDFGMAK 410
+ I HRD+K N+L K++DFG AK
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 52/232 (22%)
Query: 268 SLQFDFEAIKVATNKFSTDNK------LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQG 320
+F ++++ + F+ + +G+G G V R +A+K+LS+
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---- 61
Query: 321 AEEFKN---------EVVVVAKLQHRNLVRLLGFCLEDPE-------------------- 351
F+N E+V++ + H+N++ LL
Sbjct: 62 ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118
Query: 352 --KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMA 409
+ Y ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+A
Sbjct: 119 VIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ + T + T Y APE + + D++S G ++ E+I G
Sbjct: 175 R--TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 9/105 (8%)
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILL--DAEMNPKISDFGMAKIFGVDQTQGN 420
I+ I + YLH I HRD+K N L + K+ DFG++K F
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 421 T--SRIAGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ AGT ++APE + + K D +S GVL+ ++ G
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 7/79 (8%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVK-----RLSKSSGQGAEEFKNEVVVVAK 333
K+ +G G +G V + + A+K ++ + + + E K EV ++ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 334 LQHRNLVRLLGFCLEDPEK 352
L H N+ RL ED +
Sbjct: 85 LHHPNIARLYE-VYEDEQY 102
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 10/97 (10%)
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP-KISDFGMAKIFGVDQTQGNTSRIAG 426
+ R + ++H L I HRD+K N+L++++ N K+ DFG AK ++ + + I
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204
Query: 427 TYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 461
+ Y APE M G +++ D++S G + E+I GK
Sbjct: 205 RF-YRAPEL-MLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVV 329
++ +G+G G V R +A+K+LS+ F+N E+V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 330 VVAKLQHRNLVRLLGFCLEDPE----------------------KQGQLDWSRRYKIIGL 367
++ + H+N++ LL + Y + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ GI +LH IIHRDLK SNI++ ++ KI DFG+A+ + T + T
Sbjct: 174 L-CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-T 226
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y APE + + D++S G ++ E++ K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 47/218 (21%), Positives = 79/218 (36%), Gaps = 43/218 (19%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK------ 333
+ ++ + +G +G V GV G +A+KR+ + G + K
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 334 -----LQHRNLVRLLG-FCLEDPE--------------------KQGQLDWSR---RYKI 364
H N++ L F + ++ S +Y
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-F 139
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
+ I G+ LHE ++HRDL NILL + I DF +A+ D + T +
Sbjct: 140 MYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYV 194
Query: 425 AGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
Y APE M F+ D++S G ++ E+ K
Sbjct: 195 T-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 49/215 (22%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVV 329
+ + +G+G +G V + SG ++A+K+LS+ F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 330 VVAKLQHRNLVRLLGFCLEDPE----------------------KQGQLDWSRRYKIIGL 367
++ +QH N++ LL + +Y ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-LVYQ 134
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ +G+ Y+H ++HRDLK N+ ++ + KI DFG+A+ + T +R
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--- 188
Query: 428 YGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
Y APE + ++ D++S G ++ E++TGK
Sbjct: 189 --YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 16/196 (8%), Positives = 46/196 (23%), Gaps = 56/196 (28%)
Query: 288 KLGAGGFGEVYKG---VLPSGREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQHRNLVR 341
G + ++ L R++A+ + +E + + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 342 LLGFCLEDPEK----------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIH 385
+L + + +A H R +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVAL 152
Query: 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKS 445
S + +S G + M + +
Sbjct: 153 SIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA-------NPQD 183
Query: 446 DVYSFGVLVLEIITGK 461
D+ G + ++ +
Sbjct: 184 DIRGIGASLYALLVNR 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 56/200 (28%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK----- 333
+++ + +G G +G V + R +A+K++ + F++ + K
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLID--CKRILRE 102
Query: 334 ------LQHRNLVRLLG-FCLEDPEKQGQLDWSRRY-----------KII----GL---- 367
L H ++V++L +D EK +L Y K+ L
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDEL-----YVVLEIADSDFKKLFRTPVYLTELH 157
Query: 368 -------IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420
+ G+ Y+H S I+HRDLK +N L++ + + K+ DFG+A+ + +
Sbjct: 158 IKTLLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 421 TSRIAGTYGYMAPEYAMHGQ 440
I+ M H +
Sbjct: 215 QLPISPREDDMNLVTFPHTK 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 54/229 (23%)
Query: 272 DFEAIKVATNKFSTDNK------LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEF 324
F +V + +G+G +G V V +G ++A+K+L + F
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------F 62
Query: 325 KN---------EVVVVAKLQHRNLVRLLGFCLEDPE----------------------KQ 353
++ E+ ++ ++H N++ LL D K
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413
+L R ++ + +G+ Y+H IIHRDLK N+ ++ + KI DFG+A+
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
Query: 414 VDQTQGNTSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
+ T +R Y APE + +++ D++S G ++ E+ITGK
Sbjct: 180 SEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 41/226 (18%), Positives = 88/226 (38%), Gaps = 57/226 (25%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVV 329
+++ LG GG G V+ V + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 330 VVAKLQHRNLVRLLG-FCLEDPEKQGQLDWSRRYKIIGL--------------------- 367
++ +L H N+V++ + + + +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 368 --------IARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQ 418
+ RG+ Y+H + ++HRDLK +N+ ++ E + KI DFG+A+I +
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 419 GN--TSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 461
+ + T Y +P + ++ D+++ G + E++TGK
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 46/216 (21%), Positives = 91/216 (42%), Gaps = 46/216 (21%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVV 329
+++ + +G G +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 330 VVAKLQHRNLVRLLG-FCLEDPE--------------------KQGQLDWSRRYKIIGLI 368
++ + +H N++ + E K L + I
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 369 ARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN--TSRIAG 426
RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+A++ D T +A
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA- 193
Query: 427 TYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
T Y APE + ++ D++S G ++ E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 54/229 (23%)
Query: 272 DFEAIKVATNKFSTDNK------LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEF 324
F ++ + + +G+G +G V +G +AVK+LS+ F
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------F 66
Query: 325 KN---------EVVVVAKLQHRNLVRLL-----GFCLEDPE-----------------KQ 353
++ E+ ++ ++H N++ LL LE+ K
Sbjct: 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413
+L +I I RG+ Y+H IIHRDLK SN+ ++ + KI DFG+A+
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 414 VDQTQGNTSRIAGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
+ T +R Y APE + ++ D++S G ++ E++TG+
Sbjct: 184 DEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 49/215 (22%)
Query: 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ----------- 335
KLG G F V+ + + +A+K + + E ++E+ ++ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 336 HRNLVRLLG-FCLEDP---------EKQGQ--LDWSRRYKIIGL-------IARGIL--- 373
++++LL F + P E G+ L ++Y+ G+ I++ +L
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 374 -YLHEDSRLRIIHRDLKVSNILLDAEMNP------KISDFGMAKIFGVDQTQGNTSRIAG 426
Y+H R IIH D+K N+L++ +P KI+D G A + T +R
Sbjct: 145 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-- 200
Query: 427 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y +PE + + +D++S L+ E+ITG
Sbjct: 201 ---YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 57/225 (25%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN---------EVV 329
++ F + LG G +G V P+G +A+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 330 VVAKLQHRNLVRLLG-FCLEDPE--------------------KQGQL-DWSRRYKIIGL 367
++ +H N++ + + E L D +Y I
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQ 120
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
R + LH + +IHRDLK SN+L+++ + K+ DFG+A+ +D++ + S G
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQ 175
Query: 428 YGYM----------APEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
M APE + ++S DV+S G ++ E+ +
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 62/259 (23%)
Query: 242 FLRRKAKKKYNAVPEGNADNDLTTLESLQFDFEAIK--VATNKFSTDNKLGAGGFGEVYK 299
F + KK V D+D +D+ +++ D+ +G G FG+V K
Sbjct: 20 FQSMSSHKKERKVYNDGYDDD-------NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK 72
Query: 300 GV-LPSGREIAVK---RLSKSSGQGAEEFKNEVVVVAKLQHR------NLVR-------- 341
+A+K Q + EV ++ + +V
Sbjct: 73 AYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128
Query: 342 --------LLGFCLEDPEKQGQ-----LDWSRRYKIIGLIARGIL----YLHEDSRLRII 384
+L + L D + L+ +R++ A+ + +L L II
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF------AQQMCTALLFLA-TPELSII 181
Query: 385 HRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
H DLK NILL KI DFG + G Q SR Y +PE + +
Sbjct: 182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGMPYD 236
Query: 443 VKSDVYSFGVLVLEIITGK 461
+ D++S G +++E+ TG+
Sbjct: 237 LAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 34/203 (16%), Positives = 73/203 (35%), Gaps = 50/203 (24%)
Query: 277 KVATNKFSTDNK------LGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN--- 326
+ +G G +G VY + + +A+K++++ F++
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLID 68
Query: 327 ------EVVVVAKLQHRNLVRLLG-FCLEDPE--------------------KQGQL--D 357
E+ ++ +L+ ++RL +D K +
Sbjct: 69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE 128
Query: 358 WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417
+ I+ + G ++HE IIHRDLK +N LL+ + + K+ DFG+A+ ++
Sbjct: 129 EHIKT-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 418 QGNTSRIAGTYGYMAPEYAMHGQ 440
+ + + Q
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQ 207
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 38/165 (23%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---- 335
N++ K+G+G FG++Y G + +G E+A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 336 ------------HRNLV-RLLGFCLEDPEKQGQLDWSRR---YKIIGLIARGIL----YL 375
+ +V LLG LED ++ R K + L+A ++ Y+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPSLED-----LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPK---ISDFGMAKIFGVDQT 417
H + IHRD+K N L+ I DFG+AK + +T
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 65/234 (27%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK----- 333
K+ KLG G +G V+K + +G +AVK++ + F+N A+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQN--STDAQRTFRE 58
Query: 334 ---LQ----HRNLVRLLGFCLEDPEK-----------------QGQL--DWSRRYKIIGL 367
L H N+V LL D ++ + + ++Y ++
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-VVYQ 117
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ + I YLH S ++HRD+K SNILL+AE + K++DFG+++ F + N ++
Sbjct: 118 LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 428 YG-------------------YMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
Y APE + +++ D++S G ++ EI+ GK
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 40/162 (24%), Positives = 61/162 (37%), Gaps = 40/162 (24%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---- 335
F K+G G FGE+ G L + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 336 ------------HRNLV-RLLGFCLEDPEKQGQLDWSRR---YKIIGLIARGIL----YL 375
+ +V LLG LED D R K + +IA ++ Y+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLED-----LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPK-----ISDFGMAKIF 412
H + +I+RD+K N L+ N I DF +AK +
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 4e-10
Identities = 32/201 (15%), Positives = 55/201 (27%), Gaps = 67/201 (33%)
Query: 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRL--------SKSSGQGAEEFKNEVV 329
+ T K K+G G FGEV++ + +A+K + + S + EE E++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 330 VVAKLQ---------HRNLVRLLG------------------------------------ 344
+ +L + L
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 345 ---------FCLEDPEKQGQ--LDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393
F D E+ + I+ + + LR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 394 LLDAEMNPKISDFGMAKIFGV 414
LL K+ K +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 36/160 (22%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--QGAEEFK-----NEVVVVA 332
+ ++G G FG +++G L + +++A+K + S Q +E++ +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 333 KL-------QHRNLV-RLLGFCLEDPEKQGQLDWSRR---YKIIGLIARGIL----YLHE 377
+ H LV LLG LED LD R K + + A+ +L +HE
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGPSLED-----LLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPK-----ISDFGMAKIF 412
S +++RD+K N L+ + + DFGM K +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 53/218 (24%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHR- 337
++ +G G FG+V K + +A+K + ++ + + E+ ++ L+ +
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 338 -----NLVR----------------LLGFCLEDPEKQGQLDWSRRYKI--IGLIARGIL- 373
N++ LL L + K+ + + + + + A IL
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF---QGFSLPLVRKFAHSILQ 211
Query: 374 ---YLHEDSRLRIIHRDLKVSNILLDAEMNP--KISDFGMA-----KIFGVDQTQGNTSR 423
LH + RIIH DLK NILL + K+ DFG + +++ Q SR
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ-----SR 263
Query: 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y APE + ++ + D++S G ++ E++TG
Sbjct: 264 F-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 31/178 (17%), Positives = 61/178 (34%), Gaps = 54/178 (30%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSG------REIAVKRLSKSSGQGAEEFK--------N 326
+ +G GGFG +Y + S VK +G E K
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 327 EVVVVAKLQ----------------------HRNLV-RLLGFCLEDPEKQGQLDWSRR-- 361
++ + + +R ++ G L+ + + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-----IYEANAKRF 149
Query: 362 -YKIIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKI--SDFGMAKIF 412
K + ++ IL Y+HE +H D+K SN+LL+ + ++ D+G+A +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 31/179 (17%), Positives = 60/179 (33%), Gaps = 56/179 (31%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV---------LPSGREIAVKRLSKSSGQGAEEFK------ 325
++ + G +Y+ P ++ ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 326 --NEVVVVAKLQ-------------------HRNLV-RLLGFCLEDPEKQGQLDWSRR-- 361
+V KL +R LV LG L+ LD S +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS-----ALDVSPKHV 155
Query: 362 --YKIIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKI--SDFGMAKIF 412
+ + +A +L +LHE+ +H ++ NI +D E ++ + +G A +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 51/263 (19%), Positives = 88/263 (33%), Gaps = 89/263 (33%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ--- 335
++ KLG G F V+ + + +A+K + KS+ E +E+ ++ ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 336 -----HRNLVRLLG-FCLEDP---------EKQGQ--LDWSRRYKIIGL-------IARG 371
+V+LL F + E G L W + GL I +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 372 IL----YLHEDSRLRIIHRDLKVSNILLDAE----------------------------- 398
+L YLH ++ RIIH D+K NILL
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 399 --------------------MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
+ KI+D G A T+ +R Y + E +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIG 267
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
++ +D++S + E+ TG
Sbjct: 268 SGYNTPADIWSTACMAFELATGD 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 28/181 (15%), Positives = 64/181 (35%), Gaps = 51/181 (28%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAV--------------------KRLSKSSGQ 319
N++ K+G+GGFG +Y + A +R++K
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 320 GAEEFKNEVVVVA-------------KLQHRNLV-RLLGFCLEDPEKQGQLDWSRRY--K 363
+ ++ + +R +V LG L+ + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-----ISGQNGTFKKS 151
Query: 364 IIGLIARGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNPKI--SDFGMAKIFGVDQT 417
+ + +L Y+HE+ +H D+K +N+LL + ++ +D+G++ + +
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 418 Q 418
Sbjct: 209 H 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 38/165 (23%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---- 335
NKF K+G+G FGE+Y G + + E+A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 336 ------------HRNLV-RLLGFCLEDPEKQGQLDWSRR---YKIIGLIARGIL----YL 375
+ LV LLG LED ++ R K + ++A ++ ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPSLED-----LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPK---ISDFGMAKIFGVDQT 417
H S +HRD+K N L+ I DFG+AK + T
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 42/236 (17%), Positives = 80/236 (33%), Gaps = 71/236 (30%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV--LPSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQ 335
++ LG G FG+V + + ++A+K R + A + E+ V+ K++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIK 74
Query: 336 HR------NLVRLLGF-------CLEDPEKQGQ--LDWSRRYKIIGL-------IARGIL 373
+ V + + C+ E G+ ++ + +A +
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAF-ELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 374 ----YLHEDSRLRIIHRDLKVSNILLDAEMNP-------------------KISDFGMA- 409
+LHE ++ H DLK NIL +++DFG A
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 410 ----KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ +R Y PE + ++ DV+S G ++ E G
Sbjct: 191 FDHEHHTTIVA-----TRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 53/237 (22%), Positives = 83/237 (35%), Gaps = 69/237 (29%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQH 336
N F K+G G FG V + + + AVK R K + A K E ++ K+Q+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQN 90
Query: 337 R-----NLVR----------------LLGFCLEDPEKQGQLDWSRRYKIIGL-------I 368
N+V+ LG L + R G
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSL--------YEIITRNNYNGFHIEDIKLY 142
Query: 369 ARGIL----YLHEDSRLRIIHRDLKVSNILL--DAEMNPKISDFGMAKIFGVDQTQGNTS 422
IL YL + + + H DLK NILL I+ + + + ++
Sbjct: 143 CIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 423 RI------AGTYG------------YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
I T+ Y APE ++ + V SD++SFG ++ E+ TG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 49/240 (20%), Positives = 84/240 (35%), Gaps = 79/240 (32%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV--LPSGREIAVK------RLSKSSGQGAEEFKNEVVVV 331
+ ++ + LG G FG+V + + GR +AVK R +++ ++E+ V+
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65
Query: 332 AKLQHR------NLVRLLGF-------CLEDPEKQGQ--LDWSRRYKIIGL-------IA 369
L V++L + C+ E G D+ + + +A
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVF-ELLGLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 370 RGIL----YLHEDSRLRIIHRDLKVSNILLDAEMNP-------------------KISDF 406
I +LH ++ H DLK NIL K+ DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 407 GMA-----KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
G A + +R Y APE + +S DV+S G +++E G
Sbjct: 182 GSATYDDEHHSTLVS-----TRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 470 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.98 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.81 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.71 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.62 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.05 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.01 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.87 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.69 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 91.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 86.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.68 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 81.0 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=346.87 Aligned_cols=184 Identities=30% Similarity=0.450 Sum_probs=163.1
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||+||+|+ ..+++.||||++.+. .....+.+.+|+++|++++|||||++++++.++..
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999999 457999999999754 33456789999999999999999999998876541
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
+...+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 2457999999999999999999999998 999999999999999999999999999987654444
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4455678999999999999999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=347.94 Aligned_cols=181 Identities=27% Similarity=0.420 Sum_probs=161.3
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
..|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+...
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999994 5799999999987666667788999999999999999999998876541
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 352 ---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 228 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--ccc
Confidence 2356999999999999999999999998 99999999999999999999999999997654322 234
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 56899999999999999999999999999999999999999964
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=343.37 Aligned_cols=184 Identities=33% Similarity=0.549 Sum_probs=151.7
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
..+++.+.++||+|+||+||+|++. ..||||+++... ....+.|.+|+++|++++|||||++++++.++.
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmE 111 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQ 111 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEE
Confidence 3467888999999999999999974 369999986543 344578999999999999999999999876532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....++|.++..|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+++........
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 13457999999999999999999999987 999999999999999999999999999876543333
Q ss_pred ccccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|||||++.+ +.|+.++|||||||+||||+||+.||...
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 33445689999999999863 46899999999999999999999999754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.19 Aligned_cols=185 Identities=30% Similarity=0.481 Sum_probs=159.1
Q ss_pred hcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
.++|.+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|++.+...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888999999999999999853 478899999987776677889999999999999999999999876431
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 352 -----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 352 -----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
....++|.+++.|+.||+.||.|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 1346899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999987654433333344568999999999999999999999999999999999 89999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=347.50 Aligned_cols=182 Identities=26% Similarity=0.397 Sum_probs=152.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|+++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++|+|||||++++++.++.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999994 579999999997553 334567899999999999999999999887643
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.+...+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 23456789999999999999999999998 9999999999999999999999999998654221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|||||++.+..|+.++|||||||+||||+||+.||...
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1233467999999999999999999999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=346.07 Aligned_cols=184 Identities=30% Similarity=0.490 Sum_probs=151.3
Q ss_pred cCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
++|.+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|++.+...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778899999999999999853 478999999987776777889999999999999999999999876331
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 352 ------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 352 ------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
....++|.+++.|+.||+.||.|||+++ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 1246899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 9999999987654433333445679999999999999999999999999999999999 89999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=331.04 Aligned_cols=181 Identities=24% Similarity=0.416 Sum_probs=145.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
++|++.+.||+|+||+||+|+. .+++.||||++++.. ....+.+.+|+++|++++|||||++++++.+..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999994 579999999997542 334567999999999999999999999886643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.+...+++.++..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++......
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 166 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--- 166 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---
Confidence 13567999999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..+ +.++|||||||++|||+||+.||...
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 2334689999999999988876 58999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.80 Aligned_cols=182 Identities=27% Similarity=0.417 Sum_probs=162.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35699999999999999999994 5799999999987766677789999999999999999999998876541
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR 304 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CB
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cc
Confidence 2356899999999999999999999998 99999999999999999999999999987654322 23
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 456899999999999999999999999999999999999999964
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=339.43 Aligned_cols=184 Identities=33% Similarity=0.524 Sum_probs=156.4
Q ss_pred cCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
.++++.++||+|+||+||+|++ .+++.||||+++... ....++|.+|+.++++++|||||+++|++.+...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4567789999999999999985 256889999997543 3456789999999999999999999999865331
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 041433 352 --------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399 (470)
Q Consensus 352 --------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 399 (470)
....++|.++..|+.||+.||.|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 0245899999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 400 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.+||+|||+++.+.............||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999987654433333445679999999999999999999999999999999999 89999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.50 Aligned_cols=177 Identities=30% Similarity=0.436 Sum_probs=149.7
Q ss_pred CccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 284 STDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
++.++||+|+||+||+|.. .+++.||+|++... .....+.|.+|+++|++++|||||++++++.+..
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 6678899999999999994 57899999998654 3334567999999999999999999999765411
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecCCceeccCCCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.+...+++..+..++.||+.||.|||+++ ++|+||||||+||||+ .++.+||+|||+++....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 12357899999999999999999999875 4599999999999997 478999999999985432
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.......||+.|||||++.+ .|+.++|||||||+||||+||+.||..
T Consensus 185 -~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22345689999999998764 699999999999999999999999964
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.93 Aligned_cols=179 Identities=30% Similarity=0.415 Sum_probs=151.5
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
+.|++.++||+|+||.||+|+. .+|+.||||+++..... .+|+.++++++|||||++++++.+...
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5688889999999999999994 57999999999754322 469999999999999999998876541
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCCCCcc-
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQTQG- 419 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~- 419 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++ ++||+|||+++.+.......
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 2357999999999999999999999988 99999999999999987 69999999999765432211
Q ss_pred --cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 --NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..|+.++|||||||+||||+||+.||.-.
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 223457999999999999999999999999999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=335.19 Aligned_cols=182 Identities=29% Similarity=0.337 Sum_probs=150.2
Q ss_pred cCCCccccccccCceeEEEEEc----CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
++|++.+.||+|+||+||+|+. .+++.||||++++.. ......+.+|+++|++++|||||++++++.++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999984 257899999997542 2233468899999999999999999998876541
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
+...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 2457899999999999999999999998 9999999999999999999999999998653322
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|||||++.+..|+.++|||||||+||||+||+.||...
T Consensus 181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 2234468999999999999999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=336.20 Aligned_cols=199 Identities=29% Similarity=0.423 Sum_probs=168.1
Q ss_pred ccchhhHHHHHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCC-CC
Q 041433 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQH-RN 338 (470)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h-~n 338 (470)
+.+.++.+++++..++|++.++||+|+||+||+|.+. .++.||||++..... ...+.|.+|+++|++++| ||
T Consensus 50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 3455677778888899999999999999999999842 246899999976533 335679999999999965 89
Q ss_pred ccceeeEeeeCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 041433 339 LVRLLGFCLEDPE-----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383 (470)
Q Consensus 339 iv~l~~~~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 383 (470)
||+++|+|.+... ....+++.++..++.||+.||.|||+++ |
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 9999998865321 1245899999999999999999999998 9
Q ss_pred EeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 041433 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 462 (470)
Q Consensus 384 vH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~ 462 (470)
|||||||+|||+++++.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 9999999999999999999999999997654444334445678999999999999999999999999999999998 999
Q ss_pred CCCCCC
Q 041433 463 NSSFYQ 468 (470)
Q Consensus 463 P~~~~~ 468 (470)
||....
T Consensus 287 Pf~~~~ 292 (353)
T 4ase_A 287 PYPGVK 292 (353)
T ss_dssp SSTTCC
T ss_pred CCCCCC
Confidence 997643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=321.22 Aligned_cols=179 Identities=30% Similarity=0.471 Sum_probs=140.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999994 5799999999865433 344678999999999999999999987653221
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 352 --------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 352 --------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
.....++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 0122455668899999999999999998 99999999999999999999999
Q ss_pred cCCceeccCCCCcc----------cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 406 FGMAKIFGVDQTQG----------NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 406 fG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
||+++.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99998765432211 1233579999999999999999999999999999999997 664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=324.49 Aligned_cols=184 Identities=26% Similarity=0.356 Sum_probs=146.8
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--------- 351 (470)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||++++++.++..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5678889999999999999998 6899999999654321 2233456667778999999999999875421
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHED-----SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....++|.++.+++.|++.||.|||++ ..++|+||||||+||||+.++++||+|||+++....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 135689999999999999999999986 234599999999999999999999999999987654
Q ss_pred CCCcc--cccccccccCcccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQG--NTSRIAGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..... ......||+.|||||++.+. .++.++|||||||+||||+||++||..
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 33221 22345799999999998654 467899999999999999999887754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.29 Aligned_cols=184 Identities=23% Similarity=0.379 Sum_probs=155.5
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6799999999999999999994 579999999997543 233467889999999999999999998764321
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 23567999999999999999999999998 99999999999999999999999999987643
Q ss_pred CC--CcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQ--TQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .........||+.|||||++.+. .++.++||||+||++|||++|++||...
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 22 12233456899999999998775 5699999999999999999999999753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=315.54 Aligned_cols=188 Identities=23% Similarity=0.335 Sum_probs=153.7
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEc----CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeee
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE 348 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 348 (470)
+.+....++|++.++||+|+||+||+|+. .+++.||||++.+.. ...++.+|+++|+.+ +||||+++++++.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34445678899999999999999999973 357899999986543 346788999999998 69999999988766
Q ss_pred CCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCceec
Q 041433 349 DPE---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIF 412 (470)
Q Consensus 349 ~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~~ 412 (470)
... .-..+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 431 1135899999999999999999999998 9999999999999876 79999999999865
Q ss_pred cCCCCc--------------------------ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 413 GVDQTQ--------------------------GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 413 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
...... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432111 112234699999999998775 58999999999999999999999995
Q ss_pred C
Q 041433 466 F 466 (470)
Q Consensus 466 ~ 466 (470)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.53 Aligned_cols=180 Identities=28% Similarity=0.383 Sum_probs=152.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHH---HHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFK---NEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
-++|++.+.||+|+||.||+++. .+|+.||||++.+.. ......+. +++.+++.++|||||++++.+.+...
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999994 579999999996531 22233333 34677788899999999998876431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
+...+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+++.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 2457899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. ....+||+.|||||++.+ ..|+.++|||||||+||||++|++||..
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 334689999999999975 5799999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.01 Aligned_cols=181 Identities=24% Similarity=0.397 Sum_probs=159.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
++|++.+.||+|+||.||+++. .+|+.||+|++........+.+.+|+++|++++|||||++++++.+..
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 6899999999999999999994 579999999998776666778999999999999999999999876532
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEeecCCceeccCCCCc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE--MNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 23457899999999999999999999998 9999999999999754 799999999999875432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..|+.++|||||||+||||++|+.||...
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 233457999999999999999999999999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=292.21 Aligned_cols=194 Identities=41% Similarity=0.679 Sum_probs=166.1
Q ss_pred hhHHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 271 FDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
+.+.++...+++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++.+..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33344556778999999999999999999998889999999998776667788999999999999999999999875532
Q ss_pred C----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 351 E----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 351 ~----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 1 1235899999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++...............||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 98754333333334456899999999998889999999999999999999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=283.74 Aligned_cols=183 Identities=27% Similarity=0.475 Sum_probs=160.6
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|++.++||+|+||.||++. ..+++.||||++........+.+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4689999999999999999999 46799999999977766677889999999999999999999998765431
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 173 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--cc
Confidence 1235889999999999999999999998 99999999999999999999999999987654332 23
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3457899999999999999999999999999999999999999653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=283.76 Aligned_cols=185 Identities=29% Similarity=0.453 Sum_probs=155.7
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
..++|++.++||+|+||.||+++..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3478999999999999999999987899999999865432 23467889999999999999999999876543
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 13456899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 2233468999999999876 568999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.02 Aligned_cols=183 Identities=26% Similarity=0.335 Sum_probs=157.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++++. .....+.+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46899999999999999999995 47999999999654 33456778999999999999999999988765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 2346889999999999999999999998 9999999999999999999999999998533221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 2234467999999999999999999999999999999999999999643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.57 Aligned_cols=194 Identities=24% Similarity=0.313 Sum_probs=162.6
Q ss_pred hhhHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeE
Q 041433 270 QFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGF 345 (470)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 345 (470)
.+.+.+++...++|++.++||+|+||+||+++. .+++.||+|++.+.. ......+.+|+.++..++||||++++++
T Consensus 63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 345566777789999999999999999999995 458899999986531 2223448899999999999999999998
Q ss_pred eeeCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 346 CLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 346 ~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
+.+.. .....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 76643 12467999999999999999999999998 999999999999999999999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
|+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 999876433221 223357999999999986 467899999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=282.03 Aligned_cols=185 Identities=31% Similarity=0.514 Sum_probs=158.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|.+.++||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.++..
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36789999999999999999995 5689999999877666677889999999999999999999998876431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 2467899999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ------------cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 ------------NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 111456899999999999999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=282.48 Aligned_cols=193 Identities=30% Similarity=0.428 Sum_probs=165.0
Q ss_pred hhhHHHHHHhhcC----------CCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC
Q 041433 270 QFDFEAIKVATNK----------FSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN 338 (470)
Q Consensus 270 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n 338 (470)
.+.+++++.+.+. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4556666655543 677789999999999999954 79999999998777777788999999999999999
Q ss_pred ccceeeEeeeCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 339 LVRLLGFCLEDPE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 339 iv~l~~~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
|+++++++..... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 180 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRV 180 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcE
Confidence 9999998765431 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 181 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 181 KLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp EECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987653322 223457899999999999999999999999999999999999999643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=287.48 Aligned_cols=196 Identities=44% Similarity=0.785 Sum_probs=166.1
Q ss_pred chhhHHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEee
Q 041433 269 LQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347 (470)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 347 (470)
..+.+.++....++|++.+.||+|+||.||+++..+++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45778899999999999999999999999999987899999999976532 23346899999999999999999999876
Q ss_pred eCC----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 348 EDP----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 348 ~~~----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
... .....+++..+..++.||+.||.|||++..++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 533 1233589999999999999999999998222399999999999999999999999
Q ss_pred cCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 406 FGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 406 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 178 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 178 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999876433222 2334568999999999988899999999999999999999999995
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.85 Aligned_cols=182 Identities=29% Similarity=0.480 Sum_probs=156.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999995 68999999998654 33345678899999999999999999998765431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 1356889999999999999999999998 9999999999999999999999999998654332
Q ss_pred ccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..+. .++||||||+++|||++|+.||...
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 23445799999999999887765 8999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=285.25 Aligned_cols=186 Identities=29% Similarity=0.471 Sum_probs=156.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999995 4789999999865432 33466889999999999999999999876532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 23446899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred cccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 3345679999999999987775 788999999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=287.91 Aligned_cols=182 Identities=26% Similarity=0.396 Sum_probs=156.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|++.+.||+|+||.||++.. .+++.||+|++.+. .....+.+.+|+++++.++||||+++++++.+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999994 56899999998653 2345678899999999999999999998876543
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 13457899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 2344679999999999863 45899999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.12 Aligned_cols=192 Identities=22% Similarity=0.274 Sum_probs=160.6
Q ss_pred hHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEee
Q 041433 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 347 (470)
.+.+++...++|++.++||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445666778999999999999999999995 46899999998653 2223345789999999999999999999887
Q ss_pred eCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 348 EDPE-----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 348 ~~~~-----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
+... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 6431 1346889999999999999999999998 9999999999999999999999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+..... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 7643321 1233467999999999987655 789999999999999999999999743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=292.15 Aligned_cols=183 Identities=28% Similarity=0.386 Sum_probs=154.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC--
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~-- 351 (470)
..++|++.++||+|+||.||+++. .+++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 346899999999999999999995 468899999997652 22334678899999887 89999999998766431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 2356899999999999999999999998 999999999999999999999999999853222
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 207 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 207 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp --TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred --CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 1223456799999999999999999999999999999999999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=283.93 Aligned_cols=182 Identities=27% Similarity=0.372 Sum_probs=157.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
.++|++.+.||+|+||.||+++. .+|+.||+|++.+... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999995 4799999999876532 23578999999999999999999999876532
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEeecCCce
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM----NPKISDFGMAK 410 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~DfG~a~ 410 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 13457899999999999999999999998 99999999999998777 79999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred EcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 764322 223457999999999999889999999999999999999999999653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.74 Aligned_cols=184 Identities=29% Similarity=0.394 Sum_probs=152.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC--
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~-- 351 (470)
..++|++.+.||+|+||.||+++. .+++.||||++++. .....+.+.+|..+++.+ +||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999994 56899999999754 234556788999999988 69999999998765431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 2356899999999999999999999998 999999999999999999999999999853322
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 12234467999999999999889999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=281.69 Aligned_cols=180 Identities=30% Similarity=0.401 Sum_probs=156.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36799999999999999999995 47999999998654 23456778899999999999999999998765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 2356889999999999999999999988 999999999999999999999999999865421
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 23457899999999999999999999999999999999999999643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=278.30 Aligned_cols=182 Identities=27% Similarity=0.452 Sum_probs=152.8
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.+.||+|+||.||+++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998789999999986543 233467889999999999999999999886543
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--c
Confidence 12367899999999999999999999998 99999999999999999999999999986543221 2
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2334689999999998764 5899999999999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.88 Aligned_cols=194 Identities=22% Similarity=0.296 Sum_probs=162.2
Q ss_pred hhhHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeE
Q 041433 270 QFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGF 345 (470)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 345 (470)
.+.+++++...++|++.+.||+|+||.||+++. .+++.||||++++.. ....+.+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 345566677789999999999999999999995 579999999986532 2233457889999999999999999988
Q ss_pred eeeCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 346 CLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 346 ~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
+.+... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+||
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 765431 1247899999999999999999999998 999999999999999999999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
|+++.+...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 999876433221 223457999999999987 357899999999999999999999999653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=275.46 Aligned_cols=179 Identities=25% Similarity=0.430 Sum_probs=154.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||+||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999995 5789999999875432 33467889999999999999999999886643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence 12467999999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
......+|+.|+|||++.+.. ++.++||||||+++|||++|+.||
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 223456899999999987765 899999999999999999998886
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.53 Aligned_cols=183 Identities=15% Similarity=0.189 Sum_probs=155.1
Q ss_pred HhhcCCCccccccccCceeEEEEE------cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC---CCCccceeeEeee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV------LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---HRNLVRLLGFCLE 348 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 348 (470)
...++|.+.++||+|+||.||+|. ..+++.||||++... ...++.+|+++++.++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 456889999998654 3557788888888887 9999999988765
Q ss_pred CCC-----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------
Q 041433 349 DPE-----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-------- 397 (470)
Q Consensus 349 ~~~-----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------- 397 (470)
... ....+++.+++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 321 2456999999999999999999999988 999999999999988
Q ss_pred ---CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 398 ---EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 398 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999876433333334456799999999999999999999999999999999999999853
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=275.66 Aligned_cols=182 Identities=28% Similarity=0.377 Sum_probs=150.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--------------------------cCHHHHHHHHHHHh
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--------------------------QGAEEFKNEVVVVA 332 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~ 332 (470)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999984 5789999999865431 12356889999999
Q ss_pred cCCCCCccceeeEeeeCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 333 KLQHRNLVRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 333 ~l~h~niv~l~~~~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
+++||||+++++++.+.. .....+++.++..++.||+.||.|||+++ |+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999999999876421 12456899999999999999999999998 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|++.++.+||+|||+++.+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999987643322 223457899999999987655 47889999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.80 Aligned_cols=182 Identities=28% Similarity=0.381 Sum_probs=152.2
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.++||+|+||.||++. ..+++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999998 457899999999754 33445678899999999999999999998754321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 1235889999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 218 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 218 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp C---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 233457899999999999999999999999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=277.15 Aligned_cols=183 Identities=30% Similarity=0.464 Sum_probs=141.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.++|++.++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999995 468999999987543 334577889999999999999999999876533
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 11245889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2233468999999999876 46899999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.99 Aligned_cols=182 Identities=24% Similarity=0.410 Sum_probs=156.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999994 67999999998643 22334678999999999999999999998766431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 2356899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 2234578999999999988776 68999999999999999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=284.56 Aligned_cols=182 Identities=29% Similarity=0.381 Sum_probs=155.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~--- 351 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++.+... ...+.+.+|+.+++++ +||||+++++++.+...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 36799999999999999999995 4689999999976532 3345678899999988 89999999998765331
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 1356889999999999999999999998 9999999999999999999999999998532221
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 223446799999999999999999999999999999999999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=278.79 Aligned_cols=185 Identities=29% Similarity=0.439 Sum_probs=152.5
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
..++|++.+.||+|+||.||+++. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 357899999999999999999994 5789999999865432 334678899999999999999999998765431
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 1346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223456899999999999999999999999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=285.36 Aligned_cols=185 Identities=33% Similarity=0.579 Sum_probs=150.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
.++|++.++||+|+||.||+|+. .+++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 36799999999999999999994 3444 4688887543 3455678999999999999999999999886643
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 12456899999999999999999999998 999999999999999999999999999877554
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..........+|+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 44333344556889999999999999999999999999999999 99999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.93 Aligned_cols=187 Identities=29% Similarity=0.467 Sum_probs=147.9
Q ss_pred HhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC--
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~-- 351 (470)
...++|++.+.||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+++++. ||||+++++++.....
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345789999999999999999998 457999999998654 3334566789999999997 9999999998865431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 1346888999999999999999999998 999999999999999999999999999875321
Q ss_pred C-------------------CcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 Q-------------------TQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 0111233578999999999876 67899999999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=274.81 Aligned_cols=196 Identities=45% Similarity=0.666 Sum_probs=165.5
Q ss_pred cchhhHHHHHHhhcCCCcc------ccccccCceeEEEEEcCCCcEEEEEEccCcC----ccCHHHHHHHHHHHhcCCCC
Q 041433 268 SLQFDFEAIKVATNKFSTD------NKLGAGGFGEVYKGVLPSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKLQHR 337 (470)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~ 337 (470)
...|.++++...+++|... ++||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3457888999999998877 8999999999999997 68899999986532 23356789999999999999
Q ss_pred CccceeeEeeeCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 041433 338 NLVRLLGFCLEDPE---------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD 396 (470)
Q Consensus 338 niv~l~~~~~~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~ 396 (470)
||+++++++..... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 99999998765321 1345899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 397 AEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 397 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999987654333333344578999999998764 58899999999999999999999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=285.08 Aligned_cols=185 Identities=30% Similarity=0.455 Sum_probs=156.1
Q ss_pred hcCCCccccccccCceeEEEEEc--------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
.++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 47899999999999999999974 245679999997553 33456789999999999 899999999987653
Q ss_pred CC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 041433 350 PE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 350 ~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 395 (470)
.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 21 0135789999999999999999999998 9999999999999
Q ss_pred CCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 396 DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 396 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999987654433333334457889999999999999999999999999999999 99999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=283.84 Aligned_cols=186 Identities=30% Similarity=0.433 Sum_probs=156.9
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 351 (470)
....++|.+.+.||+|+||.||+++. .+++.||||++++.. ....+.+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44568899999999999999999995 468999999997542 34556788899999876 89999999988765431
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 1356899999999999999999999998 9999999999999999999999999998543
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 222 2234567999999999999999999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=288.81 Aligned_cols=198 Identities=28% Similarity=0.432 Sum_probs=165.0
Q ss_pred cchhhHHHHHHhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCc
Q 041433 268 SLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNL 339 (470)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~ni 339 (470)
...++...+....++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 34566777888899999999999999999999972 3568999999976432 3346789999999999 79999
Q ss_pred cceeeEeeeCCCC-------------------------------------------------------------------
Q 041433 340 VRLLGFCLEDPEK------------------------------------------------------------------- 352 (470)
Q Consensus 340 v~l~~~~~~~~~~------------------------------------------------------------------- 352 (470)
+++++++.+....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 9999987653210
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 353 ------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 353 ------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 112889999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
...........+|+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 433333444568899999999999999999999999999999998 999997643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=283.86 Aligned_cols=183 Identities=28% Similarity=0.456 Sum_probs=154.3
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.++|++.++||+|+||.||+|+. .++.||||++.... .....+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46899999999999999999997 47999999996543 233456779999999999999999998765321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHED----------SRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 124588999999999999999999988 6 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++.+.............||+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 987765444333444678999999999876 35667899999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=283.37 Aligned_cols=182 Identities=27% Similarity=0.428 Sum_probs=155.5
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
..++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999999995 478999999996543 234567889999999999999999999876533
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEeecCCceeccC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKISDFGMAKIFGV 414 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 13456899999999999999999999998 99999999999997654 599999999986643
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 22 22345789999999999998999999999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=277.11 Aligned_cols=181 Identities=27% Similarity=0.401 Sum_probs=156.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
.++|++.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35699999999999999999995 4689999999865432 24678999999999999999999999876532
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEeecCCce
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM----NPKISDFGMAK 410 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~DfG~a~ 410 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 23456899999999999999999999998 99999999999998887 79999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 764322 22345789999999999989999999999999999999999999964
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=280.43 Aligned_cols=192 Identities=33% Similarity=0.530 Sum_probs=150.5
Q ss_pred hHHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
+...+.+..++|++.++||+|+||.||+++. +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344556678899999999999999999987 68899999986553 23346788999999999999999999987654
Q ss_pred CC------------------CC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 350 PE------------------KQ---GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 350 ~~------------------~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
.. .. ..+++.+++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 31 11 12889999999999999999999875 3499999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 97543321 1223457899999999999999999999999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.06 Aligned_cols=179 Identities=27% Similarity=0.339 Sum_probs=156.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||.||+++. .+++.||||++.+. .....+.+.+|+++++.++||||+++++++.+...
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999995 47999999998654 23456778999999999999999999988765431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 1356899999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 23457999999999999999999999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=280.25 Aligned_cols=183 Identities=28% Similarity=0.382 Sum_probs=147.2
Q ss_pred hcCCCccccccccCceeEEEEEc----CCCcEEEEEEccCcC----ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999985 478999999997642 2334567889999999999999999998766431
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 1346788999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 173 HDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 222 1223457899999999999999999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=279.53 Aligned_cols=184 Identities=22% Similarity=0.277 Sum_probs=156.5
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||.||+|+ ..+++.||||++..... .+.+.+|+++++++ +||||+++++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4789999999999999999999 46799999999865432 34588999999999 99999999988765431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEEeecCCceeccC
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN-----PKISDFGMAKIFGV 414 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+..
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 1467999999999999999999999998 999999999999998887 99999999987644
Q ss_pred CCCcc-----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 415 DQTQG-----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 415 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 32211 1234679999999999999999999999999999999999999998643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=277.46 Aligned_cols=181 Identities=24% Similarity=0.323 Sum_probs=156.1
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.+.||+|+||.||++.. .+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 47899999999999999999995 46899999998644 334567889999999999999999999876532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--CCceEEeecCCceeccCCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA--EMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..+....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 12346899999999999999999999998 999999999999987 7899999999998764332
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 223456899999999998888999999999999999999999999653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=282.35 Aligned_cols=182 Identities=25% Similarity=0.371 Sum_probs=154.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-----CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-----SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999984 57999999998542 22346789999999999999999999998766431
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEeecCC
Q 041433 352 --------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN---PKISDFGM 408 (470)
Q Consensus 352 --------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~DfG~ 408 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 1235889999999999999999999998 999999999999976654 99999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 987654322 22345789999999999999999999999999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.35 Aligned_cols=184 Identities=27% Similarity=0.407 Sum_probs=150.0
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCC--CCccceeeEeeeCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQH--RNLVRLLGFCLEDP---- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~---- 350 (470)
..++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++++++| |||+++++++....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356799999999999999999998889999999986543 3344678999999999987 99999999876543
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 12456899999999999999999999998 99999999999997 57899999999987654433
Q ss_pred cccccccccccCccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 323344579999999999864 6789999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.23 Aligned_cols=178 Identities=22% Similarity=0.413 Sum_probs=138.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++|++++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999984 47899999998654 2334567889999999999999999999874432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 12356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCc-------------------------ccccccccccCccccccc-ccCCCCchhhHHHHHHHHHHHHhC
Q 041433 415 DQTQ-------------------------GNTSRIAGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITG 460 (470)
Q Consensus 415 ~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~elltG 460 (470)
.... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 2211 112345689999999976 466799999999999999999993
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=283.07 Aligned_cols=185 Identities=30% Similarity=0.353 Sum_probs=156.8
Q ss_pred HhhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc---CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC-
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS---SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~- 351 (470)
...++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+...
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44578999999999999999999954 5889999998754 234567788999999988 79999999988765331
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 1356899999999999999999999998 99999999999999999999999999985322
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 21 2234467999999999999999999999999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=275.14 Aligned_cols=184 Identities=28% Similarity=0.468 Sum_probs=151.9
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-----ccCHHHHHHHHHHHhcCC---CCCccceeeEeee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-----GQGAEEFKNEVVVVAKLQ---HRNLVRLLGFCLE 348 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 348 (470)
...++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999994 578999999986432 122356677888777765 9999999998765
Q ss_pred CCC------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEe
Q 041433 349 DPE------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKIS 404 (470)
Q Consensus 349 ~~~------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 404 (470)
... ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 321 1233899999999999999999999998 9999999999999999999999
Q ss_pred ecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 405 DFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 405 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998654322 233457899999999999999999999999999999999999999653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=282.64 Aligned_cols=182 Identities=24% Similarity=0.353 Sum_probs=157.1
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|++++++++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 36799999999999999999995 478999999997765555678899999999999999999999876532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--CCceEEeecCCceeccCCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA--EMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 12346899999999999999999999998 999999999999974 56899999999987643322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 23346899999999999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=277.32 Aligned_cols=185 Identities=28% Similarity=0.430 Sum_probs=149.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||+++. .+++.||||++...... ....+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999994 67899999999765332 34578899999999999999999987544211
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 1356899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 33221 1223356899999999999999999999999999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=288.76 Aligned_cols=183 Identities=25% Similarity=0.370 Sum_probs=154.8
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|+||.||++. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45789999999999999999998 4579999999987553 2334678999999999999999999998765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEeecCCceeccC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD---AEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 2356899999999999999999999998 99999999999998 567899999999986543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... ......||+.|+|||++.+..++.++||||||+++|+|++|++||..
T Consensus 166 ~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 166 EQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp TCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 322 22345799999999999998999999999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=280.02 Aligned_cols=186 Identities=31% Similarity=0.522 Sum_probs=152.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcE----EEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGRE----IAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
.++|++.+.||+|+||.||+|+. .+++. |++|.+.... ....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL 91 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence 36789999999999999999994 34543 7888875432 333456788999999999999999999875432
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 12346888999999999999999999998 999999999999999999999999999876554
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 44333445567889999999998999999999999999999999 999997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=280.32 Aligned_cols=190 Identities=26% Similarity=0.418 Sum_probs=143.8
Q ss_pred HHHHhhcCCCccccccccCceeEEEEEcCC-Cc---EEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeee
Q 041433 275 AIKVATNKFSTDNKLGAGGFGEVYKGVLPS-GR---EIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348 (470)
Q Consensus 275 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 348 (470)
++....++|++.+.||+|+||.||+|+... ++ .||||++... .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334556789999999999999999999543 32 7999999755 33446789999999999999999999988654
Q ss_pred CCC------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 041433 349 DPE------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE 398 (470)
Q Consensus 349 ~~~------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 398 (470)
... ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 321 1125889999999999999999999998 9999999999999999
Q ss_pred CceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 399 MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 399 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 9999999999987644333233333456788999999999999999999999999999999 99999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=281.36 Aligned_cols=191 Identities=27% Similarity=0.322 Sum_probs=161.3
Q ss_pred cchhhHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-----CCCccc
Q 041433 268 SLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-----HRNLVR 341 (470)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~ 341 (470)
...+.+++.....++|++.++||+|+||.||+++. .+++.||||++... ....+.+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455566667789999999999999999999995 57899999998643 334456788999999997 999999
Q ss_pred eeeEeeeCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----
Q 041433 342 LLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA----- 397 (470)
Q Consensus 342 l~~~~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----- 397 (470)
+++++.... .....+++.++..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 999876543 12345899999999999999999999998 999999999999975
Q ss_pred --------------------CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHH
Q 041433 398 --------------------EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 457 (470)
Q Consensus 398 --------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~el 457 (470)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999864322 2235689999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 041433 458 ITGKKNSSFY 467 (470)
Q Consensus 458 ltG~~P~~~~ 467 (470)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=276.94 Aligned_cols=182 Identities=29% Similarity=0.475 Sum_probs=149.7
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999954 79999999997543 3345779999999999999999999998754321
Q ss_pred ------------------------------------------------------------------------CCCCCCHH
Q 041433 352 ------------------------------------------------------------------------KQGQLDWS 359 (470)
Q Consensus 352 ------------------------------------------------------------------------~~~~l~~~ 359 (470)
.....++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 01223555
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc----------ccccccccccC
Q 041433 360 RRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ----------GNTSRIAGTYG 429 (470)
Q Consensus 360 ~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~----------~~~~~~~gt~~ 429 (470)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 68899999999999999998 999999999999999999999999999876543211 11233568999
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 430 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 430 y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
|+|||++.+..++.++||||||+++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999998775
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=269.20 Aligned_cols=183 Identities=31% Similarity=0.492 Sum_probs=156.8
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46799999999999999999998788999999996543 34577999999999999999999999876533
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence 12456899999999999999999999998 99999999999999999999999999986533221 12
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 223456778999999998999999999999999999999 99999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.70 Aligned_cols=194 Identities=22% Similarity=0.326 Sum_probs=157.8
Q ss_pred cchhhHHHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCcc-----------CHHHHHHHHHHHhcCCC
Q 041433 268 SLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ-----------GAEEFKNEVVVVAKLQH 336 (470)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h 336 (470)
.+.....++....++|++.+.||+|+||.||++...+++.||||++...... ..+.+.+|++++++++|
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 88 (362)
T 3pg1_A 9 AMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88 (362)
T ss_dssp HHHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC
Confidence 3455677888999999999999999999999999878999999998653221 13678999999999999
Q ss_pred CCccceeeEeeeCC-----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 337 RNLVRLLGFCLEDP-----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 337 ~niv~l~~~~~~~~-----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
|||+++++++.... .....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp TTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 99999999875422 12346899999999999999999999998 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
|++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999997543222 2233568899999998876 67899999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=276.78 Aligned_cols=185 Identities=27% Similarity=0.477 Sum_probs=152.9
Q ss_pred hcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999953 3456999999764 3344567899999999999999999999875532
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 12357899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 2211 1222345778999999998899999999999999999999 99999643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=285.09 Aligned_cols=184 Identities=26% Similarity=0.401 Sum_probs=149.9
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCC--CCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQ--HRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~----- 350 (470)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998779999999986543 334567899999999996 599999998875533
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+......
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 12346888899999999999999999988 99999999999995 578999999999876543332
Q ss_pred ccccccccccCccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 22344579999999998864 46899999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=286.73 Aligned_cols=183 Identities=22% Similarity=0.406 Sum_probs=150.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++|++++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 47899999999999999999994 57899999999754 2334567899999999999999999998876542
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 12356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCc--------------------ccccccccccCccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 415 DQTQ--------------------GNTSRIAGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 415 ~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.... .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 3211 112456789999999986 56679999999999999999999665553
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=278.72 Aligned_cols=185 Identities=33% Similarity=0.579 Sum_probs=148.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
.++|++.++||+|+||.||+|.. .+++ +|++|.+... .....+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 46899999999999999999994 3454 3577777543 4456678999999999999999999999876533
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 12456899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 33333334456788999999999999999999999999999999 99999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.66 Aligned_cols=183 Identities=32% Similarity=0.450 Sum_probs=158.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|.+.+.||+|+||.||+++. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++....
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 479999999996542 344577889999999999999999998875532
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 11346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 3322 223457999999999999999999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=274.56 Aligned_cols=181 Identities=25% Similarity=0.373 Sum_probs=154.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 46799999999999999999995 468999999997543 3456778899999999999999999988765331
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEeecCCce
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKISDFGMAK 410 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~DfG~a~ 410 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 1123899999999999999999999998 9999999999999 788889999999998
Q ss_pred eccCCCCcccccccccccCcccccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAM--------HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7654322 23356899999999886 57889999999999999999999999964
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=275.76 Aligned_cols=185 Identities=31% Similarity=0.503 Sum_probs=152.6
Q ss_pred hhcCCCccccccccCceeEEEEEc-----CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
..++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 357899999999999999999983 368899999998776666778999999999999999999999764311
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 11234899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 413 GVDQTQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 413 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...... .......++..|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 433221 112233467789999999999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.26 Aligned_cols=184 Identities=33% Similarity=0.436 Sum_probs=158.3
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
...++|++.+.||+|+||.||+++. .+++.||||++.+. .......+.+|+++|++++||||+++++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3457799999999999999999995 57999999998653 2344567889999999999999999998876532
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 11234899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 3321 23357999999999999989999999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=282.50 Aligned_cols=185 Identities=34% Similarity=0.480 Sum_probs=154.5
Q ss_pred hcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.++|++.++||+|+||.||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999842 4678999999654 33445578899999999999999999998765331
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEe
Q 041433 352 ------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKIS 404 (470)
Q Consensus 352 ------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~ 404 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 1245899999999999999999999998 99999999999998554 59999
Q ss_pred ecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 405 DFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 405 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986543333233334567899999999999999999999999999999998 99999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=282.94 Aligned_cols=182 Identities=27% Similarity=0.302 Sum_probs=146.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHHHH-HhcCCCCCccceeeEeeeCCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEVVV-VAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~---- 351 (470)
++|++.+.||+|+||.||+++. .+++.||||++.+... .....+.+|..+ ++.++||||+++++++.+...
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5789999999999999999995 4688999999976532 233456667776 577899999999988765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 1346888999999999999999999998 9999999999999999999999999998532221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 2234567999999999999999999999999999999999999999643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=271.19 Aligned_cols=185 Identities=34% Similarity=0.568 Sum_probs=144.1
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+..++|++.++||+|+||.||+++.. ..||+|+++... ....+.+.+|++++++++||||++++++.....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~ 98 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT 98 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence 45678999999999999999999963 369999986543 334567899999999999999999998754321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 23456899999999999999999999998 99999999999999999999999999986543333
Q ss_pred cccccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 33334457899999999886 567889999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.10 Aligned_cols=177 Identities=29% Similarity=0.374 Sum_probs=147.9
Q ss_pred ccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------------
Q 041433 285 TDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------------ 351 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------------ 351 (470)
..+.||+|+||.||++.. .+++.||+|+++.......+.+.+|++++++++||||+++++++.+...
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999984 5799999999987666667789999999999999999999998765431
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCCceEEeecCCceeccCCCCccccc
Q 041433 352 -------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL--DAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
....+++.++..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..... ..
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence 2345889999999999999999999998 9999999999999 6778999999999987643322 22
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 346899999999998889999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=274.80 Aligned_cols=184 Identities=24% Similarity=0.447 Sum_probs=155.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999995 579999999986543 233467889999999999999999999876532
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 12356899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc--ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQ--GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 6432221 22234568999999998876 45899999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=286.01 Aligned_cols=186 Identities=29% Similarity=0.457 Sum_probs=154.5
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
..++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.....
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999964 789999999875432 233568899999999999999999998865431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 1235888999999999999999999998 99999999999999999999999999986533222
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
........+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111122235678999999998899999999999999999998 99999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=279.30 Aligned_cols=182 Identities=25% Similarity=0.425 Sum_probs=155.5
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc--------cCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
..++|++.+.||+|+||.||+++ ..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999998 45789999999876532 1234577899999999999999999987653
Q ss_pred C-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 350 P-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 350 ~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 2 12346899999999999999999999998 9999999999999999999999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 179 YLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp ECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 7643322 234568999999999988777 7899999999999999999999964
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=266.84 Aligned_cols=183 Identities=33% Similarity=0.605 Sum_probs=153.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccC-------HHHHHHHHHHHhcCCCCCccceeeEeeeCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQG-------AEEFKNEVVVVAKLQHRNLVRLLGFCLEDP- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~- 350 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 47899999999999999999995 578999999986543322 267899999999999999999999875422
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEEeecCCc
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN-----PKISDFGMA 409 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~DfG~a 409 (470)
.....+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++. +||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 23457899999999999999999999875 34999999999999988776 999999999
Q ss_pred eeccCCCCcccccccccccCcccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 177 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 177 QQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp BCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 75332 223356899999999983 4567899999999999999999999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.37 Aligned_cols=185 Identities=18% Similarity=0.250 Sum_probs=155.6
Q ss_pred hcCCCcccccccc--CceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAG--GFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.++||+| +||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 9999999995 479999999987543 333467888999999999999999999876643
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 12366899999999999999999999998 99999999999999999999999999865422
Q ss_pred CCC-----cccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQT-----QGNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 111 111223468899999999987 67999999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=278.79 Aligned_cols=177 Identities=31% Similarity=0.470 Sum_probs=152.9
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
+.|++.+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458899999999999999999 46799999999865432 234578899999999999999999998866431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 2457899999999999999999999998 999999999999999999999999999765321
Q ss_pred ccccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
....||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2346899999999884 56789999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=279.88 Aligned_cols=185 Identities=21% Similarity=0.258 Sum_probs=150.5
Q ss_pred hhcCCCccccccccCceeEEEEEcCC------CcEEEEEEccCcCccC-----------HHHHHHHHHHHhcCCCCCccc
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPS------GREIAVKRLSKSSGQG-----------AEEFKNEVVVVAKLQHRNLVR 341 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~h~niv~ 341 (470)
..++|++.++||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998643 4789999986553211 122345666778889999999
Q ss_pred eeeEeeeCC----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--C
Q 041433 342 LLGFCLEDP----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD--A 397 (470)
Q Consensus 342 l~~~~~~~~----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~ 397 (470)
+++++.... .....+++.+++.++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 998876531 12367999999999999999999999998 99999999999998 8
Q ss_pred CCceEEeecCCceeccCCCCcc-----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 398 EMNPKISDFGMAKIFGVDQTQG-----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 398 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8999999999998764332211 11234599999999999999999999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.41 Aligned_cols=180 Identities=28% Similarity=0.429 Sum_probs=141.2
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999998 4579999999986542 234567889999999999999999999875421
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 12356899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 233578999999999876 67899999999999999999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=267.57 Aligned_cols=184 Identities=30% Similarity=0.473 Sum_probs=157.1
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..++|++.+.||+|+||.||++...++..||+|++.... ...+++.+|++++++++||||+++++++.+...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 357899999999999999999998888899999996543 345779999999999999999999998765431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV- 160 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence 1235899999999999999999999998 999999999999999999999999999876433222
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 1223346778999999988899999999999999999999 99999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=278.25 Aligned_cols=180 Identities=27% Similarity=0.430 Sum_probs=148.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36799999999999999999995 579999999986542 2334678899999999999999999998765421
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 1246889999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 233568999999999877 68999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=291.18 Aligned_cols=184 Identities=27% Similarity=0.335 Sum_probs=146.9
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
..++|++.++||+|+||.||+++ ..+++.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 34679999999999999999999 457999999998653 33344567889999999999999999998766431
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 13468899999999999999999998 77 999999999999999999999999999753322
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 1 2233467999999999999999999999999999999999999999653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=277.84 Aligned_cols=181 Identities=27% Similarity=0.420 Sum_probs=140.3
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
..++|++.+.||+|+||.||+++.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999954 68899999987543 3456889999999999999999999876532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCceeccCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 12456899999999999999999999998 999999999999975 8899999999998654321
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 223456899999999999989999999999999999999999999643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=265.46 Aligned_cols=186 Identities=29% Similarity=0.464 Sum_probs=157.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46799999999999999999995 478999999986543 334577899999999999999999999876532
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++..+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 12346899999999999999999999998 9999999999999999999999999998764333222
Q ss_pred cccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 3344578999999999987765 789999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=280.46 Aligned_cols=185 Identities=28% Similarity=0.479 Sum_probs=143.7
Q ss_pred hcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999853 57789999997543 334567999999999999999999999886543
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 12346899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 2211 1112235678999999999999999999999999999998 99999643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=266.17 Aligned_cols=182 Identities=25% Similarity=0.388 Sum_probs=157.2
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
..++|++.++||+|+||.||++.. .++..||+|++........+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 346799999999999999999995 4678999999987766778899999999999999999999998765431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceeccCCC
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 1345889999999999999999999998 9999999999999 788999999999998765332
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 2233568999999998765 4899999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.30 Aligned_cols=184 Identities=28% Similarity=0.455 Sum_probs=154.1
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
..++|++.+.||+|+||.||++...++..||+|++.... ...+++.+|++++++++||||+++++++.+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 356899999999999999999998888899999996543 345779999999999999999999998765331
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 176 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence 1356899999999999999999999998 99999999999999999999999999986533211 1
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1223346778999999998899999999999999999998 99999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=269.74 Aligned_cols=182 Identities=25% Similarity=0.340 Sum_probs=150.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||.||+++. .+++.||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6799999999999999999995 4699999999865432 22456789999999999999999999886643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-- 157 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence 12456899999999999999999999998 99999999999999999999999999987643222
Q ss_pred cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 2233468999999999876 67899999999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=278.07 Aligned_cols=191 Identities=27% Similarity=0.453 Sum_probs=158.5
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEe
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFC 346 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 346 (470)
..+....++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556789999999999999999999953 35899999997653 33356789999999999999999999987
Q ss_pred eeCCC------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 041433 347 LEDPE------------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384 (470)
Q Consensus 347 ~~~~~------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 384 (470)
.+... ....+++.+++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 65321 0156899999999999999999999998 99
Q ss_pred eecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 041433 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKN 463 (470)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P 463 (470)
||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986643332222334567889999999998999999999999999999999 9999
Q ss_pred CCCC
Q 041433 464 SSFY 467 (470)
Q Consensus 464 ~~~~ 467 (470)
|...
T Consensus 277 ~~~~ 280 (343)
T 1luf_A 277 YYGM 280 (343)
T ss_dssp TTTS
T ss_pred CCCC
Confidence 9653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.69 Aligned_cols=177 Identities=28% Similarity=0.399 Sum_probs=148.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
.+|++.+.||+|+||.||+|+. .+++.||||++..... .+.+|++++++++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4688999999999999999995 4699999999865432 2347999999999999999988764311
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEeecCCcee
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKI 411 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~DfG~a~~ 411 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 12457889999999999999999999988 9999999999999865 5789999999987
Q ss_pred ccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 643322 2335689999999998764 7899999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.01 Aligned_cols=179 Identities=27% Similarity=0.347 Sum_probs=145.4
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc--cCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG--QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.++||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||+++++++.+...
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999954 799999999865432 2233445566555555 89999999998866431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 1346999999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
......||+.|+|||++.+ .++.++||||||+++|||++|..|+.
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2233468999999998875 79999999999999999999976653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=275.61 Aligned_cols=197 Identities=29% Similarity=0.432 Sum_probs=150.8
Q ss_pred cchhhHHHHHHhhcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccc
Q 041433 268 SLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVR 341 (470)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~ 341 (470)
.+...++++....++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||++
T Consensus 21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence 334444555566788999999999999999999842 35589999986543 334567899999999999999999
Q ss_pred eeeEeeeCC-----------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 041433 342 LLGFCLEDP-----------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSN 392 (470)
Q Consensus 342 l~~~~~~~~-----------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 392 (470)
+++++.+.. .....+++.+++.++.||+.||.|||+++ |+||||||+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 999875422 12356899999999999999999999988 9999999999
Q ss_pred eeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 393 ILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 393 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999999999999999987644332222333456789999999999999999999999999999999 89998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=276.38 Aligned_cols=187 Identities=25% Similarity=0.391 Sum_probs=146.9
Q ss_pred HHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.....++|++.++||+|+||.||+++ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 34556789999999999999999998 45789999999965532 234567899999999999999999998866431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-----CCCCceEEeecCCce
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL-----DAEMNPKISDFGMAK 410 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-----~~~~~~kl~DfG~a~ 410 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 109 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 109 HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 2446899999999999999999999998 9999999999999 455569999999998
Q ss_pred eccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+..... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 186 AFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 6643222 22334679999999998774 5899999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=283.98 Aligned_cols=182 Identities=27% Similarity=0.462 Sum_probs=156.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999995 479999999986542 234567899999999999999999999876532
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 23467899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 2234578999999999988765 68999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=275.63 Aligned_cols=185 Identities=23% Similarity=0.387 Sum_probs=155.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999984 478899999987543 2334678899999999999999999988754321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 1346889999999999999999999998 9999999999999999999999999998765332
Q ss_pred Ccc-cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQG-NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 211 1234578999999998754 45899999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=275.51 Aligned_cols=182 Identities=24% Similarity=0.392 Sum_probs=146.8
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccC-HHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
++|.+.++||+|+||.||+++. .+++.||||++....... ...+.+|++++++++||||+++++++.....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999995 478999999986543221 1235579999999999999999998865431
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~ 156 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 156 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence 2456899999999999999999999998 99999999999999999999999999986542221 2
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233467999999999876 56899999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=264.66 Aligned_cols=183 Identities=30% Similarity=0.536 Sum_probs=137.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999994 579999999986432 234577899999999999999999999876543
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 12356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 2 122356899999999999888999999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=274.39 Aligned_cols=199 Identities=29% Similarity=0.442 Sum_probs=165.2
Q ss_pred ccchhhHHHHHHhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCC
Q 041433 267 ESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRN 338 (470)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~n 338 (470)
+...++...+....++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+++++++ +|||
T Consensus 13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 344566677777889999999999999999999973 3578999999976533 3345788999999999 7999
Q ss_pred ccceeeEeeeCCC--------------------C---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 041433 339 LVRLLGFCLEDPE--------------------K---------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383 (470)
Q Consensus 339 iv~l~~~~~~~~~--------------------~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 383 (470)
|+++++++..... . ...+++..+..++.||+.||.|||+++ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 9999998765321 0 112789999999999999999999998 9
Q ss_pred EeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 041433 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 462 (470)
Q Consensus 384 vH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~ 462 (470)
+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987644333333334567889999999999999999999999999999998 999
Q ss_pred CCCCCC
Q 041433 463 NSSFYQ 468 (470)
Q Consensus 463 P~~~~~ 468 (470)
||....
T Consensus 250 p~~~~~ 255 (316)
T 2xir_A 250 PYPGVK 255 (316)
T ss_dssp SSTTCC
T ss_pred CCcccc
Confidence 997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.69 Aligned_cols=186 Identities=32% Similarity=0.534 Sum_probs=156.9
Q ss_pred HHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++..++|++.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.....
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence 34557899999999999999999998888999999997543 457889999999999999999999998754220
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 0125788889999999999999999998 99999999999999999999999999986542211
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. ......+++.|+|||++....++.++||||||++||||+| |+.||...
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 1122345778999999998999999999999999999999 99999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=274.87 Aligned_cols=184 Identities=26% Similarity=0.370 Sum_probs=148.6
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc-----CHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ-----GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
..++|++.+.||+|+||.||+++. .+++.||||++...... ..+.+.+|++++++++||||+++++++....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 457899999999999999999995 46899999998654221 1246789999999999999999999876533
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 12346888999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......+|+.|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus 165 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 165 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 22 122345689999999998654 5899999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=277.33 Aligned_cols=181 Identities=27% Similarity=0.397 Sum_probs=145.1
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|++.+.||+|+||.||+++. .+++.||||++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46899999999999999999995 4799999999965433 34678899999999999999999998765431
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEEeecCCceeccCCCCc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN--PKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 418 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--- 171 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 171 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc---
Confidence 1346899999999999999999999998 999999999999987765 999999999743222
Q ss_pred ccccccccccCcccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVK-SDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 12233568999999999988887655 89999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.35 Aligned_cols=185 Identities=30% Similarity=0.352 Sum_probs=156.9
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC-
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~- 351 (470)
...++|++.+.||+|+||.||+++. .+++.||||++++. .....+.+..|..++..+ +||||+++++++.+...
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4457899999999999999999994 56889999998753 234456788899999988 79999999987655321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 1356899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......||+.|+|||++.+..++.++||||||++||||++|+.||...
T Consensus 495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 22 2234567999999999999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=269.92 Aligned_cols=182 Identities=27% Similarity=0.377 Sum_probs=156.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999995 4689999999865432 23678999999999999999999999876533
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEeecCCce
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM----NPKISDFGMAK 410 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~DfG~a~ 410 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 12456789999999999999999999998 99999999999999888 79999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 764332 123456899999999999899999999999999999999999999643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=282.26 Aligned_cols=184 Identities=27% Similarity=0.432 Sum_probs=146.2
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--------ccCHHHHHHHHHHHhcCCCCCccceeeEeee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--------GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 348 (470)
...++|.+.++||+|+||.||+|.. .+++.||||++.+.. ......+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3468899999999999999999984 578999999986532 1122357899999999999999999988643
Q ss_pred CC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEeecCC
Q 041433 349 DP-----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE---MNPKISDFGM 408 (470)
Q Consensus 349 ~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~DfG~ 408 (470)
.. .....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 21 23467899999999999999999999998 9999999999999654 4599999999
Q ss_pred ceeccCCCCcccccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 98754322 2334578999999998853 67889999999999999999999999754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=266.17 Aligned_cols=184 Identities=20% Similarity=0.310 Sum_probs=155.9
Q ss_pred hhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~----- 351 (470)
..++|++.+.||+|+||.||++. ..+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45789999999999999999999 4679999999986543 234578899999999 79999999988765331
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEEeecCCceecc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN-----PKISDFGMAKIFG 413 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~DfG~a~~~~ 413 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 2346899999999999999999999988 999999999999987776 9999999998765
Q ss_pred CCCCc-----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQ-----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 43322 1223456899999999999999999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=266.10 Aligned_cols=185 Identities=25% Similarity=0.359 Sum_probs=155.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC----ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999995 578999999986542 334577899999999999999999999874321
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 12456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 333333333456899999999887644 378999999999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=264.29 Aligned_cols=183 Identities=37% Similarity=0.583 Sum_probs=147.6
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCc----cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG----QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||++.. .++.||||++..... ...+.+.+|+++++.++||||+++++++.....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 589999999865432 335678999999999999999999998765431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------CCceEEeecCCce
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA--------EMNPKISDFGMAK 410 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--------~~~~kl~DfG~a~ 410 (470)
....+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 2467899999999999999999999987556899999999999986 6789999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 22346899999999999999999999999999999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=278.40 Aligned_cols=186 Identities=30% Similarity=0.436 Sum_probs=156.9
Q ss_pred hhcCCCccccccccCceeEEEEEc--------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeee
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE 348 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 348 (470)
..++|.+.++||+|+||.||+|+. ..+..||||++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457899999999999999999984 234679999997553 33446789999999999 89999999998765
Q ss_pred CCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 041433 349 DPE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNIL 394 (470)
Q Consensus 349 ~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 394 (470)
... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 321 0235899999999999999999999998 999999999999
Q ss_pred eCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 395 LDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 395 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999987654433333344567889999999999999999999999999999999 99999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=272.72 Aligned_cols=187 Identities=28% Similarity=0.425 Sum_probs=156.6
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
...++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3457899999999999999999984 245889999997543 344567899999999999999999999875532
Q ss_pred C------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 041433 351 E------------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388 (470)
Q Consensus 351 ~------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 388 (470)
. ....+++.+++.++.||+.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 1 0123788999999999999999999998 999999
Q ss_pred CCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 389 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433333334456788999999998889999999999999999999 99999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=275.77 Aligned_cols=181 Identities=25% Similarity=0.385 Sum_probs=149.7
Q ss_pred HHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
....++|++.+.||+|+||.||+|+ ..+++.||||++...... ..+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4566899999999999999999998 467999999998654322 247999999999999999999874321
Q ss_pred ------------------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 041433 351 ------------------------------------------------------EKQGQLDWSRRYKIIGLIARGILYLH 376 (470)
Q Consensus 351 ------------------------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH 376 (470)
.....+++..+..++.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 12356889999999999999999999
Q ss_pred hCCCCCeEeecCCCCCeeeC-CCCceEEeecCCceeccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHH
Q 041433 377 EDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLV 454 (470)
Q Consensus 377 ~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl 454 (470)
+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....+|+.|+|||.+.+. .++.++||||||+++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999997 688999999999987643322 2334679999999988764 589999999999999
Q ss_pred HHHHhCCCCCCCC
Q 041433 455 LEIITGKKNSSFY 467 (470)
Q Consensus 455 ~elltG~~P~~~~ 467 (470)
|||++|+.||...
T Consensus 233 ~ell~g~~pf~~~ 245 (383)
T 3eb0_A 233 GELILGKPLFSGE 245 (383)
T ss_dssp HHHHHSSCSSCCS
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=276.48 Aligned_cols=182 Identities=29% Similarity=0.375 Sum_probs=147.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999984 578999999986542 2334678899999999999999999998765431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 0235789999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 181 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 181 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 223357899999999999999999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=264.91 Aligned_cols=183 Identities=27% Similarity=0.420 Sum_probs=155.2
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999994 468999999986543 3344678899999999999999999998765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEeecCCceeccC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN---PKISDFGMAKIFGV 414 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~DfG~a~~~~~ 414 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 1345789999999999999999999998 999999999999976655 99999999987643
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 322 23356899999999999999999999999999999999999999643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=279.29 Aligned_cols=182 Identities=26% Similarity=0.444 Sum_probs=138.5
Q ss_pred cCCCc-cccccccCceeEEEEEcC---CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFST-DNKLGAGGFGEVYKGVLP---SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
+.|.+ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.+|++++||||+++++++.....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999953 57899999996543 23568899999999999999999998865221
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEe
Q 041433 352 -----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKIS 404 (470)
Q Consensus 352 -----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~ 404 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||| +.++.+||+
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 1224899999999999999999999998 9999999999999 778899999
Q ss_pred ecCCceeccCCCCc-ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 405 DFGMAKIFGVDQTQ-GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 405 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999876432211 223345789999999998874 5899999999999999999999999644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=275.73 Aligned_cols=189 Identities=29% Similarity=0.433 Sum_probs=157.2
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcC-C-----CcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLP-S-----GREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
+....++|++.+.||+|+||.||++... + .+.||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4455688999999999999999999842 2 2489999987553 23456789999999999 8999999999876
Q ss_pred eCCC--------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 041433 348 EDPE--------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 348 ~~~~--------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 395 (470)
.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 5321 1235789999999999999999999998 9999999999999
Q ss_pred CCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 396 DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 396 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999987644333222334457889999999999999999999999999999999 99999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=274.35 Aligned_cols=189 Identities=29% Similarity=0.444 Sum_probs=155.7
Q ss_pred HHhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeee
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLE 348 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 348 (470)
+...++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34568899999999999999999984 24668999999754 334457889999999999 89999999998765
Q ss_pred CCC-------------------C----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 041433 349 DPE-------------------K----------------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRD 387 (470)
Q Consensus 349 ~~~-------------------~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 387 (470)
... . ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 321 0 123789999999999999999999998 99999
Q ss_pred CCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 388 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654433333334567889999999999999999999999999999998 9999976
Q ss_pred CC
Q 041433 467 YQ 468 (470)
Q Consensus 467 ~~ 468 (470)
..
T Consensus 278 ~~ 279 (344)
T 1rjb_A 278 IP 279 (344)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=271.81 Aligned_cols=174 Identities=26% Similarity=0.389 Sum_probs=130.9
Q ss_pred cccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC------------
Q 041433 286 DNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE------------ 351 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~------------ 351 (470)
.+.||+|+||.||++.. .+++.||||++.+. ....+.+|+.+++.++ ||||+++++++.+...
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999995 47899999998543 3467789999999997 9999999998866431
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEeecCCceeccCCCCccccc
Q 041433 352 ------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 167 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLK 167 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccc
Confidence 2356899999999999999999999998 99999999999997665 899999999986543222 223
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 456899999999999999999999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=281.82 Aligned_cols=179 Identities=31% Similarity=0.479 Sum_probs=153.2
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
...++|++.++||+|+||.||+|.. .++.||||+++... ..+.|.+|+++|++++||||+++++++.+...
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 4457899999999999999999998 47899999997543 45789999999999999999999998765431
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 1234789999999999999999999998 9999999999999999999999999998543221
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12256789999999999999999999999999999998 99999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=270.43 Aligned_cols=182 Identities=29% Similarity=0.415 Sum_probs=150.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc--CHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.+.||+|+||.||+++. .+++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 6799999999999999999995 46899999998654332 3456789999999999999999999886643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 12456899999999999999999999998 99999999999999999999999999986543222
Q ss_pred cccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22334689999999998765 7899999999999999999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=267.63 Aligned_cols=181 Identities=27% Similarity=0.397 Sum_probs=147.9
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhc--CCCCCccceeeEeeeCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK--LQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~------ 350 (470)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999998 7899999998543 34555666666666 89999999998754321
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLH--------EDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
.....+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 12456899999999999999999999 666 9999999999999999999999999
Q ss_pred CceeccCCCCcc--cccccccccCcccccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 041433 408 MAKIFGVDQTQG--NTSRIAGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG----------KKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~elltG----------~~P~~~ 466 (470)
+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 998764433221 12234789999999998776 455799999999999999999 788754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=272.45 Aligned_cols=189 Identities=26% Similarity=0.350 Sum_probs=152.1
Q ss_pred HHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-----CccCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-----SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
+....++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345568899999999999999999994 57889999998643 334567899999999999999999999988654
Q ss_pred CC--------C--------------------------------------------------CCCCCHHHHHHHHHHHHHH
Q 041433 350 PE--------K--------------------------------------------------QGQLDWSRRYKIIGLIARG 371 (470)
Q Consensus 350 ~~--------~--------------------------------------------------~~~l~~~~~~~i~~~i~~~ 371 (470)
.. . ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 31 0 1112466778899999999
Q ss_pred HHHHHhCCCCCeEeecCCCCCeeeCCCC--ceEEeecCCceeccCCCCcc--cccccccccCccccccccc--CCCCchh
Q 041433 372 ILYLHEDSRLRIIHRDLKVSNILLDAEM--NPKISDFGMAKIFGVDQTQG--NTSRIAGTYGYMAPEYAMH--GQFSVKS 445 (470)
Q Consensus 372 l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~ 445 (470)
|.|||+++ |+||||||+|||++.++ .+||+|||++..+....... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 89999999998764322211 2234568999999999865 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 041433 446 DVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 446 Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||||||+++|||++|+.||...
T Consensus 258 DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=270.96 Aligned_cols=183 Identities=27% Similarity=0.443 Sum_probs=156.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 36789999999999999999995 468899999986542 2345678899999999999999999998766431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 1256889999999999999999999998 99999999999999999999999999987643222
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 197 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 197 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp --CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 223456899999999999889999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=269.33 Aligned_cols=185 Identities=25% Similarity=0.376 Sum_probs=150.0
Q ss_pred hcCCCcc-ccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTD-NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~----- 351 (470)
.+.|++. +.||+|+||.||+++. .+++.||||++........+.+.+|++++.++ +||||+++++++.+...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678874 7899999999999994 57999999999877666778899999999985 79999999998766431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEeecCCceeccCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN---PKISDFGMAKIFGVD 415 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 1346889999999999999999999998 999999999999988776 999999998765322
Q ss_pred CC-----cccccccccccCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QT-----QGNTSRIAGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 11 111223458999999999865 56889999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=264.45 Aligned_cols=181 Identities=30% Similarity=0.468 Sum_probs=152.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++||||+++++++.+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46899999999999999999984 46789999998543 22345678999999999999999999998766431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 1246889999999999999999999987 999999999999999999999999998654322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 123356899999999999999999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=269.56 Aligned_cols=188 Identities=30% Similarity=0.453 Sum_probs=158.1
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
...++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999973 3578999999975533 3456789999999999 999999999987653
Q ss_pred CC--------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 350 PE--------------------K----------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 350 ~~--------------------~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.. . ...+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 21 0 124899999999999999999999998 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
|++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999987654433323334457889999999999999999999999999999999 999997643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=264.93 Aligned_cols=183 Identities=27% Similarity=0.443 Sum_probs=156.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46799999999999999999995 468899999986542 2345678899999999999999999998865431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 1246889999999999999999999998 99999999999999999999999999987643222
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223356899999999999889999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=276.21 Aligned_cols=178 Identities=24% Similarity=0.377 Sum_probs=149.7
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
..+|++.+.||+|+||.||+++...+..||+|++...... ..+|+++++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3579999999999999999999767777999988544322 2469999999999999999988744221
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecCCcee
Q 041433 352 -------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKI 411 (470)
Q Consensus 352 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~ 411 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 2457889999999999999999999998 99999999999998 799999999999987
Q ss_pred ccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 643322 2335689999999988764 5899999999999999999999999754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=271.07 Aligned_cols=188 Identities=27% Similarity=0.345 Sum_probs=142.6
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~------ 350 (470)
...+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.+++++. ||||+++++++....
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346799999999999999999994 578999999987666666678899999999996 999999998874211
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 351 ----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 351 ----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
.....+++.+++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 12456999999999999999999999874 3599999999999999999999999999
Q ss_pred ceeccCCCCcc----------cccccccccCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQG----------NTSRIAGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 98764322211 11134589999999988 5677899999999999999999999999643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=265.29 Aligned_cols=186 Identities=33% Similarity=0.550 Sum_probs=157.3
Q ss_pred HHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.+..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++..+..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 34557899999999999999999998788899999986543 356789999999999999999999998754320
Q ss_pred -----------C---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 -----------K---QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 -----------~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
. ...+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 0 125889999999999999999999998 99999999999999999999999999987653322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 1 2223456788999999988889999999999999999999 99999653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=263.85 Aligned_cols=181 Identities=29% Similarity=0.452 Sum_probs=149.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|.+.++||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 36799999999999999999994 578999999986553 4456889999999999999999999998765321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceec
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIF 412 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 412 (470)
....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 1256899999999999999999999998 9999999999999 45678999999999865
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 4322 223456899999999875 57899999999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=265.56 Aligned_cols=186 Identities=25% Similarity=0.433 Sum_probs=144.8
Q ss_pred HhhcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
...++|++.+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++.++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 91 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccE
Confidence 34578999999999999999999853 24579999986543 334567899999999999999999999874432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 12346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 3221 1223346778999999998999999999999999999997 99999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.01 Aligned_cols=180 Identities=24% Similarity=0.427 Sum_probs=151.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999984 579999999997543 2334678899999999999999999998765432
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 1345899999999999999999999998 999999999999999999999999999865322
Q ss_pred CCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 198 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 198 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 233568999999999877 68899999999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=284.21 Aligned_cols=185 Identities=31% Similarity=0.532 Sum_probs=152.0
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
+..++|++.++||+|+||.||+|.+..+..||||+++... ...+.|.+|+++|++++||||+++++++.+...
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehh
Confidence 3456789999999999999999998777889999997543 346789999999999999999999998765220
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 1235889999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 1222346788999999999999999999999999999999 99999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=262.24 Aligned_cols=183 Identities=30% Similarity=0.512 Sum_probs=158.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35689999999999999999984 578999999987553 345678999999999999999999999876543
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........ .
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 175 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--C
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--c
Confidence 12457899999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 23456899999999999999999999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=272.14 Aligned_cols=190 Identities=30% Similarity=0.473 Sum_probs=157.9
Q ss_pred HHHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEee
Q 041433 275 AIKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347 (470)
Q Consensus 275 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 347 (470)
++++..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34456788999999999999999999843 46789999997543 234457889999999999999999999876
Q ss_pred eCCC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 041433 348 EDPE----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399 (470)
Q Consensus 348 ~~~~----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 399 (470)
+... ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 5331 0145688899999999999999999998 99999999999999999
Q ss_pred ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 400 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999999986543332222333456889999999998999999999999999999999 89998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=266.66 Aligned_cols=181 Identities=29% Similarity=0.442 Sum_probs=152.5
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
..++|.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 346799999999999999999995 4799999999976655555678999999999999999999998765331
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceeccCCC
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+.+ |+|+||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 1345789999999999999999999998 9999999999999 78889999999999754321
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 22334689999999999999999999999999999999999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=265.96 Aligned_cols=182 Identities=31% Similarity=0.507 Sum_probs=152.5
Q ss_pred cCCCccccccccCceeEEEEE-----cCCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-----LPSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
++|++.++||+|+||.||+++ ..+++.||+|++... .....+.+.+|++++++++||||+++++++.....
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 568899999999999999998 346899999999754 33456789999999999999999999998765421
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 1346889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 414 VDQTQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 414 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 43321 12233467888999999999999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=266.38 Aligned_cols=184 Identities=26% Similarity=0.360 Sum_probs=146.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999995 47899999999755332 24678899999999999999999998766431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 1356899999999999999999999998 99999999999999999999999999976543221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 190 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 190 -TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred -ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 1223356899999999999989999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=277.36 Aligned_cols=180 Identities=23% Similarity=0.288 Sum_probs=151.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC------CCCCccceeeEeeeCC-
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL------QHRNLVRLLGFCLEDP- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~- 350 (470)
...+|++.++||+|+||.||+|.. .+++.||||++... ......+.+|+++++.+ +|+||+++++++....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346799999999999999999984 56899999999653 23345677888888877 5779999998876532
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEEeecCCce
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN--PKISDFGMAK 410 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~DfG~a~ 410 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++.
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 12345899999999999999999999998 999999999999999887 9999999997
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 64322 22357899999999999999999999999999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=261.03 Aligned_cols=183 Identities=31% Similarity=0.491 Sum_probs=156.0
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46789999999999999999998788899999997543 345789999999999999999999998765431
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence 2345889999999999999999999998 99999999999999999999999999986532211 11
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 223456778999999998899999999999999999999 89999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=281.72 Aligned_cols=179 Identities=14% Similarity=0.192 Sum_probs=143.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHH---HHHhcCCCCCcccee-------eE
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEV---VVVAKLQHRNLVRLL-------GF 345 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~h~niv~l~-------~~ 345 (470)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999995 57999999998743 334457789999 556666899999987 43
Q ss_pred eeeCCC-----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 041433 346 CLEDPE-----------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384 (470)
Q Consensus 346 ~~~~~~-----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 384 (470)
+..... ....+++..++.|+.||+.||.|||+++ |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 322210 0111224777889999999999999998 99
Q ss_pred eecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccC-----------CCCchhhHHHHHHH
Q 041433 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-----------QFSVKSDVYSFGVL 453 (470)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~v 453 (470)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999986332 2233467 899999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 041433 454 VLEIITGKKNSSFY 467 (470)
Q Consensus 454 l~elltG~~P~~~~ 467 (470)
+|||++|+.||...
T Consensus 303 l~elltg~~Pf~~~ 316 (377)
T 3byv_A 303 IYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHSSCCC---
T ss_pred HHHHHHCCCCCccc
Confidence 99999999999653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=284.46 Aligned_cols=184 Identities=32% Similarity=0.528 Sum_probs=156.4
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
...+|++.++||+|+||.||+|.+. ++..||||+++... ...+.|.+|+.+|++++||||+++++++.....
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3467889999999999999999964 48899999996543 456789999999999999999999998865431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 2356889999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. ......+++.|+|||++.+..++.++||||||++||||+| |+.||...
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 1223345778999999998899999999999999999999 99999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=269.77 Aligned_cols=187 Identities=29% Similarity=0.461 Sum_probs=155.1
Q ss_pred HhhcCCCccccccccCceeEEEEEc--------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL--------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3457899999999999999999984 356789999997543 33456789999999999 8999999999876
Q ss_pred eCCC-------------------C---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 348 EDPE-------------------K---------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 348 ~~~~-------------------~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.... . ...+++.+++.++.||+.||.|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 5321 0 124889999999999999999999998 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999987654433233334456788999999988889999999999999999999 99999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=261.34 Aligned_cols=182 Identities=26% Similarity=0.404 Sum_probs=153.1
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCc------cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999954 789999999865422 246789999999999999999999998765431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEeecCCce
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM----NPKISDFGMAK 410 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~DfG~a~ 410 (470)
....+++.++..++.||+.||.|||+++ |+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 1346899999999999999999999998 99999999999998877 89999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 161 KIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 7643221 23346899999999999889999999999999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=270.53 Aligned_cols=184 Identities=30% Similarity=0.441 Sum_probs=157.0
Q ss_pred hcCCCccccccccCceeEEEEEc-----CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999983 4688999999987766667789999999999999999999988753221
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 1235899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 414 VDQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 414 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 333211 22234578889999999988899999999999999999999999853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=266.12 Aligned_cols=180 Identities=29% Similarity=0.458 Sum_probs=145.2
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
.++|++.+.||+|+||.||+++. .++.||||++... ...+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~ 83 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEG 83 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCC
Confidence 35788999999999999999997 5789999998643 34577899999999999999999998764311
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-eEEeecCCceeccCCCCcc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN-PKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 11124788999999999999999999943234999999999999988886 799999999764322
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 22346899999999999999999999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=262.22 Aligned_cols=185 Identities=31% Similarity=0.532 Sum_probs=154.2
Q ss_pred hcCCCccc-cccccCceeEEEEEc---CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDN-KLGAGGFGEVYKGVL---PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 35666766 999999999999984 367889999997653 344577899999999999999999999874321
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 13456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred Cc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 21 11223346789999999988889999999999999999999 99999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=275.30 Aligned_cols=184 Identities=29% Similarity=0.410 Sum_probs=152.0
Q ss_pred hcCCCccccccccCceeEEEEEc----CCCcEEEEEEccCcC----ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS----GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 350 (470)
.++|++.++||+|+||.||+++. .+++.||||++++.. ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999985 478999999986532 23445677899999999 6999999998876543
Q ss_pred C------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 351 E------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 351 ~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 1 1346889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 43222 12334578999999999875 35789999999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=261.61 Aligned_cols=181 Identities=28% Similarity=0.438 Sum_probs=155.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36799999999999999999995 46889999998643 22345678999999999999999999998765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 1245889999999999999999999988 9999999999999999999999999997654321
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 23356899999999999999999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=265.54 Aligned_cols=185 Identities=25% Similarity=0.434 Sum_probs=148.8
Q ss_pred hcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.+.||+|+||.||++... +++.||||++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999954 58999999997776666778999999999999999999998763210
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecC
Q 041433 351 ----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFG 407 (470)
Q Consensus 351 ----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG 407 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 12456889999999999999999999998 99999999999997 56799999999
Q ss_pred CceeccCCCC-cccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 408 MAKIFGVDQT-QGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 408 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 9986543211 112233457889999998865 67899999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=266.40 Aligned_cols=177 Identities=21% Similarity=0.372 Sum_probs=151.5
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPEK------ 352 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~------ 352 (470)
++|++.++||+|+||.||+++ ..+++.||||++... ..+.+.+|++++++++ ||||+++++++......
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 679999999999999999998 467899999998643 3577899999999997 99999999988763211
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCCCCccc
Q 041433 353 -----------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 353 -----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~ 420 (470)
...+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--- 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--- 186 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---
Confidence 134788999999999999999999998 99999999999998776 899999999987643322
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 233468899999999877 6789999999999999999999999954
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=269.39 Aligned_cols=185 Identities=25% Similarity=0.392 Sum_probs=152.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 47899999999999999999995 478999999996543 2334578899999999999999999987654310
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 1246889999999999999999999998 9999999999999999999999999998764322
Q ss_pred Ccc--------cccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQG--------NTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 111 1223468999999998764 67899999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=270.91 Aligned_cols=180 Identities=26% Similarity=0.387 Sum_probs=150.3
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~------ 350 (470)
..++|++.+.||+|+||.||++.. .+++.||||++.+.... ..+|++++.++ +||||+++++++.+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356799999999999999999995 47899999999765433 35688888887 7999999999876532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----CceEEeecCCceeccC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE----MNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 12456899999999999999999999998 9999999999998433 3599999999987643
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 322 223457899999999998888999999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.82 Aligned_cols=187 Identities=23% Similarity=0.315 Sum_probs=145.1
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 350 (470)
+......++|++.+.||+|+||.||+++. .+++.||||++.... .....+.+|++.++.++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34456678999999999999999999995 578999999985543 23345678888999999999999998874411
Q ss_pred --------------------------CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeecCCCCCeeeCC-CCce
Q 041433 351 --------------------------EKQGQLDWSRRYKIIGLIARGILYLH--EDSRLRIIHRDLKVSNILLDA-EMNP 401 (470)
Q Consensus 351 --------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlkp~Nill~~-~~~~ 401 (470)
.....+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 13456788889999999999999999 777 999999999999986 8999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
||+|||+++.+..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 9999999987643322 2334689999999988665 4899999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=277.26 Aligned_cols=181 Identities=25% Similarity=0.373 Sum_probs=153.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|.+.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 46799999999999999999995 469999999997543 3446778899999999999999999988765331
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEeecCCce
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL----DAEMNPKISDFGMAK 410 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~DfG~a~ 410 (470)
....+++.+++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 1123899999999999999999999998 9999999999999 778889999999998
Q ss_pred eccCCCCcccccccccccCccccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 764332 2233568999999998864 5678899999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=272.82 Aligned_cols=176 Identities=24% Similarity=0.311 Sum_probs=141.0
Q ss_pred cCCCcc-ccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHH-hcCCCCCccceeeEeee----C----
Q 041433 281 NKFSTD-NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVV-AKLQHRNLVRLLGFCLE----D---- 349 (470)
Q Consensus 281 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~---- 349 (470)
++|.+. +.||+|+||.||++.. .+++.||||++.. ...+.+|++++ +..+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 7899999999999994 4789999999853 24577888887 44589999999987643 0
Q ss_pred -----C-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCce
Q 041433 350 -----P-----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMAK 410 (470)
Q Consensus 350 -----~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a~ 410 (470)
. .....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 0 11245899999999999999999999988 999999999999987 7899999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 223457899999999999999999999999999999999999999654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=266.94 Aligned_cols=186 Identities=32% Similarity=0.521 Sum_probs=158.2
Q ss_pred HHhhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
....++|++.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345678999999999999999999954 5889999998654 344678899999999999999999999876533
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 12455899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 22233456788999999998999999999999999999999 99999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=271.71 Aligned_cols=184 Identities=20% Similarity=0.294 Sum_probs=146.9
Q ss_pred hcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcCcc-----------CHHHHHHHHHHHhcCCCCCccceee
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSSGQ-----------GAEEFKNEVVVVAKLQHRNLVRLLG 344 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~ 344 (470)
.++|++.+.||+|+||.||+|... ++..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999954 5788999998755321 1234667889999999999999999
Q ss_pred EeeeCC---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC--ce
Q 041433 345 FCLEDP---------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM--NP 401 (470)
Q Consensus 345 ~~~~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~ 401 (470)
++.... .....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence 876621 12337899999999999999999999998 99999999999998877 99
Q ss_pred EEeecCCceeccCCCCc-----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQ-----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999876432211 111345789999999999999999999999999999999999999953
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=267.24 Aligned_cols=184 Identities=27% Similarity=0.373 Sum_probs=152.6
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999994 679999999987666666778999999999999999999999875210
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 12466899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCcc-------cccccccccCcccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 412 FGVDQTQG-------NTSRIAGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 412 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 43211110 012235689999999887543 6899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=265.30 Aligned_cols=184 Identities=28% Similarity=0.375 Sum_probs=141.6
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc--CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ--GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
+..++|++.+.||+|+||.||+++. .+++.||+|++...... ..+.+.++...++.++||||+++++++.+...
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457899999999999999999994 57999999998654222 22334455566888999999999998865431
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 246799999999999999999999997 7 999999999999999999999999999865
Q ss_pred cCCCCcccccccccccCccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 43222 2234689999999996 5667899999999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=283.81 Aligned_cols=181 Identities=31% Similarity=0.491 Sum_probs=155.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
.++|++.++||+|+||.||+++. .+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46799999999999999999995 479999999986542 345678999999999999999999999876532
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceeccC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+..
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 12456899999999999999999999998 9999999999999 5678999999999986643
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|++||...
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 182 SK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 32 2234568999999998865 7999999999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=269.62 Aligned_cols=180 Identities=24% Similarity=0.425 Sum_probs=151.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36799999999999999999994 579999999986543 2334678899999999999999999988765321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 1345899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred -----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223468999999998876 67899999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=282.92 Aligned_cols=181 Identities=31% Similarity=0.483 Sum_probs=152.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.++||+|+||.||+++. .+++.||||++.+. .......+.+|++++++++||||+++++++.....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999995 47999999998643 33456789999999999999999999998765431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEeecCCceeccCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD---AEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 1356889999999999999999999998 99999999999994 5567999999999865432
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...
T Consensus 178 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2234568999999998865 6999999999999999999999999643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=261.94 Aligned_cols=184 Identities=22% Similarity=0.334 Sum_probs=150.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
..++|++.+.||+|+||.||+++. .+++.||||++...... +.+.+|+++++.++|++++..+..+....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999994 67899999987544322 35788999999999999888776653322
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceeccCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 12456899999999999999999999998 9999999999999 78899999999999876543
Q ss_pred CCcc-----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQG-----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 3211 223457899999999999999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=265.89 Aligned_cols=183 Identities=28% Similarity=0.430 Sum_probs=150.1
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc--------cCHHHHHHHHHHHhcCCCCCccceeeEeeeC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG--------QGAEEFKNEVVVVAKLQHRNLVRLLGFCLED 349 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 349 (470)
..++|.+.+.||+|+||.||++.. .+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346899999999999999999994 5689999999865421 2234578999999999999999999887543
Q ss_pred C-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEeecCCc
Q 041433 350 P-----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN---PKISDFGMA 409 (470)
Q Consensus 350 ~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~DfG~a 409 (470)
. .....+++.+...++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 2 23457899999999999999999999998 999999999999987654 999999999
Q ss_pred eeccCCCCcccccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 165 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp EECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred eeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 8754321 123356899999999874 467899999999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=274.87 Aligned_cols=180 Identities=24% Similarity=0.302 Sum_probs=153.1
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC--------CCCccceeeEeeeCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ--------HRNLVRLLGFCLEDP 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~~~~ 350 (470)
.++|++.++||+|+||.||+++ ..+++.||||++... ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4789999999999999999998 457899999999643 334567889999999986 788999998765210
Q ss_pred -----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCC-------
Q 041433 351 -----------------------EKQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEM------- 399 (470)
Q Consensus 351 -----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~------- 399 (470)
.....+++.++..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence 1235689999999999999999999998 7 99999999999998775
Q ss_pred ------------------------------------------ceEEeecCCceeccCCCCcccccccccccCcccccccc
Q 041433 400 ------------------------------------------NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437 (470)
Q Consensus 400 ------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 437 (470)
.+||+|||++...... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999875432 22346899999999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 438 HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 438 ~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+..++.++||||||+++|||++|+.||....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-33 Score=263.86 Aligned_cols=185 Identities=30% Similarity=0.469 Sum_probs=151.7
Q ss_pred hhcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
..++|.+.+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 3578999999999999999999842 2346999998765 33445778999999999999999999998754321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 1345889999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 167 DYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 221 1223456788999999988899999999999999999998 99999643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=261.24 Aligned_cols=180 Identities=31% Similarity=0.425 Sum_probs=148.3
Q ss_pred CCCccccccccCceeEEEEEc-CC---CcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PS---GREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.|.+.++||+|+||.||+|.. .+ +..||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 466679999999999999984 22 33799999875433 345678999999999999999999998765331
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 2456889999999999999999999998 9999999999999999999999999998653322
Q ss_pred C--cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 417 T--QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 417 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
. ........+++.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 1 11223346788999999999999999999999999999999965554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=265.75 Aligned_cols=183 Identities=29% Similarity=0.439 Sum_probs=153.0
Q ss_pred cCC-CccccccccCceeEEEEEc-----CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 281 NKF-STDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 281 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
++| ++.++||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 445 8999999999999988863 268899999997653 2345678999999999999999999998876421
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 1345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCc-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQ-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 3221 122334578889999999988999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=260.25 Aligned_cols=184 Identities=22% Similarity=0.330 Sum_probs=154.5
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
..++|++.+.||+|+||.||+++. .+++.||||++..... .+.+.+|+.+++.++|++++..+.++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999994 6899999999865443 246889999999999998887766553321
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceeccCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 12456899999999999999999999998 9999999999999 48889999999999876543
Q ss_pred CCcc-----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQG-----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 3211 123457899999999999999999999999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-33 Score=263.78 Aligned_cols=177 Identities=27% Similarity=0.441 Sum_probs=150.2
Q ss_pred hcCCCccccccccCceeEEEEEcC-CC-------cEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SG-------REIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
.++|.+.+.||+|+||.||+++.. ++ ..||+|++........+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999843 33 5799999987777777889999999999999999999998866431
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--------eEEe
Q 041433 352 -------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN--------PKIS 404 (470)
Q Consensus 352 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~ 404 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 1233889999999999999999999998 999999999999988887 9999
Q ss_pred ecCCceeccCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 041433 405 DFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGK-KNSS 465 (470)
Q Consensus 405 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~-~P~~ 465 (470)
|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|. +||.
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9999864321 123457889999999887 67899999999999999999955 4444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-33 Score=287.74 Aligned_cols=187 Identities=31% Similarity=0.523 Sum_probs=157.4
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
+++..++|++.++||+|+||.||+|.+..+..||||+++... ...+.|.+|+++|++++||||+++++++.+...
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~ 340 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 340 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence 345567899999999999999999998777889999997544 346789999999999999999999998755220
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 1245889999999999999999999998 9999999999999999999999999998654221
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. .......++..|+|||++....++.++||||||++||||++ |+.||...
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11122346778999999999999999999999999999999 99999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=261.66 Aligned_cols=183 Identities=27% Similarity=0.466 Sum_probs=151.8
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
...++|++.+.||+|+||.||++.. .+++.||||++.... ..+.+.+|+.++++++||||+++++++.....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3457899999999999999999995 468999999986543 35678999999999999999999998765431
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 2457899999999999999999999998 99999999999999999999999999987643222
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 223356899999999999989999999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=281.37 Aligned_cols=181 Identities=30% Similarity=0.475 Sum_probs=149.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.++||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999995 478999999987543 3446788999999999999999999998865431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCceeccCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a~~~~~~ 415 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 1346889999999999999999999998 999999999999976 445999999999876533
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||++. +.++.++||||||+++|+|++|+.||...
T Consensus 193 ~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 193 K---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp B---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 223457999999999875 57999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=265.15 Aligned_cols=186 Identities=26% Similarity=0.383 Sum_probs=154.2
Q ss_pred HHHhhcCCCcc-ccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC
Q 041433 276 IKVATNKFSTD-NKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP 350 (470)
Q Consensus 276 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 350 (470)
.....++|.+. +.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++ ||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34556778887 8999999999999995 46999999998754 2344678899999999995 699999998875532
Q ss_pred --------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecC
Q 041433 351 --------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFG 407 (470)
Q Consensus 351 --------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG 407 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 12367899999999999999999999998 999999999999987 7899999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9987643221 23356899999999999999999999999999999999999999653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-32 Score=258.44 Aligned_cols=181 Identities=29% Similarity=0.438 Sum_probs=149.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
++|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999994 578999999998776666788999999999999999999999886543
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCceeccCCCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++..+..++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 11235678889999999999999999998 999999999999987 89999999999987543221
Q ss_pred cccccccccccCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 123356899999999987643 88999999999999999999999953
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=261.60 Aligned_cols=185 Identities=29% Similarity=0.438 Sum_probs=149.9
Q ss_pred hcCCCccccccccCceeEEEEEcCC----CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPS----GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
..+|++.+.||+|+||.||+|...+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568899999999999999998532 2358999986543 334567899999999999999999999865432
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 12456889999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCc--ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQ--GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 2211 12223456788999999999999999999999999999999 55666543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=264.94 Aligned_cols=184 Identities=26% Similarity=0.410 Sum_probs=151.9
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
..++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 347899999999999999999995 4689999999987777778899999999999999999999998765431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 1356899999999999999999999998 9999999999999999999999999875432111
Q ss_pred ccccccccccCccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYA-----MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 112234689999999988 3667899999999999999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=262.54 Aligned_cols=181 Identities=24% Similarity=0.448 Sum_probs=143.5
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5799999999999999999994 579999999987532 3345678899999999999999999998765431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 2455889999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 221 12334689999999999999999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=272.68 Aligned_cols=184 Identities=29% Similarity=0.440 Sum_probs=141.9
Q ss_pred cCCCccccccccCceeEEEEEcC--C--CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP--S--GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
..|++.+.||+|+||.||+|... + ...||+|.++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677899999999999999842 2 2468999986543 344578999999999999999999999875432
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 12345788999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcc--cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQG--NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... ......+++.|+|||.+.+..++.++||||||+++|||+| |.+||...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 2111 1223456788999999999999999999999999999999 67787653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=267.09 Aligned_cols=184 Identities=32% Similarity=0.505 Sum_probs=155.6
Q ss_pred hhcCCCccccccccCceeEEEEEc-----CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-----PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346789999999999999999983 4689999999987666667789999999999999999999988654320
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceec
Q 041433 352 -------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIF 412 (470)
Q Consensus 352 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~ 412 (470)
....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 1245899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 413 GVDQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 413 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
....... ......++..|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 5432211 1222346778999999988889999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=267.89 Aligned_cols=187 Identities=25% Similarity=0.417 Sum_probs=156.3
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc--------CHHHHHHHHHHHhcC-CCCCcccee
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ--------GAEEFKNEVVVVAKL-QHRNLVRLL 343 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l-~h~niv~l~ 343 (470)
.......++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34455667899999999999999999996 47999999998654321 134678899999999 799999999
Q ss_pred eEeeeCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 344 GFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 344 ~~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
+++..... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 98765321 1246889999999999999999999998 99999999999999999999999
Q ss_pred cCCceeccCCCCcccccccccccCccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 406 FGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 406 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 99998765332 2234578999999998853 3588999999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-32 Score=279.14 Aligned_cols=182 Identities=32% Similarity=0.462 Sum_probs=151.7
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-------------cCHHHHHHHHHHHhcCCCCCccceee
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-------------QGAEEFKNEVVVVAKLQHRNLVRLLG 344 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~~ 344 (470)
..++|.+.++||+|+||.||+++. .+++.||||++.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 347899999999999999999995 4689999999865421 33567899999999999999999999
Q ss_pred EeeeCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEE
Q 041433 345 FCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM---NPKI 403 (470)
Q Consensus 345 ~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl 403 (470)
++.+... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence 8866431 1356899999999999999999999998 99999999999998776 6999
Q ss_pred eecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+|||++..+.... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||...
T Consensus 191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998765432 223456899999999876 56999999999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=287.48 Aligned_cols=184 Identities=30% Similarity=0.526 Sum_probs=149.3
Q ss_pred cCCCccc-cccccCceeEEEEEc---CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDN-KLGAGGFGEVYKGVL---PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+++.+.+ +||+|+||.||+|.+ .++..||||+++... ....+.+.+|+++|++++||||+++++++..+.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~ 414 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence 4444455 799999999999985 256789999997653 345688999999999999999999999876532
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 13456899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.. ......+++.|+|||++.+..++.++||||||++||||++ |+.||...
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 11 1112235678999999999999999999999999999998 99999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=271.80 Aligned_cols=181 Identities=29% Similarity=0.415 Sum_probs=154.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.++||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46799999999999999999995 478999999987653 3345678999999999999999999998766431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 124688899999999999999999985 6 999999999999999999999999998754322
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123357899999999999999999999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=264.52 Aligned_cols=187 Identities=27% Similarity=0.398 Sum_probs=150.0
Q ss_pred HHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCC--CCCccceeeEeeeCC--
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQ--HRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~-- 350 (470)
....++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++ ||||+++++++....
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34457899999999999999999998789999999986543 334567899999999997 599999999876533
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||++..+...
T Consensus 104 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 12356889999999999999999999998 999999999999964 88999999999876543
Q ss_pred CCcccccccccccCccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 33222334568999999998865 47889999999999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=274.50 Aligned_cols=183 Identities=23% Similarity=0.341 Sum_probs=151.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEe-eeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFC-LEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~------- 350 (470)
.++|++.++||+|+||.||+++. .+++.||||++...... +++.+|+++++.++|++.+..+.++ .+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999994 67999999987654332 3578899999999886555444333 2211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEeecCCceeccCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL---DAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.+++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+....
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 12457999999999999999999999998 9999999999999 688999999999998765433
Q ss_pred Ccc-----cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQG-----NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... ......||+.|+|||++.+..++.++||||||++||||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 221 122467899999999999999999999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=260.79 Aligned_cols=186 Identities=26% Similarity=0.415 Sum_probs=152.1
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999995 478999999986543 334567899999999999999999999775321
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDS--RLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
.....+++..++.++.||+.||.|||+.+ ..+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 01334899999999999999999999875 1339999999999999999999999999997
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 6543221 122346899999999999889999999999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=262.29 Aligned_cols=187 Identities=30% Similarity=0.485 Sum_probs=151.8
Q ss_pred HhhcCCCccc-cccccCceeEEEEEc---CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-
Q 041433 278 VATNKFSTDN-KLGAGGFGEVYKGVL---PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP- 350 (470)
Q Consensus 278 ~~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~- 350 (470)
...++|.+.+ .||+|+||.||++.+ .+++.||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 92 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW 92 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSE
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCc
Confidence 3456788888 999999999999953 3578999999975532 23567899999999999999999999874322
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 11345899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 32211 1122345688999999988889999999999999999999 99999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=264.63 Aligned_cols=186 Identities=34% Similarity=0.496 Sum_probs=150.1
Q ss_pred hhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 351 (470)
..++|++.+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999983 25778999999654 33445678899999999999999999998765321
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEE
Q 041433 352 -------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKI 403 (470)
Q Consensus 352 -------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl 403 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 1145889999999999999999999998 999999999999984 446999
Q ss_pred eecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999976543333223334567889999999988999999999999999999998 99999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=256.31 Aligned_cols=181 Identities=29% Similarity=0.422 Sum_probs=150.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
+.|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4578889999999999999994 57889999998654 23445678999999999999999999987654210
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecCCceeccC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~ 414 (470)
....+++..+..++.||+.||.|||+.+ .+|+|+||||+|||++ .++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 1256889999999999999999999875 3599999999999997 789999999999975432
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||...
T Consensus 185 ~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 185 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 223356899999999776 56899999999999999999999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=264.64 Aligned_cols=184 Identities=31% Similarity=0.504 Sum_probs=146.5
Q ss_pred hcCCCccccccccCceeEEEEEcCC-----CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPS-----GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
.++|.+.+.||+|+||.||+|.... +..||||++.... ......+.+|++++++++||||+++++++....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999998532 2469999987543 334457889999999999999999999876533
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 12356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 415 DQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 32211 1222345778999999998999999999999999999999 9999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=263.67 Aligned_cols=183 Identities=27% Similarity=0.458 Sum_probs=151.6
Q ss_pred hhcCCCccccccccCceeEEEEEc--CCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcC---CCCCccceeeEeeeC--
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL--PSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKL---QHRNLVRLLGFCLED-- 349 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~-- 349 (470)
..++|++.+.||+|+||.||+++. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999995 4688999999864322 2233566777777666 899999999987520
Q ss_pred ---C-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 350 ---P-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 350 ---~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
. .....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence 0 12345899999999999999999999998 9999999999999999999999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 998654221 223456899999999999999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=264.59 Aligned_cols=189 Identities=27% Similarity=0.467 Sum_probs=137.7
Q ss_pred HHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
+....++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345568999999999999999999995 478999999986543 3345678899999999999999999998765321
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 352 ------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 352 ------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 2345899999999999999999999998 9999999999999999999999999
Q ss_pred CceeccCCCC---cccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 408 MAKIFGVDQT---QGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 408 ~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++........ ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 9876543211 111233568999999998865 57899999999999999999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=258.57 Aligned_cols=178 Identities=31% Similarity=0.479 Sum_probs=145.6
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCCC------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK------ 352 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~------ 352 (470)
..++|++.+.||+|+||.||++.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 347899999999999999999997 58899999986543 457889999999999999999999987554311
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 353 ---------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 353 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 112678888999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 22356789999999998999999999999999999998 99999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=256.61 Aligned_cols=179 Identities=25% Similarity=0.340 Sum_probs=150.4
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46799999999999999999998 58899999987553 3345678999999999999999999998866411
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ .+|+||||||+|||++.++.++|.|||+......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 1225899999999999999999999864 4599999999999999999999999998754221
Q ss_pred CCcccccccccccCcccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFS---VKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....+|+.|+|||.+.+..++ .++||||||+++|||++|+.||...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 224678999999998766544 4899999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=257.24 Aligned_cols=183 Identities=27% Similarity=0.460 Sum_probs=147.7
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
..++|.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999954 7999999998643 23445688999999999999999999998765331
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 1346789999999999999999999998 9999999999999999999999999998654322
Q ss_pred CcccccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1223468899999999987765 68999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=265.03 Aligned_cols=190 Identities=29% Similarity=0.464 Sum_probs=151.5
Q ss_pred hHHHHHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 272 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
++.++....++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344455678999999999999999999995 578999999986543 3457789999999999 799999999988653
Q ss_pred C--------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 041433 350 P--------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKI 403 (470)
Q Consensus 350 ~--------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 403 (470)
. .....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 1 01246889999999999999999999998 999999999999999999999
Q ss_pred eecCCceeccCCCCcccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 404 SDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 404 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+|||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 171 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986543211 123346899999999986 567889999999999999999999999643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=258.37 Aligned_cols=176 Identities=30% Similarity=0.507 Sum_probs=151.2
Q ss_pred hhcCCCccccccccCceeEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeee---------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE--------- 348 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 348 (470)
..++|++.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999964 79999999986543 356789999999999999999887532
Q ss_pred ---------------CC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 349 ---------------DP------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 349 ---------------~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
+. .....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 00 11356889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 9999999987654322 23346899999999999999999999999999999999999886
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=263.85 Aligned_cols=181 Identities=24% Similarity=0.362 Sum_probs=154.9
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccC-----------------HHHHHHHHHHHhcCCCCCccce
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQG-----------------AEEFKNEVVVVAKLQHRNLVRL 342 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~h~niv~l 342 (470)
.++|++.+.||+|+||.||++.. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999986442211 1789999999999999999999
Q ss_pred eeEeeeCC------------------------CC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeee
Q 041433 343 LGFCLEDP------------------------EK--QGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 343 ~~~~~~~~------------------------~~--~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill 395 (470)
++++.+.. .. ...+++..+..++.||+.||.|||+ .+ |+|+||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 98865421 11 4678999999999999999999998 77 9999999999999
Q ss_pred CCCCceEEeecCCceeccCCCCcccccccccccCcccccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 396 DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSV-KSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 396 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
+.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999875432 22345689999999999877 6666 9999999999999999999997653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=270.37 Aligned_cols=180 Identities=17% Similarity=0.235 Sum_probs=148.9
Q ss_pred hcCCCccccccccCceeEEEEEcC---------CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccc---------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP---------SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR--------- 341 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~--------- 341 (470)
.++|++.+.||+|+||.||+|+.. +++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 368999999999999999999964 3789999998644 35789999999999999987
Q ss_pred ------eeeEeeeCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 041433 342 ------LLGFCLEDP--------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 342 ------l~~~~~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 395 (470)
+++++.... .....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 444444311 11367999999999999999999999998 9999999999999
Q ss_pred CCCC--ceEEeecCCceeccCCCCc-----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 396 DAEM--NPKISDFGMAKIFGVDQTQ-----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 396 ~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 8999999999876432211 1123347899999999999989999999999999999999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=260.82 Aligned_cols=182 Identities=30% Similarity=0.433 Sum_probs=133.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHH-HHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVV-VVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++..... ....++..|+. +++.++||||+++++++.....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 47899999999999999999995 4789999999975532 23345556665 7788899999999998765431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 256789999999999999999999998 7 9999999999999999999999999998654
Q ss_pred CCCCcccccccccccCccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 3221 2234689999999998 4567899999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=255.85 Aligned_cols=177 Identities=27% Similarity=0.366 Sum_probs=149.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+..+.++ +||||+++++++.+...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46799999999999999999995 479999999987542 33456788999999999 99999999998865431
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC----------------
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---------------- 397 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---------------- 397 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 1256899999999999999999999998 999999999999984
Q ss_pred ---CCceEEeecCCceeccCCCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 398 ---EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 398 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|++|+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4479999999998764322 23589999999998765 56789999999999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=269.13 Aligned_cols=178 Identities=10% Similarity=0.081 Sum_probs=132.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---cCHHHHHHHH---HHHhcCCCCCcccee-------eEe
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---QGAEEFKNEV---VVVAKLQHRNLVRLL-------GFC 346 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~h~niv~l~-------~~~ 346 (470)
.+|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+ ++|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 4588999999999999999994 5789999999976543 3345677784 55555 799987744 222
Q ss_pred eeCC-------------------------CC----------CCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEe
Q 041433 347 LEDP-------------------------EK----------QGQLDWSRR------YKIIGLIARGILYLHEDSRLRIIH 385 (470)
Q Consensus 347 ~~~~-------------------------~~----------~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ivH 385 (470)
.... .. ...+++..+ ..++.||+.||.|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 1110 00 112344444 677899999999999998 999
Q ss_pred ecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCC
Q 041433 386 RDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKN 463 (470)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P 463 (470)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865321 113456799999999987 6899999999999999999999999
Q ss_pred CCCC
Q 041433 464 SSFY 467 (470)
Q Consensus 464 ~~~~ 467 (470)
|...
T Consensus 293 f~~~ 296 (371)
T 3q60_A 293 FGLV 296 (371)
T ss_dssp TTBC
T ss_pred CCCc
Confidence 9765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=286.43 Aligned_cols=178 Identities=31% Similarity=0.499 Sum_probs=146.1
Q ss_pred ccccccCceeEEEEEc---CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVL---PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
++||+|+||.||+|.+ ..++.||||+++... ....+++.+|+++|++++||||+++++++..+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 4799999999999963 356889999997543 334678999999999999999999999885432
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc-ccccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ-GNTSR 423 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 423 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 12456899999999999999999999998 999999999999999999999999999876433221 11222
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..+|+.|+|||++.+..++.++||||||++||||++ |+.||...
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 346788999999999999999999999999999998 99999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=256.69 Aligned_cols=184 Identities=28% Similarity=0.406 Sum_probs=153.9
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc---------cCHHHHHHHHHHHhcCC-CCCccceeeEe
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG---------QGAEEFKNEVVVVAKLQ-HRNLVRLLGFC 346 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 346 (470)
...++|++.+.||+|+||.||++.. .+++.||||++..... ...+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3457899999999999999999995 4789999999865431 12356789999999996 99999999987
Q ss_pred eeCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 347 LEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 347 ~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
..... ....+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 65431 1346889999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCcccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+....... ......+++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 98764332 223356899999999875 456889999999999999999999999643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=260.98 Aligned_cols=185 Identities=32% Similarity=0.495 Sum_probs=144.8
Q ss_pred hcCCCccccccccCceeEEEEEc--CCCc--EEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL--PSGR--EIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.++|++.+.||+|+||.||+|++ .+++ .||||+++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 46799999999999999999984 2333 6899998654 23345778999999999999999999998765421
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 1245889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 32211 1223456778999999988889999999999999999999 99999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=260.28 Aligned_cols=181 Identities=25% Similarity=0.372 Sum_probs=152.4
Q ss_pred hhcCCCccccccccCceeEEEEEc--CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC------ccceeeEeeeCC
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL--PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN------LVRLLGFCLEDP 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~ 350 (470)
..++|++.+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++....
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999984 46889999998643 234567889999999887654 899988776533
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------------
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-------------- 397 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------------- 397 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 91 HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 12246889999999999999999999998 999999999999987
Q ss_pred -----CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 398 -----EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 398 -----~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999864322 223568999999999999999999999999999999999999997643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=265.68 Aligned_cols=180 Identities=28% Similarity=0.445 Sum_probs=141.6
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHH--HhcCCCCCccceeeEeee--------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVV--VAKLQHRNLVRLLGFCLE-------- 348 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~-------- 348 (470)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 347899999999999999999987 78999999986443 3344444444 555899999999864322
Q ss_pred -----CCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 349 -----DPE---------KQGQLDWSRRYKIIGLIARGILYLHED---------SRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 349 -----~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
+.. ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence 111 123457888999999999999999998 6 99999999999999999999999
Q ss_pred cCCceeccCCCC------cccccccccccCccccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 406 FGMAKIFGVDQT------QGNTSRIAGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 406 fG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||-
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999987643221 111223468999999999876 456788999999999999999977753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=264.46 Aligned_cols=185 Identities=24% Similarity=0.427 Sum_probs=152.8
Q ss_pred HHHHhhcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCcc------CHHHHHHHHHHHhcCC--CCCccceeeE
Q 041433 275 AIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ------GAEEFKNEVVVVAKLQ--HRNLVRLLGF 345 (470)
Q Consensus 275 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~~~ 345 (470)
+.....++|++.+.||+|+||.||+|+ ..+++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 334556889999999999999999998 457899999998654321 2245678999999996 5999999998
Q ss_pred eeeCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEee
Q 041433 346 CLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISD 405 (470)
Q Consensus 346 ~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~D 405 (470)
+..... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 765321 1356889999999999999999999998 99999999999998 788999999
Q ss_pred cCCceeccCCCCcccccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 406 FGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 406 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99998764322 223568999999999887766 6889999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=265.84 Aligned_cols=179 Identities=22% Similarity=0.324 Sum_probs=149.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-----------CCCccceeeEee
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-----------HRNLVRLLGFCL 347 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~ 347 (470)
.++|++.+.||+|+||.||+++. .+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999994 57899999998643 234567889999999886 899999998765
Q ss_pred eCC-----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeC------C
Q 041433 348 EDP-----------------------EKQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLD------A 397 (470)
Q Consensus 348 ~~~-----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~------~ 397 (470)
... .....+++..+..++.||+.||.|||++ + |+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 421 1234589999999999999999999998 7 99999999999994 4
Q ss_pred CCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 398 EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 398 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 458999999999876432 22346899999999999999999999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=260.49 Aligned_cols=181 Identities=31% Similarity=0.484 Sum_probs=147.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEE--EEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREI--AVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~---- 351 (470)
++|++.+.||+|+||.||+++. .++..+ ++|++... .....+.+.+|+++++++ +||||+++++++.+...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6799999999999999999995 356644 99988653 334456789999999999 89999999998765320
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 352 ------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 352 ------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 1236899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 999999997432211 1222356788999999988889999999999999999998 99999653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=253.89 Aligned_cols=184 Identities=30% Similarity=0.467 Sum_probs=153.7
Q ss_pred HHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
....++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 34457899999999999999999995 47899999998654 33456789999999999999999999998765321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEeecCCceec
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE---MNPKISDFGMAKIF 412 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~DfG~a~~~ 412 (470)
....+++.++..++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 1346889999999999999999999998 9999999999999654 47999999999865
Q ss_pred cCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||...
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 43221 223458899999998765 5899999999999999999999999653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=258.04 Aligned_cols=181 Identities=26% Similarity=0.403 Sum_probs=142.3
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC--CCCCccceeeEeeeCCC--
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL--QHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~~~-- 351 (470)
.....++|++.++||+|+||.||+|+. .++.||||++... ....+.+|.+++..+ +||||+++++++.....
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 344567899999999999999999997 4899999998543 234455566666554 89999999988766421
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCCeeeCCCCceEEeecC
Q 041433 352 -------------------KQGQLDWSRRYKIIGLIARGILYLHEDS-----RLRIIHRDLKVSNILLDAEMNPKISDFG 407 (470)
Q Consensus 352 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~DfG 407 (470)
....+++.+++.++.|++.||.|||++. +.+|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 1245889999999999999999999870 1139999999999999999999999999
Q ss_pred CceeccCCCCcc--cccccccccCcccccccccCCCCch------hhHHHHHHHHHHHHhC
Q 041433 408 MAKIFGVDQTQG--NTSRIAGTYGYMAPEYAMHGQFSVK------SDVYSFGVLVLEIITG 460 (470)
Q Consensus 408 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~vl~elltG 460 (470)
+++.+....... ......||+.|+|||++.+...+.. +||||||+++|||+||
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 998664332221 1123468999999999987666554 9999999999999999
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=260.57 Aligned_cols=182 Identities=25% Similarity=0.430 Sum_probs=146.3
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc------CHHHHHHHHHHHhcC----CCCCccceeeEe
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ------GAEEFKNEVVVVAKL----QHRNLVRLLGFC 346 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~h~niv~l~~~~ 346 (470)
...++|++.+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4457899999999999999999984 57899999999655322 223456789999888 899999999987
Q ss_pred eeCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeec
Q 041433 347 LEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDF 406 (470)
Q Consensus 347 ~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Df 406 (470)
..... ....+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEc
Confidence 54321 1345899999999999999999999998 99999999999998 8899999999
Q ss_pred CCceeccCCCCcccccccccccCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 041433 407 GMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 407 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
|++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||..
T Consensus 185 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 185 GSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred chhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9998765332 2335689999999998877664 589999999999999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=262.84 Aligned_cols=183 Identities=24% Similarity=0.315 Sum_probs=150.3
Q ss_pred HhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCC-----ccceeeEeeeCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRN-----LVRLLGFCLEDP 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n-----iv~l~~~~~~~~ 350 (470)
...++|++.++||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.++ |++ |+++++++....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4467899999999999999999984 47889999999643 233466778999988885 553 888888765432
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEeecCCc
Q 041433 351 -------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD--AEMNPKISDFGMA 409 (470)
Q Consensus 351 -------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~DfG~a 409 (470)
.....+++..+..++.||+.||.|||++ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 1224589999999999999999999953 12499999999999994 5778999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 22356899999999999999999999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=260.13 Aligned_cols=179 Identities=22% Similarity=0.348 Sum_probs=150.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCC-cEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC------ccceeeEeeeCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSG-REIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN------LVRLLGFCLEDP- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~- 350 (470)
.++|++.+.||+|+||.||++.. .++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 47899999999999999999995 344 78999998643 234567888999999997766 788777654422
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-----------------
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL----------------- 395 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----------------- 395 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence 12346899999999999999999999987 9999999999999
Q ss_pred --CCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 396 --DAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 396 --~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999864322 23356899999999999999999999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=258.71 Aligned_cols=184 Identities=26% Similarity=0.365 Sum_probs=151.6
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhc--CCCCCccceeeEeeeCCC--
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAK--LQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~~-- 351 (470)
.....++|++.+.||+|+||.||+++. +++.||||++... ....+.+|++++.. ++||||+++++++.....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345668899999999999999999998 6899999998543 34667888888887 789999999998766531
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCeeeCCCCceEEe
Q 041433 352 -------------------KQGQLDWSRRYKIIGLIARGILYLH--------EDSRLRIIHRDLKVSNILLDAEMNPKIS 404 (470)
Q Consensus 352 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~~kl~ 404 (470)
....+++.+++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEE
Confidence 1235788999999999999999999 666 9999999999999999999999
Q ss_pred ecCCceeccCCCCcc--cccccccccCcccccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 041433 405 DFGMAKIFGVDQTQG--NTSRIAGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG----------KKNSSF 466 (470)
Q Consensus 405 DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~elltG----------~~P~~~ 466 (470)
|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||+|| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999998765433211 12345689999999998765 334789999999999999999 778754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=270.52 Aligned_cols=179 Identities=16% Similarity=0.204 Sum_probs=140.8
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCC-CCcccee---------eE
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQH-RNLVRLL---------GF 345 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h-~niv~l~---------~~ 345 (470)
..+|...+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|+.+++.++| +|...+. ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457788999999999999999 56799999999874322 336789999999999987 3221110 00
Q ss_pred e------------eeC-----------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 041433 346 C------------LED-----------------------------PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384 (470)
Q Consensus 346 ~------------~~~-----------------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 384 (470)
. ... ......+++..++.++.||+.||.|||+++ |+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 0 000 111334667788999999999999999998 99
Q ss_pred eecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccccccc----------ccCCCCchhhHHHHHHHH
Q 041433 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYA----------MHGQFSVKSDVYSFGVLV 454 (470)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlG~vl 454 (470)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999865432 233467 999999998 555688999999999999
Q ss_pred HHHHhCCCCCCCC
Q 041433 455 LEIITGKKNSSFY 467 (470)
Q Consensus 455 ~elltG~~P~~~~ 467 (470)
|||++|+.||...
T Consensus 308 ~elltg~~Pf~~~ 320 (413)
T 3dzo_A 308 YWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHSSCCCCTT
T ss_pred HHHHHCCCCCCCc
Confidence 9999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=257.48 Aligned_cols=182 Identities=30% Similarity=0.466 Sum_probs=136.0
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc-C-HHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ-G-AEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|++.+.||+|+||.||++.. .+++.||||++...... . .+.+.++..+++.++||||+++++++.+...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 36788999999999999999995 47899999999755322 2 2334455567888999999999998766431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||++ + |+|+||||+|||++.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 145789999999999999999999985 7 99999999999999999999999999976543221
Q ss_pred cccccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....+|+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 181 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 181 ---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 22346899999999984 457889999999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=259.55 Aligned_cols=186 Identities=28% Similarity=0.470 Sum_probs=147.8
Q ss_pred HHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
+.+..++|++.+.||+|+||.||+|.... .||+|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 34456889999999999999999999743 49999986542 233456788999999999999999999876543
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 12346899999999999999999999998 99999999999998 67999999999875432
Q ss_pred CC---CcccccccccccCccccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQ---TQGNTSRIAGTYGYMAPEYAMH---------GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1112233458899999998864 45789999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=266.49 Aligned_cols=183 Identities=26% Similarity=0.367 Sum_probs=140.3
Q ss_pred hhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-------
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~------- 350 (470)
...+|++.+.||+|+||+|+.....+++.||||++...... .+.+|+++++++ +||||+++++++.+..
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34568899999999999966554558999999998654332 356899999999 7999999998876543
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEEeecCCceeccC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-----EMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~DfG~a~~~~~ 414 (470)
.....+.+.++..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++.+..
T Consensus 99 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 12233445566789999999999999998 999999999999943 33688999999987643
Q ss_pred CCCc-ccccccccccCcccccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQ-GNTSRIAGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 3211 2233457999999999987 4567889999999999999999 99998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=266.50 Aligned_cols=180 Identities=29% Similarity=0.360 Sum_probs=136.8
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~-------- 351 (470)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+...
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999998766668999999998543 245678899999876 89999999988755321
Q ss_pred ---------CCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-------------CceE
Q 041433 352 ---------KQG-------QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-------------MNPK 402 (470)
Q Consensus 352 ---------~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------~~~k 402 (470)
... ..++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+|
T Consensus 92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 001 1123345679999999999999998 9999999999999654 4899
Q ss_pred EeecCCceeccCCCCcc--cccccccccCccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQG--NTSRIAGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSSF 466 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ellt-G~~P~~~ 466 (470)
|+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999998765432211 1234579999999999865 678999999999999999999 9999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=250.95 Aligned_cols=176 Identities=31% Similarity=0.476 Sum_probs=141.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 351 (470)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999994 57999999998543 3345678899999999999999999987654210
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeec
Q 041433 352 -------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDF 406 (470)
Q Consensus 352 -------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 406 (470)
....+++.+++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeC
Confidence 1234677888999999999999999998 999999999999999999999999
Q ss_pred CCceeccCCCC------------cccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHh
Q 041433 407 GMAKIFGVDQT------------QGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIIT 459 (470)
Q Consensus 407 G~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ellt 459 (470)
|++........ ........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99986542210 1112335689999999998764 78999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=277.96 Aligned_cols=187 Identities=25% Similarity=0.431 Sum_probs=152.2
Q ss_pred HHhhcCCCccccccccCceeEEEEEcC----CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-
Q 041433 277 KVATNKFSTDNKLGAGGFGEVYKGVLP----SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP- 350 (470)
Q Consensus 277 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~- 350 (470)
....++|++.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 465 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 465 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCce
Confidence 345578999999999999999999853 25679999986543 333467899999999999999999999875432
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 12346889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 543 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 543 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 33221 1223456789999999998899999999999999999997 99999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=279.73 Aligned_cols=177 Identities=23% Similarity=0.361 Sum_probs=150.2
Q ss_pred hhcCCCccccccccCceeEEEEEcC--CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLP--SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999953 68999999986543 3344578899999999999999999988764321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 1236899999999999999999999998 9999999999999886 899999999987543
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
. ....||+.|+|||++.+. ++.++||||||+++|||++|.+||..
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred C------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 2 335689999999988765 48999999999999999999988753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=252.56 Aligned_cols=178 Identities=23% Similarity=0.278 Sum_probs=126.9
Q ss_pred hhcCCCccc-cccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 279 ATNKFSTDN-KLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 279 ~~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
..++|.+.+ .||+|+||.||+++. .+++.||||++... .....+....++.++||||+++++++....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 347788855 699999999999995 47999999998543 222233344567789999999998775410
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCc
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMA 409 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a 409 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 11246999999999999999999999998 999999999999976 455999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 8654221 23356799999999998888999999999999999999999999643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=262.42 Aligned_cols=174 Identities=18% Similarity=0.210 Sum_probs=143.5
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--------ccCHHHHHHHHHHHhcCC---------CCCccce
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--------GQGAEEFKNEVVVVAKLQ---------HRNLVRL 342 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------h~niv~l 342 (470)
.++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999998 78999999997542 233478899999998886 7777776
Q ss_pred eeEee-----------------e-------------CC-----------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 041433 343 LGFCL-----------------E-------------DP-----------------EKQGQLDWSRRYKIIGLIARGILYL 375 (470)
Q Consensus 343 ~~~~~-----------------~-------------~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~L 375 (470)
.+.+. + .. .....+++.++..++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 65432 1 11 1235679999999999999999999
Q ss_pred H-hCCCCCeEeecCCCCCeeeCCCC--------------------ceEEeecCCceeccCCCCcccccccccccCccccc
Q 041433 376 H-EDSRLRIIHRDLKVSNILLDAEM--------------------NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434 (470)
Q Consensus 376 H-~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE 434 (470)
| +++ |+||||||+||||+.++ .+||+|||+++..... ...||+.|+|||
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE 247 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED 247 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence 9 888 99999999999999887 8999999999876421 347899999999
Q ss_pred ccccCCCCchhhHHHHHHH-HHHHHhCCCCCC
Q 041433 435 YAMHGQFSVKSDVYSFGVL-VLEIITGKKNSS 465 (470)
Q Consensus 435 ~~~~~~~~~~~Dv~SlG~v-l~elltG~~P~~ 465 (470)
++.+.. +.++|||||+++ .+++++|..||.
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 988666 899999998776 788899999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=270.72 Aligned_cols=181 Identities=31% Similarity=0.474 Sum_probs=150.6
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeee------CC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE------DP- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~- 350 (470)
.++|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999995 56899999998754 33445678999999999999999999887543 10
Q ss_pred --------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEeecC
Q 041433 351 --------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMN---PKISDFG 407 (470)
Q Consensus 351 --------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~DfG 407 (470)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 11225888999999999999999999988 999999999999987664 9999999
Q ss_pred CceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 408 MAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 408 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 998764332 22345789999999999999999999999999999999999999953
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=234.85 Aligned_cols=157 Identities=8% Similarity=0.032 Sum_probs=131.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 46799999999999999999995 45899999999765433 23678999999999999999999998766431
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 352 ------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
........+...++.||+.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence 0122456678899999999999999998 9999999999999999999997442
Q ss_pred cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
|++| ++.++||||||+++|||+||+.||....
T Consensus 175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3333 6889999999999999999999997543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=229.26 Aligned_cols=155 Identities=24% Similarity=0.340 Sum_probs=129.8
Q ss_pred cCCCcc-ccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHH-hcCCCCCccceeeEeee----CC---
Q 041433 281 NKFSTD-NKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVV-AKLQHRNLVRLLGFCLE----DP--- 350 (470)
Q Consensus 281 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~--- 350 (470)
++|.+. +.||+|+||.||++.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 7799999999999994 5789999999853 24677888888 66699999999987754 10
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCce
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMAK 410 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a~ 410 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 11346899999999999999999999998 999999999999988 7889999999986
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
... +..++.++||||||+++|||++|+.||...
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 432 234678999999999999999999999643
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.8e-25 Score=174.10 Aligned_cols=106 Identities=25% Similarity=0.407 Sum_probs=98.3
Q ss_pred CCCeeEEecccCcCchhhHHHHHHHHHHHHHHHHhccCCceEeeeeccCCCccEEEEeeccCCCChhhHHHHHHHHHhhc
Q 041433 79 AAPTVSLLNTENVTDQGRFNELVGTQMSQAVTQAVNNTKRFATRKANFTASQTLYSLAQCTPDLSSSACNRCLREAIARL 158 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~~a~~~~~~~~~~~vy~l~QC~~dls~~~C~~Cl~~~~~~~ 158 (470)
....+..||.+++++.+.|+++++.||..|...|+.++.+|+++.....+.++||||+||+|||++++|..||+.|+.++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 45567889999999889999999999999999998888888888776667789999999999999999999999999999
Q ss_pred ccccCCCCCCeEeccccccccccccc
Q 041433 159 PICCSGKQGGRVLTPSCNVWYELYPF 184 (470)
Q Consensus 159 ~~~~~~~~~~~~~~~~C~lr~~~~~F 184 (470)
+.+|++++||++++++|++|||.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-26 Score=238.27 Aligned_cols=165 Identities=16% Similarity=0.138 Sum_probs=109.3
Q ss_pred cccccCceeEEEEE-cCCCcEEEEEEccCcC----------ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCCC----
Q 041433 288 KLGAGGFGEVYKGV-LPSGREIAVKRLSKSS----------GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 288 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~---- 351 (470)
.++.|+.|.+..++ .-.|+.+++|.+.+.. ....++|.+|+++|+++ .|+||+++++++.++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666666666655 3368899999986542 22345799999999999 69999999999877541
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....++.. +|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+++.......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 34566654 48899999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~ 461 (470)
......||+.|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 395 --~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 --WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred --cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 2344679999999998865 4677899999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-24 Score=223.01 Aligned_cols=176 Identities=16% Similarity=0.178 Sum_probs=127.1
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCcc--------CHHHHHHHHHHHhcCCCCCccceeeEeeeCCCCC--
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ--------GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEKQ-- 353 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~-- 353 (470)
...++||+|+||.||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..+........
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 6788999986443211 1345789999999999999995544443322110
Q ss_pred ----CCCCHHH----HHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc-----c
Q 041433 354 ----GQLDWSR----RYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-----N 420 (470)
Q Consensus 354 ----~~l~~~~----~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-----~ 420 (470)
..-+..+ +..++.||+++|.|||+++ |+||||||+|||+++ .+||+|||+++......... .
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence 0001111 5689999999999999998 999999999999998 99999999999765332211 1
Q ss_pred ccccccccCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.....||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 234679999999999876 567888999999999999998888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.4e-21 Score=180.85 Aligned_cols=155 Identities=16% Similarity=0.110 Sum_probs=114.0
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCc------------------cCHHHHHHHHHHHhcCC
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG------------------QGAEEFKNEVVVVAKLQ 335 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~ 335 (470)
..+......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455666788899999999999999987799999999864321 12456889999999999
Q ss_pred CCCccceeeEeeeCC-------CCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEee
Q 041433 336 HRNLVRLLGFCLEDP-------EKQG---QLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISD 405 (470)
Q Consensus 336 h~niv~l~~~~~~~~-------~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 405 (470)
| +++.+++.... -... .+...+...++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 163 ~---~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 163 G---LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp T---SSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred C---CCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 4 44444332211 0010 1333455689999999999999998 99999999999999 99999999
Q ss_pred cCCceeccCCCCcccccccccccCccccccccc----------CCCCchhhHHHH
Q 041433 406 FGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH----------GQFSVKSDVYSF 450 (470)
Q Consensus 406 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~Sl 450 (470)
||+++. +..++|||++.+ ..+...+|+|.+
T Consensus 236 FG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 236 FPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999973 234788987743 345555676653
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=148.84 Aligned_cols=69 Identities=19% Similarity=0.526 Sum_probs=62.6
Q ss_pred cCCCceeeccC-CCCCcEEEEEEccCCCCccchHHHHHHHHHHHhhhCCCCcceeEEccceEEEEccccc
Q 041433 5 FSSGFFNATAG-QDPNRVYGLFLCRGDQTTSGCQDCVTYATRNVLQLCPVSKQTTLWYAECLLRYSDQSF 73 (470)
Q Consensus 5 ~~~~f~~~~~g-~~~~~v~~~~~C~~d~~~~~c~~c~~~a~~~~~~~c~~~~~~~~~~~~c~~ry~~~~f 73 (470)
++.+|++..+| .++++||||+|||||+++++|..||+.|+.++.+.||++++|+||++.|+||||+++|
T Consensus 39 s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 39 SGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp TTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred ccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 34457776666 4569999999999999999999999999999999999999999999999999999998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=153.15 Aligned_cols=126 Identities=16% Similarity=0.123 Sum_probs=93.2
Q ss_pred CCCccccccccCceeEEEEEc-CCCcE--EEEEEccCcCcc------------------------CHHHHHHHHHHHhcC
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGRE--IAVKRLSKSSGQ------------------------GAEEFKNEVVVVAKL 334 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l 334 (470)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999996 68889 999987543111 013578899999999
Q ss_pred CCCCc--cceeeE-----eeeCCCC-C---CC-------CCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeecCCCCCeee
Q 041433 335 QHRNL--VRLLGF-----CLEDPEK-Q---GQ-------LDWSRRYKIIGLIARGILYLH-EDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 335 ~h~ni--v~l~~~-----~~~~~~~-~---~~-------l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlkp~Nill 395 (470)
+|+++ ..++.. ..+.... . .. .++.....++.||+.+|.||| +.+ |+||||||+|||+
T Consensus 128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl 204 (258)
T 1zth_A 128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMY 204 (258)
T ss_dssp HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEE
T ss_pred HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEE
Confidence 87753 333321 1111100 0 01 123366789999999999999 887 9999999999999
Q ss_pred CCCCceEEeecCCceec
Q 041433 396 DAEMNPKISDFGMAKIF 412 (470)
Q Consensus 396 ~~~~~~kl~DfG~a~~~ 412 (470)
+. .++|+|||++...
T Consensus 205 ~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 205 ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SS--SEEECCCTTCEET
T ss_pred cC--cEEEEECcccccC
Confidence 88 8999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-14 Score=140.97 Aligned_cols=139 Identities=16% Similarity=0.201 Sum_probs=92.8
Q ss_pred hhHHHHHHhhcC---CCccccccccCceeEEEEEcCCCcEEEEEEccCcCc--------------cCHHH--------HH
Q 041433 271 FDFEAIKVATNK---FSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSG--------------QGAEE--------FK 325 (470)
Q Consensus 271 ~~~~~~~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~ 325 (470)
+++-.+....++ |++.++||+|++|.||+|...+|+.||||+++.... ..... ..
T Consensus 82 yD~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~ 161 (397)
T 4gyi_A 82 LDYLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAI 161 (397)
T ss_dssp HHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHH
Confidence 444444444333 899999999999999999988999999998753210 00111 23
Q ss_pred HHHHHHhcCCCCCcc--ceeeE-----eee---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 041433 326 NEVVVVAKLQHRNLV--RLLGF-----CLE---DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILL 395 (470)
Q Consensus 326 ~Ei~~l~~l~h~niv--~l~~~-----~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 395 (470)
+|...|.++.+.++. ..++. ..+ ...-....+......++.||+.+|.+||+.+ ||||||||.|||+
T Consensus 162 kE~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred HHHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 566777777544432 11111 011 0000111222344678899999999999988 9999999999999
Q ss_pred CCCC----------ceEEeecCCceec
Q 041433 396 DAEM----------NPKISDFGMAKIF 412 (470)
Q Consensus 396 ~~~~----------~~kl~DfG~a~~~ 412 (470)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=4.8e-09 Score=97.72 Aligned_cols=133 Identities=21% Similarity=0.143 Sum_probs=96.6
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~----- 351 (470)
.....|.+...++.|+.+.||+... .++.+++|+...........+.+|+.+++.+. |..+.+++++......
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888899999999999986 46899999986532233346889999999885 6677788876654321
Q ss_pred ---CCCCC-----CHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 041433 352 ---KQGQL-----DWSRRYKIIGLIARGILYLHEDS-------------------------------------------- 379 (470)
Q Consensus 352 ---~~~~l-----~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 379 (470)
.+..+ +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 90 SEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp ECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred EecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 11111 11234578899999999999821
Q ss_pred ------------CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 380 ------------RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 380 ------------~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.71 E-value=9.3e-09 Score=95.37 Aligned_cols=128 Identities=15% Similarity=0.118 Sum_probs=87.3
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC--ccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN--LVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~-------- 350 (470)
..+.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++.....
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345544444456669999998777888999997543 2245788999998886544 445766544321
Q ss_pred CCCCCCC--HHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 041433 351 EKQGQLD--WSRRYKIIGLIARGILYLHEDS------------------------------------------------- 379 (470)
Q Consensus 351 ~~~~~l~--~~~~~~i~~~i~~~l~~LH~~~------------------------------------------------- 379 (470)
.....+. ......++.+++..|..||+..
T Consensus 97 i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 97 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred cCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 1111221 1123367888899999999753
Q ss_pred ------CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 380 ------RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 380 ------~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.62 E-value=1.4e-07 Score=92.06 Aligned_cols=126 Identities=17% Similarity=0.294 Sum_probs=90.7
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEcc--CcC-ccCHHHHHHHHHHHhcCCC--CCccceeeEeeeCCC--------
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLS--KSS-GQGAEEFKNEVVVVAKLQH--RNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~-------- 351 (470)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+.+ ..+.+++.++.+...
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4577899999999999874 4688899875 322 1234567889999999874 456777766544310
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDS----------------------------------------- 379 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 379 (470)
....++..++..++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 1123567888899999999999999731
Q ss_pred --------------CCCeEeecCCCCCeeeCCCCc--eEEeecCCcee
Q 041433 380 --------------RLRIIHRDLKVSNILLDAEMN--PKISDFGMAKI 411 (470)
Q Consensus 380 --------------~~~ivH~dlkp~Nill~~~~~--~kl~DfG~a~~ 411 (470)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.56 E-value=6.1e-08 Score=92.33 Aligned_cols=167 Identities=20% Similarity=0.208 Sum_probs=105.5
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCC--ccceeeEeeeCC-----------C
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRN--LVRLLGFCLEDP-----------E 351 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~-----------~ 351 (470)
.+.++.|....||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... .
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 46889986432 33567889999998874 322 333443321111 1
Q ss_pred CCC--------CCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 041433 352 KQG--------QLDWSRRYKIIGLIARGILYLHEDS-------------------------------------------- 379 (470)
Q Consensus 352 ~~~--------~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 379 (470)
.+. .++.+++..++.+++..|..||+..
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 111 2345567788999999999999621
Q ss_pred -----------CCCeEeecCCCCCeeeCC--CCceEEeecCCceeccCCCCcccccccccccCc---cccccccc-----
Q 041433 380 -----------RLRIIHRDLKVSNILLDA--EMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGY---MAPEYAMH----- 438 (470)
Q Consensus 380 -----------~~~ivH~dlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~----- 438 (470)
.+.++|+|++|.||++++ ...+.|+||+.+..-..... ......+ ..|+....
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHHHHHHc
Confidence 135899999999999987 45678999999875321100 0000011 12221100
Q ss_pred C---------CCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 439 G---------QFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 439 ~---------~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
+ ......+.|+++.++|.+.+|+.+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 1122368999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00039 Score=65.84 Aligned_cols=120 Identities=22% Similarity=0.189 Sum_probs=80.9
Q ss_pred cccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCC---CccceeeEeeeCC---------CCC
Q 041433 286 DNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHR---NLVRLLGFCLEDP---------EKQ 353 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~---------~~~ 353 (470)
.+.++.|....||+. +..+++|+-. .......+.+|.++|+.+.+. .+.+.+.+..... ...
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 5678888842 223346788999999999753 2445554443111 111
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 041433 354 --------GQLDWSRRYKIIGLIARGILYLHEDS---------------------------------------------- 379 (470)
Q Consensus 354 --------~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 379 (470)
..++..+...++.++...|..||+..
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 12344556677777777777777532
Q ss_pred -----------CCCeEeecCCCCCeeeCC---CCc-eEEeecCCcee
Q 041433 380 -----------RLRIIHRDLKVSNILLDA---EMN-PKISDFGMAKI 411 (470)
Q Consensus 380 -----------~~~ivH~dlkp~Nill~~---~~~-~kl~DfG~a~~ 411 (470)
.+.++|+|++|.|||++. ++. ..|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 455 48999998875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00022 Score=66.95 Aligned_cols=56 Identities=18% Similarity=0.176 Sum_probs=45.3
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ 335 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~ 335 (470)
..+....+.+|.|..+.||+.+..+|+.|++|+...........|..|...|+.|.
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 34566678899999999999999899999999876555555566888999888874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00025 Score=68.66 Aligned_cols=126 Identities=10% Similarity=0.071 Sum_probs=78.0
Q ss_pred cccc-cccCceeEEEEEcC-------CCcEEEEEEccCcC---ccCHHHHHHHHHHHhcCCC---CCccceeeEeeeCC-
Q 041433 286 DNKL-GAGGFGEVYKGVLP-------SGREIAVKRLSKSS---GQGAEEFKNEVVVVAKLQH---RNLVRLLGFCLEDP- 350 (470)
Q Consensus 286 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~~- 350 (470)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+.. -.+.+++.+..+..
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999998753 26789999865432 1112456788888877742 24556665443221
Q ss_pred ----------CCCC----------------CCCHHHHHHHHHHHHHHHHHHHhC--------------------------
Q 041433 351 ----------EKQG----------------QLDWSRRYKIIGLIARGILYLHED-------------------------- 378 (470)
Q Consensus 351 ----------~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~-------------------------- 378 (470)
.... .++..++..+..++.+.|.-||+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW 184 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence 0010 234444444455555544444421
Q ss_pred -----------------------------------CCCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 379 -----------------------------------SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 379 -----------------------------------~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 134689999999999998644578999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.001 Score=61.40 Aligned_cols=121 Identities=19% Similarity=0.168 Sum_probs=78.0
Q ss_pred cccccCce-eEEEEEcC-CCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCCC--------CCCCC
Q 041433 288 KLGAGGFG-EVYKGVLP-SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDPE--------KQGQL 356 (470)
Q Consensus 288 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~--------~~~~l 356 (470)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+... ....+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68988753 5678999986433 3456888999988875 2235566666544321 11111
Q ss_pred ------CHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------------
Q 041433 357 ------DWSRRYKIIGLIARGILYLHEDS--------------------------------------------------- 379 (470)
Q Consensus 357 ------~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------------- 379 (470)
.......+..++...|.-||...
T Consensus 108 ~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 108 FQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 11223456667777777777531
Q ss_pred ----CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 380 ----RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 380 ----~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999877777999998874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0021 Score=63.12 Aligned_cols=50 Identities=12% Similarity=0.159 Sum_probs=34.2
Q ss_pred cccccccCceeEEEEEcC-CCcEEEEEEccCcCc-------cCHHHHHHHHHHHhcCC
Q 041433 286 DNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSG-------QGAEEFKNEVVVVAKLQ 335 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~ 335 (470)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~ 92 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 92 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence 467999999999999753 468899998643211 23345677888888764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0046 Score=58.13 Aligned_cols=120 Identities=14% Similarity=0.070 Sum_probs=74.1
Q ss_pred ccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCc-cceeeEeeeCC------C-CCCCC
Q 041433 285 TDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL-VRLLGFCLEDP------E-KQGQL 356 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~------~-~~~~l 356 (470)
-.+.|+.|....+|+. +.+++|+........ ....+|..+++.+....+ .++++...+.. . ....+
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 3678889999999998 568899876432211 123567777766642222 34444322111 1 33344
Q ss_pred CHHHHH---HHHHHHHHHHHHHHhCC--------------------------------------------------CCCe
Q 041433 357 DWSRRY---KIIGLIARGILYLHEDS--------------------------------------------------RLRI 383 (470)
Q Consensus 357 ~~~~~~---~i~~~i~~~l~~LH~~~--------------------------------------------------~~~i 383 (470)
+..... .+..++++.|.-||+.. ...+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 443322 25667777777777642 1237
Q ss_pred EeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 384 IHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 384 vH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0054 Score=58.13 Aligned_cols=31 Identities=26% Similarity=0.283 Sum_probs=26.4
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
..++|+|+++.|||++++..+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4589999999999998776568999988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.021 Score=56.34 Aligned_cols=79 Identities=10% Similarity=0.044 Sum_probs=44.8
Q ss_pred CCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccC---CCCchhhHHHHHHHHHH
Q 041433 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLE 456 (470)
Q Consensus 380 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~e 456 (470)
...++|+|++|.|||++.++ ++|+||+.+..-.......... ..-...|++|+..... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999998776 9999999887532110000000 0001235555543211 11223455566777777
Q ss_pred HHhC
Q 041433 457 IITG 460 (470)
Q Consensus 457 lltG 460 (470)
++++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.23 E-value=0.011 Score=58.51 Aligned_cols=58 Identities=16% Similarity=0.259 Sum_probs=39.1
Q ss_pred cccccccCceeEEEEEcCC--------CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCc-cceeeE
Q 041433 286 DNKLGAGGFGEVYKGVLPS--------GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL-VRLLGF 345 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~ 345 (470)
.+.|+.|-...+|+....+ ++.+++|+.... ...+.+.+|..+++.|...++ .++++.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~ 144 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGI 144 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEE
Confidence 4567888889999998643 578999988432 122556689888888753333 455543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.03 Score=55.89 Aligned_cols=59 Identities=12% Similarity=0.058 Sum_probs=36.6
Q ss_pred cccccccCceeEEEEEcCC-CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCc-cceeeE
Q 041433 286 DNKLGAGGFGEVYKGVLPS-GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL-VRLLGF 345 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~ 345 (470)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..+++.|...++ .++++.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~ 173 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVF 173 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEE
Confidence 3567888889999998754 57899998754322211 12578888888865444 345543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.84 E-value=0.021 Score=54.08 Aligned_cols=47 Identities=19% Similarity=0.097 Sum_probs=33.7
Q ss_pred ccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC
Q 041433 287 NKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ 335 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~ 335 (470)
..|+ |....||+....+|+.+++|+..... .....+..|..+++.+.
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLV 78 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHH
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHH
Confidence 4466 77789999887677789999986332 23456777888777764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.049 Score=51.38 Aligned_cols=58 Identities=22% Similarity=0.193 Sum_probs=42.1
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ---HRNLVRLLGF 345 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~ 345 (470)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~ 99 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGI 99 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEE
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEE
Confidence 3456789999999999987 5678899987533 3567888988888774 2446666544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.16 E-value=0.1 Score=50.63 Aligned_cols=124 Identities=22% Similarity=0.239 Sum_probs=69.7
Q ss_pred ccccccCceeEEEEEcC--------CCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCC-ccceeeEeee-----CC--
Q 041433 287 NKLGAGGFGEVYKGVLP--------SGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRN-LVRLLGFCLE-----DP-- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~-----~~-- 350 (470)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.|...+ ..++++.+.. -.
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g~v~e~i~G 134 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYIPS 134 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECCSE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCccEEEEecC
Confidence 56777888899998864 3578999986332 234566778999888774222 2444443311 00
Q ss_pred -----------------------------CCCCCCC--HHHHHHHHHHHHH-------------------HHHH----HH
Q 041433 351 -----------------------------EKQGQLD--WSRRYKIIGLIAR-------------------GILY----LH 376 (470)
Q Consensus 351 -----------------------------~~~~~l~--~~~~~~i~~~i~~-------------------~l~~----LH 376 (470)
....... |.+..++..++.. .+.. |.
T Consensus 135 ~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~ 214 (379)
T 3feg_A 135 RPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLE 214 (379)
T ss_dssp EECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHH
T ss_pred ccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHh
Confidence 0011111 3344444433211 1222 32
Q ss_pred hC-CCCCeEeecCCCCCeeeCCC----CceEEeecCCcee
Q 041433 377 ED-SRLRIIHRDLKVSNILLDAE----MNPKISDFGMAKI 411 (470)
Q Consensus 377 ~~-~~~~ivH~dlkp~Nill~~~----~~~kl~DfG~a~~ 411 (470)
.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 215 ~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 215 STPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp TSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 23458999999999999876 6899999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.95 E-value=0.02 Score=54.50 Aligned_cols=32 Identities=19% Similarity=0.257 Sum_probs=28.1
Q ss_pred CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 380 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 34699999999999998888899999998854
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.15 E-value=0.51 Score=41.51 Aligned_cols=90 Identities=10% Similarity=0.070 Sum_probs=57.0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCccc
Q 041433 353 QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432 (470)
Q Consensus 353 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 432 (470)
..++++++++.++.|.+..|.-+-... .+ ..+=+.|..|+|..+|.+...+ ..+. .....+.+
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~ 105 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVA 105 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------------------
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc--------------ccccCCCC
Confidence 578999999999999999987762211 01 1223456889999999887654 1110 11224678
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhC
Q 041433 433 PEYAMHGQFSVKSDVYSFGVLVLEIITG 460 (470)
Q Consensus 433 PE~~~~~~~~~~~Dv~SlG~vl~elltG 460 (470)
||... ...+.+.=|||||+++|.-+-=
T Consensus 106 pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 106 GKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred hhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 88653 3456788999999999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=91.50 E-value=0.19 Score=47.49 Aligned_cols=32 Identities=31% Similarity=0.488 Sum_probs=27.5
Q ss_pred CCCeEeecCCCCCeeeCCC----CceEEeecCCcee
Q 041433 380 RLRIIHRDLKVSNILLDAE----MNPKISDFGMAKI 411 (470)
Q Consensus 380 ~~~ivH~dlkp~Nill~~~----~~~kl~DfG~a~~ 411 (470)
...++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6789999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=86.62 E-value=0.46 Score=45.64 Aligned_cols=30 Identities=23% Similarity=0.411 Sum_probs=24.9
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
..++|+|+++.|||++++. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4589999999999998655 89999987764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.92 E-value=0.099 Score=52.22 Aligned_cols=62 Identities=6% Similarity=0.078 Sum_probs=18.6
Q ss_pred CccccccccCceeEEEEEcCC-CcEEEE------EEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeee
Q 041433 284 STDNKLGAGGFGEVYKGVLPS-GREIAV------KRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLE 348 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 348 (470)
.+.++|| ||.||+|.+.. ..+||+ |..+.. .......+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4556776 99999999743 457888 665432 22333567889999999999999998876543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.68 E-value=0.4 Score=45.56 Aligned_cols=31 Identities=23% Similarity=0.374 Sum_probs=27.7
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.00 E-value=0.026 Score=35.66 Aligned_cols=21 Identities=19% Similarity=0.199 Sum_probs=9.3
Q ss_pred hhhHhhhheeeeEEEEeeccc
Q 041433 229 IVVTAVLFIVGFCFLRRKAKK 249 (470)
Q Consensus 229 ~vv~~~ll~~~~~~~~~~~~~ 249 (470)
++++++++++.++++|||+.+
T Consensus 21 v~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 21 LLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTTCC
T ss_pred HHHHHHHHHHHHHHhhhhHhh
Confidence 334444444444555554443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 470 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-60
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ + ++G+G FG VYKG + + ++ + Q + FKNEV V+ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 341 RLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
+G+ + + + + I A+G+ YLH S
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH---G 439
IIHRDLK +NI L ++ KI DFG+A + +++G+ +MAPE
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 440 QFSVKSDVYSFGVLVLEIITGKK 462
+S +SDVY+FG+++ E++TG+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-60
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA-EEFKNEVVVVAK 333
+++ + F ++LGAG G V+K PSG +A K + + E+ V+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 334 LQHRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYL 375
+V G D E K G++ K+ + +G+ YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
+ +I+HRD+K SNIL+++ K+ DFG++ + GT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
+SV+SD++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-58
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+LGAG FGEV+ G ++AVK L + S + F E ++ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 341 RLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
RL ++P +L ++ + IA G+ ++ E +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
IHRDL+ +NIL+ ++ KI+DFG+A++ ++ + APE +G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTF 187
Query: 442 SVKSDVYSFGVLVLEIITGKK 462
++KSDV+SFG+L+ EI+T +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR 208
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-55
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
++ + ++G+G FG V+ G + ++A+K + + + E+F E V+ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 341 RLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+L G CLE ++G + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEA 120
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
+IHRDL N L+ K+SDFGM + DQ +++ + +PE ++
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRY 179
Query: 442 SVKSDVYSFGVLVLEIITGKK 462
S KSDV+SFGVL+ E+ + K
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGK 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-54
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ KLG G FGEV+ G +A+K L + E F E V+ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 341 RLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+L E+P E L + + IA G+ Y+ R+
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 132
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
+HRDL+ +NIL+ + K++DFG+A++ ++ + APE A++G+F
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 191
Query: 442 SVKSDVYSFGVLVLEIITGKK 462
++KSDV+SFG+L+ E+ T +
Sbjct: 192 TIKSDVWSFGILLTELTTKGR 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-54
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA-EEFKNEVVVVAKLQHRN 338
+ LG G +GEV V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 339 LVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
+V+ G E E + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ 440
+ I HRD+K N+LLD N KISDFG+A +F + + +++ GT Y+APE +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 441 F-SVKSDVYSFGVLVLEIITGK 461
F + DV+S G+++ ++ G+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-53
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +LG G FG V G ++A+K + + S +EF E V+ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 341 RLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+L G C + + + + ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
+ +HRDL N L++ + K+SDFG+++ +D ++ + PE M+ +F
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 442 SVKSDVYSFGVLVLEIITGKK 462
S KSD+++FGVL+ EI + K
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK 199
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 3e-53
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 266 LESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGAEEF 324
++ +++ ++ + +KLG G +GEVY+GV +AVK L + + + EEF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF 60
Query: 325 KNEVVVVAKLQHRNLVRLLGFCLEDPE--------------------KQGQLDWSRRYKI 364
E V+ +++H NLV+LLG C +P + ++ +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 365 IGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRI 424
I+ + YL + IHRDL N L+ K++DFG++++ D +
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-A 176
Query: 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ APE + +FS+KSDV++FGVL+ EI T
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-52
Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 261 NDLTTLESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ 319
+D LE L+ ++ K++ K+G G G VY + + +G+E+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 320 GAEEFKNEVVVVAKLQHRNLVRLLGFC-----------------LEDPEKQGQLDWSRRY 362
E NE++V+ + ++ N+V L L D + +D +
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA 119
Query: 363 KIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422
+ + + +LH ++IHRD+K NILL + + K++DFG +Q++ S
Sbjct: 120 AVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RS 174
Query: 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ GT +MAPE + K D++S G++ +E+I G+
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 4e-52
Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 34/207 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAE---EFKNEVVVVAKLQ 335
FS ++G G FG VY + + +A+K++S S Q E + EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 336 HRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHE 377
H N ++ G L + + L + +G+ YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+IHRD+K NILL K+ DFG A I + GT +MAPE +
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 438 ---HGQFSVKSDVYSFGVLVLEIITGK 461
GQ+ K DV+S G+ +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-52
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 273 FEAIKVATN---KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEV 328
+E + N + +LG G FG+VYK + A K + S + E++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 329 VVVAKLQHRNLVRLLGFCLED-------------------PEKQGQLDWSRRYKIIGLIA 369
++A H N+V+LL + E + L S+ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 370 RGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYG 429
+ YLH+ +IIHRDLK NIL + + K++DFG++ +T GT
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPY 175
Query: 430 YMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGK 461
+MAPE M + K+DV+S G+ ++E+ +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-52
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 34/207 (16%)
Query: 282 KFSTDN-----KLGAGGFGEVYKGVLP-SGREIAVKRLSKSSGQGA---EEFKNEVVVVA 332
+++ ++ LG G FG VY S +A+K L K+ + A + + EV + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 333 KLQHRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILY 374
L+H N++RL G+ + K + D R I +A + Y
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
H R+IHRD+K N+LL + KI+DFG + + + GT Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPE 174
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIITGK 461
K D++S GVL E + GK
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-52
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 32/203 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
+ +G G FG+V G G ++AVK + + + F E V+ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 341 RLLGFCLEDP---------------------EKQGQLDWSRRYKIIGLIARGILYLHEDS 379
+LLG +E+ + L K + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+HRDL N+L+ + K+SDFG+ K Q G + APE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREK 175
Query: 440 QFSVKSDVYSFGVLVLEIITGKK 462
+FS KSDV+SFG+L+ EI + +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 286 DNKLGAGGFGEVYKGVLP---SGREIAVKRLSKSSGQGA--EEFKNEVVVVAKLQHRNLV 340
D +LG+G FG V KG + +AVK L + A +E E V+ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 341 RLLGFCLEDP-----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRI 383
R++G C + ++ + +++ ++ G+ YL
Sbjct: 72 RMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 384 IHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS-RIAGTYGYMAPEYAMHGQFS 442
+HRDL N+LL + KISDFG++K D+ + APE + +FS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 443 VKSDVYSFGVLVLEIITGKK 462
KSDV+SFGVL+ E + +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-51
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 36/217 (16%)
Query: 288 KLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCL 347
+G G FGEV++G G E+AVK S + + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 348 EDPE---------------------KQGQLDWSRRYKIIGLIARGILYLHED-----SRL 381
+D + + K+ A G+ +LH + +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIF--GVDQTQGNTSRIAGTYGYMAPEY---- 435
I HRDLK NIL+ I+D G+A D + GT YMAPE
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 436 --AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
H + ++D+Y+ G++ EI ++
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-51
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 278 VATNKFS-TDNKLGAGGFGEVYKGVL---PSGREIAVKRLSKSSGQG-AEEFKNEVVVVA 332
+ + D +LG G FG V +GV ++A+K L + + + EE E ++
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 64
Query: 333 KLQHRNLVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILY 374
+L + +VRL+G C + K+ ++ S +++ ++ G+ Y
Sbjct: 65 QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN-TSRIAGTYGYMAP 433
L +HRDL N+LL KISDFG++K G D + S + AP
Sbjct: 125 LE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
E +FS +SDV+S+GV + E ++ +
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-51
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 286 DNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRL 342
D ++G G F VYKG+ + E+A L + + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 343 LGFCLEDPE----------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR 380
+ + + I +G+ +LH +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 381 LRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
IIHRDLK NI + + KI D G+A + + + GT +MAPE
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM-YEE 187
Query: 440 QFSVKSDVYSFGVLVLEIITGKK 462
++ DVY+FG+ +LE+ T +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEY 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 9e-51
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 271 FDFEAIKVATNKFST---------DNKLGAGGFGEVYKGVLPS----GREIAVKRLSKS- 316
F FE A +F+ + +GAG FGEV G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 317 SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------------------KQGQLD 357
+ + +F +E ++ + H N++ L G + GQ
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 358 WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417
+ ++ IA G+ YL + +HRDL NIL+++ + K+SDFG+++ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 418 QGNTSR---IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ + APE + +F+ SDV+S+G+++ E+++ +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-50
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 33/231 (14%)
Query: 262 DLTTLES-LQFDFEAIKVATNKFST--DNKLGAGGFGEVYKGVLP----SGREIAVKRLS 314
DL+ L L + + + + + +G G FG VY G L AVK L+
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 315 KSSGQG-AEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------------------EKQ 353
+ + G +F E +++ H N++ LLG CL +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 354 GQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413
+A+G + + + +HRDL N +LD + K++DFG+A+
Sbjct: 125 HNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181
Query: 414 VDQTQGNTSR--IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ ++ +MA E +F+ KSDV+SFGVL+ E++T
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-50
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 27/204 (13%)
Query: 283 FSTDNKLGAGGFGEVYKGV-LPSGRE----IAVKRLSKS-SGQGAEEFKNEVVVVAKLQH 336
F LG+G FG VYKG+ +P G + +A+K L ++ S + +E +E V+A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 337 RNLVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHED 378
++ RLLG CL E + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 128
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
R++HRDL N+L+ + KI+DFG+AK+ G ++ + + +MA E +H
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 439 GQFSVKSDVYSFGVLVLEIITGKK 462
++ +SDV+S+GV V E++T
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 5e-50
Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 31/209 (14%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA--EEFKNEVVVVAKLQHRN 338
+ +G G +G K G+ + K L S A + +EV ++ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 339 LVRLLGFCLEDPEK------------------------QGQLDWSRRYKIIGLIARGILY 374
+VR ++ + LD +++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 375 LHE--DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432
H D ++HRDLK +N+ LD + N K+ DFG+A+I D + GT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE ++ KSD++S G L+ E+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 7e-50
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGVLPSG-----REIAVKRLSKSSGQGA-EEFKNEVVV 330
++ + + +GAG FGEVYKG+L + +A+K L + +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 331 VAKLQHRNLVRLLGFCLEDP-------------------EKQGQLDWSRRYKIIGLIARG 371
+ + H N++RL G + EK G+ + ++ IA G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 372 ILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGTYGY 430
+ YL + +HRDL NIL+++ + K+SDFG++++ D T S +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 431 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
APE + +F+ SDV+SFG+++ E++T + + ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 272 DFEAIKVATNKFSTDNKLGAGGFGEVYKGVLPS----GREIAVKRLSKSSGQGA-EEFKN 326
D+E + + +G G FG+V++G+ S +A+K + E+F
Sbjct: 1 DYE---IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57
Query: 327 EVVVVAKLQHRNLVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLI 368
E + + + H ++V+L+G E+P ++ LD + +
Sbjct: 58 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 369 ARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTY 428
+ + YL R +HRD+ N+L+ + K+ DFG+++ D T S+
Sbjct: 118 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPI 173
Query: 429 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+MAPE +F+ SDV+ FGV + EI+
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 58/202 (28%), Positives = 80/202 (39%), Gaps = 29/202 (14%)
Query: 287 NKLGAGGFGEVYKGVLPS----GREIAVKRLSK---SSGQGAEEFKNEVVVVAKLQHRNL 339
KLG G FG V +G + +AVK L S + ++F EV + L HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 340 VRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
+RL G L P + QG + +A G+ YL
Sbjct: 74 IRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-NTSRIAGTYGYMAPEYAMHGQ 440
R IHRDL N+LL KI DFG+ + + + + APE
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 441 FSVKSDVYSFGVLVLEIITGKK 462
FS SD + FGV + E+ T +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-47
Identities = 55/256 (21%), Positives = 96/256 (37%), Gaps = 53/256 (20%)
Query: 257 GNADNDLTTLESLQFDF-EAIKVATNKFSTDNKLGAGGFGEVYKGVLPS------GREIA 309
G++DN+ ++ ++++ + LG+G FG+V ++A
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 310 VKRLSKSSGQGA-EEFKNEVVVVAKL-QHRNLVRLLGFCLED------------------ 349
VK L + + E +E+ ++ +L H N+V LLG C
Sbjct: 72 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131
Query: 350 -----------------------PEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHR 386
E L + +A+G+ +L +HR
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 188
Query: 387 DLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSD 446
DL N+L+ KI DFG+A+ D +MAPE G +++KSD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
Query: 447 VYSFGVLVLEIITGKK 462
V+S+G+L+ EI +
Sbjct: 249 VWSYGILLWEIFSLGV 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-47
Identities = 56/207 (27%), Positives = 84/207 (40%), Gaps = 25/207 (12%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVA 332
K F LG G F V L + RE A+K L K E V++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 333 KLQHRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILY 374
+L H V+L +D + K G D + I + Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
LH IIHRDLK NILL+ +M+ +I+DFG AK+ + Q + GT Y++PE
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 435 YAMHGQFSVKSDVYSFGVLVLEIITGK 461
SD+++ G ++ +++ G
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 1e-46
Identities = 51/243 (20%), Positives = 92/243 (37%), Gaps = 52/243 (21%)
Query: 269 LQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSSGQGAE 322
L +++ N +G G FG V++ P +AVK L + + +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 323 -EFKNEVVVVAKLQHRNLVRLLGFCLEDPE------------------------------ 351
+F+ E ++A+ + N+V+LLG C
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 352 ------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM 399
L + + I +A G+ YL E + +HRDL N L+ M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 400 NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 459
KI+DFG+++ A +M PE + +++ +SDV+++GV++ EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 460 GKK 462
Sbjct: 238 YGL 240
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (406), Expect = 8e-46
Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 28/203 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL 339
+ + +LG G FG V++ +G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 340 VRLLGFCLED-------------------PEKQGQLDWSRRYKIIGLIARGILYLHEDSR 380
V L +D ++ ++ + + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--- 142
Query: 381 LRIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
+H DLK NI+ + + K+ DFG+ Q+ T+ GT + APE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEG 199
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
+D++S GVL +++G
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 56/234 (23%), Positives = 87/234 (37%), Gaps = 47/234 (20%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQG-AEEFKNEVVVVAK 333
N+ S LGAG FG+V + + +AVK L S+ E +E+ V++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 334 L-QHRNLVRLLGFCLED------------------------------------PEKQGQL 356
L H N+V LLG C + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
D +A+G+ +L IHRDL NILL KI DFG+A+ D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 470
+MAPE + ++ +SDV+S+G+ + E+ + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-45
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQG-AEEFKNEVVVVAKLQHR 337
+++ + +G G +G V + +A+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 338 NLVRLLGFCLEDPE---------------------KQGQLDWSRRYKIIGLIARGILYLH 376
N++ + K L + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 377 EDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT-SRIAGTYGYMAPEY 435
++HRDLK SN+LL+ + KI DFG+A++ D + T Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 436 AMHGQFSVKS-DVYSFGVLVLEIITGK 461
++ + KS D++S G ++ E+++ +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 45/221 (20%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSG---REIAVKRLSK-SSGQGAEEFKNEVVVVAKL-Q 335
N + +G G FG+V K + + A+KR+ + +S +F E+ V+ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 336 HRNLVRLLGFCLEDPE----------------------------------KQGQLDWSRR 361
H N++ LLG C L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 362 YKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
+ARG+ YL + + IHRDL NIL+ KI+DFG+++ +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+ +MA E + ++ SDV+S+GVL+ EI++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (394), Expect = 6e-44
Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 28/203 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL 339
+ + +LG+G FG V++ V +GR K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 340 VRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR 380
+ L + E + ++ + + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--- 145
Query: 381 LRIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
I+H D+K NI+ + + KI DFG+A D+ T + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDR 202
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
+D+++ GVL +++G
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 3e-43
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 24/201 (11%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQH 336
F LG G FG V+ +GR A+K L K + E +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 337 RNLVRLLGFCLEDPE--------------KQGQLDWSRRYKIIGLIARGIL-YLHEDSRL 381
++R+ G + + + + A + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF 441
II+RDLK NILLD + KI+DFG AK T + GT Y+APE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 442 SVKSDVYSFGVLVLEIITGKK 462
+ D +SFG+L+ E++ G
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 2e-42
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---EEFKNEVVVVAKLQ 335
++++ LG GG EV+ L R++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 336 HRNLVRLLGFCLEDPE----------------------KQGQLDWSRRYKIIGLIARGIL 373
H +V + + +G + R ++I + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 374 YLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-NTSRIAGTYGYMA 432
+ H+ IIHRD+K +NI++ A K+ DFG+A+ T+ + GT Y++
Sbjct: 126 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 433 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
PE A +SDVYS G ++ E++TG+
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 2e-42
Identities = 41/221 (18%), Positives = 81/221 (36%), Gaps = 34/221 (15%)
Query: 276 IKVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL 334
++V N++ K+G+G FG++Y G + +G E+A+K + + E + +
Sbjct: 3 LRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMM 59
Query: 335 QHRNLVRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYL 375
Q + + +C + + + + + I Y+
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 376 HEDSRLRIIHRDLKVSNIL---LDAEMNPKISDFGMAKIFGVDQTQGN-----TSRIAGT 427
H IHRD+K N L I DFG+AK + +T + + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468
Y + + + S + D+ S G +++ G +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-42
Identities = 53/225 (23%), Positives = 84/225 (37%), Gaps = 46/225 (20%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV------LPSGREIAVKRLSKSSGQG-AEEFKNEVVVVAK 333
++ LG G FG+V + + R +AVK L + + +E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 334 -LQHRNLVRLLGFCLEDPEK-----------------------------------QGQLD 357
H N+V LLG C + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 358 WSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417
+A+G+ +L + IHRDL NILL + KI DFG+A+ D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+MAPE ++++SDV+SFGVL+ EI +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 8e-42
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 33/207 (15%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQ- 335
N FS +G GGFGEVY +G+ A+K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 336 --HRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYL 375
+V + + + G + I G+ ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H +++RDLK +NILLD + +ISD G+A F + GT+GYMAPE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEV 176
Query: 436 AMHGQ-FSVKSDVYSFGVLVLEIITGK 461
G + +D +S G ++ +++ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-42
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 38/217 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSGQGA-EEFKNEVVVVAK 333
K + +LG G FG VY+GV +A+K +++++ EF NE V+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 334 LQHRNLVRLLGFC----------------------------LEDPEKQGQLDWSRRYKII 365
++VRLLG + + S+ ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIA 425
G IA G+ YL+ + + +HRDL N ++ + KI DFGM + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 426 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
+M+PE G F+ SDV+SFGV++ EI T +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 6e-41
Identities = 32/211 (15%), Positives = 77/211 (36%), Gaps = 35/211 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL 339
+ ++G G FG +++G L + +++A+K + S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 340 VRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR 380
+ + + ++ + + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119
Query: 381 LRIIHRDLKVSNILLDAEMNP-----KISDFGMAKIFGVDQTQGN-----TSRIAGTYGY 430
+++RD+K N L+ + + DFGM K + T+ + ++GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 431 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
M+ + + S + D+ + G + + + G
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-41
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 279 ATNKFSTDNKLGAGGFGEVYKG--VLPSGREIAVKRLSKSSGQG--AEEFKNEVVVVAKL 334
A ++ ++G G +G+V+K + GR +A+KR+ +G+ EV V+ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 335 ---QHRNLVRLLGFCLEDPE------------------------KQGQLDWSRRYKIIGL 367
+H N+VRL C + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 368 IARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ RG+ +LH R++HRDLK NIL+ + K++DFG+A+I+ + + T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 428 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
Y APE + ++ D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG---QGAEEFKNEVVVVAK-LQ 335
F LG G FG+V+ + + A+K L K E E V++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 336 HRNLVRLLGFCLEDP------------------EKQGQLDWSRRYKIIGLIARGILYLHE 377
H L + + + D SR I G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
I++RDLK+ NILLD + + KI+DFGM K + + NT GT Y+APE +
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILL 176
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
+++ D +SFGVL+ E++ G+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 45/202 (22%), Positives = 75/202 (37%), Gaps = 29/202 (14%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLV 340
K+ LG G FG V++ V S + K + K G K E+ ++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 341 RLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
L E +L+ + + + +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---H 121
Query: 382 RIIHRDLKVSNILLDAEMNP--KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
I H D++ NI+ + KI +FG A+ N + Y APE H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
S +D++S G LV +++G
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 3e-40
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 26/202 (12%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVK--RLSKSSGQGAEEFKNEVVVVAKLQHRN 338
K+ K+G G +G VYK G A+K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 339 LVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSR 380
+V+L +G L+ + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--- 118
Query: 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM-HG 439
R++HRDLK N+L++ E KI+DFG+A+ FG+ + T Y AP+ M
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSK 176
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
++S D++S G + E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 5e-40
Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 23/202 (11%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-FKNEVVVVAKLQHR 337
+ + + LG G F EV + + +A+K ++K + +G E +NE+ V+ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 338 NLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDS 379
N+V L ++G ++I + + YLH+
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHG 439
+ + + LD + ISDFG++K+ S GT GY+APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQK 184
Query: 440 QFSVKSDVYSFGVLVLEIITGK 461
+S D +S GV+ ++ G
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGY 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-39
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 287 NKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE-----FKNEVVVVAKLQHRNLV 340
+ LG G F VYK + + +A+K++ A++ E+ ++ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 341 RLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLR 382
LL L S + + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQ-F 441
I+HRDLK +N+LLD K++DFG+AK FG + T Y APE + +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMY 178
Query: 442 SVKSDVYSFGVLVLEIITGK 461
V D+++ G ++ E++
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-39
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 47/226 (20%)
Query: 281 NKFSTDNKLGAGGFGEVYKGVLPS--------GREIAVKRLSK-SSGQGAEEFKNEVVVV 331
++ LG G FG+V ++AVK L ++ + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 332 AKL-QHRNLVRLLGFCLEDPE----------------------------------KQGQL 356
+ +H+N++ LLG C +D + QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 357 DWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416
+ARG+ YL + IHRDL N+L+ + KI+DFG+A+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 462
T+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-39
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRN 338
F K+G G +G VYK +G +A+K++ + E+ ++ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 339 LVRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGILYLHEDS 379
+V+LL + + + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 380 RLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE-YAMH 438
R++HRDLK N+L++ E K++DFG+A+ FGV T Y APE
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGC 177
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
+S D++S G + E++T +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 1e-38
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 41/215 (19%)
Query: 282 KFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA---------EEFKNEVVVV 331
+ LG G V + + P+ +E AVK + + G E EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 332 AKLQ-HRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGI 372
K+ H N+++L + ++ L KI+ + I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMA 432
LH+ L I+HRDLK NILLD +MN K++DFG + + + GT Y+A
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLA 177
Query: 433 PEYAM------HGQFSVKSDVYSFGVLVLEIITGK 461
PE H + + D++S GV++ ++ G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 21/204 (10%)
Query: 277 KVATNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVA 332
KV N F LG G FG+V +GR A+K L K + E V+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 333 KLQHRNLVRLLGFCLEDPE--------KQGQLDWSRRYK-------IIGLIARGILYLHE 377
+H L L G+L + + A + L
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 378 DSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAM 437
+++RD+K+ N++LD + + KI+DFG+ K D GT Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 178
Query: 438 HGQFSVKSDVYSFGVLVLEIITGK 461
+ D + GV++ E++ G+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 38/208 (18%)
Query: 283 FSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVR 341
++ +G G FG VY+ L SG +A+K++ + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 342 LLGFCLEDPEKQ---------------------------GQLDWSRRYKIIGLIARGILY 374
L F EK+ L + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 375 LHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAP 433
+H I HRD+K N+LLD + K+ DFG AK + + N S I Y
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192
Query: 434 EYAMHGQFSVKSDVYSFGVLVLEIITGK 461
++ DV+S G ++ E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-37
Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGA--EEFKNEVVVVAKLQHR 337
+K+ K+G G FGEV+K +G+++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 338 NLVRLLGFCLEDPEKQGQLDWS----------------------RRYKIIGLIARGIL-Y 374
N+V L+ C + S I + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT--SRIAGTYGYMA 432
L+ R +I+HRD+K +N+L+ + K++DFG+A+ F + + + T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 433 PEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 461
PE + + + D++ G ++ E+ T
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-37
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 35/210 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS------GQGAEEFKNEVVVVAK 333
+ + T +LG+G F V K +G + A K + K G E+ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 334 LQHRNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYL 375
+QH N++ L + ++ L + + I G +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---V 126
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNP----KISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ L+I H DLK NI+L P KI DFG+A I GT ++
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFV 183
Query: 432 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
APE + +++D++S GV+ +++G
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 45/211 (21%), Positives = 83/211 (39%), Gaps = 37/211 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEE------FKNEVVVVAK 333
+++ LG+GGFG VY G+ + +A+K + K E EVV++ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 334 LQ--HRNLVRLLGFCLEDPE-------------------KQGQLDWSRRYKIIGLIARGI 372
+ ++RLL + ++G L + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 373 LYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYM 431
+ H ++HRD+K NIL+D K+ DFG + + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 176
Query: 432 APEYAMHGQF-SVKSDVYSFGVLVLEIITGK 461
PE+ + ++ + V+S G+L+ +++ G
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 37/200 (18%), Positives = 81/200 (40%), Gaps = 19/200 (9%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHR 337
K+ K+G G +G V+K + +A+KR+ E+ ++ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 338 NLVRLLGFCLEDPEKQGQLDWSRRYK---------------IIGLIARGILYLHEDSRLR 382
N+VRL D + ++ + + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 383 IIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFS 442
++HRDLK N+L++ K+++FG+A+ FG+ ++ + + +S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYS 180
Query: 443 VKSDVYSFGVLVLEIITGKK 462
D++S G + E+ +
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 1e-36
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 30/203 (14%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQH 336
++F LG G FG V SG A+K L K + E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 337 RNLVRLLGFCLEDPE------------------KQGQLDWSRRYKIIGLIARGILYLHED 378
LV+L ++ + G+ I YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 159
Query: 379 SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMH 438
L +I+RDLK N+L+D + +++DFG AK + +G T + GT +APE +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILS 212
Query: 439 GQFSVKSDVYSFGVLVLEIITGK 461
++ D ++ GVL+ E+ G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 34/207 (16%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHR 337
+ +G+G +G V V +G ++A+K+L + S A+ E+ ++ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 338 NLVRLLGFCLEDPE----------------------KQGQLDWSRRYKIIGLIARGILYL 375
N++ LL D K +L R ++ + +G+ Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 376 HEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
H IIHRDLK N+ ++ + KI DFG+A+ Q + T Y APE
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 436 AMHGQ-FSVKSDVYSFGVLVLEIITGK 461
++ ++ D++S G ++ E+ITGK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-34
Identities = 43/206 (20%), Positives = 76/206 (36%), Gaps = 40/206 (19%)
Query: 285 TDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKL-QHRNLVRL 342
T LG G G+V + + + A+K L + + EV + + Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70
Query: 343 LGFCLEDPEKQGQ------------------------LDWSRRYKIIGLIARGILYLHED 378
+ + +I+ I I YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 379 SRLRIIHRDLKVSNILLDAEMNP---KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEY 435
+ I HRD+K N+L ++ K++DFG AK + T Y+APE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184
Query: 436 AMHGQFSVKSDVYSFGVLVLEIITGK 461
++ D++S GV++ ++ G
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-33
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 272 DFEAIKVATNKFSTDNK------LGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAE 322
F +++V + F+ + +G+G G V R +A+K+LS+ + A+
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 323 EFKNEVVVVAKLQHRNLVRLLGFCLEDPE---------------------KQGQLDWSRR 361
E+V++ + H+N++ LL Q +LD R
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 362 YKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
++ + GI +LH IIHRDLK SNI++ ++ KI DFG+A+ G
Sbjct: 122 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 175
Query: 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
+ T Y APE + + D++S G ++ E++ K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-32
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 266 LESLQFDFEAIKVATNKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKSS---- 317
L + A KV F LG G +G+V+ +G+ A+K L K++
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 318 GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK---------QGQLDWSRRYK----- 363
+ E + E V+ ++ + L + + K G+L +
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 128
Query: 364 --IIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421
+ + +L L +L II+RD+K+ NILLD+ + ++DFG++K F D+T+
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RA 187
Query: 422 SRIAGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGK 461
GT YMAP+ G D +S GVL+ E++TG
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 1e-31
Identities = 40/215 (18%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 271 FDFEAIKVAT---NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKN 326
+D+E+ V + + KLG G + EV++ + + + ++ VK L ++ K
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR 78
Query: 327 EVVVVAKLQ-HRNLVRLLGFCLEDPEKQ-----------------GQLDWSRRYKIIGLI 368
E+ ++ L+ N++ L + + L + I
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI 138
Query: 369 ARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRIAGT 427
+ + Y H + I+HRD+K N+++D E ++ D+G+A+ + Q + +
Sbjct: 139 LKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
Query: 428 YGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 461
+ PE + + + D++S G ++ +I K
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQH 336
++ + +G+G +G V +G +AVK+LS+ S A+ E+ ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 337 RNLVRLLGFCL----------------------EDPEKQGQLDWSRRYKIIGLIARGILY 374
N++ LL + K +L +I I RG+ Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 375 LHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPE 434
+H IIHRDLK SN+ ++ + KI DFG+A+ + T +R Y APE
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPE 188
Query: 435 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 461
++ ++ D++S G ++ E++TG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 1e-29
Identities = 34/217 (15%), Positives = 74/217 (34%), Gaps = 39/217 (17%)
Query: 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL 339
++ KLG G F V+ + + +A+K + E ++E+ ++ ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 340 VRLLGFCLEDP----------------------------------EKQGQLDWSRRYKII 365
+ + + +I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 366 GLIARGILYLHEDSRLRIIHRDLKVSNILLDAE-MNPKISDFGMAKIFGVDQTQGNTSRI 424
+ G+ Y+H R IIH D+K N+L++ + +A + + +
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 425 AGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 461
T Y +PE + + +D++S L+ E+ITG
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.1 bits (246), Expect = 9e-25
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 36/196 (18%)
Query: 287 NKLGAGGFGEVYKGVLPSGREIAVK--RLSKSSGQ--------GAEEFKNEVVVVAKLQH 336
+G G V+ E VK ++ +S + G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 337 RNLVRLLGFC---------------LEDPEKQGQLDWSRRYKIIGLIARGILYLHEDSRL 381
R L +L G L D ++ ++ +++ +I + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR--- 122
Query: 382 RIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSR-IAGTYGYMAPEYAMHGQ 440
I+H DL N+L+ E I DF + G + + R + Y + Y
Sbjct: 123 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY----- 176
Query: 441 FSVKSDVYSFGVLVLE 456
+ D+ S +L+
Sbjct: 177 -RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 470 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.44 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=331.51 Aligned_cols=186 Identities=29% Similarity=0.464 Sum_probs=158.4
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 36799999999999999999995 579999999987553 234467899999999999999999999887643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++.++..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+.......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 23567999999999999999999999998 9999999999999999999999999999775444333
Q ss_pred cccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
......||+.|||||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 4455689999999999988776 578999999999999999999997543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=330.14 Aligned_cols=182 Identities=27% Similarity=0.467 Sum_probs=161.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+...
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999994 5799999999987766677889999999999999999999998876541
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccccc
Q 041433 352 ---------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTS 422 (470)
Q Consensus 352 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 422 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+..... ...
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--ccc
Confidence 2356899999999999999999999998 99999999999999999999999999987653322 234
Q ss_pred ccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 423 RIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 423 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
...||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 457999999999999999999999999999999999999999643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=330.19 Aligned_cols=185 Identities=34% Similarity=0.568 Sum_probs=152.5
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
+..++|++.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||++++++.+..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~ 82 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT 82 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEE
Confidence 34578999999999999999999964 36999998654 3445678999999999999999999999875532
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 23466999999999999999999999987 99999999999999999999999999987654433
Q ss_pred cccccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
........||+.|||||++.+ ..++.++|||||||+||||+||+.||...
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 334455679999999999864 35899999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=327.82 Aligned_cols=184 Identities=29% Similarity=0.437 Sum_probs=157.1
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||+||+|+. .+++.||||++.+. .....+.+.+|++++++++||||+++++++.++..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999995 57999999998653 33456789999999999999999999998876431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 2457899999999999999999999998 999999999999999999999999999987654444
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 4444567999999999999999999999999999999999999999754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=322.10 Aligned_cols=180 Identities=31% Similarity=0.473 Sum_probs=158.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||+||+|+. .+++.||+|++.+. .....+.+.+|++++++++|||||++++++.+...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 57899999998643 23456778999999999999999999999876431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 2457899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..++.++|||||||+||||++|+.||...
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 233467999999999999999999999999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=326.02 Aligned_cols=182 Identities=28% Similarity=0.412 Sum_probs=158.4
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
+.|++.++||+|+||+||+|+. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+...
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999994 5799999999987777777889999999999999999999998876541
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 2456999999999999999999999998 9999999999999999999999999997653221 12
Q ss_pred ccccccccCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|||||++. +..++.++|||||||++|||+||+.||...
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 23457999999999884 456899999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=322.11 Aligned_cols=185 Identities=26% Similarity=0.415 Sum_probs=147.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999984 579999999987653 2334678899999999999999999998764221
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDS--RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
....+++.+++.++.||+.||.|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 1356899999999999999999999864 23599999999999999999999999999987
Q ss_pred ccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 412 FGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
+..... ......||+.|||||++.+..++.++|||||||++|||+||++||...
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 643322 233467999999999999999999999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=323.67 Aligned_cols=182 Identities=33% Similarity=0.552 Sum_probs=156.2
Q ss_pred HhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
+..++|++.++||+|+||.||+|++++++.||||+++... ...+.|.+|++++++++|||||++++++.++..
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey 88 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY 88 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEe
Confidence 3456899999999999999999998888999999996543 456789999999999999999999998765321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.+++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+++.+......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 1225899999999999999999999988 999999999999999999999999999987543322
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 464 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~ 464 (470)
......||+.|||||++.++.++.++|||||||++|||+||..|+
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 233456899999999999899999999999999999999965554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=333.35 Aligned_cols=182 Identities=29% Similarity=0.412 Sum_probs=157.6
Q ss_pred hhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
..++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457899999999999999999994 579999999997653 3335678999999999999999999998876541
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHED-SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
+...+++..+..++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 245689999999999999999999974 6 999999999999999999999999999865422
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..|+.++||||+||++|||++|+.||...
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 223468999999999999999999999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=317.40 Aligned_cols=181 Identities=31% Similarity=0.488 Sum_probs=147.3
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578899999999999999999888889999999754 345678999999999999999999999986543
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
.....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........ ..
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence 23466899999999999999999999988 999999999999999999999999999876433222 22
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSSF 466 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG-~~P~~~ 466 (470)
....||+.|+|||++.+..++.++|||||||++|||+|+ ++||..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 335689999999999999999999999999999999995 555554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-42 Score=323.39 Aligned_cols=185 Identities=32% Similarity=0.515 Sum_probs=158.3
Q ss_pred HHHhhcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 276 IKVATNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 276 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
+++..++|++.++||+|+||+||+|++ .+++.||||+++.. ....++|.+|+++|++++|||||++++++.+..
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 334457899999999999999999995 46889999998654 345678999999999999999999999987643
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 13457899999999999999999999988 99999999999999999999999999987644
Q ss_pred CCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 168 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 168 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp SSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 3222 2233468899999999999999999999999999999999777654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=310.24 Aligned_cols=183 Identities=28% Similarity=0.460 Sum_probs=160.4
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--------- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--------- 351 (470)
++|++.++||+|+||+||+|++++++.||||++++.. ...++|.+|++++++++||||++++|++.++..
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999998888899999997653 356789999999999999999999999876431
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcccc
Q 041433 352 ----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNT 421 (470)
Q Consensus 352 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 421 (470)
....+++..+.+++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+...... ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence 3456889999999999999999999988 999999999999999999999999999876543222 23
Q ss_pred cccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 422 SRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 422 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 34568999999999999999999999999999999998 899998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-41 Score=321.09 Aligned_cols=178 Identities=31% Similarity=0.467 Sum_probs=154.3
Q ss_pred cCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc---cCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG---QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
..|++.++||+|+||+||+|+ ..+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 358999999999999999999 45789999999876543 234568899999999999999999999876541
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 2467999999999999999999999998 99999999999999999999999999986432
Q ss_pred ccccccccccCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 223579999999999853 46899999999999999999999999643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-41 Score=321.19 Aligned_cols=179 Identities=30% Similarity=0.405 Sum_probs=157.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999995 57999999998653 33456789999999999999999999998876431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 2456788888999999999999999988 999999999999999999999999999876432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 23467999999999999999999999999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=323.04 Aligned_cols=183 Identities=26% Similarity=0.335 Sum_probs=160.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
-++|++.+.||+|+||.||+|+. .+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+...
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999994 57999999999754 33456788999999999999999999998876541
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 2457899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|||||++.+..|+.++|||||||++|||++|++||...
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 2234468999999999999999999999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-40 Score=323.57 Aligned_cols=181 Identities=24% Similarity=0.393 Sum_probs=159.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.++.
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999994 579999999998776666778999999999999999999999887643
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEeecCCceeccCCCCc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD--AEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence 23456999999999999999999999998 99999999999995 46789999999998765332
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 233467899999999999999999999999999999999999999743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=323.16 Aligned_cols=184 Identities=33% Similarity=0.582 Sum_probs=152.9
Q ss_pred cCCCccccccccCceeEEEEEc-CCCc----EEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGR----EIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.+|++.++||+|+||+||+|++ .+|+ +||+|+++.. .....++|.+|++++++++|||||+++|++.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 4699999999999999999985 3444 6899988654 4456778999999999999999999999987643
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 351 --------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 13567899999999999999999999988 9999999999999999999999999999775544
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.........||+.|||||++.++.++.++|||||||++|||+| |++||...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 4434444568999999999999999999999999999999999 89998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-41 Score=325.08 Aligned_cols=179 Identities=27% Similarity=0.339 Sum_probs=157.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
++|+++++||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+++|+.++|||||++++++.+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999995 57999999998643 33456778999999999999999999998765431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 2457899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 23467999999999999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=310.57 Aligned_cols=178 Identities=30% Similarity=0.433 Sum_probs=149.4
Q ss_pred CccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 284 STDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
++.++||+|+||+||+|+. .+++.||+|++... .....+.+.+|+++|++++|||||++++++.+..
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 6677899999999999995 57899999998654 2334567899999999999999999999875421
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEeecCCceeccCCCC
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD-AEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||++||.|||+++ ++|+||||||+||||+ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 12356899999999999999999999875 4599999999999996 5789999999999854322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+ .++.++|||||||++|||++|+.||...
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 2334679999999998765 6999999999999999999999999643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-40 Score=322.00 Aligned_cols=181 Identities=24% Similarity=0.352 Sum_probs=159.3
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--------- 350 (470)
++|++.++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.++.
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999994 579999999998766666678899999999999999999999876533
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEeecCCceeccCCCCc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD--AEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 12446899999999999999999999998 99999999999997 67899999999999765432
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 233457899999999999999999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-40 Score=317.78 Aligned_cols=185 Identities=27% Similarity=0.474 Sum_probs=144.7
Q ss_pred hcCCCccccccccCceeEEEEEcC-CC---cEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLP-SG---REIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 350 (470)
.++|++.++||+|+||+||+|++. ++ ..||||++... .....+.|.+|+++|++++|||||+++|++.+..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356788899999999999999953 33 35899988654 3344567999999999999999999999986643
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 12457999999999999999999999988 999999999999999999999999999876543
Q ss_pred CCccc---ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 416 QTQGN---TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 416 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..... .....||+.|||||.+.++.++.++|||||||+||||+| |++||...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 32211 122457899999999999999999999999999999998 89999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=315.88 Aligned_cols=183 Identities=30% Similarity=0.498 Sum_probs=146.5
Q ss_pred cCCCccccccccCceeEEEEEcCC-C----cEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC---
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPS-G----REIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE--- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 351 (470)
+.|++.++||+|+||.||+|.+.. + ..||||+++... .....+|.+|++++++++|||||+++|++.+...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 568889999999999999998543 2 479999986543 3344578999999999999999999999876431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 3467999999999999999999999988 999999999999999999999999999876443
Q ss_pred CCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 416 QTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 416 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.... ......||+.|||||++.++.++.++|||||||++|||++|..||..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 2221 22334689999999999999999999999999999999997666543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-40 Score=317.24 Aligned_cols=182 Identities=27% Similarity=0.387 Sum_probs=141.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
.+.|++.+.||+|+||+||+|+. .+++.||||++.+... ...+.+.+|+++|++++|||||++++++.++.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46799999999999999999995 5789999999976532 33456889999999999999999999886643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEeecCCceeccCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD---AEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 13457999999999999999999999998 99999999999994 57899999999998654322
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 165 ---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 223457999999999999999999999999999999999999999643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=311.99 Aligned_cols=184 Identities=31% Similarity=0.535 Sum_probs=155.8
Q ss_pred cCCCccc-cccccCceeEEEEEcC---CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDN-KLGAGGFGEVYKGVLP---SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 350 (470)
++|.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++..+.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 5566777 4999999999999743 45679999997553 344578999999999999999999999886532
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 351 -------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 23467999999999999999999999988 99999999999999999999999999997754332
Q ss_pred c-ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 418 Q-GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 418 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
. .......||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 2 22234468899999999999999999999999999999998 99999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=315.62 Aligned_cols=182 Identities=31% Similarity=0.515 Sum_probs=151.3
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++.++..
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 4679999999999999999999888889999999654 3456789999999999999999999998865431
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 352 -----------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 352 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
....++|.+++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++....... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-ee
Confidence 1346899999999999999999999998 99999999999999999999999999987643322 22
Q ss_pred ccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....||+.|+|||++..+.++.++||||||+++|||++|..||..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 3335689999999999999999999999999999999997766544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=310.41 Aligned_cols=178 Identities=31% Similarity=0.495 Sum_probs=148.4
Q ss_pred ccccccCceeEEEEEcC---CCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-----------
Q 041433 287 NKLGAGGFGEVYKGVLP---SGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP----------- 350 (470)
Q Consensus 287 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----------- 350 (470)
++||+|+||+||+|.+. .++.||||+++... ....++|.+|+++|++++|||||++++++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999843 35789999996543 233567999999999999999999999986533
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc-cccc
Q 041433 351 ------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG-NTSR 423 (470)
Q Consensus 351 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~ 423 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....... ....
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 12467999999999999999999999988 9999999999999999999999999998765433222 2234
Q ss_pred cccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 424 IAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 424 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..||+.|||||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 568999999999999999999999999999999998 89999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=308.75 Aligned_cols=182 Identities=27% Similarity=0.411 Sum_probs=157.2
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC------ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS------GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999995 579999999986542 2246789999999999999999999998876431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEeecCCce
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM----NPKISDFGMAK 410 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~DfG~a~ 410 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 2357899999999999999999999998 99999999999998776 49999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 166 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp ECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 7643322 23457899999999999999999999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=315.87 Aligned_cols=188 Identities=28% Similarity=0.435 Sum_probs=154.6
Q ss_pred HhhcCCCccccccccCceeEEEEEcC-CC-----cEEEEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP-SG-----REIAVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
+..++|++.++||+|+||+||+|+.. .+ ..||+|++... .......+.+|+.+|.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 34578999999999999999999842 22 36999998654 334456789999999998 899999999988654
Q ss_pred CC-----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 041433 350 PE-----------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDL 388 (470)
Q Consensus 350 ~~-----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 388 (470)
.. ....+++.+++.++.||++||.|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 31 1135889999999999999999999988 999999
Q ss_pred CCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 389 KVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 389 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
||+|||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654443333344568999999999999999999999999999999998 89999764
Q ss_pred C
Q 041433 468 Q 468 (470)
Q Consensus 468 ~ 468 (470)
.
T Consensus 271 ~ 271 (325)
T d1rjba_ 271 P 271 (325)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-40 Score=313.10 Aligned_cols=191 Identities=26% Similarity=0.422 Sum_probs=158.4
Q ss_pred HHHHHhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcCc-cCHHHHHHHHHHHhcCCCCCccceeeEe
Q 041433 274 EAIKVATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSSG-QGAEEFKNEVVVVAKLQHRNLVRLLGFC 346 (470)
Q Consensus 274 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 346 (470)
.+++...++|++.++||+|+||+||+|+. .+++.||||+++.... ...++|.+|+++|++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 44555678999999999999999999984 2467899999976533 3356799999999999999999999988
Q ss_pred eeCCC------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 041433 347 LEDPE------------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRII 384 (470)
Q Consensus 347 ~~~~~------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 384 (470)
.+... ....+++.+++.++.||+.||.|||+++ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 65321 1234889999999999999999999988 99
Q ss_pred eecCCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCC-CC
Q 041433 385 HRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KN 463 (470)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~-~P 463 (470)
||||||+||||+.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765443333344567889999999999999999999999999999999996 56
Q ss_pred CCCC
Q 041433 464 SSFY 467 (470)
Q Consensus 464 ~~~~ 467 (470)
|...
T Consensus 243 ~~~~ 246 (301)
T d1lufa_ 243 YYGM 246 (301)
T ss_dssp TTTS
T ss_pred CCCC
Confidence 7654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.3e-39 Score=304.44 Aligned_cols=185 Identities=28% Similarity=0.437 Sum_probs=151.4
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCcc---CHHHHHHHHHHHhcCCCCCccceeeEeeeCCC----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSGQ---GAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 351 (470)
.++|++.+.||+|+||+||+|+ ..+++.||||++++.... ..+.+.+|++++++++||||+++++++..+..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4789999999999999999999 457999999999765332 34578999999999999999999988765321
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++..+|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 2457899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCC-cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQT-QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... ........||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 3222 12234467999999999999999999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=306.87 Aligned_cols=182 Identities=26% Similarity=0.426 Sum_probs=155.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999994 679999999996543 234578899999999999999999999887643
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 351 ------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 351 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 23567999999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2233457899999999877655 578999999999999999999999643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=306.83 Aligned_cols=186 Identities=25% Similarity=0.429 Sum_probs=146.5
Q ss_pred hhcCCCccccccccCceeEEEEEcCC----CcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC---
Q 041433 279 ATNKFSTDNKLGAGGFGEVYKGVLPS----GREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 279 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 350 (470)
..++|++.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|++++++++|||||++++++.++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~i 84 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 84 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEE
Confidence 35689999999999999999998532 3568999986543 333567999999999999999999999886532
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 351 ---------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 351 ---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 13457899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 468 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~~ 468 (470)
.. .......||+.|+|||.+.+..++.++|||||||++|||+| |++||....
T Consensus 162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 22 22334568899999999999999999999999999999998 899997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-39 Score=304.51 Aligned_cols=181 Identities=28% Similarity=0.456 Sum_probs=154.7
Q ss_pred cCCCccccccccCceeEEEEEcCCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
++|++.++||+|+||+||+|+.++++.||||+++... ....+.+.+|+.+|++++||||+++++++..+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998889999999986543 334578999999999999999999999887654
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence 24677999999999999999999999988 99999999999999999999999999987643322 2
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 2334688999999998754 568999999999999999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-39 Score=305.01 Aligned_cols=178 Identities=27% Similarity=0.372 Sum_probs=148.2
Q ss_pred ccccccccCceeEEEEEc-CCCcEEEEEEccCcCccC-----HHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 285 TDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQG-----AEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 285 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.+++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++|||||++++++..+.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999995 579999999986543221 246889999999999999999999887654
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCccc
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence 23567899999999999999999999998 99999999999999999999999999986543322 2
Q ss_pred ccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.....||+.|+|||++.. ..++.++|||||||++|||+||++||...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 234578999999998865 46799999999999999999999999653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-39 Score=313.14 Aligned_cols=180 Identities=28% Similarity=0.381 Sum_probs=151.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC---ccCHHHHH---HHHHHHhcCCCCCccceeeEeeeCCC--
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS---GQGAEEFK---NEVVVVAKLQHRNLVRLLGFCLEDPE-- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~Ei~~l~~l~h~niv~l~~~~~~~~~-- 351 (470)
++|++.+.||+|+||.||+|+. .+|+.||||++.+.. ......+. +|+.+++.++|||||++++++.+...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999994 579999999986432 22223333 45778888899999999998766431
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCC
Q 041433 352 ----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVD 415 (470)
Q Consensus 352 ----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 415 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 2456788999999999999999999998 999999999999999999999999999876533
Q ss_pred CCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 416 QTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 416 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .....||+.|||||++.. ..++.++|||||||+||||+||+.||...
T Consensus 161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 2 234579999999999875 56899999999999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=307.67 Aligned_cols=195 Identities=28% Similarity=0.402 Sum_probs=151.7
Q ss_pred hhHHHHHHhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccce
Q 041433 271 FDFEAIKVATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRL 342 (470)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l 342 (470)
++.+++++..++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 445566666789999999999999999999842 35789999997543 33445677888888776 68999999
Q ss_pred eeEeeeCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 041433 343 LGFCLEDPE-----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRD 387 (470)
Q Consensus 343 ~~~~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 387 (470)
++++.+... ....+++.++..++.||++||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 988755321 1235889999999999999999999998 99999
Q ss_pred CCCCCeeeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 041433 388 LKVSNILLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KNSSF 466 (470)
Q Consensus 388 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~-~P~~~ 466 (470)
|||+||||++++.+||+|||+++...............||+.|||||++.+..++.++|||||||++|||+||. +||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765444444445567999999999999999999999999999999999975 57765
Q ss_pred CC
Q 041433 467 YQ 468 (470)
Q Consensus 467 ~~ 468 (470)
..
T Consensus 240 ~~ 241 (299)
T d1ywna1 240 VK 241 (299)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-39 Score=307.24 Aligned_cols=182 Identities=30% Similarity=0.438 Sum_probs=156.0
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc---CccCHHHHHHHHHHHh-cCCCCCccceeeEeeeCCC----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS---SGQGAEEFKNEVVVVA-KLQHRNLVRLLGFCLEDPE---- 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~---- 351 (470)
++|.+.+.||+|+||+||+|+. .+++.||||++++. .....+.+..|..++. .++|||||++++++.+...
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999994 57999999999653 2344566777777665 6899999999998876541
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCC
Q 041433 352 --------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 352 --------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 417 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 2456899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 2334467999999999999999999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=304.90 Aligned_cols=185 Identities=32% Similarity=0.486 Sum_probs=146.5
Q ss_pred hcCCCccccccccCceeEEEEEc--CCC--cEEEEEEccCc---CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL--PSG--REIAVKRLSKS---SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 351 (470)
.++|++.+.||+|+||.||+|++ .++ ..||||++.+. .....++|.+|+++|++++||||++++|++.+...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~ 86 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 86 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence 36799999999999999999984 223 37899998654 23345689999999999999999999999865431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 1346899999999999999999999988 99999999999999999999999999998654
Q ss_pred CCCcc-cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 415 DQTQG-NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
..... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 43322 2233457889999999999999999999999999999998 89999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=304.37 Aligned_cols=180 Identities=24% Similarity=0.436 Sum_probs=151.5
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc------CHHHHHHHHHHHhcCC--CCCccceeeEeeeCC
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ------GAEEFKNEVVVVAKLQ--HRNLVRLLGFCLEDP 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~ 350 (470)
.++|++.++||+|+||+||+|+. .+++.||||++.+.... ...++.+|+.++++++ |||||++++++.+..
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999994 57999999998654211 1234678999999987 899999999886643
Q ss_pred C-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEeecCCce
Q 041433 351 E-------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-EMNPKISDFGMAK 410 (470)
Q Consensus 351 ~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~DfG~a~ 410 (470)
. ....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 1 2457899999999999999999999998 999999999999985 4799999999998
Q ss_pred eccCCCCcccccccccccCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 65432 2234679999999999987765 5779999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=304.47 Aligned_cols=182 Identities=26% Similarity=0.437 Sum_probs=151.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CC-CcEEEEEEccCcC--ccCHHHHHHHHHHHhcC---CCCCccceeeEeeeCC--
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PS-GREIAVKRLSKSS--GQGAEEFKNEVVVVAKL---QHRNLVRLLGFCLEDP-- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~-- 350 (470)
.++|++.++||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+|+.| +||||+++++++....
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999985 44 6679999986542 22233456777776655 8999999998774310
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCC
Q 041433 351 ----------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGM 408 (470)
Q Consensus 351 ----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~ 408 (470)
.....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 23566899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 409 AKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 409 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 8864322 2234567999999999999999999999999999999999999999743
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=302.57 Aligned_cols=181 Identities=23% Similarity=0.310 Sum_probs=155.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.+.||+|+||+||+|.. .+++.||||+++.... ....+.+|+++|++++|||||++++++.++.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 47899999999999999999995 5789999999976543 3456889999999999999999999887643
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEeecCCceeccCCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAE--MNPKISDFGMAKIFGVDQT 417 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~DfG~a~~~~~~~~ 417 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 12347899999999999999999999998 9999999999999754 589999999998764322
Q ss_pred cccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 418 QGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 418 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 223456899999999999999999999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-38 Score=295.93 Aligned_cols=182 Identities=28% Similarity=0.401 Sum_probs=155.3
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCcc---------CHHHHHHHHHHHhcCC-CCCccceeeEeee
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQ---------GAEEFKNEVVVVAKLQ-HRNLVRLLGFCLE 348 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 348 (470)
.++|++.+.||+|+||+||+|+. .+++.||||++++.... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999994 57999999998765321 1235789999999997 9999999998876
Q ss_pred CCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 349 DPE------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 349 ~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
+.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 431 2457899999999999999999999998 9999999999999999999999999999
Q ss_pred eccCCCCcccccccccccCccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 411 IFGVDQTQGNTSRIAGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.-.
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 7654322 234579999999998853 35788999999999999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=295.26 Aligned_cols=177 Identities=31% Similarity=0.474 Sum_probs=146.0
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPEK------- 352 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~------- 352 (470)
.++|++.+.||+|+||.||+|++ .|+.||||++++. ...+.|.+|++++++++||||++++|++.++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45788899999999999999998 5789999999654 3457899999999999999999999988654311
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 353 --------------QGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 353 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 124789999999999999999999987 999999999999999999999999999865322
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
.....++..|+|||++.++.++.++||||||+++|||+| |++||...
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 223457889999999999999999999999999999998 78888754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=298.46 Aligned_cols=184 Identities=24% Similarity=0.448 Sum_probs=152.9
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCc--CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKS--SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++.+....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999994 57999999998654 3344577899999999999999999998764421
Q ss_pred --------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCce
Q 041433 351 --------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAK 410 (470)
Q Consensus 351 --------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~ 410 (470)
.....+++.+...++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 23457888999999999999999999998 9999999999999999999999999998
Q ss_pred eccCCCCc--ccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 411 IFGVDQTQ--GNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 411 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
.+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 76533222 122335689999999998765 689999999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=301.14 Aligned_cols=185 Identities=23% Similarity=0.403 Sum_probs=153.4
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
+.+|++.++||+|+||+||+|+ ..+|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999998 4689999999997543 3345678899999999999999999988754321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 1346899999999999999999999998 9999999999999999999999999998764432
Q ss_pred Cc-ccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQ-GNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 22 12344568999999998854 56789999999999999999999999643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=300.79 Aligned_cols=176 Identities=24% Similarity=0.309 Sum_probs=148.6
Q ss_pred hcCCCccc-cccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhc-CCCCCccceeeEeeeC--C----
Q 041433 280 TNKFSTDN-KLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAK-LQHRNLVRLLGFCLED--P---- 350 (470)
Q Consensus 280 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~--~---- 350 (470)
.++|.+.+ .||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.+ .+|||||++++++.+. .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788875 599999999999994 6799999999853 2567889998765 5899999999876531 0
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEeecCCc
Q 041433 351 ------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA---EMNPKISDFGMA 409 (470)
Q Consensus 351 ------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~DfG~a 409 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 12346999999999999999999999998 999999999999975 557999999999
Q ss_pred eeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 410 KIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 410 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
+....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||..
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 87654322 3345799999999999999999999999999999999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=301.37 Aligned_cols=187 Identities=30% Similarity=0.470 Sum_probs=157.6
Q ss_pred HhhcCCCccccccccCceeEEEEEcC------CCcEEEEEEccCcC-ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP------SGREIAVKRLSKSS-GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP 350 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 350 (470)
+..++|++.++||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++||||+++++++..+.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 44578899999999999999999852 35789999997543 334456899999999999999999999886543
Q ss_pred C----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 041433 351 E----------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPK 402 (470)
Q Consensus 351 ~----------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 402 (470)
. ....+++.++..++.|+++||.|||+++ |+||||||+||||++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 1 1234688899999999999999999987 99999999999999999999
Q ss_pred EeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCC
Q 041433 403 ISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KNSSFY 467 (470)
Q Consensus 403 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~-~P~~~~ 467 (470)
|+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+||+ +||...
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 99999998765544444444556899999999999999999999999999999999985 677543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=297.04 Aligned_cols=187 Identities=29% Similarity=0.434 Sum_probs=153.8
Q ss_pred HhhcCCCccccccccCceeEEEEEcC--------CCcEEEEEEccCcCc-cCHHHHHHHHHHHhcC-CCCCccceeeEee
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVLP--------SGREIAVKRLSKSSG-QGAEEFKNEVVVVAKL-QHRNLVRLLGFCL 347 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 347 (470)
+..++|++.+.||+|+||.||+|+.. ++..||||++++... ....++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34578999999999999999999842 234799999976543 3456788899999888 7999999999987
Q ss_pred eCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 348 EDPE----------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 348 ~~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
++.. ....+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 6431 1245899999999999999999999998 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|++.++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |++||...
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999998765554444555678999999999999999999999999999999998 78888754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=295.70 Aligned_cols=179 Identities=29% Similarity=0.447 Sum_probs=149.7
Q ss_pred cccccccCceeEEEEEcCC----CcEEEEEEccCc-CccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 286 DNKLGAGGFGEVYKGVLPS----GREIAVKRLSKS-SGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
.++||+|+||+||+|++.+ ...||||++++. +....++|.+|+++|++++||||++++|++.+..
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999999533 235899998753 4445678999999999999999999999986533
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc-
Q 041433 351 ----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG- 419 (470)
Q Consensus 351 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 419 (470)
.....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 13456778899999999999999999988 9999999999999999999999999998765432221
Q ss_pred -cccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 420 -NTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 420 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......||+.|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 223356899999999999999999999999999999999988887543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-38 Score=299.02 Aligned_cols=187 Identities=30% Similarity=0.447 Sum_probs=157.7
Q ss_pred HhhcCCCccccccccCceeEEEEEc------CCCcEEEEEEccCcC-ccCHHHHHHHHHHHhcC-CCCCccceeeEeeeC
Q 041433 278 VATNKFSTDNKLGAGGFGEVYKGVL------PSGREIAVKRLSKSS-GQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLED 349 (470)
Q Consensus 278 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 349 (470)
...++|++.++||+|+||.||+|++ .+++.||||+++... ......|.+|+.+++++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4457899999999999999999973 356789999997653 33455789999999999 699999999998653
Q ss_pred CC------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 041433 350 PE------------------------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNI 393 (470)
Q Consensus 350 ~~------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 393 (470)
.. ....+++..+..++.||+.||.|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 31 1236899999999999999999999998 99999999999
Q ss_pred eeCCCCceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 041433 394 LLDAEMNPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFY 467 (470)
Q Consensus 394 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ellt-G~~P~~~~ 467 (470)
|++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+| |++||...
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999999999999997765444444455678999999999999999999999999999999999 55656543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-37 Score=291.87 Aligned_cols=183 Identities=19% Similarity=0.290 Sum_probs=153.8
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCC-CCccceeeEeeeCC-------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQH-RNLVRLLGFCLEDP------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~------- 350 (470)
.++|++.++||+|+||+||+|+. .+|+.||||+++.... .+.+.+|++.++.++| +|++.++++..+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57899999999999999999994 5789999999865432 2356789999999975 89999888765533
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEEeecCCceeccC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDA-----EMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 13457899999999999999999999998 999999999999964 56899999999997653
Q ss_pred CCCc-----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQ-----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.... .......||+.|||||++.+..++.++||||||+++|||+||+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 3221 1233467999999999999999999999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=300.84 Aligned_cols=180 Identities=27% Similarity=0.430 Sum_probs=149.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC-----
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE----- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 351 (470)
.++|+++++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++.....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999994 579999999997542 2334678899999999999999999998765431
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 352 -----------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 352 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
+...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 1356899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 2 234578999999999876 45689999999999999999999999754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-37 Score=292.46 Aligned_cols=184 Identities=22% Similarity=0.336 Sum_probs=152.7
Q ss_pred hcCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 350 (470)
.++|++.++||+|+||.||+|+. .+++.||||++...... +++.+|+++++.++|+|++..+..+..+.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 36799999999999999999994 57899999998654332 45788999999999888777665543322
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEeecCCceeccCCC
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLD---AEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~ 416 (470)
.....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 13567999999999999999999999998 99999999999985 45579999999999875433
Q ss_pred Cc-----ccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 417 TQ-----GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 417 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.. .......||+.|||||.+.+..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 22 12334579999999999999999999999999999999999999997643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=296.59 Aligned_cols=185 Identities=26% Similarity=0.351 Sum_probs=146.6
Q ss_pred hcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC--------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE-------- 351 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------- 351 (470)
.++|.+.++||+|+||.||+|++ +|+.||||+++.... .....+.|+..+.+++||||+++++++.+...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35678889999999999999997 689999999864422 12223445556677899999999999876431
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 -------------KQGQLDWSRRYKIIGLIARGILYLHED-----SRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....++|.+++.++.|++.||.|||+. +.++|+||||||+||||+.++.+||+|||+++...
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 134689999999999999999999974 12459999999999999999999999999998775
Q ss_pred CCCCcc--cccccccccCcccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 041433 414 VDQTQG--NTSRIAGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSSF 466 (470)
Q Consensus 414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~elltG~~P~~~ 466 (470)
...... ......||+.|+|||++.+. .++.++|||||||+||||+||..||..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 433221 23346799999999988654 257889999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=296.93 Aligned_cols=176 Identities=28% Similarity=0.405 Sum_probs=148.9
Q ss_pred CCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC----------
Q 041433 282 KFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP---------- 350 (470)
Q Consensus 282 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---------- 350 (470)
+|+..++||+|+||+||+|+. .+|+.||||++.+.... +.+|+++|++++||||+++++++....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999995 57999999999665332 347999999999999999998874321
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceec
Q 041433 351 -----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIF 412 (470)
Q Consensus 351 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~ 412 (470)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 12456899999999999999999999988 99999999999999775 8999999999876
Q ss_pred cCCCCcccccccccccCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 413 GVDQTQGNTSRIAGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 413 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 43322 233578999999998765 57899999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=287.38 Aligned_cols=180 Identities=25% Similarity=0.421 Sum_probs=154.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCC-------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 350 (470)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+|++++||||+++++++....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999994 678999999986543 234578899999999999999999999886644
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCcc
Q 041433 351 -----------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQG 419 (470)
Q Consensus 351 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 419 (470)
.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 23567899999999999999999999988 99999999999999999999999999987654332
Q ss_pred cccccccccCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 041433 420 NTSRIAGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSS 465 (470)
Q Consensus 420 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~elltG~~P~~ 465 (470)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 223345678899999887654 6899999999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-37 Score=291.89 Aligned_cols=180 Identities=31% Similarity=0.471 Sum_probs=147.9
Q ss_pred cCCCccccccccCceeEEEEEcC-CCc--EEEEEEccCc-CccCHHHHHHHHHHHhcC-CCCCccceeeEeeeCC-----
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVLP-SGR--EIAVKRLSKS-SGQGAEEFKNEVVVVAKL-QHRNLVRLLGFCLEDP----- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----- 350 (470)
++|++.++||+|+||.||+|++. ++. .||||+++.. .....+.|.+|+++|+++ +|||||++++++.+..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67889999999999999999953 444 5788887544 344566899999999999 7999999999987643
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 041433 351 -----------------------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNP 401 (470)
Q Consensus 351 -----------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 401 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 12367899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 041433 402 KISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KNSSF 466 (470)
Q Consensus 402 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~-~P~~~ 466 (470)
||+|||+++...... ......||..|+|||.+.++.++.++||||||+++|||++|. +||..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 999999998643222 223346899999999999999999999999999999999976 46754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-36 Score=289.35 Aligned_cols=179 Identities=21% Similarity=0.340 Sum_probs=152.6
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC--------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP-------- 350 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-------- 350 (470)
++|+++++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ ||||+++++++....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999994 57999999998643 3567899999999995 999999999876432
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEeecCCceeccCCCCccc
Q 041433 351 ---------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEM-NPKISDFGMAKIFGVDQTQGN 420 (470)
Q Consensus 351 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~ 420 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--- 185 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--- 185 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc---
Confidence 12357899999999999999999999998 99999999999998655 699999999987653322
Q ss_pred ccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 041433 421 TSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 468 (470)
Q Consensus 421 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~~ 468 (470)
.....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||....
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 3345689999999998765 57999999999999999999999997544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-36 Score=289.56 Aligned_cols=183 Identities=29% Similarity=0.427 Sum_probs=151.7
Q ss_pred cCCCccccccccCceeEEEEEc----CCCcEEEEEEccCc----CccCHHHHHHHHHHHhcCCC-CCccceeeEeeeCCC
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL----PSGREIAVKRLSKS----SGQGAEEFKNEVVVVAKLQH-RNLVRLLGFCLEDPE 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~ 351 (470)
++|++.++||+|+||+||+|+. .+|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999983 25889999998653 22345678899999999976 899999988765431
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceecc
Q 041433 352 ------------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFG 413 (470)
Q Consensus 352 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 413 (470)
....+.+.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 2346778888999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 414 VDQTQGNTSRIAGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 414 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
..... ......|++.|++||.+.+. .++.++|||||||+||||++|+.||...
T Consensus 181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 33322 23345789999999998754 4678999999999999999999999654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-35 Score=288.19 Aligned_cols=181 Identities=28% Similarity=0.374 Sum_probs=146.7
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcC--ccCHHHHHHHHHHHhcCCCCCccceeeEeeeCCC------
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSS--GQGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDPE------ 351 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 351 (470)
++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.++++++||||+++++++.....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999994 579999999997543 3334568899999999999999999998754321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCC
Q 041433 352 ---------------KQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQ 416 (470)
Q Consensus 352 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 416 (470)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccccc
Confidence 1356899999999999999999999998 9999999999999999999999999988654322
Q ss_pred CcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 417 TQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 417 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 174 ---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 233457899999999999999999999999999999999999999643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=289.40 Aligned_cols=180 Identities=28% Similarity=0.431 Sum_probs=150.2
Q ss_pred hcCCCccccccccCceeEEEEE-cCCCcEEEEEEccCcCc--cCHHHHHHHHHHHhcCCCCCccceeeEeeeCC------
Q 041433 280 TNKFSTDNKLGAGGFGEVYKGV-LPSGREIAVKRLSKSSG--QGAEEFKNEVVVVAKLQHRNLVRLLGFCLEDP------ 350 (470)
Q Consensus 280 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 350 (470)
.++|++.++||+|+||+||+|+ ..+|+.||||++++... ...+.+.+|+++|++++|||||++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999 46799999999975532 33457889999999999999999998875321
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccC
Q 041433 351 ----------------EKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGV 414 (470)
Q Consensus 351 ----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 414 (470)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 12457999999999999999999999998 99999999999999999999999999975432
Q ss_pred CCCcccccccccccCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 415 DQTQGNTSRIAGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...
T Consensus 174 -----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 174 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 22345689999999987665 5689999999999999999999999653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=7.3e-33 Score=271.09 Aligned_cols=178 Identities=22% Similarity=0.313 Sum_probs=147.2
Q ss_pred cCCCccccccccCceeEEEEEc-CCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-----------CCCccceeeEeee
Q 041433 281 NKFSTDNKLGAGGFGEVYKGVL-PSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-----------HRNLVRLLGFCLE 348 (470)
Q Consensus 281 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~ 348 (470)
++|+++++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999994 579999999996543 23467788999988875 4778888877643
Q ss_pred CC-----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCC-----
Q 041433 349 DP-----------------------EKQGQLDWSRRYKIIGLIARGILYLHE-DSRLRIIHRDLKVSNILLDAEM----- 399 (470)
Q Consensus 349 ~~-----------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~----- 399 (470)
.. .....+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 21 245678899999999999999999998 55 99999999999997655
Q ss_pred -ceEEeecCCceeccCCCCcccccccccccCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 041433 400 -NPKISDFGMAKIFGVDQTQGNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 467 (470)
Q Consensus 400 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~elltG~~P~~~~ 467 (470)
.+||+|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3899999999865322 23457899999999999999999999999999999999999998743
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=4e-23 Score=182.48 Aligned_cols=162 Identities=17% Similarity=0.158 Sum_probs=111.9
Q ss_pred CccccccccCceeEEEEEcCCCcEEEEEEccCcCcc------------------CHHHHHHHHHHHhcCCCCCccceeeE
Q 041433 284 STDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQ------------------GAEEFKNEVVVVAKLQHRNLVRLLGF 345 (470)
Q Consensus 284 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~Ei~~l~~l~h~niv~l~~~ 345 (470)
.+.++||+|+||+||+|+..+|+.||||+++..... ......+|...+.++.|.++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999888999999987532110 01234568889999999999987754
Q ss_pred ee-----e--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEeecCCceeccCCCCc
Q 041433 346 CL-----E--DPEKQGQLDWSRRYKIIGLIARGILYLHEDSRLRIIHRDLKVSNILLDAEMNPKISDFGMAKIFGVDQTQ 418 (470)
Q Consensus 346 ~~-----~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 418 (470)
.. + +......++......++.|++.+|.|||+++ |+||||||+|||++++ .++|+|||++.....+...
T Consensus 83 ~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~ 158 (191)
T d1zara2 83 EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR 158 (191)
T ss_dssp ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH
T ss_pred cCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH
Confidence 21 1 1112233556667789999999999999998 9999999999999865 4899999999865422211
Q ss_pred ccccccccccCcccccccccCCCCchhhHHHHHHHH
Q 041433 419 GNTSRIAGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 454 (470)
Q Consensus 419 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl 454 (470)
........ . -.| ...+.|+.++|+||+.--+
T Consensus 159 ~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 159 EILERDVR---N-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred HHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHH
Confidence 10000000 0 001 1235678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.78 E-value=3.4e-05 Score=68.98 Aligned_cols=136 Identities=21% Similarity=0.161 Sum_probs=85.0
Q ss_pred HHHHhhcCCCccccccccCceeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC-CCCccceeeEeeeCC---
Q 041433 275 AIKVATNKFSTDNKLGAGGFGEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ-HRNLVRLLGFCLEDP--- 350 (470)
Q Consensus 275 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--- 350 (470)
+++..-..|+..+..+-++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556777777655555678999875 56678889886655445556788888877764 322455655443321
Q ss_pred -----CCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 041433 351 -----EKQG-----QLDWSRRYKIIGLIARGILYLHEDS----------------------------------------- 379 (470)
Q Consensus 351 -----~~~~-----~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 379 (470)
.... ..+......++.++++.|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred EEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 0000 0111222345555666666666421
Q ss_pred ---------------CCCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 380 ---------------RLRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 380 ---------------~~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
...++|+|+.|.|||+++++..-|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999998876677999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0032 Score=57.76 Aligned_cols=40 Identities=20% Similarity=0.133 Sum_probs=31.8
Q ss_pred eeEEEEEcCCCcEEEEEEccCcCccCHHHHHHHHHHHhcCC
Q 041433 295 GEVYKGVLPSGREIAVKRLSKSSGQGAEEFKNEVVVVAKLQ 335 (470)
Q Consensus 295 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~ 335 (470)
-.||++..++|+.+++|+.+.. ....+++..|...+..|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLV 75 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHH
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHH
Confidence 4799999989999999998654 234577888988887774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.55 E-value=0.0047 Score=54.05 Aligned_cols=29 Identities=21% Similarity=0.320 Sum_probs=25.8
Q ss_pred eEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 383 IIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 383 ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
++|+|+.|.|||++++..+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999998876678999998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.34 E-value=0.0019 Score=58.93 Aligned_cols=31 Identities=26% Similarity=0.283 Sum_probs=27.4
Q ss_pred CCeEeecCCCCCeeeCCCCceEEeecCCcee
Q 041433 381 LRIIHRDLKVSNILLDAEMNPKISDFGMAKI 411 (470)
Q Consensus 381 ~~ivH~dlkp~Nill~~~~~~kl~DfG~a~~ 411 (470)
.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4599999999999999887778999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.98 E-value=0.0061 Score=57.37 Aligned_cols=60 Identities=12% Similarity=0.096 Sum_probs=36.6
Q ss_pred cccccccCceeEEEEEcC-CCcEEEEEEccCc-------CccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 041433 286 DNKLGAGGFGEVYKGVLP-SGREIAVKRLSKS-------SGQGAEEFKNEVVVVAKLQ---HRNLVRLLGF 345 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~ 345 (470)
.+.||.|....||+.... +++.++||.-... .....++...|.+.|+.+. ...+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 356899999999999864 4678999974321 1123345566777776652 2345555544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.44 E-value=0.047 Score=50.99 Aligned_cols=59 Identities=15% Similarity=0.238 Sum_probs=39.1
Q ss_pred cccccccCceeEEEEEcCC--------CcEEEEEEccCcCccCHHHHHHHHHHHhcCCCCCc-cceeeEe
Q 041433 286 DNKLGAGGFGEVYKGVLPS--------GREIAVKRLSKSSGQGAEEFKNEVVVVAKLQHRNL-VRLLGFC 346 (470)
Q Consensus 286 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~ 346 (470)
++.|+.|-.-.+|+...++ .+.|.+++... ........+|..+++.+.-.++ .++++++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3568888888999988543 35688887653 2334456789888888753344 4566554
|